Citrus Sinensis ID: 001370
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1091 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.300 | 0.156 | 0.525 | 1e-102 | |
| Q60592 | 1734 | Microtubule-associated se | yes | no | 0.296 | 0.186 | 0.473 | 4e-85 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | no | 0.285 | 0.172 | 0.480 | 6e-85 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.278 | 0.205 | 0.481 | 3e-83 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.278 | 0.230 | 0.484 | 7e-83 | |
| O15021 | 2626 | Microtubule-associated se | no | no | 0.278 | 0.115 | 0.471 | 1e-82 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.329 | 0.228 | 0.433 | 2e-82 | |
| Q811L6 | 2618 | Microtubule-associated se | no | no | 0.296 | 0.123 | 0.462 | 2e-82 | |
| O60307 | 1309 | Microtubule-associated se | no | no | 0.278 | 0.232 | 0.481 | 4e-82 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.319 | 0.222 | 0.436 | 6e-82 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 372 bits (956), Expect = e-102, Method: Compositional matrix adjust.
Identities = 197/375 (52%), Positives = 241/375 (64%), Gaps = 47/375 (12%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
I DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ ERNIL V+
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVERNILAMVQ 1583
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE VL LEYLH
Sbjct: 1584 NEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLHK 1643
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI-------------NNTIDLSGPETDG 851
IVHRDLKPDN+LI GHIKLTDFGLSKIG+I N + S T+
Sbjct: 1644 SAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDDKKMEDSGNTNTNTHFNFSTSPTNT 1703
Query: 852 IMPSDAH-----------------------YPEYQQT----DNRNRHSAVGTPDYLAPEI 884
M D+ YP+ + T + VGTPDYL+PEI
Sbjct: 1704 SMMDDSSTTGNPNGNGNTSLNSSQTNILSPYPQRKNTLKTPLKKPVKKVVGTPDYLSPEI 1763
Query: 885 LLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL--NRKIPWPCVPSDMSFE 942
LLGT HG DWW++GIIL+EF+TG PPF ++PE+IF +IL +R++ W P ++S E
Sbjct: 1764 LLGTGHGQTVDWWALGIILYEFLTGSPPFNDDTPELIFQHILHRDREMEW---PEEISSE 1820
Query: 943 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA--VFVPQPESVDDTSY 1000
A+DLI + L DP +RLGANGA EVK HPFF VNWD+L Q+ +F+P+PE+ DT Y
Sbjct: 1821 AKDLILKLLNPDPYKRLGANGAYEVKTHPFFANVNWDTLIDQEMDNIFLPKPENNYDTDY 1880
Query: 1001 FLSRFSQISSGLPDD 1015
F R S DD
Sbjct: 1881 FWDRQSMYDDEAEDD 1895
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (812), Expect = 4e-85, Method: Compositional matrix adjust.
Identities = 163/344 (47%), Positives = 219/344 (63%), Gaps = 21/344 (6%)
Query: 663 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 722
DSV + GVS P + E +DFE IK IS GA+G VFL R ++T FA+K + K
Sbjct: 433 DSV-EGRGVSQPSQKTPSE----EDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQ 487
Query: 723 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 782
++I +N I++ ER+IL NPFVV F SF + +L +VMEY+ GGD +LL+ +G
Sbjct: 488 NLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA 547
Query: 783 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842
L D+ R+Y AE VLALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T
Sbjct: 548 LPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 607
Query: 843 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 900
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 608 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 653
Query: 901 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 960
IIL+EF+ G PF ++PE +F +++ +I WP + +AQDL ++ L +P +RLG
Sbjct: 654 IILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNPLERLG 713
Query: 961 ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 1004
+ A EVK HPFF G++W L QKA F+PQ ES DDTSYF +R
Sbjct: 714 TSSAYEVKQHPFFMGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 757
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 6e-85, Method: Compositional matrix adjust.
Identities = 157/327 (48%), Positives = 211/327 (64%), Gaps = 16/327 (4%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 739
K+ S +DFE IK IS GA+G VFL R ++T FA+K + K ++I +N I++ ER+I
Sbjct: 504 KKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDI 563
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
L NPFVV F SF + +L +VMEY+ GGD +LL+ +G L D+ R+Y AE VLAL
Sbjct: 564 LTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLAL 623
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
EYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L Y
Sbjct: 624 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL--------------Y 669
Query: 860 PEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917
+ + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++
Sbjct: 670 EGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 729
Query: 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
PE +F +++ +I WP + +AQDL ++ L +P +RLG A EVK HPFF G++
Sbjct: 730 PEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGLD 789
Query: 978 WDSLALQKAVFVPQPESVDDTSYFLSR 1004
W L QKA F+PQ ES DDTSYF +R
Sbjct: 790 WTGLLRQKAEFIPQLESEDDTSYFDTR 816
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 154/320 (48%), Positives = 205/320 (64%), Gaps = 16/320 (5%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
DFE IK IS GA+G V+L R + T FA+K + K ++I +N I ++ ER+IL NP
Sbjct: 398 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIHQVFVERDILTFAENP 457
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
FVV F SF R +L +VMEY+ GGD +LL+ +G L D++R+Y AE VLALEYLH+ G
Sbjct: 458 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVLALEYLHNYG 517
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
IVHRDLKPDNLLI GHIKLTDFGLSK+GL+N T +L Y + + D
Sbjct: 518 IVHRDLKPDNLLITSLGHIKLTDFGLSKVGLMNMTTNL--------------YEGHIEKD 563
Query: 867 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 564 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 623
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 984
+++ I WP + ++QDLI R L + +RLG GA EVK H FF ++W+ L Q
Sbjct: 624 VISDDIIWPGGEEALPADSQDLITRLLRQNSLERLGTGGAQEVKQHTFFLSLDWNGLLRQ 683
Query: 985 KAVFVPQPESVDDTSYFLSR 1004
KA FVPQ E+ DDTSYF +R
Sbjct: 684 KAEFVPQLEADDDTSYFDTR 703
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 7e-83, Method: Compositional matrix adjust.
Identities = 155/320 (48%), Positives = 202/320 (63%), Gaps = 16/320 (5%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 388 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 447
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 448 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 507
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 508 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 553
Query: 867 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
R GTP+Y+APE++ +G DWW++G+IL+EF+ G PF ++PE +F
Sbjct: 554 AREFVDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPFFGDTPEELFGQ 613
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 984
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 614 VVSDEIMWPEGDEALPLDAQDLITRLLRQSPMDRLGTGGTHEVKQHPFFLALDWAGLLRH 673
Query: 985 KAVFVPQPESVDDTSYFLSR 1004
KA FVPQ E+ DDTSYF +R
Sbjct: 674 KAEFVPQLEAEDDTSYFDTR 693
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 151/320 (47%), Positives = 206/320 (64%), Gaps = 16/320 (5%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
DFE IK IS GA+G V+ R + + FA+K + K ++I +N I++ ER+IL NP
Sbjct: 572 DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 631
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
FVV + SF R +L +VMEY+ GGD +L++ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 632 FVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYG 691
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
IVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T +L Y + + D
Sbjct: 692 IVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNL--------------YEGHIEKD 737
Query: 867 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 738 AREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 797
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 984
+++ +I WP +AQDLI L +P +RLG GA EVK H FF+ ++W+SL Q
Sbjct: 798 VISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQ 857
Query: 985 KAVFVPQPESVDDTSYFLSR 1004
KA F+PQ ES DDTSYF +R
Sbjct: 858 KAEFIPQLESEDDTSYFDTR 877
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 169/390 (43%), Positives = 230/390 (58%), Gaps = 31/390 (7%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
S K+ +DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ E
Sbjct: 363 SKAKKPPGENDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVE 422
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
R+IL NPFVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE V
Sbjct: 423 RDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETV 482
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
LALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L
Sbjct: 483 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL------------ 530
Query: 857 AHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914
Y + + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF
Sbjct: 531 --YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 588
Query: 915 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
++PE +F +++ I WP + EAQ LI+ L +P RLGA GA EVK H FF+
Sbjct: 589 GDTPEELFGQVISDDILWPEGDEALPTEAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFR 648
Query: 975 GVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRT 1034
++W L QKA F+P ES DDTSYF +R + SY + DT +
Sbjct: 649 DLDWTGLLRQKAEFIPHLESEDDTSYFDTRSDRY------HHVNSYDEDDTTE------- 695
Query: 1035 EMDECGDLAEFGSCPLDLSLINFSFKNLSQ 1064
+E ++ +F SC S + S + LSQ
Sbjct: 696 --EEPVEIRQFSSCSPRFSKVYSSMEQLSQ 723
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 159/344 (46%), Positives = 217/344 (63%), Gaps = 21/344 (6%)
Query: 663 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 722
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K + K
Sbjct: 548 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 602
Query: 723 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 782
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 603 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 662
Query: 783 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 663 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 722
Query: 843 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 900
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 723 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 768
Query: 901 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 960
IIL+EF+ G PF ++PE +F +++ +I WP +AQ+LI L +P +RLG
Sbjct: 769 IILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQELITLLLRQNPLERLG 828
Query: 961 ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 1004
GA EVK H FF+ ++W+SL QKA F+PQ ES DDTSYF +R
Sbjct: 829 TGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 872
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60307|MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 154/320 (48%), Positives = 202/320 (63%), Gaps = 16/320 (5%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 366 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 425
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 426 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARLYFAETVLALEYLHNYG 485
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 486 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 531
Query: 867 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
R GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F
Sbjct: 532 AREFIDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQ 591
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 984
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 592 VVSDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFLALDWAGLLRH 651
Query: 985 KAVFVPQPESVDDTSYFLSR 1004
KA FVPQ E+ DDTSYF +R
Sbjct: 652 KAEFVPQLEAEDDTSYFDTR 671
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 6e-82, Method: Compositional matrix adjust.
Identities = 166/380 (43%), Positives = 226/380 (59%), Gaps = 31/380 (8%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ ER+IL NP
Sbjct: 375 DFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 434
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
FVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE VLALEYLH+ G
Sbjct: 435 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNYG 494
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
IVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L Y + + D
Sbjct: 495 IVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL--------------YEGHIEKD 540
Query: 867 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 541 AREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 600
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 984
+++ I WP + +AQ LI+ L +P RLGA GA EVK H FF+ ++W L Q
Sbjct: 601 VISDDILWPEGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTGLLRQ 660
Query: 985 KAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAE 1044
KA F+P ES DDTSYF +R + SY + DT + +E ++ +
Sbjct: 661 KAEFIPHLESEDDTSYFDTRSDRY------HHVNSYDEDDTTE---------EEPVEIRQ 705
Query: 1045 FGSCPLDLSLINFSFKNLSQ 1064
F SC S + S + LSQ
Sbjct: 706 FSSCSPRFSKVYSSMEQLSQ 725
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1091 | ||||||
| 359492673 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.983 | 0.967 | 0.699 | 0.0 | |
| 255538590 | 1106 | kinase, putative [Ricinus communis] gi|2 | 0.938 | 0.925 | 0.709 | 0.0 | |
| 145324180 | 1067 | protein kinase-like protein [Arabidopsis | 0.963 | 0.985 | 0.582 | 0.0 | |
| 7767670 | 1092 | F27F5.23 [Arabidopsis thaliana] | 0.963 | 0.962 | 0.570 | 0.0 | |
| 297852258 | 1101 | predicted protein [Arabidopsis lyrata su | 0.957 | 0.949 | 0.562 | 0.0 | |
| 145336472 | 1042 | protein kinase-like protein [Arabidopsis | 0.912 | 0.955 | 0.584 | 0.0 | |
| 110740013 | 1042 | similar to IRE homolog 1 [Arabidopsis th | 0.912 | 0.955 | 0.583 | 0.0 | |
| 302142471 | 948 | unnamed protein product [Vitis vinifera] | 0.627 | 0.722 | 0.761 | 0.0 | |
| 168060390 | 1073 | predicted protein [Physcomitrella patens | 0.868 | 0.882 | 0.470 | 0.0 | |
| 356529485 | 1395 | PREDICTED: uncharacterized protein LOC10 | 0.857 | 0.670 | 0.486 | 0.0 |
| >gi|359492673|ref|XP_002282958.2| PREDICTED: uncharacterized protein LOC100259179 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1473 bits (3813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 770/1101 (69%), Positives = 867/1101 (78%), Gaps = 28/1101 (2%)
Query: 12 GIPSGLNRIKTRGGVSKP---------DELTESRSYGVSRPPQKHKQKTVAQGHVKLANS 62
GIP+GLNRIKTR SK D+ ESR G+SRPP K +GH K A S
Sbjct: 16 GIPTGLNRIKTRRESSKDQLNWKPDDDDKFHESRPRGISRPPANQKHN---KGHAKFAGS 72
Query: 63 FTEVRKGKKIAQWFTSYISK-----FNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNHL 117
KGKKIA+WFTS++SK F+ V P ++S S+ K D E RTK EG HL
Sbjct: 73 IEGFHKGKKIARWFTSHLSKDSSQGFDDVPPKVQDSNSKVKAPDKEGSTRTKQWKEGKHL 132
Query: 118 NEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAK 177
KQS E +SS KV KGLKSFSHELGPKGGIP S+PRAHSYNDLKELL +LHSRFDAAK
Sbjct: 133 TGKQSSPEGLSSIKVPKGLKSFSHELGPKGGIPPSHPRAHSYNDLKELLGSLHSRFDAAK 192
Query: 178 EVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQD 237
EVVN EL++ D+M+ L++ DS S G++M E LLILAQQC+EMT FR CETIVQ
Sbjct: 193 EVVNVELSSLTGDIMDALQRNDS--SPGQKMAEGLLILAQQCMEMTPSEFRIKCETIVQG 250
Query: 238 LTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVET 297
LTEKRQ CQ +KWL TRMLFILTRCTRLL FQK+SEPI EKSLH F KCLES+PAVE
Sbjct: 251 LTEKRQHCQTAFLKWLFTRMLFILTRCTRLLRFQKDSEPIDEKSLHNFTKCLESIPAVEM 310
Query: 298 SWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKSV 354
+W P +S DY S K++AK ++ + +VS++ E + C E D TS S+
Sbjct: 311 NWAPYSRIVDSGSDYDSNGKSDAKHELQWRNRVSSLLEQTWCRSEEPADKSGITSRKDSM 370
Query: 355 FIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEE 414
+ Q Q SQ +Q G+ + + GS HE + LDGSDSVICRICEE
Sbjct: 371 VLVQKPLSQNSQIDFLPHIEQDGDYPGKSMNSFED--GSLHEPERGLDGSDSVICRICEE 428
Query: 415 VVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSR 474
VP SHLESHSYICAYADKC+L LD+DERL KL+EILEQI ES N + SPENSR
Sbjct: 429 NVPTSHLESHSYICAYADKCDLKYLDIDERLSKLAEILEQIIESRNLNFQASFCSPENSR 488
Query: 475 TQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKLS 533
Q NSA+ +G SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KLS
Sbjct: 489 MQITNSAVISEGCSPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKLS 548
Query: 534 GYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFS 593
YGA SSTGSMTS+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD S
Sbjct: 549 QYGAPSSTGSMTSMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDLS 608
Query: 594 KEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFS 652
KEGS +FLLACM DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S +
Sbjct: 609 KEGSCDFLLACMEDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSDN 668
Query: 653 KYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD 712
+ KE+SRL+ D+ S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTGD
Sbjct: 669 RIKESSRLLFDNASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTGD 728
Query: 713 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 772
LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGGD
Sbjct: 729 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGGD 788
Query: 773 LYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 832
LYSLLRK+GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFGL
Sbjct: 789 LYSLLRKLGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFGL 848
Query: 833 SKIGLINNTIDLSGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 890
SKIGLIN+T+DLSGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTEH
Sbjct: 849 SKIGLINSTVDLSGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTEH 908
Query: 891 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 950
GYAADWWSVGIILFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINRF
Sbjct: 909 GYAADWWSVGIILFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINRF 968
Query: 951 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1010
LIHDP+ RLGANG +EVK HPFFKGVNWD+LALQKAVFVPQP+S DDTSYF+SR+SQI S
Sbjct: 969 LIHDPDLRLGANGLSEVKTHPFFKGVNWDTLALQKAVFVPQPDSADDTSYFVSRYSQIPS 1028
Query: 1011 GLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINH 1070
GLPD+Q+ S S D+ D SNS EMDECGDLAEF S PL+LSLINFSFKNLSQLASIN+
Sbjct: 1029 GLPDEQDCSDSATDSSDLYSNSGLEMDECGDLAEFDSSPLNLSLINFSFKNLSQLASINY 1088
Query: 1071 EVLVQNVKDSTRSSPAKDAGT 1091
+VL+Q KD T+ SP+K T
Sbjct: 1089 DVLLQTGKDPTKCSPSKSRDT 1109
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538590|ref|XP_002510360.1| kinase, putative [Ricinus communis] gi|223551061|gb|EEF52547.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1468 bits (3801), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/1047 (70%), Positives = 841/1047 (80%), Gaps = 23/1047 (2%)
Query: 62 SFTEVRKGKKIAQWFTSYISKFNI-----VSPNTENSGSEDKDVDVEDPRRTKLRHEGNH 116
+ E KGKKI +W SY SK VS N E E K +D + RR K + NH
Sbjct: 58 NLKEFHKGKKITRWLASYFSKGTSQVTADVSSNIEKRSLEHKTLDKFEQRRIKFVNGENH 117
Query: 117 LNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAA 176
L+ Q E +S SK SKGLKSFSHELGP+GGIP + PRAHSY+DLKELL + HSRFDAA
Sbjct: 118 LDGNQPSVEILSQSKASKGLKSFSHELGPRGGIPPAQPRAHSYSDLKELLGSFHSRFDAA 177
Query: 177 KEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQ 236
KEVVN+ELA+FA+D M+VLE +DS E +M EDLLILAQ C+EM FR CE IVQ
Sbjct: 178 KEVVNAELASFARDAMDVLEIIDSSLQEELKMAEDLLILAQLCMEMACSQFRLKCEIIVQ 237
Query: 237 DLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVE 296
DLTEKR QCQ GLVKWL TRMLFILTRCTRLL FQK++EPI EKSL K KKCLESVP+V+
Sbjct: 238 DLTEKRLQCQTGLVKWLYTRMLFILTRCTRLLQFQKDTEPIDEKSLRKLKKCLESVPSVD 297
Query: 297 TSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKS 353
SWV + ++DLD A QK + K+K+ GQ +S++PE C ES D TS S
Sbjct: 298 MSWVANHVIDDTDLDDALNQKGDIKRKLQGQNNLSSLPEAVCCGSQESDDQSGVTSGKDS 357
Query: 354 VFIEQNFPPQKSQHYSRMQEQQ------------SHIVEGRIVEVTKSNCGSPHEQGQSL 401
+ EQ QKS++ S + +Q + + + K S EQ + L
Sbjct: 358 LDFEQKLSCQKSRNESLFEVRQFCETDKSAISNSVNNSSCSLHDQEKFLDDSLQEQERVL 417
Query: 402 DGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNS 461
DGSD VICRICEE+VPISHLESHSYICAYADKC+LNCLDVDERL L+E+LEQI ES N
Sbjct: 418 DGSDLVICRICEEIVPISHLESHSYICAYADKCDLNCLDVDERLSNLAEMLEQIVESRNM 477
Query: 462 SSHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS 521
+ H GSPENSR Q+ NSA T + SPKISEWRNKGVEGMFEDIHEMDTA IDDSHL
Sbjct: 478 NVHQSHGSPENSRPQNANSATT-EACSPKISEWRNKGVEGMFEDIHEMDTAFIDDSHLPP 536
Query: 522 LNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELA 581
+NL+GHLG+KL YGA SSTGSMTS+SSTNTPKAGHFD FWLE N+P+ELEDV QMI LA
Sbjct: 537 VNLKGHLGMKLCNYGAPSSTGSMTSLSSTNTPKAGHFDSFWLEHNNPSELEDVPQMINLA 596
Query: 582 DIARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILAC 640
DIAR VA+TD SKEGS EFLLACM DLQDVLQHSKLKALVIDTFG RIEKLLREKY+LAC
Sbjct: 597 DIARSVANTDLSKEGSYEFLLACMQDLQDVLQHSKLKALVIDTFGGRIEKLLREKYLLAC 656
Query: 641 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 700
++ D KSP S SK KENSRL+LD+ SQSS +STP+HSSHKERTSIDDFEIIKPISRGAFG
Sbjct: 657 DITDAKSPKSDSKLKENSRLLLDNASQSSAMSTPVHSSHKERTSIDDFEIIKPISRGAFG 716
Query: 701 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760
+VFLARKR TGDLFAIKVLKKLDM+RKND++RILAERNILITVRNPFVVRFFYSFTCRDN
Sbjct: 717 KVFLARKRITGDLFAIKVLKKLDMLRKNDVQRILAERNILITVRNPFVVRFFYSFTCRDN 776
Query: 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA 820
LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIA
Sbjct: 777 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIA 836
Query: 821 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 880
HDGHIKLTDFGLSKIGLIN+T+DL+GPET+ SDAH P + QT+ NR SAVGTPDYL
Sbjct: 837 HDGHIKLTDFGLSKIGLINSTMDLAGPETNEDEVSDAHNP-HIQTEETNRQSAVGTPDYL 895
Query: 881 APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMS 940
APEILLGTEHGYAADWWSVGIILFE ITGIPPFTAE PEIIFDNILNRKIPWP VP MS
Sbjct: 896 APEILLGTEHGYAADWWSVGIILFELITGIPPFTAERPEIIFDNILNRKIPWPPVPESMS 955
Query: 941 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSY 1000
+EAQDLINR + +DP+QRLG+NG+AEVK++PFF+G++WD+LALQKAVFVP P+S DDTSY
Sbjct: 956 YEAQDLINRLITYDPDQRLGSNGSAEVKSYPFFRGIDWDNLALQKAVFVPSPDSADDTSY 1015
Query: 1001 FLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFK 1060
F+SRFSQ+SSG+P+D + S+SD D DSS NS EMDECGDLAEF S PL+LSLINFSFK
Sbjct: 1016 FVSRFSQMSSGMPNDCSSSHSDTDAYDSSPNSGVEMDECGDLAEFDSSPLNLSLINFSFK 1075
Query: 1061 NLSQLASINHEVLVQNVKDSTRSSPAK 1087
NLSQLASINH+V +Q KDS ++SP++
Sbjct: 1076 NLSQLASINHDVYLQTGKDSAKNSPSR 1102
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145324180|ref|NP_001077679.1| protein kinase-like protein [Arabidopsis thaliana] gi|332193965|gb|AEE32086.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1191 bits (3080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 643/1103 (58%), Positives = 791/1103 (71%), Gaps = 52/1103 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNH 116
+ S + RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQERKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNSG 112
Query: 117 LNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFD 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRFD
Sbjct: 113 KDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRFD 172
Query: 175 AAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETI 234
AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+I
Sbjct: 173 VAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCESI 232
Query: 235 VQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPA 294
VQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA
Sbjct: 233 VQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPA 292
Query: 295 VETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSENK 352
+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 293 LETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAAREG 352
Query: 353 SVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRIC 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRIC
Sbjct: 353 YAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRIC 405
Query: 413 EEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPEN 472
EE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G EN
Sbjct: 406 EEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLEN 465
Query: 473 SRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKL 532
S + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 466 SVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKF 523
Query: 533 SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDF 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TDF
Sbjct: 524 CHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDF 582
Query: 593 SKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSF 651
SKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 583 SKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVGN 642
Query: 652 SKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTG 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTTG
Sbjct: 643 IKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTTG 693
Query: 712 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771
D FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNGG
Sbjct: 694 DFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNGG 753
Query: 772 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831
DLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFG
Sbjct: 754 DLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFG 813
Query: 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 891
LSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEHG
Sbjct: 814 LSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHG 873
Query: 892 YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFL 951
YAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR L
Sbjct: 874 YAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRLL 933
Query: 952 IHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSG 1011
+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S
Sbjct: 934 VHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSCS 993
Query: 1012 LPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHE 1071
+ N S S+ D+ D E+DEC +L +F S P LSLINFSFKNLSQLASINH+
Sbjct: 994 DTETGNNSGSNPDSGD-------ELDECTNLEKFDSPPYYLSLINFSFKNLSQLASINHD 1046
Query: 1072 VLVQNVKDSTRS---SPAKDAGT 1091
VL+Q KD + SP K GT
Sbjct: 1047 VLLQ--KDPAKGGGDSPFKSHGT 1067
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7767670|gb|AAF69167.1|AC007915_19 F27F5.23 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1171 bits (3030), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 643/1128 (57%), Positives = 791/1128 (70%), Gaps = 77/1128 (6%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNH 116
+ S + RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQERKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNSG 112
Query: 117 LNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFD 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRFD
Sbjct: 113 KDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRFD 172
Query: 175 AAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETI 234
AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+I
Sbjct: 173 VAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCESI 232
Query: 235 VQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPA 294
VQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA
Sbjct: 233 VQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPA 292
Query: 295 VETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSENK 352
+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 293 LETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAAREG 352
Query: 353 SVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRIC 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRIC
Sbjct: 353 YAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRIC 405
Query: 413 EEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPEN 472
EE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G EN
Sbjct: 406 EEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLEN 465
Query: 473 SRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKL 532
S + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 466 SVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKF 523
Query: 533 SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDF 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TDF
Sbjct: 524 CHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDF 582
Query: 593 SKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSF 651
SKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 583 SKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVGN 642
Query: 652 SKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTG 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTTG
Sbjct: 643 IKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTTG 693
Query: 712 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFFYSFTCRDNLY 762
D FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+ VRFFYSFTCRDNLY
Sbjct: 694 DFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLAEHLMLLMQVRFFYSFTCRDNLY 753
Query: 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 822
LVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++
Sbjct: 754 LVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYN 813
Query: 823 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 882
GHIKLTDFGLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAP
Sbjct: 814 GHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAP 873
Query: 883 EILLGTEHG----------------YAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
EILLGTEHG YAADWWS GI+LFE +TGIPPFTA PE IFDNIL
Sbjct: 874 EILLGTEHGLDTTFKSGFHEAPVNCYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNIL 933
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA 986
N K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA
Sbjct: 934 NGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKA 993
Query: 987 VFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFG 1046
FVPQPES++DTSYF+SRFS+ S + N S S+ D+ D E+DEC +L +F
Sbjct: 994 AFVPQPESINDTSYFVSRFSESSCSDTETGNNSGSNPDSGD-------ELDECTNLEKFD 1046
Query: 1047 SCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRS---SPAKDAGT 1091
S P LSLINFSFKNLSQLASINH+VL+Q KD + SP K GT
Sbjct: 1047 SPPYYLSLINFSFKNLSQLASINHDVLLQ--KDPAKGGGDSPFKSHGT 1092
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852258|ref|XP_002894010.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297339852|gb|EFH70269.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1162 bits (3006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 643/1143 (56%), Positives = 792/1143 (69%), Gaps = 98/1143 (8%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVS--KPDELTESRSYGVSRPPQKHKQKT-VAQ 54
A +N D G IPSGLNRIKTR S +P++ +++ V +PP QK V +
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGLRPEDSSDT----VVKPPFNRNQKIIVPR 57
Query: 55 GHVKLANSFTEVRKGKKIAQWFTSYISKFNIVSPN---TENSGSEDKDVDVEDPRRTKLR 111
G+ + S + RKG K+++W SY K++ P + + SED KLR
Sbjct: 58 GYGRTTGSSKQERKGTKLSRWLASYKPKYSCHPPKYACSSTTSSED----------IKLR 107
Query: 112 HEGNHLNEKQSLAEHVSSSKV----SKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLD 167
G + + + + VS + + S G+KSFSHELGP+GG+ + YPR HSYNDLKELL
Sbjct: 108 --GKNCGKDEEMIIKVSETNLPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLG 165
Query: 168 TLHSRFDAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLF 227
+LHSRFD AKE V+ +L F DV +EKMD P E +EM E+LL +A+ C+EMTS
Sbjct: 166 SLHSRFDVAKETVDKKLDVFVIDVKEAMEKMDPPCPEDREMAEELLDVARACMEMTSAQL 225
Query: 228 RANCETIVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKK 287
RA CE+IV DLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+
Sbjct: 226 RATCESIVHDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKE 285
Query: 288 CLESVPAVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH 347
CLE +PA+ET W +P +S Y YQ+ A +K ++ S E + + DH
Sbjct: 286 CLERIPALETDWGSTPRVDDSGSGYPKYQRDEAGQKFKRRETESLESETTFDYVIPN-DH 344
Query: 348 TSENKS---VFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGS 404
++ + +Q FP Q+ Q S++ +Q+ ++ + E P ++ L S
Sbjct: 345 SNNAATEGYAVAKQEFPSQEPQFDSKVVQQRFYLSD----EYEHKMLNEPVKE---LGRS 397
Query: 405 DSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSH 464
D VICRICEE VP+SHLE HSYICAYADKCE+NCLDVDERLLKL EILEQI +S + +S
Sbjct: 398 DYVICRICEEEVPLSHLEPHSYICAYADKCEINCLDVDERLLKLEEILEQIIDSRSLNSF 457
Query: 465 PILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNL 524
G ENS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ +NL
Sbjct: 458 TQAGGLENSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPINL 515
Query: 525 RGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIA 584
+ H+G K+ + SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED+Q M++L+DIA
Sbjct: 516 KSHVGAKICHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLQLMMDLSDIA 574
Query: 585 RCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELL 643
RC A TD SKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL
Sbjct: 575 RCGASTDLSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLYARELT 634
Query: 644 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVF 703
+KS K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VF
Sbjct: 635 ADKSSVGNVKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVF 685
Query: 704 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFFYS 754
LARKRTTGD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+ VRFFYS
Sbjct: 686 LARKRTTGDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLAEHLILLMQVRFFYS 745
Query: 755 FTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 814
FTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKP
Sbjct: 746 FTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKP 805
Query: 815 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 874
DNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D + +H+ + Q + R RHSAV
Sbjct: 806 DNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTGSHHFQKNQEEERIRHSAV 865
Query: 875 GTPDYLAPEILLGTEH------------------------GYAADWWSVGIILFEFITGI 910
GTPDYLAPEILLGTEH GYA+DWWSVGI+LFE ITGI
Sbjct: 866 GTPDYLAPEILLGTEHGLDTTLYLGFSEAIGNYIQLLGLAGYASDWWSVGIVLFELITGI 925
Query: 911 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970
PPFTA PEIIFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+H
Sbjct: 926 PPFTAARPEIIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSH 985
Query: 971 PFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSS 1030
PFF+GV+WD+LALQKA FVPQPES+ DTSYF+SRF + S+ + N S S D+ D
Sbjct: 986 PFFQGVDWDNLALQKAAFVPQPESIADTSYFVSRFCENSASDSETDNNSGSFPDSGD--- 1042
Query: 1031 NSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQN--VKDSTRSSPAKD 1088
E+DEC +L +F S P LSLINFSFKNLSQLASINH+VL+Q K SP K
Sbjct: 1043 ----ELDECTNLEKFDSPPYYLSLINFSFKNLSQLASINHDVLLQKDPAKGGGGDSPFKS 1098
Query: 1089 AGT 1091
GT
Sbjct: 1099 HGT 1101
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145336472|ref|NP_175130.2| protein kinase-like protein [Arabidopsis thaliana] gi|332193964|gb|AEE32085.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1135 bits (2936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/1036 (58%), Positives = 748/1036 (72%), Gaps = 40/1036 (3%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNH 116
+ S + RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQERKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNSG 112
Query: 117 LNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFD 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRFD
Sbjct: 113 KDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRFD 172
Query: 175 AAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETI 234
AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+I
Sbjct: 173 VAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCESI 232
Query: 235 VQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPA 294
VQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA
Sbjct: 233 VQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPA 292
Query: 295 VETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSENK 352
+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 293 LETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAAREG 352
Query: 353 SVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRIC 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRIC
Sbjct: 353 YAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRIC 405
Query: 413 EEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPEN 472
EE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G EN
Sbjct: 406 EEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLEN 465
Query: 473 SRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKL 532
S + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 466 SVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKF 523
Query: 533 SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDF 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TDF
Sbjct: 524 CHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDF 582
Query: 593 SKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSF 651
SKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 583 SKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVGN 642
Query: 652 SKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTG 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTTG
Sbjct: 643 IKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTTG 693
Query: 712 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771
D FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNGG
Sbjct: 694 DFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNGG 753
Query: 772 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831
DLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFG
Sbjct: 754 DLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFG 813
Query: 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 891
LSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEHG
Sbjct: 814 LSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHG 873
Query: 892 YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFL 951
YAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR L
Sbjct: 874 YAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRLL 933
Query: 952 IHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSG 1011
+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S
Sbjct: 934 VHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSCS 993
Query: 1012 LPDDQNGSYSDADTCD 1027
+ N S S+ D+ D
Sbjct: 994 DTETGNNSGSNPDSGD 1009
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110740013|dbj|BAF01910.1| similar to IRE homolog 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1132 bits (2927), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 605/1036 (58%), Positives = 747/1036 (72%), Gaps = 40/1036 (3%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNH 116
+ S + RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQERKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNSG 112
Query: 117 LNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFD 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRFD
Sbjct: 113 KDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRFD 172
Query: 175 AAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETI 234
AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+I
Sbjct: 173 VAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCESI 232
Query: 235 VQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPA 294
VQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA
Sbjct: 233 VQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPA 292
Query: 295 VETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSENK 352
+ET W +P +S Y Q+ A +K + K S E + ++ ++ +
Sbjct: 293 LETDWGSTPRVDDSGSGYPECQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAAREG 352
Query: 353 SVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRIC 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRIC
Sbjct: 353 YAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRIC 405
Query: 413 EEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPEN 472
EE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G EN
Sbjct: 406 EEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLEN 465
Query: 473 SRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKL 532
S + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 466 SVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKF 523
Query: 533 SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDF 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TDF
Sbjct: 524 CHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDF 582
Query: 593 SKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSF 651
SKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 583 SKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVGN 642
Query: 652 SKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTG 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTTG
Sbjct: 643 IKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTTG 693
Query: 712 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771
D FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNGG
Sbjct: 694 DFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNGG 753
Query: 772 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831
DLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFG
Sbjct: 754 DLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFG 813
Query: 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 891
LSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEHG
Sbjct: 814 LSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHG 873
Query: 892 YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFL 951
YAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR L
Sbjct: 874 YAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRLL 933
Query: 952 IHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSG 1011
+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S
Sbjct: 934 VHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSCS 993
Query: 1012 LPDDQNGSYSDADTCD 1027
+ N S S+ D+ D
Sbjct: 994 DTETGNNSGSNPDSGD 1009
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142471|emb|CBI19674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1076 bits (2782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 555/729 (76%), Positives = 607/729 (83%), Gaps = 44/729 (6%)
Query: 375 QSHIVEGRIVEVTKSNCGSPHEQGQSL-------DGSDSVICRICEEVVPISHLESHSYI 427
Q IV GR++ N E G L DGSDSVICRICEE VP SHLESHSYI
Sbjct: 252 QIMIVMGRVM----PNMNYSGETGYLLSLSKLGADGSDSVICRICEENVPTSHLESHSYI 307
Query: 428 CAYADKCELNCLDVDERLLKLSEILEQISES-CNSSSHPILGSPENSRTQSMNSAITYDG 486
CAYADKC+L LD+DERL KL+EILEQI ES C
Sbjct: 308 CAYADKCDLKYLDIDERLSKLAEILEQIIESRC--------------------------- 340
Query: 487 YSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKLSGYGASSSTGSMT 545
SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KLS YGA SSTGSMT
Sbjct: 341 -SPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKLSQYGAPSSTGSMT 399
Query: 546 SVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACM 604
S+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD SKEGS +FLLACM
Sbjct: 400 SMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDLSKEGSCDFLLACM 459
Query: 605 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS 664
DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S ++ KE+SRL+ D+
Sbjct: 460 EDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSDNRIKESSRLLFDN 519
Query: 665 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 724
S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTGDLFAIKVLKKLDM
Sbjct: 520 ASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTGDLFAIKVLKKLDM 579
Query: 725 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 784
IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGGDLYSLLRK+GCLE
Sbjct: 580 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGGDLYSLLRKLGCLE 639
Query: 785 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844
EDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFGLSKIGLIN+T+DL
Sbjct: 640 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFGLSKIGLINSTVDL 699
Query: 845 SGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902
SGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTEHGYAADWWSVGII
Sbjct: 700 SGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTEHGYAADWWSVGII 759
Query: 903 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962
LFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINRFLIHDP+ RLGAN
Sbjct: 760 LFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINRFLIHDPDLRLGAN 819
Query: 963 GAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSD 1022
G +EVK HPFFKGVNWD+LALQKAVFVPQP+S DDTSYF+SR+SQI SGLPD+Q+ S S
Sbjct: 820 GLSEVKTHPFFKGVNWDTLALQKAVFVPQPDSADDTSYFVSRYSQIPSGLPDEQDCSDSA 879
Query: 1023 ADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTR 1082
D+ D SNS EMDECGDLAEF S PL+LSLINFSFKNLSQLASIN++VL+Q KD T+
Sbjct: 880 TDSSDLYSNSGLEMDECGDLAEFDSSPLNLSLINFSFKNLSQLASINYDVLLQTGKDPTK 939
Query: 1083 SSPAKDAGT 1091
SP+K T
Sbjct: 940 CSPSKSRDT 948
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|168060390|ref|XP_001782179.1| predicted protein [Physcomitrella patens subsp. patens] gi|162666345|gb|EDQ53002.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2218), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/1057 (47%), Positives = 653/1057 (61%), Gaps = 110/1057 (10%)
Query: 133 SKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVM 192
S +KSFSHEL P+G + R DL+E++ L +RF AK+ VN+ELA FA D++
Sbjct: 24 STDIKSFSHELDPRGVRSYEFLRPRDLLDLEEVMAALGARFHTAKDEVNAELAVFAGDLV 83
Query: 193 NVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKW 252
VLE +E +EDLLILA+ C M +FR CE IVQDL +KRQ+ +G++K
Sbjct: 84 GVLEDTTDMDPYHQERIEDLLILARDCAFMDPQVFRKECEAIVQDLDDKRQELPMGVLKR 143
Query: 253 LSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKK------CLESVPAVETSWVPSPGTA 306
L TRMLFILTRCTRLL F+KE+ + E LH+ ++ C+ES + SW G A
Sbjct: 144 LHTRMLFILTRCTRLLQFEKEN-GLDEVELHRLQQQAKTGSCIESWKKI-ISW-NEKGKA 200
Query: 307 ------ESDLDYASYQKANAKKKISGQQKVSTVPEISDC------SCSESLDHTSENKSV 354
L +S + + K++S + +S P S S ES+ S
Sbjct: 201 LLKVVRPQRLSLSSKPQEKSSKRVSDEVSISGTPTFSGITEQAVESDKESISKASGGSVS 260
Query: 355 FIEQNFPPQKS--QHYSRM--QEQQSHIVE-------GRIVEVT---------------- 387
I +++ +H+S E +SH E G +V +T
Sbjct: 261 PIHSVVADRQTSWKHFSVAPPNELKSHGGESDVETEMGSVVYITPESSQLCADGGMVISR 320
Query: 388 ---------------KSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYAD 432
+ G +Q + LD + ICRICE+ V S LE HS ICA AD
Sbjct: 321 TSEEVQRIPSSKRHQRVAWGHWTDQPEVLDDNLDFICRICEDEVATSCLEDHSRICALAD 380
Query: 433 KCELNCLDVDERLLKLSEILEQISESCNSSSHPIL--GSPENSRTQSMNSA--------- 481
+C+ LDVD+RL +++E LE+++ES S + GSP+ ++T N+
Sbjct: 381 RCDQQGLDVDDRLRRIAETLERMAESLTPKSFSLAAGGSPDTAKTSGSNNGGCSSDGALS 440
Query: 482 ---ITYDGYSPKI-SEWRNKGVEGMFEDIHEMDTACI--DDSHLGSLNLRGHLGLKL--- 532
ITY ++ K+ E KG E + ED +E+D A + D+ S+ + G K+
Sbjct: 441 ERCITYPTFTDKVWGELLRKGSEELLEDTYEIDAASMGDDNKKANSVTCKTRFGPKIEQS 500
Query: 533 --------SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIA 584
S +SS GS+T S TP+ D +RN E++D Q+ E+ADIA
Sbjct: 501 SVPTSSPGSALAPASSAGSLTPRSPLATPRISQIDVLLSDRNGFNEIDDALQINEIADIA 560
Query: 585 RCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLD 644
RC+A ++G+E+LL+C+ D+QD+L+++K++AL + TFG RIEKL EKY E+LD
Sbjct: 561 RCIAGASPDEDGTEYLLSCLEDVQDILRYNKVEALTVATFGKRIEKLCMEKYHKFLEILD 620
Query: 645 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFL 704
S ++ +L+ + S STP+H S+K+RT+IDDFEIIKPISRGAFGRVFL
Sbjct: 621 PNGVEVASSVGDDE--LLEDDTFHSYKSTPVHPSYKDRTTIDDFEIIKPISRGAFGRVFL 678
Query: 705 ARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764
ARKRTTGDLFAIKVLKK DMIRKN +E + AERNILI+ RNPFVVRFFYSFTC +NLYLV
Sbjct: 679 ARKRTTGDLFAIKVLKKADMIRKNAVESVKAERNILISARNPFVVRFFYSFTCAENLYLV 738
Query: 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 824
MEYLNGGD+YSLLR +GCL+E +AR+YIAELVLALE LHSLG+VHRDLKPDN+LIAHDGH
Sbjct: 739 MEYLNGGDMYSLLRTLGCLDEALARVYIAELVLALECLHSLGVVHRDLKPDNILIAHDGH 798
Query: 825 IKLTDFGLSKIGLINNTIDLSGPETDGIM------PSDAHYPEYQ-QTDNRNRHSAVGTP 877
IKLTDFGLS++GLIN+T DLSGP G M + P+++ Q R + SAVGTP
Sbjct: 799 IKLTDFGLSRVGLINSTDDLSGPAATGTMVMEESTKNQCASPKHEHQRKIRQQRSAVGTP 858
Query: 878 DYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPS 937
DYLAPEILLGT HG AADWWS G+ILFEF+TGIPPF AE P+++FDNILNR IPWP VP
Sbjct: 859 DYLAPEILLGTSHGPAADWWSTGVILFEFLTGIPPFNAEHPQVVFDNILNRHIPWPAVPE 918
Query: 938 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 997
MS+EAQDLI+R L DP +RLGANGAAEVKAHPFFK +NW++LA QKA F+P P+ D
Sbjct: 919 YMSYEAQDLIDRLLTEDPTERLGANGAAEVKAHPFFKDINWETLARQKAAFIPSPDGAHD 978
Query: 998 TSYFLSRFSQISS-GLPDDQNGSYSDADTCDSSSNSRTEM----DECGDLAEF---GSCP 1049
TSYF SR++ S+ G D ++ SD ++ S S S + + DE GD+AEF SC
Sbjct: 979 TSYFSSRYAWNSNEGNFDTEHFDESDDESTCSGSTSDSALVLQTDEFGDMAEFENSSSCK 1038
Query: 1050 LDLSLINFSFKNLSQLASINHEVLVQNVKDSTRSSPA 1086
S NFSFKNLSQLASIN+++L Q+ + + P+
Sbjct: 1039 YTFS--NFSFKNLSQLASINYDLLQQSERRDSPQGPS 1073
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529485|ref|XP_003533321.1| PREDICTED: uncharacterized protein LOC100776995 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2218), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/1008 (48%), Positives = 640/1008 (63%), Gaps = 73/1008 (7%)
Query: 136 LKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVL 195
+KSFSHEL KG P + + N+L+E+L + ++FD AKE VNS+LA FA D++ +L
Sbjct: 295 IKSFSHELNSKGVWPFPFSKPRRLNNLEEILVVIRAKFDKAKEDVNSDLAIFAADLVGIL 354
Query: 196 EKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLST 255
EK + +E +EDLL+LA+ C +S F CE+IVQ+L ++RQ+ G++K L T
Sbjct: 355 EKNADTHPDWQETIEDLLVLARSCAMTSSGEFWLQCESIVQELDDRRQEHPPGMLKQLHT 414
Query: 256 RMLFILTRCTRLLLFQKES-----EPI----AEKSLHKFKKCLESVPAVETSWVPSPGTA 306
RMLFILTRCTRLL F KES EP+ + LH K + +T +A
Sbjct: 415 RMLFILTRCTRLLQFHKESGLAEDEPVFNLRQSRVLHSAGKFIPPSVGRDTK----SSSA 470
Query: 307 ESDLDYASYQKANAKKKISGQQKVSTVPE----ISDCSCSESLDHTSENKSVFIEQNFP- 361
L +S + + ++ + G +K PE +D ++ D +S + + FP
Sbjct: 471 AKALKPSSKKAFSQEQSMMGWKKDVMQPENLSIPADDDNAKLFDSSSGRNRMASWKKFPS 530
Query: 362 -----PQ-----KSQHYSRMQEQQSHIVEGRIVEVT------------------------ 387
P+ K Q+Y R++ ++ + +V
Sbjct: 531 PTGRSPKEAVQLKDQNYGRVESSKASNNKRFTSDVDLSTAKPSELLPVKDSLDHASKHQH 590
Query: 388 KSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLK 447
K + G +Q + +S+ICRICEE VP SH+E HS ICA AD+C+ L V+ERL++
Sbjct: 591 KVSWGYWGDQQNNNSEENSIICRICEEDVPTSHVEDHSRICAVADRCDQKGLSVNERLVR 650
Query: 448 LSEILEQISESCNSS-SHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDI 506
+S+ LE++ ESC + ++GSP+ ++ + + D SPK+S+W +G E M +
Sbjct: 651 ISDTLEKMMESCTQKDTQQMVGSPDVAKVSNSSMTEESDVPSPKLSDWSRRGSEDMLDCF 710
Query: 507 HEMDTACIDDSHLGS--LNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLE 564
E D + D G ++ + G K +SS GSMT S TP+ D
Sbjct: 711 PEADNSVFMDDLKGLPLMSCKTRFGPKSDQGMTTSSAGSMTPRSPLMTPRTSQIDLLLAG 770
Query: 565 RNHPAELEDVQQMIELADIARCVADTDFSKE-GSEFLLACMHDLQDVLQHSKLKALVIDT 623
+ +E +D+ QM ELADIARCVA+ + + +LL+C+ DL+ V+ K AL ++T
Sbjct: 771 KGAYSEHDDLPQMNELADIARCVANAPLDDDRTTSYLLSCLDDLRVVVDRRKFDALTVET 830
Query: 624 FGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERT 683
FG+RIEKL+REKY+ E++D + + S ++ ++ D V +S S P+HSS ++RT
Sbjct: 831 FGTRIEKLIREKYLQLTEMVDVEKIDTESTVDDD--ILEDDVVRSLRTS-PIHSS-RDRT 886
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
SIDDFEIIKPISRGAFGRVFLA+KRTTGDLFAIKVLKK DMIRKN +E ILAER+ILITV
Sbjct: 887 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILITV 946
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803
RNPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSLLR +GCL+E+VAR+YIAE+VLALEYLH
Sbjct: 947 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEEVARVYIAEVVLALEYLH 1006
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG--IMPSDAH--Y 859
SL +VHRDLKPDNLLIAHDGHIKLTDFGLSK+GLIN+T DLSGP +G ++ D +
Sbjct: 1007 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVNGTSLLEEDETDVF 1066
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
Q + R + SAVGTPDYLAPEILLGT HG+ ADWWSVG+ILFE + GIPPF AE P+
Sbjct: 1067 TSADQRERREKRSAVGTPDYLAPEILLGTGHGFTADWWSVGVILFELLVGIPPFNAEHPQ 1126
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979
IIFDNILNRKIPWP VP +MS EA DLI+R L DPNQRLG+ GA+EVK H FFK +NWD
Sbjct: 1127 IIFDNILNRKIPWPAVPEEMSPEALDLIDRLLTEDPNQRLGSKGASEVKQHVFFKDINWD 1186
Query: 980 SLALQKAVFVPQPESVDDTSYFLSRFS-QISSGL--PDDQNGSYSDAD----TCDSSSNS 1032
+LA QKA FVP ES DTSYF SR+S S G P SDAD + SN
Sbjct: 1187 TLARQKAAFVPASESALDTSYFTSRYSWNTSDGFVYPASDVEDSSDADSLSGSSSCLSNR 1246
Query: 1033 RTEMDECGDLAEFGS-CPLDLSLINFSFKNLSQLASINHEVLVQNVKD 1079
+ E DECG L EF S ++ S NFSFKNLSQLASIN++ L + KD
Sbjct: 1247 QDEGDECGGLTEFDSGTSVNYSFSNFSFKNLSQLASINYD-LTKGWKD 1293
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1091 | ||||||
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.847 | 0.866 | 0.611 | 9e-299 | |
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.651 | 0.548 | 0.528 | 1.3e-222 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.658 | 0.581 | 0.500 | 3.7e-208 | |
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.944 | 0.881 | 0.425 | 2.6e-198 | |
| DICTYBASE|DDB_G0276157 | 1367 | pkgA "MAST family protein kina | 0.247 | 0.197 | 0.436 | 3.1e-92 | |
| DICTYBASE|DDB_G0272282 | 2102 | DDB_G0272282 "MAST family prot | 0.150 | 0.078 | 0.682 | 6.5e-92 | |
| UNIPROTKB|F1S920 | 729 | MAST3 "Uncharacterized protein | 0.306 | 0.458 | 0.468 | 9.9e-82 | |
| RGD|1310139 | 968 | Mast4 "microtubule associated | 0.309 | 0.349 | 0.460 | 1.5e-81 | |
| POMBASE|SPAPB18E9.02c | 1318 | ppk18 "serine/threonine protei | 0.179 | 0.148 | 0.492 | 5.8e-80 | |
| POMBASE|SPCC1450.11c | 1338 | cek1 "serine/threonine protein | 0.156 | 0.127 | 0.569 | 6.7e-79 |
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2868 (1014.6 bits), Expect = 9.0e-299, P = 9.0e-299
Identities = 584/955 (61%), Positives = 702/955 (73%)
Query: 141 HELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDS 200
HELGP+GG+ + YPR HSYNDLKELL +LHSRFD AKE V+ +L F +DV +EKMD
Sbjct: 139 HELGPRGGVQTPYPRPHSYNDLKELLGSLHSRFDVAKETVDKKLDVFVRDVKEAMEKMDP 198
Query: 201 PSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFI 260
E +EM E LL +A+ C+EMTS RA CE+IVQDLT KR+QCQ GLVKWL +++LFI
Sbjct: 199 SCPEDREMAEQLLDVARACMEMTSAQLRATCESIVQDLTRKRKQCQAGLVKWLFSQLLFI 258
Query: 261 LTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYASYQKANA 320
LT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y YQ+ A
Sbjct: 259 LTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYPEYQRNEA 318
Query: 321 KKKISGQQKVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSRMQEQQSHIVE 380
+K + K S E + DH N + + + K + S + S +VE
Sbjct: 319 GQKFKRRDKESLESETA-LDYVVPNDH-GNNAA---REGYAAAKQEFPSHEPQFDSKVVE 373
Query: 381 GRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLD 440
R + +E G+ L GSD VICRICEE VP+ HLE HSYICAYADKCE+NC+D
Sbjct: 374 QRFYLSDEYEDKMSNEPGKELGGSDYVICRICEEEVPLFHLEPHSYICAYADKCEINCVD 433
Query: 441 VDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVE 500
VDERLLKL EILEQI +S + +S G ENS + S + +G SPKI+EWRNKG+E
Sbjct: 434 VDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLRK--SGVASEGCSPKINEWRNKGLE 491
Query: 501 GMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDP 560
GMFED+HEMDTA ID+S+ ++L+ H+G K NTP+ HFD
Sbjct: 492 GMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHATSSSTGSITSVSSTNTPRTSHFDS 551
Query: 561 FWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKAL 619
+WLER+ P E ED++ M++L+DIARC A TDFSKEGS ++++ACM D+Q VL+ KLKAL
Sbjct: 552 YWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGSCDYIMACMQDIQAVLKQGKLKAL 610
Query: 620 VIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSH 679
VIDTFG RIEKLL EKY+ A EL +KS S KE S +L+ S +TP
Sbjct: 611 VIDTFGGRIEKLLCEKYLHARELTADKS--SVGNIKE-SEDVLEHAS-----ATP-QLLL 661
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 739
K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKNDIERIL ERNI
Sbjct: 662 KDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKNDIERILQERNI 721
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
LITVR PF+VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLAL
Sbjct: 722 LITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLAL 781
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
EYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D +++H+
Sbjct: 782 EYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHH 841
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
+ Q + R RHSAVGTPDYLAPEILLGTEHGYAADWWS GI+LFE +TGIPPFTA PE
Sbjct: 842 FQKNQEEERIRHSAVGTPDYLAPEILLGTEHGYAADWWSAGIVLFELLTGIPPFTASRPE 901
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979
IFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+HPFF+GV+W+
Sbjct: 902 KIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWE 961
Query: 980 SLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDEC 1039
+LALQKA FVPQPES++DTSYF+SRFS+ S + N S S+ D+ D E+DEC
Sbjct: 962 NLALQKAAFVPQPESINDTSYFVSRFSESSCSDTETGNNSGSNPDSGD-------ELDEC 1014
Query: 1040 GDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRS---SPAKDAGT 1091
+L +F S P LSLINFSFKNLSQLASINH+VL+Q KD + SP K GT
Sbjct: 1015 TNLEKFDSPPYYLSLINFSFKNLSQLASINHDVLLQ--KDPAKGGGDSPFKSHGT 1067
|
|
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1829 (648.9 bits), Expect = 1.3e-222, Sum P(3) = 1.3e-222
Identities = 394/745 (52%), Positives = 484/745 (64%)
Query: 359 NFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPI 418
NFPP K H + H + + G EQ + S++CRICEE VP
Sbjct: 565 NFPPAKDSH--EHSSKHRHNI----------SWGYWGEQ-PLISEESSIMCRICEEEVPT 611
Query: 419 SHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSPENSRTQS 477
+H+E HS +C ADK + L VDERL+ ++ L++I+E+ + S SP+ + +
Sbjct: 612 THVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKDSLAAAESPDGMKVSN 671
Query: 478 MNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHLGLKLXXX 535
+ D SP++S+W KG E M + E D + +DD L ++ R G K
Sbjct: 672 SHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSDQG 731
Query: 536 XXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKE 595
TP+ + + + +D+ QM ELADIA+C AD +
Sbjct: 732 MTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPGDD 791
Query: 596 GS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKY 654
S FLL+C+ DL+ V+ K AL ++TFG+RIEKL+REKY+ CEL+D++ S
Sbjct: 792 QSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLSTV 851
Query: 655 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 714
+ + D V +S S P+H ++RTSIDDFEIIKPISRGAFGRVFLA+KRTTGDLF
Sbjct: 852 IDEDAPLEDDVVRSLRTS-PVHP--RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 715 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 774
AIKVLKK DMIRKN +E ILAER+ILI VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 775 SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
SLLR +GCLEED+ R+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 835 IGLINNTIDLSGPETDGIMPSDAHYPEY----QQTDNRNRHSAVGTPDYLAPEILLGTEH 890
+GLIN+T DL+GP G D +Q + R + SAVGTPDYLAPEILLGT H
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 891 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 950
G ADWWSVGIILFE I GIPPF AE P+ IFDNILNRKIPWP VP +MS EA D+I+RF
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRF 1148
Query: 951 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1010
L DP+QRLGA GAAEVK H FFK +NWD+LA QKA FVP ES DTSYF SR+S +S
Sbjct: 1149 LTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTS 1208
Query: 1011 G---LPDDQNGSYSDADT------CDSSSNSRTEMDECGDLAEFGS-CPLDLSLINFSFK 1060
P + YSDAD+ C S+ + E +EC AEF S P+D S NFSFK
Sbjct: 1209 DEQFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFK 1268
Query: 1061 NLSQLASINHEVLVQNVKDSTRSSP 1085
NLSQLASIN+++L + KD + P
Sbjct: 1269 NLSQLASINYDLLSKGWKDEPQQIP 1293
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1703 (604.5 bits), Expect = 3.7e-208, Sum P(3) = 3.7e-208
Identities = 374/747 (50%), Positives = 476/747 (63%)
Query: 352 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 411
K V I + K S + Q H+ + R ++ G H+ + S+ICRI
Sbjct: 500 KLVAISDDMAVAKLPEVSSAKASQEHMSKNRH-NISWGYWG--HQS--CISEESSIICRI 554
Query: 412 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSP 470
CEE +P +H+E HS ICA ADK + + VDERL+ ++ LE+I+++ S + SP
Sbjct: 555 CEEEIPTTHVEDHSRICALADKYDQKGVGVDERLMAVAVTLEKITDNVIQKDSLAAVESP 614
Query: 471 ENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHL 528
E + + + D SPK+S+W +G E M + E D + +DD L S++ R
Sbjct: 615 EGMKISNASLTEELDVLSPKLSDWSRRGSEDMLDCFPETDNSVFMDDMGCLPSMSCRTRF 674
Query: 529 GLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVA 588
G K TP+ + + + +D QM ELADIARC A
Sbjct: 675 GPKSDQGMATSSAGSMTPRSPIPTPRPDPIELLLEGKGTFHDQDDFPQMSELADIARCAA 734
Query: 589 DT-DFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKS 647
+ + + LL+C+ DL+ V+ K AL+++TFG+RIEKL++EKY+ CEL+D++
Sbjct: 735 NAIPVDDQSIQLLLSCLEDLRVVIDRRKFDALIVETFGTRIEKLIQEKYLQLCELMDDEK 794
Query: 648 PTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARK 707
T E++ L D V +S S P+H ++R SIDDFE++K ISRGAFG V LARK
Sbjct: 795 GTIID---EDAPLE-DDVVRSLRTS-PVHL--RDRISIDDFEVMKSISRGAFGHVILARK 847
Query: 708 RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767
TTGDLFAIKVL+K DMIRKN +E ILAER+ILI RNPFVVRFFYSFTC +NLYLVMEY
Sbjct: 848 NTTGDLFAIKVLRKADMIRKNAVESILAERDILINARNPFVVRFFYSFTCSENLYLVMEY 907
Query: 768 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 827
LNGGD YS+LRK+GCL+E AR+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGH+KL
Sbjct: 908 LNGGDFYSMLRKIGCLDEANARVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHVKL 967
Query: 828 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 887
TDFGLSK+GLINNT DLSGP + P+ D++ SAVGTPDYLAPEILLG
Sbjct: 968 TDFGLSKVGLINNTDDLSGPVSSATSLLVEEKPKLPTLDHKR--SAVGTPDYLAPEILLG 1025
Query: 888 TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 947
T HG ADWWSVGIIL+EF+ GIPPF A+ P+ IFDNILNR I WP VP DMS EA+DLI
Sbjct: 1026 TGHGATADWWSVGIILYEFLVGIPPFNADHPQQIFDNILNRNIQWPPVPEDMSHEARDLI 1085
Query: 948 NRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQ 1007
+R L DP+QRLGA GAAEVK H FFK ++W++LA QKA FVP E+ DTSYF SR+S
Sbjct: 1086 DRLLTEDPHQRLGARGAAEVKQHSFFKDIDWNTLAQQKAAFVPDSENAFDTSYFQSRYSW 1145
Query: 1008 ISSG---LPDDQNGSYSDADT-CDSSSNSRTEMDE-----CGDLAEFG-SCPLDLSLINF 1057
SG P ++N S+ D+ C SS DE CG AEF S + NF
Sbjct: 1146 NYSGERCFPTNENEDSSEGDSLCGSSGRLSNHHDEGVDIPCGP-AEFETSVSENYPFDNF 1204
Query: 1058 SFKNLSQLASINHEVLVQNVKDSTRSS 1084
SFKNLSQLA IN+ ++ + KD T+ S
Sbjct: 1205 SFKNLSQLAYINYNLMSKGHKDETQPS 1231
|
|
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1920 (680.9 bits), Expect = 2.6e-198, P = 2.6e-198
Identities = 477/1120 (42%), Positives = 651/1120 (58%)
Query: 16 GLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKTVAQGHVKLANSFTEVR-------- 67
GLN I+T+ + P L S + + P Q K + V + ++ + R
Sbjct: 79 GLNHIRTKSSPA-PSPLRFSSATPLISPGQDDKDVAKEKPRVGVVDARADARARWPIPPH 137
Query: 68 ---KGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLNEKQSLA 124
+GKK+ QW S + P N G E V + ++ + +
Sbjct: 138 QPDQGKKV-QWSQSKSQRV----PANSNPGVESTHVGLAKETQSPRFQAILRVTSGRKKK 192
Query: 125 EHVXXXXXXXXXXXXXHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSEL 184
H HEL KG P R+ + ++E++ + ++FD KE V+++L
Sbjct: 193 AH--------DIKSFSHELNSKGVRPFPVWRSRAVGHMEEIMAAIRTKFDKQKEDVDADL 244
Query: 185 ATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQ 244
FA ++ LE + E + LEDLL+ A+QC M + F CE IVQ L +KRQ+
Sbjct: 245 GVFAGYLVTTLESTPESNKELRVGLEDLLVEARQCATMPASEFWLKCEGIVQKLDDKRQE 304
Query: 245 CQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPG 304
+G +K R+LFILTRC RL+ F+KES + E L + L + V
Sbjct: 305 LPMGGLKQAHNRLLFILTRCNRLVQFRKESGYVEEHILGMHQ--LSDLGVYPEQMVEI-- 360
Query: 305 TAESDL-DYASYQKANAKKKISGQQKVSTVPEISD---CSCSESLDHTSENKSVFIEQNF 360
+ + DL QK N K+ ++G+Q +D + + S D TS N + +
Sbjct: 361 SRQQDLLREKEIQKINEKQNLAGKQDDQNSNSGADGVEVNTARSTDSTSSNFRMSSWKKL 420
Query: 361 PP--QKSQHYSRMQEQQSHI-VEGRIV-EVTKSNCGSPHEQGQSLDGS------------ 404
P +K++ + + + ++ ++ + N SP Q S D S
Sbjct: 421 PSAAEKNRSLNNTPKAKGESKIQPKVYGDENAENLHSPSGQPASADRSALWGFWADHQCV 480
Query: 405 ---DSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNS 461
+S+ICRICE +P+ H+E HS IC AD+C+L ++V+ RL +++E LE+I ES
Sbjct: 481 TYDNSMICRICEVEIPVVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTP 540
Query: 462 SSHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDI-HEMDTACIDDSHLG 520
S + +S S NS+ D + E + + M + + +T +D+
Sbjct: 541 KSSVTPRAVADSARLS-NSSRQED-----LDEISQRCSDDMLDCVPRSQNTFSLDE---- 590
Query: 521 SLNLRGHLGLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIEL 580
LN+ + + TP+ D R +ELE+ QQ+ +L
Sbjct: 591 -LNILNEMSM---TNGTKDSSAGSLTPPSPATPRNSQVDLLLSGRKTISELENYQQINKL 646
Query: 581 ADIARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILA 639
DIAR VA+ + S +F++ + +L+ V+Q K ALV++TFG RIEKLL+EKYI
Sbjct: 647 LDIARSVANVNVCGYSSLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIEL 706
Query: 640 CELLD-EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGA 698
C L+D EK +S + E S D+V ++PL+ K+RTSI+DFEIIKPISRGA
Sbjct: 707 CGLIDDEKVDSSNAMPDEESSADEDTVRSLR--ASPLNPRAKDRTSIEDFEIIKPISRGA 764
Query: 699 FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758
FGRVFLA+KR TGDLFAIKVLKK DMIRKN +E ILAERNILI+VRNPFVVRFFYSFTCR
Sbjct: 765 FGRVFLAKKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 824
Query: 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 818
+NLYLVMEYLNGGDL+SLLR +GCL+ED+ARIYIAE+VLALEYLHS+ I+HRDLKPDNLL
Sbjct: 825 ENLYLVMEYLNGGDLFSLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLL 884
Query: 819 IAHDGHIKLTDFGLSKIGLINNTIDLSGPET---DGIMPSDAHYPEYQQ-TDNRNRHSAV 874
I DGHIKLTDFGLSK+GLIN+T DLSG + G D ++ Q D+R +H+ V
Sbjct: 885 INQDGHIKLTDFGLSKVGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVV 944
Query: 875 GTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC 934
GTPDYLAPEILLG HG ADWWSVG+ILFE + GIPPF AE+P+ IF+NI+NR IPWP
Sbjct: 945 GTPDYLAPEILLGMGHGKTADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPN 1004
Query: 935 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPES 994
VP ++S+EA DLIN+ L +P QRLGA GA EVK H FFK +NWD+LA QKA+FVP E
Sbjct: 1005 VPEEISYEAHDLINKLLTENPVQRLGATGAGEVKQHHFFKDINWDTLARQKAMFVPSAEP 1064
Query: 995 VDDTSYFLSRFSQISSGLPDDQN---GS-YSD-ADTCDSSS-NSRTEM-DECGDLAEFGS 1047
DTSYF+SR+ I + P+D+N GS + D DTC SSS N++ E DECG LAEFG+
Sbjct: 1065 -QDTSYFMSRY--IWN--PEDENVHGGSDFDDLTDTCSSSSFNTQEEDGDECGSLAEFGN 1119
Query: 1048 CP---LDLSLINFSFKNLSQLASINHEVLVQNVKDSTRSS 1084
P + S NFSFKNLSQLASIN++++++N K+S +S
Sbjct: 1120 GPNLAVKYSFSNFSFKNLSQLASINYDLVLKNAKESVEAS 1159
|
|
| DICTYBASE|DDB_G0276157 pkgA "MAST family protein kinase PkgA" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 3.1e-92, Sum P(4) = 3.1e-92
Identities = 128/293 (43%), Positives = 186/293 (63%)
Query: 563 LERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVID 622
L R++ E + +IEL +IA + KE L +H + D++++ K +
Sbjct: 676 LTRSNDIPHEKRKMIIELREIALFAVENGI-KEN----LKMIHIMNDIIKNFDPKDDNRE 730
Query: 623 TFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS-----VSQSS------GV 671
+I+ L+ +K + A + D+ +S ++ NS IL S +SQ+
Sbjct: 731 -LAIKIQSLISDK-VNALKRADDVINSSPRIFRTNSPRILKSPREEELSQTPLGGRLRSD 788
Query: 672 STPLHSS---HKER--TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 726
S P+H + +K + +I DFE IKPI++G +G+VFLA+K TGD++AIK LKK DMI+
Sbjct: 789 SDPVHQTQIEYKPKGVPTISDFEFIKPITKGGYGKVFLAKKIRTGDIYAIKRLKKSDMIK 848
Query: 727 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 786
KN ++ + ERNIL NPFVV+ +YSF ++ YLVMEYL GGD +SLL+ +G ++E+
Sbjct: 849 KNQLDHVKVERNILAYTSNPFVVKMYYSFQTKEYYYLVMEYLQGGDCFSLLQMLGSMDEN 908
Query: 787 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839
+A++ IAE VLALEYLHS GIVHRD+KPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 909 MAKMIIAETVLALEYLHSHGIVHRDVKPDNLLIDKKGHIKLTDFGLSKVGLLD 961
|
|
| DICTYBASE|DDB_G0272282 DDB_G0272282 "MAST family protein kinase DDB_G0272282" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 6.5e-92, Sum P(7) = 6.5e-92
Identities = 112/164 (68%), Positives = 130/164 (79%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
SS+ SI DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ E
Sbjct: 1516 SSNTTSISIADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVE 1575
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
RNIL V+N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE V
Sbjct: 1576 RNILAMVQNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETV 1635
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840
L LEYLH IVHRDLKPDN+LI GHIKLTDFGLSKIG+I++
Sbjct: 1636 LCLEYLHKSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDD 1679
|
|
| UNIPROTKB|F1S920 MAST3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 9.9e-82, Sum P(3) = 9.9e-82
Identities = 163/348 (46%), Positives = 216/348 (62%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 376 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 435
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 436 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 495
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L +G + D E+ D
Sbjct: 496 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLY----EGHIEKDTR--EF--VD 547
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
+ GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F ++
Sbjct: 548 KQ----VCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQVV 603
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA 986
+ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L KA
Sbjct: 604 SDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFWTLDWAGLLRHKA 663
Query: 987 VFVPQPESVDDTSYFLSRFSQISS-GLPDDQ-NGSYSDADTCDSSSNS 1032
FVPQ E+ DDTSYF +R + G DD+ N S + SS S
Sbjct: 664 EFVPQLEAEDDTSYFDTRSERYRHLGSEDDETNDEESSTEIPQFSSCS 711
|
|
| RGD|1310139 Mast4 "microtubule associated serine/threonine kinase family member 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 1.5e-81, Sum P(3) = 1.5e-81
Identities = 165/358 (46%), Positives = 227/358 (63%)
Query: 663 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 722
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K + K
Sbjct: 301 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 355
Query: 723 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 782
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 356 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 415
Query: 783 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 416 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 475
Query: 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902
+L +G + DA E+ D + GTP+Y+APE++L +G DWW++GII
Sbjct: 476 NLY----EGHIEKDAR--EF--LDKQ----VCGTPEYIAPEVILRQGYGKPVDWWAMGII 523
Query: 903 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962
L+EF+ G PF ++PE +F +++ +I WP +AQDLI L +P +RLG
Sbjct: 524 LYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTG 583
Query: 963 GAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR---FSQISSGLPDDQN 1017
GA EVK H FF+ ++W+SL QKA F+PQ ES DDTSYF +R + + + DD N
Sbjct: 584 GAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTRSEKYHHMETEEEDDTN 641
|
|
| POMBASE|SPAPB18E9.02c ppk18 "serine/threonine protein kinase Ppk18 (predicted)" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 5.8e-80, Sum P(3) = 5.8e-80
Identities = 98/199 (49%), Positives = 138/199 (69%)
Query: 665 VSQSSGVSTPLH--SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 722
+S+ G+ST SS K SI D+EIIKPIS+G FG V+L+RK TTG+++AIKVL+K+
Sbjct: 541 LSRQIGISTLSSNISSGKGTPSIQDYEIIKPISKGTFGTVYLSRKNTTGEIYAIKVLRKV 600
Query: 723 DMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 781
DMI KN + + AER +L+ + FV + +Y+F RD LYLVME++NGGD SLL+ +
Sbjct: 601 DMISKNQVANVKAERAVLMAQEESAFVAKLYYAFQSRDYLYLVMEFMNGGDCASLLKSLY 660
Query: 782 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841
+ E A+IYIAE+ L LE+LH LGI+HRD+KPDN+L++ GH+KL DFGLS++GL
Sbjct: 661 TIPESWAKIYIAEVALGLEHLHRLGIIHRDIKPDNILMSITGHLKLADFGLSQLGLTTRQ 720
Query: 842 IDLSGPETDGIMPSDAHYP 860
+ L + + + P P
Sbjct: 721 LRLQKGKNNILSPPSFQSP 739
|
|
| POMBASE|SPCC1450.11c cek1 "serine/threonine protein kinase Cek1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 6.7e-79, Sum P(3) = 6.7e-79
Identities = 98/172 (56%), Positives = 130/172 (75%)
Query: 666 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 725
S S + T + +S E SI+D++I+KPIS+GAFG V+LA+KRTTGD FAIK+LKK +MI
Sbjct: 567 SPSPRIHTIVPNSAPEHPSINDYKILKPISKGAFGSVYLAQKRTTGDYFAIKILKKSNMI 626
Query: 726 RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 784
KN + + AER IL++ +PFV + +Y+F +D LYLVMEYLNGGD SLL+ +G L+
Sbjct: 627 AKNQVINVRAERAILMSQGESPFVAKLYYTFQSKDYLYLVMEYLNGGDCGSLLKTMGVLD 686
Query: 785 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836
D R YIAE VL L LH GI+HRD+KP+NLLI+ +GH+KLTDFGLS++G
Sbjct: 687 LDWIRTYIAETVLCLGDLHDRGIIHRDIKPENLLISQNGHLKLTDFGLSRVG 738
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1091 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-148 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-120 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-119 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-118 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-117 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-115 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-108 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-101 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-99 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-97 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-94 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-93 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-90 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-87 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-86 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-85 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-84 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-83 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-83 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-82 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-81 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-79 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-77 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-77 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-76 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-76 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-76 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-76 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-75 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-75 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-74 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-73 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-72 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-72 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-72 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-70 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-70 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-69 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-69 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-68 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-67 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-67 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-67 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-66 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-66 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-66 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-64 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-64 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-64 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-63 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-62 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-62 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-62 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-62 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-62 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-61 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-60 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-59 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-58 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-58 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-57 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-56 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-53 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-52 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-52 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-49 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-49 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-48 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-48 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-47 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-46 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-46 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-45 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-43 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-43 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-43 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-42 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-42 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-42 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-41 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-41 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-40 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-39 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-39 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-37 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-36 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-35 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-35 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-34 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-34 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-34 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-32 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-31 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-31 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-30 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-30 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-30 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-29 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-29 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-28 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-28 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-27 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-26 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-24 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-24 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-23 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-20 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 5e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-09 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-08 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 6e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 8e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.002 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 443 bits (1141), Expect = e-148
Identities = 166/285 (58%), Positives = 210/285 (73%), Gaps = 20/285 (7%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
IS+GA+GRVFLA+K++TGD++AIKV+KK DMIRKN ++++L ER+IL ++P+VV+ +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813
SF + NLYLVMEYL GGDL SLL VG L+EDVARIYIAE+VLALEYLHS GI+HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 873
PDN+LI +GH+KLTDFGLSK+GL+ I+L+ E + D R
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE---------------DKR----I 161
Query: 874 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933
VGTPDY+APE++LG H DWWS+G IL+EF+ GIPPF E+PE IF NILN KI WP
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978
S EA DLI++ L+ DP +RLGA E+K HPFFKG++W
Sbjct: 222 EDVEV-SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 369 bits (950), Expect = e-120
Identities = 131/280 (46%), Positives = 183/280 (65%), Gaps = 30/280 (10%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ +G+FG+V L RK+ TG L+A+KVLKK +I++ ++E L ERNIL + +PF+V+ Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813
+F + LYLV+EY GG+L+S L K G E+ AR Y AE+VLALEYLHSLGI++RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 873
P+N+L+ DGHIKLTDFGL+K ++ ++
Sbjct: 121 PENILLDADGHIKLTDFGLAKELS---------------------------SEGSRTNTF 153
Query: 874 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933
GTP+YLAPE+LLG +G A DWWS+G++L+E +TG PPF AE + I++ IL + +
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF- 212
Query: 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
P +S EA+DLI+ L DP +RLG+ GA E+KAHPFF
Sbjct: 213 --PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 366 bits (942), Expect = e-119
Identities = 155/291 (53%), Positives = 195/291 (67%), Gaps = 33/291 (11%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVV 749
+KPIS+GAFG V+LA+KR+TGD FAIKVLKK DMI KN + + AER I++ +P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 750 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 809
+ +YSF +D LYLVMEYLNGGD SL++ +G L ED A+ YIAE+VL +E LH GI+H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 810 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 869
RD+KP+NLLI GH+KLTDFGLS+ GL N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF--------------------------- 153
Query: 870 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 929
VGTPDYLAPE +LG +DWWS+G ++FEF+ G PPF AE+P+ +FDNIL+R+
Sbjct: 154 ----VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209
Query: 930 IPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979
I WP V S EA DLINR L DP +RLGANG E+K+HPFFK +NWD
Sbjct: 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 367 bits (943), Expect = e-118
Identities = 149/321 (46%), Positives = 204/321 (63%), Gaps = 10/321 (3%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFE+IK I RGAFG V+L R + TG ++A+KVL+K DMI++N I + AER+IL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P++V+ +YSF ++LYLVMEY+ GGDL +LL + E+ AR YIAELVLAL+ +H L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN---TIDLSGPETDGIMPSDAHYPEY 862
G +HRD+KPDN+LI DGHIKL DFGL K + L+ +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK-KMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
+ +S VGTPDY+APE+L GT +G DWWS+G+IL+E + G PPF +++ + +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 923 DNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980
+ I+N K P D +S EA DLI R L DP RLG+ E+K+HPFFKG++W++
Sbjct: 240 NKIINWKESL-RFPPDPPVSPEAIDLICRLLC-DPEDRLGS--FEEIKSHPFFKGIDWEN 295
Query: 981 LALQKAVFVPQPESVDDTSYF 1001
L K FVP+ S DTS F
Sbjct: 296 LRETKPPFVPELSSPLDTSNF 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 363 bits (934), Expect = e-117
Identities = 156/316 (49%), Positives = 209/316 (66%), Gaps = 12/316 (3%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+DFE IK IS GA+G V+L R + T FA+K + K ++I +N I+++ ER+IL N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
PFVV F SF + +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L +G + D +Q
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY----EGHIEKDTREFLDKQV 176
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F +
Sbjct: 177 --------CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 985
++ I WP + +AQDLI+R L +P +RLG GA EVK H FF G++W+ L QK
Sbjct: 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQK 288
Query: 986 AVFVPQPESVDDTSYF 1001
A F+PQ ES DDTSYF
Sbjct: 289 AEFIPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 357 bits (919), Expect = e-115
Identities = 137/321 (42%), Positives = 197/321 (61%), Gaps = 39/321 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFE IK + G+FGRV L R + +G +A+K+L K +++ +E +L E+ IL ++R+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
PF+V + SF NLYLVMEY+ GG+L+S LRK G E VAR Y A++VLALEYLHSL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
IV+RDLKP+NLL+ DG+IK+TDFG +K + T
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRT------------------------ 155
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
++ GTP+YLAPEI+L +G A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 156 -----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 983
L K+ PS S +A+DLI L D +RLG NG ++K HP+F G++W +L L
Sbjct: 211 LEGKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL-L 266
Query: 984 QKAV---FVPQPESVDDTSYF 1001
Q+ + F+P+ + DTS F
Sbjct: 267 QRKIEAPFIPKVKGPGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 342 bits (878), Expect = e-108
Identities = 143/331 (43%), Positives = 202/331 (61%), Gaps = 19/331 (5%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFE IK I RGAFG V L +K+ TG ++A+K L+K +M+ K + + AER+IL N
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P+VV+ +YSF + LYL+MEYL GGD+ +LL K E+ R YIAE +LA++ +H L
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPSDAHYP 860
G +HRD+KPDNLL+ GHIKL+DFGL GL + LS P
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPS-NFLDFISKP 178
Query: 861 EYQ----QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912
+T RNR +S VGTPDY+APE+ L T + DWWS+G+I++E + G PP
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 913 FTAESPEIIFDNILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970
F +++P+ + I+N K P ++ S EA+DLI R + +RLG NG E+K+H
Sbjct: 239 FCSDNPQETYRKIINWKETLQ-FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296
Query: 971 PFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1001
PFFKGV+W+ + + A +P+ +S+ DTS F
Sbjct: 297 PFFKGVDWEHIRERPAPIIPELKSITDTSNF 327
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 319 bits (819), Expect = e-101
Identities = 129/287 (44%), Positives = 173/287 (60%), Gaps = 34/287 (11%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+EI++ + G+FG+V+LAR + TG L AIKV+KK + K D ERIL E IL +++P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
+VR + F D LYLVMEY GGDL+ LL+K G L ED AR Y+ +++ ALEYLHS GI
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
VHRDLKP+N+L+ DGH+KL DFGL++ Q
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR----------------------------QLDPG 150
Query: 868 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNIL 926
+ VGTP+Y+APE+LLG +G A D WS+G+IL+E +TG PPF + +F I
Sbjct: 151 EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
K P+P D+S EA+DLI + L+ DP +RL A E HPFF
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 316 bits (811), Expect = 3e-99
Identities = 136/326 (41%), Positives = 195/326 (59%), Gaps = 24/326 (7%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
F+ IK + +G GRVFL R + TG LFA+KVL K +MI++N ++R+L E+ IL T+ +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLH 803
PF+ + SF L LVM+Y GG+L+ LL++ CL E+VAR Y AE++LALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET-----DGIMPSDAH 858
LGIV+RDLKP+N+L+ GHI L+DF LSK S E S
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSK---------QSDVEPPPVSKALRKGSRRS 171
Query: 859 YPEYQQTD------NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912
++ + +S VGT +Y+APE++ G HG A DWW++GI+L+E + G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 913 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHP 971
F + + F NIL +++ +P P S A+DLI + L+ DP++RLG GAAE+K HP
Sbjct: 232 FKGSNRDETFSNILKKEVTFPGSPPV-SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290
Query: 972 FFKGVNWDSLALQKAVFVPQPESVDD 997
FF+GVNW + +P+P+ D
Sbjct: 291 FFRGVNWALIRHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 313 bits (804), Expect = 2e-97
Identities = 157/370 (42%), Positives = 211/370 (57%), Gaps = 30/370 (8%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F IK I GAFG V L RK T L+A+K L+K D++ +N + AER+IL N +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++G EED+AR YIAEL A+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINN-----TIDLSGPETDGIM 853
+HRD+KPDN+LI DGHIKLTDFGL SK + +++ S E I
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS-EEWSEID 181
Query: 854 PSDAHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910
E ++ R HS VGTP+Y+APE+LL T + DWWSVG+IL+E + G
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 911 PPFTAESPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966
PPF A++P ++N + IP + +S EA DLI R L RLG NGA E
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIP-SQ--AKLSREASDLILR-LCCGAEDRLGKNGADE 297
Query: 967 VKAHPFFKGVNWDSLAL-QKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADT 1025
+KAHPFFKG+++ SL QKA ++P+ DTS F L D +G S
Sbjct: 298 IKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNF-DPVDP--EKLRSDDSGESSPDRN 354
Query: 1026 CDSSSNSRTE 1035
++ RTE
Sbjct: 355 VKPNNRKRTE 364
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 301 bits (774), Expect = 2e-94
Identities = 109/290 (37%), Positives = 170/290 (58%), Gaps = 12/290 (4%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVR 744
DDF+ K I G+F V LA+++ T +AIK+L K +I++ ++ + E+ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+P +++ +Y+F +NLY V+EY G+L +RK G L+E R Y AE++LALEYLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
GI+HRDLKP+N+L+ D HIK+TDFG +K+ + D+ + +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVL---DPNSSPESNKGDATNIDSQIEKNR- 176
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
R S VGT +Y++PE+L G ++D W++G I+++ +TG PPF + + F
Sbjct: 177 ---RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFF 973
IL + + P + +A+DLI + L+ DP RLG N G E+KAHPFF
Sbjct: 234 ILKLEYSF---PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 301 bits (772), Expect = 2e-93
Identities = 129/320 (40%), Positives = 193/320 (60%), Gaps = 38/320 (11%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
DF+I+ + +G +G+VFLA+K+ TG++ A+K +KK + + N++ +L ER+IL T ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
++V+ Y+F + LYL MEY+ GGD +LL +G L ED AR Y+AE+ A++ LH LG
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
+HRDLKP+N LI GHIKLTDFGLSK + +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYA--------------------- 155
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
+S VG+PDY+APE+L G + + D+WS+G +L+EF+ G PPF+ +P ++N+
Sbjct: 156 ----NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211
Query: 927 NRK--IPWPC---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981
K + P ++S EA DLI + LI+DP++R G ++K HPFFK V+W+ L
Sbjct: 212 YWKETLQRPVYDDPRFNLSDEAWDLITK-LINDPSRRFG--SLEDIKNHPFFKEVDWNEL 268
Query: 982 ALQKAVFVPQPESVDDTSYF 1001
K FVP+ ES DT YF
Sbjct: 269 RELKPPFVPELESEIDTGYF 288
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 295 bits (757), Expect = 1e-90
Identities = 146/352 (41%), Positives = 205/352 (58%), Gaps = 52/352 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+DF +K I +GAFG V L +K+ TG ++A+K L K +M +K+ + + AER++L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P+VV +YSF LYL+ME+L GGDL ++L K EDV R Y+AE VLA+E +H L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLS---------------------------KIGLI 838
G +HRD+KPDN+LI GHIKL+DFGLS + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR----HSAVGTPDYLAPEILLGTEHGYAA 894
++I+L+ D I T +NR +S VGTPDY+APEI L +G
Sbjct: 181 VDSINLTMSSKDQI-----------ATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 895 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP---CVPSD--MSFEAQDLINR 949
DWWS+G I+FE + G PPF +E+ + I+N W P D +S EA+DLI R
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIIN----WRETLYFPDDIHLSVEAEDLIRR 285
Query: 950 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1001
LI + RLG GA E+K+HPFF+GV+WD++ +A F+PQ +S+ DTSYF
Sbjct: 286 -LITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYF 336
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 283 bits (727), Expect = 3e-87
Identities = 115/331 (34%), Positives = 186/331 (56%), Gaps = 36/331 (10%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 750
K + +G+FG+V LA + T +L+A+KVLKK +++ +D+E + E+ +L PF+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
F +D L+ VMEY+NGGDL +++ G +E AR Y AE+VL L++LH GI++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLK DN+L+ +GHIK+ DFG+ K G++
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILG--------------------------GVTTS 154
Query: 871 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ GTPDY+APEIL +G A DWW++G++L+E + G PF + + +F +IL ++
Sbjct: 155 -TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV- 987
+ P +S EA+ ++ FL +P +RLG G ++K HPFF+ ++WD L ++
Sbjct: 214 RY---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKP 270
Query: 988 -FVPQPESVDDTSYFLSRFSQISSGL-PDDQ 1016
F P+ + D S F F++ L P D+
Sbjct: 271 PFKPKIKGRFDVSNFDDEFTKEKPVLTPPDE 301
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 4e-86
Identities = 129/318 (40%), Positives = 185/318 (58%), Gaps = 44/318 (13%)
Query: 687 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 742
+FE+++ + GA+G+VFL RK G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 743 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
VR PF+V Y+F L+L+++Y+NGG+L++ L + E R+YIAE+VLAL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK L
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL------------------------ 156
Query: 862 YQQTDNRNR-HSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE-- 916
+ R +S GT +Y+APE++ G G+ A DWWS+G++ FE +TG PFT +
Sbjct: 157 ---AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
Query: 917 --SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
S I IL K P P MS EA+D I + L DP +RLGANGA E+K HPFF+
Sbjct: 214 QNSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
Query: 975 GVNWDSLALQ--KAVFVP 990
G++WD LA + A F P
Sbjct: 271 GIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 278 bits (712), Expect = 1e-85
Identities = 122/320 (38%), Positives = 179/320 (55%), Gaps = 37/320 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DD E IK + G FGRV L R R + +A+KV+ ++IR + + E+ +L V +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
PF++R F++ + LY++MEY+ GG+L+S LR G Y +E+V ALEYLHS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
IV+RDLKP+N+L+ +GHIKLTDFG +K L + T L
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWTL--------------------- 158
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
GTP+YLAPE++ H A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 159 --------CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 983
L K+ + P + A+DLI + L+ D +RLG NGA +VK H +FK V+WD +
Sbjct: 211 LAGKLEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ 267
Query: 984 QKAV--FVPQPESVDDTSYF 1001
+K VP+ DTS F
Sbjct: 268 RKLKPPIVPKVSHDGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 276 bits (707), Expect = 2e-84
Identities = 141/340 (41%), Positives = 203/340 (59%), Gaps = 39/340 (11%)
Query: 691 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNP 746
+K + +G +G+VF RK T TG +FA+KVLKK ++R + D AERNIL V++P
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
F+V Y+F LYL++EYL+GG+L+ L + G ED A Y++E+ LALE+LH G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
I++RDLKP+N+L+ GH+KLTDFGL K + T+
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT----------------------- 157
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
H+ GT +Y+APEIL+ + HG A DWWS+G ++++ +TG PPFTAE+ + D IL
Sbjct: 158 ----HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 984
K+ +P ++ EA+DL+ + L +P+ RLGA AAEV++HPFF+ VNWD L +
Sbjct: 214 KGKL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLAR 270
Query: 985 K--AVFVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYS 1021
K F P +S +D S F S+F+ Q PDD S S
Sbjct: 271 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSES 310
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 271 bits (694), Expect = 2e-83
Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 36/291 (12%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+E+++ + G+FG V+ A+ + TG + A+K+LKK + + E IL + +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
+VR +F +D+LYLVMEY GGDL+ L + G L ED A+ +++ LEYLHS GI
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
+HRDLKP+N+L+ +G +K+ DFGL+K L +++
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-------------------------- 153
Query: 868 RNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFD 923
+ + VGTP Y+APE+LL G +G D WS+G+IL+E +TG PPF+ E +
Sbjct: 154 -SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 924 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
IL + + S S EA+DLI + L DP++R A E+ HP+F
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP---TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 273 bits (700), Expect = 3e-83
Identities = 126/330 (38%), Positives = 191/330 (57%), Gaps = 42/330 (12%)
Query: 680 KERTS---IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
K TS + DFE+ + + G+FGRV +A+ + TG+ +AIK LKK ++++ ++ + E
Sbjct: 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
++IL+ + +PF+V SF + +Y ++E++ GG+L++ LRK G DVA+ Y AELV
Sbjct: 69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
LA EYLHS I++RDLKP+NLL+ + GH+K+TDFG +K
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---------------------- 166
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916
P+ T GTP+YLAPE++ HG A DWW++G++L+EFI G PPF +
Sbjct: 167 -KVPDRTFT-------LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
Query: 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFK 974
+P I++ IL ++ + P+ A+DL+ L D +RLG G A+VK HP+F
Sbjct: 219 TPFRIYEKILAGRLKF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275
Query: 975 GVNWDSLALQKAVFVPQP---ESVDDTSYF 1001
G NWD L + P P +S DTS F
Sbjct: 276 GANWDKL-YARYYPAPIPVRVKSPGDTSNF 304
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 269 bits (689), Expect = 1e-82
Identities = 104/293 (35%), Positives = 169/293 (57%), Gaps = 39/293 (13%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ G FGRV L + ++ FA+K +KK ++ E I +E+ IL +PF+V+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813
+F + +Y++MEY GG+L+++LR G +E AR YIA +VLA EYLH+ GI++RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR-HS 872
P+NLL+ +G++KL DFG +K + + + +
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-----------------------------KLKSGQKTWT 151
Query: 873 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA--ESPEIIFDNIL--NR 928
GTP+Y+APEI+L + ++ D+WS+GI+L+E +TG PPF E P I+++IL N
Sbjct: 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211
Query: 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWD 979
K+ + P+ + A+DLI + L +P +RLG G ++K H +F G +W+
Sbjct: 212 KLEF---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 9e-81
Identities = 143/329 (43%), Positives = 205/329 (62%), Gaps = 18/329 (5%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 863
G +HRD+KPDNLL+ GH+KL+DFGL GL PSD +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCT-GLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 864 ---QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916
+T +NR +S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 917 SPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+P+ + ++N K P P VP +S +A+DLI RF D R+G+NG E+K+HPF
Sbjct: 240 TPQETYRKVMNWKETLVFP-PEVP--ISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295
Query: 973 FKGVNWDSLALQKAVFVPQPESVDDTSYF 1001
F+GV+W + + A + +S+DDTS F
Sbjct: 296 FEGVDWGHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 263 bits (673), Expect = 6e-79
Identities = 148/336 (44%), Positives = 200/336 (59%), Gaps = 23/336 (6%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F IK + GAFG V LARK T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
VVR +YSF +DNLY VM+Y+ GGD+ SLL ++G ED+AR YIAEL A+E +H +G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGL--------------SKIGLINNTIDLSGPETD--G 851
+HRD+KPDN+LI DGHIKLTDFGL S + +++D S D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 852 IMPSDAHYP-EYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907
D P E + R HS VGTP+Y+APE+LL T + DWWSVG+IL+E +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 908 TGIPPFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAE 966
G PPF A++P ++N + P + +S EA DLI + L P RLG NGA E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301
Query: 967 VKAHPFFKGVNWDS-LALQKAVFVPQPESVDDTSYF 1001
+KAHPFFK +++ S L Q A ++P+ DTS F
Sbjct: 302 IKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNF 337
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 258 bits (660), Expect = 1e-77
Identities = 135/324 (41%), Positives = 194/324 (59%), Gaps = 35/324 (10%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFEI+K I RGAFG V + + + TG ++A+K+L K +M+++ + ER++L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 804
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+VLA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
LG VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLL----------ADGTVQSNV------- 162
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 919
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 920 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ I+N K +P +D+S EA+DLI R LI P RLG NG + K HPFF+G++
Sbjct: 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR-LICSPETRLGRNGLQDFKDHPFFEGID 273
Query: 978 WDSLALQKAVFVPQPESVDDTSYF 1001
WD++ A +VP+ S DTS F
Sbjct: 274 WDNIRNSTAPYVPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 2e-77
Identities = 141/328 (42%), Positives = 206/328 (62%), Gaps = 16/328 (4%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+DFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 863
G +HRD+KPDNLL+ GH+KL+DFGL GL + +PSD +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCT-GLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 864 ---QTDNRNRH----SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916
+T RNR S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 917 SPEIIFDNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+P+ + ++N K I P VP +S +A+DLI RF + R+GA G E+K +PFF
Sbjct: 240 TPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFF 296
Query: 974 KGVNWDSLALQKAVFVPQPESVDDTSYF 1001
+GV+W+ + + A + +S+DDTS F
Sbjct: 297 EGVDWEHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 255 bits (652), Expect = 1e-76
Identities = 127/333 (38%), Positives = 180/333 (54%), Gaps = 35/333 (10%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 751
K + +G FG+V L R++ TG +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 811
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL YLHS +V+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
LK +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213
Query: 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 987
+ P +S EA+ L+ L DP QRLG A E+ H FF +NW + +K
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPP 270
Query: 988 FVPQPESVDDTSYFLSRF-SQISSGLPDDQNGS 1019
F PQ S DT YF F +Q + P D+ S
Sbjct: 271 FKPQVTSETDTRYFDEEFTAQSITITPPDRYDS 303
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 253 bits (649), Expect = 3e-76
Identities = 125/344 (36%), Positives = 187/344 (54%), Gaps = 41/344 (11%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 750
K I +G+FG+V LA+ + G +A+KVL+K +++K + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
YSF D LY V++Y+NGG+L+ L++ E AR Y AE+ AL YLHSL I++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLKP+N+L+ GH+ LTDFGL K +GI S
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIEHSK------------TT 153
Query: 871 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNILN+ +
Sbjct: 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQK--AV 987
+ ++S A+ L+ L D +RLGA + E+K H FF +NWD L +K
Sbjct: 214 R---LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP 270
Query: 988 FVPQPESVDDTSYFLSRFSQI----SSGLPDDQN---GSYSDAD 1024
F P D +F F++ S G D S +AD
Sbjct: 271 FNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEAD 314
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 3e-76
Identities = 125/328 (38%), Positives = 187/328 (57%), Gaps = 37/328 (11%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
R +DF++IK I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
+ ++V+ Y+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDA 157
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
+HS+G +HRD+KPDN+L+ GH+KL DFG + + + +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFG--------TCMKM---DANGMVRCD----- 201
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 917
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 918 PEIIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ I++ K P D +S +A+DLI FL D RLG NG E+K+HPFFK
Sbjct: 252 LVGTYSKIMDHKNSL-TFPDDIEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPFFKN 309
Query: 976 --VNWDSLALQKAVFVPQPESVDDTSYF 1001
+D++ A VP+ S DTS F
Sbjct: 310 DQWTFDNIRETVAPVVPELSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 9e-76
Identities = 154/382 (40%), Positives = 206/382 (53%), Gaps = 49/382 (12%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F IK + GAFG V LA K T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++ E +AR YIAEL LA+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINNTIDLSGPETDGIMPSD-- 856
+HRD+KPDN+LI DGHIKLTDFGL SK + I D + PSD
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI-----RQDSMEPSDLW 177
Query: 857 -----------AHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902
E + T R HS VGTP+Y+APE+LL + DWWSVG+I
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 903 LFEFITGIPPFTAESPE------IIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHD 954
LFE + G PPF A +P I ++N L+ +P +S EA DLI + L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH-------IPPQVKLSPEAVDLITK-LCCS 289
Query: 955 PNQRLGANGAAEVKAHPFFKGVNWDS-LALQKAVFVPQPESVDDTSYFLSRFSQISSGLP 1013
+RLG NGA ++KAHPFF V++ S + Q A +VP+ DTS F + S
Sbjct: 290 AEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDP--VEEESPWN 347
Query: 1014 DDQNGSYSDADTCDSSSNSRTE 1035
D S DT S + E
Sbjct: 348 DASGDSTRTWDTLCSPNGKHPE 369
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 2e-75
Identities = 132/333 (39%), Positives = 197/333 (59%), Gaps = 37/333 (11%)
Query: 687 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 742
+FE++K + GA+G+VFL RK T TG L+A+KVL+K +++K +E ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 743 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
VR +PF+V Y+F L+L+++Y++GG++++ L + ED R Y E++LALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LH LGIV+RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK--------------------------E 154
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920
+ + +S GT +Y+APEI+ G HG A DWWS+GI++FE +TG PFT E
Sbjct: 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214
Query: 921 IFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 977
+ R + P PS + EAQDL+++ L DP +RLGA GA+E+K HPFFKG++
Sbjct: 215 TQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
Query: 978 WDSLALQK--AVFVPQPESVDDTSYFLSRFSQI 1008
W++LAL+K F P + D F F+ +
Sbjct: 275 WEALALRKVNPPFRPSIRNELDVGNFAEEFTNL 307
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 3e-75
Identities = 120/318 (37%), Positives = 183/318 (57%), Gaps = 36/318 (11%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I +G+FG+V RKR T ++A+K ++K ++ ++++ LAER +L V PF+V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813
SF + LYLV+ ++NGG+L+ L++ G + AR Y AEL+ ALE LH +++RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 873
P+N+L+ + GHI L DFGL K+ + + D N +
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKD-------------------------DDKTN--TF 153
Query: 874 VGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931
GTP+YLAPE+LLG HGY A DWW++G++L+E +TG+PPF E+ ++ IL +
Sbjct: 154 CGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV--FV 989
+ P +A+DL+ L DP +RLG NGA E+K HPFF ++W L ++ F
Sbjct: 212 F---PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFK 268
Query: 990 PQPESVDDTSYFLSRFSQ 1007
P S DTS F F++
Sbjct: 269 PAVSSAIDTSNFDEEFTR 286
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 3e-74
Identities = 120/328 (36%), Positives = 178/328 (54%), Gaps = 40/328 (12%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 744
F + + RG FG+V LA + TG+L+AIK LKK D+I ++++E ++ E+ I T R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+PF+V F F D++ VMEY GGDL + E A Y A +VL L+YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
IV+RDLK DNLL+ +G +K+ DFGL K +G+ D
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK---------------EGMGFGD-------- 156
Query: 865 TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923
R S GTP++LAPE+L T + A DWW +G++++E + G PF + E +FD
Sbjct: 157 -----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 981
+I+N ++ +P +S EA ++ R L +P +RLG+ A +VK PFF+ +NWD L
Sbjct: 212 SIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268
Query: 982 ALQK--AVFVPQPESVDDTSYFLSRFSQ 1007
+K FVP + +D S F F+
Sbjct: 269 LARKIKPPFVPTIKGPEDVSNFDEEFTS 296
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 4e-73
Identities = 133/342 (38%), Positives = 194/342 (56%), Gaps = 48/342 (14%)
Query: 691 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+K + +G+FG+VFL RK T G L+A+KVLKK + + D R ER+IL V +PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPF 59
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLG 806
+V+ Y+F LYL++++L GGDL++ L K V EEDV + Y+AEL LAL++LHSLG
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALALDHLHSLG 118
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
I++RDLKP+N+L+ +GHIKLTDFGLSK + D
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK----------------------------ESID 150
Query: 867 NRNR-HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
+ + +S GT +Y+APE++ H +ADWWS G+++FE +TG PF + + I
Sbjct: 151 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLAL 983
L K+ +P +S EAQ L+ +P RLGA +G E+K HPFF ++W+ L
Sbjct: 211 LKAKLG---MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL-Y 266
Query: 984 QKAV---FVPQPESVDDTSYFLSRFS----QISSGLPDDQNG 1018
++ + F P DDT YF F+ + S G+P N
Sbjct: 267 RREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANA 308
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 1e-72
Identities = 106/287 (36%), Positives = 157/287 (54%), Gaps = 31/287 (10%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
FE+++ I +GAFG+V + +KR T +FA+K + K + K + +L ER IL + +PF
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
+V +YSF +N+YLV++ L GGDL Y L +KV E+ + +I E+VLALEYLHS G
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEIVLALEYLHSKG 120
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
I+HRD+KPDN+L+ GH+ +TDF ++ T
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATK----------------------------VTP 152
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
+ S GTP Y+APE+L + A DWWS+G+ +E + G P+ S I
Sbjct: 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
++ P+ S EA D IN+ L DP +RLG N ++K HP+F
Sbjct: 213 KQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 242 bits (618), Expect = 8e-72
Identities = 121/325 (37%), Positives = 179/325 (55%), Gaps = 40/325 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DF++ + RG FG V + R++ TGD++A+KV+KK ++ + + ER+IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLHS 804
P++ + Y+F +DNLYLVMEY GGDL SLL R +ED+A+ Y+AELVLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+G VHRD+KP+N+LI GHIKL DFG + + ++
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSA-----------------ARLTANKMV----- 158
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESP 918
N VGTPDY+APE+L +G DWWS+G+I +E I G PF +
Sbjct: 159 ----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
Query: 919 EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
++NI+N R + +P P +S + DLI L+ +RLG G + HPFF +
Sbjct: 215 AKTYNNIMNFQRFLKFPEDPK-VSSDFLDLIQS-LLCGQKERLGYEG---LCCHPFFSKI 269
Query: 977 NWDSLALQKAVFVPQPESVDDTSYF 1001
+W+++ FVP +S DDTS F
Sbjct: 270 DWNNIRNSLPPFVPTLKSDDDTSNF 294
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 9e-72
Identities = 109/337 (32%), Positives = 180/337 (53%), Gaps = 36/337 (10%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 745
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
GI++RDLK DN+++ +GHIK+ DFG+ K + I
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK---------------ENIFGGK--------- 156
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 983
+ + + P +S EA + L P +RLG G +++ H FF+ ++W+ L
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLER 270
Query: 984 Q--KAVFVPQPESVDDTSYFLSRFSQISSGL-PDDQN 1017
+ + F P+ + F F++ L P D+
Sbjct: 271 REIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKL 307
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 2e-70
Identities = 118/321 (36%), Positives = 187/321 (58%), Gaps = 38/321 (11%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 752
+ +G+FG+V LAR + +G L+A+KVLKK +++ +D+E + E+ IL RN PF+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 812
F D L+ VME++NGGDL ++K +E AR Y AE+ AL +LH GI++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 813 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 872
K DN+L+ H+GH KL DFG+ K G+ N G S +
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFN-----------GKTTS----------------T 155
Query: 873 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 932
GTPDY+APEIL +G + DWW++G++L+E + G PF AE+ + +F+ ILN ++ +
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215
Query: 933 PCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKAV-- 987
P+ +S +A D++ F+ +P RLG+ G + HPFFK ++W+ L ++ +
Sbjct: 216 ---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN-RRQIEP 271
Query: 988 -FVPQPESVDDTSYFLSRFSQ 1007
F P+ +S +D S F F +
Sbjct: 272 PFRPRIKSREDVSNFDPDFIK 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 2e-70
Identities = 126/324 (38%), Positives = 185/324 (57%), Gaps = 38/324 (11%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVR 750
I +G FG+V+ RK+ T ++A+KVL K +++ K ++ + ERNIL+ +PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
+SF +LYLV +Y++GG+L+ L+K G ED A+ YIAELVLALE+LH IV+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLKP+N+L+ GHI L DFGLSK L TDN+
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANL---------------------------TDNKTT 153
Query: 871 HSAVGTPDYLAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 928
++ GT +YLAPE+LL E GY D+WS+G+++FE G PF AE + ++ NI
Sbjct: 154 NTFCGTTEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212
Query: 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKAV 987
K+ +P + +S E + + L +P RLGA A E+K HPFF ++WD L+ ++
Sbjct: 213 KVRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQIT 270
Query: 988 --FVPQPESVDDTSYFLSRFSQIS 1009
F P +S +D S F F+ S
Sbjct: 271 PPFKPIVDSDEDVSNFDPEFTNSS 294
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 1e-69
Identities = 116/317 (36%), Positives = 179/317 (56%), Gaps = 35/317 (11%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 750
K + +G+FG+V LA + T + FAIK LKK ++ +D+E + ER +L +PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
F +F +++L+ VMEYLNGGDL ++ G +E AR Y AE++ L++LH GI++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEG---------------------------KA 153
Query: 871 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ GTPDY+APEIL G ++ + DWWS G++L+E + G PF E + +FD+ILN
Sbjct: 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DR 212
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--AVF 988
P P +S EA+D +++ DP +RLG +G +++ HPFF+G++W+ L ++ F
Sbjct: 213 PH--FPRWISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGIDWERLEKREIPPPF 268
Query: 989 VPQPESVDDTSYFLSRF 1005
P+ +S D S F F
Sbjct: 269 KPKVKSPSDASNFDREF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 2e-69
Identities = 123/319 (38%), Positives = 191/319 (59%), Gaps = 45/319 (14%)
Query: 687 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 742
+FE++K + GA+G+VFL RK + +G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 743 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
+R +PF+V Y+F L+L+++Y+NGG+L++ L + +E +IY E+VLALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--------------------------E 154
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE--- 916
+ + + +S GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT +
Sbjct: 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214
Query: 917 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 973
S I IL + P+ P +MS A+D+I R L+ DP +RLG + A E+K HPFF
Sbjct: 215 NSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271
Query: 974 KGVNWDSLALQKAVFVPQP 992
+ +NWD LA +K VP P
Sbjct: 272 QKINWDDLAAKK---VPAP 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 2e-68
Identities = 124/342 (36%), Positives = 184/342 (53%), Gaps = 38/342 (11%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 751
K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 811
Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEYLHS +V+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
+K +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
Query: 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 987
+ P +S EA+ L+ L DP QRLG + A EV H FF +NW + +K +
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270
Query: 988 FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDS 1028
F PQ S DT YF F+ S + P D+ Y +
Sbjct: 271 FKPQVTSEVDTRYFDDEFTAQSITITPPDR---YDSLGLLEL 309
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 1e-67
Identities = 133/347 (38%), Positives = 191/347 (55%), Gaps = 39/347 (11%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 751
K + +G FG+V L R++ +G +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 811
YSF +D L VMEY+NGG+L+ L + ED R Y AE+V AL+YLHS IV+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
LK +NL++ DGHIK+TDFGL K G+ TD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------TDAATMK 153
Query: 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
Query: 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 987
+ P +S +A+ L++ LI DPN+RLG + A E+ H FF GVNW + +K V
Sbjct: 214 F---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPP 270
Query: 988 FVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYSDADTCDSSSNSR 1033
F PQ S DT YF F+ Q + P ++ D D D N R
Sbjct: 271 FKPQVTSETDTRYFDEEFTAQTITITPPEK----YDEDGMDCMDNER 313
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 1e-67
Identities = 111/323 (34%), Positives = 186/323 (57%), Gaps = 37/323 (11%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 750
K + +G+FG+V LA + T +++AIKVLKK +++ +D++ + E+ IL + ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
F +D L+ VMEY+NGGDL +++ +E +R Y AE+ LAL +LH G+++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLK DN+L+ +GH KL DFG+ K G++N
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--------------------------- 153
Query: 871 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ GTPDY+APEIL E+G + DWW++G++++E + G PPF A++ + +F++IL+ +
Sbjct: 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLG----ANGAAEVKAHPFFKGVNWDSLALQ-- 984
+P +S EA ++ F+ +PN+RLG G +K HPFFK ++W L +
Sbjct: 214 LYPVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKI 270
Query: 985 KAVFVPQPESVDDTSYFLSRFSQ 1007
K F P+ ++ D + F F++
Sbjct: 271 KPPFKPKIKTKRDVNNFDQDFTK 293
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 3e-67
Identities = 129/324 (39%), Positives = 186/324 (57%), Gaps = 35/324 (10%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFEIIK I RGAFG V + + + T ++A+K+L K +M+++ + ERN+L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 804
++ Y+F + LYLVM+Y GGDL +LL K L ED+AR YIAE+VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
L VHRD+KPDN+L+ +GHI+L DFG S + + DG + S
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQ----------DGTVQSSV------- 162
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYA-----ADWWSVGIILFEFITGIPPFTAESPE 919
AVGTPDY++PEIL E G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 920 IIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ I+N + +P +D+S EA+DLI R LI +RLG NG + K H FF+G++
Sbjct: 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGID 273
Query: 978 WDSLALQKAVFVPQPESVDDTSYF 1001
W+++ +A ++P S DTS F
Sbjct: 274 WENIRNLEAPYIPDVSSPSDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 227 bits (579), Expect = 2e-66
Identities = 129/324 (39%), Positives = 190/324 (58%), Gaps = 35/324 (10%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+DFEI+K I RGAFG V + + + +FA+K+L K +M+++ + ER++L+ N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 804
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
L VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLME----------DGTVQSSV------- 162
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 919
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 920 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ I+N K +P +D+S +A+DLI R LI RLG NG + K HPFF G++
Sbjct: 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRR-LICSREHRLGQNGIEDFKQHPFFTGID 273
Query: 978 WDSLALQKAVFVPQPESVDDTSYF 1001
WD++ +A ++P+ S DTS F
Sbjct: 274 WDNIRNCEAPYIPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 3e-66
Identities = 97/290 (33%), Positives = 152/290 (52%), Gaps = 33/290 (11%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
++ + + RG+FG V+LA + TG+L A+K ++ + +E + E IL ++++P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHP 59
Query: 747 FVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+VR++ S ++ L + +EY++GG L SLL+K G L E V R Y +++ L YLHS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
GIVHRD+K N+L+ DG +KL DFG +K T +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE--------------------- 158
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
S GTP ++APE++ G E+G AAD WS+G + E TG PP++ +
Sbjct: 159 ----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214
Query: 925 -ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
I + P P +P +S EA+D + + L DP +R A E+ HPF
Sbjct: 215 KIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 5e-66
Identities = 115/319 (36%), Positives = 184/319 (57%), Gaps = 39/319 (12%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 750
K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L + +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--IYIAELVLALEYLHSLGIV 808
+ +F ++NL+ VMEYLNGGDL ++ C + D+ R Y AE++ L++LHS GIV
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 809 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 868
+RDLK DN+L+ DGHIK+ DFG+ K ++ DA +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENML----------------GDAKTCTF------ 156
Query: 869 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 928
GTPDY+APEILLG ++ + DWWS G++L+E + G PF E +F +I
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--- 208
Query: 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--A 986
++ PC P ++ EA+D++ + + +P +RLG G +++ HPFF+ ++W +L ++
Sbjct: 209 RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDWSALEEREIEP 266
Query: 987 VFVPQPESVDDTSYFLSRF 1005
F P+ +S +D S F F
Sbjct: 267 PFKPKVKSANDCSNFDKEF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 9e-66
Identities = 121/342 (35%), Positives = 190/342 (55%), Gaps = 39/342 (11%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 750
K I +G+FG+V LA++++ G +A+KVL+K +++K + I+AERN+L+ +++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
YSF + LY V++Y+NGG+L+ L++ C E AR Y AE+ A+ YLHSL I++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLKP+N+L+ GH+ LTDFGL K +G+ P +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGVEPEE------------TT 153
Query: 871 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNIL++ +
Sbjct: 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA-AEVKAHPFFKGVNWDSLALQKAV-- 987
+P + A DL+ L D +RLGA E+K H FF +NWD L ++
Sbjct: 214 Q---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPP 270
Query: 988 FVPQPESVDDTSYFLSRFSQ--ISSGL---PDDQNGSYSDAD 1024
+ P D +F F+Q +SS + PD S S +
Sbjct: 271 YNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASS 312
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 5e-64
Identities = 129/328 (39%), Positives = 186/328 (56%), Gaps = 37/328 (11%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
+P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 157
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
+HS+G +HRD+KPDN+L+ GH+KL DFG +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-----------KMNKEGMVRCD----- 201
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 917
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 918 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ I+N K + +P +D+S EA++LI FL D RLG NG E+K H FFK
Sbjct: 252 LVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309
Query: 976 VN--WDSLALQKAVFVPQPESVDDTSYF 1001
W++L A VP S DTS F
Sbjct: 310 DQWAWETLRDTVAPVVPDLSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 5e-64
Identities = 128/340 (37%), Positives = 186/340 (54%), Gaps = 36/340 (10%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 751
K + +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHR 810
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATM 153
Query: 871 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRL--GANGAAEVKAHPFFKGVNWDSLALQKAV- 987
+ P +S EA+ L++ L DP QRL G + A E+ H FF G+ W + +K V
Sbjct: 214 RF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVP 270
Query: 988 -FVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYSDADT 1025
F PQ S DT YF F+ Q+ + P DQ+ S D
Sbjct: 271 PFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDN 310
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 9e-64
Identities = 120/320 (37%), Positives = 181/320 (56%), Gaps = 34/320 (10%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 750
K I +G+FG+V LAR + +A+KVL+K +++K + + I++ERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
+SF D LY V++Y+NGG+L+ L++ C E AR Y AE+ AL YLHSL IV+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLKP+N+L+ GHI LTDFGL K + I N
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK---------------ENIEH------------NGTT 153
Query: 871 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + + ++DNILN+
Sbjct: 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-- 211
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKAV-- 987
P P +++ A+ L+ L D +RLGA + E+K H FF +NWD L +K
Sbjct: 212 PLQLKP-NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPP 270
Query: 988 FVPQPESVDDTSYFLSRFSQ 1007
F P +D +F F++
Sbjct: 271 FNPNVSGPNDLRHFDPEFTE 290
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 1e-63
Identities = 124/333 (37%), Positives = 180/333 (54%), Gaps = 42/333 (12%)
Query: 676 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERI 733
K + +DF I+ + G+FGRV LA + D AIK +K +I++ ++ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 734 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 793
+ER IL + +PF V + SF LYLV+E++ GG+ ++ LR+ DV Y A
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 794 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
++VL EYL SL IV+RDLKP+NLL+ DG IK+TDFG +K+
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV------------------ 180
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913
D R ++ GTP+Y+APEILL HG AADWW++GI ++E + G PPF
Sbjct: 181 -----------VDTRT-YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
Query: 914 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHP 971
A P +I+ IL I + P + + L+ + L HD +R G GA VK HP
Sbjct: 229 YANEPLLIYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285
Query: 972 FFKGVNWDSLALQKAVFVP-QP--ESVDDTSYF 1001
+F ++W SL L K V VP +P ++V D+S F
Sbjct: 286 WFGNIDWVSL-LHKNVEVPYKPKYKNVFDSSNF 317
|
Length = 340 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 1e-62
Identities = 125/324 (38%), Positives = 183/324 (56%), Gaps = 37/324 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+D++++K I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+ +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P+VV+ F +F LY+VMEY+ GGDL +L+ + E A+ Y AE+VLAL+ +HS+
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
G++HRD+KPDN+L+ GH+KL DFG M D +T
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTC-------------------MKMD-------ET 195
Query: 866 DNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
+AVGTPDY++PE+L +G DWWSVG+ LFE + G PF A+S
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT 255
Query: 922 FDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG--VN 977
+ I++ K P D +S A++LI FL D RLG NG E+K HPFFK N
Sbjct: 256 YSKIMDHKNSL-NFPEDVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKNDQWN 313
Query: 978 WDSLALQKAVFVPQPESVDDTSYF 1001
WD++ A VP+ S D+S F
Sbjct: 314 WDNIRETAAPVVPELSSDIDSSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 216 bits (550), Expect = 1e-62
Identities = 121/345 (35%), Positives = 187/345 (54%), Gaps = 43/345 (12%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 750
K I +G+FG+V LA+++ G +A+KVL+K ++ + + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
YSF + LY V++++NGG+L+ L++ E AR Y AE+ AL YLHS+ IV+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLKP+N+L+ GH+ LTDFGL K +GI SD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIAQSD------------TT 153
Query: 871 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ GTP+YLAPE++ + DWW +G +L+E + G+PPF ++DNIL++ +
Sbjct: 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQK--AV 987
+ S A ++ L D +RLGA E++ HPFF+ ++W L +K
Sbjct: 214 ---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP 270
Query: 988 FVPQPESVDDTSYFLSRFSQ--------ISSGLPDDQNGSYSDAD 1024
F P E DD S F + F++ SS N S +AD
Sbjct: 271 FNPNVEGPDDISNFDAVFTEETVPYSVCFSSD-YSIVNASVLEAD 314
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 1e-62
Identities = 119/351 (33%), Positives = 192/351 (54%), Gaps = 48/351 (13%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 750
K + +G+FG+V LA + G+ FA+K LKK ++ +D+E + E+ +L + NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
+ +F +++L+ VME+LNGGDL ++ G + A Y AE+V L++LHS GI++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLK DN+++ DGHIK+ DFG+ K + DNR
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFG--------------------------DNRAS 154
Query: 871 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ GTPDY+APEIL G ++ ++ DWWS G++L+E + G PF + + +F++I ++
Sbjct: 155 -TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RV 210
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--AVF 988
P P ++ E++D++ + DP +RLG G ++ HPFFK +NW +L ++ F
Sbjct: 211 DTPHYPRWITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINWTALEKRELDPPF 268
Query: 989 VPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDEC 1039
P+ +S D S F F L + SYSD + DS MD+
Sbjct: 269 KPKVKSPSDYSNFDREF------LSEKPRLSYSDKNLIDS-------MDQS 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 93/276 (33%), Positives = 151/276 (54%), Gaps = 34/276 (12%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+EIIK I +G+FG+V+L R+++ G L+ +K + +M K + E L E IL + +P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLNHP 59
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYL 802
+++++ SF + L +VMEY +GGDL ++K E+ + +L LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS I+HRD+KP N+ + +G +KL DFG+SK+ +++T+DL+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLA----------------- 160
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
+ VGTP YL+PE+ + Y +D WS+G +L+E T PF E+ +
Sbjct: 161 --------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
Query: 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
IL + P P PS S E ++L++ L DP +R
Sbjct: 213 LKILKGQYP-PI-PSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 5e-62
Identities = 118/339 (34%), Positives = 188/339 (55%), Gaps = 48/339 (14%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 752
I RG++ +V L + T ++A+KV+KK + DI+ + E+++ T N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 812
F L+ V+E+++GGDL +++ L E+ AR Y AE+ LAL +LH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 813 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 872
K DN+L+ +GHIKLTD+G+ K +GI P D +
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCK---------------EGIRPGDT------------TST 155
Query: 873 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESPE-----IIFD 923
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF +++P+ +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDS 980
IL ++I +P +S +A ++ FL DP +RLG + G ++K+HPFF+ ++WD
Sbjct: 216 VILEKQIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272
Query: 981 LALQKAV---FVPQPESVDDTSYFLSRFSQISSGL-PDD 1015
L QK V + P ES D F +F+ L PDD
Sbjct: 273 LE-QKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDD 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-61
Identities = 98/290 (33%), Positives = 149/290 (51%), Gaps = 41/290 (14%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
FEI++ I +G FG V+ AR + TG AIKV+K + K E+I+ E IL ++P
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSL 805
+V+++ S+ +D L++VME+ +GG L LL+ L E EL+ LEYLHS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
GI+HRD+K N+L+ DG +KL DFGLS Q +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------QLS 149
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 924
D + R++ VGTP ++APE++ G + Y AD WS+GI E G PP++ P + +F
Sbjct: 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-- 207
Query: 925 ILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
P + + S E +D + + L +P +R A ++ HPF
Sbjct: 208 -KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 218 bits (556), Expect = 5e-60
Identities = 88/154 (57%), Positives = 120/154 (77%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
SI++F I+KPISRGAFG+V+L RK+ L+A+KV+KK DMI KN + ++ AER+ L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803
++PF+V +YS +N+YLVMEYL GGD+ SLL G +E++A YI+E+ LAL+YLH
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837
GI+HRDLKPDN+LI+++GHIKLTDFGLSK+ L
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 9e-59
Identities = 96/304 (31%), Positives = 149/304 (49%), Gaps = 35/304 (11%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ +G FG V + + TG ++A K L K + ++ + L E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRD 811
+F +D+L LVM +NGGDL + VG E A Y A+++ LE+LH IV+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
LKP+N+L+ G+++++D GL+ ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA-----------------------VELKGGKKI-----K 152
Query: 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931
GTP Y+APE+L G + ++ DW+++G L+E I G PF ++ + + R +
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 932 WPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQKAV- 987
P S EA+DL L DP +RLG G A EV+ HP FK +NW L
Sbjct: 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEP 272
Query: 988 -FVP 990
F+P
Sbjct: 273 PFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 204 bits (519), Expect = 2e-58
Identities = 111/335 (33%), Positives = 183/335 (54%), Gaps = 35/335 (10%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 745
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L ++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
GI++RDLK DN+++ +GHIK+ DFG+ K + DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-----------DGV------------- 156
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PF E + +F +I
Sbjct: 157 ---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLAL 983
+ + + P MS EA + + P +RLG G ++K H FF+ ++W+ L
Sbjct: 214 MEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 270
Query: 984 QKAVFVPQPESVD-DTSYFLSRFSQISSGL-PDDQ 1016
++ +P++ D F F++ L P DQ
Sbjct: 271 KEVQPPYKPKACGRDAENFDKFFTRHPPVLTPPDQ 305
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 202 bits (514), Expect = 8e-58
Identities = 120/341 (35%), Positives = 191/341 (56%), Gaps = 50/341 (14%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFF 752
I RG++ +V L R + ++A+KV+KK + DI+ + E+++ NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 812
F L+LV+EY+NGGDL +++ L E+ AR Y AE+ +AL +LH GI++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 813 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 872
K DN+L+ DGHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCK---------------EGLGPGD------------TTST 155
Query: 873 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF--TAESPEI-----IFDNI 925
GTP+Y+APEIL G E+G++ DWW++G+++FE + G PF ++P++ +F I
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLA 982
L + I +P +S +A ++ FL DP +RLG G +++K+H FF+ ++WD L
Sbjct: 216 LEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLE 272
Query: 983 LQKAVFVP-QPESVDDTSYFLSRF-SQISSG----LPDDQN 1017
+K V P +P+ DD Y L F +Q +S PDD++
Sbjct: 273 -KKQVTPPFKPQITDD--YGLENFDTQFTSEPVQLTPDDED 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 3e-57
Identities = 116/340 (34%), Positives = 187/340 (55%), Gaps = 46/340 (13%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 752
I RG++ +V L R + T ++A+KV+KK + DI+ + E+++ N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 812
F L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 813 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 872
K DN+L+ +GHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCK---------------EGLRPGDT------------TST 155
Query: 873 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESP-----EIIFD 923
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF ++++P + +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDS 980
IL ++I +P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD
Sbjct: 216 VILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDL 272
Query: 981 LALQKAV--FVPQPESVDDTSYFLSRFSQISSGL-PDDQN 1017
+ ++ V F P F ++F+ L PDD +
Sbjct: 273 MEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDD 312
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 6e-57
Identities = 102/299 (34%), Positives = 169/299 (56%), Gaps = 33/299 (11%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 745
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
GI++RDLK DN+++ +GHIK+ DFG+ K ++ DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-----------DGV------------- 156
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLA 982
+ + + P +S EA + + P++RLG G +++ H FF+ ++WD L
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-56
Identities = 95/281 (33%), Positives = 136/281 (48%), Gaps = 69/281 (24%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ G FG V+LAR + TG AIK++KK D + +E +L E IL + +P +V+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDL 812
F ++LYLVMEY GG L LL++ G L ED + +++ LEYLHS GI+HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 813 KPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
KP+N+L+ D G +KL DFGLSK+ +D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLL---------------------------TSDKSLLK 151
Query: 872 SAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
+ VGTP Y+APE+LLG + +D WS+G+IL+E
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE------------------------- 186
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
+ E +DLI + L DP +R A E+ H
Sbjct: 187 --------LP-ELKDLIRKMLQKDPEKRPSAK---EILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 5e-53
Identities = 93/295 (31%), Positives = 147/295 (49%), Gaps = 39/295 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D E +K + +G+ G V+ R + TG ++A+K + + +++L E L + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCES 58
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 804
P+VV+ + +F + +V+EY++GG L LL+KVG + E V +++ L+YLH+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
I+HRD+KP NLLI G +K+ DFG+SK+ + NT+D
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD--------------------- 155
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII-- 921
++ VGT Y++PE + G + YAAD WS+G+ L E G PF P
Sbjct: 156 ----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 922 FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
I + P P + S E +D I+ L DP +R AAE+ HPF K
Sbjct: 212 MQAICDGPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 3e-52
Identities = 99/284 (34%), Positives = 146/284 (51%), Gaps = 33/284 (11%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I G FG+V+ A TG+L A+K ++ D K I+ I E +L +++P +V+++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKYYG 66
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813
R+ +Y+ MEY +GG L LL L+E V R+Y +L+ L YLHS GIVHRD+K
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 873
P N+ + H+G IKL DFG + + + E Q S
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVK----------------LKNNTTTMGEEVQ-------SL 163
Query: 874 VGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESPE--IIFDNILNR 928
GTP Y+APE++ G + HG AAD WS+G ++ E TG P++ E I+F
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH 223
Query: 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
K P P +S E +D ++R L DP +R A+E+ HPF
Sbjct: 224 KPPIP-DSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 7e-52
Identities = 94/289 (32%), Positives = 148/289 (51%), Gaps = 37/289 (12%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
++ ++ I GA G V+ A R TG AIK ++ +RK + E I+ E I+ ++P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 805
+V ++ S+ D L++VMEY++GG L ++ V E +A + E++ LEYLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
++HRD+K DN+L++ DG +KL DFG + L+
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQ--------LT-------------------K 168
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
+ R+S VGTP ++APE++ ++G D WS+GI+ E G PP+ E P I
Sbjct: 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ IP P S E +D +N+ L+ DP +R A E+ HPF K
Sbjct: 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-49
Identities = 99/312 (31%), Positives = 152/312 (48%), Gaps = 35/312 (11%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 805
VV Y++ +D L LV+ +NGGDL + +G +E+ A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA-----------------------VEIPEGETI 158
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
R VGT Y+APE++ + ++ DWW +G +++E I G PF ++ + +
Sbjct: 159 RGR-----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
Query: 926 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSL- 981
R S+ S A+ + + L DP RLG GA EVKAHPFF+ N+ L
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE 273
Query: 982 -ALQKAVFVPQP 992
+ + F P P
Sbjct: 274 AGMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 81/287 (28%), Positives = 143/287 (49%), Gaps = 33/287 (11%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
++++ I RGAFG V+ TGD AIK + I++ ++ I+ E ++L +++P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
+V++ S D+LY+++EY G L +++K G E + +Y+ +++ L YLH G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
++HRD+K N+L DG +KL DFG++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKL---------------------------NDV 152
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
+++ S VGTP ++APE++ + A+D WS+G + E +TG PP+ +P I+
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
P +P +S E +D + + DPN R A ++ HP+
Sbjct: 213 QD--DHPPLPEGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 6e-49
Identities = 88/282 (31%), Positives = 138/282 (48%), Gaps = 35/282 (12%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRF 751
+ G+FG V+ GD FA+K + D + ++++ E +L +++P +V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 811
+ DNLY+ +E + GG L LL+K G E V R+Y +++L LEYLH VHRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
+K N+L+ +G +KL DFG++K Q +
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK----------------------------QVVEFSFAK 159
Query: 872 SAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
S G+P ++APE++ +G AAD WS+G + E TG PP++ I K
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
P +P +S EA+D I + L DP+ R AAE+ HPF
Sbjct: 220 -LPPIPDHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 105/313 (33%), Positives = 157/313 (50%), Gaps = 37/313 (11%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 805
VV Y++ +D L LV+ +NGGDL + +G EE+ A Y AE++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
V+RDLKP+N+L+ GHI+++D GL+ KI PE + I
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKI-----------PEGESI------------ 158
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
R R VGT Y+APE+L + + D+W +G +++E I G PF ++ +
Sbjct: 159 ---RGR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212
Query: 925 ILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 981
+ R + V + S EA+ + L DP QRLG GA EVK HPFF+ +N+ L
Sbjct: 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272
Query: 982 --ALQKAVFVPQP 992
+ FVP P
Sbjct: 273 EAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 89/289 (30%), Positives = 144/289 (49%), Gaps = 34/289 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ F +++ I +G+FG V+ A + T + AIKV+ L+ +++IE I E L R+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-LEE-AEDEIEDIQQEIQFLSQCRS 58
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P++ +++ SF L+++MEY GG LL K G L+E + E++L LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
G +HRD+K N+L++ +G +KL DFG+S G + +T+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMS---------------------- 153
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 154 ---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
P + S +D ++ L DP +R A E+ H F K
Sbjct: 211 PKNNPP-SLEGNKFSKPFKDFVSLCLNKDPKERPSAK---ELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 176 bits (446), Expect = 4e-48
Identities = 117/403 (29%), Positives = 180/403 (44%), Gaps = 45/403 (11%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N 745
+ I++ + G+FG V+LAR R A+KVL K + ++ER L E IL ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYL 802
P +V+ + F +LYLVMEY++GG L LL+K G L E A +A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 803 HSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
HS GI+HRD+KP+N+L+ DG +KL DFGL+K+ P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL---------------------LPDPG 156
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPFTAES- 917
+ ++VGTP Y+APE+LLG Y ++D WS+GI L+E +TG+PPF E
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 918 ---PEIIFDNILNRKIPWPCVPSDMSF------EAQDLINRFLIHDPNQRLGANGA--AE 966
IL P P S A DL+ + L DP RL ++ +
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 967 VKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTC 1026
+ AH K + L + +S + ++ D + + +
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
Query: 1027 DSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1069
+ S + L + SL S ++ S +
Sbjct: 337 APNGVSSSP-HNSSSLLLSTASSKRSSLPKISARSSPSSLSSS 378
|
Length = 384 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 103/301 (34%), Positives = 152/301 (50%), Gaps = 41/301 (13%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 750
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 871 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF---TAESPEIIFDNIL 926
H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF + I L
Sbjct: 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ 984
+ P S E + L+ L D N+RLG GA EVK HPFF+ ++W + LQ
Sbjct: 213 TMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269
Query: 985 K 985
K
Sbjct: 270 K 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 103/313 (32%), Positives = 154/313 (49%), Gaps = 37/313 (11%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 805
VV Y++ +D L LV+ +NGGDL + +G EE A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
IV+RDLKP+N+L+ GHI+++D GL+ H PE Q
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA-----------------------VHVPEGQTI 158
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
R VGT Y+APE++ + ++ DWW++G +L+E I G PF +I + +
Sbjct: 159 KGR-----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
Query: 926 --LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSL 981
L +++ S +A+ L L DP +RLG G A EVK HP FK +N+ L
Sbjct: 214 ERLVKEVQEE-YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL 272
Query: 982 A--LQKAVFVPQP 992
+ + F P P
Sbjct: 273 EAGMLEPPFKPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-46
Identities = 90/306 (29%), Positives = 153/306 (50%), Gaps = 36/306 (11%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ +G FG V + R TG L+A K L K + ++ E + E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 754 SFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 809
+F + +L LVM +NGGDL Y++ + E A Y A+++ LE+LH I++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 810 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 869
RDLKP+N+L+ +DG+++++D GL+ E + ++
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV--------------------------ELKDGQSKT 154
Query: 870 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 929
+ A GTP ++APE+L G E+ ++ D++++G+ L+E I PF A ++ + R
Sbjct: 155 KGYA-GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213
Query: 930 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG-ANGA-AEVKAHPFFKGVNWDSL--ALQ 984
+ D S ++ L DP +RLG +G ++ HP F+ +NW L +
Sbjct: 214 LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGML 273
Query: 985 KAVFVP 990
FVP
Sbjct: 274 PPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 4e-45
Identities = 106/303 (34%), Positives = 157/303 (51%), Gaps = 45/303 (14%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 750
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
Y+F D L +++ +NGGDL+ L + G E R Y E++L LE++H+ +V+R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 871 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF----TAESPEIIFDNI 925
H++VGT Y+APE+L GT + +ADW+S+G +LF+ + G PF T + EI D +
Sbjct: 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRM 210
Query: 926 -LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 982
L + +P S E + L+ L D ++RLG GA EVK H FFKG++W +
Sbjct: 211 TLTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267
Query: 983 LQK 985
LQK
Sbjct: 268 LQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-45
Identities = 99/319 (31%), Positives = 147/319 (46%), Gaps = 70/319 (21%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 743
+E ++ + G +G V+ AR + TG++ A+K ++ LD N+ E I L E ++L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LD----NEEEGIPSTALREISLLKEL 55
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 802
++P +V+ LYLV EY + DL L K G L ++ + + +L+ L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS I+HRDLKP N+LI DG +KL DFGL++ I P + E
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI---------------PLRTYTHE- 158
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 920
V T Y APEILLG++H A D WSVG I E ITG P F +S EI
Sbjct: 159 -----------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-EID 206
Query: 921 ----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFLIHD 954
IF + +P + E DL+++ L ++
Sbjct: 207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYN 266
Query: 955 PNQRLGANGAAEVKAHPFF 973
P +R+ A A + HP+F
Sbjct: 267 PAKRISAKEALK---HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 5e-45
Identities = 88/299 (29%), Positives = 142/299 (47%), Gaps = 43/299 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 744
DD+E+I+ I GA V+ A + AIK ++D+ + ++ + E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIK---RIDLEKCQTSVDELRKEVQAMSQCN 57
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALEY 801
+P VV+++ SF D L+LVM YL+GG L +++ G L+E + + E++ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LHS G +HRD+K N+L+ DG +K+ DFG+S A +
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVS-----------------------ASLAD 154
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 919
+ R + VGTP ++APE+ + HGY AD WS GI E TG P++ P
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPEV-MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213
Query: 920 IIFDNILNRKIPWPCVPSDMSFEA-----QDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ L P + + ++ + +I+ L DP++R A E+ H FF
Sbjct: 214 KVLMLTLQN--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKR---PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 97/320 (30%), Positives = 139/320 (43%), Gaps = 68/320 (21%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVR 744
++I+ I GA G VF A+ R TG+ A+K K+ + R + L E L +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQ 57
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 803
+P+VV+ F LVMEY+ DL +LR L E + Y+ L+ + Y+H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
+ GI+HRDLKP NLLI+ DG +K+ DFGL++ + +
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLAR-----------------LFSEEEPRLYSH 159
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES----- 917
Q V T Y APE+L G D W+VG I E + G P F E+
Sbjct: 160 Q---------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210
Query: 918 ---------------PE---------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 953
P I F ++ IP + D S EA DL+ L++
Sbjct: 211 AIVFRTLGTPNEETWPGLTSLPDYNKITFPE--SKPIPLEEIFPDASPEALDLLKGLLVY 268
Query: 954 DPNQRLGANGAAEVKAHPFF 973
DP++RL AAE HP+F
Sbjct: 269 DPSKRL---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 85/286 (29%), Positives = 143/286 (50%), Gaps = 47/286 (16%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
D+E+++ I +G+FG V R+++ G + K + +M K + +++++E NIL +++P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHP 59
Query: 747 FVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 800
+VR++ R N LY+VMEY GGDL L++K +EE+ + +L+LAL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 801 YLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
H+ ++HRDLKP N+ + + ++KL DFGL+KI
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-------------------- 159
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915
D+ + VGTP Y++PE L + +D WS+G +++E PPFTA
Sbjct: 160 -------LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212
Query: 916 ESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ L KI + +P S E ++I L DP++R
Sbjct: 213 RNQL-----QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 98/312 (31%), Positives = 150/312 (48%), Gaps = 35/312 (11%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 805
VV Y++ +D L LV+ +NGGDL + +G +E A Y AEL LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA-----------------------VQIPEGETV 158
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
R VGT Y+APE++ ++ ++ DWW +G +++E I G PF + + +
Sbjct: 159 RGR-----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213
Query: 926 LNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 982
R K S +A+ + L +P +RLG NGAA VK HP FK +N+ L
Sbjct: 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE 273
Query: 983 --LQKAVFVPQP 992
+ + F P P
Sbjct: 274 ANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 84/292 (28%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ F+I++ + G++G V+ A + TG + AIKV+ + D++ I+ E +IL +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-----EEDLQEIIKEISILKQCDS 57
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAELVLALEYL 802
P++V+++ S+ +L++VMEY G D+ + K L E+ + + + LEYL
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYL 115
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS +HRD+K N+L+ +G KL DFG+S
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--------------------------- 148
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 921
R++ +GTP ++APE++ + AD WS+GI E G PP++ P I
Sbjct: 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
F I N+ P P S E D + + L+ DP +R A ++ HPF
Sbjct: 209 F-MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER---PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 98/299 (32%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+D+E+I+ I G +G V+ AR TG+L AIKV+K + +D E I E ++L R+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIA----ELVLA 798
P +V +F S+ RD L++VMEY GG D+Y + R G L E IA E +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQ----IAYVCRETLKG 113
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
L YLH G +HRD+K N+L+ DG +KL DFG+S + TI
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATI---------------- 155
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTA 915
R S +GTP ++APE + + GY D W++GI E PP
Sbjct: 156 ---------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
Query: 916 ESPEIIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
P I P P + S D I + L DP +R A ++ HPF
Sbjct: 207 LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR---PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-42
Identities = 70/131 (53%), Positives = 89/131 (67%), Gaps = 3/131 (2%)
Query: 874 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933
+GTPDYLAPE+LLG HG A DWW++G+ LFEF+TGIPPF E+P+ +F NILNR IPWP
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPE 993
+S AQ+ I L DP +R G E+K HP F GV+W++L Q F+PQP+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLK---ELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 994 SVDDTSYFLSR 1004
DTSYF +R
Sbjct: 658 DETDTSYFEAR 668
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 89/294 (30%), Positives = 144/294 (48%), Gaps = 39/294 (13%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
R+ +D+F I G+ G V +A ++TG A+K K+D+ ++ E + E I+
Sbjct: 18 RSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMR 71
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 800
++P +V + S+ D L++VME+L GG L ++ EE +A + VL AL
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALS 129
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
+LH+ G++HRD+K D++L+ DG +KL+DFG + +P
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA-------------QVSKEVP------ 170
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 --------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222
Query: 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
I + P +S + ++R L+ DP QR AAE+ HPF
Sbjct: 223 AMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 45/292 (15%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 744
DF+++K + +G++G V+ ++ + +A LK++D+ + ER + E IL +V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYA---LKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-----EEDVARIYIAELVLAL 799
+P ++ + +F + L +VMEY GDL + K E+++ RI+I +L+ L
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGL 116
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+ LH I+HRDLK N+L+ + +K+ D G+SK+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKV------------------------ 152
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
+ +GTP Y+APE+ G + Y +D WS+G +L+E T PPF A S +
Sbjct: 153 -----LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
+ + K +P +P S + Q+ I L P R + ++ A P
Sbjct: 208 DLRYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCD---KILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 102/325 (31%), Positives = 148/325 (45%), Gaps = 77/325 (23%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 745
+E I I G +G+V+ AR + TG+L A LKK+ M + + I A R I + +R+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 746 PFVVRFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 802
P +VR T + ++Y+V EY++ DL LL E + Y+ +L+ L+YL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS GI+HRD+K N+LI +DG +KL DFGL++ Y +
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLAR-----------------------PYTKR 153
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 918
D NR V T Y PE+LLG T +G D WSVG IL E G P F +
Sbjct: 154 NSADYTNR---VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210
Query: 919 -EIIFD-----NILNRKIPWPCVPSDMSF------------------------EAQDLIN 948
E IF+ N WP V S + + A DL++
Sbjct: 211 LEKIFELCGSPTDEN----WPGV-SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLD 265
Query: 949 RFLIHDPNQRLGANGAAEVKAHPFF 973
+ L DP +R+ A+ A + H +F
Sbjct: 266 KLLTLDPKKRISADQALQ---HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 97/301 (32%), Positives = 151/301 (50%), Gaps = 46/301 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DD E + + G G V R TG + A+K ++ L+ I + ++IL E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR-LE-INEAIQKQILRELDILHKCNS 58
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDV-ARIYIAELVLALEYLH 803
P++V F+ +F ++ + MEY++GG L +L++V G + E + +I +A ++ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLH 117
Query: 804 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
I+HRD+KP N+L+ G IKL DFG+S L+N+
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNSLAK------------------- 157
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--SPEI 920
+ VGT Y+APE + G ++ +D WS+G+ L E TG P+ E P+
Sbjct: 158 ---------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 921 IFD---NILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
IF+ I+N P P +PS S + QD +N LI DP +R E+ HPF K
Sbjct: 209 IFELLQYIVNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK---ELLEHPFIKKY 263
Query: 977 N 977
Sbjct: 264 E 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 7e-40
Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 67/325 (20%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITVRN 745
+E++KPI GA+G V A + TG AIK K+ + + I+ RIL E +L +R+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 746 PFVVR---FFY--SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 800
++ S +++Y+V E + DL+ +++ L +D + ++ +++ L+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
YLHS ++HRDLKP N+L+ + +K+ DFGL++ + + G +
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD-------EDEKGFLT------ 164
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP- 918
EY V T Y APE+LL + A D WSVG I E +T P F
Sbjct: 165 EY-----------VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213
Query: 919 ---EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRFL 951
+I + I + K P + S EA DL+ + L
Sbjct: 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKML 273
Query: 952 IHDPNQRLGANGAAEVKAHPFFKGV 976
+ DP +R+ A E AHP+ +
Sbjct: 274 VFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 8e-40
Identities = 91/317 (28%), Positives = 148/317 (46%), Gaps = 65/317 (20%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITVRN 745
++ + I G +G V+ AR + TG++ AIK K+ + +++ A R I L + +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 804
P +++ F + +LYLV E+++ DLY L++ L E + + Y+ +L+ L + HS
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
GI+HRDLKP+NLLI +G +KL DFGL++ Y Y
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS----------------FGSPVRPYTHY-- 158
Query: 865 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES------ 917
V T Y APE+LLG + D WSVG I E ++ P F +S
Sbjct: 159 ---------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
Query: 918 --------------PEII---FDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPN 956
P+ + + +P P + + S +A DL+++ L +DP+
Sbjct: 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 957 QRLGANGAAEVKAHPFF 973
+R+ A A AHP+F
Sbjct: 270 KRITAEQAL---AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-39
Identities = 87/285 (30%), Positives = 139/285 (48%), Gaps = 32/285 (11%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 749
K + +GAFGRV+L TG A+K + K ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 750 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 809
+++ + L + MEY+ GG + L+ G L E V R Y +++ +EYLHS IVH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 810 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 869
RD+K N+L G++KL DFG SK TI SG T +
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASK---RLQTICSSG------------------TGMK- 165
Query: 870 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNR 928
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF +
Sbjct: 166 --SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IAT 221
Query: 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ P +PS +S +A++ + R + + +R A E+ H F
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 6e-39
Identities = 87/304 (28%), Positives = 148/304 (48%), Gaps = 36/304 (11%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ +G FG V + + TG ++A K L K + +K+ + L E+ IL V +PF+V Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 811
+F + +L LVM +NGGDL + VG ++ R+ Y A++ + +LHS+ IV+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
+KP+N+L+ G+ +L+D GL+ + + R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA-----------------------VELKDGKTITQR--- 154
Query: 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931
GT Y+APEIL + Y DW+++G ++E + G PF ++ + + R +
Sbjct: 155 --AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 932 WPCVPSDMSF--EAQDLINRFLIHDPNQRLGANGAA-EVKAHPFFKGVNWDSLALQKAVF 988
+F E++D+ FL P RLG+ + + H FFK +N+ L +A
Sbjct: 213 DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL---EAGL 269
Query: 989 VPQP 992
+P P
Sbjct: 270 IPPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 96/320 (30%), Positives = 143/320 (44%), Gaps = 71/320 (22%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITV-R 744
+++IK + G FG V+LAR + TG+L AIK +KK + E + R + L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK----KFYSWEECMNLREVKSLRKLNE 56
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYL 802
+P +V+ F D LY V EY+ G +LY L+ RK E V R I +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
H G HRDLKP+NLL++ +K+ DFGL++ E P Y +Y
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------------EIRSRPP----YTDY 158
Query: 863 QQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF--TAESPE 919
V T Y APEILL T + D W++G I+ E T P F ++E +
Sbjct: 159 -----------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207
Query: 920 I--IFD-----------------NILNRKIPWPCVPSDMSF-------EAQDLINRFLIH 953
+ I + L + P P+ + EA DLI L
Sbjct: 208 LYKICSVLGTPTKQDWPEGYKLASKLGFRFP-QFAPTSLHQLIPNASPEAIDLIKDMLRW 266
Query: 954 DPNQRLGANGAAEVKAHPFF 973
DP +R A++ HP+F
Sbjct: 267 DPKKRP---TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 73/234 (31%), Positives = 114/234 (48%), Gaps = 34/234 (14%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVR 744
+E++ + GA+G V R + TG++ AIK K+ + ++K L E +L +R
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT----ALREVKVLRQLR 58
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+ +V +F + LYLV EY+ L L G L D R YI +L+ A+ Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
I+HRD+KP+N+L++ G +KL DFG ++ L + +Y
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARA--------LRA-------RPASPLTDY-- 161
Query: 865 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917
V T Y APE+L+G T +G D W++G I+ E + G P F +S
Sbjct: 162 ---------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 39/295 (13%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
D +EII + GAFG+V+ A+ + TG A K++ + + ++E + E +IL +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK 60
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLH 803
+P +V + ++ + L++++E+ +GG L S++ ++ L E R +++ AL +LH
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
S ++HRDLK N+L+ DG +KL DFG+S
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK-------------------------- 154
Query: 864 QTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 918
T + R + +GTP ++APE++ + Y AD WS+GI L E PP +P
Sbjct: 155 STLQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213
Query: 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ IL + P PS S D + L+ DP+ R AAE+ HPF
Sbjct: 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 9e-37
Identities = 83/275 (30%), Positives = 139/275 (50%), Gaps = 34/275 (12%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
DFEI+ I +G+FG VF ++ ++A+K + M R+ + E + E +L + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSS 59
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLH 803
+++R++ SF + L +VMEY GDL+ LL R E+ V R +I +++L L +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
S I+HRD+K NL + ++K+ D G++K+ L +NT +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTN-------------------FA 158
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923
T VGTP YL+PE+ + +D W++G++L+E TG PF A + +
Sbjct: 159 NT-------IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
I+ +P V S + LI++ L D QR
Sbjct: 212 KIIRGV--FPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 92/303 (30%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
FE+++ I G +G+V+ AR + TG L AIK++ I +++ E I E NIL N
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61
Query: 746 -PFVVRFFYSF------TCRDNLYLVMEYLNGG---DLYSLLRKVG-CLEEDVARIYIAE 794
P + F+ +F D L+LVME GG DL LRK G L+E+ + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ L YLH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-------------------- 161
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITG 909
+ T R R++ +GTP ++APE++ E + +D WS+GI E G
Sbjct: 162 ------QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
Query: 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969
PP P I P P + S + D I+ LI + QR E+
Sbjct: 215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR---PFMEELLE 271
Query: 970 HPF 972
HPF
Sbjct: 272 HPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 98/319 (30%), Positives = 139/319 (43%), Gaps = 66/319 (20%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 743
+E K + G + V+ AR + TG + AIK +K + RK + I L E +L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQEL 59
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYL 802
++P ++ F + N+ LV E++ DL +++ K L + Y+ + LEYL
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS I+HRDLKP+NLLIA DG +KL DFGL++ S
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----------------SFGS------- 154
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP--- 918
NR V T Y APE+L G H G D WSVG I E + +P +S
Sbjct: 155 ---PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211
Query: 919 -EIIFDNILNRKIP--WPCVPSDMSF--------------------EAQDLINRFLIHDP 955
IF L WP V S + +A DL+ R L +P
Sbjct: 212 LGKIF-EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 956 NQRLGANGAAEVKAHPFFK 974
N+R+ A A E HP+F
Sbjct: 271 NKRITARQALE---HPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 90/281 (32%), Positives = 134/281 (47%), Gaps = 34/281 (12%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I +GA G V+ A TG AIK + +K E I+ E ++ ++P +V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 873
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 874 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
P +S +D +NR L D +R A E+ HPF K
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 37/280 (13%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 750
I RGA+G V+ + TG + A+K++ LD +D+ I E +L +R P + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN-LDT-PDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
++ S+ L+++MEY GG + +L+ K G + E + I E+++AL+Y+H +G++HR
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125
Query: 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 870
D+K N+L+ + G++KL DFG++ Q ++ R
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAA--------------------------LLNQNSSK-R 158
Query: 871 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 929
+ VGTP ++APE++ G + AD WS+GI ++E TG PP++ I K
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK 218
Query: 930 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVK 968
P + + S ++ + L +P +RL A + K
Sbjct: 219 PPR--LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 5e-35
Identities = 95/297 (31%), Positives = 151/297 (50%), Gaps = 47/297 (15%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
RT +D+F IK I G+ G V +A +++G L A+K K+D+ ++ E + E I+
Sbjct: 19 RTYLDNF--IK-IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMR 72
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
++ VV + S+ D L++VME+L GG L ++ EE +A + +A L AL
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK-ALSV 131
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LH+ G++HRD+K D++L+ HDG +KL+DFG ++ +
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEV------------------- 170
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--- 918
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 ------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
Query: 919 -EIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
++I DN+ + K PS F ++R L+ DP QR A E+ HPF
Sbjct: 225 MKMIRDNLPPKLKNLHKVSPSLKGF-----LDRLLVRDPAQRATAA---ELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 91/296 (30%), Positives = 146/296 (49%), Gaps = 39/296 (13%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+EII + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +P+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPY 70
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLG 806
+V+ +F L++++E+ GG + +++ ++ L E ++ +++ AL+YLHS+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
I+HRDLK N+L+ DG IKL DFG+S N L
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTL---------------------- 164
Query: 867 NRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
+ R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P +
Sbjct: 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 223
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
I + P PS S E +D + L P R AA++ HPF V
Sbjct: 224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR---PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 92/281 (32%), Positives = 138/281 (49%), Gaps = 34/281 (12%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I +GA G VF A TG AIK ++++ ++ E I+ E ++ ++NP +V F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIK---QINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813
SF D L++VMEYL GG L ++ + C++E E + ALE+LH+ ++HRD+K
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 873
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 874 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
P +S +D +NR L D +R A E+ HPF K
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 89/281 (31%), Positives = 138/281 (49%), Gaps = 34/281 (12%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I +GA G V+ A TG AIK ++++ ++ E I+ E ++ +NP +V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIK---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813
S+ D L++VMEYL GG L ++ + C++E E + AL++LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 873
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 874 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
P +S +D +NR L D ++R A E+ HPF K
Sbjct: 236 QNPERLSAVFRDFLNRCLEMDVDRR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-34
Identities = 100/323 (30%), Positives = 156/323 (48%), Gaps = 68/323 (21%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRN- 745
+EI++ + +GA+G V+ A R T ++ A+K K D R D +R E L + +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 746 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYL 802
P +V+ ++ +YLV EY+ DL++++R LE DV + YI +L+ AL+Y+
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA-NILE-DVHKRYIMYQLLKALKYI 123
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID-LSGPETDGIMPSDAHYPE 861
HS ++HRDLKP N+L+ D +KL DFGL++ ++ L + ++ +
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLAR------SLSELEENPENPVLT------D 171
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG---------- 909
Y V T Y APEILLG+ Y D WSVG IL E + G
Sbjct: 172 Y-----------VATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
Query: 910 ---------IPPFTAE------SP--EIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFL 951
I P +AE SP + D++ +R P + S +A DL+ + L
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279
Query: 952 IHDPNQRLGANGAAEVKAHPFFK 974
+ +PN+RL A A E HP+
Sbjct: 280 VFNPNKRLTAEEALE---HPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 6e-34
Identities = 96/332 (28%), Positives = 139/332 (41%), Gaps = 91/332 (27%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR-- 744
+E + I GA+G V+ AR TG A LKK+ + L+E I L T+R
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVA---LKKVRVP--------LSEEGIPLSTLREI 49
Query: 745 ----------NPFVVRFF-YSFTCRDN----LYLVMEYLNGGDLYSLLRKV---GCLEED 786
+P +VR R + L LV E+++ DL + L K G L +
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPE 107
Query: 787 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846
+ + +L+ +++LHS IVHRDLKP N+L+ DG +K+ DFGL++I
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI----------- 156
Query: 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906
Y + S V T Y APE+LL + + D WSVG I E
Sbjct: 157 ------------Y-----SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
Query: 907 ITGIPPFTAESPEI-----IFDNI---------LNRKIPWPCVPS-----------DMSF 941
P F S E IFD I N +P PS ++
Sbjct: 200 FRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICE 258
Query: 942 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
E DL+ + L +P++R+ A E HP+F
Sbjct: 259 EGLDLLKKMLTFNPHKRI---SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 88/294 (29%), Positives = 150/294 (51%), Gaps = 41/294 (13%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
R+ ++++ IK I G+ G V +AR++ +G A+K++ D+ ++ E + E I+
Sbjct: 20 RSLLENY--IK-IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMR 73
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 800
++ VV + S+ + L+++ME+L GG L ++ + EE +A + E VL AL
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV--CESVLQALC 131
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHY 859
YLHS G++HRD+K D++L+ DG +KL+DFG ++I
Sbjct: 132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------------------------ 167
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
D R S VGTP ++APE++ T +G D WS+GI++ E + G PP+ ++SP
Sbjct: 168 ----SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV 223
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ + P +S +D + R L +P +R A E+ HPF
Sbjct: 224 QAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER---ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 79/282 (28%), Positives = 134/282 (47%), Gaps = 36/282 (12%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
+ +F+I K I +G F V+ A G + A+K ++ +M+ + L E ++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALE 800
+P V+++ SF + L +V+E + GDL +++ + E Y +L ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
++HS I+HRD+KP N+ I G +KL D GL + S T
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAA--------- 163
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920
HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 164 ----------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 921 --IFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRL 959
+ I K +P +P+D S E +DL++R + DP +R
Sbjct: 214 YSLCKKI--EKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 86/289 (29%), Positives = 142/289 (49%), Gaps = 39/289 (13%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRN 745
+ I+ + +GAFG L R+ L V K++++ R ++ ER A E IL +++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLV---VWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 803
P ++ ++ F + L + MEY NGG LY + +K EE++ Y+ ++V A+ Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
GI+HRD+K N+ + G IKL DFG+SKI + S+ E
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-----------------LGSEYSMAE-- 159
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923
+ VGTP Y++PE+ G ++ + +D W++G +L+E +T F A +P +
Sbjct: 160 --------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
I+ + V S S E L++ L DP +R A EV P
Sbjct: 212 KIVQGN--YTPVVSVYSSELISLVHSLLQQDPEKR---PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 41/280 (14%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILITV 743
E+ K + GAFG V+ + G+ A+K LK+ + E L E +I+ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIA-ELVLAL 799
+P +VR T + LY+V EY+ GGDL LRK G L++ + +A ++ +
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD---LLQMALQIAKGM 115
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
EYL S VHRDL N L+ + +K++DFGLS+ I D
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD----------------IYEDD--- 156
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918
Y++ ++APE L + +D WS G++L+E T G P+ S
Sbjct: 157 -YYRKRGG-----GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN 210
Query: 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
E + + + + P P + E +L+ + +DP R
Sbjct: 211 EEVLELLEDGYRL-PR-PENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 89/281 (31%), Positives = 136/281 (48%), Gaps = 34/281 (12%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +NP +V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 873
DN+L+ DG +KLTDFG I P + R +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 176
Query: 874 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933
VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P I P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
P +S +D +NR L D +R A E+ H F K
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKR---GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 85/289 (29%), Positives = 145/289 (50%), Gaps = 40/289 (13%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIK------VLKKLDMIRKNDIERILAERNILITVRNPF 747
I G+FG V+L ++G+L A+K V +++ ++ + E +L +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
+V++ S D+L + +EY+ GG + +LL G EE + R ++ +++ L YLH+ GI
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
+HRD+K N+L+ + G IK++DFG+SK N+ N
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLS---------------------TKTN 166
Query: 868 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF-TAESPEIIF---D 923
R S G+ ++APE++ T + AD WS+G ++ E +TG PF + IF +
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
N P +PS++S EA D + + D N+R AAE+ HPF
Sbjct: 227 NAS------PEIPSNISSEAIDFLEKTFEIDHNKR---PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 74/279 (26%), Positives = 144/279 (51%), Gaps = 36/279 (12%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 745
+ +K I G+FG+ L + + G + V+K++++ + + ER + + + + +++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQY---VIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 803
P +V++ SF NLY+VM+Y GGDLY + ++ ED + ++ LAL+++H
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
I+HRD+K N+ + DG IKL DFG++++ +N+T++L+
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA------------------ 158
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923
+ +GTP YL+PEI + +D W++G +L+E T F A + + +
Sbjct: 159 -------RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962
I+ +P V S S++ ++L+++ +P R N
Sbjct: 212 KIIRGS--YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVN 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 94/301 (31%), Positives = 143/301 (47%), Gaps = 46/301 (15%)
Query: 688 FEIIKP--ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL-------AERN 738
F+ +K I +G +GRV+LA TTG++ A+K ++ I R +E
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 739 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 798
L + + +V++ T + L + +EY+ GG + S LR G EE + R + +++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
L YLHS GI+HRDLK DNLL+ DG K++DFG+SK SD
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-------------------KSDDI 161
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF-TA 915
Y DN S G+ ++APE++ GY+A D WS+G ++ E G P+
Sbjct: 162 Y------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
Query: 916 ESPEIIFDNILNRKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
E+ +F L K P +P D +S A D +N +P+ R A E+ HP
Sbjct: 216 EAIAAMFK--LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR---ELLQHP 270
Query: 972 F 972
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 48/282 (17%)
Query: 689 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
+ K + GAFG V+ + A+K LK+ + IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 797
+P VV+ T + LY+VMEY+ GGDL S LRK ++ +++L+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIAR 113
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
+EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL--------------------- 152
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916
+ R + ++APE L + +D WS G++L+E T G P+
Sbjct: 153 --YDDDYYRKRGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
Query: 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
S E + + + N P + E DL+ + DP R
Sbjct: 208 SNEEVLEYLKNGYRLPQ--PPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 43/280 (15%)
Query: 689 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
+ K + GAFG V+ A+K LK+ IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY-----IAELVLAL 799
+P +V+ T + L +VMEY+ GGDL LRK E ++ + IA +
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR---GM 116
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL----------------------- 153
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918
+ + + ++APE L + +D WS G++L+E T G P+ S
Sbjct: 154 YDDDYYKVKGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN 210
Query: 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ + + P + E L+ + DP R
Sbjct: 211 AEVLEYLKKGYRLPK--PPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 84/279 (30%), Positives = 126/279 (45%), Gaps = 47/279 (16%)
Query: 697 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756
G +V L T F +K L+K + ER +I P +V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 757 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 816
D+++LV+++ GG L+S + K + E+ + + AE+V+AL+ LH GIV RDL P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 817 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 876
+L+ GHI+LT F E + +A +N
Sbjct: 116 ILLDDRGHIQLTYFS-------------RWSEVEDSCDGEA-------VENM-------- 147
Query: 877 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 936
Y APE+ +E A DWWS+G ILFE +TG I LN +P
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN-------IP 198
Query: 937 SDMSFEAQDLINRFLIHDPNQRLGANGAA--EVKAHPFF 973
+S EA+ L+ + L +P +RLGA A ++K+HPFF
Sbjct: 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 76/280 (27%), Positives = 116/280 (41%), Gaps = 42/280 (15%)
Query: 692 KPISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 748
K + GAFG V+ + K A+K LK+ + + + L E ++ + +P V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNV 58
Query: 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---------AL 799
VR T + LYLV+EY+ GGDL LRK + + ++ L +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
EYL S VHRDL N L+ D +K++DFGLS+ ++ T G +P
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK---TGGKLP----- 170
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918
R ++APE L +D WS G++L+E T G P+ S
Sbjct: 171 -------IR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
E + + + P P E +L+ DP R
Sbjct: 214 EEVLEYLRKGYRL-PK-PEYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 89/321 (27%), Positives = 138/321 (42%), Gaps = 74/321 (23%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 744
++I+ I G F V A+ R TG +AIK +KK +E++ R I R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 745 NPFVVRF----FYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLAL 799
+P ++R F T R L LV E ++ +LY L++ + L E + Y+ +L+ +L
Sbjct: 57 HPNILRLIEVLFDRKTGR--LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+++H GI HRD+KP+N+LI D +KL DFG + I P Y
Sbjct: 114 DHMHRNGIFHRDIKPENILI-KDDILKLADFGSCR------GIYSKPP-----------Y 155
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE-- 916
EY + T Y APE LL +G D W+VG + FE ++ P F
Sbjct: 156 TEY-----------ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
Query: 917 --------------SPEIIFD----NILNRKIP------WPCVPSDMSFEAQDLINRFLI 952
E++ +N P + + S E DL+ + L
Sbjct: 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLA 264
Query: 953 HDPNQRLGANGAAEVKAHPFF 973
+DP++R+ A A HP+F
Sbjct: 265 YDPDERITAKQALR---HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 101/347 (29%), Positives = 148/347 (42%), Gaps = 113/347 (32%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI------LAER 737
S+D++E + I G +G V+ AR + TG++ A LKKL K + E+ L E
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVA---LKKL----KMEKEKEGFPITSLREI 55
Query: 738 NILITVRNPFVVRFFYSFTCR--------DNLYLVMEYLNGGDLYSLLR---------KV 780
NIL+ +++P +V T + D +Y+VMEY+ DL SL+ +V
Sbjct: 56 NILLKLQHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEV 108
Query: 781 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840
CL + +L+ + +LH I+HRDLK NLL+ + G +K+ DFGL++
Sbjct: 109 KCL--------MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR------ 154
Query: 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 899
EY + V T Y APE+LLG E+ A D WSV
Sbjct: 155 --------------------EYGSP-LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193
Query: 900 GIILFEFITGIPPFTAESP----EIIFD-----------------------------NIL 926
G I E +T P F +S IF N L
Sbjct: 194 GCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL 253
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+K P +S DL+NR L +DP +R+ A A + HP+F
Sbjct: 254 RKKFP----ALSLSDNGFDLLNRLLTYDPAKRISAEDALK---HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 90/293 (30%), Positives = 144/293 (49%), Gaps = 37/293 (12%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
R +D F IK I G+ G V +A ++ TG A+K K+D+ ++ E + E I+
Sbjct: 21 REYLDSF--IK-IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMR 74
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
+ VV + S+ D L++VME+L GG L ++ EE +A + ++ ++ AL Y
Sbjct: 75 DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSY 133
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LH+ G++HRD+K D++L+ DG IKL+DFG + +P
Sbjct: 134 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA-------------QVSKEVP------- 173
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
R S VGTP ++APE++ +G D WS+GI++ E I G PP+ E P
Sbjct: 174 -------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
I + P +S + ++ L+ +P+QR A E+ HPF K
Sbjct: 227 MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 98/343 (28%), Positives = 152/343 (44%), Gaps = 78/343 (22%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFE + + G G V R +G + A K L L+ I+ +I+ E +L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARK-LIHLE-IKPAIRNQIIRELKVLHECNS 58
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 804
P++V F+ +F + + ME+++GG L +L+K G + E++ +I IA ++ L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLRGLTYLRE 117
Query: 805 -LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
I+HRD+KP N+L+ G IKL DFG+S LI++ +
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMAN-------------------- 156
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 920
S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 157 --------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208
Query: 921 IF---------------------------------DNILNRKIPWPCVPSD-MSFEAQDL 946
+F D I+N P P +PS S E QD
Sbjct: 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE--PPPKLPSGAFSDEFQDF 266
Query: 947 INRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFV 989
+++ L +P +R E+ HPF K + + A +V
Sbjct: 267 VDKCLKKNPKERA---DLKELTKHPFIK--RAELEEVDFAGWV 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 38/290 (13%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILITVRNPFVVR 750
+ GAF + AR TG L A+K + + +E + E ++ + +P ++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 751 FFYSFTCRDNLY-LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 809
TC D+ + L +E++ GG + LL K G +E V Y +L+ L YLH I+H
Sbjct: 68 M-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 810 RDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 868
RD+K NLLI G +++ DFG + + +G E G +
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAA--ARLAAKGTGAG-EFQGQL--------------- 168
Query: 869 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDN 924
+GT ++APE+L G ++G + D WSVG ++ E T PP+ AE +IF
Sbjct: 169 -----LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-K 222
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
I + P +P +S +D+ R L P R + E+ HP F+
Sbjct: 223 IASATTA-PSIPEHLSPGLRDVTLRCLELQPEDR---PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 95/323 (29%), Positives = 147/323 (45%), Gaps = 77/323 (23%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILIT 742
++ ++ I G +G V+ AR + TG++ A LKK IR + + E + + E ++L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA---LKK---IRLETEDEGVPSTAIREISLLKE 54
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 800
+ +P +VR + LYLV E+L+ DL + L+ + + Y+ +L+ +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
Y HS ++HRDLKP NLLI +G +KL DFGL++ G+ P
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--------------GV-------P 152
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP 918
T H V T Y APEILLG+ Y D WS+G I E + P F +S
Sbjct: 153 VRTYT-----HEVV-TLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDS- 204
Query: 919 EI-----IFDNILN--RKIPWPCVPSDMSF---------------------EAQDLINRF 950
EI IF L + WP V S + + DL+++
Sbjct: 205 EIDQLFRIF-RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKM 263
Query: 951 LIHDPNQRLGANGAAEVKAHPFF 973
L++DP +R+ A A + HP+F
Sbjct: 264 LVYDPAKRISAKAALQ---HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 86/333 (25%), Positives = 140/333 (42%), Gaps = 81/333 (24%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRKNDIE 731
++ I+ I GA+G V A +G AIK L++L ++R +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 732 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 791
I+A R+IL F ++Y+VM+ L DL+ ++ L E+ R +
Sbjct: 65 NIIAIRDILRPPGADF-----------KDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYF 112
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851
+ +L+ L+Y+HS ++HRDLKP NLL+ D +++ DFG+++ GL ++ +
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSPTEHKY----- 166
Query: 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFI--- 907
EY V T Y APE+LL E+ A D WSVG I E +
Sbjct: 167 ------FMTEY-----------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
Query: 908 ------------------TGIPP------FTAESPEIIFDNILNRK-IPWPCVPSDMSFE 942
G P ++ N+ ++ +PW + S E
Sbjct: 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE 269
Query: 943 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
A DL+++ L DP +R+ A + HPF
Sbjct: 270 ALDLLSQMLQFDPEERITVEQALQ---HPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 47/287 (16%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTG-DLFAIK-------VLKKLDMIRKNDIERILAERNI 739
+ +++ + GAFG V+ RK+ G +L A+K K R I I++E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 740 LI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNG---GDLYSLLRKVG--CLEEDVARIYIA 793
+ +R+P +VR++ +F D LY+VM+ + G G+ ++ L++ EE + I++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV- 120
Query: 794 ELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
++VLAL YLH IVHRDL P+N+++ D + +TDFGL+K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912
Q+ S VGT Y PEI+ +G AD W+ G IL++ T PP
Sbjct: 163 ----------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
Query: 913 FTAESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQR 958
F + + + I+ + +P M S + D+I L D R
Sbjct: 213 FYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 95/330 (28%), Positives = 139/330 (42%), Gaps = 79/330 (23%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILI 741
S+ +FE + I G +G V+ AR T+G++ A LKK+ M + D I L E +L+
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLL 61
Query: 742 TVRNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 798
+R+P +V + D+++LVMEY DL SLL + E + + +L+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
L+YLH I+HRDLK NLL+ G +K+ DFGL++
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART---------------------YG 159
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917
P T V T Y APE+LLG T + A D W+VG IL E + P +S
Sbjct: 160 LPAKPMTPK------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213
Query: 918 P----EIIFD-----------------------------NILNRKIPWPCVPSDMSFEAQ 944
++I N L K PW +S
Sbjct: 214 EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPW------LSEAGL 267
Query: 945 DLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
L+N L++DP +R A E +FK
Sbjct: 268 RLLNFLLMYDPKKRA---TAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 6e-30
Identities = 90/300 (30%), Positives = 136/300 (45%), Gaps = 60/300 (20%)
Query: 687 DFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
+ EI+K + G FG+V + + + T LF K++K + N IE V
Sbjct: 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---NAIE---------PMVH 62
Query: 745 -----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
NP ++ +YS T L+M+Y+ GDL+ LL+K G L E + I +LV AL
Sbjct: 63 QLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 800 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
LH I+H D+K +N+L I L D+GL KI I T D
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IG---------TPSCY--D-- 167
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918
GT DY +PE + G + + DWW+VG++ +E +TG PF +
Sbjct: 168 ----------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 919 EII-FDNILNR---KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
E + +++L R K+P ++S A D + L ++ N RL E+ HPF K
Sbjct: 212 EELDLESLLKRQQKKLP---FIKNVSKNANDFVQSMLKYNINYRL--TNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 84/287 (29%), Positives = 141/287 (49%), Gaps = 39/287 (13%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F ++ I +G+FG V+ T ++ AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
+ R++ S+ L+++MEYL GG LL K G LEE + E++ L+YLHS
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 868 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 925
+ R++ VGTP ++APE++ + + + AD WS+GI E G PP + P ++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--L 212
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ + P P + S ++ + L DP R A E+ H F
Sbjct: 213 IPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 83/233 (35%), Positives = 119/233 (51%), Gaps = 29/233 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 744
+ FE++ + GA+G V R + T ++ AIK K D ++ E L E +L T++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLK 58
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+V +F R LYLV EY+ L L + + R YI +L+ A+ + H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
IVHRD+KP+NLLI+H+ +KL DFG ++ +LS +G S+A+Y EY
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFAR--------NLS----EG---SNANYTEY-- 161
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917
V T Y +PE+LLG +G A D WSVG IL E G P F ES
Sbjct: 162 ---------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 96/330 (29%), Positives = 148/330 (44%), Gaps = 72/330 (21%)
Query: 664 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KK 721
S S SS S+ S+ S+ + E + I GA G V+ R TG L+A+KV+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 722 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 781
D +R+ +I E IL V +P VV+ F + +++E+++GG L +
Sbjct: 112 EDTVRR----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIA 165
Query: 782 CLEE--DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839
+ DVAR +++ + YLH IVHRD+KP NLLI ++K+ DFG+S+I +
Sbjct: 166 DEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LA 219
Query: 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 894
T+D P + S+VGT Y++PE + G GYA
Sbjct: 220 QTMD----------PCN---------------SSVGTIAYMSPERINTDLNHGAYDGYAG 254
Query: 895 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW------------PCVPSDMSFE 942
D WS+G+ + EF G PF + R+ W P P+ S E
Sbjct: 255 DIWSLGVSILEFYLGRFPFG-----------VGRQGDWASLMCAICMSQPPEAPATASRE 303
Query: 943 AQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ I+ L +P +R A ++ HPF
Sbjct: 304 FRHFISCCLQREPAKRWSAM---QLLQHPF 330
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 87/293 (29%), Positives = 143/293 (48%), Gaps = 39/293 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ +EII + GAFG+V+ A+ + TG L A KV+ D + ++E + E +IL + +
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDILASCDH 61
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 804
P +V+ +F +NL++++E+ GG + +++ ++ L E R+ + + AL YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
I+HRDLK N+L DG IKL DFG+S NT +
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTI-------------------- 157
Query: 865 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ I + P PS S E +D + + L + + R ++ HPF
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 85/302 (28%), Positives = 136/302 (45%), Gaps = 52/302 (17%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV--LKKLDMIRKNDIERILAERNILITV 743
+D E I + G G V + TG + A KV + +RK +IL E I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK----QILRELQIMHEC 60
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803
R+P++V F+ +F +N+ + ME+++ G L + +K G + ++ +V L YL+
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 804 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
+ I+HRD+KP N+L+ G IKL DFG+S LIN+ D
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD------------------- 160
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA------- 915
+ VGT Y++PE + G ++ +D WS+GI + E G PF
Sbjct: 161 ---------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 916 -ESPEIIFD---NILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970
+ P I D I+ P P +PS D + +D ++ L+ DP +R
Sbjct: 212 QDDPMGILDLLQQIVQE--PPPRLPSSDFPEDLRDFVDACLLKDPTER--PTPQQLCAMP 267
Query: 971 PF 972
PF
Sbjct: 268 PF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 92/328 (28%), Positives = 142/328 (43%), Gaps = 74/328 (22%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 744
D +E ++ I G +G+V+ AR + TG L A+K +L+M + L E ++L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 745 NPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLL----RKVGC-LEEDVARIYIAE 794
+ ++VR + +LYLV EYL+ DL + R G L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
L+ + + H G++HRDLKP NLL+ G +K+ D GL + +I +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----AFSIPVK-------- 166
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 912
H V T Y APE+LLG+ H D WSVG I E P
Sbjct: 167 --------------SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
Query: 913 FTAESPEI-----IFDNI--LNRKIPWPCV-------------PSDMSF-------EAQD 945
F +S E+ IF + ++ WP V P D+S E D
Sbjct: 212 FPGDS-ELQQLLHIFKLLGTPTEQV-WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD 269
Query: 946 LINRFLIHDPNQRLGANGAAEVKAHPFF 973
L+ + L +DP +R+ A A HP+F
Sbjct: 270 LLQKMLRYDPAKRISAKAALT---HPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 80/288 (27%), Positives = 136/288 (47%), Gaps = 39/288 (13%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+E I+ + RGAFG V L R++ L IK + M + E +L + +P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPN 60
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 805
++ ++ +F L +VMEY GG L ++K L+ED + +++LAL ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 806 GIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
I+HRDLK N+L+ H +K+ DFG+SKI LS S A
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LSS-------KSKA------- 158
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 923
++ VGTP Y++PE+ G + +D W++G +L+E + F A + P ++
Sbjct: 159 ------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
+ P + S + + LI L DP++R + ++ A P
Sbjct: 213 IMSGTFAP---ISDRYSPDLRQLILSMLNLDPSKRPQLS---QIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 37/286 (12%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
V +++ S+ L+++MEYL GG LLR G +E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 868 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI- 213
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
K P + + S ++ I+ L DP+ R A E+ H F
Sbjct: 214 -PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 77/286 (26%), Positives = 138/286 (48%), Gaps = 36/286 (12%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER----ILAERNILITVRNPFVV 749
+ +GA+G V+ G L A+K ++ LD E+ + E ++L ++++ +V
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQVE-LDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 750 RFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
+ Y TC D+ + + ME++ GG + S+L + G L E V Y +++ + YLH+ +
Sbjct: 66 Q--YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
VHRD+K +N+++ +G IKL DFG ++ + + L G ++ +
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG----LHGTHSNML-------------- 165
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
S GTP ++APE++ + +G +D WS+G +FE TG PP + I
Sbjct: 166 ----KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ P +P S A D + L D ++R A ++ H F
Sbjct: 222 AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER---PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 80/274 (29%), Positives = 136/274 (49%), Gaps = 33/274 (12%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+EIIK I G+FG+++LA+ ++ + IK + M K E E +L +++P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCL-EEDVARIYIAELVLALEYLHSL 805
+V FF SF L++VMEY +GGDL + R+ G L ED + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 806 GIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
I+HRD+K N+ ++ +G + KL DFG+++ +N++++L+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA------------------- 159
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
++ VGTP YL+PEI + D WS+G +L+E T PF + +
Sbjct: 160 ------YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
I P P + S + + LI++ P R
Sbjct: 214 ICQGYFA-PISP-NFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-28
Identities = 95/305 (31%), Positives = 138/305 (45%), Gaps = 51/305 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D +EII+ I +G +G+V+ + G L A+K+L D I D E I AE NIL ++ N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVD-EEIEAEYNILQSLPN 77
Query: 746 -PFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 795
P VV+F+ F D L+LV+E NGG + L L L+E + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
+L L++LH+ I+HRD+K +N+L+ +G +KL DFG+S
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 176
Query: 856 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEILLGTE---HGYAA--DWWSVGIILFEFITG 909
Q T R R+++VGTP ++APE++ + + Y A D WS+GI E G
Sbjct: 177 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969
PP P I P P I++ LI D R E
Sbjct: 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE--- 286
Query: 970 HPFFK 974
HPF K
Sbjct: 287 HPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 77/234 (32%), Positives = 112/234 (47%), Gaps = 33/234 (14%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
R +DFE+I+ I G +G V+ AR TG+L AIKV+K + D + E ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMK 61
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
++ +V +F S+ RD L++ ME+ GG L + G L E E + L Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LHS G +HRD+K N+L+ +GH+KL DFG+S I TI
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATI------------------- 160
Query: 862 YQQTDNRNRHSAVGTPDYLAPEI-LLGTEHGY--AADWWSVGIILFEFITGIPP 912
R S +GTP ++APE+ + + GY D W+VGI E PP
Sbjct: 161 ------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 78/273 (28%), Positives = 135/273 (49%), Gaps = 37/273 (13%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITVRNPFV 748
++ + +G++G V L R RT G + V+KKL++ + ER AE+ +L +++P +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQY---VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 749 VRFFYSFTCRDN-LYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 805
V + S+ D LY+VM + GGDLY L+ K L E+ + ++ +AL+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
I+HRDLK N+ + IK+ D G++++ + N D++
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMAS------------------- 160
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
+ +GTP Y++PE+ + Y +D W++G ++E T F A+ + I
Sbjct: 161 ------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ K+ P +P D S E +LI L P +R
Sbjct: 215 IEGKL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 95/317 (29%), Positives = 148/317 (46%), Gaps = 65/317 (20%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F+ ++ I G +G V+ AR + TG++ A+K ++ LD + + E ++L + +P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+V+ + LYLV E+L+ DL + + + + + Y+ +L+ L + HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
++HRDLKP NLLI +G IKL DFGL++ G+ P
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------------------PVRTY 157
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI--- 920
T H V T Y APEILLG + + A D WS+G I E +T F +S EI
Sbjct: 158 T-----HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQL 210
Query: 921 --IFDNI-LNRKIPWPCV--------------PSDMSF-------EAQDLINRFLIHDPN 956
IF + ++ WP V D S + +DL+++ L +DPN
Sbjct: 211 FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN 270
Query: 957 QRLGANGAAEVKAHPFF 973
+R+ A A AHPFF
Sbjct: 271 KRISAKAAL---AHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 88/289 (30%), Positives = 134/289 (46%), Gaps = 48/289 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D +EII+ I +G +G+VF + G A+K+L D I D E I AE NIL + +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDID-EEIEAEYNILKALSD 73
Query: 746 -PFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 795
P VV+F+ + +D L+LV+E NGG + L L++ +EE + + E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
++ L++LH +HRD+K +N+L+ +G +KL DFG+S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 172
Query: 856 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEIL-----LGTEHGYAADWWSVGIILFEFITG 909
Q T R R+++VGTP ++APE++ L + + D WS+GI E G
Sbjct: 173 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
Query: 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
PP P I P P S E D I + L D +R
Sbjct: 226 DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 37/279 (13%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+ +++ + G+FGR L + + +A+K ++ + +E E +L +++P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL--PKSSSAVEDSRKEAVLLAKMKHP 58
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHS 804
+V F SF +LY+VMEY +GGDL ++ + ED + ++ L ++++H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
++HRD+K N+ + +G +KL DFG +++ L+ P Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSP-----GAYACTY----- 160
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
VGTP Y+ PEI + +D WS+G IL+E T PF A S + N
Sbjct: 161 ---------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----WKN 207
Query: 925 ILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 961
++ + + + +PS S+E + LI + +P R A
Sbjct: 208 LILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSA 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 93/336 (27%), Positives = 144/336 (42%), Gaps = 92/336 (27%)
Query: 688 FEI------IKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRK 727
FE+ IKPI RGA+G V A+ T + AIK L+++ ++R
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 728 NDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 786
D E ++A ++I+ R F +++Y+V E L DL+ ++R L +D
Sbjct: 61 LDHENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDD 108
Query: 787 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846
+ ++ +L+ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------- 159
Query: 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFE 905
E M EY V T Y APE+LL +E+ A D WSVG I E
Sbjct: 160 -EKGDFM------TEY-----------VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 906 FITGIPPFTAE--------------SP-EIIFDNILN-------RKIP-WPCVP-----S 937
+ P F + SP E I N R +P P
Sbjct: 202 LLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP 261
Query: 938 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ A DL+ + L+ DP++R+ A HP+
Sbjct: 262 HANPLAIDLLEKMLVFDPSKRITVEEALA---HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 82/287 (28%), Positives = 141/287 (49%), Gaps = 39/287 (13%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG----------------------------QLTDT 154
Query: 868 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 925
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--L 212
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ + P P + + S ++ + L +P+ R A E+ H F
Sbjct: 213 IPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 51/303 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIERILAERNILITVR 744
D+ E++ + +G +G V+ R TG A+K ++ +LD + N +I+ E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN---QIIMELDILHKAV 57
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGD---LYSLLRKVGCLEEDVARIYIAELVLALEY 801
+P++V F+ +F +Y+ MEY++ G LY+ + EDV R +V L++
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 802 L-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
L I+HRD+KP N+L+ +G +KL DFG+S + S +T+
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN---------- 161
Query: 861 EYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYA-----ADWWSVGIILFEFITGIPPFT 914
+G Y+APE I G + +D WS+G+ + E G P+
Sbjct: 162 -------------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208
Query: 915 AESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
E+ IF + I P +PS S +AQD + + L PN+R A++ HP
Sbjct: 209 PETYANIFAQL--SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR---PTYAQLLEHP 263
Query: 972 FFK 974
+
Sbjct: 264 WLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 89/310 (28%), Positives = 135/310 (43%), Gaps = 59/310 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 743
+ + + GA G V R + TG +FA+K + N ++IL E I +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSC 56
Query: 744 RNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------YIAEL 795
++P++V+++ +F ++ + MEY GG L S+ +KV ++ RI IAE
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV---KKRGGRIGEKVLGKIAES 113
Query: 796 VL-ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
VL L YLHS I+HRD+KP N+L+ G +KL DFG+S L+N S T
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVN-----SLAGT----- 162
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914
GT Y+APE + G + +D WS+G+ L E PF
Sbjct: 163 ------------------FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 915 AESPEI-----IFDNILNRKIPW----PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965
E + I+N P P S E +D I + L DP +R
Sbjct: 205 PEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR---PTPW 261
Query: 966 EVKAHPFFKG 975
++ HP+ K
Sbjct: 262 DMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 77/280 (27%), Positives = 130/280 (46%), Gaps = 38/280 (13%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+F I K I RG F V+ A G A+K ++ D++ + E ++L + +P
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYL 802
V++++ SF + L +V+E + GDL +++ + E Y +L ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS ++HRD+KP N+ I G +KL D GL + +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR---------------------------F 155
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
+ HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY- 214
Query: 923 DNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 958
L +KI +P +PSD S E + L+N + DP +R
Sbjct: 215 --SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 35/286 (12%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 749
K + +GAFGRV+L TG A K ++ ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 750 RFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
+++ R L + MEY+ GG + L+ G L E V R Y +++ + YLHS I
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
VHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSG---TGI--------------- 166
Query: 868 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 926
S GTP +++PE++ G +G AD WS+G + E +T PP+ E+ IF +
Sbjct: 167 ---RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--I 221
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ P +PS +S A+D + + + R A E+ HPF
Sbjct: 222 ATQPTNPQLPSHISEHARDFLGCIFV-EARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
D+E+I+ + G +G V+ AR TG+L A+K++K + +D I E ++ ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHC 66
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
+V +F S+ R+ L++ MEY GG L + G L E E + L YLHS G
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
+HRD+K N+L+ +G +KL DFG++ I TI
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVA--AKITATI------------------------ 160
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPP 912
R S +GTP ++APE+ ++G D W+VGI E PP
Sbjct: 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 31/228 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI-LAERNILITVR 744
+ +E + I G++G VF R R TG + AIK K ++ I++I L E +L ++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLK 58
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+P +V F + L+LV EY + L L + + E + + I + + A+ + H
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+HRD+KP+N+LI G IKL DFG ++I L+GP D Y +Y
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARI--------LTGPGDD--------YTDY-- 160
Query: 865 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 911
V T Y APE+L+G T++G D W++G + E +TG P
Sbjct: 161 ---------VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 89/331 (26%), Positives = 135/331 (40%), Gaps = 64/331 (19%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI- 741
+ + D+EI+ + G FG V+ AR+ TG + A LKK+ M + D I A R I I
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKIL 61
Query: 742 -TVRNPFVVRF---FYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 791
+++P VV R ++Y+V Y++ DL LL L E + Y
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCY 120
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE-TD 850
+ +L+ + YLH I+HRD+K N+LI + G +K+ DFGL++ D P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP------YDGPPPNPKG 174
Query: 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 909
G Y + V T Y PE+LLG + A D W +G + E T
Sbjct: 175 GGGGGTRKYT-----------NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 910 IPPFTAESP----EIIFD-----------------NILNRKIPWPCVPS-DMSFEAQ--- 944
P +S +IF + + F
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283
Query: 945 --DLINRFLIHDPNQRLGANGAAEVKAHPFF 973
DL+++ L DP +RL A+ A HP+F
Sbjct: 284 GLDLLSKLLSLDPYKRLTASDA---LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 90/336 (26%), Positives = 138/336 (41%), Gaps = 83/336 (24%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--T 742
+ +E + I +G FG VF AR + T + A LKK+ M + + I A R I I
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQL 67
Query: 743 VRNPFVVRFF---------YSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIY 791
+++ VV Y+ + + YLV E+ DL LL + V ++ ++
Sbjct: 68 LKHENVVNLIEICRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV- 124
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL++ ++
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS------------ 172
Query: 852 IMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 909
+ NR++ V T Y PE+LLG G D W G I+ E T
Sbjct: 173 ------------KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
Query: 910 IPPFTAES----------------PEI--------IFDNI-----LNRKIP---WPCVPS 937
P + PE+ +F + RK+ P V
Sbjct: 221 SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD 280
Query: 938 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
A DLI++ L+ DP +R+ A+ A H FF
Sbjct: 281 P---HALDLIDKLLVLDPAKRIDADTALN---HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 82/276 (29%), Positives = 130/276 (47%), Gaps = 38/276 (13%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ +G +G V+ AR +T AIK + + D ++ + E + +++ +V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 810
S + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 811 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 869
D+K DN+L+ + G +K++DFG SK GI P +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSK-------------RLAGINPCTETF---------- 169
Query: 870 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 926
GT Y+APE++ GY AD WS+G + E TG PPF P+ +
Sbjct: 170 ----TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962
KI P +P +S EA++ I R DP++R A+
Sbjct: 226 MFKIH-PEIPESLSAEAKNFILRCFEPDPDKRASAH 260
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 83/267 (31%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 751
K + +GAFGRV+L TG A+K ++ D + + A + ++N R
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ-FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 752 FYSFTC-RD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
+ C RD L + ME++ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
IVHRD+K N+L G++KL DFG SK TI LSG G+
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSG---TGMK------------- 167
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNI 925
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF
Sbjct: 168 -----SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-- 220
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLI 952
+ + P +P +S +D + R +
Sbjct: 221 IATQPTNPVLPPHVSDHCRDFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 94/325 (28%), Positives = 146/325 (44%), Gaps = 78/325 (24%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILI 741
D+ I+ I G +G V+ R + TG + A +KK IR +++ E + + E ++L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVA---MKK---IRLESEEEGVPSTAIREISLLK 54
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLA 798
+++P +V LYL+ E+L+ DL L K ++ ++ + Y+ +++
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+ + HS ++HRDLKP NLLI + G IKL DFGL++ GI P +
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--------------AFGI-PVRVY 158
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917
E V T Y APE+LLG + D WS+G I E T P F +S
Sbjct: 159 THE------------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206
Query: 918 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 948
EI IF IL + WP V S ++ + DL+
Sbjct: 207 -EIDQLFRIF-RILGTPTEDV-WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLE 263
Query: 949 RFLIHDPNQRLGANGAAEVKAHPFF 973
+ LI+DP +R+ A A HP+F
Sbjct: 264 KMLIYDPAKRISAKKALN---HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 86/301 (28%), Positives = 144/301 (47%), Gaps = 48/301 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR 744
DD E+I+ + RGA+G V R TG + A+K ++ + + +R+L + +I + +V
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA--TVNSQEQKRLLMDLDISMRSVD 58
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 800
P+ V F+ + ++++ ME ++ L +KV + ED+ +V ALE
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 801 YLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
YLHS L ++HRD+KP N+LI +G +KL DFG+S
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG------------------------- 152
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEIL--LGTEHGY--AADWWSVGIILFEFITGIPPFTA 915
D+ + G Y+APE + + GY +D WS+GI + E TG P+
Sbjct: 153 ---YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 916 ESPEIIFDNILN-RKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+S + F + + P P +P++ S E QD +N+ L + +R E+ HPFF
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP---ELLQHPFF 264
Query: 974 K 974
+
Sbjct: 265 E 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
D + + + G G V+ A T + A+KV+ LD I ++I++E IL +P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP-LD-ITVELQKQIMSELEILYKCDSP 59
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
+++ F+ +F + + + E+++GG L + RK+ E + RI +A +V L YL SL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIP--EHVLGRIAVA-VVKGLTYLWSLK 115
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
I+HRD+KP N+L+ G +KL DFG+S Q
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST-----------------------------QLV 146
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913
N + VGT Y+APE + G ++G +D WS+GI E G P+
Sbjct: 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 94/328 (28%), Positives = 142/328 (43%), Gaps = 79/328 (24%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 743
D ++ + P+ GA+G+V A TG AIK KL ++ I +R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK---KLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 744 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 796
+ V+ FT +L YLV L G DL ++++ + L +D + + +++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQK--LSDDHIQFLVYQIL 128
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
L+Y+HS GI+HRDLKP N+ + D +K+ DFGL++ TD M
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-------------HTDDEM--- 172
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFT 914
T V T Y APEI+L H Y D WSVG I+ E +TG F
Sbjct: 173 --------TGY------VATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFP 217
Query: 915 AESPEIIFDNILN----------RKIP----------WPCVP--------SDMSFEAQDL 946
I+N +KI P +P S + A DL
Sbjct: 218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDL 277
Query: 947 INRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ + L+ DP++R+ AAE AHP+
Sbjct: 278 LEKMLVLDPDKRI---TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 90/321 (28%), Positives = 137/321 (42%), Gaps = 80/321 (24%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK--------LDMIRKNDIERILAERNILIT 742
++P+ GAFG V AR + TG AIK + K R+ + + L NI I+
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-IS 73
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 802
+ + F+ + +++Y V E L G DL+ LL LE+ + ++ +++ L+Y+
Sbjct: 74 LSDIFI-------SPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS G+VHRDLKP N+LI + +K+ DFGL++I D Y
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI-------------------QDPQMTGY 165
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 918
V T Y APEI+L ++ D WS G I E + G P F +
Sbjct: 166 -----------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214
Query: 919 -EIIFD----------------NILN--------RKIPWPCVPSDMSFEAQDLINRFLIH 953
II D N L +P+ + A DL+ + L+
Sbjct: 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF 274
Query: 954 DPNQRLGANGAAEVKAHPFFK 974
DP +R+ AAE AHP+
Sbjct: 275 DPQKRI---SAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 90/332 (27%), Positives = 146/332 (43%), Gaps = 82/332 (24%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAE-------- 736
D E +PI GAFG V+ G A LKK+ + +N +R+ E
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVA---LKKMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 737 -RNIL--ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 793
N+L + + P + F + +Y+V E + DL+ ++ L D ++++
Sbjct: 58 HDNVLSALDILQPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLY 110
Query: 794 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
+++ L+YLHS GI+HRD+KP NLL+ + +K+ DFGL+++
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV------------------ 152
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 912
+ ++++ V T Y APEIL+G+ H A D WSVG I E +
Sbjct: 153 --------EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRIL 204
Query: 913 FTAESP----EIIFD-------------------NILNRKIPWPCVP------SDMSFEA 943
F A+SP ++I D +IL P +P S + EA
Sbjct: 205 FQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEA 264
Query: 944 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
L+ R L+ DP++R+ AA+ AHP+
Sbjct: 265 VHLLCRMLVFDPDKRI---SAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 39/236 (16%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVL---KKLDMIRKNDIERILAERNI--LIT 742
+E + + G++G V + + TG + AIK + M++K +A R I L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKK------IAMREIRMLKQ 56
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 802
+R+ +V F + LYLV E+++ L L + L+E R Y+ +++ +E+
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P Y +Y
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAPGEV--------YTDY 160
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917
V T Y APE+L+G T++G A D W+VG ++ E +TG P F +S
Sbjct: 161 -----------VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 72/282 (25%), Positives = 134/282 (47%), Gaps = 38/282 (13%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
+ +F+I K I RG F V+ A A+K ++ +M+ + + E ++L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 800
+P V+++ SF + L +V+E + GDL ++ ++ + E Y +L A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
++HS ++HRD+KP N+ I G +KL D GL +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-------------------------- 154
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920
+ + HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 155 -FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 921 IFDNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 958
L +KI +P +P++ S + ++L++ + DP+QR
Sbjct: 214 F---SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 94/332 (28%), Positives = 143/332 (43%), Gaps = 74/332 (22%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERI 733
+ +D F+II I G +G+V+ AR + TG+L A+K ++ + IR+ I R
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 734 LAERNIL----ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVA 788
L RNI+ I + F + YLV EY++ DL LL + ED
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKD---KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 789 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848
+ ++ +L+ L Y H +HRD+K N+L+ + G IKL DFGL+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL------------- 165
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFI 907
Y ++R + V T Y PE+LLG E +G A D WS G IL E
Sbjct: 166 -------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
Query: 908 TGIPPFTAES--------------------PEII----FDNILNRKIPWPCVPSDMSF-- 941
T P F A P++I F+ + +K + + SF
Sbjct: 213 TKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIP 272
Query: 942 -EAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
A DL++ L DP++R A E P+
Sbjct: 273 TPALDLLDHMLTLDPSKRCTAE---EALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 41/289 (14%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVRNPFV 748
K + RGAFG V+L TG A+K + D ++ + E +L +R+ +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVP-FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 749 VRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
V+++ RD L + +EY+ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 67 VQYYGCL--RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
IVHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSG---TGI------------ 166
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFD 923
S GTP +++PE++ G +G AD WSV + E +T PP+ E+ IF
Sbjct: 167 ------KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK 220
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ + P +P +S +D + + + + + A + HPF
Sbjct: 221 --IATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPT----AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 49/247 (19%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 744
FE+++ + G +G+V+ R TG L AIKV+ + +++ E I E N+L R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 745 NPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 796
N + ++ +F + D L+LVME+ G + L++ L+ED E++
Sbjct: 74 N--IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
L +LH+ ++HRD+K N+L+ + +KL DFG+S
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 169
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIP 911
+ +T R R++ +GTP ++APE++ E + Y +D WS+GI E G P
Sbjct: 170 ----QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
Query: 912 PFTAESP 918
P P
Sbjct: 225 PLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 87/330 (26%), Positives = 147/330 (44%), Gaps = 83/330 (25%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-------------VLKKLDMIRKNDIER 732
++ + I GA+G V A + TG AIK L+++ ++R+ E
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 733 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 792
I+ +I+ F SF +++Y+V E + DLY L++ L D + ++
Sbjct: 65 IIGILDIIR-------PPSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFL 112
Query: 793 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
+++ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++I + D +G T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT--- 167
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGI 910
EY V T Y APEI+L GY A D WSVG IL E ++
Sbjct: 168 --------EY-----------VATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
Query: 911 PPFTAE--------------SPEII-FDNILNRK-------------IPWPCVPSDMSFE 942
P F + +P + I++ + +PW + + +
Sbjct: 208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPK 267
Query: 943 AQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
A DL+++ L +P++R+ E AHP+
Sbjct: 268 ALDLLDKMLTFNPHKRITVE---EALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 92/336 (27%), Positives = 145/336 (43%), Gaps = 84/336 (25%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 804
P++V F+ +F + + ME+++GG L +L+K G + E + ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-VIKGLTYLRE 121
Query: 805 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 920
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E+
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212
Query: 921 IF-----------------------------------------DNILNRKIPWPCVPSDM 939
+F D I+N P P +PS +
Sbjct: 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE--PPPKLPSGV 270
Query: 940 -SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
E QD +N+ LI +P +R ++ H F K
Sbjct: 271 FGAEFQDFVNKCLIKNPAERADLK---QLMVHAFIK 303
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 89/324 (27%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRN 745
+E+IK + +GA+G V AR T + + + KK+ + I +R L E +L R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAI-KKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 746 --------PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
+ F +F + LYL E L DL+ ++R L + + +I +++
Sbjct: 61 HKNITCLYDMDIVFPGNF---NELYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
L+Y+HS ++HRDLKP NLL+ D +K+ DFGL++ G N + +G
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAG----------- 164
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 916
EY V T Y APEI+L + A D WSVG IL E + P F +
Sbjct: 165 FMTEY-----------VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213
Query: 917 S-----PEIIF------DNILNR-----------------KIPWPCVPSDMSFEAQDLIN 948
+I+ + L+R K P+ + + + A DL+
Sbjct: 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273
Query: 949 RFLIHDPNQRLGANGAAEVKAHPF 972
+ L DP +R+ A E HP+
Sbjct: 274 KLLAFDPTKRISVEEALE---HPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 80/307 (26%), Positives = 141/307 (45%), Gaps = 50/307 (16%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 739
K ++D E + I G G+V+ R + TG + A+K +++ K + +RIL + ++
Sbjct: 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDV 66
Query: 740 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL 797
++ + P++V+ + F ++++ ME L L LL+++ G + ED+ +V
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 798 ALEYL---HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
AL YL H G++HRD+KP N+L+ G++KL DFG+S G +
Sbjct: 126 ALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS-----------------GRL- 165
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFITGI 910
D++ + + G Y+APE + ++ AD WS+GI L E TG
Sbjct: 166 ----------VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
Query: 911 PPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEV 967
P+ E + IL P +P + F + ++ L D +R E+
Sbjct: 216 FPYKNCKTEFEVLTKILQE--EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR---EL 270
Query: 968 KAHPFFK 974
HPF +
Sbjct: 271 LQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 94/330 (28%), Positives = 152/330 (46%), Gaps = 76/330 (23%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAERNILITVRN 745
++I + I +G++G V A TG+ AIK K++ + ++ D RIL E +L +R+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KINDVFEHVSDATRILREIKLLRLLRH 58
Query: 746 PFVV---RFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 800
P +V + R+ ++Y+V E L DL+ +++ L + + ++ +L+ AL+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
Y+H+ + HRDLKP N+L D +K+ DFGL+++ N+T P+ +
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDT------------PTAIFWT 164
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE- 916
+Y V T Y APE L G +++ A D WS+G I E +TG P F +
Sbjct: 165 DY-----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212
Query: 917 ---------------SPEII----------FDNILNRKIPWPCVPSDMSFEAQD-----L 946
SPE I + + + +K P VP F D L
Sbjct: 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP---VPFSQKFPNADPLALRL 269
Query: 947 INRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
+ R L DP R A E A P+FKG+
Sbjct: 270 LERLLAFDPKDR---PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 89/326 (27%), Positives = 135/326 (41%), Gaps = 83/326 (25%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--------MIRKNDIERILAERNI 739
F+ ++ + G + V+ R RTTG++ A+K + LD IR+ + + L NI
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIREISLMKELKHENI 60
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKV-GCLEEDVARIYIAELV 796
VR + L LV EY++ DL Y V G L+ + + + +L+
Sbjct: 61 ---------VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPS 855
+ + H ++HRDLKP NLLI G +KL DFGL++ G+ NT
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS------------ 158
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 914
+ V T Y AP++LLG+ + + D WSVG I+ E ITG P F
Sbjct: 159 ----------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202
Query: 915 AESPE----IIFDNI----------------LNRKIPWPCVPSDMSF-------EAQDLI 947
+ E IF + P P D+ DL+
Sbjct: 203 GTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP-RYPPQDLQQLFPHADPLGIDLL 261
Query: 948 NRFLIHDPNQRLGANGAAEVKAHPFF 973
+R L +P R+ A+ A HP+F
Sbjct: 262 HRLLQLNPELRISAHDAL---QHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 97/325 (29%), Positives = 146/325 (44%), Gaps = 72/325 (22%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LIT 742
+D +E ++ I G +G V+ AR R T + A LKK+ + ++++ A R I L
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKE 57
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED--VARIYIAELVLALE 800
+++ +VR LYLV EYL+ DL + ++ + + Y+ +++ +
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
Y HS ++HRDLKP NLLI + +KL DFGL++ GI P
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--------------AFGI-PVRTFT 161
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFTAES 917
E V T Y APEILLG+ H Y+ D WSVG I E + P F +S
Sbjct: 162 HE------------VVTLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
Query: 918 PEI-----IFDNILN--RKIPWPCVPSDMSFEAQ---------------------DLINR 949
EI IF IL + WP V S +++ DL+++
Sbjct: 209 -EIDELFKIF-RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSK 266
Query: 950 FLIHDPNQRLGANGAAEVKAHPFFK 974
L DP++R+ A A E H +FK
Sbjct: 267 MLRLDPSKRITARAALE---HEYFK 288
|
Length = 294 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 80/301 (26%), Positives = 136/301 (45%), Gaps = 53/301 (17%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 748 VVRFFYSFTCR-------DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLA 798
+ +Y + D L+LVME+ G + L++ K L+E+ E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
L +LH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------------------------ 159
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPF 913
+ +T R R++ +GTP ++APE++ E + + +D WS+GI E G PP
Sbjct: 160 --QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
Query: 914 TAESP-EIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
P +F L + P P + S S + Q I L+ + +QR ++ HP
Sbjct: 217 CDMHPMRALF---LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR---PTTEQLMKHP 270
Query: 972 F 972
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER---ILAERNILITVR 744
F ++ I G+FG V+ AR T ++ AIK K+ K E+ I+ E L +R
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNG--GDLYSLLRKVGCLEEDVARIYIAELVLALEYL 802
+P + + + +LVMEY G D+ + +K E ++A I L L YL
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQ-GLAYL 131
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS +HRD+K N+L+ G +KL DFG + + + P++
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASL----------------VSPAN------ 169
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 913
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 81/319 (25%), Positives = 135/319 (42%), Gaps = 69/319 (21%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 743
+E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L +
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLLKEL 56
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 802
++ +VR + L LV EY + DL G ++ ++ + ++ +L+ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
HS ++HRDLKP NLLI +G +KL DFGL++ GI P + E
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLAR--------------AFGI-PVRCYSAE- 159
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEF--------------- 906
V T Y P++L G + + D WS G I E
Sbjct: 160 -----------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
Query: 907 -------ITGIP-----PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 954
+ G P P ++ P+ + V ++ +DL+ L+ +
Sbjct: 209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCN 268
Query: 955 PNQRLGANGAAEVKAHPFF 973
P QR+ A A + HP+F
Sbjct: 269 PVQRISAEEALQ---HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 87/326 (26%), Positives = 137/326 (42%), Gaps = 75/326 (23%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNIL 740
++ ++ + + G++ V+ R + TG L A+K IR E + E ++L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLL 57
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLAL 799
+++ +V + L LV EYL+ DL + G L R+++ +L+ L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
Y H ++HRDLKP NLLI+ G +KL DFGL++ + PS +
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---------------PSKTYS 161
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----- 913
E V T Y P++LLG TE+ + D W VG I +E TG P F
Sbjct: 162 NE------------VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209
Query: 914 TAESPEIIFDNILNRKIP--WPCVPSDMSF------------------------EAQDLI 947
+ IF +L WP V S+ F ++L
Sbjct: 210 VEDQLHKIF-RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELA 268
Query: 948 NRFLIHDPNQRLGANGAAEVKAHPFF 973
+FL ++P +R+ AAE HP+F
Sbjct: 269 LKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 53/294 (18%)
Query: 686 DDFEIIKPISRGAFGRVF--LARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNIL 740
+ +I+ + +G+FG V+ LA+ G+ AIK + + +R + L E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVM 63
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA----------RI 790
VVR + +VME + GDL S LR E +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQKF 121
Query: 791 Y--IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848
AE+ + YL + VHRDL N ++A D +K+ DFG+++ I T D
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYET-DYYRKG 178
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
G++P ++APE L +D WS G++L+E T
Sbjct: 179 GKGLLPV----------------------RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
Query: 909 -GIPPFTAESPEIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRL 959
P+ S E + +++ P P + +L+ ++P R
Sbjct: 217 LAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKL----LELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 42/275 (15%)
Query: 697 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756
GA G V A++ + G+ FA+KV+ ++ + + D R AE L+ +V+ F
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101
Query: 757 CRDN--------LYLVMEYLNGGDLYSLLR---KVG-CLEEDVARIYIAELVLALEYLHS 804
+D + LV++Y N GDL ++ K E A + +++LA+ ++HS
Sbjct: 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS 161
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
++HRD+K N+L+ +G +KL DFG SK + T+
Sbjct: 162 KHMIHRDIKSANILLCSNGLVKLGDFGFSK--MYAATV---------------------- 197
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 923
+D+ R + GTP Y+APEI + AD +S+G++L+E +T PF E+ E++
Sbjct: 198 SDDVGR-TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ R P +P +S E Q+++ L DP +R
Sbjct: 257 TLAGRYDP---LPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-20
Identities = 72/242 (29%), Positives = 117/242 (48%), Gaps = 37/242 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFE I + G G V + + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 804
P++V F+ +F + + ME+++GG L +L++ + E++ ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-VLRGLAYLRE 121
Query: 805 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 920
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212
Query: 921 IF 922
IF
Sbjct: 213 IF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-20
Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 46/295 (15%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE------RILAERNILI 741
++II+ I +G G V+LA A LKK IR++ E R L E I
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVA---LKK---IREDLSENPLLKKRFLREAKIAA 57
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV---GCLEEDVA---------R 789
+ +P +V + + D +Y M Y+ G L SLL+ V L +++A
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 790 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG--LSKIGLINNTIDLSGP 847
I+ ++ +EY+HS G++HRDLKPDN+L+ G + + D+G + K + +D+
Sbjct: 118 IFH-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 848 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907
E I S P VGTPDY+APE LLG + D +++G+IL++ +
Sbjct: 177 ER-NICYSSMTIP----------GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
Query: 908 TGIPPFTAES-PEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 958
T P+ + +I + +++ I P+ +P +S + + L DP +R
Sbjct: 226 TLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-20
Identities = 85/274 (31%), Positives = 124/274 (45%), Gaps = 43/274 (15%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILITVRNPFVV 749
+ R F+A T G KV+ K M+ ND ER A E + L + +V
Sbjct: 75 VGRNPTTAAFVA---TRGSDPKEKVVAKFVML--ND-ERQAAYARSELHCLAACDHFGIV 128
Query: 750 RFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+ F F D L L+MEY +GGDL L++ +E + ++VLAL+ +HS
Sbjct: 129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
++HRDLK N+ + G IKL DFG SK + ++D++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS------------------- 229
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
S GTP YLAPE+ + AD WS+G+IL+E +T PF S I +
Sbjct: 230 ------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
Query: 926 LNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQR 958
L K P+PC S + L++ L +P R
Sbjct: 284 LYGKYDPFPCPVSS---GMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-20
Identities = 91/326 (27%), Positives = 141/326 (43%), Gaps = 75/326 (23%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 743
D + +K + GA+G V A R TG AIK KL ++++ +R E +L +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 71
Query: 744 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
++ V+ FT +L YLVM ++ G DL L+ K L ED + + +++
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLM-KHEKLSEDRIQFLVYQMLK 129
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
L+Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----------------------- 166
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 916
QTD+ V T Y APE++L H D WSVG I+ E +TG P F
Sbjct: 167 ------QTDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219
Query: 917 --------------SPEIIFDNILN--------------RKIPWPCVPSDMSFEAQDLIN 948
+P F L RK + + + + A +++
Sbjct: 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLE 279
Query: 949 RFLIHDPNQRLGANGAAEVKAHPFFK 974
+ L+ D R+ AAE AHP+F+
Sbjct: 280 KMLVLDAESRI---TAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 86/321 (26%), Positives = 133/321 (41%), Gaps = 60/321 (18%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERI---------LAERNILIT 742
+ G +G+V A TG + AIK +K ++ D + + L E I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 801
+++ ++ + D + LVM+ + DL ++ RK+ E V I + +++ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCI-LLQILNGLNV 134
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LH +HRDL P N+ I G K+ DFGL++ SD +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLAR-------------RYGYPPYSDTLSKD 181
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI 920
S V T Y APE+L+G E + +A D WSVG I E +TG P F E+ EI
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN-EI 240
Query: 921 -----IFDNILNRKIP--WP---CVPSDMSF-----------------EAQDLINRFLIH 953
IF +L WP +P F +A DL+ L
Sbjct: 241 DQLGRIF-ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299
Query: 954 DPNQRLGANGAAEVKAHPFFK 974
+P +R+ A A + H +FK
Sbjct: 300 NPLERISAKEALK---HEYFK 317
|
Length = 335 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 43/287 (14%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRNPFVVRF 751
+ +G+FG V+L + + +KVLK++ + N E + A E +L + +P +V+F
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE----LVLALEYLHSLGI 807
SF RD ++ EY G DL L ++ + ++ + E L+L + Y+H I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
+HRDLK N+ + ++ +K+ DFG+S+ L+ + DL+ T
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSR--LLMGSCDLATTFT------------------ 166
Query: 868 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 927
GTP Y++PE L + +D WS+G IL+E F ++ F +++
Sbjct: 167 -------GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVL 215
Query: 928 RKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
R + P P +P S + ++ L DP+ R AAE+ +PF
Sbjct: 216 RIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 49/245 (20%)
Query: 691 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVR 744
IK + G FG+V L R TG+ A+K L ++D ER E IL T+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFER---EIEILRTLD 64
Query: 745 NPFVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 797
+ +V++ +L L+MEYL G L L++ +I + L+L
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQI 118
Query: 798 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
++YL S +HRDL N+L+ + +K++DFGL+K ++P
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK-----------------VLPE 161
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915
D Y S + + APE L ++ A+D WS G+ L+E T P +
Sbjct: 162 DKDY----YYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
Query: 916 ESPEI 920
E
Sbjct: 215 PPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 9e-20
Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 63/264 (23%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 742
+ ++++E+IK I G FG VFL + + T + F K + + ++ + +++ E N++
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRE 68
Query: 743 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELV 796
+++ +VR+ F + N LY++ME+ + GDL ++K G +EE +L+
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 797 LALEYLHSLG-------IVHRDLKPDNLL----IAHDGHI-------------KLTDFGL 832
AL Y H+L ++HRDLKP N+ I H G I K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 833 SK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 891
SK IG+ HS VGTP Y +PE+LL
Sbjct: 189 SKNIGI-----------------------------ESMAHSCVGTPYYWSPELLLHETKS 219
Query: 892 Y--AADWWSVGIILFEFITGIPPF 913
Y +D W++G I++E +G PF
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 84/332 (25%), Positives = 137/332 (41%), Gaps = 85/332 (25%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIK------------VLKKLDMIRKNDIERILAERN 738
++P+ G+ G VF A A+K L+++ +IR+ D + I+
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 739 ILIT--VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
+L V +++Y+V EY+ DL ++L + G L E+ AR+++ +L+
Sbjct: 70 VLGPSGSDLTEDVGSLTEL---NSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLL 124
Query: 797 LALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
L+Y+HS ++HRDLKP N+ I D +K+ DFGL++I
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI-------------------V 165
Query: 856 DAHYPEYQQTDNRNRHSA-----VGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 909
D HY H + T Y +P +LL + A D W+ G I E +TG
Sbjct: 166 DPHY----------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
Query: 910 IPPFTA----ESPEIIFDNI----------LNRKIPW--------PCVP-----SDMSFE 942
P F E ++I +++ L IP P P ++ E
Sbjct: 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE 275
Query: 943 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
A D + + L +P RL A A HP+
Sbjct: 276 ALDFLEQILTFNPMDRLTAEEAL---MHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 90/326 (27%), Positives = 135/326 (41%), Gaps = 79/326 (24%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERILAERNI 739
+E + I GA+G V+ AR +G A+K ++ L +R E L +R
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR----EVALLKR-- 55
Query: 740 LITVRNPFVVRFF----YSFTCRD-NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYI 792
L +P +VR S T R+ + LV E+++ DL + L KV L + + +
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 793 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
+ + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++I +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT--------- 165
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912
V T Y APE+LL + + D WSVG I E P
Sbjct: 166 -------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206
Query: 913 FTAESPE----IIFDNI-LNRKIPWP--------------------CVPSDMSFEAQDLI 947
F S IFD I L + WP VP ++ L+
Sbjct: 207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVP-EIEESGAQLL 265
Query: 948 NRFLIHDPNQRLGANGAAEVKAHPFF 973
L +P++R+ A A + HPFF
Sbjct: 266 LEMLTFNPHKRISAFRALQ---HPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 81/318 (25%), Positives = 133/318 (41%), Gaps = 71/318 (22%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITVRNP 746
++ + G++ V+ R G L A+KV I E + + E ++L +++
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
+V ++ L V EY++ +++ G L R+++ +L+ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
I+HRDLKP NLLI++ G +KL DFGL++ I PS + E
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSI---------------PSQTYSSE----- 163
Query: 867 NRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF--TAESPEII-- 921
V T Y P++LLG T++ A D W G I E + G P F ++ E +
Sbjct: 164 -------VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
Query: 922 ---------------FDNILNRKIPW--PCVPSDM---------SFEAQDLINRFLIHDP 955
+ N K W PC P + +A+DL ++ L+ P
Sbjct: 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276
Query: 956 NQRLGANGAAEVKAHPFF 973
R+ A A HP+F
Sbjct: 277 KDRISAQDAL---LHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 3e-19
Identities = 83/322 (25%), Positives = 136/322 (42%), Gaps = 69/322 (21%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D +E ++ + G++ V+ + + G L A+KV++ + + + E ++L +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+V ++ L LV EY++ + + G L + ++++ +L+ L Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
I+HRDLKP NLLI+ G +KL DFGL++ + PS + E
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV---------------PSHTYSNE---- 163
Query: 866 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA-----ESPE 919
V T Y P++LLG TE+ D W VG I E I G+ F + E
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE 215
Query: 920 IIFDNILNRKIP----WPCVPSDMSFE------------------------AQDLINRFL 951
IF L P WP V S F+ A+DL ++ L
Sbjct: 216 RIF---LVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLL 272
Query: 952 IHDPNQRLGANGAAEVKAHPFF 973
P RL A A +H +F
Sbjct: 273 QCFPKNRLSAQAAL---SHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 84/308 (27%), Positives = 139/308 (45%), Gaps = 59/308 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILI 741
+D + + I RGAFG V + +G + A+K IR E R+L + ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEKEQKRLLMDLDVVM 57
Query: 742 TVRN-PFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSL--LRKVGCLEEDV-ARIYIAEL 795
+ P++V+F+ + + ++ ME ++ Y + E++ +I +A
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-T 116
Query: 796 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
V AL YL L I+HRD+KP N+L+ +G+IKL DFG+S G + ++I
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI------------ 162
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIP 911
+T + G Y+APE I GY +D WS+GI L+E TG
Sbjct: 163 --------AKTRD------AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208
Query: 912 PFTAESPEIIFDNILN-RKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAE 966
P+ + +FD + K P + + S + IN LI D ++R E
Sbjct: 209 PYPKWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK---E 263
Query: 967 VKAHPFFK 974
+ HPF K
Sbjct: 264 LLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 77/274 (28%), Positives = 115/274 (41%), Gaps = 45/274 (16%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I RG FG VF R R A+K + + + + + L E IL +P +VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 806
T + +Y+VME + GGD + LR G R+ + EL+ +EYL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH 114
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
+HRDL N L+ +K++DFG+S+ E DG+ S +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR------------EEEDGVYASTGGMKQ----- 157
Query: 867 NRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDN 924
P + APE L + +D WS GI+L+E F G P+ S + +
Sbjct: 158 ---------IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
I + + PC P L+ R +DP QR
Sbjct: 209 I-EQGVRLPC-PELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 78/242 (32%), Positives = 111/242 (45%), Gaps = 43/242 (17%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFA----IKVLKKLDMIRKNDIERILAERNILITV 743
+E + I GA+G+VF AR G F ++V + + + I + R+ L T
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETF 61
Query: 744 RNPFVVRFF----YSFTCRDN-LYLVMEYLNGGDLYSLLRKV---GCLEEDVARIYIAEL 795
+P VVR F S T R+ L LV E+++ DL + L KV G E + + + +L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-MFQL 119
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------------------- 159
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915
+Q S V T Y APE+LL + + D WSVG I E P F
Sbjct: 160 ----YSFQMALT----SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211
Query: 916 ES 917
S
Sbjct: 212 SS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 88/316 (27%), Positives = 130/316 (41%), Gaps = 76/316 (24%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITVRNP 746
+ G + VF R + T +L A+K ++ IR+ + + L NI +T+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-VTLHD- 70
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-DVARIYIAELVLALEYLHSL 805
++ T LV EYL+ DL L G L +I++ +L+ L Y H
Sbjct: 71 -IIHTERCLT------LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
I+HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV---------------PTKTYSNE---- 163
Query: 866 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----TAESPEI 920
V T Y P++LLG TE+ D W VG IL+E TG P F E +
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
Query: 921 IFDNI-LNRKIPWPCVPSDMSFE--------AQDLINR--------------FLIHDPNQ 957
IF + + WP + S+ F AQ LIN L+++
Sbjct: 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKS 275
Query: 958 RLGANGAAEVKAHPFF 973
R+ A A H +F
Sbjct: 276 RISAEAALR---HSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-18
Identities = 65/255 (25%), Positives = 104/255 (40%), Gaps = 29/255 (11%)
Query: 710 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYLVMEYL 768
TG AIK+L+ ++ R E + + +P +V S L+ V EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 769 NGGDLYSLLRKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---H 824
G L +L G L + R+ + +++ AL H+ GIVHRDLKP N++++ G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 825 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 884
K+ DFG+ + + +GTP Y APE
Sbjct: 121 AKVLDFGIGTLL------------------PGVRDADVATLTRT--TEVLGTPTYCAPEQ 160
Query: 885 LLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEA 943
L G +D ++ G+I E +TG S EI++ + + P P
Sbjct: 161 LRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP--PWIAGHPL 218
Query: 944 QDLINRFLIHDPNQR 958
++ + L DP QR
Sbjct: 219 GQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 8e-18
Identities = 91/347 (26%), Positives = 144/347 (41%), Gaps = 87/347 (25%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 748
+K + GA+G V A + TG+ AIK KL +++I +R E +L +++ V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIK---KLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 749 VRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLE--EDVARIYIAELVLALE 800
+ FT + YLVM Y+ + L+K+ ED + + +++ L+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
Y+HS GI+HRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADAEMT 172
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES-- 917
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 173 GY-----------VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221
Query: 918 --------------PEII--FDNILNRKI--PWPCVPS--------DMSFEAQDLINRFL 951
PE + ++ + P P S +A DL+ + L
Sbjct: 222 DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281
Query: 952 IHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 998
D ++RL A A E HP+F + + A + + DD+
Sbjct: 282 ELDVDKRLTATEALE---HPYFD-------SFRDADEETEQQPYDDS 318
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 67/248 (27%), Positives = 109/248 (43%), Gaps = 55/248 (22%)
Query: 688 FEIIKPISRGAFGRVFLAR--KRTTGDLFAIKVLK--KLDM-------IRKNDIERILAE 736
+EI I RG +GRV+ A+ G +AIK K K R+ + R L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIY 791
N+ +++ F+ S +YL+ +Y DL+ +++ K + + +
Sbjct: 62 ENV-VSLVEVFLEHADKS------VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINNTIDLSGP 847
+ +++ + YLHS ++HRDLKP N+L+ +G +K+ D GL++ L N +
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLAD 171
Query: 848 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFE 905
D + V T Y APE+LLG H Y A D W++G I E
Sbjct: 172 L-DPV---------------------VVTIWYRAPELLLGARH-YTKAIDIWAIGCIFAE 208
Query: 906 FITGIPPF 913
+T P F
Sbjct: 209 LLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-17
Identities = 88/326 (26%), Positives = 137/326 (42%), Gaps = 77/326 (23%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITV 743
+ ++ + P+ GA+G V A TG A+K L + +I +R E +L +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHM 73
Query: 744 RNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
++ V+ FT +++YLV +L G DL +++ K L +D + I +++
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQILR 131
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ TD M
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMT--- 175
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 916
V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 176 --------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
Query: 917 SPEIIFDNILN----------RKIP----------WPCVPSDMSFE---------AQDLI 947
IL +KI +P M+F A DL+
Sbjct: 222 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK-MNFANVFIGANPLAVDLL 280
Query: 948 NRFLIHDPNQRLGANGAAEVKAHPFF 973
+ L+ D ++R+ AA+ AH +F
Sbjct: 281 EKMLVLDSDKRI---TAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 691 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
I+ + +G FG V L R + TG++ A+K L+ D ER E IL ++++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIEILKSLQHD 65
Query: 747 FVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEY 801
+V+ Y C R NL LVMEYL G L L+K L+ +Y +++ +EY
Sbjct: 66 NIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
L S VHRDL N+L+ + +K+ DFGL+K+ +P D Y +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKV-----------------LPQDKEYYK 166
Query: 862 YQQTDNRNRHSAVGTPDY-LAPEILLGTEHGYAADWWSVGIILFEFIT 908
++ +P + APE L ++ A+D WS G++L+E T
Sbjct: 167 VREPGE--------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+++ + +LVMEY G DL + +K E ++A + L L YLHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGAL-QGLAYLHSH 134
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
++HRD+K N+L++ G +KL DFG + I + P++
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI----------------MAPAN--------- 169
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 913
VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I +G FG V+ + ++ A+K + + + L E IL +P +V+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 806
+ +Y+VME + GG L + LRK R+ + +L+ +EYL S
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
+HRDL N L+ + +K++DFG+S+ E GI Y +D
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------EEEGGI---------YTVSD 152
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 913
+ T APE L + +D WS GI+L+E F G P+
Sbjct: 153 GLKQIPIKWT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F ++ I G+FG V+ AR T ++ AIK + + I+ E L +++P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+ + + +LVMEY G DL + +K E ++A I L L YLHS
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSH 144
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
++HRD+K N+L+ G +KL DFG + I P++
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASI----------------ASPAN--------- 179
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 913
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 180 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
+ + ++ I +G FG V L R G A+K LK + LAE +++ T+
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTL 57
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEY 801
R+P +V+ + LY+V EY+ G L LR G + + ++ +EY
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
L VHRDL N+L++ D K++DFGL+K
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 38/225 (16%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I G+FG V+ A T ++ A+K + + I+ E L +++P + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 754 SFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 811
+ +LVMEY G DL + +K E ++A I L L YLHS ++HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSHNMIHRD 146
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
+K N+L+ G +KL DFG + S P +
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASK---------SSPA----------------------N 175
Query: 872 SAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 913
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 748
+KPI GA G V A TG AIK KL +N +R E ++ V + +
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 749 VRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALE 800
+ FT + +L YLVME ++ L +V ++ D R+ + +++ ++
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
+LHS GI+HRDLKP N+++ D +K+ DFGL++ M + Y
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------------GTSFMMTP--Y- 177
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 178 -------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 83/314 (26%), Positives = 129/314 (41%), Gaps = 72/314 (22%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILITVRNPFVV 749
+ G + V+ R + T +L A+K IR E + E ++L +++ +V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK------EIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 750 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIV 808
+L LV EYL+ DL L G + ++++ +L+ L Y H ++
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 809 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 868
HRDLKP NLLI G +KL DFGL++ I P+ + E
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSI---------------PTKTYSNE------- 164
Query: 869 NRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE----IIFD 923
V T Y P+ILLG T++ D W VG I +E TG P F + E IF
Sbjct: 165 -----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF- 218
Query: 924 NILNRKI--PWPCVPSDMSF----------------------EAQDLINRFLIHDPNQRL 959
IL WP + S+ F + +L+++ L + +R+
Sbjct: 219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278
Query: 960 GANGAAEVKAHPFF 973
A A + HP+F
Sbjct: 279 SAEEAMK---HPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ +++K + G FG V++ + AIK LK+ M E LAE N++ +++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 803
P +VR Y+ ++ +Y++ EY+ G L L+ ++ + ++ A++ + ++
Sbjct: 61 PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
+HRDL+ N+L++ K+ DFGL+++ I + EY
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDN-------------------EYT 158
Query: 864 QTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEI 920
R A + APE I GT +D WS GI+L E +T IP +PE+
Sbjct: 159 A-----REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
Query: 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
I + L R P P + E +L+ P +R
Sbjct: 213 IQN--LERGYRMPR-PDNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 68/235 (28%), Positives = 100/235 (42%), Gaps = 48/235 (20%)
Query: 694 ISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 748
+ GAFG+VFLA L A+K LK+ + D +R E +L +++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLE--EDVA--------RIYIAE 794
VRF+ T L +V EY+ GDL LR G L EDVA + IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 795 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
+ + + YL SL VHRDL N L+ +K+ DFG+S+
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------------------- 170
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
D + +Y + R P PE +L + +D WS G++L+E T
Sbjct: 171 --DIYSTDYYRVGGRTMLPIRWMP----PESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-15
Identities = 82/337 (24%), Positives = 139/337 (41%), Gaps = 84/337 (24%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 742
T + ++ +KPI GA G V A G A+K L + + +R E +L
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKC 76
Query: 743 VRNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 794
V + ++ FT + ++YLVME ++ L +V +E D R+ + +
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQ 131
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ N
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--------------- 176
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT------ 908
+ T V T Y APE++LG + D WSVG I+ E +
Sbjct: 177 -------FMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
Query: 909 ---------------GIPP--FTAESPEIIFDNILNRK----------IPWPCVPSD--- 938
G P F + + + NR P PS+
Sbjct: 224 GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESER 283
Query: 939 ---MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ +A+DL+++ L+ DP++R+ + E HP+
Sbjct: 284 DKLKTSQARDLLSKMLVIDPDKRISVD---EALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 33/229 (14%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 750
+K + G FG V L + R + AIK + + M ++ IE E +++ + +P +V+
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQ 63
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVH 809
+ T + LY+V E++ G L + LR + G L +D+ ++ +EYL +H
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 810 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 869
RDL N L++ G +K++DFG+++ L + SG A +P
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG----------AKFP--------- 164
Query: 870 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 917
+ PE+ +++ +D WS G++++E F G PF +S
Sbjct: 165 -------VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 82/322 (25%), Positives = 136/322 (42%), Gaps = 76/322 (23%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITV 743
++ + G + VF R + T +L A+K ++ IR+ + + L NI +T+
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-VTL 69
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYL 802
+ +V S T LV EYL+ DL + G + +I++ +++ L Y
Sbjct: 70 HD--IVHTDKSLT------LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
H ++HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV---------------PTKTYSNE- 164
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 919
V T Y P++LLG +E+ D W VG I FE +G P F + E
Sbjct: 165 -----------VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
Query: 920 --IIFDNI-LNRKIPWPCVPSDMSF----------------------EAQDLINRFLIHD 954
+IF + + WP + S+ F E +L+ +FL ++
Sbjct: 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYE 273
Query: 955 PNQRLGANGAAEVKAHPFFKGV 976
+R+ A E H +F+ +
Sbjct: 274 SKKRISAE---EAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-15
Identities = 85/327 (25%), Positives = 134/327 (40%), Gaps = 83/327 (25%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITVRN 745
++ + P+ GA+G V A A+K L + +I R E +L +++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHMKH 73
Query: 746 PFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
V+ FT ++ YLV L G DL +++ K L ++ + I +L+ L
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRGL 131
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+Y+HS GI+HRDLKP N+ + D +++ DFGL++
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR------------------------- 166
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 918
Q D+ V T Y APEI+L H D WSVG I+ E + G F P
Sbjct: 167 ----QADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF----P 217
Query: 919 EIIFDNILNRKI-----PWPCVPSDMSFE---------------------------AQDL 946
+ + L R + P P V +S E A DL
Sbjct: 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDL 277
Query: 947 INRFLIHDPNQRLGANGAAEVKAHPFF 973
+ + L+ D ++R+ A+E AHP+F
Sbjct: 278 LEKMLVLDSDKRI---SASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 35/231 (15%)
Query: 694 ISRGAFGR--VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 751
I + V LA+ + T L A+K + LD K D++ + E +++P ++ +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVH 809
SF LY+V + G LL+ L E + +++ AL+Y+HS G +H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124
Query: 810 RDLKPDNLLIAHDGHIKLTDF----GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
R +K ++L++ DG + L+ + K G +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP------------------- 165
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFT 914
+ S P +L+PE+L GY D +SVGI E G PF
Sbjct: 166 ----KSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKR---TTGD--LFAIKVLKK--LDMIRKNDIERILAERN 738
D + + + GAFG+VFL D L A+K LK+ + RK D ER E
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK-DFER---EAE 60
Query: 739 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------CL 783
+L ++ +V+F+ T D +V EY+ GDL LR G
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 784 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
+ +I + ++ + YL S VHRDL N L+ +D +K+ DFG+S+
Sbjct: 121 LSQLLQIAV-QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-14
Identities = 83/337 (24%), Positives = 139/337 (41%), Gaps = 84/337 (24%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 742
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 743 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 794
V + ++ FT + +L YLVME ++ L +V +E D R+ + +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQ 127
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T G
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSF 173
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------- 907
Y V T Y APE++LG + D WSVG I+ E +
Sbjct: 174 MMTPY--------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 908 ----------------TGIPPFTAESPEIIFDNILNRK----------IPWPCVPSD--- 938
T P F + + + + NR P P+D
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 939 ---MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ +A+DL+++ L+ DP +R+ + A + HP+
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDEALQ---HPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 77/299 (25%), Positives = 121/299 (40%), Gaps = 70/299 (23%)
Query: 691 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
I+ + G FG+V L TG++ A+K LK+ + ++N E NIL T+ +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNT-SGWKKEINILKTLYHE 66
Query: 747 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 797
+V+ Y C + L L+MEY+ G L L K ++ +A+L+L
Sbjct: 67 NIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQI 116
Query: 798 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
+ YLHS +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--------------------- 155
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915
PE + R R + A E L + YA+D WS G+ L+E +T
Sbjct: 156 --AVPEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK-- 210
Query: 916 ESPEIIFD----------------NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+SP F+ +L R + PC P + E L+ + R
Sbjct: 211 QSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC-PKNCPQEVYILMKNCWETEAKFR 268
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 79/298 (26%), Positives = 126/298 (42%), Gaps = 58/298 (19%)
Query: 687 DFEIIKPISRGAFGRVFLAR---KRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILI 741
D + + + GAFG+VFLA T D L A+K LK + + D +R E +L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 797
+++ +V+F+ D L +V EY+ GDL LR G L + R EL L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 798 A------------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845
+ + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----------- 171
Query: 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905
D + +Y + H+ + ++ PE ++ + +D WS G+IL+E
Sbjct: 172 ----------DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSFGVILWE 217
Query: 906 FIT-GIPPFTAESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRL 959
T G P+ S + + I ++ P C P E D++ +P QRL
Sbjct: 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVC-PK----EVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 8e-14
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 49/226 (21%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+ +IK ++ G+ GRVF+A K D +K+ +K L E +L V +P
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPS 118
Query: 748 VVR-----FFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 801
V+R + TC +V+ + + DLY+ L ++ L D A I +++ L Y
Sbjct: 119 VIRMKDTLVSGAITC-----MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LH+ I+HRD+K +N+ I + + D G ++ + P G+
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-------FPVVAPAFLGL--------- 216
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907
GT + APE+L ++ AD WS GI+LFE +
Sbjct: 217 ------------AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 44/236 (18%)
Query: 697 GAFG----RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 752
G FG V+ RK+ AIKVLK + K+ + ++ E I+ + NP++VR
Sbjct: 6 GNFGCVKKGVYKMRKKQID--VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 753 YSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALEYLHSLGI 807
C + L LVME +GG L L ++++ + EL+ + ++YL
Sbjct: 62 G--VCEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
VHRDL N+L+ + + K++DFGLSK + D++Y
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSK----------------ALGADDSYY-------- 152
Query: 868 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESPEII 921
+ R + + APE + + +D WS GI ++E F G P+ + PE++
Sbjct: 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+F + + + G FG V+ + + AIK+LK D++++ D ++ E L +R+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQK---EVQALKRLRHK 62
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-ALEYLHS 804
++ F + + +Y++ E + G L + LR VA I +A V + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+HRDL N+L+ D K+ DFGL+++ I + LS SD P Y+
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLS---------SDKKIP-YKW 170
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIP 911
T APE +D WS GI+L+E T +P
Sbjct: 171 T---------------APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 73/303 (24%), Positives = 131/303 (43%), Gaps = 71/303 (23%)
Query: 692 KPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
K + G FG+V F + R A+K+LK+ +++ +L+E N+L V +P
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE--NASSSELRDLLSEFNLLKQVNHP 63
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGC-------------LEEDVARI 790
V++ + + + L L++EY G L S LR KVG L+ R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 791 YIAELVLA--------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842
+++ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-------- 175
Query: 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGI 901
+ + D+ + S P ++A E L + +D WS G+
Sbjct: 176 ------------------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 902 ILFEFIT-GIPPFTAESPEIIFDNI-----LNRKIPWPCVPSDMSFEAQDLINRFLIHDP 955
+L+E +T G P+ +PE +F+ + + R P + S E +L+ +P
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER-------PENCSEEMYNLMLTCWKQEP 270
Query: 956 NQR 958
++R
Sbjct: 271 DKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 697 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756
G +G V+ + A+K LK+ M ++E L E ++ +++P +V+ T
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 757 CRDNLYLVMEYLNGGDLYSLLRKVGCLEED-VARIYIA-ELVLALEYLHSLGIVHRDLKP 814
Y++ E++ G+L LR+ E + V +Y+A ++ A+EYL +HRDL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 815 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 874
N L+ + +K+ DFGLS++ D H+
Sbjct: 133 RNCLVGENHLVKVADFGLSRL---------------------------MTGDTYTAHAGA 165
Query: 875 GTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 691 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
I+ + G FG+V L R TG+ A+K LK N I + E IL + +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 66
Query: 747 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 801
+V+ Y C ++ + L+ME+L G L L R + Y ++ ++Y
Sbjct: 67 NIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
L S VHRDL N+L+ + +K+ DFGL+K + +D Y
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----------------IETDKEY-- 165
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
Y D+ + S V + APE L+ ++ A+D WS G+ L+E +T
Sbjct: 166 YTVKDDLD--SPVF---WYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 43/228 (18%)
Query: 694 ISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 750
+ +G FG VF L K A+K K+ D+ ++ I + L+E IL +P +V+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV----AVKTCKE-DLPQELKI-KFLSEARILKQYDHPNIVK 56
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----ALEYLHSLG 806
T R +Y+VME + GGD S LRK ++++ + + L + YL S
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
+HRDL N L+ + +K++DFG+S+ E DGI S +Q
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------QEDDGIYSSSG----LKQIP 157
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 913
+ + APE L + +D WS GI+L+E F G+ P+
Sbjct: 158 IK----------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
D +K + G FG V + R D+ AIK++K+ M IE E +++ + +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSHE 59
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSL 805
+V+ + T + +Y+V EY++ G L + LR+ G + + + + V + YL S
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
+HRDL N L+ G +K++DFGLS+ L D Y
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL------------------DDEYT----- 156
Query: 866 DNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
S+VG+ + PE+LL ++ +D W+ G++++E +
Sbjct: 157 ------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
+RTSI ++++ + G FG V+ T + A+K LK M D + LAE I+
Sbjct: 4 DRTSI---QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIM 55
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEE--DVARIYIAE 794
+R+P +++ + T + +Y+V E + G L L+ L + D+A A+
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQ 111
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ + YL + +HRDL N+L+ + K+ DFGL+++ I
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV----------------IKE 155
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
Y+ R A + APE L +D WS GI+L E +T
Sbjct: 156 D-----IYEA-----REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-13
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 42/235 (17%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 742
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 79
Query: 743 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 794
V + ++ FT + +L Y+VME ++ L +V +E D R+ + +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQ 134
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T + P
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY------ 185
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 186 -------------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-13
Identities = 89/331 (26%), Positives = 138/331 (41%), Gaps = 77/331 (23%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERNIL 740
R+ +++ I G+FG V+ A T + AIK VL+ D KN I+ N +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ--DPQYKNRELLIMKNLNHI 119
Query: 741 ITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGG-----DLYSLLRKVGCLEEDVARI 790
+ F+ ++Y+ + N L +VME++ Y+ R L + ++
Sbjct: 120 NII---FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--RNNHALPLFLVKL 174
Query: 791 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPET 849
Y +L AL Y+HS I HRDLKP NLLI + H +KL DFG +K +L
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLA--- 223
Query: 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 908
+ S + + Y APE++LG T + D WS+G I+ E I
Sbjct: 224 -----------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 909 GIPPFTAESP-------------------EIIFDNILNRKIP-------WPCVPSDMSFE 942
G P F+ +S + + N + K P P +
Sbjct: 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDD 326
Query: 943 AQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
A + I++FL ++P +RL E A PFF
Sbjct: 327 AINFISQFLKYEPLKRL---NPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 54/238 (22%)
Query: 685 IDDFEI--IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 742
ID E+ +K + G FG V L + R D+ AIK++++ M + IE E +++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMK 55
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 797
+ +P +V+ + T + +++V EY+ G L + LR+ E +L
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG-------TEWLLDMCSD 108
Query: 798 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
A+EYL S G +HRDL N L+ D +K++DFGL++ L
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL----------------- 151
Query: 855 SDAHYPEYQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFITG 909
D Y S+ GT + PE+ + +D WS G++++E +
Sbjct: 152 -DDQYT-----------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 48/235 (20%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
R S+ ++ + + G FG V++ T + A+K LK M E L E I+
Sbjct: 5 RESL---KLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMK 56
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAE 794
+R+ +V+ + + + +Y+V EY++ G L L+ ++ L + A+I AE
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AE 114
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIM 853
+ YL S +HRDL N+L+ + + K+ DFGL++ LI E D
Sbjct: 115 ---GMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLAR--LI---------EDD--- 156
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
EY R A + APE +D WS GI+L E +T
Sbjct: 157 -------EYTA-----REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 52/264 (19%)
Query: 684 SIDDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
S D + KP+ G FG+V +A K A+K+LK D + D+ +++E
Sbjct: 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSE 70
Query: 737 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIY 791
++ + ++ ++ + T LY+++EY + G+L LR D+AR+
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 792 IAELVL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839
++ +EYL S +HRDL N+L+ + +K+ DFGL++ +N
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--VN 188
Query: 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 899
N ID T+G +P ++APE L + + +D WS
Sbjct: 189 N-IDYYKKTTNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSF 225
Query: 900 GIILFEFIT-GIPPFTAESPEIIF 922
G++++E T G P+ E +F
Sbjct: 226 GVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I G FG V + TG A+K +K D+ + L E ++ + + +VR
Sbjct: 14 IGEGEFGAVL--QGEYTGQKVAVKNIK-CDVT----AQAFLEETAVMTKLHHKNLVRLL- 65
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA--LEYLHSLGIVHRD 811
+ LY+VME ++ G+L + LR G V ++ L +A +EYL S +VHRD
Sbjct: 66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
L N+L++ DG K++DFGL+++G +
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVG------------------------------SMGVD 155
Query: 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 913
++ + APE L + +D WS G++L+E F G P+
Sbjct: 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 33/240 (13%)
Query: 692 KPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 748
K + G+FG V + G + A+K LK + + ++ L E I+ ++ + +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENL 58
Query: 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLG 806
+R Y L +V E G L LRK ++ + Y ++ + YL S
Sbjct: 59 IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
+HRDL N+L+A D +K+ DFGL + L N + H Y +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN---------------EDH---YVMEE 158
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNI 925
+ A + APE L +A+D W G+ L+E F G P+ S I I
Sbjct: 159 HLKVPFA-----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 47/281 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++IK + G FG V++ + A+K LK M E L E I+ +R+
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM----SPESFLEEAQIMKKLRH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVLA 798
+V+ Y+ + +Y+V EY++ G L L+ K+ L D+A A++
Sbjct: 61 DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV-DMA----AQVAAG 114
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+ Y+ + +HRDL+ N+L+ K+ DFGL++ LI +
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDN----------------- 155
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917
EY R A + APE L +D WS GI+L E +T G P+ +
Sbjct: 156 --EYTA-----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
Query: 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ + + R PC P D +L+ + DP +R
Sbjct: 209 NREVLEQV-ERGYRMPC-PQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 52/264 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 740
D + KP+ GAFG+V A + A+K+LK D + D+ +++E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMM 69
Query: 741 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIYIAEL 795
+ ++ ++ T LY+V+EY G+L LR E D R L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 796 VL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843
+E+L S +HRDL N+L+ D +K+ DFGL++
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--------- 180
Query: 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGII 902
D H+ +Y + R P ++APE L + + +D WS G++
Sbjct: 181 ------------DIHHIDYYRKTTNGR-----LPVKWMAPEALFDRVYTHQSDVWSFGVL 223
Query: 903 LFEFIT-GIPPFTAESPEIIFDNI 925
L+E T G P+ E +F +
Sbjct: 224 LWEIFTLGGSPYPGIPVEELFKLL 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-12
Identities = 60/230 (26%), Positives = 91/230 (39%), Gaps = 52/230 (22%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
F I++ + GA G F T + IK ++ E +IL + +P
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPS 144
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALE 800
+++ +FT L++ DLY C I I +++ A++
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKT-DLY-------CYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
YLH I+HRD+K +N+ I H G + L DFG + P D
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAA------------------CFPVDI--- 235
Query: 861 EYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909
N N++ GT APE+L +G A D WS GI+LFE T
Sbjct: 236 ------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 66/250 (26%), Positives = 107/250 (42%), Gaps = 50/250 (20%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITV 743
E IK + GAFG V+ G+ AIKVL++ + K + IL E ++ +V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKA-NKEILDEAYVMASV 66
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLAL 799
+P VVR + L+ + + G L +R +G + IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LDVDEK---------- 164
Query: 860 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIP 911
EY + P ++A E +L + + +D WS G+ ++E +T GIP
Sbjct: 165 -EYHAEGGK-------VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
Query: 912 PFTAESPEII 921
E P+++
Sbjct: 217 --AVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 44/227 (19%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILI 741
++ + ++++ I +G FG V L R G+ A+K +K ND + LAE +++
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK-------NDATAQAFLAEASVMT 54
Query: 742 TVRNPFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLA 798
+R+ +V+ + LY+V EY+ G L LR G L D + ++ A
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+EYL + VHRDL N+L++ D K++DFGL+K + S + G +P
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPV--- 163
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905
+ APE L + +D WS GI+L+E
Sbjct: 164 -------------------KWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 692 KPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+ + GAFG+VFLA L A+K LK + D R E +L +++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR------------IYIAE 794
+V+F+ D L +V EY+ GDL LR G +A ++IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 795 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
+ A + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------------- 168
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
D + +Y + H+ + ++ PE ++ + +D WS+G++L+E T
Sbjct: 169 --DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 11/124 (8%)
Query: 715 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 774
A+K LK+ + + L E +++ + +P +VR + L LVME G L
Sbjct: 27 AVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIVRLI-GVCKGEPLMLVMELAPLGPLL 83
Query: 775 SLLRKVGCLEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 830
L+K ++ + EL + YL S VHRDL N+L+ + K++DF
Sbjct: 84 KYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF 139
Query: 831 GLSK 834
G+S+
Sbjct: 140 GMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 71/316 (22%), Positives = 120/316 (37%), Gaps = 81/316 (25%)
Query: 686 DDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKK---LDMIRKNDIERILAER 737
++ E ++ I +GAFGRVF AR + A+K+LK+ DM + D +R E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQR---EA 59
Query: 738 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------------KVGCLE 784
++ +P +V+ + L+ EY+ GDL LR +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 785 EDVARIYIAELVL---------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
+ + ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 836 GLINNTIDLSGPETDGI----MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 891
I + E D I MP PE + +
Sbjct: 180 --IYSADYYKASENDAIPIRWMP---------------------------PESIFYNRYT 210
Query: 892 YAADWWSVGIILFE-FITGIPPFTAES-PEIIF----DNILNRKIPWPCVPSDMSFEAQD 945
+D W+ G++L+E F G+ P+ + E+I+ N+L+ C P + E +
Sbjct: 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS------C-PDNCPLELYN 263
Query: 946 LINRFLIHDPNQRLGA 961
L+ P+ R
Sbjct: 264 LMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 51/282 (18%)
Query: 692 KPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDI---ERILAERNILITVRN 745
+ G FG V K++ + A+K+LK + ND + +L E N++ + N
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTV-AVKILKNDN----NDPALKDELLREANVMQQLDN 55
Query: 746 PFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALE 800
P++VR C ++ LVME G L L+K + V I ELV + ++
Sbjct: 56 PYIVRMIG--ICEAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMK 109
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
YL VHRDL N+L+ + K++DFGLSK + +D +Y
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSK-----------------ALGADENYY 152
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESP 918
+ + + APE + + +D WS G++++E F G P+ +
Sbjct: 153 KAKTHGK-------WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205
Query: 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 960
E+ ++ C P E DL+ + ++R G
Sbjct: 206 EVT--QMIESGERMEC-PQRCPPEMYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ +++K + G FG V++ + + A+K LK M ++ L E N++ T+++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 803
+VR + T + +Y++ EY+ G L L+ + + ++ + A++ + Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
+HRDL+ N+L++ K+ DFGL+++ D Y
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARV------------------IEDNEYTA-- 160
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917
R A + APE + +D WS GI+L+E +T G P+ S
Sbjct: 161 ------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 691 IKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
I + RG FG VFLA+ + + L +K L+K +N E ++ + +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67
Query: 746 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDV--------ARIYIA-E 794
VVR CR+ Y+++EY + GDL LR +E + ++ + +
Sbjct: 68 KNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ L +++L + VHRDL N L++ +K++ LSK
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------------- 165
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 913
D + EY + N A+ +LAPE + + +D WS G++++E F G PF
Sbjct: 166 -DVYNSEYYKLRN-----ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
Query: 914 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
S E + + + K+ P VP L+ R +P R
Sbjct: 220 YGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVL-----------KKLD-MIRKNDIERILAERN 738
+K I RGA ++L GD IK + +LD IR+ ER E
Sbjct: 1 MKLIKRGAEAEIYL------GDFLGIKAVIKWRIPKRYRHPELDERIRR---ERTRREAR 51
Query: 739 ILIT-----VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 793
I+ V P V +N +VMEY+ G L L+ G E +++R
Sbjct: 52 IMSRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR---- 102
Query: 794 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
E+ + LHS GI+H DL N+++ G I L DFGL++
Sbjct: 103 EIGRLVGKLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 52/256 (20%)
Query: 692 KPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV- 743
KP+ G FG+V +A K A+K+LK D K D+ +++E ++ +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS-DATEK-DLSDLISEMEMMKMIG 81
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------CLEED---VARIYIAE 794
++ ++ + T LY+++EY + G+L LR C ++ +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 795 LV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 847
LV +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------------- 188
Query: 848 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907
D H+ +Y + R ++APE L + + +D WS G++L+E
Sbjct: 189 --------DIHHIDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 908 T-GIPPFTAESPEIIF 922
T G P+ E +F
Sbjct: 237 TLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 59/243 (24%), Positives = 108/243 (44%), Gaps = 46/243 (18%)
Query: 694 ISRGAFGRVFLARKRT-----TGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+ GAFG V+ +G + A+K L+K ++ + L E +++ +P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE------ 800
+V+ + Y++ME + GGDL S LR + + EL+ + L+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
YL + +HRDL N L++ G+ +K+ DFGL++ + + D E +G++P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKS--DYYRKEGEGLLPV 177
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 914
++APE LL + +D WS G++++E +T G P+
Sbjct: 178 ----------------------RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 915 AES 917
A +
Sbjct: 216 ALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-11
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 50/274 (18%)
Query: 641 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID-------DFEIIKP 693
EL D T + Y + +S+S + V + +S D + I+
Sbjct: 47 ELGDSDDVTHATDYDADE----ESLSPQTDVCQ---EPCETTSSSDPASVVRMQYNILSS 99
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
++ G+ G VF+ K GD KV+ K + R E +IL T+ + ++ +
Sbjct: 100 LTPGSEGEVFVCTKH--GDEQRKKVIVKA-VTGGKTPGR---EIDILKTISHRAIINLIH 153
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDL 812
++ + + +VM DL++ + + G L + A I I +L AL YLH GI+HRD+
Sbjct: 154 AYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRGIIHRDV 211
Query: 813 KPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
K +N+ + + L DFG + K+ +T P +
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPDT------------PQC--------------Y 245
Query: 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905
GT + +PE+L + D WS G++LFE
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 51/270 (18%)
Query: 691 IKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
++ + AFG+++ G L AIK LK D+ E +++ + +P
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHP 67
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVARI---------- 790
+V T + ++ EYLN GDL+ L VGC ++ +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 791 YIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 849
+IA ++ +EYL S VH+DL N+LI H+K++D GLS+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR--------------- 172
Query: 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FIT 908
I +D + R + ++ ++ PE ++ + +D WS G++L+E F
Sbjct: 173 -EIYSADYY---------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222
Query: 909 GIPPFTAESPEIIFDNILNRKIPWPCVPSD 938
G+ P+ S + + + + R++ PC D
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQL-LPC-SED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 47/273 (17%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ +G FG V++ T + AIK LK M+ E L E I+ +R+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMP----EAFLQEAQIMKKLRHDKLVPL-Y 67
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLG 806
+ + +Y+V E++ G L L+ E D + + +LV + Y+ +
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLK-----EGDGKYLKLPQLVDMAAQIADGMAYIERMN 122
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
+HRDL+ N+L+ + K+ DFGL++ LI + EY
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR--LIEDN-------------------EYTA-- 159
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 925
R A + APE L +D WS GI+L E +T G P+ + + +
Sbjct: 160 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
R PC P +L+ DP++R
Sbjct: 217 -ERGYRMPC-PQGCPESLHELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 37/268 (13%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ +G FG V++ T + AIK LK M E L E ++ +R+ +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 811
+ + +Y+V EY++ G L L+ + ++ A++ + Y+ + VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
L+ N+L+ + K+ DFGL++ LI + EY R
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDN-------------------EYTA-----RQ 161
Query: 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKI 930
A + APE L +D WS GI+L E T G P+ + D + R
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGY 220
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQR 958
PC P + DL+ + +P +R
Sbjct: 221 RMPC-PPECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 55/262 (20%)
Query: 691 IKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+K + GAFG V+ G+ AIKVL++ + N + IL E ++ V +P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------YIAELVLAL 799
+V R + LV + + G L +R E+ RI + ++ +
Sbjct: 70 YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVR------ENKDRIGSQDLLNWCVQIAKGM 122
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
YL + +VHRDL N+L+ H+K+TDFGL+++ I+ T
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET------------------ 164
Query: 860 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-- 915
EY + P ++A E +L + +D WS G+ ++E +T G P+
Sbjct: 165 -EYHADGGK-------VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216
Query: 916 --ESPEIIFDNILNRKIPWPCV 935
E P+++ ++P P +
Sbjct: 217 AREIPDLLEK---GERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-10
Identities = 63/265 (23%), Positives = 109/265 (41%), Gaps = 70/265 (26%)
Query: 692 KPISRGAFGRVFLA------RKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITV- 743
KP+ G FG+V +A + + + A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK--DDATDKDLSDLVSEMEMMKMIG 75
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK------------------------ 779
++ ++ + T LY+++EY + G+L LR
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 780 -VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838
V C + VAR +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 136 LVSCAYQ-VAR--------GMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---- 182
Query: 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 898
D H +Y + R ++APE L + + +D WS
Sbjct: 183 -----------------DVHNIDYYKKTTNGRLPV----KWMAPEALFDRVYTHQSDVWS 221
Query: 899 VGIILFEFIT-GIPPFTAESPEIIF 922
G++L+E T G P+ E +F
Sbjct: 222 FGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 690 IIKPISRGAFGRVFLARKRTTGD---LFAIKVLKK--LDMIRKNDIERILAERNILITVR 744
I K I G FG V R + G AIK LK + R++ L+E +I+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD----FLSEASIMGQFD 63
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------L 797
+P ++ T + +V EY+ G L + LRK + + +LV
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK------HDGQFTVIQLVGMLRGIAS 117
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
++YL +G VHRDL N+L+ + K++DFGLS++ + + + + G +P
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPI-- 173
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
+ APE + + A+D WS GI+++E ++
Sbjct: 174 --------------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 35/151 (23%)
Query: 767 YLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-------ALEYLHSLGIVHRDLKPDNLL 818
Y+N G+L L++ E + + + +LV + YLH G++H+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 819 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP- 877
I + +K+TD LS+ DL P D H DN NR P
Sbjct: 150 IDEELQVKITDNALSR--------DL--------FPMDYHC----LGDNENR------PV 183
Query: 878 DYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
++A E L+ E+ A+D WS G++L+E +T
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILIT 742
+F+ IK + GAFG V+ G+ AIK L++ + N + IL E ++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI----AELVLA 798
V NP V R + L+ + + G L +R+ ++++ Y+ ++
Sbjct: 66 VDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 121
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+ YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LGADEK--------- 164
Query: 859 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913
EY + P ++A E +L + + +D WS G+ ++E +T G P+
Sbjct: 165 --EYHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 49/166 (29%), Positives = 66/166 (39%), Gaps = 53/166 (31%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LD-MIRKNDIERILAERNILI 741
I++GA ++L GD +K + K LD IR+ ER E +L
Sbjct: 2 IAKGAEAIIYL------GDFLGLKAVIKERVPKSYRHPELDERIRR---ERTRNEARLLS 52
Query: 742 TVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEEDVAR 789
R N VV DN +VMEY+ G L LLR++G V +
Sbjct: 53 RARKAGVNTPVVYDVD----PDNKTIVMEYIEGKPLKDVIEEGNDELLREIG---RLVGK 105
Query: 790 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
LH GIVH DL N+++ D + L DFGL K
Sbjct: 106 ------------LHKAGIVHGDLTTSNIIV-RDDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 53/280 (18%)
Query: 682 RTSIDDFEIIKPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIR-KNDIERILA 735
+ ++ + GAFG+V +R + AIK LK+ + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 736 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVAR 789
E ++ +++P +V T ++ EYL GDL+ L VG D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 790 ---------IYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839
++IA + A +EYL S VHRDL N L+ +K++DFGLS+
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-- 175
Query: 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 899
S +Y R + ++ ++ PE +L + +D WS
Sbjct: 176 ---------------SADYY--------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 900 GIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPSD 938
G++L+E F G+ P+ S + + + I +R++ PC P D
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPC-PED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 41/235 (17%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERI--LAER 737
I K I G FG V R + G AIK LK +D +R+ L E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA----GSSDKQRLDFLTEA 56
Query: 738 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV- 796
+I+ +P ++R T + ++ EY+ G L LR+ + + ++
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLR 113
Query: 797 ---LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
++YL + VHRDL N+L+ + K++DFGLS+ +
Sbjct: 114 GIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR----------------LE 157
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
S+A Y T + T APE + + A+D WS GI+++E ++
Sbjct: 158 DSEATY-----TTKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 692 KPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV 749
K + G FG V++A K T A+K +K M +E LAE N++ T+++ +V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK---VAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLV 64
Query: 750 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGI 807
+ ++ ++ +Y++ E++ G L L+ ++ + ++ + A++ + ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
+HRDL+ N+L++ K+ DFGL+++ N G A +P
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----------AKFP------- 166
Query: 868 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-ESPEII 921
+ APE + +D WS GI+L E +T G P+ +PE+I
Sbjct: 167 ---------IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 686 DDFEIIKPISRGAFGRVFLA-RKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 742
+D + + I G FG V+ + A+K K + E+ L E I+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQ 63
Query: 743 VRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALE 800
+P +V+ +N +++VME G+L S L+ L+ +Y +L AL
Sbjct: 64 FDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
YL S VHRD+ N+L++ +KL DFGLS+
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 56/258 (21%)
Query: 692 KPISRGAFGRVFLAR----KRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITV- 743
KP+ G FG+V A ++ D A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK--DNATDKDLADLISEMELMKLIG 75
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR------------------KVGCLEE 785
++ ++ T LY+++EY G+L LR + ++
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 786 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845
V+ Y ++ +EYL S +HRDL N+L+ D +K+ DFGL++ G+ + ID
Sbjct: 136 LVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GV--HDIDYY 190
Query: 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905
++G +P ++APE L + + +D WS GI+++E
Sbjct: 191 KKTSNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSFGILMWE 228
Query: 906 FIT-GIPPFTAESPEIIF 922
T G P+ E +F
Sbjct: 229 IFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 63/255 (24%), Positives = 112/255 (43%), Gaps = 42/255 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
++ K + GAFG+V A K A+K+LK ++ E +++E I+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP--TAHSSEREALMSELKIM 92
Query: 741 ITVRNPF-VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVL 797
+ N +V + T + ++ EY GDL + LR+ L + + ++
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
+ +L S +HRDL N+L+ H G I K+ DFGL++ IM +D
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLAR----------------DIM-ND 194
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA 915
++Y + +A ++APE + + + +D WS GI+L+E F G P+
Sbjct: 195 SNYV--------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY-- 244
Query: 916 ESPEIIFDNILNRKI 930
P + D+ + I
Sbjct: 245 --PGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 44/218 (20%)
Query: 713 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 772
L A+K+L+ + KN L E I+ +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 773 LYSLLR----KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAH 821
L L + + DV I + L+ ++YL SL VHRDL N L+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165
Query: 822 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 881
+ IK+ DFG+S+ + + +Y + R AV +++
Sbjct: 166 NYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWMS 200
Query: 882 PE-ILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918
E ILLG + A+D W+ G+ L+E +T E P
Sbjct: 201 WESILLG-KFTTASDVWAFGVTLWEILT----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 17/166 (10%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 744
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------------- 790
+P ++ + R LYL +EY G+L LRK LE D A
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 791 --YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 48/233 (20%)
Query: 713 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 772
L A+K+L+ KN L E IL +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKILRP--DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 773 LYSLLRKVGCLEEDV------------------ARIYIA-ELVLALEYLHSLGIVHRDLK 813
L L +++ + +++A ++ ++YL SL VHRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 873
N L+ + IK+ DFG+S+ + + +Y + R A
Sbjct: 166 TRNCLVGENLTIKIADFGMSR---------------------NLYAGDYYRIQGR----A 200
Query: 874 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDN 924
V ++A E +L + A+D W+ G+ L+E + P+ + E + +N
Sbjct: 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ +++ I G FG V+L AIK +++ M ++ IE E +++ + +
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFIE----EAQVMMKLSH 58
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 804
P +V+ + T R + LV E++ G L LR + G ++ ++ + YL S
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
++HRDL N L+ + +K++DFG+++ L D Y
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL------------------DDQYT---- 156
Query: 865 TDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 917
S+ GT + +PE+ +++ +D WS G++++E F G P+ S
Sbjct: 157 -------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 7e-09
Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 52/251 (20%)
Query: 694 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 747
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA------ 62
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 798
+ + F S + R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHSDR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 913
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 914 TAESPEIIFDN 924
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-09
Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 64/225 (28%)
Query: 671 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK------------- 717
V PL R S DDF++ + G FG F + D +
Sbjct: 130 VGAPLADGANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRV 189
Query: 718 VLKKLDMIR--------------KNDIERILAERNILITV-RNPFVVR-------FFYSF 755
VLK+++M R K E + E + + RNP +F S
Sbjct: 190 VLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSN 249
Query: 756 TC-----RDNLYLVMEYLNGGDLYSLLR-KVG----CLEE-------------------D 786
T + + +LV ++ + L L K+G CLEE +
Sbjct: 250 TADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309
Query: 787 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831
V + + +++ L LH +GIVHRD+KP+NLL+ DG +K+ DFG
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 56/293 (19%)
Query: 688 FEIIKPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
F + + + +G FG V L + + A+K+LK D+ +DIE L E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFD 59
Query: 745 NPFVVRFF-YSFTCRDNLYL-----VMEYLNGGDLYS--LLRKVG----CLEEDVARIYI 792
+P V++ S R L ++ ++ GDL++ L+ ++G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 793 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
++ +EYL S +HRDL N ++ + + + DFGLSK I
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK----------------KI 163
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 910
D Y+Q A P +LA E L + +D W+ G+ ++E +T G
Sbjct: 164 YSGDY----YRQG------CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
Query: 911 PPFTA-ESPEI----IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
P+ E+ EI I N L + P D + +L+ + +P R
Sbjct: 214 TPYAGVENSEIYNYLIKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 58/255 (22%), Positives = 93/255 (36%), Gaps = 70/255 (27%)
Query: 689 EIIKPISRGAFGRVFLA-----------------RKRTTGDLFAIKVLKK-LDMIRKNDI 730
++ + G FG V L L A+KVL+ + D
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAP-VLVAVKVLRPDASDNAREDF 66
Query: 731 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------- 779
+ E IL + +P + R T L ++MEY+ GDL L+K
Sbjct: 67 LK---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 780 -----VGCLEEDVARIYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833
L +Y+A + + + YL SL VHRDL N L+ + IK+ DFG
Sbjct: 124 SKSLSFSTL------LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG-- 175
Query: 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 893
M + + +Y + R A ++A E +L +
Sbjct: 176 -------------------MSRNLYSSDYYRVQGR----APLPIRWMAWESVLLGKFTTK 212
Query: 894 ADWWSVGIILFEFIT 908
+D W+ G+ L+E +T
Sbjct: 213 SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 45/169 (26%), Positives = 63/169 (37%), Gaps = 53/169 (31%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LDM-IRKNDIERILAERN 738
+ I +GA ++L D + + K LD +R+ ER E
Sbjct: 1 MDLIKQGAEAIIYL------TDFLGLPAVVKERIPKRYRHPELDEKLRR---ERTRREAR 51
Query: 739 ILITVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEED 786
IL R +V DN +VMEY+ G L LLR+VG
Sbjct: 52 ILAKAREAGVPVPIVYDVDP----DNGLIVMEYIEGELLKDALEEARPDLLREVG---RL 104
Query: 787 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
V + LH GIVH DL N++++ G I DFGL +
Sbjct: 105 VGK------------LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 33/234 (14%)
Query: 689 EIIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
E++ I RG V LAR + TG+ ++ + L+ + + E ++ +P
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 747 FVVRFFYSFTCRDNLYLV---MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYL 802
+V + +F + L++V M Y + DL G E +A YI + VL AL+Y+
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIA--YILQGVLKALDYI 117
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHYPE 861
H +G VHR +K ++LI+ DG + L+ GL S + +IN H
Sbjct: 118 HHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIN------------------HGQR 157
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF 913
+ + ++S P +L+PE+L GY A D +SVGI E G PF
Sbjct: 158 LRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 34/139 (24%)
Query: 772 DLYSLL----RKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 826
DLY+ L R +G + VAR +L+ A++Y+H GI+HRD+K +N+L+ I
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300
Query: 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 886
L DFG + G + HY GT D APE+L
Sbjct: 301 LGDFGAACF-------------ARGSWSTPFHY------------GIAGTVDTNAPEVLA 335
Query: 887 GTEHGYAADWWSVGIILFE 905
G + + D WS G+++FE
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 713 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 772
L A+K+L+ + K L E I+ ++NP ++R D L ++ EY+ GD
Sbjct: 46 LVAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 773 LYSLL-----RKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIA 820
L L ++ + IA L+ ++YL SL VHRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 821 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 880
+ IK+ DFG+S+ + + +Y + R AV ++
Sbjct: 164 NHYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWM 198
Query: 881 APEILLGTEHGYAADWWSVGIILFEFITGIP--PFTAESPEIIFDN 924
A E +L + A+D W+ G+ L+E T P++ S E + +N
Sbjct: 199 AWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 41/244 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKV-LKKL-DMIRKNDIERILAERNILIT 742
D +++ + GAFG V+ R GD ++V +K L + + D L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 743 VRNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE 800
+ +VR SF R ++++E + GGDL S LR+ E + + + +L+ A +
Sbjct: 66 FNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 801 ------YLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDG 851
YL +HRD+ N L+ G K+ DFG+++
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----------------- 167
Query: 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGI 910
D + Y + R A+ ++ PE L D WS G++L+E F G
Sbjct: 168 ----DIYRASYYRKGGR----AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219
Query: 911 PPFT 914
P+
Sbjct: 220 MPYP 223
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 702 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT---VRNPFVVRFFYSFTCR 758
V+LAR TG L +++ D+ + E + A +N ++ R+P ++ + FT
Sbjct: 16 VYLARHTPTGTLVTVRIT---DLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 759 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 816
L+++ ++ G SLL+ + E + + + L YLH G +HR++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 817 LLIAHDGHIKLTDFGLSKI-GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 875
+LI+ DG + L+ GLS + L+ N G + + +P++ S
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRN-----GQKAKVVY----DFPQF---------STSV 171
Query: 876 TPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF 913
P +L+PE+L +GY +D +SVGI E TG PF
Sbjct: 172 LP-WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV 743
+D + I G FG+V A + G AIK+LK + +ND E +L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 744 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------------ 790
+P ++ + R LY+ +EY G+L LRK LE D A
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 791 ----YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
+ +++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 6e-08
Identities = 47/160 (29%), Positives = 63/160 (39%), Gaps = 42/160 (26%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRN-- 745
I +GA + + +V K +LD +R ER AE +L R
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRT---ERTRAEARLLSEARRAG 397
Query: 746 ---PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-------SLLRKVGCLEEDVARIYIAEL 795
P + Y + +VMEY+ G DL L+RKVG E VA+
Sbjct: 398 VPTPVI----YDVD-PEEKTIVMEYIGGKDLKDVLEGNPELVRKVG---EIVAK------ 443
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
LH GIVH DL N ++ D + L DFGL K
Sbjct: 444 ------LHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-08
Identities = 61/251 (24%), Positives = 110/251 (43%), Gaps = 52/251 (20%)
Query: 694 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 747
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS------ 62
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 798
+ + F S R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHADR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 913
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 914 TAESPEIIFDN 924
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-07
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 43/242 (17%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-DMIRKNDIERILAERNILIT 742
S F+I+ + G FG+V A R + A+K+++ + R IE E+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 743 VRNPF----VVRFFYSFTCRDNLYLVM-EYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
+ F + R+F + T ++ +VM +Y G L + K G ++A+++
Sbjct: 187 PADRFPLMKIQRYFQNET--GHMCIVMPKY--GPCLLDWIMKHGPFSHR----HLAQIIF 238
Query: 798 ----ALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
AL+Y H+ L ++H DLKP+N+L+ + +D P T+
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETS----------------DTVVD---PVTNRA 279
Query: 853 MPSDAHYPEYQQ----TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907
+P D D R+ +A V T Y +PE++LG Y+ D WS+G I++E
Sbjct: 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339
Query: 908 TG 909
TG
Sbjct: 340 TG 341
|
Length = 467 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 71/260 (27%)
Query: 686 DDFEIIKPISRGAFGRVF--LARKRTTGDL---FAIKVLKKLDMIRKNDIERI--LAERN 738
+ +++ + +G+FG V+ AR G+ A+K + + +R ERI L E +
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEAS 61
Query: 739 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--------- 789
++ VVR + +VME + GDL S LR L +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR---SLRPEAENNPGRPPPTL 118
Query: 790 ----IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845
AE+ + YL++ VHRDL N ++AHD +K+ DFG+++ D+
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIY 170
Query: 846 GPETD-------GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 898
ETD G++P ++APE L ++D WS
Sbjct: 171 --ETDYYRKGGKGLLPV----------------------RWMAPESLKDGVFTTSSDMWS 206
Query: 899 VGIILFEFITGIPPFTAESP 918
G++L+E + AE P
Sbjct: 207 FGVVLWEITS-----LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 694 ISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 750
I G FG+V AR + G AIK +K + K+D E +L + +P ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----------------YIAE 794
+ R LYL +EY G+L LRK LE D A + A+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
+ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 694 ISRGAFGRVFLARKRTTG---DLFAIKVLKK--LDMIRKNDIERILAERNILITVRNPFV 748
I G FG V R + G AIK LK + R++ L+E +I+ +P +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD----FLSEASIMGQFDHPNI 67
Query: 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEY 801
+ T + ++ E++ G L S LR ++ + + +LV ++Y
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR------QNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
L + VHRDL N+L+ + K++DFGLS+ L ++T D P
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSD----------------PT 164
Query: 862 YQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
Y S++G + APE + + A+D WS GI+++E ++
Sbjct: 165 YT--------SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-07
Identities = 64/276 (23%), Positives = 113/276 (40%), Gaps = 51/276 (18%)
Query: 656 ENSRLILDSVSQSSGVSTPLHSSHKERTS--IDDFEIIKPISRGAFGRVFL-ARKRTTGD 712
+ S L D + PL + + + F +I + GAFG++F+ A + +T +
Sbjct: 116 DASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEE 175
Query: 713 LFAIKVLKKLDMIRKNDIERILA-------------ERNILITVR--NPFVVRFFYSFTC 757
A + + + K ER++A E IL R + +++
Sbjct: 176 AEARRGVNSTNQ-GKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRS 234
Query: 758 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLALEYLHSLGIVHRDL 812
N Y++ + + DLYS + +D R + +L+ A+EY+H ++HRD+
Sbjct: 235 EANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293
Query: 813 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 872
K +N+ + DG I L DFG MP +++ +
Sbjct: 294 KLENIFLNCDGKIVLGDFGT-------------------AMP-------FEKEREAFDYG 327
Query: 873 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
VGT +PEIL G + D WS G+IL + ++
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 16/158 (10%)
Query: 692 KPISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 748
K + G FG V L++ + A+K +K LD+ ++IE L+E + +P V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 749 VRFF-YSFTCRDNLYL-----VMEYLNGGDLYSLL--RKVGCLEEDVAR----IYIAELV 796
++ F + ++ ++ GDL+S L ++G L E + ++ ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
L +EYL + +HRDL N ++ D + + DFGLSK
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 690 IIKPISRGAFGRVFLARKRTTGDLFAIKV----LKKLDMIRKNDIERILAERNILITVRN 745
IK + G RV+L T + + +K+ K D R+ I ++LA + + +
Sbjct: 2 SIKLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLARKGLPV---- 55
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P V+ S YL+ME++ G L +V E++ +AEL+ L L L
Sbjct: 56 PKVL---ASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836
+ H DL P N+L+ + + D+ + G
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 50/231 (21%)
Query: 692 KPISRGAFGRVFLARKRTTGD---LFAIKVLKK-LDMIRKNDIERILAERNILITVRNPF 747
K I G FG VF + G AIK LK ++ D L+E +I+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF---LSEASIMGQFSHHN 67
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDL----------YSLLRKVGCLEEDVARIYIAELVL 797
++R T ++ EY+ G L +S + VG L A
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAA--------- 118
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
++YL + VHRDL N+L+ + K++DFGLS++ + + + + + G +P
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPI-- 174
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
+ APE + + A+D WS GI+++E ++
Sbjct: 175 --------------------RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 48/246 (19%)
Query: 691 IKPISRGAFGRVF----LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+K + GAFG V+ + T AIK+L + + N + E I+ ++ +P
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN--VEFMDEALIMASMDHP 69
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----YIAELVLALEYL 802
+VR + LV + + G LL V ++++ + ++ + YL
Sbjct: 70 HLVRLL-GVCLSPTIQLVTQLMPHG---CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
+VHRDL N+L+ H+K+TDFGL+++ L G E EY
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARL--------LEGDEK-----------EY 166
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIPPFTA 915
N ++A E + + + +D WS G+ ++E +T GIP T
Sbjct: 167 ------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TR 218
Query: 916 ESPEII 921
E P+++
Sbjct: 219 EIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 36/188 (19%)
Query: 674 PLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---I 730
PL + DDF + K + GAFG V+ + + K K + + + +
Sbjct: 120 PLEGLFRPSFKKDDFVLGKKLGEGAFGVVY----KASLVNKQSKKEGKYVLKKATEYGAV 175
Query: 731 ERILAERNILITVRNPFVVRFFYSFTC------RDNLYLVMEYLNGGDLYSL-------- 776
E + ER + N F Y F D +LV Y L L
Sbjct: 176 EIWMNER-VRRACPN-SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPY 233
Query: 777 ------LRKVGCL------EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DG 823
L KV L E + + + +++ AL+ LHS GIVHRD+KP N++ + G
Sbjct: 234 NVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG 293
Query: 824 HIKLTDFG 831
K+ D G
Sbjct: 294 SFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 64/263 (24%)
Query: 694 ISRGAFGRVFLARKRTTGDLF---------AIKVLKKLDMIRKNDIERILAERNILITVR 744
I +G FG V+ G L A+K L ++ + ++E+ L E I+
Sbjct: 3 IGKGHFGCVY------HGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFS 54
Query: 745 NPFVVRFFYSFTCRDNLYLV-MEYLNGGDLYSLLRK----------VGCLEEDVARIYIA 793
+P V+ + LV + Y+ GDL + +R +G VA+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAK---- 109
Query: 794 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
+EYL S VHRDL N ++ +K+ DFGL++
Sbjct: 110 ----GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR------------------- 146
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 911
D + EY N H+ P ++A E L + +D WS G++L+E +T G P
Sbjct: 147 --DIYDKEYYSVHN---HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
Query: 912 PFTAESPEIIFDNILN-RKIPWP 933
P+ I +L R++ P
Sbjct: 202 PYPDVDSFDITVYLLQGRRLLQP 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 46.3 bits (111), Expect = 2e-05
Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 7/72 (9%)
Query: 763 LVMEYLNGGDLYS-LLRKVGCLEEDVARIY--IAELVLALEYLHSLGIVHRDLKPDNLLI 819
LVME++ G + + L+ V L ED +Y I EL+ L G+VH DL N+L+
Sbjct: 92 LVMEFIGGDGIPAPRLKDVR-LLEDPEELYDQILELMRKL--YREAGLVHGDLSEYNILV 148
Query: 820 AHDGHIKLTDFG 831
DG + + D
Sbjct: 149 -DDGKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 32/238 (13%)
Query: 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKL--DMIRKNDIERILAERNILITVRNPFV 748
+K + G FG V GD I V K D + + I + ++ + ++
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGI 807
VR +L LV + G L +R+ L+ + ++ + YL +
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
VHR+L N+L+ D +++ DFG+ +D YP+ D
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGV----------------------ADLLYPD----DK 164
Query: 868 RNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 923
+ +S TP ++A E +L + + +D WS G+ ++E ++ G P+ P + D
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 60/245 (24%), Positives = 101/245 (41%), Gaps = 53/245 (21%)
Query: 692 KPISRGAFGRVF--LAR---KRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 744
+ + +G+FG V+ +A+ K AIK + + +R ERI L E +++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR----ERIEFLNEASVMKEFN 67
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA---------RIYIA-E 794
VVR + ++ME + GDL S LR + E+ I +A E
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ + YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------------------- 167
Query: 855 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913
+ +TD + P +++PE L +D WS G++L+E T
Sbjct: 168 ------DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 216
Query: 914 TAESP 918
AE P
Sbjct: 217 LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 54/241 (22%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 715 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 774
AIK LK D E E + +++P +V T L ++ Y + DL+
Sbjct: 39 AIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96
Query: 775 SLL------RKVGCLEEDVARI----------YIAELVLALEYLHSLGIVHRDLKPDNLL 818
L VG ++D + ++ +E+L S +VH+DL N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 819 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 878
+ ++K++D GL + + L G + ++P
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMG---NSLLPI----------------------R 191
Query: 879 YLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPS 937
+++PE ++ + +D WS G++L+E F G+ P+ S + + + I NR++ PC P
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-LPC-PD 249
Query: 938 D 938
D
Sbjct: 250 D 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 72/298 (24%)
Query: 692 KPISRGAFGRVFL--ARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILIT 742
I G FG+V L A + + +K L+ +L +++ R L N+L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 743 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAEL 795
+ C ++ LV+E+ GDL + LR ++DV + E+
Sbjct: 61 LGQ-----------CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
L +LH +H DL N + D +K+ D+GL+
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL--------------------- 148
Query: 856 DAHYPE-YQQTDNRNRHSAVGTPDYLAPEI-------LLGTEHGYAADWWSVGIILFE-F 906
YPE Y T + + +LAPE+ LL + ++ WS+G+ ++E F
Sbjct: 149 -EQYPEDYYITKDCH----AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203
Query: 907 ITGIPPFTAESPEIIFDNIL---NRKIPWPCVP---SDMSFEAQDLINRFLIHDPNQR 958
P+ S E + ++ + K+P P + SD +E + +F DP R
Sbjct: 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE----VMQFCWLDPETR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIK----VLKKLDMIRKNDIERILAERNILITVRNPFVV 749
+ +G F ++F +R GD + +LK LD +N E +++ + + +V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 750 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 808
+ C D +V EY+ G L + L+K L ++ +A +L AL +L G+
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 809 HRDLKPDNLLIAHDGH--------IKLTDFGLS 833
H ++ N+L+ + IKL+D G+S
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 30/134 (22%)
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
+E+L S VHRDL N+L+A +K+ DFGL++ IM D+
Sbjct: 249 GMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----------------DIM-HDS 291
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAE 916
+Y ++ S ++APE + + +D WS GI+L+E F G P+
Sbjct: 292 NYV--------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY--- 340
Query: 917 SPEIIFDNILNRKI 930
P +I D+ KI
Sbjct: 341 -PGMIVDSTFYNKI 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 19/90 (21%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 750 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 809
R +Y F + L + + +++ C + + + + +++ LEY+H GI H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 810 RDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839
D+KP+N+++ + + D+G++ +I+
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 32/124 (25%), Positives = 57/124 (45%), Gaps = 26/124 (20%)
Query: 791 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850
Y ++ +E+L S +HRDL N+L++ + +K+ DFGL++ D+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--------DI------ 224
Query: 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITG 909
Y+ D + SA ++APE + + +D WS G++L+E F G
Sbjct: 225 -----------YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 910 IPPF 913
P+
Sbjct: 274 ASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 18/37 (48%), Positives = 21/37 (56%), Gaps = 1/37 (2%)
Query: 798 ALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLS 833
AL LH GI H DL KP N L+ DG + DF L+
Sbjct: 123 ALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159
|
Length = 365 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 31/143 (21%)
Query: 772 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831
DLY +KV LE+ + Y ++ +E+L S +HRDL N+L++ + +K+ DFG
Sbjct: 170 DLY---KKVLTLEDLIC--YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224
Query: 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 891
L++ D+ + D + DA P ++APE + +
Sbjct: 225 LAR--------DIY-KDPDYVRKGDARLPL----------------KWMAPETIFDRVYT 259
Query: 892 YAADWWSVGIILFE-FITGIPPF 913
+D WS G++L+E F G P+
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 40/187 (21%), Positives = 61/187 (32%), Gaps = 47/187 (25%)
Query: 793 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
A + L L L HR K N+L+ DG +KL G PE
Sbjct: 21 AVCLQCLGALREL---HRQAKSGNILLTWDGLLKL--DGSVAF---------KTPEQSR- 65
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912
P ++APE++ G + AD +S+GI L+E + P
Sbjct: 66 ----------------------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
Query: 913 FTAESP-----EIIFDNILNRKIPWPCVPSDMS--FEAQDLINRFLIHDPNQRLGANGAA 965
+ E EI+ + + +S +D + P +R AN
Sbjct: 104 YNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN--- 160
Query: 966 EVKAHPF 972
AH
Sbjct: 161 HYLAHCR 167
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 40/169 (23%)
Query: 693 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNI--------LI 741
IS G V+ AR G+ A+K+ K + K+ + I + R+ L+
Sbjct: 4 CISTGKEANVYHAR-TGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLV 62
Query: 742 TV------RN-----------PFVVRFFYSFTCRDNLYLVMEYL-NGGDLYSLLRKVGCL 783
RN P + + N+ LVME++ + G L+ V
Sbjct: 63 FAWAEKEFRNLKRLYEAGVPVPEPI------LLKKNV-LVMEFIGDDGSPAPRLKDVPLE 115
Query: 784 EEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831
EE+ +Y ++V + L G+VH DL N+L HDG + D
Sbjct: 116 EEEAEELY-EQVVEQMRRLYQEAGLVHGDLSEYNILY-HDGKPYIIDVS 162
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 28/147 (19%)
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+E+L S VHRDL N+LI +K+ DFGL++ IM D++
Sbjct: 252 MEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR----------------DIM-RDSN 294
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917
Y ++ S ++APE + + +D WS GI+L+E T G P+
Sbjct: 295 YI--------SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 918 PEIIFDNILNR--KIPWPCVPSDMSFE 942
F N + R ++ P SD +E
Sbjct: 347 MNEQFYNAIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 27/176 (15%)
Query: 734 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYI 792
LAE L + +VR T + + +V EY++ G L S LRK G L +
Sbjct: 54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113
Query: 793 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
L ++YL +G VH+ L +L+ D K++ F E
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------------RLQEDK-- 158
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
S+A Y T + + APE + A+D WS GI+++E ++
Sbjct: 159 --SEAIY-----TTMSGKSPVLWA----APEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 823
VMEY++G +LY + R + ED + E++ + + GI+H DL N+L+ D
Sbjct: 109 VMEYIDGVELYRV-RVL----EDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162
Query: 824 HIKLTDF 830
I + D+
Sbjct: 163 KIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKV-LKKLDMIRKNDIERILAERNILITVRNPFVVR 750
K + G FG V + + + V K+ + ++++E L+E + +P V+R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 751 FFYSFTCRDNL--------YLVMEYLNGGDLYSLL--RKVG----CLEEDVARIYIAELV 796
C + +++ ++ GDL+S L ++G L + ++ ++
Sbjct: 65 LIG--VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
+EYL S +HRDL N ++ + ++ + DFGLSK
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 26/116 (22%)
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+ +L S +HRDL N+L+ H K+ DFGL++ I N +++ ++ +A
Sbjct: 227 MSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IRN-------DSNYVVKGNAR 277
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 913
P ++APE + + + +D WS GI+L+E F G P+
Sbjct: 278 LP----------------VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 49/229 (21%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
ISRG G + + G F +K + ++ I ++I + +++P +V+
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-------MGKLQHPNIVKLIG 750
Query: 754 SFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIV 808
CR YL+ EY+ G +L +LR + I IA+ AL +LH S +V
Sbjct: 751 --LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAK---ALRFLHCRCSPAVV 805
Query: 809 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 868
+L P+ ++I DG D ++ L P TD +
Sbjct: 806 VGNLSPEKIII--DG----KDEPHLRLSL----------------------PGLLCTDTK 837
Query: 869 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917
S+ Y+APE + +D + G+IL E +TG P AE
Sbjct: 838 CFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 22/80 (27%), Positives = 34/80 (42%), Gaps = 6/80 (7%)
Query: 758 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817
L + L LL ++ L E + + L+ AL L +VH DL P NL
Sbjct: 123 LKLLRQLAAALRRLVAAELLDRLAELWERLLA-ALLALLPALP----LVLVHGDLHPGNL 177
Query: 818 LIAHDGHIK-LTDFGLSKIG 836
L+ G + + DF + +G
Sbjct: 178 LVDPGGRVTGVIDFEDAGLG 197
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 7/69 (10%)
Query: 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDLKPDNLLIAH 821
+VMEY+ G +LY L V +E I + +L + + GIVH DL N+L+
Sbjct: 184 VVMEYIEGVELYRLRLDVENPDE------ILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237
Query: 822 DGHIKLTDF 830
DG I + D+
Sbjct: 238 DGDIVVIDW 246
|
Length = 304 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1091 | |||
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.59 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.58 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.16 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.14 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.14 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.07 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.03 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.97 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.94 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.89 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.73 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.71 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.51 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.49 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.38 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.28 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.15 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.14 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.02 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.91 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.87 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.83 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.82 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.9 | |
| PLN02236 | 344 | choline kinase | 95.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.8 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 95.51 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.4 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.38 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.28 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.78 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.67 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.39 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.35 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.14 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.61 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 91.52 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 90.57 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 89.66 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 88.98 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 88.39 | |
| PTZ00296 | 442 | choline kinase; Provisional | 87.52 |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-79 Score=730.25 Aligned_cols=1020 Identities=35% Similarity=0.440 Sum_probs=788.6
Q ss_pred CCCcccccccccCCCC-CCccccccccccCCCCCc---ccccccccccceecc-chhh--hhhccchH--HHHHH-----
Q 001370 12 GIPSGLNRIKTRGGVS-KPDELTESRSYGVSRPPQ---KHKQKTVAQGHVKLA-NSFT--EVRKGKKI--AQWFT----- 77 (1091)
Q Consensus 12 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~--~~~~~~~~--~~~~~----- 77 (1091)
-+++|+|+|||+-.-. -+-.|..- -+.|+|- -.||+-|+.|+...| |.|. .-+++-|+ .+|..
T Consensus 80 p~e~df~~IklisngAygavylvrh---~~trqrfa~kiNkq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdmvla~ 156 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRH---KETRQRFAMKINKQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDMVLAV 156 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeec---cccccchhhcccccchhhhccccccCCcceechhhhhcccCCCCcchhhHHh
Confidence 4678999999974221 11111100 1223332 257888998877766 4453 23444444 34443
Q ss_pred hhcccceecCCCCCCCCCCCCCCCcCCccccccccccccchhhhHHHHhhhcccccCCccccccccCCCCCCCCCCccCC
Q 001370 78 SYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAH 157 (1091)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (1091)
.|.-.+.||-+.--+.+.+-+-+ -+.||-..| ..|.+|.-..- -+.+-++++|+||++.||.-.--+.+++
T Consensus 157 Eylh~ygivhrdlkpdnllIT~m-----GhiKlTDfg---Lsk~GLms~at-nl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 157 EYLHSYGIVHRDLKPDNLLITSM-----GHIKLTDFG---LSKKGLMSLAT-NLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred HhhccCCeecCCCCCCcceeeec-----ccccccchh---hhhhhhhhccc-hhhhcchHHHHHHhhhccccCCccccCh
Confidence 37777889988777666554433 234444443 56777765554 6778899999999999998888889999
Q ss_pred CcCCHH--------HHHHHHHHHHHHHHHhhhhh-----HhhhHHHHHHHHhhcCCCCchhhhHHHHHHHHHHHhhhhhc
Q 001370 158 SYNDLK--------ELLDTLHSRFDAAKEVVNSE-----LATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTS 224 (1091)
Q Consensus 158 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (1091)
.|+..+ +.+|.|+.+|.-.++-|..+ +|+|+.|.+...|+++-.-.|-++++++||..+-+|..||.
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 999999 99999999999999999999 99999999999999998899999999999999999999999
Q ss_pred chhhhhhhHHHHhhHHh---HhcCcchHHHHhhhhhHHHhHhhhHHhhccccccchhcc--chhhHhhhcccCCcccccc
Q 001370 225 CLFRANCETIVQDLTEK---RQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEK--SLHKFKKCLESVPAVETSW 299 (1091)
Q Consensus 225 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 299 (1091)
=-||+-||-|+|.||.+ ||+|+-+.++|...+|+||+|||+|+-+|.+|...+++- ..++|.-|.+-..++..+|
T Consensus 308 ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~~~ees~~~~~qFsscs~r~~kv~ss~ 387 (1205)
T KOG0606|consen 308 GALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDTGDEESSLEFRQFSSCSPRFSKVYSSW 387 (1205)
T ss_pred hhhhhhhccceeecccchhhhhhccccccccccccchhhcccchheeeccccCCccccccccccccccccccccccccch
Confidence 99999999999999999 999999999999999999999999999999999999888 6789999999999999999
Q ss_pred cC-------CCCccccchhhHHHHhhhccccccccc--cccccccccccCccCccccccccccceeccCCCCccccchhh
Q 001370 300 VP-------SPGTAESDLDYASYQKANAKKKISGQQ--KVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSR 370 (1091)
Q Consensus 300 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (1091)
-- .+-.-++...+-.++- +-.++. +...-|++..-.-+..+++..+| -.--|.|.+-++-
T Consensus 388 ~~l~~~~t~~~~~~~~~~~~~~~~~-----~~~g~k~~~~~~sp~~~kl~~st~~ss~s~~------~~~s~~~~~~~~~ 456 (1205)
T KOG0606|consen 388 ESLAQLETATPREKSSQSSQGEVSP-----SSAGQKDSWKSNSPESSKLELSTALSSVSPN------HPGSPSKSLTSAA 456 (1205)
T ss_pred hhhhccccccccccccccccccccC-----CccccccccccCChhhhhccccchhhhcccc------cCCCccccccchh
Confidence 65 1111111111111110 111111 12222322222222122222222 0122223332221
Q ss_pred h----h------hhccccccce------EEEEeecC-------C--------------CCCCcCCCCCCCCCceeeeecc
Q 001370 371 M----Q------EQQSHIVEGR------IVEVTKSN-------C--------------GSPHEQGQSLDGSDSVICRICE 413 (1091)
Q Consensus 371 ~----~------~~~~~~~~~~------~~~~~~~~-------~--------------~~~~~~~~~~~~~~~~~~~~~~ 413 (1091)
- + --.+++..+| ++.-++.. | ...|..-+.+..+|+.||||||
T Consensus 457 s~~~~~~~~s~~~~ds~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~d~s~~~~~~r~~~~~v~~~d~~i~~~~e 536 (1205)
T KOG0606|consen 457 STLRTALRTSSPSEDSKIFPLRAPPPPSSYASEEPESPKPKFSVSPESGQPGDDSEALDRSRLWSKCVGTSDSGICRICE 536 (1205)
T ss_pred hhhccccccCCCCCCccccccCCCCCccccccCCCCCCCcccccCCCCCCcccchhhhccccccccccccCCcccccccc
Confidence 1 1 1123333343 22111110 1 1345566889999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhHHhHHHHHHHHHhhcc--CCCCCCCCCCcccccccCccceeccCCCccc
Q 001370 414 EVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCN--SSSHPILGSPENSRTQSMNSAITYDGYSPKI 491 (1091)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (1091)
.++|..|.|.|++||+++++|+.+|++++.|+.|+.+.++++..|.. ++.+| .|+|..+..+ +...-++..| +.
T Consensus 537 ~~~p~~~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~s~~~~-~~~~l~s~lS--~~~~sS~p~S-rd 612 (1205)
T KOG0606|consen 537 AEGPRLHSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMINSSDTP-TGGPLCSPLS--PRSLSSNPSS-RD 612 (1205)
T ss_pred cccccccccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccccccCC-cccccccccC--CCCCCCCccc-Cc
Confidence 99999999999999999999999999999999999999999877654 33444 4667776663 5556677777 99
Q ss_pred hhhhccCcchhhhccccccccccccCCCc--ceeecccccccccCCCCcCCCCcccccCCCCCCCCCCCcccccccCCCC
Q 001370 492 SEWRNKGVEGMFEDIHEMDTACIDDSHLG--SLNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPA 569 (1091)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~s~t~~~~~~~p~~~~~~~~~~~~~~~~ 569 (1091)
+.|+|+++++|+++.+.++.. +.+..+| .+.++-..|-+. .|.-.++.++-+..||..+|...+.|+||.++-++-
T Consensus 613 sspsrd~s~~~~~~~ppI~i~-~~~~~yGft~~airVy~Gd~d-~ytvhh~v~sv~egsPA~~agls~~DlIthvnge~v 690 (1205)
T KOG0606|consen 613 SSPSRDSSAAMLSLRPPITIH-FSGKKYGFTLRAIRVYMGDKD-VYTVHHSVGSVEEGSPAFEAGLSAGDLITHVNGEPV 690 (1205)
T ss_pred cccccccchhhcCcCCceeee-ccccccCceeeeEEEecCCcc-cceeeeeeeeecCCCCccccCCCccceeEeccCccc
Confidence 999999999999999987654 4555677 667778889888 888899999999999999999999999999999999
Q ss_pred chhhHHhhhhhhh--hhhhhhhhhhhccchhhHh-hhccchHHHHhhcccceEeccchh-HHHHHHhhhhHHhhhhhccc
Q 001370 570 ELEDVQQMIELAD--IARCVADTDFSKEGSEFLL-ACMHDLQDVLQHSKLKALVIDTFG-SRIEKLLREKYILACELLDE 645 (1091)
Q Consensus 570 ~~~d~~~~~~~~~--~~~~~~~~~~~ke~~~~l~-~~~~~~~~~~~~~kl~~lvid~~g-~rI~kllr~k~~l~~~lL~~ 645 (1091)
+-.+.+||++|.+ ++++++.+--.++.+-+.. +|..+.+-+|.+.+.+..++.+++ +|+.++++..+.-.|.++..
T Consensus 691 ~gl~H~ev~~Lll~~gn~v~~~ttplenTSik~g~arr~~~k~~m~~R~kk~~~~E~~~~rr~~kLlr~~~~q~~~l~~~ 770 (1205)
T KOG0606|consen 691 HGLVHTEVMELLLKSGNKVTLRTTPLENTSIKSGPARRDSYKAVMARRKKKALVPETFGIRRIEKLLRKISKQDCELLHT 770 (1205)
T ss_pred chhhHHHHHHHHHhcCCeeEEEeeccccchhhhhHHHHHHHHHHHhhcccccccccccccccHHHHHHHHHhhhhhhhcc
Confidence 9999999999999 9999999999999995555 999999999999999999999999 78999999988877776654
Q ss_pred CCCCcccccccchhhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc
Q 001370 646 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 725 (1091)
Q Consensus 646 ksp~s~Sk~~ensrllldsvs~ssg~~tpl~ss~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~ 725 (1091)
......+ .+.+.-+... .....|..... .+...++|.+.+-+-+|+|+.++.++...+|...++|+..+..+.
T Consensus 771 ~~s~~ss----~eS~pgdp~~--sls~sP~sp~~-yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i 843 (1205)
T KOG0606|consen 771 SRSFLSS----SESLPGDPTR--SLSASPRSPTK-YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI 843 (1205)
T ss_pred ccccccc----cccCCCCccc--ccccCCCCccc-ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhh
Confidence 3321000 0000000000 00111222222 567889999999999999999999999999999999999888888
Q ss_pred chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 001370 726 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805 (1091)
Q Consensus 726 ~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~ 805 (1091)
..++.+.+..+..++....+|.++..+..|.....++|||+|+.||+|...|++.++.+++.++.++..++.+++|||..
T Consensus 844 ~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~ 923 (1205)
T KOG0606|consen 844 RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS 923 (1205)
T ss_pred ccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc
Confidence 88888889999999888899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeecccCCCceEecCCCcEEEEecC-CcccccccccccCCCCCCCCC---CCCCCCCCcccccCcCCccCccCCCCCCC
Q 001370 806 GIVHRDLKPDNLLIAHDGHIKLTDFG-LSKIGLINNTIDLSGPETDGI---MPSDAHYPEYQQTDNRNRHSAVGTPDYLA 881 (1091)
Q Consensus 806 GIIHRDLKPeNILLD~nG~VKLsDFG-LAk~~~~~~s~dls~~~t~g~---lps~~~~~~~~~~~~~~~~s~vGTp~YmA 881 (1091)
.++|||++|.|+|+..+|+.+++||| +.+.+.....++++++...+. .....+-+.............+||+.|.|
T Consensus 924 ~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~la 1003 (1205)
T KOG0606|consen 924 LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLA 1003 (1205)
T ss_pred hhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccC
Confidence 99999999999999999999999999 555555555555543332221 12222233333333455677899999999
Q ss_pred hhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc
Q 001370 882 PEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 961 (1091)
Q Consensus 882 PEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa 961 (1091)
||.+.+...+..+|||++|++++|.++|.+||....++.+++.|.++..+||.-+...++++++++.++|..+|.+|.++
T Consensus 1004 Pe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1004 PEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred CcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccHHHHHcCCCCCCCCcchhhcccCCccCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCC-cCCCCCCcchhhccC
Q 001370 962 NGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADT-CDSSSNSRTEMDECG 1040 (1091)
Q Consensus 962 ~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st-~~sss~~~~em~et~ 1040 (1091)
.++.+++.||||+.++|+.|..+...|+|++.+..|+++|.+.|.....++.....+..+...+ +....+.+.++
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~~~~~~~e~~sg~s~~~~~~s~~~~~~~~~pe~---- 1159 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFVPQPESTQDTSYFESRFSEESQDETVSGSSSGSKLDSPDESPECTTPEL---- 1159 (1205)
T ss_pred ccccccccCCccCCCCccccccccCccCCCCCCCCccchhhcccccccccccccCCCcccCccCccccccccCccc----
Confidence 8889999999999999999999999999999999999999999885533333222222222111 22222222222
Q ss_pred CccccCCCCCCCcccCceeecchhhhccchhhhhc
Q 001370 1041 DLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQ 1075 (1091)
Q Consensus 1041 ~f~e~~~~~~d~~Fig~tyk~~~~~~~~~~~~~~~ 1075 (1091)
+....-++.|+||+||+..+|.+|||+++++
T Consensus 1160 ----~~~~~~~~sl~~~~~k~~s~l~s~~p~~~l~ 1190 (1205)
T KOG0606|consen 1160 ----KPAMCGNLSLINFSFKNLSQLASINPDKLLQ 1190 (1205)
T ss_pred ----cCCcCccccccccCccChhhccccChHhhcC
Confidence 2232337779999999999999999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-78 Score=684.57 Aligned_cols=373 Identities=46% Similarity=0.797 Sum_probs=319.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
++..++|+++++||+|+||.||+|+.+.||++||||+++|..+...+++++++.|++||...++||||+||++||+.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||||||++|||++++|.+.+.|+++.+++|+++++.||+.||+.|||||||||+|+|||..||+||+|||||+.....+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999975444333
Q ss_pred ccCCC------CCCCCCC----C----------CCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhh
Q 001370 842 IDLSG------PETDGIM----P----------SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 901 (1091)
Q Consensus 842 ~dls~------~~t~g~l----p----------s~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGV 901 (1091)
++... ....... + ....+.+|+.+++..+++++|||.|||||||.+.+|+..||||||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 33211 0000001 1 12234467777888899999999999999999999999999999999
Q ss_pred hHHHHHhCCCCCCCCChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 902 ILFEFITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 902 ILYEMLTGkpPF~~~s~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
||||||.|+|||++.++.+++++|++.. +.||. ...++++|+|||.+||+ ||++|++..++.||++||||++|+|+
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999999999999999999999999976 66774 46788999999999999 99999999999999999999999999
Q ss_pred hhhcccCCccCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCcCCCCCCcchhhccCCccccCCCCCCCcccCcee
Q 001370 980 SLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSF 1059 (1091)
Q Consensus 980 ~L~~~~pPfiP~~~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~~em~et~~f~e~~~~~~d~~Fig~ty 1059 (1091)
.|....|||+|++.++.|++||+.+ ++.....+. ...+..|+. |. .+...+...++-+|+||||
T Consensus 455 ~l~~~~apfvP~v~~~~DT~yFddF-~e~~~~~~~-----------~~~~~~~~k-~~---~~~~~~~~~~~~~FvgfTy 518 (550)
T KOG0605|consen 455 HLREMPAPFVPQVNSELDTQYFDDF-PEEDSMTPT-----------ADKSGPSRK-ML---SMVDTNNSSKDINFVGFTY 518 (550)
T ss_pred hhhcCCCCCCCCCCCcccccccccC-cccccCccc-----------ccccccchh-hh---hcccccCCcccccccceee
Confidence 9999999999999999999999963 333221111 111112222 11 1122224567888999999
Q ss_pred ecchhhhccchhh
Q 001370 1060 KNLSQLASINHEV 1072 (1091)
Q Consensus 1060 k~~~~~~~~~~~~ 1072 (1091)
|+|+++.+-+...
T Consensus 519 k~~~~~~~~~~~~ 531 (550)
T KOG0605|consen 519 KNFDGLNKANSLL 531 (550)
T ss_pred ecccccccccccc
Confidence 9999999887764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-70 Score=603.54 Aligned_cols=302 Identities=49% Similarity=0.913 Sum_probs=284.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....++|+++++||+|+||+||+|+.++|++.||||+++|..+....+++++++|+.||..++||+||+++++||+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|||+||++||+|+.+|++.+.|+|..+++|+++|+.||.|||++|||||||||+|||||.+||++|+|||||+...
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~---- 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL---- 176 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999532
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.....+.++|||+.|||||++.+.+|+..+||||||++|||||+|.+||.+.+...+
T Consensus 177 -----------------------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~ 233 (357)
T KOG0598|consen 177 -----------------------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM 233 (357)
T ss_pred -----------------------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence 223455679999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC-cccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCc
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 998 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS-a~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dt 998 (1091)
+++|+.++...+ |..++.+++|||+++|++||++|++ ..++.+|++||||++++|+.+.++ .|||+|......|+
T Consensus 234 ~~~I~~~k~~~~--p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~ 311 (357)
T KOG0598|consen 234 YDKILKGKLPLP--PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDT 311 (357)
T ss_pred HHHHhcCcCCCC--CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCcccc
Confidence 999999986555 4679999999999999999999997 457999999999999999999877 79999999999999
Q ss_pred cccccccccCCCCC
Q 001370 999 SYFLSRFSQISSGL 1012 (1091)
Q Consensus 999 s~Fds~fs~~~s~l 1012 (1091)
++|+..|+...+..
T Consensus 312 ~~Fd~eft~~~~~~ 325 (357)
T KOG0598|consen 312 SNFDNEFTSYTVDY 325 (357)
T ss_pred ccccHHHHhccccC
Confidence 99999998885543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-66 Score=553.55 Aligned_cols=289 Identities=43% Similarity=0.837 Sum_probs=276.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
..+++|+++++||.|+||+|.+++.+.+|..||||+++|..+.+-.++++..+|..+|+.+.||++++|++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
|||||++||.|+++|++.++|++..++||++||++||+|||+++||||||||+|||||++|++||+|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999863
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
...+++.||||.|+|||++..++|+.++|||||||++|||+.|++||...++..+|
T Consensus 195 ------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY 250 (355)
T KOG0616|consen 195 ------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY 250 (355)
T ss_pred ------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH
Confidence 22367899999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC--cccHHHHHcCCCCCCCCcchhhcc--cCCccC-CCCCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVP-QPESVDD 997 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS--a~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP-~~~s~~D 997 (1091)
.+|+.+++.|| ..++.+++|||+++|++|-.+|.+ .+|..+|+.||||++++|..+..+ ++|++| ....+.|
T Consensus 251 ~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gd 327 (355)
T KOG0616|consen 251 EKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGD 327 (355)
T ss_pred HHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcc
Confidence 99999999998 789999999999999999999988 458999999999999999999877 789988 6778899
Q ss_pred ccccccc
Q 001370 998 TSYFLSR 1004 (1091)
Q Consensus 998 ts~Fds~ 1004 (1091)
+++|+..
T Consensus 328 tsnfd~y 334 (355)
T KOG0616|consen 328 TSNFDDY 334 (355)
T ss_pred ccccccc
Confidence 9999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-65 Score=594.51 Aligned_cols=303 Identities=38% Similarity=0.766 Sum_probs=285.2
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded 759 (1091)
.+..+++|.++++||+|+||+|+++..+.+++.||||+++|..+...++++..+.|.+|+.... ||++++||.+||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4688999999999999999999999999999999999999999999999999999999998886 999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
++|+||||+.||| +.+++..+.|++..+++|+++|+.||.|||++||||||||.+|||||.+||+||+|||||+.++
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-- 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-- 519 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--
Confidence 9999999999999 4455566889999999999999999999999999999999999999999999999999999642
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.....+.++||||.|||||++.++.|+..+|||||||+|||||+|..||.+++.+
T Consensus 520 -------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 520 -------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred -------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 2244678999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 995 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~ 995 (1091)
+++..|++..+.+| ..+|.++.+++++||.++|++|++. .++.+|+.||||+.|+|+.|..+ +|||+|...++
T Consensus 575 e~FdsI~~d~~~yP---~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~ 651 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYP---RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP 651 (694)
T ss_pred HHHHHHhcCCCCCC---CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence 99999999998887 7999999999999999999999995 57999999999999999999877 89999999999
Q ss_pred CCccccccccccCCCCCCC
Q 001370 996 DDTSYFLSRFSQISSGLPD 1014 (1091)
Q Consensus 996 ~Dts~Fds~fs~~~s~l~~ 1014 (1091)
.|.+|||.+|+.....+.+
T Consensus 652 ~D~snFd~eFt~e~p~Lt~ 670 (694)
T KOG0694|consen 652 EDVSNFDEEFTSEKPALTP 670 (694)
T ss_pred hhhcccchhhhcCCCccCC
Confidence 9999999999998776664
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-65 Score=610.46 Aligned_cols=296 Identities=44% Similarity=0.773 Sum_probs=276.1
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
+.++..+||+++++||+|+||.|.+++++.|++.||||+++|-.+.++.+...|..|++||.-.+.+|||+|++.|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 45678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
++|||||||+||||..+|.+.+.++++.++||+++|+.||..||++|+|||||||+|||||.+||+||+|||.|-.+..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~- 227 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA- 227 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999875321
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
.........||||.|++||+|.. +.|+..|||||+||+|||||+|..||+
T Consensus 228 -------------------------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 228 -------------------------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred -------------------------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 12234556899999999999963 458999999999999999999999999
Q ss_pred CCChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCC
Q 001370 915 AESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQP 992 (1091)
Q Consensus 915 ~~s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~ 992 (1091)
.++-.++|.+|++. .+.||. ...+|.++++||.++|+ +|+.|+|.+|+.+|+.||||.|++|+.++...|||+|.+
T Consensus 283 adslveTY~KIm~hk~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 283 ADSLVETYGKIMNHKESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred HHHHHHHHHHHhchhhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 99999999999986 677773 45699999999999999 899999999999999999999999999999999999999
Q ss_pred CCCCCcccccc
Q 001370 993 ESVDDTSYFLS 1003 (1091)
Q Consensus 993 ~s~~Dts~Fds 1003 (1091)
.+++||+||+.
T Consensus 361 ssd~DTsnFd~ 371 (1317)
T KOG0612|consen 361 SSDDDTSNFDV 371 (1317)
T ss_pred CCCCccccccc
Confidence 99999999954
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-64 Score=563.21 Aligned_cols=412 Identities=33% Similarity=0.544 Sum_probs=342.5
Q ss_pred hhhhhhhhhhhhhhhhccchhhHhhhccchH--HHHhhcc---cceEeccchhHHHHHHhhhhHHhhhhhcccCCCCccc
Q 001370 578 IELADIARCVADTDFSKEGSEFLLACMHDLQ--DVLQHSK---LKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFS 652 (1091)
Q Consensus 578 ~~~~~~~~~~~~~~~~ke~~~~l~~~~~~~~--~~~~~~k---l~~lvid~~g~rI~kllr~k~~l~~~lL~~ksp~s~S 652 (1091)
-++.+.|+.|++.|||+| +.+|+|+.+ +++.+.. ......+.|...++.. |..+.. ..|.
T Consensus 96 ~~r~~~~~~i~~~~l~~~----~~~~~~~~s~~~~v~~~~~~l~~~~~~~lf~~~~~~~--------~~~L~~---~pF~ 160 (591)
T KOG0986|consen 96 DERKDKARQILDAYLMKE----LLACLPQFSSKDLVTHVQEHLLEKPPKDLFQPLARAI--------CAYLRG---DPFQ 160 (591)
T ss_pred ccchhhHHHHHHHHhhcc----ccccCCCcchhhhhHHHhhhccccCchhhhHHHHHHH--------HHHhcc---chHh
Confidence 356789999999999999 999999984 5555442 2222344444443332 222222 1122
Q ss_pred ccccchhhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHH
Q 001370 653 KYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 732 (1091)
Q Consensus 653 k~~ensrllldsvs~ssg~~tpl~ss~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~ 732 (1091)
+|.+. ...++..+.. -.+...+..+.|...++||+||||+||-++.+.||++||+|.+.|..+..+.....
T Consensus 161 ~f~~S--~yf~rFlQWK-------~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~m 231 (591)
T KOG0986|consen 161 EFLES--DYFTRFLQWK-------WLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETM 231 (591)
T ss_pred HhHHH--HHHHHHHHHH-------HHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHH
Confidence 22111 1112222221 11224567789999999999999999999999999999999999998888888999
Q ss_pred HHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 001370 733 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHR 810 (1091)
Q Consensus 733 ~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHR 810 (1091)
.++|..||.+++.|+||.|-++|++.+.++|||..|+||||..+|.+.+ .|++..++||++||++||++||+.+||+|
T Consensus 232 aLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYR 311 (591)
T KOG0986|consen 232 ALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYR 311 (591)
T ss_pred hhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeec
Confidence 9999999999999999999999999999999999999999999999887 79999999999999999999999999999
Q ss_pred ccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC
Q 001370 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 890 (1091)
Q Consensus 811 DLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y 890 (1091)
||||+|||||+.|||+|+|+|||..+.. +......+||.+|||||++.+..|
T Consensus 312 DLKPeNILLDd~GhvRISDLGLAvei~~----------------------------g~~~~~rvGT~GYMAPEvl~ne~Y 363 (591)
T KOG0986|consen 312 DLKPENILLDDHGHVRISDLGLAVEIPE----------------------------GKPIRGRVGTVGYMAPEVLQNEVY 363 (591)
T ss_pred cCChhheeeccCCCeEeeccceEEecCC----------------------------CCccccccCcccccCHHHHcCCcc
Confidence 9999999999999999999999985421 233345699999999999999999
Q ss_pred CccceeechhhhHHHHHhCCCCCCCCC----hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccH
Q 001370 891 GYAADWWSVGIILFEFITGIPPFTAES----PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGA 964 (1091)
Q Consensus 891 s~ksDIWSLGVILYEMLTGkpPF~~~s----~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA 964 (1091)
+.++|||||||+||||+.|+.||.... .+++-+++++....+| ..+|+++++|++.+|++||.+|++. +++
T Consensus 364 ~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga 440 (591)
T KOG0986|consen 364 DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGA 440 (591)
T ss_pred cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCc
Confidence 999999999999999999999997643 4577788888887777 7999999999999999999999994 589
Q ss_pred HHHHcCCCCCCCCcchhhcc--cCCccCCCCC-----CCCccccccccccCCCCCCCCCCCCCCCCCCcCCCCCCcchhh
Q 001370 965 AEVKAHPFFKGVNWDSLALQ--KAVFVPQPES-----VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMD 1037 (1091)
Q Consensus 965 ~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s-----~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~~em~ 1037 (1091)
.++++||||+++||..+..+ .|||+|.+.. ..|+..|+ +-.++.++++|.++|..|.|+..+++|++||.
T Consensus 441 ~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs---~VKGV~ld~~D~~fy~~F~tg~vsipWQnE~~ 517 (591)
T KOG0986|consen 441 QEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFS---TVKGVKLDDTDTDFYKNFATGSVSIPWQNEMI 517 (591)
T ss_pred chhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcc---cccceecccccHHHHHhccCCcccchHHHHHH
Confidence 99999999999999999887 8999999864 45666554 33488999999999999999999999999999
Q ss_pred ccCCccccCC
Q 001370 1038 ECGDLAEFGS 1047 (1091)
Q Consensus 1038 et~~f~e~~~ 1047 (1091)
||++|.+.+-
T Consensus 518 ET~~f~elnv 527 (591)
T KOG0986|consen 518 ETECFEELNV 527 (591)
T ss_pred HhhhHHHhhc
Confidence 9999998744
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-62 Score=526.30 Aligned_cols=308 Identities=41% Similarity=0.748 Sum_probs=291.4
Q ss_pred CccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 678 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 678 s~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
..+.++..++|+.+++||+|.||+|.+|+.+.+|+.||||+++|.-+..+.++.+.+.|-++|+..+||++..|-++|+.
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 34556789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+.+|+||||+.||.|+.+|.+...|+++.+++|.++|+.||.|||+++||+||||.+|+|||.+||+||+|||||+...
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
..+....++||||.|+|||++....|+..+|||.+||+||||++|+.||+..+
T Consensus 320 ---------------------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 320 ---------------------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred ---------------------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 23456678999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC--cccHHHHHcCCCCCCCCcchhhcc--cCCccCCCC
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPE 993 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS--a~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~ 993 (1091)
...++..|+...+.|| ..++++++.|+..+|.+||.+|++ .++|.||..|+||.+++|+.+..+ .|||+|++.
T Consensus 373 h~kLFeLIl~ed~kFP---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 373 HEKLFELILMEDLKFP---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred hhHHHHHHHhhhccCC---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence 9999999999999988 799999999999999999999998 568999999999999999998766 899999999
Q ss_pred CCCCccccccccccCCCCCCCC
Q 001370 994 SVDDTSYFLSRFSQISSGLPDD 1015 (1091)
Q Consensus 994 s~~Dts~Fds~fs~~~s~l~~~ 1015 (1091)
+..|++|||.+|+..++.+.+-
T Consensus 450 SetDTryFD~EFT~q~v~lTPP 471 (516)
T KOG0690|consen 450 SETDTRYFDEEFTSQPVTLTPP 471 (516)
T ss_pred cccchhhhhhhhhcceeEecCC
Confidence 9999999999999998777553
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-60 Score=541.45 Aligned_cols=322 Identities=44% Similarity=0.739 Sum_probs=278.3
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
.++...-|..++.||-|+||+|.+++..+|...||||.++|.+++.++++.++++|++||...+++|||+||++|++.++
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 34566779999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+||||++|||++.+|.+.+.|+|+.++||++++.+||+++|++|+|||||||+|||||.+|||||+|||||+-+.=..
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998543111
Q ss_pred cccCCCCCCCCCCCCCCCCCcc---------------cccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEY---------------QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~---------------~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYE 905 (1091)
..............+-...++| .+..+-.+.+.+||+.|+|||+|...+|+..|||||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1111111110000000011111 1222345677899999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhc
Q 001370 906 FITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 983 (1091)
Q Consensus 906 MLTGkpPF~~~s~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~ 983 (1091)
|+.|++||-..++.++..+|.+.. +.+| ....+|.++.+||.+|++ +++.|++..++.+++.||||++|||..++.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~-~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRk 941 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIP-YQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRK 941 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccc-cccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhh
Confidence 999999999999988888887743 3333 236899999999999887 999999999999999999999999999999
Q ss_pred ccCCccCCCCCCCCccccccc
Q 001370 984 QKAVFVPQPESVDDTSYFLSR 1004 (1091)
Q Consensus 984 ~~pPfiP~~~s~~Dts~Fds~ 1004 (1091)
++++|+|.+..+.|++||+..
T Consensus 942 q~ApYIP~ItHptDTSNFdpv 962 (1034)
T KOG0608|consen 942 QRAPYIPRITHPTDTSNFDPV 962 (1034)
T ss_pred ccCCcCccccCCCccccCCcC
Confidence 999999999999999999874
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-59 Score=516.00 Aligned_cols=315 Identities=40% Similarity=0.716 Sum_probs=273.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.+.++.|++++.||+|.-|+||+|+.+.++..+|||++.|..+..++...++..|.+||+.++||+++.||..|+.++..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 46678999999999999999999999999999999999999998889999999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
|+|||||+||+|..+++++ ..|++..++||+++++.||+|||-+|||||||||+||||-++|||.|+||.|+......
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999999876 46999999999999999999999999999999999999999999999999998754322
Q ss_pred ccccCC-CCCC------------CCCCCC-----C----------CCCCcc-cccCcCCccCccCCCCCCChhhhcCCCC
Q 001370 840 NTIDLS-GPET------------DGIMPS-----D----------AHYPEY-QQTDNRNRHSAVGTPDYLAPEILLGTEH 890 (1091)
Q Consensus 840 ~s~dls-~~~t------------~g~lps-----~----------~~~~~~-~~~~~~~~~s~vGTp~YmAPEVL~g~~Y 890 (1091)
.+.-.+ .+.. ..+.+. . ..++.. ......+..++|||-.|+|||++.|.++
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 211110 0000 000000 0 001111 1223456788999999999999999999
Q ss_pred CccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC-cccHHHHHc
Q 001370 891 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKA 969 (1091)
Q Consensus 891 s~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS-a~gA~EIL~ 969 (1091)
+.++|||+|||+|||||+|..||.+.+..+++.+|+...+.||..+ .++..++|||+++|.+||.+|++ ..||.||++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 9999999999999999999999999999999999999999999755 78999999999999999999999 568999999
Q ss_pred CCCCCCCCcchhhcccCCccCCCCCCCC
Q 001370 970 HPFFKGVNWDSLALQKAVFVPQPESVDD 997 (1091)
Q Consensus 970 HPFFkgIdWd~L~~~~pPfiP~~~s~~D 997 (1091)
||||++++|.-++...||++|.+.....
T Consensus 392 HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 392 HPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred CccccCCChhheeccCCCcCCCccccCc
Confidence 9999999999777779999998865433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-58 Score=525.76 Aligned_cols=288 Identities=39% Similarity=0.750 Sum_probs=261.6
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR 758 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqde 758 (1091)
+++....||.+.+.||.|+|++|++|+.+.+++.||||++.|..+.++..+..+..|.++|.+| .||.||+||..|+|+
T Consensus 67 ~~kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 67 EEKKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred hccCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 3467899999999999999999999999999999999999999999999999999999999999 799999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..+|+|+||+++|+|.++|++.|.|++..+|+|++||+.||+|||++|||||||||+|||||.+||+||+|||-|+.+..
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999996432
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
..... .. +...........++|||..|.+||+|.....++.+|+|+||||||.|+.|.|||.+.+.
T Consensus 227 ~~~~~-------------~~-~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 227 SQKSQ-------------EN-PVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred hhccc-------------cC-ccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 11100 00 00000111224679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV 987 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pP 987 (1091)
..++++|+.-.+.|| ..+++.++|||+++|..||.+|+| +.+|++||||.+|+|+.|..+.||
T Consensus 293 yliFqkI~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt---~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 293 YLIFQKIQALDYEFP---EGFPEDARDLIKKLLVRDPSDRLT---SQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred HHHHHHHHHhcccCC---CCCCHHHHHHHHHHHccCcccccc---HHHHhhCcccccCChhhhhhcCCC
Confidence 999999999999988 799999999999999999999999 789999999999999999888543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-59 Score=517.48 Aligned_cols=335 Identities=35% Similarity=0.700 Sum_probs=304.9
Q ss_pred CccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeec
Q 001370 678 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFT 756 (1091)
Q Consensus 678 s~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfq 756 (1091)
+....+...+|.++.+||+|+||+|.++..+.|.+.||||+++|..+...++++..+.|.++|.... -|++++|+.+|+
T Consensus 341 ~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 341 SKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred CcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 3445678899999999999999999999999999999999999988888888999999999998774 789999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+-+.+|+||||+.||+|+.+++..|.|.|..+.+|+++|+-||-|||++|||+||||.+|||||.+|||||+|||+|+..
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999953
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
. .....+.++||||.|||||++..++|+.++||||+||+|||||.|.+||.++
T Consensus 501 i---------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 501 I---------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred c---------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 2 1244567899999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 992 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 992 (1091)
+..++++.|....+.+| ..+|.++.++++.+|.+.|.+|++. .+-.+|..||||+.|+|+.++.. +|||.|.+
T Consensus 554 DE~elF~aI~ehnvsyP---KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 554 DEDELFQAIMEHNVSYP---KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred CHHHHHHHHHHccCcCc---ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 99999999999998887 7999999999999999999999993 56789999999999999999877 89999999
Q ss_pred CCCCCccccccccccCCCCCCCCCCCCCCCCCCcCCCCCCcchhhccCCccccCCCCCCCcccCceeecchhhhcc
Q 001370 993 ESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASI 1068 (1091)
Q Consensus 993 ~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~~em~et~~f~e~~~~~~d~~Fig~tyk~~~~~~~~ 1068 (1091)
..-.+.+||+..|+.....+++.|.-+... .++ -.|+||||.|++.+..+
T Consensus 631 k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~n----------------------ldq----~eF~gFsfvNpefv~~~ 680 (683)
T KOG0696|consen 631 KCGRDAENFDKFFTREPTDLTPPDKLVMMN----------------------LDQ----SEFEGFSFVNPEFVKPI 680 (683)
T ss_pred ccCCchhhhhHHHhcCCCCCCCchHHHHhc----------------------Cch----hhcCceeeeChhhcCCC
Confidence 999999999999999988877665433321 111 23999999999988765
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-55 Score=483.10 Aligned_cols=351 Identities=41% Similarity=0.746 Sum_probs=279.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765555566778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999753211110000
Q ss_pred CCCCCCC-----------CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001370 846 GPETDGI-----------MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 846 ~~~t~g~-----------lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
....... .........|.........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0000000 00000011111122223446789999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCC
Q 001370 915 AESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQP 992 (1091)
Q Consensus 915 ~~s~~ei~~kIl~~~l--~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~ 992 (1091)
+.+..+.+..+..... .+|. ...+++++++||.+||. +|.+|++...+.+++.||||++++|+.+....+++.|..
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 318 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPEL 318 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCCC
Confidence 9998888888876543 3332 23579999999999997 999999877799999999999999999888888999999
Q ss_pred CCCCCccccccccccCCCCCCCCCCCCCCCCCCcCCCCCCcchhhccCCccccCCCCCCCcccCceeecch
Q 001370 993 ESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 1063 (1091)
Q Consensus 993 ~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~~em~et~~f~e~~~~~~d~~Fig~tyk~~~ 1063 (1091)
.+..|.++|+.+ .......+... . ... -....+||.|+||||++|+
T Consensus 319 ~~~~~~~~~~~~-~~~~~~~~~~~-----------~--~~~-----------~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 319 KSITDTSNFDDF-EEIDLDVPTSP-----------G--PPR-----------GKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred CCchhhhhcccc-ccccccccCCC-----------c--ccc-----------ccccccCCCCCCCeeeCCC
Confidence 888898888753 22221111100 0 000 1123569999999999986
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-55 Score=484.17 Aligned_cols=352 Identities=40% Similarity=0.715 Sum_probs=274.8
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.++..++||||+++++.|++...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555666778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999753211110000
Q ss_pred CCCCCCCCCCCCCC---------CcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 846 GPETDGIMPSDAHY---------PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 846 ~~~t~g~lps~~~~---------~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
... ....+.+..+ ..+...........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 161 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNL-NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccc-cccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 000 0000111000 011111222335678999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCC
Q 001370 917 SPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPES 994 (1091)
Q Consensus 917 s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s 994 (1091)
+..+.+.++... .+.+|. ...+++++++||.+|++ +|.+|++..++.+|++||||++++|+.+...+++..+...+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKS 317 (363)
T ss_pred CHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCCC
Confidence 999999988864 344443 23578999999999887 77777654459999999999999999998776555556667
Q ss_pred CCCccccccccccCCCCCCCCCCCCCCCCCCcCCCCCCcchhhccCCccccCCCCCCCcccCceeecch
Q 001370 995 VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 1063 (1091)
Q Consensus 995 ~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~~em~et~~f~e~~~~~~d~~Fig~tyk~~~ 1063 (1091)
..|+++|+.... .....+ +...+ .. .+.+..+.+|.|+||||+.|+
T Consensus 318 ~~~~~~~~~~~~-~~~~~~-----------~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~ 363 (363)
T cd05628 318 IDDTSNFDEFPD-SDILKP-----------TVATS-NH----------PETDYKNKDWVFINYTYKRFE 363 (363)
T ss_pred cchhhccCCCCc-cccccc-----------ccccc-CC----------cccccCcCCcccCCceeecCC
Confidence 778888765321 110000 00000 00 123345779999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=480.85 Aligned_cols=317 Identities=43% Similarity=0.802 Sum_probs=259.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|++++..++|||||+++++|.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998766555666788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999642110000000
Q ss_pred ----C--CCCC------CC--------CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001370 846 ----G--PETD------GI--------MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905 (1091)
Q Consensus 846 ----~--~~t~------g~--------lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYE 905 (1091)
. .... .. .........+.........+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 0000 00 00000001111111112235689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhc
Q 001370 906 FITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 983 (1091)
Q Consensus 906 MLTGkpPF~~~s~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~ 983 (1091)
|++|.+||.+.+..+.+..+.... +.+|. ...++.++++||.+||+ +|.+|++...+.+++.||||++++|+.+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~ 318 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIRQ 318 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHcc
Confidence 999999999998888888887643 33442 13578999999999998 888887555699999999999999999988
Q ss_pred ccCCccCCCCCCCCccccccc
Q 001370 984 QKAVFVPQPESVDDTSYFLSR 1004 (1091)
Q Consensus 984 ~~pPfiP~~~s~~Dts~Fds~ 1004 (1091)
..+|++|......+..+|...
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T cd05629 319 IRAPFIPQLKSITDTSYFPTD 339 (377)
T ss_pred CCCCcccCCCCccccccCCcc
Confidence 889999999888888877554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-54 Score=478.72 Aligned_cols=316 Identities=44% Similarity=0.730 Sum_probs=258.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|.+++|||||++++.|.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999987666566677889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.............
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999986321100000000
Q ss_pred C------CCCCCC-----CCCCCC---------CcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001370 847 P------ETDGIM-----PSDAHY---------PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 847 ~------~t~g~l-----ps~~~~---------~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEM 906 (1091)
. ...... +..... ............+.+||+.|||||++.+..|+.++|||||||+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0 000000 000000 00000111123457899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhh-c
Q 001370 907 ITGIPPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA-L 983 (1091)
Q Consensus 907 LTGkpPF~~~s~~ei~~kIl~~~l--~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~-~ 983 (1091)
++|++||.+.++.+....+.+... .+|. ...+++++.+||.+|+. +|.+|++..++.++++||||++++|.... .
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~ 319 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPP-QAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTIDFSSDLRQ 319 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCC-cccCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhcCCCcCCcChHHHHhc
Confidence 999999999988888888776432 3332 24689999999999864 99999997779999999999999998754 3
Q ss_pred ccCCccCCCCCCCCccccccc
Q 001370 984 QKAVFVPQPESVDDTSYFLSR 1004 (1091)
Q Consensus 984 ~~pPfiP~~~s~~Dts~Fds~ 1004 (1091)
..+|+.|....+.|+++|+..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~ 340 (382)
T cd05625 320 QSAPYIPKITHPTDTSNFDPV 340 (382)
T ss_pred CCCCccCcCCCcchhhhcCCC
Confidence 478999999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-55 Score=502.42 Aligned_cols=256 Identities=35% Similarity=0.650 Sum_probs=246.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|+..+.||+|||++||.+++..+|+.||+|++.|..+.+..+.+.+.+|++|.+.++|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 67999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
|+|..|+|+.++++...++|.++++|+.||+.||.|||+++|||||||..||||+++.+|||+|||||....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le-------- 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE-------- 169 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec--------
Confidence 999999999999999999999999999999999999999999999999999999999999999999998631
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.+.++..+.||||.|+||||+...+++..+||||+||+||-||+|+|||...+-.+++.+|
T Consensus 170 -------------------~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I 230 (592)
T KOG0575|consen 170 -------------------YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI 230 (592)
T ss_pred -------------------CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence 2346678999999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
....+.+| ..+|.+|+|||.+||..||.+||+ +.+|+.|+||+
T Consensus 231 k~~~Y~~P---~~ls~~A~dLI~~lL~~~P~~Rps---l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 231 KLNEYSMP---SHLSAEAKDLIRKLLRPNPSERPS---LDEVLDHPFFK 273 (592)
T ss_pred HhcCcccc---cccCHHHHHHHHHHhcCCcccCCC---HHHHhcCHhhh
Confidence 99999988 699999999999999999999999 88999999993
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-54 Score=473.20 Aligned_cols=350 Identities=40% Similarity=0.717 Sum_probs=275.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.++..++||||+++++.|++.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998766555667788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++.+.+.+++..++.+++|++.||.|||++||+||||||+||||+.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998753211110000
Q ss_pred CCCC----CC----CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 846 GPET----DG----IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 846 ~~~t----~g----~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
.... .. .+........+.........+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 0000 00 000000001111122233456789999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCCC
Q 001370 918 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESV 995 (1091)
Q Consensus 918 ~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~ 995 (1091)
+...+.++.+.. +.+|. ...++.++++||.+|+. ||.+|++..++.++++||||++++|..+....++..+...+.
T Consensus 241 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~ 318 (360)
T cd05627 241 PQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSI 318 (360)
T ss_pred HHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCCc
Confidence 999888887643 33442 13478999999999875 999999977899999999999999999877755555566777
Q ss_pred CCccccccccccCCCCCCCCCCCCCCCCCCcCCCCCCcchhhccCCccccCCCCCCCcccCceeecch
Q 001370 996 DDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 1063 (1091)
Q Consensus 996 ~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~~em~et~~f~e~~~~~~d~~Fig~tyk~~~ 1063 (1091)
.|.++|+... +. +.. . ...+ -.+-....++|.|-||+|++|+
T Consensus 319 ~~~~~~~~~~-~~-------~~~--~------~~~~----------~~~~~~~~~~~~~~~~~~~~~~ 360 (360)
T cd05627 319 DDTSNFDEFP-ES-------DIL--Q------PAEN----------TIEPDYKSKDWVFLNYTYKRFE 360 (360)
T ss_pred chhhhcCCCC-cc-------ccc--C------CCcc----------ccccccCcCCcccCCceeecCC
Confidence 8888875421 11 000 0 0000 0022345679999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-55 Score=485.68 Aligned_cols=265 Identities=36% Similarity=0.605 Sum_probs=236.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----KNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~----~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
...+.|.+.+.||+|+||.|.+|..+.||+.||||++++..... ......+.+|++||++++|||||+++++|..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 35567888999999999999999999999999999999865443 22344578999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC---CcEEEEecCCccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKI 835 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n---G~VKLsDFGLAk~ 835 (1091)
+..||||||+.||+|++.+...+.+.+...+.|++|++.||.|||++||+||||||+|||+..+ -.+||+|||||++
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999876 7899999999996
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC---CccceeechhhhHHHHHhCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y---s~ksDIWSLGVILYEMLTGkpP 912 (1091)
.. ......+.||||.|.|||++.+.++ ..++|+|||||+||-||+|++|
T Consensus 329 ~g----------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 329 SG----------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred cc----------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 31 1334578999999999999988664 4588999999999999999999
Q ss_pred CCCCChHH-HHHHHhhcCCCCC-CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 913 FTAESPEI-IFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 913 F~~~s~~e-i~~kIl~~~l~fP-~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
|.+..... +.++|..+.+.|- .....+|.++.+||.+||..||++||+ +.|+|+||||+.+.-
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s---~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS---ADEALNHPWFKDAPC 445 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC---HHHHhcChhhhcccc
Confidence 99877666 8999999988763 445789999999999999999999999 889999999997653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-53 Score=470.43 Aligned_cols=315 Identities=43% Similarity=0.689 Sum_probs=253.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+.+|..++|||||+++++|.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998866666677788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++.+.+.+++..++.+++||+.||.|||++||+||||||+||||+.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998642111000000
Q ss_pred CCC----CCCCCCC----CC-------CC-----CcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001370 846 GPE----TDGIMPS----DA-------HY-----PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905 (1091)
Q Consensus 846 ~~~----t~g~lps----~~-------~~-----~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYE 905 (1091)
... .....+. .. .. ............+.+||+.|||||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000 0000000 00 00 0000011112346789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHhhhccCCCC--CCCCcccHHHHHcCCCCCCCCcchh
Q 001370 906 FITGIPPFTAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPN--QRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 906 MLTGkpPF~~~s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~rcL~kDPe--KRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
|++|.+||...+..+....+... ...+|. ...+++++++||.+||+.+++ .|++ +.++++||||.+++|...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~---~~~~l~hp~f~~~~~~~~ 316 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPP-QVKLSPEAVDLITKLCCSAEERLGRNG---ADDIKAHPFFSEVDFSSD 316 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCC-CCCCCHHHHHHHHHHccCcccccCCCC---HHHHhcCcccCCCChhHH
Confidence 99999999998887777777653 333332 235899999999997765444 4888 889999999999999875
Q ss_pred hc-ccCCccCCCCCCCCccccccc
Q 001370 982 AL-QKAVFVPQPESVDDTSYFLSR 1004 (1091)
Q Consensus 982 ~~-~~pPfiP~~~s~~Dts~Fds~ 1004 (1091)
.. ..+|+.|....+.++++|+..
T Consensus 317 ~~~~~~~~~p~~~~~~~~~~~~~~ 340 (381)
T cd05626 317 IRTQPAPYVPKISHPMDTSNFDPV 340 (381)
T ss_pred hhcCCCCccCcCCCcchhhhcCCC
Confidence 43 477899999989999888653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-53 Score=458.80 Aligned_cols=288 Identities=43% Similarity=0.773 Sum_probs=256.6
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GG 771 (1091)
+.||+|+||.||+|+++.+|+.||||++++..........++.+|+.+|..++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555566778899999999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001370 772 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851 (1091)
Q Consensus 772 SL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g 851 (1091)
+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~------------- 147 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-------------
Confidence 9999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCC
Q 001370 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931 (1091)
Q Consensus 852 ~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~ 931 (1091)
........+||+.|||||++.+..|+.++|||||||++|||++|..||...+...++..+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05571 148 --------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213 (323)
T ss_pred --------------CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 011223568999999999999999999999999999999999999999999988888888877766
Q ss_pred CCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccccccccc
Q 001370 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1007 (1091)
Q Consensus 932 fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1007 (1091)
+| ..+++++.+||.+||++||++||+. ..+.++++||||.+++|..+... .+|+.|...+..++.+|+..++.
T Consensus 214 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05571 214 FP---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTA 290 (323)
T ss_pred CC---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccc
Confidence 65 6899999999999999999999952 24899999999999999988754 67889998888899998876655
Q ss_pred CC
Q 001370 1008 IS 1009 (1091)
Q Consensus 1008 ~~ 1009 (1091)
..
T Consensus 291 ~~ 292 (323)
T cd05571 291 QS 292 (323)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=468.85 Aligned_cols=309 Identities=37% Similarity=0.730 Sum_probs=282.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~ 760 (1091)
.+.+++|.++++||+|+|++|.++++++|.+.||||+++|.-....+++..+..|..+..+. +||++|.|+.+|+++..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 35678999999999999999999999999999999999987766777888999999998776 59999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+++|.||++||+|+.++++...++++.+++|.++|+.||.|||++|||+||||.+|+|||..||+||+|+|+|+.+.
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--- 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--- 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999642
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC-----
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA----- 915 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~----- 915 (1091)
.++..+.++||||.|+|||++.+..|++++|||+|||+||||+.|+.||.-
T Consensus 403 ------------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 403 ------------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred ------------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 234566789999999999999999999999999999999999999999952
Q ss_pred ---CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc---ccHHHHHcCCCCCCCCcchhhcc--cCC
Q 001370 916 ---ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAV 987 (1091)
Q Consensus 916 ---~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa---~gA~EIL~HPFFkgIdWd~L~~~--~pP 987 (1091)
.+...+++-|+..++.+| ..+|-.+..+++..|.+||.+|++. -+..+++.||||+.++|+.+.++ .||
T Consensus 459 ~d~ntedylfqvilekqirip---rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp 535 (593)
T KOG0695|consen 459 PDMNTEDYLFQVILEKQIRIP---RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP 535 (593)
T ss_pred cccchhHHHHHHHhhhccccc---ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence 234567888888888876 7899999999999999999999983 37899999999999999999877 799
Q ss_pred ccCCCCCCCCccccccccccCCCCCCCCCCCCC
Q 001370 988 FVPQPESVDDTSYFLSRFSQISSGLPDDQNGSY 1020 (1091)
Q Consensus 988 fiP~~~s~~Dts~Fds~fs~~~s~l~~~d~~s~ 1020 (1091)
|.|.+.+..+..+|+..|+...+++.+++.+..
T Consensus 536 f~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i 568 (593)
T KOG0695|consen 536 FQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAI 568 (593)
T ss_pred CCCccccccCccccccccccCCcccCCCCHHHH
Confidence 999999999999999999999999887765543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-52 Score=452.14 Aligned_cols=289 Identities=42% Similarity=0.809 Sum_probs=258.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....++|++.+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|..++||||++++++|.+.+.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 35578999999999999999999999999999999999876555555677899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~---- 169 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---- 169 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...+
T Consensus 170 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 170 --------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred --------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 011245799999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 997 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~D 997 (1091)
+..+..+...+| ..++..+++||.+||+.||.+||+. ..+.+++.||||++++|..+..+ .+|+.+......+
T Consensus 224 ~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (329)
T PTZ00263 224 YEKILAGRLKFP---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGD 300 (329)
T ss_pred HHHHhcCCcCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCccc
Confidence 999988877665 6789999999999999999999983 45899999999999999988654 4566666666667
Q ss_pred cccccc
Q 001370 998 TSYFLS 1003 (1091)
Q Consensus 998 ts~Fds 1003 (1091)
..+|..
T Consensus 301 ~~~~~~ 306 (329)
T PTZ00263 301 TSNFEK 306 (329)
T ss_pred chhccC
Confidence 777654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=449.67 Aligned_cols=315 Identities=46% Similarity=0.809 Sum_probs=260.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+|++..+|+.||||++++...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998766555567788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999753221100000
Q ss_pred --CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 846 --GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 846 --~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
........+...................+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 000000000000000001111123345689999999999999999999999999999999999999999999888888
Q ss_pred HHhh--cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCCCCCcccc
Q 001370 924 NILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 1001 (1091)
Q Consensus 924 kIl~--~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~F 1001 (1091)
++.. ....+|.. ..+++++.+||.+||. ||.+|++ .+.++++||||++++|+......+|++|...+..+..+|
T Consensus 241 ~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~--s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (350)
T cd05573 241 KIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLG--SFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNF 316 (350)
T ss_pred HHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCC--CHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchhhhhc
Confidence 8877 44455532 3479999999999998 9999998 377999999999999999887789999999888888887
Q ss_pred ccc
Q 001370 1002 LSR 1004 (1091)
Q Consensus 1002 ds~ 1004 (1091)
+..
T Consensus 317 ~~~ 319 (350)
T cd05573 317 DDF 319 (350)
T ss_pred CCC
Confidence 663
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-54 Score=485.47 Aligned_cols=297 Identities=35% Similarity=0.682 Sum_probs=277.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
...+.+++++..||-||||.|-+++.......+|+|+++|..+....+.+++..|.+||..+++|+||+||-.|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 46788999999999999999999998766667999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||+||-|-||+|+..|+..+.|++..++||++.++.|++|||.+|||+|||||+|+|||.+|.+||.|||+|+.+
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki----- 570 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI----- 570 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999964
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
..+..++++||||.|.|||++++++++.++|+||||+++||||+|.|||.+.++..+
T Consensus 571 -----------------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt 627 (732)
T KOG0614|consen 571 -----------------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT 627 (732)
T ss_pred -----------------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 235678899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC--cccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 997 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS--a~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~D 997 (1091)
|..|+.+--.+ .+|..++..+.+||++++..+|.+|++ .+++.+|+.|.||.++||+.|..+ +||++|.+.++.|
T Consensus 628 Yn~ILkGid~i-~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD 706 (732)
T KOG0614|consen 628 YNLILKGIDKI-EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTD 706 (732)
T ss_pred HHHHHhhhhhh-hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCccc
Confidence 99999874322 234899999999999999999999999 689999999999999999999887 8999999999999
Q ss_pred cccccccccc
Q 001370 998 TSYFLSRFSQ 1007 (1091)
Q Consensus 998 ts~Fds~fs~ 1007 (1091)
++||+.+...
T Consensus 707 ~s~Fd~~p~d 716 (732)
T KOG0614|consen 707 VSNFDNFPPD 716 (732)
T ss_pred chhccCCCcc
Confidence 9999986333
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=444.31 Aligned_cols=291 Identities=36% Similarity=0.742 Sum_probs=256.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVM 765 (1091)
+|++++.||+|+||+||+|+++.+++.||||++++...........+..|..++..+ .||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999875544455667788888888877 4899999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~------- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW------- 153 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...++..+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 154 --------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred --------------------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011223467999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccc
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1001 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1001 (1091)
......+| ..++.++.+||.+||++||.+|++. ....+++.||||+.++|+.+... .+|+.|... ..|..+|
T Consensus 214 ~~~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 289 (323)
T cd05616 214 MEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC-GRDAENF 289 (323)
T ss_pred HhCCCCCC---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC-Cchhhhc
Confidence 88877666 6789999999999999999999984 35789999999999999998755 678888764 4677777
Q ss_pred ccccccC
Q 001370 1002 LSRFSQI 1008 (1091)
Q Consensus 1002 ds~fs~~ 1008 (1091)
+..+...
T Consensus 290 ~~~~~~~ 296 (323)
T cd05616 290 DKFFTRH 296 (323)
T ss_pred CchhccC
Confidence 7765543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-51 Score=444.57 Aligned_cols=290 Identities=36% Similarity=0.757 Sum_probs=255.8
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCeeEEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H-PNIVkL~gsfqded~LYLVM 765 (1091)
+|++++.||+|+||.||+|+++.+++.||||++++.........+.+..|..++..+.| ++|++++++|...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999987655455667788999999999976 46889999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~------- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF------- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (324)
T cd05587 154 --------------------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213 (324)
T ss_pred --------------------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011123467999999999999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccc
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1001 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1001 (1091)
......+| ..++.++.+||.+||.+||.+|++. ....++++||||+.++|..+... .+++.|......+.++|
T Consensus 214 ~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (324)
T cd05587 214 MEHNVSYP---KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENF 290 (324)
T ss_pred HcCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhc
Confidence 88776655 6789999999999999999999984 34589999999999999988655 67888888877888888
Q ss_pred ccccc
Q 001370 1002 LSRFS 1006 (1091)
Q Consensus 1002 ds~fs 1006 (1091)
+..+.
T Consensus 291 ~~~~~ 295 (324)
T cd05587 291 DKFFT 295 (324)
T ss_pred Ccccc
Confidence 76543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=442.45 Aligned_cols=285 Identities=42% Similarity=0.791 Sum_probs=256.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+|..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998655444456678899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~-------- 152 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------- 152 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i 210 (291)
T cd05612 153 ----------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210 (291)
T ss_pred ----------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0112457999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccc
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1001 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1001 (1091)
..+...+| ..++..+++||++||+.||.+|++. ..+.+++.||||+.++|..+... .+++.|......++.+|
T Consensus 211 ~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 287 (291)
T cd05612 211 LAGKLEFP---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNF 287 (291)
T ss_pred HhCCcCCC---ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccc
Confidence 88877766 6789999999999999999999962 35889999999999999987655 67788888888888887
Q ss_pred cc
Q 001370 1002 LS 1003 (1091)
Q Consensus 1002 ds 1003 (1091)
++
T Consensus 288 ~~ 289 (291)
T cd05612 288 DD 289 (291)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=444.87 Aligned_cols=287 Identities=40% Similarity=0.783 Sum_probs=249.8
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieI-LskL~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+|+.||||++.+...........++.|..+ +..++||||+++++.|...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999987554444555667777664 5779999999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~------------ 148 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE------------ 148 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|||||++.+..|+.++|||||||++|||++|.+||...+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 213 (323)
T cd05575 149 ---------------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213 (323)
T ss_pred ---------------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122346799999999999999999999999999999999999999999999999999888766
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCc-ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccccccccc
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1007 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa-~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1007 (1091)
.++ ..++.++.+||.+||++||.+||++ ....+++.||||..++|..+... .+|+.|......+...|+..+.+
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05575 214 RLK---PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTE 290 (323)
T ss_pred CCC---CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccc
Confidence 554 5789999999999999999999995 35689999999999999988655 67888888887777777665444
Q ss_pred C
Q 001370 1008 I 1008 (1091)
Q Consensus 1008 ~ 1008 (1091)
.
T Consensus 291 ~ 291 (323)
T cd05575 291 E 291 (323)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=441.73 Aligned_cols=284 Identities=41% Similarity=0.819 Sum_probs=254.9
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001370 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 773 (1091)
Q Consensus 694 LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL 773 (1091)
||+|+||+||+|+++.+++.||+|++++...........+.+|+.+|.+++||||++++++|...+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876555566778889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001370 774 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853 (1091)
Q Consensus 774 ~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~l 853 (1091)
.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--------------- 145 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--------------- 145 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc---------------
Confidence 99999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC
Q 001370 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933 (1091)
Q Consensus 854 ps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP 933 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..+......+|
T Consensus 146 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 213 (312)
T cd05585 146 ------------DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213 (312)
T ss_pred ------------CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC
Confidence 01122346799999999999999999999999999999999999999999999999999888876665
Q ss_pred CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccccccccc
Q 001370 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1007 (1091)
Q Consensus 934 ~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1007 (1091)
..+++++++||.+||..||.+||+...+.+++.||||+.++|..+... .+++.|...+..++++|+..+..
T Consensus 214 ---~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (312)
T cd05585 214 ---DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTR 286 (312)
T ss_pred ---CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccc
Confidence 679999999999999999999999878999999999999999877544 67888888888888888776543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-51 Score=450.35 Aligned_cols=290 Identities=40% Similarity=0.772 Sum_probs=258.0
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TG-k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
......++|++.+.||+|+||.||+|+++.++ ..||+|++.+...........+.+|+.++..++||||++++++|.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34567889999999999999999999977655 68999999876555556677899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~- 182 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD- 182 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC-
Confidence 9999999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
....+.+||+.|||||++.+..++.++|||||||++|||++|.+||.+.++
T Consensus 183 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 183 -----------------------------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred -----------------------------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 012346799999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 994 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s 994 (1091)
..++..+..+...+| ..+++++++||++||..||.+|++. ..+.++++||||++++|..+... .+|+.|....
T Consensus 234 ~~~~~~i~~~~~~~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 234 LLIYQKILEGIIYFP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred HHHHHHHhcCCCCCC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 999999988876665 6789999999999999999999852 35899999999999999987654 6788888877
Q ss_pred CCCccccc
Q 001370 995 VDDTSYFL 1002 (1091)
Q Consensus 995 ~~Dts~Fd 1002 (1091)
..+.++|.
T Consensus 311 ~~~~~~~~ 318 (340)
T PTZ00426 311 VFDSSNFE 318 (340)
T ss_pred CcchhhcC
Confidence 77766664
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=449.70 Aligned_cols=316 Identities=46% Similarity=0.760 Sum_probs=254.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++||||+++++.|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765555556778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|............
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998632110000000
Q ss_pred CC----CCCCCCCCCC-------CCCc-----ccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001370 846 GP----ETDGIMPSDA-------HYPE-----YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 846 ~~----~t~g~lps~~-------~~~~-----~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
.. ......+... .... ............+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00 0000000000 0000 000011122356899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhh-cccC
Q 001370 910 IPPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA-LQKA 986 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l--~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~-~~~p 986 (1091)
++||.+.++.+....+..... .+|. ...+++++.+||.+|+. +|.+|++...+.++++||||++++|..+. ...+
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~ 318 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPS-QAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKA 318 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCC
Confidence 999999988887777765432 2221 24689999999999875 99999965559999999999999999885 3478
Q ss_pred CccCCCCCCCCcccccc
Q 001370 987 VFVPQPESVDDTSYFLS 1003 (1091)
Q Consensus 987 PfiP~~~s~~Dts~Fds 1003 (1091)
++.|....+.++++|+.
T Consensus 319 ~~~~~~~~~~~~~~~~~ 335 (376)
T cd05598 319 PYIPKITHPTDTSNFDP 335 (376)
T ss_pred CCCCcCCCcchhhhcCC
Confidence 89999888888888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=444.00 Aligned_cols=286 Identities=39% Similarity=0.766 Sum_probs=249.6
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieI-LskL~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+|+.||||++.+...........+..|+.+ ++.++||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999987554444555667777664 6779999999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~------------ 148 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA------------ 148 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC------------
Confidence 99999998888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|||||++.+..|+.++|||||||++|||++|.+||...+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~ 213 (325)
T cd05604 149 ---------------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213 (325)
T ss_pred ---------------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 01122356799999999999999999999999999999999999999999999999998888765
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCc-ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccccccccc
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1007 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa-~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1007 (1091)
.++ ...+..+.++|.+||.+||.+||+. ....+++.||||++++|..+... .+|+.|......+.++|+..+.+
T Consensus 214 ~~~---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05604 214 VLR---PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTE 290 (325)
T ss_pred cCC---CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCcccc
Confidence 544 5689999999999999999999995 36789999999999999987655 67888888888888888765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=444.85 Aligned_cols=287 Identities=43% Similarity=0.789 Sum_probs=254.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GG 771 (1091)
+.||+|+||.||+++++.+|+.||+|++.+...........+.+|+.+|..++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555667788999999999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001370 772 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851 (1091)
Q Consensus 772 SL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g 851 (1091)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~------------- 147 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT------------- 147 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCC
Q 001370 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931 (1091)
Q Consensus 852 ~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~ 931 (1091)
........+||+.|+|||++.+..++.++|||||||++|||++|..||...+...+...+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 213 (328)
T cd05593 148 --------------DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213 (328)
T ss_pred --------------cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc
Confidence 011123467999999999999999999999999999999999999999998888888888777666
Q ss_pred CCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccccccccc
Q 001370 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1007 (1091)
Q Consensus 932 fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1007 (1091)
+| ..++.++.+||.+||.+||.+|++. ..+.++++||||.+++|..+... .+|+.|...+..+..+|+..++.
T Consensus 214 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (328)
T cd05593 214 FP---RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTA 290 (328)
T ss_pred CC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCccccc
Confidence 55 6899999999999999999999852 35899999999999999987655 67888888888888888776554
Q ss_pred C
Q 001370 1008 I 1008 (1091)
Q Consensus 1008 ~ 1008 (1091)
.
T Consensus 291 ~ 291 (328)
T cd05593 291 Q 291 (328)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=441.90 Aligned_cols=287 Identities=41% Similarity=0.745 Sum_probs=251.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||+|+||+||+|+++.+|+.||||++++...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765545556677889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~----- 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN----- 155 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC-----
Confidence 999999999999876 67999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc------CCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~------g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
........+||+.|+|||++. +..|+.++|||||||++|||++|..||...+.
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 156 ---------------------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ---------------------CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 001123357999999999997 45678999999999999999999999999888
Q ss_pred HHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCCCC
Q 001370 919 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 996 (1091)
Q Consensus 919 ~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~ 996 (1091)
...+..++... ..+|. ...++.++.+||.+||+ +|.+||+ +.++++||||..++|..+....+++.|......
T Consensus 215 ~~~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t---~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (330)
T cd05601 215 AKTYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLG---YEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDD 289 (330)
T ss_pred HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCC---HHHHhCCCCcCCCCHHHHhhCCCCccCcCCCcc
Confidence 88888887643 33442 23589999999999998 9999999 889999999999999999887888999888888
Q ss_pred Ccccccc
Q 001370 997 DTSYFLS 1003 (1091)
Q Consensus 997 Dts~Fds 1003 (1091)
|.++|..
T Consensus 290 ~~~~~~~ 296 (330)
T cd05601 290 DTSNFDE 296 (330)
T ss_pred hhhhcCC
Confidence 8877754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=440.96 Aligned_cols=285 Identities=39% Similarity=0.776 Sum_probs=251.0
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+|+.||||++++...........+..|..++..+ +||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876555556677788999999866 799999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~------------ 148 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL------------ 148 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05591 149 ---------------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213 (321)
T ss_pred ---------------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122346799999999999999999999999999999999999999999999999999988876
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc----cHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccccc
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN----GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSR 1004 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~----gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~ 1004 (1091)
.+| ..++.++.+||.+||.+||.+|++.. .+.++++||||.+++|..+... .+++.|......+..+|++.
T Consensus 214 ~~p---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (321)
T cd05591 214 LYP---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQD 290 (321)
T ss_pred CCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCc
Confidence 655 67899999999999999999999532 4889999999999999988655 57788888777777777665
Q ss_pred cc
Q 001370 1005 FS 1006 (1091)
Q Consensus 1005 fs 1006 (1091)
+.
T Consensus 291 ~~ 292 (321)
T cd05591 291 FT 292 (321)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=440.88 Aligned_cols=285 Identities=43% Similarity=0.802 Sum_probs=253.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||.||+|++..+|+.||||++++...........+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544556778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~-------- 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-------- 152 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+..+.+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 210 (333)
T cd05600 153 ----------------------TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210 (333)
T ss_pred ----------------------cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence 0223567999999999999999999999999999999999999999999988888777
Q ss_pred hhcC--CCCCCCC---CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCCCCCccc
Q 001370 926 LNRK--IPWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSY 1000 (1091)
Q Consensus 926 l~~~--l~fP~ip---~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~ 1000 (1091)
.... ...|... ..++.++.+||.+||..+|.+||+ +.++++||||++++|..+....+|+.|......+..+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s---~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (333)
T cd05600 211 KYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS---LEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGY 287 (333)
T ss_pred HhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC---HHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcchhhh
Confidence 6532 2222211 256899999999999999999999 8899999999999999988778899999888777777
Q ss_pred ccc
Q 001370 1001 FLS 1003 (1091)
Q Consensus 1001 Fds 1003 (1091)
|+.
T Consensus 288 ~~~ 290 (333)
T cd05600 288 FDD 290 (333)
T ss_pred ccC
Confidence 654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=441.96 Aligned_cols=287 Identities=39% Similarity=0.780 Sum_probs=253.9
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+++.||||++++...........+..|..++..+ +||||++++++|...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999875544555677888999998876 699999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~------------ 148 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF------------ 148 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc------------
Confidence 99999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~ 213 (320)
T cd05590 149 ---------------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213 (320)
T ss_pred ---------------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC
Confidence 01122346799999999999999999999999999999999999999999999999999988776
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCc---ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccccccc
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRF 1005 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa---~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~f 1005 (1091)
.+| ..++.++.+||.+||++||.+||++ .+..+++.||||++++|+.+..+ .|||.|...+..|.++|+..+
T Consensus 214 ~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (320)
T cd05590 214 VYP---TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDF 290 (320)
T ss_pred CCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccc
Confidence 655 6789999999999999999999995 34589999999999999987654 688999999999999988654
Q ss_pred ccC
Q 001370 1006 SQI 1008 (1091)
Q Consensus 1006 s~~ 1008 (1091)
...
T Consensus 291 ~~~ 293 (320)
T cd05590 291 IKE 293 (320)
T ss_pred ccC
Confidence 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-51 Score=443.09 Aligned_cols=290 Identities=41% Similarity=0.750 Sum_probs=256.3
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GG 771 (1091)
+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.++..++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555566778889999999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001370 772 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851 (1091)
Q Consensus 772 SL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g 851 (1091)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~------------- 147 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCC
Q 001370 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931 (1091)
Q Consensus 852 ~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~ 931 (1091)
........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+....+..+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05595 148 --------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213 (323)
T ss_pred --------------CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence 011123467999999999999999999999999999999999999999999988888888877766
Q ss_pred CCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccccccccc
Q 001370 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1007 (1091)
Q Consensus 932 fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1007 (1091)
+| ..+++++.+||.+||..||.+|++. ..+.++++||||.+++|..+... .||+.|...+..+..+|+..++.
T Consensus 214 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05595 214 FP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTA 290 (323)
T ss_pred CC---CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCccccc
Confidence 55 6889999999999999999999952 35999999999999999987655 57889999888899888877666
Q ss_pred CCCC
Q 001370 1008 ISSG 1011 (1091)
Q Consensus 1008 ~~s~ 1011 (1091)
....
T Consensus 291 ~~~~ 294 (323)
T cd05595 291 QSIT 294 (323)
T ss_pred CCcc
Confidence 5433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=442.01 Aligned_cols=292 Identities=37% Similarity=0.736 Sum_probs=248.1
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||.||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876554555667888999999988 699999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~------------ 148 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR------------ 148 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc------------
Confidence 99999998888999999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC---------ChHHH
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEII 921 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~---------s~~ei 921 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||... .....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 149 ---------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 011223568999999999999999999999999999999999999999632 12334
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc---cHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 996 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~---gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~ 996 (1091)
+..+......+| ..++.++.+||.+||++||.+|+++. .+.++++||||+.++|+.+... .|++.|......
T Consensus 214 ~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
T cd05588 214 FQVILEKQIRIP---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDR 290 (329)
T ss_pred HHHHHcCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcc
Confidence 555666655544 68899999999999999999999852 4889999999999999987654 567788877777
Q ss_pred CccccccccccCCCCCC
Q 001370 997 DTSYFLSRFSQISSGLP 1013 (1091)
Q Consensus 997 Dts~Fds~fs~~~s~l~ 1013 (1091)
+..+|...+.......+
T Consensus 291 ~~~~~~~~~~~~~~~~~ 307 (329)
T cd05588 291 DLDNFDPQFTDEPVQLT 307 (329)
T ss_pred hhhhcCCccccCccccC
Confidence 77777766555544333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-51 Score=451.01 Aligned_cols=259 Identities=32% Similarity=0.573 Sum_probs=235.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe-
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN- 760 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~- 760 (1091)
.+..++++.++.||+|..|+||+|+|+.|++.||+|++.- ..+....+++.+|++|+..++|||||++|++|..+..
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3566789999999999999999999999999999999942 3345667889999999999999999999999999995
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
++|+||||.||+|.+++.+.++++|.....++.++++||.|||+ ++||||||||+||||+..|.|||||||.++...
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv-- 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV-- 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence 99999999999999999999999999999999999999999995 999999999999999999999999999988531
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC---
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 916 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~--- 916 (1091)
+..+.+++||..|||||-+.+..|+.++||||||+.++||++|+.||...
T Consensus 231 ---------------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~ 283 (364)
T KOG0581|consen 231 ---------------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP 283 (364)
T ss_pred ---------------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC
Confidence 12457899999999999999999999999999999999999999999875
Q ss_pred --ChHHHHHHHhhcCCCCCCCCCC-CCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 917 --SPEIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 917 --s~~ei~~kIl~~~l~fP~ip~~-lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+..+++..|+.+.. |.+|.. +|+++++||..||++||.+|++ +.++++|||++..
T Consensus 284 ~~~~~~Ll~~Iv~~pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 284 YLDIFELLCAIVDEPP--PRLPEGEFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKF 341 (364)
T ss_pred CCCHHHHHHHHhcCCC--CCCCcccCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhc
Confidence 67788888988654 344565 9999999999999999999999 8899999999864
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=438.41 Aligned_cols=287 Identities=38% Similarity=0.737 Sum_probs=247.0
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+.+.+++.||+|++++...........+.+|+.++.++ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555556677889999999888 599999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~------------ 148 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG------------ 148 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC-------ChHHHHH
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEIIFD 923 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~-------s~~ei~~ 923 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||... ....++.
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 149 ---------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred ---------------CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence 011223568999999999999999999999999999999999999999632 2334555
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc---ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCc
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 998 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa---~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dt 998 (1091)
.+......+| ..++..+.+||.+||.+||.+|++. .+..+++.||||++++|+.+... .++|.|......+.
T Consensus 214 ~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (327)
T cd05617 214 VILEKPIRIP---RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGL 290 (327)
T ss_pred HHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcch
Confidence 6655555544 6789999999999999999999984 35789999999999999988655 67889988877788
Q ss_pred cccccccccC
Q 001370 999 SYFLSRFSQI 1008 (1091)
Q Consensus 999 s~Fds~fs~~ 1008 (1091)
++|+..+...
T Consensus 291 ~~~~~~~~~~ 300 (327)
T cd05617 291 ENFDTQFTSE 300 (327)
T ss_pred hhcCCccccC
Confidence 8887654433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=439.31 Aligned_cols=290 Identities=37% Similarity=0.740 Sum_probs=245.7
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+++.||+|++++...........+.+|+.++.++ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876554555667788999998876 799999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~------------ 148 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR------------ 148 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC---------CChHHH
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA---------ESPEII 921 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~---------~s~~ei 921 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.. .....+
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 149 ---------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 01122346899999999999999999999999999999999999999952 122345
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc---ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 996 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa---~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~ 996 (1091)
...+......+| ..++.++.+||.+||.+||.+||++ .++.++++||||++++|+.+... .+++.|......
T Consensus 214 ~~~i~~~~~~~p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
T cd05618 214 FQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEF 290 (329)
T ss_pred HHHHhcCCCCCC---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcc
Confidence 556666665555 6889999999999999999999984 24789999999999999987654 678888887777
Q ss_pred CccccccccccCCCC
Q 001370 997 DTSYFLSRFSQISSG 1011 (1091)
Q Consensus 997 Dts~Fds~fs~~~s~ 1011 (1091)
+..+|++.+......
T Consensus 291 ~~~~~~~~~~~~~~~ 305 (329)
T cd05618 291 GLDNFDAQFTNEPVQ 305 (329)
T ss_pred cchhcCcccccCCcc
Confidence 777776654444333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=436.48 Aligned_cols=288 Identities=40% Similarity=0.780 Sum_probs=249.9
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+++.||||++++...........+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999875544445566677788887654 799999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~------------ 148 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC------------
Confidence 99999998888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05592 149 ---------------GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP 213 (316)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122346799999999999999999999999999999999999999999998888888876654
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccccccccC
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 1008 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~~ 1008 (1091)
.+ +..++.++.+||.+||..||.+||+. +.+++.||||+.++|..+... .+++.|......+.++|+..|+..
T Consensus 214 ~~---~~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd05592 214 HF---PRWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNE 288 (316)
T ss_pred CC---CCCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccc
Confidence 44 47789999999999999999999983 358899999999999987654 678889888888899988776555
Q ss_pred CCC
Q 001370 1009 SSG 1011 (1091)
Q Consensus 1009 ~s~ 1011 (1091)
...
T Consensus 289 ~~~ 291 (316)
T cd05592 289 KVR 291 (316)
T ss_pred ccc
Confidence 433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=445.29 Aligned_cols=292 Identities=41% Similarity=0.734 Sum_probs=246.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+...+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 45678999999999999999999999999999999998765555556677889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~---- 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---- 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc----
Confidence 999999999999998654 589999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.......+.+||+.|||||++.+.. |+.++|||||||+||||++|.+||.+.+.
T Consensus 195 ----------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 195 ----------------------TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred ----------------------CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 0011223568999999999997643 78999999999999999999999999998
Q ss_pred HHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch--hhcccCCccCCCCC
Q 001370 919 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS--LALQKAVFVPQPES 994 (1091)
Q Consensus 919 ~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~--L~~~~pPfiP~~~s 994 (1091)
...+..|.... +.+|. ...++..+++||.+||+. +.+|++..++.++++||||++..|+. +....+|+.|...+
T Consensus 253 ~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~-~~~r~~R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~ 330 (370)
T cd05621 253 VGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTD-REVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSS 330 (370)
T ss_pred HHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccC-chhccCCCCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCC
Confidence 88888888643 34442 235799999999999984 44443323389999999999876654 44447788998888
Q ss_pred CCCcccccc
Q 001370 995 VDDTSYFLS 1003 (1091)
Q Consensus 995 ~~Dts~Fds 1003 (1091)
..|.++|+.
T Consensus 331 ~~~~~~~~~ 339 (370)
T cd05621 331 DIDSSNFDD 339 (370)
T ss_pred cchhhhcCC
Confidence 888887764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=437.79 Aligned_cols=286 Identities=42% Similarity=0.773 Sum_probs=249.4
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 694 LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL---~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
||+|+||+||+|+++.+|+.||||++.+...........+..|..++... .||||+++++.|...+.+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876555555666777888888766 699999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~------------ 148 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT------------ 148 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC------------
Confidence 99999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 929 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~ 929 (1091)
........+||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+..+++..+..+.
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 149 ---------------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred ---------------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 01122356799999999999764 58999999999999999999999999999999998888877
Q ss_pred CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc-ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccccccc
Q 001370 930 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1006 (1091)
Q Consensus 930 l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa-~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs 1006 (1091)
..+|. ..++.++.+||.+||..||.+||++ ..+.+++.||||+.++|+.+... .+++.|......+.++|+..|.
T Consensus 214 ~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (330)
T cd05586 214 VRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFT 291 (330)
T ss_pred CCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCcccc
Confidence 77663 4689999999999999999999974 36899999999999999987655 6788888888888888876544
Q ss_pred cC
Q 001370 1007 QI 1008 (1091)
Q Consensus 1007 ~~ 1008 (1091)
..
T Consensus 292 ~~ 293 (330)
T cd05586 292 NS 293 (330)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=435.13 Aligned_cols=291 Identities=36% Similarity=0.743 Sum_probs=253.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLVM 765 (1091)
+|++.+.||+|+||+||+|+++.+|+.||||++++...........+..|..++..+. ||+|++++++|.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999998755545556677888999998886 578889999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~------- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------- 153 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...++..+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 154 --------------------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred --------------------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011223467999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccc
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1001 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1001 (1091)
......+| ..++.++.+||.+||++||.+|++.. ...++++||||++++|..+... .+|+.|.... ....+|
T Consensus 214 ~~~~~~~p---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 289 (323)
T cd05615 214 MEHNVSYP---KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCG-KGAENF 289 (323)
T ss_pred HhCCCCCC---ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCC-Cchhhc
Confidence 88776665 67899999999999999999999843 5789999999999999988765 5788886544 346677
Q ss_pred ccccccC
Q 001370 1002 LSRFSQI 1008 (1091)
Q Consensus 1002 ds~fs~~ 1008 (1091)
+..+...
T Consensus 290 ~~~~~~~ 296 (323)
T cd05615 290 DKFFTRG 296 (323)
T ss_pred Ccccccc
Confidence 6655443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=435.81 Aligned_cols=287 Identities=39% Similarity=0.795 Sum_probs=251.9
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+++.||||++++...........+..|..++..+ +||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876555555677788999999888 699999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------------ 148 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL------------ 148 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc------------
Confidence 99999998888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+...++..+.....
T Consensus 149 ---------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~ 213 (318)
T cd05570 149 ---------------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213 (318)
T ss_pred ---------------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122345799999999999999999999999999999999999999999998888888887776
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccccccc
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1006 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs 1006 (1091)
.+| ..++.++.+||.+||..||.+||++ ....+++.||||+.++|..+... .+|+.|......+.++|+..|.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (318)
T cd05570 214 RYP---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFT 290 (318)
T ss_pred CCC---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhc
Confidence 555 6789999999999999999999993 22389999999999999877654 6788888888888888876554
Q ss_pred cC
Q 001370 1007 QI 1008 (1091)
Q Consensus 1007 ~~ 1008 (1091)
..
T Consensus 291 ~~ 292 (318)
T cd05570 291 KE 292 (318)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=433.06 Aligned_cols=286 Identities=40% Similarity=0.781 Sum_probs=247.7
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~Eie-ILskL~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|+. ++..++||||+++++.|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765544445566666665 57889999999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~------------ 148 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE------------ 148 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+...++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05603 149 ---------------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213 (321)
T ss_pred ---------------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 01112346799999999999999999999999999999999999999999998888888888766
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCc-ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccccccccc
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 1007 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa-~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~ 1007 (1091)
.+| ...+.++.++|.+||++||.+|+++ ..+.++++||||..++|..+... .+++.|......+...|+..++.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (321)
T cd05603 214 QLP---GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQ 290 (321)
T ss_pred CCC---CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccc
Confidence 555 6788999999999999999999984 46789999999999999987654 57778877777777777655443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=443.67 Aligned_cols=291 Identities=41% Similarity=0.709 Sum_probs=250.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45678999999999999999999999999999999999876555555667788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||++||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~--- 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA--- 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC---
Confidence 999999999999998865 4689999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC----CCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~----~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
.........+||+.|||||++.+. .++.++|||||||++|||++|.+||.+.+
T Consensus 195 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 195 -----------------------NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred -----------------------CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 000112346799999999999754 37899999999999999999999999999
Q ss_pred hHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCC--CCCcccHHHHHcCCCCCCCCcchh--hcccCCccCC
Q 001370 918 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSL--ALQKAVFVPQ 991 (1091)
Q Consensus 918 ~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeK--RpSa~gA~EIL~HPFFkgIdWd~L--~~~~pPfiP~ 991 (1091)
....+..|.... +.+|. ...+|.++++||.+||..+|.+ |++ +.++++||||++.+|... ....+|++|.
T Consensus 252 ~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s---~~ell~h~~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05596 252 LVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNG---VDEIKSHPFFKNDQWTFDNIRETVAPVVPE 327 (370)
T ss_pred HHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCC---HHHHhcCcccCCCChhhHHhcCCCcCccCc
Confidence 988898888754 34442 2357999999999999988987 887 889999999999888754 3346788998
Q ss_pred CCCCCCcccccc
Q 001370 992 PESVDDTSYFLS 1003 (1091)
Q Consensus 992 ~~s~~Dts~Fds 1003 (1091)
..+..+.++|+.
T Consensus 328 ~~~~~~~~~~~~ 339 (370)
T cd05596 328 LSSDIDTSNFDD 339 (370)
T ss_pred CCCcchhhhcCC
Confidence 888888888764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-50 Score=426.06 Aligned_cols=275 Identities=33% Similarity=0.615 Sum_probs=236.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.++..++||||++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987555444455678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------
Confidence 99999999888653 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH----H
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE----I 920 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~----e 920 (1091)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||...+.. .
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 155 ----------------------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred ----------------------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 01112457999999999999999999999999999999999999999876543 2
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 992 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 992 (1091)
+...+......+ +..++.++.+||.+||..||.+||+. .++.++++||||.+++|+.+... +|||+|.+
T Consensus 213 ~~~~~~~~~~~~---~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05631 213 VDRRVKEDQEEY---SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285 (285)
T ss_pred HHHHhhcccccC---CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCCC
Confidence 333333333333 36789999999999999999999984 35899999999999999999877 88999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=451.01 Aligned_cols=260 Identities=34% Similarity=0.647 Sum_probs=239.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+..+ .++..+.+..|+.||+.++|||||.|++++.+.+.+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 46799999999999999999999999999999999988654 55667889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC------CcEEEEecCCccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD------GHIKLTDFGLSKIGL 837 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n------G~VKLsDFGLAk~~~ 837 (1091)
|||||.||||.+||++.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+..
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L- 165 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL- 165 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC-
Confidence 99999999999999999999999999999999999999999999999999999999875 35899999999963
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
..+....+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|++||...+
T Consensus 166 ---------------------------~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 166 ---------------------------QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred ---------------------------CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 12445678999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+.+++..+-.+....|.++..++....+|+..+|+++|..|.+ ..+...|+|...
T Consensus 219 ~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~---~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 219 PKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS---FEDFFDHPFLAA 273 (429)
T ss_pred HHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc---hHHhhhhhhccc
Confidence 9999999888877777778889999999999999999999998 567778888753
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=433.11 Aligned_cols=291 Identities=44% Similarity=0.806 Sum_probs=250.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998766555666778899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD----- 155 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-----
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998642110
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
........+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 156 ---------------------GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ---------------------CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 0011123579999999999973 45788999999999999999999999999888
Q ss_pred HHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCCCCC
Q 001370 920 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 997 (1091)
Q Consensus 920 ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~D 997 (1091)
+.+..+.... ..+|.....++.++++||++||+. |.+|++...+.++++||||.+++|..+....+++.|...+..+
T Consensus 215 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
T cd05597 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTD 293 (331)
T ss_pred HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCcCCCcch
Confidence 8888887643 344443456899999999999985 5565554459999999999999999988878889998888888
Q ss_pred cccccc
Q 001370 998 TSYFLS 1003 (1091)
Q Consensus 998 ts~Fds 1003 (1091)
+++|+.
T Consensus 294 ~~~~~~ 299 (331)
T cd05597 294 TSNFDV 299 (331)
T ss_pred hhhcCC
Confidence 877754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=434.24 Aligned_cols=285 Identities=41% Similarity=0.782 Sum_probs=246.4
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~Eie-ILskL~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|.. ++..++||||++++++|...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998755444444455666655 46788999999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~------------ 148 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE------------ 148 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05602 149 ---------------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213 (325)
T ss_pred ---------------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc
Confidence 01122356799999999999999999999999999999999999999999999999988887765
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCc-ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccccccc
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1006 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa-~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs 1006 (1091)
.++ ..++.++.+||.+||++||.+|+++ +...++++|+||..++|+.+... .+++.|....+.+...|+..++
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (325)
T cd05602 214 QLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFT 289 (325)
T ss_pred CCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCccc
Confidence 544 5789999999999999999999995 35779999999999999998654 5677888777777777765543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=433.13 Aligned_cols=286 Identities=45% Similarity=0.849 Sum_probs=245.6
Q ss_pred EEeeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 691 IKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~-~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
++.||+|+||.||+|+.. .+++.||+|++++.... .......+.+|+.+|..++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999864 47899999999875432 22345677899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-------- 152 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-------- 152 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--------
Confidence 999999999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 926 (1091)
........+||+.|+|||++.+..++.++|||||||++|||++|++||...+....+..+.
T Consensus 153 -------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~ 213 (323)
T cd05584 153 -------------------EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213 (323)
T ss_pred -------------------CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 0112234679999999999999999999999999999999999999999999888888888
Q ss_pred hcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC--cccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccc
Q 001370 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFL 1002 (1091)
Q Consensus 927 ~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS--a~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fd 1002 (1091)
.+...+| ..+++++.+||.+||++||.+||+ ...+.+++.||||+..+|..+... .+++.+...+..+.+.|+
T Consensus 214 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05584 214 KGKLNLP---PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFD 290 (323)
T ss_pred cCCCCCC---CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcC
Confidence 8776655 678999999999999999999994 234889999999999999887654 566777766666666666
Q ss_pred cccc
Q 001370 1003 SRFS 1006 (1091)
Q Consensus 1003 s~fs 1006 (1091)
..++
T Consensus 291 ~~~~ 294 (323)
T cd05584 291 SKFT 294 (323)
T ss_pred chhc
Confidence 5443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=442.76 Aligned_cols=294 Identities=43% Similarity=0.747 Sum_probs=250.3
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..+..++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34667899999999999999999999999999999999987655555566778899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~-- 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-- 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc--
Confidence 99999999999999998654 589999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeechhhhHHHHHhCCCCCCCC
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.........+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.
T Consensus 195 ------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 195 ------------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred ------------------------CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 0011123568999999999997643 789999999999999999999999999
Q ss_pred ChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc--chhhcccCCccCCC
Q 001370 917 SPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW--DSLALQKAVFVPQP 992 (1091)
Q Consensus 917 s~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW--d~L~~~~pPfiP~~ 992 (1091)
+....+.+|.... ..+|. ...++.++++||.+||. +|..|++..++.++++||||++..| ..+....+|++|..
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~ 328 (371)
T cd05622 251 SLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 328 (371)
T ss_pred CHHHHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCCCCC
Confidence 9988999888754 34443 34689999999999998 7777766556999999999998655 45555577888888
Q ss_pred CCCCCcccccc
Q 001370 993 ESVDDTSYFLS 1003 (1091)
Q Consensus 993 ~s~~Dts~Fds 1003 (1091)
.+..+.++|+.
T Consensus 329 ~~~~~~~~~~~ 339 (371)
T cd05622 329 SSDIDTSNFDD 339 (371)
T ss_pred CCcchhhhcCC
Confidence 77777776653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=432.56 Aligned_cols=289 Identities=40% Similarity=0.759 Sum_probs=252.1
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hcCCCceEEEeeeeccCCeeEEE
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI---TVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILs---kL~HPNIVkL~gsfqded~LYLV 764 (1091)
|++++.||+|+||.||+|.++.+|+.||||++++.........+.+.+|+.++. .++||||++++++|...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999998765555556677888877764 56799999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||++||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~------ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG------ 153 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC------
Confidence 999999999988854 5799999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
........+||+.|||||++.+..++.++|||||||++|||++|..||.+.+..+.+..
T Consensus 154 ---------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~ 212 (324)
T cd05589 154 ---------------------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS 212 (324)
T ss_pred ---------------------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01122356899999999999999999999999999999999999999999999989888
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccc
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSY 1000 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~ 1000 (1091)
+......+| ..++.++.+||.+||+.||.+||+.. .+.++++||||++++|..+... .+|+.|......|.++
T Consensus 213 i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 289 (324)
T cd05589 213 IVNDEVRYP---RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSN 289 (324)
T ss_pred HHhCCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhh
Confidence 888776655 67899999999999999999999742 5899999999999999987554 6788888888888888
Q ss_pred ccccccc
Q 001370 1001 FLSRFSQ 1007 (1091)
Q Consensus 1001 Fds~fs~ 1007 (1091)
|...+..
T Consensus 290 ~~~~~~~ 296 (324)
T cd05589 290 FDEEFTS 296 (324)
T ss_pred cCccccc
Confidence 7665433
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=430.67 Aligned_cols=290 Identities=42% Similarity=0.779 Sum_probs=249.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~----- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED----- 155 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-----
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
........+||+.|||||++. ...|+.++|||||||++|||++|+.||...+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 156 ---------------------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred ---------------------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 011122357999999999986 346889999999999999999999999999998
Q ss_pred HHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCCCCC
Q 001370 920 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 997 (1091)
Q Consensus 920 ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~D 997 (1091)
+.+.++.... ..+|.....++.++++||.+||+.++ +|++...+.++++||||.+++|+.+....++++|...++.+
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~-~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 293 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE-HRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTD 293 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChh-hhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccCCCCCCcc
Confidence 9998887754 34454445789999999999998644 45444448999999999999999998888899998887777
Q ss_pred ccccc
Q 001370 998 TSYFL 1002 (1091)
Q Consensus 998 ts~Fd 1002 (1091)
.+++.
T Consensus 294 ~~~~~ 298 (332)
T cd05623 294 TSNFD 298 (332)
T ss_pred cccCC
Confidence 77653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=431.91 Aligned_cols=291 Identities=42% Similarity=0.755 Sum_probs=250.8
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998755555556677889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||++||+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD----- 155 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-----
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
........+||+.|||||++.+ ..++.++|||||||++|||++|+.||...+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 156 ---------------------GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ---------------------CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 0011123579999999999976 46789999999999999999999999999888
Q ss_pred HHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCCCCC
Q 001370 920 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 997 (1091)
Q Consensus 920 ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~D 997 (1091)
+.+..+.... .++|.....++.++++||.+||+.+ .+|++...+.++++||||++++|+.+....+|+.|....+.+
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~-~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~~~~ 293 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSR-ERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSD 293 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCc-hhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCCCcch
Confidence 8888887644 3445434567999999999999964 466655569999999999999999998888899998887777
Q ss_pred cccccc
Q 001370 998 TSYFLS 1003 (1091)
Q Consensus 998 ts~Fds 1003 (1091)
.++|+.
T Consensus 294 ~~~~~~ 299 (331)
T cd05624 294 TSNFDV 299 (331)
T ss_pred hhhcCC
Confidence 777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=433.15 Aligned_cols=283 Identities=37% Similarity=0.756 Sum_probs=245.8
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||.||+|+++.+|+.||+|++++...........+..|..++... +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999875443344566778888888764 899999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+...++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (316)
T cd05620 149 ---------------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP 213 (316)
T ss_pred ---------------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 01122356799999999999999999999999999999999999999999998888888776654
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccccccc
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1006 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs 1006 (1091)
.+| ..++.++++||.+||..||.+|++. +.++++||||++++|..+... .+|+.|....+.+.++|+..+.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (316)
T cd05620 214 HYP---RWITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFL 286 (316)
T ss_pred CCC---CCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccc
Confidence 444 6789999999999999999999993 358999999999999987554 5788888888888888876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=434.81 Aligned_cols=287 Identities=42% Similarity=0.767 Sum_probs=253.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GG 771 (1091)
+.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.++..++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555566778889999999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 772 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 772 SL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
+|..++.+...+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~------------ 148 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK------------ 148 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC------------
Confidence 999999888889999999999999999999997 7999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+...+...+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05594 149 ---------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213 (325)
T ss_pred ---------------CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC
Confidence 01112345799999999999999999999999999999999999999999988888888887776
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccccccc
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 1006 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs 1006 (1091)
.+| ..+++++.+||.+||++||.+|++. ..+.++++||||.++.|...... .+|+.|...+..++.+|+..+.
T Consensus 214 ~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05594 214 RFP---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFT 290 (325)
T ss_pred CCC---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhh
Confidence 665 6789999999999999999999842 24899999999999999987654 5788888888888888887665
Q ss_pred cC
Q 001370 1007 QI 1008 (1091)
Q Consensus 1007 ~~ 1008 (1091)
..
T Consensus 291 ~~ 292 (325)
T cd05594 291 AQ 292 (325)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=451.27 Aligned_cols=261 Identities=39% Similarity=0.684 Sum_probs=238.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--NDIERILAERNILITVR-NPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~--~eie~~l~EieILskL~-HPNIVkL~gsfqded 759 (1091)
...+.|.+.+.||.|+||+|++|++..+|..||+|++.+...... ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 567899999999999999999999999999999998877533211 34566778999999999 999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC-CcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~~~~ 838 (1091)
.+|+||||+.||+|++++.+.+++.|..++.|+.||+.|++|||++||+||||||+|||+|.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998521
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-C-CccceeechhhhHHHHHhCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-H-GYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Y-s~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.......+.||||.|+|||++.+.+ | +.++||||+||+||.|++|+.||...
T Consensus 173 --------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 173 --------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred --------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 1233456899999999999999988 8 58999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCC-CHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~l-S~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+...++.+|..+.+.+| ..+ |+++++||.+||..||.+|++ +.+|+.||||+.-
T Consensus 227 ~~~~l~~ki~~~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~t---~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 227 NVPNLYRKIRKGEFKIP---SYLLSPEARSLIEKMLVPDPSTRIT---LLEILEHPWFQKE 281 (370)
T ss_pred cHHHHHHHHhcCCccCC---CCcCCHHHHHHHHHHcCCCcccCCC---HHHHhhChhhccC
Confidence 99999999999999887 567 999999999999999999999 8899999999863
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=427.72 Aligned_cols=289 Identities=45% Similarity=0.822 Sum_probs=244.3
Q ss_pred CeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001370 687 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~-~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~L 761 (1091)
+|++++.||+|+||+||+|+.. .+|+.||+|++.+.... .....+.+..|+.+|..++ ||||++++++|...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999999875432 2234567889999999995 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~--- 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--- 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCC----
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE---- 916 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~---- 916 (1091)
.........+||+.|||||++.+. .++.++|||||||++|||++|..||...
T Consensus 158 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 158 -----------------------EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred -----------------------cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 011122356899999999999875 4889999999999999999999999643
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCccCCC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 992 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 992 (1091)
....+...+......+ +..+++.+.+||.+||..||.+||++. .+.++++||||++++|..+... .+++.|..
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 291 (332)
T cd05614 215 TQSEVSRRILKCDPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSI 291 (332)
T ss_pred CHHHHHHHHhcCCCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 3344555555555444 367899999999999999999999755 6999999999999999987654 67788888
Q ss_pred CCCCCccccccc
Q 001370 993 ESVDDTSYFLSR 1004 (1091)
Q Consensus 993 ~s~~Dts~Fds~ 1004 (1091)
....+..+|...
T Consensus 292 ~~~~~~~~~~~~ 303 (332)
T cd05614 292 RNELDVGNFAEE 303 (332)
T ss_pred CCcchhhhcCcc
Confidence 777777776554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=427.85 Aligned_cols=285 Identities=38% Similarity=0.754 Sum_probs=248.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILsk-L~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||+|+||+||+|+++.+++.||||++++...........+..|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987544334455667788888876 4899999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05619 149 ---------------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP 213 (316)
T ss_pred ---------------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 01112346799999999999999999999999999999999999999999988888888766554
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccccccccC
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 1008 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~~ 1008 (1091)
.+| ..++.++++||.+||++||.+||++. .+++.||||+.++|..+... .+++.|...+..+.++|+..+...
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~P~~R~~~~--~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd05619 214 CYP---RWLTREAKDILVKLFVREPERRLGVK--GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNE 288 (316)
T ss_pred CCC---ccCCHHHHHHHHHHhccCHhhcCCCh--HHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcC
Confidence 444 67899999999999999999999932 48999999999999987654 688999999999999998875544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=425.93 Aligned_cols=283 Identities=43% Similarity=0.781 Sum_probs=245.0
Q ss_pred EEeeccCCceEEEEEEE---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 691 IKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~---k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
++.||+|+||.||+++. +.+|+.||+|++++... .......+.+|+.+|.+++||||++++++|.+.+.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999986 35789999999987443 223445678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCC
Q 001370 768 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 847 (1091)
Q Consensus 768 m~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~ 847 (1091)
++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--------- 150 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--------- 150 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC---------
Confidence 99999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhh
Q 001370 848 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 927 (1091)
Q Consensus 848 ~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~ 927 (1091)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..
T Consensus 151 ------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~ 212 (318)
T cd05582 151 ------------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212 (318)
T ss_pred ------------------CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 01123356899999999999999999999999999999999999999999998888888887
Q ss_pred cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc--HHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccccc
Q 001370 928 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLS 1003 (1091)
Q Consensus 928 ~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g--A~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds 1003 (1091)
....+| ..+++++.+||.+||+.||.+||++.+ +.+++.||||..++|..+... .+++.|......+..+++.
T Consensus 213 ~~~~~p---~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (318)
T cd05582 213 AKLGMP---QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDP 289 (318)
T ss_pred CCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCc
Confidence 776655 678999999999999999999999766 899999999999999987654 5677776666555555554
Q ss_pred c
Q 001370 1004 R 1004 (1091)
Q Consensus 1004 ~ 1004 (1091)
.
T Consensus 290 ~ 290 (318)
T cd05582 290 E 290 (318)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=454.28 Aligned_cols=261 Identities=34% Similarity=0.629 Sum_probs=244.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
-.++-|++.+.||+|+-|.|.+|++..||+..|||++.+...........+.+|+-||+.+.||||++||+.+.+..++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 34567899999999999999999999999999999999875566667788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+|+||++||.|+++|.+.|.|++.++..|+.||+.|+.|+|..+|+||||||+|+|||..++|||+|||+|.+-
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe------ 162 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE------ 162 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999741
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
..+....+.||+|.|.|||++.|.+| +.++||||.|||||.||+|+.||.+++...+
T Consensus 163 ----------------------~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L 220 (786)
T KOG0588|consen 163 ----------------------VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL 220 (786)
T ss_pred ----------------------cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH
Confidence 22445567899999999999999999 6899999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
+.++..+.+.+| ..+|.+++|||.+||.+||.+|+| .+||++|||+.+..
T Consensus 221 LlKV~~G~f~MP---s~Is~eaQdLLr~ml~VDp~~RiT---~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 221 LLKVQRGVFEMP---SNISSEAQDLLRRMLDVDPSTRIT---TEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHcCcccCC---CcCCHHHHHHHHHHhccCcccccc---HHHHhhCchhhcCC
Confidence 999999999888 799999999999999999999999 88999999998754
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=403.04 Aligned_cols=275 Identities=34% Similarity=0.617 Sum_probs=234.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.++..++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999986554444445667899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999999888654 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH-
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD- 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~- 923 (1091)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+......
T Consensus 155 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 155 ----------------------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred ----------------------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 011124579999999999999999999999999999999999999998876543332
Q ss_pred ---HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCccCCC
Q 001370 924 ---NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 992 (1091)
Q Consensus 924 ---kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 992 (1091)
.+...... ++..++..+.+||.+||..||.+||+.. .+.+++.||||...+|..+... .|||.|.|
T Consensus 213 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05605 213 VERRVKEDQEE---YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285 (285)
T ss_pred HHHHhhhcccc---cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCCC
Confidence 22222222 3367899999999999999999999533 5899999999999999988665 67888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=444.81 Aligned_cols=255 Identities=36% Similarity=0.630 Sum_probs=237.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+.|... .+.+...+.+|++|+..++|||||.++++|+...++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 678899999999999999999999999999999988654 3457888999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||+.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||+.+|++|+||||+|+....+
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~------ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN------ 153 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC------
Confidence 99988 99999999999999999999999999999999999999999999999999999999999999964221
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.....++.|||.|||||++.+++|+..+|.||||||+|||++|+|||+..+...+.+.|
T Consensus 154 ---------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I 212 (808)
T KOG0597|consen 154 ---------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI 212 (808)
T ss_pred ---------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 12335678999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+.....|| ...|.++..|++.+|.+||.+|++ -.+++.|||.++
T Consensus 213 ~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 213 LKDPVKPP---STASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKG 256 (808)
T ss_pred hcCCCCCc---ccccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhh
Confidence 99998888 689999999999999999999999 679999999876
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=402.86 Aligned_cols=267 Identities=33% Similarity=0.631 Sum_probs=226.6
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001370 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 773 (1091)
Q Consensus 694 LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL 773 (1091)
||+|+||+||+|.++.+|+.||+|++.+...........+..|+.++..++||||++++++|.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999875554445567788999999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001370 774 YSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 849 (1091)
Q Consensus 774 ~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t 849 (1091)
.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~----------- 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD----------- 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC-----------
Confidence 988753 34689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh----HHHHHHH
Q 001370 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNI 925 (1091)
Q Consensus 850 ~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~----~ei~~kI 925 (1091)
.........||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ......+
T Consensus 150 ----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 150 ----------------GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred ----------------CCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 00112345799999999999999999999999999999999999999986543 3334444
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCccC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 990 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfiP 990 (1091)
......+ +..++.++.+|+.+||+.||.+||+.. .+.++++||||++++|..+... .+||.|
T Consensus 214 ~~~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 214 LNDSVTY---PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred cccCCCC---cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 4444333 367899999999999999999999742 4899999999999999988654 456655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=401.71 Aligned_cols=305 Identities=51% Similarity=0.889 Sum_probs=260.8
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||.||++.++.+++.||+|.+.+...........+.+|++++..++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998755444455678889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.........+.
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211110000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
. ..... ...........|++.|+|||.+.+..++.++|+|||||++|||++|..||.+.+..+....+
T Consensus 161 ~----~~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 161 E----GHIEK--------DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred c----ccccc--------chhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0 00000 00011122356899999999999889999999999999999999999999999888888888
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCCCCCccccc
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFL 1002 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~Fd 1002 (1091)
......+|..+..++.++.+||.+||..||.+||+..++.++++||||.+.+|..+......++|++...++.+||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCCCccccccCC
Confidence 87776666655578999999999999999999999888999999999999999998877888999998888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=397.30 Aligned_cols=285 Identities=47% Similarity=0.868 Sum_probs=253.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||+|+||.||++.+..+++.||+|++++...........+.+|+++|.+++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998766555566788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|.|||++.+|.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~------- 153 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------- 153 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.....+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 154 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 210 (290)
T cd05580 154 -----------------------RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210 (290)
T ss_pred -----------------------CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 023457999999999999888999999999999999999999999988888888888
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccc
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1001 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1001 (1091)
..+...+| ..++..++++|.+||..||.+|++. ..+.++++||||+.++|..+... .+|+.|......+.+.|
T Consensus 211 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (290)
T cd05580 211 LEGKVRFP---SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNF 287 (290)
T ss_pred hcCCccCC---ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccc
Confidence 77765555 6789999999999999999999952 35899999999999999988655 67888887777777766
Q ss_pred cc
Q 001370 1002 LS 1003 (1091)
Q Consensus 1002 ds 1003 (1091)
+.
T Consensus 288 ~~ 289 (290)
T cd05580 288 DD 289 (290)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=407.01 Aligned_cols=262 Identities=35% Similarity=0.664 Sum_probs=245.1
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.....++++|++.+.||+|-||.||+|+.+.++-.||+|++.|..+....-...+.+|++|-+.++||||+++|++|.+.
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 34457899999999999999999999999999999999999998887777778899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~--k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
..+||++||.++|+|+..|. ....|++..+..|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||.+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999999 6678999999999999999999999999999999999999999999999999998641
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
+.....+.|||..|.+||+..+..++..+|+|++|++.||+|.|.+||...
T Consensus 175 -----------------------------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 175 -----------------------------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred -----------------------------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 133456789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+..++|++|....+.+| ..++.+++|||.+||.++|.+|+. ..+++.|||...
T Consensus 226 ~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 226 SHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred hhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 99999999999998888 799999999999999999999998 889999999753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=419.22 Aligned_cols=261 Identities=35% Similarity=0.600 Sum_probs=222.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--eeE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NLY 762 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded--~LY 762 (1091)
..++...+.||+|+||.||++.++.+|..+|||.+.... ....+.+.+|+.+|.+++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888999999999999999999999999999887542 122677899999999999999999999865555 699
Q ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~~~ 840 (1091)
++|||++||+|.+++.+.+ .|++..++.|++||+.||.|||++|||||||||+||||+. +|.+||+|||+++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES-- 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--
Confidence 9999999999999999887 7999999999999999999999999999999999999999 79999999999985311
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCC-CCh
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTA-ESP 918 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~-~s~ 918 (1091)
............|||.|||||++.+. ..+.++|||||||++.||+||.+||.. ...
T Consensus 171 ----------------------~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~ 228 (313)
T KOG0198|consen 171 ----------------------KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE 228 (313)
T ss_pred ----------------------ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch
Confidence 00112234467899999999999962 233599999999999999999999987 444
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
....-.|.... ..|.+|..+|.++++||.+||.+||.+||| |.++|.|||.+..
T Consensus 229 ~~~~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt---a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 229 AEALLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPT---AEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcC---HHHHhhChhhhcc
Confidence 45445555444 446788999999999999999999999999 8999999999753
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=396.68 Aligned_cols=267 Identities=33% Similarity=0.597 Sum_probs=225.3
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001370 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 773 (1091)
Q Consensus 694 LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL 773 (1091)
||+|+||+||+++.+.+|+.||+|.+.+...........+..|++++.+++||||++++++|.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765544444455667799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001370 774 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851 (1091)
Q Consensus 774 ~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g 851 (1091)
.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~------------- 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD------------- 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC-------------
Confidence 98886543 488899999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh----HHHHHHHhh
Q 001370 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 927 (1091)
Q Consensus 852 ~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~----~ei~~kIl~ 927 (1091)
........||+.|+|||++.+..++.++|+|||||++|||++|+.||..... .++...+..
T Consensus 148 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05607 148 ---------------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212 (277)
T ss_pred ---------------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc
Confidence 0111234699999999999998899999999999999999999999976432 344445544
Q ss_pred cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc-cHHHHHcCCCCCCCCcchhhcc--cCCccC
Q 001370 928 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 990 (1091)
Q Consensus 928 ~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~-gA~EIL~HPFFkgIdWd~L~~~--~pPfiP 990 (1091)
....++ ...++.++++||.+||++||.+||++. ...+++.||||++++|..+... .+||+|
T Consensus 213 ~~~~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 213 DEVKFE--HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred cccccc--cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 444433 256899999999999999999999953 3478999999999999998865 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=426.88 Aligned_cols=270 Identities=37% Similarity=0.671 Sum_probs=230.3
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc-----------hhHHHHHHHHHHHHHhcCCCc
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----------KNDIERILAERNILITVRNPF 747 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~-----------~~eie~~l~EieILskL~HPN 747 (1091)
...+..+++|++++.||+|.||.|.+|+...+++.||||++.|..... ...++.+.+|+.||+++.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 445678999999999999999999999999999999999998754322 123578999999999999999
Q ss_pred eEEEeeeeccC--CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcE
Q 001370 748 VVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 825 (1091)
Q Consensus 748 IVkL~gsfqde--d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~V 825 (1091)
||+|+.+..+. +.+|||+|||..|.+...=....-+++.+++.|+++++.||+|||.+|||||||||+|+||+.+|+|
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 99999998876 4699999999999886432222238999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---CC-Cccceeechhh
Q 001370 826 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EH-GYAADWWSVGI 901 (1091)
Q Consensus 826 KLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~Y-s~ksDIWSLGV 901 (1091)
||+|||.+....... . . .........+|||.|||||...+. .| +.+.|||||||
T Consensus 250 KIsDFGVs~~~~~~~---------------~------~-~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGS---------------D------E-GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred EeeccceeeecccCC---------------c------c-ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 999999887431100 0 0 011112237999999999999872 23 68899999999
Q ss_pred hHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 902 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 902 ILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
+||.|+.|+.||.++...+++.+|++..+.||..+ .+..+++|||.+||++||++|++ +.+|+.|||..
T Consensus 308 TLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~---l~~ik~Hpwvt 376 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRIT---LPDIKLHPWVT 376 (576)
T ss_pred hHHHhhhccCCcccchHHHHHHHHhcCcccCCCcc-cccHHHHHHHHHHhhcChhheee---hhhheecceec
Confidence 99999999999999999999999999999999643 68999999999999999999999 88999999975
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=395.12 Aligned_cols=276 Identities=35% Similarity=0.631 Sum_probs=232.5
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.++..++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987555444455678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------ 154 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC------
Confidence 999999999986543 589999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH---HH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE---II 921 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~---ei 921 (1091)
........||+.|+|||++.+..++.++|+|||||++|+|++|.+||...... ..
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 155 ----------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred ----------------------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 01112347999999999999999999999999999999999999999865432 22
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCccCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 992 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 992 (1091)
...+.... . ...+..+++++.+||.+||+.||.+|||.+ .+.++++||||+.++|..+... +|+|+|.+
T Consensus 213 ~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 213 VERLVKEV-Q-EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred HHhhhhhh-h-hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence 22222211 1 112367889999999999999999999843 5889999999999999987653 67888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=421.62 Aligned_cols=261 Identities=40% Similarity=0.669 Sum_probs=238.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LY 762 (1091)
....|++.+.||+|.||.||+|+.+.||+.||+|++.|...........+.+|+.||+++. |||||.+++.|.+...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4467999999999999999999999999999999999877766667789999999999999 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC----CcEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n----G~VKLsDFGLAk~~~~ 838 (1091)
+|||++.||+|++.+.+. .+++..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||+++...
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~- 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK- 190 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc-
Confidence 999999999999999877 49999999999999999999999999999999999999643 579999999998631
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
........||||.|+|||++.+.+|+..+|+||+||++|.||+|.+||.+.+.
T Consensus 191 ---------------------------~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 191 ---------------------------PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred ---------------------------CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 13345678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 919 EIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
...+..|..+.+.|+.- -..++..+++||++||..||.+|++ |.++|+|||+++.
T Consensus 244 ~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t---a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 244 FEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT---AAQALQHPWIKSI 299 (382)
T ss_pred hHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC---HHHHhcCccccCC
Confidence 99999999998876542 2567999999999999999999999 8899999998865
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=391.80 Aligned_cols=258 Identities=34% Similarity=0.498 Sum_probs=215.8
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||+|+||+||+|+++.+++.||+|+++.... .......+.+|+.++..++||||++++++|...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976432 2334567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------ 153 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG------ 153 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc------
Confidence 99999877666555567999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+
T Consensus 154 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 154 --------------------SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred --------------------ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011122457999999999999999999999999999999999999999987654443333
Q ss_pred hhc-------------------CCCCCCC----------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 926 LNR-------------------KIPWPCV----------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 926 l~~-------------------~l~fP~i----------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
... ...+|.. ...+|.++.+||++||++||++||+ +.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s---~~~~l~hp~f 287 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL---TEQCLNHPAF 287 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 221 0111110 1237889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=413.87 Aligned_cols=249 Identities=30% Similarity=0.552 Sum_probs=224.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee-eeccCCe
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY-SFTCRDN 760 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~g-sfqded~ 760 (1091)
.....+|+++++||+|+||+||++++..+|..+|.|.++ -.+......+.+..|+.+|++++|||||++|+ .|..+..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 456778999999999999999999999999999999998 55667778888999999999999999999998 6666555
Q ss_pred -eEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeecccCCCceEecCCCcEEEEecC
Q 001370 761 -LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS--LG--IVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 761 -LYLVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs--~G--IIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
++||||||.+|||..+++. ...++|..++.|+.|++.||.++|. .. |+||||||.||+|+.+|.|||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 9999999999999999864 3469999999999999999999999 44 9999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
|++++. .....+.+.+|||.||+||.+.+.+|+.++|||||||++|||+.-.+
T Consensus 174 L~r~l~---------------------------s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~ 226 (375)
T KOG0591|consen 174 LGRFLS---------------------------SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQS 226 (375)
T ss_pred hHhHhc---------------------------chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCC
Confidence 999743 12334568899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCC-CCCCHHHHHHHhhhccCCCCCCCC
Q 001370 912 PFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 912 PF~~~s~~ei~~kIl~~~l~fP~ip-~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
||++++-.++.++|-++.+ |.+| ...|.++..||.-|+..||..||+
T Consensus 227 PF~g~n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 227 PFYGDNLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred CcccccHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence 9999999999999999865 4344 678999999999999999999998
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=390.78 Aligned_cols=307 Identities=43% Similarity=0.806 Sum_probs=250.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||+|+||.||+|....+++.||+|.+.+...........+.+|++++..++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765544456778999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 766 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||+.|++|.+++.+. ..+++..++.++.|++.||.|||++||+|+||||+|||++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 469999999999999999999999999999999999999999999999999987532111000
Q ss_pred CCCCCCCCCCC--CCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 844 LSGPETDGIMP--SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 844 ls~~~t~g~lp--s~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
........... ...................+||..|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000000000 0000000111122233456899999999999998999999999999999999999999999988888
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC-cccHHHHHcCCCCCCCCcchhhcccCCccCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPE 993 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS-a~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~ 993 (1091)
+..+......++. ...++.++.+||.+||+.||++||+ ...+.+++.||||++++|..+....+|.+|.+.
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 241 FSNILKKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred HHHHhcCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 8888777666653 2237999999999999999999999 456889999999999999999887777777654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=391.18 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=215.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
.+++|++++.||.|+||+||+|+++.++..||+|+++.... ......+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 35789999999999999999999999999999999875322 2234567899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~---- 155 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV---- 155 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC----
Confidence 9999985 9999887654 478999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.........||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.
T Consensus 156 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 156 -----------------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred -----------------------CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0111233578999999999876 5689999999999999999999999998887666
Q ss_pred HHHHhhcC-------------------CCCCC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 922 FDNILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 922 ~~kIl~~~-------------------l~fP~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
...+.... ..+|. ....++.+++|||.+||+.||.+||| +.|+++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t---~~~~l~hp~f 288 (288)
T cd07871 213 LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS---AEAALRHSYF 288 (288)
T ss_pred HHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC---HHHHhcCCCC
Confidence 65543310 01111 11357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=405.04 Aligned_cols=259 Identities=28% Similarity=0.492 Sum_probs=219.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
+.|+.+..+|.|+||+||+|++++||+.||||.+...+. ...-.+-.++|+++|++++|||+|.|..+|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 578999999999999999999999999999999865432 2333456789999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||.. ++.+.|.+. ..++.+.++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+...
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~------- 152 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS------- 152 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc-------
Confidence 99988 555555554 469999999999999999999999999999999999999999999999999998532
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
.++......+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+.+..+..-
T Consensus 153 --------------------~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy 212 (396)
T KOG0593|consen 153 --------------------APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY 212 (396)
T ss_pred --------------------CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence 11233345789999999999998 799999999999999999999999999988766554
Q ss_pred HHhh-------------------cCCCCCCCC---------CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 924 NILN-------------------RKIPWPCVP---------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 924 kIl~-------------------~~l~fP~ip---------~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.|.. ..+.+|..+ +.++.-+.||+++||..||.+|++ .++++.||||.+
T Consensus 213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s---c~qll~H~yFd~ 289 (396)
T KOG0593|consen 213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS---CEQLLHHPYFDG 289 (396)
T ss_pred HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc---HHHHhcChHHHH
Confidence 4432 112233311 356778999999999999999999 889999999965
Q ss_pred C
Q 001370 976 V 976 (1091)
Q Consensus 976 I 976 (1091)
+
T Consensus 290 ~ 290 (396)
T KOG0593|consen 290 F 290 (396)
T ss_pred H
Confidence 3
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=393.43 Aligned_cols=261 Identities=29% Similarity=0.520 Sum_probs=212.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++++.||.|+||+||+|+.+.+|+.||||+++.... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999975432 22334678899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+. |+|.+++.+. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV----- 155 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC-----
Confidence 99996 5888877654 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh-HHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 921 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~-~ei 921 (1091)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+... .+.
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 156 ----------------------PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred ----------------------CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 0111234578999999999876 4588999999999999999999999987543 233
Q ss_pred HHHHhhc--C---CCCCC------C------------------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 922 FDNILNR--K---IPWPC------V------------------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 922 ~~kIl~~--~---l~fP~------i------------------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
...+... . ..++. . ....++++++||.+||+.||.+||| +.++++|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s---~~~~l~h~~ 290 (303)
T cd07869 214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS---AQAALSHEY 290 (303)
T ss_pred HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC---HHHHhcCcc
Confidence 3222210 0 00000 0 0124578999999999999999999 889999999
Q ss_pred CCCCCc
Q 001370 973 FKGVNW 978 (1091)
Q Consensus 973 FkgIdW 978 (1091)
|+++.+
T Consensus 291 f~~~~~ 296 (303)
T cd07869 291 FSDLPP 296 (303)
T ss_pred cccCCh
Confidence 998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=403.23 Aligned_cols=261 Identities=33% Similarity=0.553 Sum_probs=236.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..+.|++.++||+|.|+.||++.++.||+.+|+|++.-..+ .....+.+.+|+.|-..++|||||+|...+......||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 45789999999999999999999999999999999875443 33477889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CCcEEEEecCCcccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+|+|.||+|..-+-..-.++|..+-.|++||+.||.|+|.+||||||+||+|+||-. ..-+||+|||+|...
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l---- 163 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV---- 163 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe----
Confidence 9999999999887776677999999999999999999999999999999999999964 346999999999752
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
..+.....++|||+|||||++...+|+..+|||+-|||||-||.|++||.+++...
T Consensus 164 ------------------------~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 164 ------------------------NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred ------------------------CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 12344567899999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 921 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 921 i~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+|+.|..+.+.+|. .-+.+++++++||++||..||.+|+| |.|.|+|||.++-
T Consensus 220 lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 220 LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICNR 273 (355)
T ss_pred HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcch
Confidence 99999999998876 44679999999999999999999999 8899999999863
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=386.35 Aligned_cols=275 Identities=35% Similarity=0.622 Sum_probs=234.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|+..+.||.|+||+||+|.+..+|+.||+|++.+...........+.+|+++|..++|+||+.+++.|...+.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37889999999999999999999999999999987554444455667899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|+++|+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE------ 154 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC------
Confidence 999999998886543 699999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
........||+.|+|||++.+..++.++|+|||||++|+|++|..||...........
T Consensus 155 ----------------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 155 ----------------------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred ----------------------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0111235799999999999999999999999999999999999999988765443333
Q ss_pred Hh----hcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCccCCC
Q 001370 925 IL----NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 992 (1091)
Q Consensus 925 Il----~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~ 992 (1091)
+. ..... ++..++.++.+||.+||..||.+||+.. .+.+++.||||+.++|+.+... .|+|+|.+
T Consensus 213 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 213 VDRRVLETEEV---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred HHHhhhccccc---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence 32 22222 2367889999999999999999999943 4789999999999999987655 67888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=393.40 Aligned_cols=263 Identities=30% Similarity=0.487 Sum_probs=213.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----Cee
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----DNL 761 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde-----d~L 761 (1091)
.|++.+.||+|+||.||+|+++.+|+.||||+++... ........+.+|+.+|..++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 2233456788999999999999999999887543 358
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||+. ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 157 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT- 157 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc-
Confidence 99999995 6999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..
T Consensus 158 -----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~ 214 (338)
T cd07859 158 -----------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214 (338)
T ss_pred -----------------------CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence 00011234679999999999976 67899999999999999999999999876643
Q ss_pred HHHHHHhh--------------------------cC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCC
Q 001370 920 IIFDNILN--------------------------RK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971 (1091)
Q Consensus 920 ei~~kIl~--------------------------~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HP 971 (1091)
.....+.. .. .++......+++++.+||.+||+.||++||+ +.++++||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~e~l~hp 291 (338)
T cd07859 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT---AEEALADP 291 (338)
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC---HHHHhcCc
Confidence 33221111 00 0111111346788999999999999999999 88999999
Q ss_pred CCCCCCc
Q 001370 972 FFKGVNW 978 (1091)
Q Consensus 972 FFkgIdW 978 (1091)
||+++..
T Consensus 292 ~f~~~~~ 298 (338)
T cd07859 292 YFKGLAK 298 (338)
T ss_pred hhhhcCc
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=425.43 Aligned_cols=257 Identities=35% Similarity=0.569 Sum_probs=228.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
...|.....||+|+.|.||.++...+++.||||.+..... ...+-+++|+.+|+..+|+|||+++.+|...+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 3567888899999999999999999999999999976443 2346789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||||+||+|.+.+.. -.++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+..
T Consensus 349 MEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~------ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE------ 421 (550)
T ss_pred EeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc------
Confidence 999999999998865 4599999999999999999999999999999999999999999999999999985421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
......+.+|||+|||||++....|+.++||||||+++.||+-|.|||..+++-.....
T Consensus 422 ---------------------~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL 480 (550)
T KOG0578|consen 422 ---------------------EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 480 (550)
T ss_pred ---------------------ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH
Confidence 12245678999999999999999999999999999999999999999998888776666
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
|.....+--..+..+|++++||+.+||+.|+.+|++ |.|+|.||||+-
T Consensus 481 Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras---A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 481 IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS---AKELLEHPFLKM 528 (550)
T ss_pred HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC---HHHHhcChhhhh
Confidence 665443322346889999999999999999999999 889999999953
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=412.81 Aligned_cols=257 Identities=31% Similarity=0.609 Sum_probs=240.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
...|++.+.||+|.||+|-+|.....|+.||||.|+|..+..+.+.-++.+|++||+.++||||+.+|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||..+|+|++|+.+.+.|++.+++.+++||+.|+.|+|+++++|||||.+|||||.|+++||+||||+...
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly-------- 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY-------- 203 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh--------
Confidence 999999999999999999999999999999999999999999999999999999999999999999998642
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
.......++||+|.|.+||+++|.+| +..+|-|||||+||-|+.|..||.+.+...+.+
T Consensus 204 --------------------~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 204 --------------------ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred --------------------ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 12344568999999999999999999 689999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
+|.++.+.-| .-+.++.-||++||.+||++|.| +.+|..|-|. ||.
T Consensus 264 QIs~GaYrEP----~~PSdA~gLIRwmLmVNP~RRAT---ieDiAsHWWv---Nwg 309 (668)
T KOG0611|consen 264 QISRGAYREP----ETPSDASGLIRWMLMVNPERRAT---IEDIASHWWV---NWG 309 (668)
T ss_pred HhhcccccCC----CCCchHHHHHHHHHhcCcccchh---HHHHhhhhee---ecc
Confidence 9999987655 34568999999999999999999 8899999986 465
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=408.46 Aligned_cols=270 Identities=31% Similarity=0.536 Sum_probs=234.9
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.......++|++..+||.|.-++||+|+.+.+++.||||++.-... ..+.+.+.+|+..|..++||||++++.+|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3455778999999999999999999999999999999999975332 23478899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
..+|+||.||.+|++.++++.. ..|+|..+..+++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999864 35999999999999999999999999999999999999999999999999987643
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCc-cCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR-HSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~-~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
... | .+.... .+++|||.|||||+++. .+|+.|+||||||++..||.+|..||
T Consensus 177 ~~~-----------G-------------~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 177 FDS-----------G-------------DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred ccc-----------C-------------ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 210 0 011111 67899999999999765 68999999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCCCCCC-------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 914 TAESPEIIFDNILNRKIPWPCV-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 914 ~~~s~~ei~~kIl~~~l~fP~i-------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
....+..+.-..+++..+.+.. ...++..++.+|..||++||.+||+ |.++|+|+||+...
T Consensus 233 ~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt---AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 233 SKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT---ASKLLKHAFFKKAK 300 (516)
T ss_pred ccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC---HHHHhccHHHhhcc
Confidence 9999999888888887764431 1345678999999999999999999 89999999998753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=416.19 Aligned_cols=264 Identities=33% Similarity=0.521 Sum_probs=228.1
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 758 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde- 758 (1091)
+.....+.|+.++.||+|+||.||+|++..||+.||+|.++... .+..-..-..+|+.||++++||||++|.+...+.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 33456788999999999999999999999999999999997643 2344566778999999999999999999998877
Q ss_pred -CeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 -DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 -d~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
..+|||+|||+. ||.-++...+ .|++.+++.|+.||+.||+|||.+||+|||||.+|||||.+|.+||+|||||++.
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 679999999998 9999998754 6999999999999999999999999999999999999999999999999999963
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
.. .........|-|.+|.|||.|+| ..|+.++|+||.||||.||++|++.|.+
T Consensus 269 ~~--------------------------~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G 322 (560)
T KOG0600|consen 269 TP--------------------------SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG 322 (560)
T ss_pred cC--------------------------CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence 21 11222456789999999999998 6899999999999999999999999999
Q ss_pred CChHHHHHHHhhc-----CCCCC-----C----------------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 916 ESPEIIFDNILNR-----KIPWP-----C----------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 916 ~s~~ei~~kIl~~-----~l~fP-----~----------------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
.+..+...+|..- .-.|+ . ....++..+.+|+..||+.||.+|.| |.+.|.
T Consensus 323 ~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t---A~~aL~ 399 (560)
T KOG0600|consen 323 RTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT---ASSALQ 399 (560)
T ss_pred ccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc---HHHHhc
Confidence 9998888888751 00122 1 11357899999999999999999999 889999
Q ss_pred CCCCC
Q 001370 970 HPFFK 974 (1091)
Q Consensus 970 HPFFk 974 (1091)
|+||.
T Consensus 400 seyF~ 404 (560)
T KOG0600|consen 400 SEYFT 404 (560)
T ss_pred Ccccc
Confidence 99994
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=392.13 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=221.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++++.||+|+||.||+++++.+|..||+|++.... .......+.+|+++|.+++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999987531 23445679999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||++||+|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~----- 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----- 155 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc-----
Confidence 999999999999998888899999999999999999999986 69999999999999999999999999987421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++.
T Consensus 156 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 211 (331)
T cd06649 156 ------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211 (331)
T ss_pred ------------------------ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 01112457999999999999999999999999999999999999999876554433
Q ss_pred HHH----------------------------------------------hhcCCCCCCC-CCCCCHHHHHHHhhhccCCC
Q 001370 923 DNI----------------------------------------------LNRKIPWPCV-PSDMSFEAQDLINRFLIHDP 955 (1091)
Q Consensus 923 ~kI----------------------------------------------l~~~l~fP~i-p~~lS~eakDLI~rcL~kDP 955 (1091)
..+ .+... |.. ...+++++++||.+||++||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~~P 289 (331)
T cd06649 212 AIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP--PKLPNGVFTPDFQEFVNKCLIKNP 289 (331)
T ss_pred HHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCC--cCCCCccccHHHHHHHHHHccCCc
Confidence 221 11110 111 12468899999999999999
Q ss_pred CCCCCcccHHHHHcCCCCCCCCcc
Q 001370 956 NQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 956 eKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
++||+ +.++++||||+.....
T Consensus 290 ~~Rpt---~~ell~h~~~~~~~~~ 310 (331)
T cd06649 290 AERAD---LKMLMNHTFIKRSEVE 310 (331)
T ss_pred ccCCC---HHHHhcChHHhhcccc
Confidence 99999 8899999999865433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=407.33 Aligned_cols=258 Identities=31% Similarity=0.505 Sum_probs=222.1
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcE-EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~-VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.+.+...++.+.+.||+|+||+||.|.++ |.. ||+|++......... .+.|.+|+.+|.+++|||||++++++...
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34455677788888999999999999997 555 999999876544443 78999999999999999999999999998
Q ss_pred C-eeEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecccCCCceEecCCC-cEEEEecCCc
Q 001370 759 D-NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAHDG-HIKLTDFGLS 833 (1091)
Q Consensus 759 d-~LYLVMEYm~GGSL~dlL~k--~g~LsE~~ar~yaaQIa~ALeYLHs~G-IIHRDLKPeNILLD~nG-~VKLsDFGLA 833 (1091)
. .+++|||||++|+|..++.+ ...++...+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 8 79999999999999999988 578999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--CCCCCccceeechhhhHHHHHhCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~--g~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
+..... ........||+.|||||++. ...|+.++||||||++||||+||..
T Consensus 192 r~~~~~---------------------------~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 192 REKVIS---------------------------KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred eeeccc---------------------------cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 852110 01122368999999999999 6699999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 912 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 912 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
||.+..+......+.....+ |.+|..+++.+..||.+||..||.+||++..+...|
T Consensus 245 Pf~~~~~~~~~~~v~~~~~R-p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGLR-PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred CCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 99999987777776655443 556677999999999999999999999965444444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=416.33 Aligned_cols=259 Identities=32% Similarity=0.494 Sum_probs=222.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC-e
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-N 760 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded-~ 760 (1091)
...++|.+++.||.|+||.||+|+.+.+|+.||||.+++.- .. -+...-++|+.-|.+++ |||||+|+..+.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-cc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 34678999999999999999999999999999999997643 22 23344578999999999 999999999999998 9
Q ss_pred eEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
+|+|||||.. +|+++++..+ .|++..++.|+.||+.||+|+|++|+.||||||+|||+..+..|||+|||||+.+..
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc-
Confidence 9999999976 9999998654 599999999999999999999999999999999999999999999999999996421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.......+-|.+|+|||+|+. ..|+.++|+||+||||+|+++-++-|.|.+.
T Consensus 163 ---------------------------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 163 ---------------------------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred ---------------------------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 112234688999999999986 5689999999999999999999999999988
Q ss_pred HHHHHHHhh-------------------cCCCCCCC--------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCC
Q 001370 919 EIIFDNILN-------------------RKIPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971 (1091)
Q Consensus 919 ~ei~~kIl~-------------------~~l~fP~i--------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HP 971 (1091)
.+..-+|.. ..+.||.. -...+.++.+||.+||..||.+||| |.++|+||
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT---A~~al~~p 292 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT---ASQALQHP 292 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc---HHHHhcCc
Confidence 777666643 12333332 1348899999999999999999999 88999999
Q ss_pred CCCC
Q 001370 972 FFKG 975 (1091)
Q Consensus 972 FFkg 975 (1091)
||+.
T Consensus 293 ffq~ 296 (538)
T KOG0661|consen 293 FFQV 296 (538)
T ss_pred cccc
Confidence 9974
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=377.98 Aligned_cols=255 Identities=33% Similarity=0.517 Sum_probs=209.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeec-----
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFT----- 756 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~-TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL---~HPNIVkL~gsfq----- 756 (1091)
.+|++++.||+|+||+||+|++.. +|+.||+|+++.... .......+.+|+.++..+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 468899999875332 222334566777777665 6999999999875
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
....+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999997 5999998754 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
.... ........||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccC----------------------------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 4210 112234679999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCC-----CCC-------------------CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 915 AESPEIIFDNILNRKI-----PWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 915 ~~s~~ei~~kIl~~~l-----~fP-------------------~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+.+..+.+..++.... .+| .+...++..+++||.+||+.||++||+ +.++++|
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~l~h 287 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALSH 287 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC---HHHHhcC
Confidence 9888777777654210 111 011357888999999999999999999 8899999
Q ss_pred CCC
Q 001370 971 PFF 973 (1091)
Q Consensus 971 PFF 973 (1091)
|||
T Consensus 288 p~f 290 (290)
T cd07862 288 PYF 290 (290)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=370.96 Aligned_cols=257 Identities=60% Similarity=1.054 Sum_probs=224.7
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieIL-skL~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||.|+||.||+|.+..+|+.||+|++++...........+..|..++ ...+||||+++++++...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999875543344445556666554 445899999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------------- 148 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------------- 148 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999887421
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
......|++.|+|||.+.+..++.++||||||+++|+|++|.+||...+...++..+.....
T Consensus 149 ------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 210 (260)
T cd05611 149 ------------------ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI 210 (260)
T ss_pred ------------------ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 01234688999999999988899999999999999999999999999888888888777665
Q ss_pred CCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 931 PWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 931 ~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
.++. ....++.++.++|.+||..||++||++.++.+++.||||++++|+
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 5443 234678999999999999999999998889999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.53 Aligned_cols=264 Identities=30% Similarity=0.503 Sum_probs=234.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITVR-NPFVVRFFYSF 755 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i-----~~~~eie~~l~EieILskL~-HPNIVkL~gsf 755 (1091)
+-....|+--+.||+|..++|.++.++.||+.+|+|+|.-... ......+....|+.||+++. ||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 3445678888899999999999999999999999999864221 12233456678999999985 99999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 756 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 756 qded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
+.+..+++|+|.|+.|.|+++|...-.+++..++.+++|+..|++|||.++||||||||+|||+|++.++||+|||+|+.
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999999999989999999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc------CCCCCccceeechhhhHHHHHhC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~------g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
. .++......||||+|+|||.+. ..+|+..+|+||+|||||.||.|
T Consensus 173 l----------------------------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 173 L----------------------------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred c----------------------------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 3 2345566789999999999984 35799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.+||.......+.+.|+.+++.|..- -.++|.+++|||.+||+.||.+|+| +.|+|+||||..+
T Consensus 225 cpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit---ake~LaHpff~q~ 289 (411)
T KOG0599|consen 225 CPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT---AKEALAHPFFIQI 289 (411)
T ss_pred CCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc---HHHHhcChHHHHH
Confidence 99999999999999999999887541 2568999999999999999999999 8899999999654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=425.55 Aligned_cols=316 Identities=51% Similarity=0.959 Sum_probs=264.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++++.||+|+||+||+|.+..+++.||||++++...........+.+|+.++..++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876666666678899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc--
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-- 842 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~-- 842 (1091)
|||+.||+|.+++...+.+++..++.|+.||+.||.|||..|||||||||+||||+.+|++||+|||+++........
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~~ 162 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCccccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999743210000
Q ss_pred cC---------------------------------------------------------C-----C----C---------
Q 001370 843 DL---------------------------------------------------------S-----G----P--------- 847 (1091)
Q Consensus 843 dl---------------------------------------------------------s-----~----~--------- 847 (1091)
++ . . +
T Consensus 163 ~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (669)
T cd05610 163 DILTTPSMAKPKNDYSRTPGQVLSLISSLGFNTPVGEKDQGSVNSGQNNGTSSVRTGTSHPLLMINKESLPMSLKLSKSC 242 (669)
T ss_pred ccccCccccCccccccCCCCceeeeeeecCcCCccccccccccccccccccccccccCCCCcccccccccccccHhhhhc
Confidence 00 0 0 0
Q ss_pred ----CCCCCCCC--------------------------------------------------------------------
Q 001370 848 ----ETDGIMPS-------------------------------------------------------------------- 855 (1091)
Q Consensus 848 ----~t~g~lps-------------------------------------------------------------------- 855 (1091)
......|.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (669)
T cd05610 243 LETSESSPSLPVRSLTPNLLKSRKRPEASTSSTHSCMTNSLSSCESECCSSNLKLLEQASSPSQSPRWSVDEGNIISEGE 322 (669)
T ss_pred cccccCCCCCCccccCcccccccccCCcccccchhhhhhhhhhccccccCcchhhhhhccCCCCCccccccCCCCccccc
Confidence 00000000
Q ss_pred --------------------------------------------------------------------------------
Q 001370 856 -------------------------------------------------------------------------------- 855 (1091)
Q Consensus 856 -------------------------------------------------------------------------------- 855 (1091)
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (669)
T cd05610 323 KSEKGSVKRSFELVEKSPCQELLQSKKTNAEYKRGCSITETNGNQSTGLTMEIQSLNLSKHKSRPKFLAGNEKRTGPKKK 402 (669)
T ss_pred ccccCCccccccccccChHHHHhcccccccccccceeeccccccccccceeecchhhhhhhhcCchhhhccccccCcccC
Confidence
Q ss_pred -----------C---------------------------------CCCC-------ccc-------c-------------
Q 001370 856 -----------D---------------------------------AHYP-------EYQ-------Q------------- 864 (1091)
Q Consensus 856 -----------~---------------------------------~~~~-------~~~-------~------------- 864 (1091)
. ...+ .|. .
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (669)
T cd05610 403 SNPVVAKNLMCELDDDGEKDGKYSNSSTSCGDDREIVLKLSLNSDSSFPEMSKNAVAFRSYNSPINVSNVSEPSTMSSLD 482 (669)
T ss_pred CCcchhhhhhccccccccccCCccccccccCccHHHhhhhhhccccccccccccceeeeccCchhhccccCCCCcccccc
Confidence 0 0000 000 0
Q ss_pred -------------------------------------------------cCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001370 865 -------------------------------------------------TDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 895 (1091)
Q Consensus 865 -------------------------------------------------~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 895 (1091)
.........+||+.|||||++.+..|+.++|
T Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~D 562 (669)
T cd05610 483 AMKMSGSQSGSYPAITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVD 562 (669)
T ss_pred hhhccccccCCCcccCCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHH
Confidence 0000012247899999999999999999999
Q ss_pred eechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 896 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 896 IWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
||||||+||||++|.+||.+....+.+..++...+++|.....++..+.+++.+||..||.+||+ +.+++.||||..
T Consensus 563 iwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~t---a~e~l~h~~~~~ 639 (669)
T cd05610 563 WWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAG---LKELKQHPLFHG 639 (669)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcC---HHHHHhCHhhcC
Confidence 99999999999999999999999999999998888888766788999999999999999999999 889999999999
Q ss_pred CCcchhhcccCCccCCCCCCCCcccccc
Q 001370 976 VNWDSLALQKAVFVPQPESVDDTSYFLS 1003 (1091)
Q Consensus 976 IdWd~L~~~~pPfiP~~~s~~Dts~Fds 1003 (1091)
++|..+.....+|.|.+....|+.+|+.
T Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (669)
T cd05610 640 VDWENLQNQTMPFIPQPDDETDTSYFEA 667 (669)
T ss_pred CCHHHhcccCCCCCCCCCCccccccccc
Confidence 9999999889999999888888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=374.45 Aligned_cols=266 Identities=36% Similarity=0.664 Sum_probs=224.7
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001370 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 773 (1091)
Q Consensus 694 LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL 773 (1091)
||.|+||+||+|.+..+|+.||+|++.+...........+.+|+.+|..++||||+++++.|...+.+|+||||++||+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999875544444566778999999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 001370 774 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851 (1091)
Q Consensus 774 ~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g 851 (1091)
.+++.+.. .+++..+..++.|++.||.|||+.||+||||+|+|||++.++.+||+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 99998765 799999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh----HHHHHHHhh
Q 001370 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 927 (1091)
Q Consensus 852 ~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~----~ei~~kIl~ 927 (1091)
........|+..|+|||++.+..++.++|+|||||++|+|++|+.||..... ..+...+..
T Consensus 148 ---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05577 148 ---------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212 (277)
T ss_pred ---------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc
Confidence 0111234688999999999988899999999999999999999999977654 333333333
Q ss_pred cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc-c-cHHHHHcCCCCCCCCcchhhcc--cCCccC
Q 001370 928 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-N-GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 990 (1091)
Q Consensus 928 ~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa-~-gA~EIL~HPFFkgIdWd~L~~~--~pPfiP 990 (1091)
.... .+..+++++.+||.+||+.||.+||+. + .+.+++.||||+.++|..+... .|||.|
T Consensus 213 ~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 213 MAVE---YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred cccc---CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 3323 336789999999999999999999962 2 4889999999999999887544 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=373.34 Aligned_cols=254 Identities=30% Similarity=0.498 Sum_probs=208.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccC-----
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCR----- 758 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL---~HPNIVkL~gsfqde----- 758 (1091)
+|++++.||+|+||+||+|+++.+|+.||+|.++.... .......+.+|+.++..+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999875322 122223456677776655 799999999988653
Q ss_pred CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
..+|+||||+++ +|.+++.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999985 898888764 34899999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 159 ~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 159 SC----------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cC----------------------------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 10 01112357899999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHhhcC-----CCCC-------------------CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 917 SPEIIFDNILNRK-----IPWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 917 s~~ei~~kIl~~~-----l~fP-------------------~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
+..+...++.... ..+| .....++.++.+||.+||++||.+||+ +.+++.|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~l~hp~ 287 (288)
T cd07863 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS---AFRALQHPF 287 (288)
T ss_pred CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC---HHHHhcCCC
Confidence 7776666554310 0111 011356788999999999999999999 889999999
Q ss_pred C
Q 001370 973 F 973 (1091)
Q Consensus 973 F 973 (1091)
|
T Consensus 288 f 288 (288)
T cd07863 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=392.32 Aligned_cols=261 Identities=31% Similarity=0.503 Sum_probs=218.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----ee
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 761 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded-----~L 761 (1091)
+|++.+.||+|+||+||+|.+..+|+.||||.+.+.. ........+.+|+.+|..++||||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 22334567889999999999999999999998877 79
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-- 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-- 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC--
Confidence 99999997 589998888788999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.++.+
T Consensus 157 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 157 ------------------------ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred ------------------------ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 01111234689999999999874 57999999999999999999999999887766
Q ss_pred HHHHHhh-----------------------cCCCCC------CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCC
Q 001370 921 IFDNILN-----------------------RKIPWP------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971 (1091)
Q Consensus 921 i~~kIl~-----------------------~~l~fP------~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HP 971 (1091)
....|.. .....| .+....++++.+||.+||+.||.+||+ +.++++||
T Consensus 213 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t---~~e~l~hp 289 (372)
T cd07853 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS---AADALAHP 289 (372)
T ss_pred HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC---HHHHhcCH
Confidence 5554432 111111 122456889999999999999999999 88999999
Q ss_pred CCCCCCc
Q 001370 972 FFKGVNW 978 (1091)
Q Consensus 972 FFkgIdW 978 (1091)
||++..+
T Consensus 290 ~~~~~~~ 296 (372)
T cd07853 290 YLDEGRL 296 (372)
T ss_pred hhCCCcc
Confidence 9998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=375.55 Aligned_cols=260 Identities=38% Similarity=0.673 Sum_probs=213.3
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hcCCCceEEEeeeeccCCeeEEEEeecC
Q 001370 693 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI---TVRNPFVVRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILs---kL~HPNIVkL~gsfqded~LYLVMEYm~ 769 (1091)
.||+|+||.||++.+..+|+.||+|++.+...........+.+|..++. ..+||+|+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998754433333344455554443 3479999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001370 770 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 849 (1091)
Q Consensus 770 GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t 849 (1091)
||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~------------ 148 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc------------
Confidence 99999999888889999999999999999999999999999999999999999999999999986311
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHhCCCCCCCCCh---HHHHHHH
Q 001370 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNI 925 (1091)
Q Consensus 850 ~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~---~ei~~kI 925 (1091)
........||+.|+|||++. +..++.++|+|||||++|+|++|..||..... .......
T Consensus 149 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 211 (279)
T cd05633 149 -----------------KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (279)
T ss_pred -----------------ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh
Confidence 00112346999999999986 46689999999999999999999999975432 2222222
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC--cccHHHHHcCCCCCCCCcchhhcc
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ 984 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS--a~gA~EIL~HPFFkgIdWd~L~~~ 984 (1091)
...... ++..++.++.+||.+||..||.+|++ ...+.++++||||++++|......
T Consensus 212 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 269 (279)
T cd05633 212 LTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269 (279)
T ss_pred hcCCcC---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcC
Confidence 222222 34678999999999999999999995 234889999999999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=407.19 Aligned_cols=258 Identities=30% Similarity=0.415 Sum_probs=211.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde---- 758 (1091)
....+|++.+.||+|+||+||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34568999999999999999999999999999999886422 2345799999999999999998876432
Q ss_pred ----CeeEEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEe
Q 001370 759 ----DNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTD 829 (1091)
Q Consensus 759 ----d~LYLVMEYm~GGSL~dlL~----k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsD 829 (1091)
..+|+||||+++ +|.+++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 247899999986 6766664 345799999999999999999999999999999999999999765 699999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHh
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 908 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLT 908 (1091)
||+|+.... .......+||+.|||||++.+ ..|+.++|||||||+||||++
T Consensus 215 FGla~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 266 (440)
T PTZ00036 215 FGSAKNLLA----------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266 (440)
T ss_pred cccchhccC----------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999974210 111234678999999999876 469999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 909 GIPPFTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 909 GkpPF~~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
|.+||.+.+..+.+.++... .+.+|. +|...+.++.+||.+||++||.+||+
T Consensus 267 G~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t-- 344 (440)
T PTZ00036 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN-- 344 (440)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC--
Confidence 99999998876666555431 111221 23457889999999999999999999
Q ss_pred cHHHHHcCCCCCCCCcc
Q 001370 963 GAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 963 gA~EIL~HPFFkgIdWd 979 (1091)
+.++++||||..+...
T Consensus 345 -a~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 345 -PIEALADPFFDDLRDP 360 (440)
T ss_pred -HHHHhCChhHHhhhcc
Confidence 8899999999876543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=362.78 Aligned_cols=260 Identities=31% Similarity=0.503 Sum_probs=224.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~--~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
++|++.+.||.|+||.||+|....+++.||||.+...... .......+.+|+.++.+++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754322 22345678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||||++|++|.+++.+.+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~--- 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--- 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
..........|++.|+|||++.+..++.++|+||||+++|||++|++||...+......
T Consensus 159 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 217 (263)
T cd06625 159 ---------------------SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217 (263)
T ss_pred ---------------------cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence 00011124568899999999999889999999999999999999999998877666655
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+...... +.++..++.++.+||.+||..+|.+||+ +.++++||||
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 263 (263)
T cd06625 218 KIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPS---AEELLRHFFV 263 (263)
T ss_pred HHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCC---HHHHhhCCCC
Confidence 55544333 3355788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=405.02 Aligned_cols=261 Identities=34% Similarity=0.585 Sum_probs=239.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
...=|.+-+.||+|-|+.|.+|++.-||..||||++.|..+. .....++++|++.|+.+.|||||+||.+......+||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 345688899999999999999999999999999999987654 3456789999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec-CCCcEEEEecCCccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+|+-.+|+|++||.++. .+.|+.++.|++||+.||.|+|+..+|||||||+|+.+. .-|-|||+|||++..+
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf----- 169 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF----- 169 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC-----
Confidence 999999999999998875 599999999999999999999999999999999999876 4689999999998642
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC-ccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys-~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.++....+.||+..|-|||+++|..|+ .++||||||||||-|++|++||...+..+
T Consensus 170 -----------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 170 -----------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred -----------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 235566789999999999999999996 68999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
+..+|+..++..| ..+|.+++|||..||.+||.+|.+ +++|..|+|++.++-.
T Consensus 227 TLTmImDCKYtvP---shvS~eCrdLI~sMLvRdPkkRAs---lEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 227 TLTMIMDCKYTVP---SHVSKECRDLIQSMLVRDPKKRAS---LEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhhhhcccccCc---hhhhHHHHHHHHHHHhcCchhhcc---HHHHhccccccCCCCC
Confidence 9999999998877 799999999999999999999998 8899999999987643
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=388.63 Aligned_cols=257 Identities=31% Similarity=0.492 Sum_probs=211.8
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....++|+.++.||+|+||+||+|+++.+|+.||||++.+.. .......+.+|+.+|..++||||++++++|...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 355788999999999999999999999999999999986532 233456789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||+.+|+|... ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~--- 220 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ--- 220 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc---
Confidence 999999999998643 3456778888999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
........+||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 221 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 221 ------------------------TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred ------------------------ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 0011234579999999999843 23457899999999999999999999754
Q ss_pred ChHH---HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 917 SPEI---IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 917 s~~e---i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
...+ ....+.... .+..+..++.++++||.+||..||++||+ +.|+++||||.+.
T Consensus 277 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~ell~hp~~~~~ 334 (353)
T PLN00034 277 RQGDWASLMCAICMSQ--PPEAPATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRA 334 (353)
T ss_pred CCccHHHHHHHHhccC--CCCCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccccC
Confidence 3322 222222111 23334678999999999999999999999 8899999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=379.23 Aligned_cols=258 Identities=33% Similarity=0.543 Sum_probs=222.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|..++.||+|.||.||+|++..||+.||||.++..+.. ..-....++|+..|+.++||||+.|.++|...+++-||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4688899999999999999999999999999999865332 222356789999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||+. ||...++... .|+...++.|+.++++||+|||.+.|+||||||.|+||+.+|.+||+|||||+.+..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~------ 153 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS------ 153 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC------
Confidence 99987 9999997654 599999999999999999999999999999999999999999999999999996421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
+.......+-|.+|.|||.+.| ..|+..+|+||.|||+.||+.|.|-|.+.+.-+...
T Consensus 154 ---------------------p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~ 212 (318)
T KOG0659|consen 154 ---------------------PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS 212 (318)
T ss_pred ---------------------CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence 1111122388999999999987 579999999999999999999999999999888887
Q ss_pred HHhhc-----CCCCCC--------------------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 924 NILNR-----KIPWPC--------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 924 kIl~~-----~l~fP~--------------------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.|+.. .-.||. +....+.++.||+.+||.+||.+|++ |.+.++|+||+.
T Consensus 213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit---a~qaL~~~yf~~ 286 (318)
T KOG0659|consen 213 KIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT---ASQALKHPYFKS 286 (318)
T ss_pred HHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc---HHHHhcchhhhc
Confidence 77651 112222 11345788999999999999999999 889999999985
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=361.87 Aligned_cols=265 Identities=62% Similarity=1.121 Sum_probs=230.5
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001370 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 773 (1091)
Q Consensus 694 LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL 773 (1091)
||.|+||.||+|++..+|+.||+|++.+...........+.+|++++..++||||+++++.+.....+|+||||+++|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999876554556678899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001370 774 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853 (1091)
Q Consensus 774 ~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~l 853 (1091)
.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---------- 150 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN---------- 150 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc----------
Confidence 9999988889999999999999999999999999999999999999999999999999987532110000
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC
Q 001370 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933 (1091)
Q Consensus 854 ps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP 933 (1091)
. ...........+++.|+|||++.+..++.++|+||||+++|+|++|..||......+.+..+..+...+|
T Consensus 151 -----~----~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (265)
T cd05579 151 -----L----NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221 (265)
T ss_pred -----c----ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 0 0001122345689999999999988899999999999999999999999999998888888887666665
Q ss_pred CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 934 ~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
.. ..++..+.+||.+||+.+|.+||++..+.++++||||++++|
T Consensus 222 ~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 222 ED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred cc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 32 235899999999999999999999877799999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=363.20 Aligned_cols=257 Identities=39% Similarity=0.787 Sum_probs=225.4
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001370 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 773 (1091)
Q Consensus 694 LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL 773 (1091)
||.|+||.||+|+...+++.||+|++.+...........+.+|+.++..++||||+++++.+.+...+|+||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999876555555667899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001370 774 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853 (1091)
Q Consensus 774 ~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~l 853 (1091)
.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~--------------- 145 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--------------- 145 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc---------------
Confidence 99998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC--hHHHHHHHhhcCCC
Q 001370 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PEIIFDNILNRKIP 931 (1091)
Q Consensus 854 ps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s--~~ei~~kIl~~~l~ 931 (1091)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ....+..+..+...
T Consensus 146 -------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 212 (262)
T cd05572 146 -------------GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212 (262)
T ss_pred -------------ccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC
Confidence 001234578999999999998889999999999999999999999998776 67777777642222
Q ss_pred CCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcc
Q 001370 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 932 fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd 979 (1091)
+..|...+.++.++|.+||+.||.+||+. ..+.|+++||||++.+|+
T Consensus 213 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 213 -LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 22345668999999999999999999982 458899999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=388.53 Aligned_cols=263 Identities=33% Similarity=0.516 Sum_probs=223.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 759 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d 759 (1091)
.-.+++|+.+..|+.|+||.||+|+++.|++.||+|.++-.. .+..---.-++|+.+|.+++|||||.+-.+.... +
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 456789999999999999999999999999999999987532 1222223468999999999999999998776544 4
Q ss_pred eeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+|||||||+. ||..++.+.+ +|...+++.++.|++.||+|||.+.|+||||||+|+|+...|.+||+|||||+...
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg- 228 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG- 228 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc-
Confidence 69999999988 9999998876 79999999999999999999999999999999999999999999999999999531
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
.........+-|.+|.|||.+++ ..|+..+|+||+|||+.|||+++|-|.+.+
T Consensus 229 --------------------------sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 229 --------------------------SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred --------------------------CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 11223445789999999999998 469999999999999999999999999999
Q ss_pred hHHHHHHHhhc-----CCCCCC--------------CC----------CCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 918 PEIIFDNILNR-----KIPWPC--------------VP----------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 918 ~~ei~~kIl~~-----~l~fP~--------------ip----------~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
..+...+|+.. .-.||. .| ..++....+|+.++|.+||.+|+| |.+.|
T Consensus 283 E~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t---A~~~L 359 (419)
T KOG0663|consen 283 EIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT---AEDGL 359 (419)
T ss_pred hHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc---HHHhh
Confidence 88888888751 111222 11 126789999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001370 969 AHPFFKGV 976 (1091)
Q Consensus 969 ~HPFFkgI 976 (1091)
+|.||...
T Consensus 360 ~h~~F~e~ 367 (419)
T KOG0663|consen 360 KHEYFRET 367 (419)
T ss_pred cccccccC
Confidence 99999863
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=376.78 Aligned_cols=259 Identities=27% Similarity=0.510 Sum_probs=215.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|.+++.||+|+||.||+|+.+.+++.||+|.++.... ......+.+|+.++..++||||+++++++..++.+|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999875332 22334577899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 156 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV----- 156 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC-----
Confidence 999986 8888886654 589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+..
T Consensus 157 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 214 (309)
T cd07872 157 ----------------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214 (309)
T ss_pred ----------------------CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 0011123468999999999875 46899999999999999999999999987765554
Q ss_pred HHHhhc-------------------CCCCCC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 923 DNILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 923 ~kIl~~-------------------~l~fP~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
..+... ...+|. ....++.++++||.+||+.||.+||+ +.|++.||||++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~ 291 (309)
T cd07872 215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS---AEEAMKHAYFRS 291 (309)
T ss_pred HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC---HHHHhcChhhhh
Confidence 444321 011111 11357889999999999999999999 889999999986
Q ss_pred C
Q 001370 976 V 976 (1091)
Q Consensus 976 I 976 (1091)
+
T Consensus 292 ~ 292 (309)
T cd07872 292 L 292 (309)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=396.73 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=210.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
....+|++++.||+|+||.||+|.+..+++.||||.... ..+.+|+++|+.++|||||+++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 445789999999999999999999999999999996532 34678999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+|||++. ++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~---- 234 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD---- 234 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc----
Confidence 9999995 69999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-----
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 917 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s----- 917 (1091)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..||....
T Consensus 235 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~ 292 (391)
T PHA03212 235 ----------------------INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292 (391)
T ss_pred ----------------------ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccccc
Confidence 00112234689999999999999999999999999999999999998875432
Q ss_pred --hHHHHHHHhhc--------------------------CCCCCC-C-----CCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 918 --PEIIFDNILNR--------------------------KIPWPC-V-----PSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 918 --~~ei~~kIl~~--------------------------~l~fP~-i-----p~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
.......++.. ....|. . ...++.++.+||.+||+.||.+||+
T Consensus 293 ~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt--- 369 (391)
T PHA03212 293 CDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS--- 369 (391)
T ss_pred CchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC---
Confidence 11111111110 000000 0 0135678999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 001370 964 AAEVKAHPFFKGV 976 (1091)
Q Consensus 964 A~EIL~HPFFkgI 976 (1091)
|.|+++||||+.+
T Consensus 370 a~elL~hp~f~~~ 382 (391)
T PHA03212 370 AEALLDFAAFQDI 382 (391)
T ss_pred HHHHhcChhhccC
Confidence 8899999999764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=383.16 Aligned_cols=257 Identities=32% Similarity=0.525 Sum_probs=218.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++.+.||.|+||.||++.++.+|..+|+|+++.. ........+.+|+++|..++||||++++++|.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 457899999999999999999999999999999988753 123445678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||++||+|.+++.+.+.+++..+..++.+++.||.|||+. +|+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~----- 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----- 155 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh-----
Confidence 999999999999999888899999999999999999999985 79999999999999999999999999987421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......+.
T Consensus 156 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 211 (333)
T cd06650 156 ------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211 (333)
T ss_pred ------------------------hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 00112357999999999999989999999999999999999999999865543332
Q ss_pred HH--------------------------------------------HhhcCCCCCCCC-CCCCHHHHHHHhhhccCCCCC
Q 001370 923 DN--------------------------------------------ILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQ 957 (1091)
Q Consensus 923 ~k--------------------------------------------Il~~~l~fP~ip-~~lS~eakDLI~rcL~kDPeK 957 (1091)
.. +.+... |.++ ..++.++++||.+||++||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~ 289 (333)
T cd06650 212 LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAE 289 (333)
T ss_pred HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCccc
Confidence 11 111110 1111 246789999999999999999
Q ss_pred CCCcccHHHHHcCCCCCCC
Q 001370 958 RLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 958 RpSa~gA~EIL~HPFFkgI 976 (1091)
||+ +.+++.||||+..
T Consensus 290 Rpt---~~ell~h~~~~~~ 305 (333)
T cd06650 290 RAD---LKQLMVHAFIKRS 305 (333)
T ss_pred CcC---HHHHhhCHHHhcC
Confidence 999 8899999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=381.87 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=207.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSF 755 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsf 755 (1091)
.+..++|++.+.||+|+||.||+|.+ +.+++.||||+++... .......+.+|+.+|..+ +|||||++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45667999999999999999999975 2446789999987532 234557789999999999 899999999988
Q ss_pred ccCC-eeEEEEeecCCCcHHHHHHhc------------------------------------------------------
Q 001370 756 TCRD-NLYLVMEYLNGGDLYSLLRKV------------------------------------------------------ 780 (1091)
Q Consensus 756 qded-~LYLVMEYm~GGSL~dlL~k~------------------------------------------------------ 780 (1091)
...+ .+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7654 589999999999999999752
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCC
Q 001370 781 --------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852 (1091)
Q Consensus 781 --------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~ 852 (1091)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~------------ 228 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------ 228 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc------------
Confidence 237778889999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCC
Q 001370 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIP 931 (1091)
Q Consensus 853 lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~ 931 (1091)
.........+|+.|||||++.+..|+.++|||||||+||||++ |.+||.+....+.+...+.....
T Consensus 229 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 295 (338)
T cd05102 229 -------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295 (338)
T ss_pred -------------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC
Confidence 0011123456789999999999999999999999999999997 99999886644433333332222
Q ss_pred CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 932 fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+..+..+++++.+||.+||..||.+||++.++.+.+
T Consensus 296 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 296 -MRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 223567899999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=401.87 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=206.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC------CceEEEeeeec
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN------PFVVRFFYSFT 756 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H------PNIVkL~gsfq 756 (1091)
...++|++++.||+|+||+||+|.+..+++.||||++++.. .....+..|+.++..+.| ++|++++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34678999999999999999999999999999999997532 123345567777766654 56899998887
Q ss_pred cC-CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCC-----------
Q 001370 757 CR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDG----------- 823 (1091)
Q Consensus 757 de-d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG----------- 823 (1091)
.. ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 65 4689999988 77999999888899999999999999999999998 5999999999999998766
Q ss_pred -----cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeec
Q 001370 824 -----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 898 (1091)
Q Consensus 824 -----~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWS 898 (1091)
.+||+|||++... .......+||+.|||||++.+..|+.++||||
T Consensus 281 ~~~~~~vkl~DfG~~~~~------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 330 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDE------------------------------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330 (467)
T ss_pred CCCCceEEECCCCccccC------------------------------ccccccccCCccccCcHHhhcCCCCcHHHHHH
Confidence 4999999987531 01123568999999999999999999999999
Q ss_pred hhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC------------------------CC---------------CCCC
Q 001370 899 VGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP------------------------CV---------------PSDM 939 (1091)
Q Consensus 899 LGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP------------------------~i---------------p~~l 939 (1091)
|||++|||++|++||.+.+..+....+......+| .. ....
T Consensus 331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (467)
T PTZ00284 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410 (467)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhc
Confidence 99999999999999988776554443322110000 00 0011
Q ss_pred CHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 940 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 940 S~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
++.+.|||.+||++||.+||+ +.|+|+||||...
T Consensus 411 ~~~~~dli~~mL~~dP~~R~t---a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 411 DDLLCDLIYGLLHYDRQKRLN---ARQMTTHPYVLKY 444 (467)
T ss_pred hHHHHHHHHHhCCcChhhCCC---HHHHhcCcccccc
Confidence 456789999999999999999 8899999999753
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.86 Aligned_cols=260 Identities=38% Similarity=0.650 Sum_probs=215.1
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH---HHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001370 693 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI---LITVRNPFVVRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieI---LskL~HPNIVkL~gsfqded~LYLVMEYm~ 769 (1091)
.||+|+||.||+|.+..+++.||+|++.+...........+..|..+ +....||+|+.+++.|...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987544333333334445444 444579999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001370 770 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 849 (1091)
Q Consensus 770 GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t 849 (1091)
||+|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~------------ 148 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC------------
Confidence 99999999888889999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC---ChHHHHHHH
Q 001370 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFDNI 925 (1091)
Q Consensus 850 ~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~---s~~ei~~kI 925 (1091)
.......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||... ........+
T Consensus 149 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 211 (278)
T cd05606 149 -----------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (278)
T ss_pred -----------------ccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh
Confidence 001123579999999999975 46899999999999999999999999876 333333333
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ 984 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~ 984 (1091)
......+ +..++.++.++|.+||..+|.+||... .+.++++||||++++|+.+...
T Consensus 212 ~~~~~~~---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 212 LTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred hccCCCC---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 3333333 356799999999999999999999422 4889999999999999987655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=383.65 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=212.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
..++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||+++++.|....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4679999999999999999999999999999999987532 23344567889999999999999999998876543
Q ss_pred --eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+++ +|..++.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 57999999976 77777753 48889999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 178 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 178 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred C----------------------------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 0 011234579999999999999999999999999999999999999999887
Q ss_pred hHHHHHHHhhcCC----------------------CC--------------C---CCCCCCCHHHHHHHhhhccCCCCCC
Q 001370 918 PEIIFDNILNRKI----------------------PW--------------P---CVPSDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 918 ~~ei~~kIl~~~l----------------------~f--------------P---~ip~~lS~eakDLI~rcL~kDPeKR 958 (1091)
..+.+..++..-. .+ + ......+.++++||.+||+.||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 230 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 7666655543100 00 0 0011235678999999999999999
Q ss_pred CCcccHHHHHcCCCCCC
Q 001370 959 LGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkg 975 (1091)
|| +.++++||||..
T Consensus 310 ~t---~~e~L~hp~~~~ 323 (364)
T cd07875 310 IS---VDEALQHPYINV 323 (364)
T ss_pred CC---HHHHhcCccccc
Confidence 99 889999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=383.10 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=210.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
..++|++++.||+|+||.||+|.++.+|+.||+|++.+.. ........+.+|+.++..++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4689999999999999999999999999999999997542 23345567889999999999999999999987554
Q ss_pred --eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 47999999976 5666654 348899999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. ........||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+
T Consensus 175 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 175 T----------------------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred c----------------------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 0 011234578999999999999999999999999999999999999998776
Q ss_pred hHHHHHHHhh----------------------cCCCCCC-----------------CCCCCCHHHHHHHhhhccCCCCCC
Q 001370 918 PEIIFDNILN----------------------RKIPWPC-----------------VPSDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 918 ~~ei~~kIl~----------------------~~l~fP~-----------------ip~~lS~eakDLI~rcL~kDPeKR 958 (1091)
....+..+.. ....++. .....+.++++||.+||+.||.+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 227 HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 5443322221 1111110 112246789999999999999999
Q ss_pred CCcccHHHHHcCCCCCC
Q 001370 959 LGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkg 975 (1091)
|| +.|+++||||..
T Consensus 307 ~t---~~e~l~hp~~~~ 320 (359)
T cd07876 307 IS---VDEALRHPYITV 320 (359)
T ss_pred CC---HHHHhcCchhhh
Confidence 99 889999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=368.08 Aligned_cols=269 Identities=33% Similarity=0.572 Sum_probs=228.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...+.|++++.||.|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++.+.....+|
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 3446799999999999999999999999999999998753 3445677889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
+||||++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--- 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--- 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc---
Confidence 99999999999888765 45689999999999999999999999999999999999999999999999998863210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.........|++.|+|||++. ...++.++|||||||++|||++|.+||...
T Consensus 163 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 163 ------------------------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ------------------------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 011122456899999999985 345788999999999999999999999888
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 984 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~ 984 (1091)
+....+.++.....+....+..++.++.+||.+||..||++||+ +.++++||||..++|......
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~~~ 283 (292)
T cd06644 219 NPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS---AAQLLEHPFVSSVTSNRPLRE 283 (292)
T ss_pred cHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccccchhHHH
Confidence 77776666655443322234678899999999999999999999 889999999999999875433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=354.47 Aligned_cols=254 Identities=28% Similarity=0.534 Sum_probs=220.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-CeeEEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVM 765 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde-d~LYLVM 765 (1091)
+|++++.||+|+||.||+++++.+++.||+|.+.... ........+.+|+.++++++||||+++++.+... ..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999987533 2334566788999999999999999999988754 4689999
Q ss_pred eecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 766 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||+++++|.+++... ..+++..+..++.+++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~----- 154 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN----- 154 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc-----
Confidence 999999999999763 4589999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
.........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 155 ----------------------QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred ----------------------cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0011224568999999999999999999999999999999999999999888777776
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+..+.. +..+..+++++.+||.+||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKL--PPMPKDYSPELGELIATMLSKRPEKRPS---VKSILRQPYI 257 (257)
T ss_pred HHHhcCC--CCCccccCHHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 7666544 3345778999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=388.82 Aligned_cols=261 Identities=33% Similarity=0.540 Sum_probs=219.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----CCe
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-----RDN 760 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd-----ed~ 760 (1091)
..|..++.||+|+||.|+.+.++.||+.||||.+.. .+...-..++..+|+.+|+.++|+||+.+++.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456668999999999999999999999999998864 24455677899999999999999999999999876 345
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+|+|+|. -||...++....|+++.++++++||+.||.|+|+.||+||||||.|+|++.+..+||+|||||+.....
T Consensus 101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 999999995 499999988878999999999999999999999999999999999999999999999999999953110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.........+.|.+|.|||++.. ..|+..+||||+|||+.|||+|++-|.|.+.-
T Consensus 179 ------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v 234 (359)
T KOG0660|consen 179 ------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV 234 (359)
T ss_pred ------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH
Confidence 01122245688999999999864 78999999999999999999999999998755
Q ss_pred HHHHHHhh-----------------------c-----CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCC
Q 001370 920 IIFDNILN-----------------------R-----KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971 (1091)
Q Consensus 920 ei~~kIl~-----------------------~-----~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HP 971 (1091)
.....|+. . +.+|..+.+..++.+.||+.+||..||.+|+| |+|.|+||
T Consensus 235 ~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit---a~eAL~hP 311 (359)
T KOG0660|consen 235 HQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT---AEEALAHP 311 (359)
T ss_pred HHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC---HHHHhcCh
Confidence 54444432 0 11122233578999999999999999999999 88999999
Q ss_pred CCCCC
Q 001370 972 FFKGV 976 (1091)
Q Consensus 972 FFkgI 976 (1091)
||...
T Consensus 312 Yl~~~ 316 (359)
T KOG0660|consen 312 YLAPY 316 (359)
T ss_pred hhhhh
Confidence 99764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=380.63 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=211.5
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 758 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde------ 758 (1091)
.++|++++.||+|+||+||+|.+..+++.||||++.+.. ........+.+|+.+|+.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 468999999999999999999999999999999987532 2223456678999999999999999999988644
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
...|++|+++ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~- 169 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD- 169 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC-
Confidence 3479999988 779988775 4569999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+
T Consensus 170 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 170 -----------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred -----------------------------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 01124579999999999987 568999999999999999999999998876
Q ss_pred hHHHHHHHhhcCC--------------------CCCC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 918 PEIIFDNILNRKI--------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 918 ~~ei~~kIl~~~l--------------------~fP~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..+....+..... .++. .....++.+.+||.+||..||.+||+ +.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s---~~ell~ 297 (343)
T cd07878 221 YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS---ASEALA 297 (343)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC---HHHHhc
Confidence 6555444432100 0011 11245678899999999999999999 889999
Q ss_pred CCCCCCC
Q 001370 970 HPFFKGV 976 (1091)
Q Consensus 970 HPFFkgI 976 (1091)
||||...
T Consensus 298 hp~~~~~ 304 (343)
T cd07878 298 HPYFSQY 304 (343)
T ss_pred Ccchhcc
Confidence 9999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=352.64 Aligned_cols=254 Identities=30% Similarity=0.529 Sum_probs=223.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58999999999999999999999999999999875433 34456788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|++|++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~------ 153 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD------ 153 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC------
Confidence 99999999999764 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......
T Consensus 154 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 154 ---------------------NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred ---------------------ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01111245689999999999999999999999999999999999999998888777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+..+.. +.++..++.++.++|.+||+.+|++||+ +.+++.|||+
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPD---TFQLLRNPSL 256 (256)
T ss_pred HHcCCC--CCCccccCHHHHHHHHHHccCCcccCcC---HHHHhhCCCC
Confidence 766543 3344578899999999999999999999 8899999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=405.61 Aligned_cols=258 Identities=30% Similarity=0.503 Sum_probs=229.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
...|..+..||+|+||.||+|.+..|++.||+|++.-.. .+.+++.+.+|+.+|.+++++||.++|++|.....++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 345788899999999999999999999999999997533 356788999999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||||.||++.++|.....+.+..+..++++++.||.|||..+.||||||+.|||+..+|.+||+|||.+....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~------- 162 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT------- 162 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee-------
Confidence 9999999999999887778999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.......+++|||.||||||+.+.+|+.++||||||++.|||++|.|||....+......
T Consensus 163 --------------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl 222 (467)
T KOG0201|consen 163 --------------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL 222 (467)
T ss_pred --------------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe
Confidence 112334789999999999999999999999999999999999999999999888444433
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
|-+.. .|.+...+|+.+++||..||.+||+.||+ |.++|+|+|.+..
T Consensus 223 Ipk~~--PP~L~~~~S~~~kEFV~~CL~k~P~~Rps---A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 223 IPKSA--PPRLDGDFSPPFKEFVEACLDKNPEFRPS---AKELLKHKFIKRA 269 (467)
T ss_pred ccCCC--CCccccccCHHHHHHHHHHhhcCcccCcC---HHHHhhhHHHHhc
Confidence 43332 35556789999999999999999999999 8999999999874
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=361.11 Aligned_cols=255 Identities=38% Similarity=0.663 Sum_probs=215.6
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
|++.+.||+|+||+||+++...+++.||+|++....... .......+|+.++.+++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 789999999999999999999999999999998754332 2233445699999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCC
Q 001370 768 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 847 (1091)
Q Consensus 768 m~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~ 847 (1091)
+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---------- 149 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS---------- 149 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 9999999999988899999999999999999999999999999999999999999999999999987420
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHhCCCCCCCCC---hHHHHH
Q 001370 848 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAES---PEIIFD 923 (1091)
Q Consensus 848 ~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s---~~ei~~ 923 (1091)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||.... ......
T Consensus 150 -----------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 150 -----------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp -----------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred -----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 1112334567899999999998 7889999999999999999999999999873 333444
Q ss_pred HHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+........+. .....+.++.+||.+||+.||++||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~l~~~~~~ 260 (260)
T PF00069_consen 213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS---AEELLKHPWF 260 (260)
T ss_dssp HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT---HHHHHTSGGG
T ss_pred hcccccccccccccchhHHHHHHHHHHHccCChhHCcC---HHHHhcCCCC
Confidence 33332211110 01123489999999999999999999 8899999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=358.40 Aligned_cols=262 Identities=27% Similarity=0.465 Sum_probs=221.9
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc---ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~---i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
+|++.+.||+|+||+||+|.. .+|+.+|+|.++... .........+.+|+++|+.++|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 578899999999999999986 478999999886432 1223445678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||||++||+|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.+|.+||+|||++.........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 158 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH- 158 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998743110000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
...........||+.|+|||++.+..++.++|+|||||++|+|++|..||...+......
T Consensus 159 --------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 218 (265)
T cd06631 159 --------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218 (265)
T ss_pred --------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH
Confidence 000111234569999999999999999999999999999999999999998776655555
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+.......|.++..++.++.+||.+||..+|.+||+ +.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~ 265 (265)
T cd06631 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS---ALQLLRHDFL 265 (265)
T ss_pred HhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 5554434455566789999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=364.98 Aligned_cols=274 Identities=46% Similarity=0.847 Sum_probs=229.2
Q ss_pred CeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001370 687 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~~-~~eie~~l~EieILskL-~HPNIVkL~gsfqded~L 761 (1091)
+|++.+.||+|+||.||+++.. .+++.||||++++..... .....++.+|+.++..+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 467899999998644322 23456788999999999 599999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998742110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC--CCccceeechhhhHHHHHhCCCCCCCCC--
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES-- 917 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--Ys~ksDIWSLGVILYEMLTGkpPF~~~s-- 917 (1091)
.........|++.|+|||.+.+.. ++.++|+||||+++|||++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 159 ------------------------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred ------------------------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 011122456899999999987654 7889999999999999999999996433
Q ss_pred --hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc--cCCcc
Q 001370 918 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFV 989 (1091)
Q Consensus 918 --~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~--~pPfi 989 (1091)
..++...+.....+. +..++.++.+||.+||+.||++||++.++.++++||||+.++|+.+... .++|.
T Consensus 215 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 287 (288)
T cd05583 215 NSQSEISRRILKSKPPF---PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFK 287 (288)
T ss_pred chHHHHHHHHHccCCCC---CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhhccCCCCC
Confidence 234444444444333 4678899999999999999999999989999999999999999988665 34444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=398.55 Aligned_cols=259 Identities=29% Similarity=0.406 Sum_probs=224.5
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~T-Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
...|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+|..++|||||+++++|...+.+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998877 788999976432 33455678889999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 764 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999988753 346899999999999999999999999999999999999999999999999999752100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 223 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 223 -------------------------VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred -------------------------cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0011234568999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+++..+..+... ..+..++.++.+||.+||..||++||+ +.+++.|||++.+
T Consensus 278 ~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~~~~~~~~ 329 (478)
T PTZ00267 278 EIMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRPT---TQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCcC---HHHHHhCHHHHHH
Confidence 888888776543 234678999999999999999999999 8899999999643
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=367.86 Aligned_cols=261 Identities=27% Similarity=0.503 Sum_probs=216.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++++.||.|+||.||+|+++.+++.||+|.++.... ......+.+|+.++..++||||+++++++...+.+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 46789999999999999999999999999999999875322 2234567789999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||++ ++|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---- 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI---- 156 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC----
Confidence 999997 4898888764 4689999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.........+++.|+|||++.+ ..++.++|||||||++|||++|++||...+..+.
T Consensus 157 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~ 213 (301)
T cd07873 157 -----------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213 (301)
T ss_pred -----------------------CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0011123467899999999876 4578899999999999999999999998876655
Q ss_pred HHHHhhc-------------------CCCCCC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 922 FDNILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 922 ~~kIl~~-------------------~l~fP~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
...+... ...+|. ....+++++++||.+||+.||.+||+ +.++++||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~eil~h~~f~ 290 (301)
T cd07873 214 LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS---AEEAMKHPYFH 290 (301)
T ss_pred HHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC---HHHHhcCcccc
Confidence 5443321 001111 11357889999999999999999999 88999999998
Q ss_pred CCC
Q 001370 975 GVN 977 (1091)
Q Consensus 975 gId 977 (1091)
.+.
T Consensus 291 ~~~ 293 (301)
T cd07873 291 CLG 293 (301)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=379.36 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=210.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
..++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4679999999999999999999999999999999987532 23344567889999999999999999999886543
Q ss_pred --eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+.+ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 47999999976 67666653 48899999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. .......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+
T Consensus 171 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 171 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred C----------------------------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0 011234579999999999999999999999999999999999999998877
Q ss_pred hHHHHHHHhhc----------------------CC-----CCCC------------CCCCCCHHHHHHHhhhccCCCCCC
Q 001370 918 PEIIFDNILNR----------------------KI-----PWPC------------VPSDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 918 ~~ei~~kIl~~----------------------~l-----~fP~------------ip~~lS~eakDLI~rcL~kDPeKR 958 (1091)
..+.+..++.. .. .+|. .+...+.++++||.+||..||.+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 302 (355)
T cd07874 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhc
Confidence 54443332211 00 0000 112245688999999999999999
Q ss_pred CCcccHHHHHcCCCCCC
Q 001370 959 LGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkg 975 (1091)
|+ +.++++||||..
T Consensus 303 ps---~~ell~hp~~~~ 316 (355)
T cd07874 303 IS---VDEALQHPYINV 316 (355)
T ss_pred CC---HHHHhcCcchhc
Confidence 99 889999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=400.58 Aligned_cols=264 Identities=29% Similarity=0.478 Sum_probs=227.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-- 759 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded-- 759 (1091)
....++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++|+||++++..|...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3456799999999999999999999999999999999976433 3456677889999999999999999988775432
Q ss_pred ------eeEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEe
Q 001370 760 ------NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 829 (1091)
Q Consensus 760 ------~LYLVMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsD 829 (1091)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||||+.+|++||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 378999999999999998643 4689999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
||+++..... .........+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 187 FGls~~~~~~-------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 187 FGFSKMYAAT-------------------------VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred cccCeecccc-------------------------ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9998752100 001122356899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+.||.+.+..+++..+..+... .++..+++++.+||.+||+.||.+||+ +.++++|||++..
T Consensus 242 ~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs---~~ell~~p~~~~~ 303 (496)
T PTZ00283 242 KRPFDGENMEEVMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPS---SSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHhCHHHHHh
Confidence 9999999988888888776543 245789999999999999999999999 8899999998753
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=363.48 Aligned_cols=260 Identities=33% Similarity=0.576 Sum_probs=224.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++++.||.|+||.||+|.+..++..||+|+++.. .......+.+|+.++++++||||+++++.+.....+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 46799999999999999999999989999999998643 344567888999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+++|+|.+++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~----- 155 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS----- 155 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc-----
Confidence 9999999999998764 4699999999999999999999999999999999999999999999999998764210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.........||+.|+|||++. ...++.++|+|||||++|||++|++||...+.
T Consensus 156 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 156 ----------------------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred ----------------------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 011123457999999999985 34567899999999999999999999998887
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
......+.....+....+..++.++.+||.+||+.+|.+||+ +.++++||||....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~ 269 (280)
T cd06611 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT---AAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC---HHHHhcChhhcccc
Confidence 777777766543332334678999999999999999999999 88999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=357.89 Aligned_cols=255 Identities=40% Similarity=0.739 Sum_probs=222.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||.|+||.||+|++..+++.||+|++.+...........+.+|++++++++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665555667889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|+.|++|..++.+...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~-------- 152 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-------- 152 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC--------
Confidence 999999999998877899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh---HHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFD 923 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~---~ei~~ 923 (1091)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ..+..
T Consensus 153 --------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (258)
T cd05578 153 --------------------DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212 (258)
T ss_pred --------------------CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 0011235688999999999988899999999999999999999999988774 33333
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
...... +..+..++.++.++|.+||..||.+||+.. ..|+++||||
T Consensus 213 ~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 213 KQETAD---VLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred Hhcccc---ccCcccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 322222 334467899999999999999999999943 4899999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=355.99 Aligned_cols=261 Identities=31% Similarity=0.524 Sum_probs=221.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~------~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
.|.+...||.|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.++..++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999999899999999887543221 2334678899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987532100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
. ............|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 161 ~---------------------~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 219 (267)
T cd06628 161 L---------------------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219 (267)
T ss_pred c---------------------cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence 0 0000111234568999999999999889999999999999999999999998876655
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
....+... ..|.++..++.++.++|.+||+.||.+||+ +.++++||||
T Consensus 220 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 267 (267)
T cd06628 220 AIFKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRPT---AAELLKHPFL 267 (267)
T ss_pred HHHHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCcC---HHHHhhCCCC
Confidence 55554442 234455778999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=361.19 Aligned_cols=257 Identities=32% Similarity=0.500 Sum_probs=216.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.++..++||||+++++++...+.+|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999987532 234456788999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~---- 158 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA---- 158 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC----
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999864210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.........||+.|+|||++. ...++.++|+|||||++|+|++|.+||....+.
T Consensus 159 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 159 -----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred -----------------------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence 001123457999999999985 456889999999999999999999999776654
Q ss_pred HHHHHHhhcCCCCCCC--CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 920 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~i--p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
.....+.......+.. ...++..+.+||.+||..||++||+ +.+++.|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~ll~~~~ 267 (267)
T cd06645 216 RALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT---AEKLLQHPF 267 (267)
T ss_pred hhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC---HHHHhcCCC
Confidence 4433333333322221 1257789999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.20 Aligned_cols=260 Identities=32% Similarity=0.538 Sum_probs=221.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||.|+||+||+|....++..+|+|++...... .....+.+|+.+|+.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 5799999999999999999999989999999998754332 25678999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 766 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~---g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~- 157 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD- 157 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc-
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999875321000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.........+|++.|+|||++... .++.++|+|||||++|+|++|+.||...+....
T Consensus 158 ----------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 215 (267)
T cd06610 158 ----------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215 (267)
T ss_pred ----------------------ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh
Confidence 000122446799999999999876 789999999999999999999999998877766
Q ss_pred HHHHhhcCC-CCCCCC--CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 922 FDNILNRKI-PWPCVP--SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 922 ~~kIl~~~l-~fP~ip--~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+..+..... .++... ..++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~ll~~p~~ 267 (267)
T cd06610 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267 (267)
T ss_pred HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC---HHHHhhCCCC
Confidence 666655432 122111 367899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=362.09 Aligned_cols=256 Identities=33% Similarity=0.556 Sum_probs=219.6
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
|++.+.||.|+||.||+|++..++..+|+|.+... .......+.+|+.++..++||||+++++.|...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 68889999999999999999999999999998643 234567788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 768 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 768 m~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
+++|+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~-------- 155 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-------- 155 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--------
Confidence 999999988765 45699999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.........||+.|+|||++. +..++.++|||||||++|||++|.+||...+....
T Consensus 156 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 216 (282)
T cd06643 156 -------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216 (282)
T ss_pred -------------------cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence 001123456899999999984 35578899999999999999999999998887777
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
...+.....+....+..++.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 268 (282)
T cd06643 217 LLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT---TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCCCEecc
Confidence 666655443322335678899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=368.56 Aligned_cols=256 Identities=31% Similarity=0.514 Sum_probs=216.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||+|+||.||++++..+|..||+|.++.. ........+.+|++++.+++||||++++++|.+.+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 4799999999999999999999999999999998642 22344567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ .+|+||||||+|||++.+|.+||+|||++....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------- 151 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------- 151 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc-------
Confidence 999999999999988889999999999999999999997 599999999999999999999999999886321
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 209 (308)
T cd06615 152 ----------------------DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209 (308)
T ss_pred ----------------------ccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh
Confidence 0011345799999999999888899999999999999999999999976654433322
Q ss_pred HhhcCC----------------------------------CCCCCC-CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 925 ILNRKI----------------------------------PWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 925 Il~~~l----------------------------------~fP~ip-~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+..... ..|..+ ..++.++++||.+||..||++||+ +.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~ 286 (308)
T cd06615 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD---LKELTK 286 (308)
T ss_pred hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC---HHHHhc
Confidence 211000 001111 236789999999999999999999 889999
Q ss_pred CCCCCC
Q 001370 970 HPFFKG 975 (1091)
Q Consensus 970 HPFFkg 975 (1091)
||||.+
T Consensus 287 ~~~~~~ 292 (308)
T cd06615 287 HPFIKR 292 (308)
T ss_pred Chhhhh
Confidence 999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=367.06 Aligned_cols=242 Identities=20% Similarity=0.229 Sum_probs=209.5
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCeeEEEEee
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYLVMEY 767 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd----ed~LYLVMEY 767 (1091)
..||.|++|.||+|.. +|+.||||++++.........+.+.+|+.+|.+++|||||++++++.+ ...+|+||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999987 589999999987544444446788899999999999999999999877 3578999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 768 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 768 m~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
++||+|.+++.+...+++.....++.+++.||.|||+. +++||||||+|||++.+|.+||+|||+++...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~--------- 174 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS--------- 174 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc---------
Confidence 99999999999888899999999999999999999984 99999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+++..
T Consensus 175 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~ 233 (283)
T PHA02988 175 ---------------------SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233 (283)
T ss_pred ---------------------cccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 00123568999999999976 6899999999999999999999999999998888888
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
+......++ ++...+.++++||.+||+.||.+||++.++.+
T Consensus 234 i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 234 IINKNNSLK-LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHhcCCCCC-CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 876654433 44578999999999999999999999544433
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=357.56 Aligned_cols=257 Identities=29% Similarity=0.474 Sum_probs=216.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++.+.||+|+||.||+|+.+.+|+.||+|++.... ......+.+|+.++..++||||+++++++...+.+|
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 34568999999999999999999999999999999986432 234456889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~---- 158 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA---- 158 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc----
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.........|++.|+|||.+. ...++.++|+|||||++|||++|.+||....+.
T Consensus 159 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 159 -----------------------TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred -----------------------cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 001122456899999999985 345788999999999999999999999776655
Q ss_pred HHHHHHhhcCCCCCCC--CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 920 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~i--p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
.....+.......+.. ...++..+.+||++||+.||++||+ +.++++|+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~l~ 267 (267)
T cd06646 216 RALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT---AERLLTHLF 267 (267)
T ss_pred hhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC---HHHHhcCCC
Confidence 4443333333322221 2357889999999999999999999 889999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.42 Aligned_cols=269 Identities=43% Similarity=0.820 Sum_probs=225.1
Q ss_pred CeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001370 687 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~-~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~L 761 (1091)
+|++.+.||.|+||.||+|+.. .+|+.||+|++++.... .....+++.+|+.+|..+ +||||++++++|.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999874 47899999999764332 223456788999999999 599999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||+++|+|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-- 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCC--
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES-- 917 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s-- 917 (1091)
.........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 159 ------------------------EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred ------------------------cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 0111234679999999999875 357889999999999999999999997543
Q ss_pred --hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc
Q 001370 918 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 984 (1091)
Q Consensus 918 --~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~ 984 (1091)
...+...+.....++ +..+++.+.+|+.+||..||.+||+. ..+.+++.||||..++|+.+...
T Consensus 215 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 282 (290)
T cd05613 215 NSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAK 282 (290)
T ss_pred ccHHHHHHHhhccCCCC---CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhc
Confidence 344444444444443 36789999999999999999999963 36899999999999999887543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=360.63 Aligned_cols=252 Identities=28% Similarity=0.478 Sum_probs=212.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||.||+|.+..+++.||+|++.+.. .......+.+|+.++.+++||||+++++.|...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 47899999999999999999999999999999987532 2344567899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||+++|+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.+||+|||++....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~-------- 146 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-------- 146 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc--------
Confidence 99999998654 357889999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh-------
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP------- 918 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~------- 918 (1091)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 147 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 205 (279)
T cd06619 147 ---------------------NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205 (279)
T ss_pred ---------------------cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch
Confidence 0112245799999999999999999999999999999999999999975321
Q ss_pred HHHHHHHhhcCC-CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 919 EIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 919 ~ei~~kIl~~~l-~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
......+..... ..+ ....++++.+||.+||+.||.+||+ +.+++.||||...+
T Consensus 206 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~---~~eil~~~~~~~~~ 260 (279)
T cd06619 206 LQLLQCIVDEDPPVLP--VGQFSEKFVHFITQCMRKQPKERPA---PENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHhccCCCCCC--CCcCCHHHHHHHHHHhhCChhhCCC---HHHHhcCccccccc
Confidence 223333332221 111 2457889999999999999999999 88999999998664
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.41 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=209.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||.|+||.||+|+++.+|..||||+++... ........+.+|+.++..++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999986532 222334678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 767 YLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~---g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 153 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI----- 153 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC-----
Confidence 997 5898888643 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.........|++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.....
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 154 ----------------------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred ----------------------CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 0011123467899999999875 45789999999999999999999999877654333
Q ss_pred HHHhhcC------------------CCCC--------CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 923 DNILNRK------------------IPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 923 ~kIl~~~------------------l~fP--------~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..+.... ..++ .....+++++++||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~ll~~~~~ 285 (285)
T cd07861 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS---AKKALNHPYF 285 (285)
T ss_pred HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC---HHHHhcCCCC
Confidence 2221100 0000 012357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.85 Aligned_cols=268 Identities=23% Similarity=0.355 Sum_probs=220.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq 756 (1091)
.+..++|++.+.||+|+||.||+|..+. .+..||+|.++... .......+.+|+.++..++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567899999999999999999997653 34589999886532 2233456889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEE
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g----------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 826 (1091)
+....|+||||+++|+|.+++.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999997532 245677888999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEM 906 (1091)
|+|||+++...... .........++..|+|||.+.+..++.++|+|||||++|||
T Consensus 160 L~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 160 IGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred ECcCCccccccccc-------------------------cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 99999987421000 00011223467889999999988999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc---CCCCCCCCc
Q 001370 907 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKGVNW 978 (1091)
Q Consensus 907 LT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~---HPFFkgIdW 978 (1091)
++ |.+||.+....+....+..+.. +..+...++.++++|.+||+.||.+||++.++.+.+. ||||++++|
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 98 8999998888887777765533 2234677899999999999999999999655544433 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=379.90 Aligned_cols=261 Identities=31% Similarity=0.536 Sum_probs=221.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCC----
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRD---- 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN-IVkL~gsfqded---- 759 (1091)
...|+.++.||.|+||+||+|+.+.+|+.||+|+++-... .+.--....+|+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 4568888899999999999999999999999999874322 1223345689999999999999 999999999988
Q ss_pred --eeEEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g----~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
.+|+||||+.. +|..++.... .++...++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999976 9999998765 5788899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
+... .+.......++|.+|.|||++.+. .|+..+||||+|||++||+++++-
T Consensus 168 ra~~---------------------------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFS---------------------------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhc---------------------------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 8421 012223457899999999999986 799999999999999999999999
Q ss_pred CCCCChHHHHHHHhh-----cCCCCCC-------------CC---------CCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 913 FTAESPEIIFDNILN-----RKIPWPC-------------VP---------SDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~-----~~l~fP~-------------ip---------~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
|.+.+..+...+|.. ....||. .+ +..++++.||+.+||+++|.+|++ |.
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S---a~ 297 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS---AK 297 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC---HH
Confidence 999998888777765 1122322 11 233468999999999999999999 88
Q ss_pred HHHcCCCCCCCC
Q 001370 966 EVKAHPFFKGVN 977 (1091)
Q Consensus 966 EIL~HPFFkgId 977 (1091)
.++.||||....
T Consensus 298 ~al~h~yf~~~~ 309 (323)
T KOG0594|consen 298 GALTHPYFSELP 309 (323)
T ss_pred HHhcChhhcccc
Confidence 899999998763
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=383.68 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=215.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~--TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
..+|++++.||.|+||.||+|.... ++..||+|.+.+. ....+|+.+|..++|||||+++++|.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 4579999999999999999997643 4678999987652 23457999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||+. ++|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.....
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~--- 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH--- 238 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc---
Confidence 9999996 589999977788999999999999999999999999999999999999999999999999998742110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh---H
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---E 919 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~---~ 919 (1091)
.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+... .
T Consensus 239 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 296 (392)
T PHA03207 239 ----------------------PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296 (392)
T ss_pred ----------------------cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence 001122356899999999999999999999999999999999999999976542 1
Q ss_pred HHHHHHhh----cCCCCCC----------------------C-----CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILN----RKIPWPC----------------------V-----PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~----~~l~fP~----------------------i-----p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
..+..++. ....+|. . ...++.++++||.+||+.||++||+ +.+++
T Consensus 297 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps---a~e~l 373 (392)
T PHA03207 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS---AQDIL 373 (392)
T ss_pred HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC---HHHHh
Confidence 22222221 0101110 0 1235678999999999999999999 88999
Q ss_pred cCCCCCCCCcchhhc
Q 001370 969 AHPFFKGVNWDSLAL 983 (1091)
Q Consensus 969 ~HPFFkgIdWd~L~~ 983 (1091)
.||||....|+.+..
T Consensus 374 ~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 374 SLPLFTKEPINLLNI 388 (392)
T ss_pred hCchhhccchhhhcC
Confidence 999999998887753
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.19 Aligned_cols=262 Identities=29% Similarity=0.499 Sum_probs=218.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR---KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~---~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
+|+..+.||+|+||.||+|....+++.||+|++....... ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987533211 2245788999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||++|++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~-- 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG-- 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc--
Confidence 999999999999998888899999999999999999999999999999999999998876 59999999987421000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
...........||..|+|||++.+..++.++|+|||||++|+|++|..||.........
T Consensus 159 ---------------------~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 159 ---------------------TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred ---------------------ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 00011122356899999999999889999999999999999999999999765433333
Q ss_pred HHHhh--cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 923 DNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 923 ~kIl~--~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
..+.. .....+.++..+++++.++|.+||..+|.+||+ +.++++||||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~ll~~~~~~ 268 (268)
T cd06630 218 ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP---SRELLKHPVFR 268 (268)
T ss_pred HHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC---HHHHhcCcccC
Confidence 32222 111224455678999999999999999999999 88999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.43 Aligned_cols=260 Identities=29% Similarity=0.483 Sum_probs=219.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 761 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~--i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~L 761 (1091)
.+|++.+.||+|+||.||+|.+..+|+.||||.+.... .........+.+|+.++..++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 58999999999999999999999999999999886422 12234567889999999999999999999998764 468
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~- 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC- 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
..........||..|+|||++.+..++.++|||||||++|||++|++||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 161 -----------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred -----------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 000112335699999999999988899999999999999999999999988766655
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
...+.... ..+..+..++..+.++|.+||. +|++||+ +.++++|||++
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~---~~~il~~~~~~ 265 (265)
T cd06652 218 IFKIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPS---ADELLRHTFVH 265 (265)
T ss_pred HHHHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCC---HHHHhcCcccC
Confidence 55544332 2344567788999999999996 9999999 88999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=394.21 Aligned_cols=257 Identities=31% Similarity=0.539 Sum_probs=234.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe-eEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYL 763 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~-LYL 763 (1091)
.++|..++.||+|+||.+++++++..++.|++|.+.-.... ....+...+|+.+++++.|||||.+++.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57899999999999999999999999999999999765443 3345578999999999999999999999999998 999
Q ss_pred EEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||+||+||+|.+.+.+.. .|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|||.|||+|+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~---- 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN---- 157 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC----
Confidence 999999999999997654 59999999999999999999999999999999999999999999999999999631
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.....+.+.+|||.||.||++.+.+|+.++|||||||++|||++-+++|.+.+...+
T Consensus 158 -----------------------~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 158 -----------------------PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred -----------------------CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 112356788999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
..+|.+..+ ..+|...+.+++.||+.||.++|..||+ |.++|.+|...
T Consensus 215 i~ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPs---a~~LL~~P~l~ 262 (426)
T KOG0589|consen 215 ILKINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPS---ALELLRRPHLL 262 (426)
T ss_pred HHHHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCC---HHHHhhChhhh
Confidence 999998873 3356899999999999999999999999 88999998876
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.94 Aligned_cols=254 Identities=31% Similarity=0.568 Sum_probs=218.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||.|+||.||+|.++.+++.||+|.++... ....+.+|+++++.++||||+++++.+.+...+|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 368999999999999999999999989999999986532 267899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~----- 151 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD----- 151 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc-----
Confidence 999999999999975 35689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
.........|+..|+|||++.+..++.++|||||||++|+|++|++||...++.....
T Consensus 152 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 152 ----------------------TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred ----------------------CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 0011233558999999999999999999999999999999999999998877655554
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+..........+..++.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~il~~~~~ 256 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS---AIQLLQHPFI 256 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC---HHHHhcCCCC
Confidence 4433322222223567889999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=353.82 Aligned_cols=260 Identities=30% Similarity=0.489 Sum_probs=218.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 761 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i--~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~L 761 (1091)
.+|+..+.||+|+||.||+|.+..+|..||+|+++.... ........+.+|+.++..++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999875332 1234566789999999999999999999988763 578
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|++|||+++++|.+++.+.+.+++.....++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~- 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC- 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
..........|+..|+|||++.+..++.++|+|||||++|||++|.+||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 161 -----------------------MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred -----------------------ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 000111235689999999999998899999999999999999999999987766555
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
...+.... ..|.++..+++.+++|| +||..+|++||+ +.+++.||||+
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~---~~eil~hp~~~ 265 (266)
T cd06651 218 IFKIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPS---AEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcC---HHHHhcCcccc
Confidence 55443322 22445577889999999 577789999999 88999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.35 Aligned_cols=255 Identities=29% Similarity=0.505 Sum_probs=212.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR---- 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqde---- 758 (1091)
..+.|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ +||||+++++.|...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3467899999999999999999999999999999987532 2345688999999998 699999999998753
Q ss_pred --CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 759 --DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 759 --d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4689999999999999999864 368999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
.... .........|++.|+|||++. +..|+.++|||||||++|||++|
T Consensus 160 ~~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 160 QLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred eccc---------------------------ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence 4210 001123467999999999986 34688899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..||....+......+....... ..+..++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~~ 272 (272)
T cd06637 213 APPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPT---TEQLMKHPFI 272 (272)
T ss_pred CCCccccCHHHHHHHHhcCCCCC-CCCCCcCHHHHHHHHHHcCCChhhCCC---HHHHhhCCCC
Confidence 99998766655554443332211 123567899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=354.87 Aligned_cols=257 Identities=30% Similarity=0.480 Sum_probs=213.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875432 1223456789999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 152 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG------- 152 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC-------
Confidence 9999999888887777899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....
T Consensus 153 --------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 153 --------------------PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred --------------------CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 0001123468899999999876 5578999999999999999999999988765444333
Q ss_pred Hhhc-------------------CCCCCC---------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 925 ILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 925 Il~~-------------------~l~fP~---------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+... ....|. ....++..+.+||.+||+.||++||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~eil~~~~f 286 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS---CEELLEHPYF 286 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC---HHHHhcCCCC
Confidence 2210 000111 01356888999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.84 Aligned_cols=255 Identities=35% Similarity=0.548 Sum_probs=219.4
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||.|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.....+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999997532 23567889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.+|.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~----- 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA----- 153 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh-----
Confidence 9999999999999776 7899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---CCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.........|+..|+|||++.+. .++.++|+|||||++|+|++|.+||...++..
T Consensus 154 ----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 154 ----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred ----------------------hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00112245789999999999876 88999999999999999999999998877666
Q ss_pred HHHHHhhcCCCCCC--CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 921 IFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 921 i~~kIl~~~l~fP~--ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
....+....+..+. .+...+.++.+||.+||..+|..||+ +.+++.|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~ 262 (262)
T cd06613 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT---ATKLLQHPF 262 (262)
T ss_pred HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC---HHHHhcCCC
Confidence 55555444322221 23456788999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.91 Aligned_cols=255 Identities=30% Similarity=0.550 Sum_probs=216.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||.||+|++..+|..||+|.++.. ........+.+|+.++.+++||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 4789999999999999999999999999999988642 23344578899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 766 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~---g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||++|++|..++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999988763 379999999999999999999997 599999999999999999999999999986421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC------CCCccceeechhhhHHHHHhCCCCCCC
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~------~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
........|++.|+|||++.+. .++.++|+|||||++|+|++|..||..
T Consensus 155 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 155 -------------------------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred -------------------------CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 0011234689999999998653 358899999999999999999999987
Q ss_pred CChHHHHHH---HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 916 ESPEIIFDN---ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 916 ~s~~ei~~k---Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
......+.. +... ..+.++..++.++.+||.+||+.+|.+||+ +.+++.||||...
T Consensus 210 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~~~~~~~~ 268 (286)
T cd06622 210 ETYANIFAQLSAIVDG--DPPTLPSGYSDDAQDFVAKCLNKIPNRRPT---YAQLLEHPWLVKY 268 (286)
T ss_pred cchhhHHHHHHHHhhc--CCCCCCcccCHHHHHHHHHHcccCcccCCC---HHHHhcChhhhhc
Confidence 665554443 3222 223345678999999999999999999999 8899999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=369.93 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=210.9
Q ss_pred EEEeeccC--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 690 IIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 690 ilr~LGkG--gFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
++++||+| +||+||+++.+.+|+.||+|.++.... .......+.+|+.+++.++||||++++++|..++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999875322 234456788899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 768 LNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 768 m~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||.+...... .
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~-~---- 155 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH-G---- 155 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccc-c----
Confidence 9999999999653 45899999999999999999999999999999999999999999999999875421100 0
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
. ... .........+++..|+|||++.+ ..|+.++|||||||++|||++|+.||..........
T Consensus 156 ------~---~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 156 ------Q---RLR------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred ------c---ccc------ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 0 000 00011123467889999999976 468999999999999999999999998765544443
Q ss_pred HHhhcCCCC-------------------------------------------CCCCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 924 NILNRKIPW-------------------------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 924 kIl~~~l~f-------------------------------------------P~ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
....+..+. ......+++++.+||.+||+.||.+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 333221110 0011235778999999999999999999
Q ss_pred cccHHHHHcCCCCCCCC
Q 001370 961 ANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 961 a~gA~EIL~HPFFkgId 977 (1091)
+.++++||||+.+.
T Consensus 301 ---~~ell~~p~f~~~~ 314 (327)
T cd08227 301 ---ASTLLNHSFFKQIK 314 (327)
T ss_pred ---HHHHhcChhhhhcc
Confidence 88999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=380.81 Aligned_cols=252 Identities=33% Similarity=0.560 Sum_probs=213.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----ee
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 761 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded-----~L 761 (1091)
.|+-.+++|.|+||.||.|....+++.||||.+-.... .--+|..||..++|||||+|.++|.... .+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 58889999999999999999999999999997754322 2246899999999999999998886432 46
Q ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC-CcEEEEecCCcccc
Q 001370 762 YLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIG 836 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~~ 836 (1091)
.+|||||+. +|...++. ...++.-.++.|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 689999987 99999874 4578889999999999999999999999999999999999986 89999999999964
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
. .+....+...|..|+|||.+.| ..|+.+.||||.||+|.||+-|++-|.+
T Consensus 177 ~----------------------------~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 177 V----------------------------KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred c----------------------------cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 2 1223355678999999999987 6799999999999999999999999999
Q ss_pred CChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 916 ESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 916 ~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
++..+....|++. ...+|. +...+++++.||+.++|+++|.+|.+ +.+++.
T Consensus 229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~---~~~~l~ 305 (364)
T KOG0658|consen 229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS---ALEALA 305 (364)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC---HHHHhc
Confidence 9987777766541 111222 23567999999999999999999999 899999
Q ss_pred CCCCCCCC
Q 001370 970 HPFFKGVN 977 (1091)
Q Consensus 970 HPFFkgId 977 (1091)
||||..+.
T Consensus 306 h~fFdelr 313 (364)
T KOG0658|consen 306 HPFFDELR 313 (364)
T ss_pred chhhHHhh
Confidence 99997653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.04 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=194.0
Q ss_pred EEeeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeEEEEe
Q 001370 691 IKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVME 766 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~--TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd--ed~LYLVME 766 (1091)
.+.||+|+||+||+|+++. +++.||+|.+..... ...+.+|+.+|+.++||||+++++.|.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 3579999999999999763 678999999865322 2446789999999999999999998854 456899999
Q ss_pred ecCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe----cCCCcEEEEecCCc
Q 001370 767 YLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLS 833 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~---------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKLsDFGLA 833 (1091)
|+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9865 888887532 258999999999999999999999999999999999999 45689999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
+...... .........+||+.|+|||++.+ ..|+.++|||||||++|||++|++|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCC------------------------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 7421000 00112234679999999999987 4589999999999999999999999
Q ss_pred CCCCCh---------HHHHHHHhhc-CC----------CCCC------------------------CCCCCCHHHHHHHh
Q 001370 913 FTAESP---------EIIFDNILNR-KI----------PWPC------------------------VPSDMSFEAQDLIN 948 (1091)
Q Consensus 913 F~~~s~---------~ei~~kIl~~-~l----------~fP~------------------------ip~~lS~eakDLI~ 948 (1091)
|..... ......+.+. .. .+|. .....+.++.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 975432 1122222110 00 0000 00123567899999
Q ss_pred hhccCCCCCCCCcccHHHHHcCCCC
Q 001370 949 RFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 949 rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+||+.||.+||| +.|+++||||
T Consensus 296 ~mL~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07868 296 KLLTMDPIKRIT---SEQAMQDPYF 317 (317)
T ss_pred HHhccCcccCCC---HHHHhcCCCC
Confidence 999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.26 Aligned_cols=278 Identities=39% Similarity=0.745 Sum_probs=231.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLV 764 (1091)
++|++.+.||+|+||.||+|..+.+|+.||+|++.+...........+.+|..++.++. ||||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765555556678899999999999 99999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~- 159 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE- 159 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc-
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987532111000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
......... ...............|+..|+|||++.+..++.++|+||||+++|+|++|..||...+....+..
T Consensus 160 --~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 160 --SNKGDATNI----DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred --cCCCCCccc----cccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 000000000 00000112234456789999999999988899999999999999999999999998887777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc-ccHHHHHcCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFF 973 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa-~gA~EIL~HPFF 973 (1091)
+......+| ..+++.+.+||.+||..||.+||++ ....++++||||
T Consensus 234 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 776665555 6789999999999999999999992 112899999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=346.22 Aligned_cols=254 Identities=31% Similarity=0.536 Sum_probs=224.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|++++.||.|+||.||.++...+++.+++|.+..... .......+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 48999999999999999999999999999999875432 33456778899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~----- 154 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE----- 154 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc-----
Confidence 99999999999765 46899999999999999999999999999999999999999999999999998753110
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
........||+.|+|||++.+..++.++|+||||+++|||++|..||...+..+....
T Consensus 155 ----------------------~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 155 ----------------------YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred ----------------------cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 0012345689999999999988899999999999999999999999999888888888
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+..+... ..+..++.++.++|.+||..+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s---~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPT---ADEVLDQPLL 256 (256)
T ss_pred HHcCCCC--CCccccCHHHHHHHHHHcccCcccCCC---HHHHhhCcCC
Confidence 8766543 234678999999999999999999999 8899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=347.24 Aligned_cols=254 Identities=29% Similarity=0.536 Sum_probs=223.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||+|+||.||+++...+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875433 23455678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~------ 153 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS------ 153 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc------
Confidence 999999999987643 578999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....
T Consensus 154 ---------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 154 ---------------------TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred ---------------------chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 00111234689999999999988899999999999999999999999998888888888
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
++.+.. +..+..++.++.++|.+||+.+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSY--PPVSSHYSYDLRNLVSQLFKRNPRDRPS---VNSILEKNFI 256 (256)
T ss_pred HhcCCC--CCCcccCCHHHHHHHHHHhhCChhhCcC---HHHHhhCcCC
Confidence 776653 3345788999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.24 Aligned_cols=255 Identities=30% Similarity=0.524 Sum_probs=208.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||+|+||.||+|+++.+|+.||+|.++.... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48999999999999999999999999999999875322 22234567889999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 767 YLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 767 Ym~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
|+.+ +|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~------- 151 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI------- 151 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC-------
Confidence 9975 78887765 46799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCC-CCCChHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPF-TAESPEIIFD 923 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF-~~~s~~ei~~ 923 (1091)
.........+|+.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+.
T Consensus 152 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 152 --------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred --------------------CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 00111234678999999998774 4789999999999999999988775 4555444444
Q ss_pred HHhhc-----------------CCCCCC---------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+... ...++. ....+++++.+||.+||..||.+||| +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~il~h~~f 284 (284)
T cd07839 212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS---AEEALQHPYF 284 (284)
T ss_pred HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC---HHHHhcCCCC
Confidence 43221 000111 11357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=354.65 Aligned_cols=258 Identities=33% Similarity=0.573 Sum_probs=223.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||.|+||.||+|++..+|+.||+|++.... .......+.+|+++++.++||||+++++++.+...+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47899999999999999999999999999999987532 2344567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||+++|+|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.+|.++|+|||+++.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~------ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST------ 151 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc------
Confidence 999999999998765 7899999999999999999999999999999999999999999999999998753100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
........|++.|+|||++.+..++.++|||||||++|+|++|.+||...++......+
T Consensus 152 ---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 210 (274)
T cd06609 152 ---------------------MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210 (274)
T ss_pred ---------------------ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh
Confidence 01123457899999999999988999999999999999999999999887776666655
Q ss_pred hhcCCCCCCCCCC-CCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 926 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 926 l~~~l~fP~ip~~-lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
..... |.++.. ++.++.++|.+||..||.+||+ +.++++||||.+..-
T Consensus 211 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt---~~~il~~~~~~~~~~ 259 (274)
T cd06609 211 PKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLKHKFIKKAKK 259 (274)
T ss_pred hhcCC--CCCcccccCHHHHHHHHHHhhCChhhCcC---HHHHhhChhhcCCCc
Confidence 55432 222334 8899999999999999999999 889999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=360.85 Aligned_cols=257 Identities=34% Similarity=0.542 Sum_probs=219.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
..+|++++.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++..++||||+++++.|.....+|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999999999999999999999999875332 2356788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||++||+|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~------ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 168 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc------
Confidence 999999999999864 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|++||...++......
T Consensus 169 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~ 227 (296)
T cd06654 169 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (296)
T ss_pred ---------------------cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence 00111235689999999999988899999999999999999999999988776544433
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+.....+....+..++..+.+||.+||.+||++||+ +.+++.||||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~eil~~~~~~~ 275 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC---HHHHhhChhhhc
Confidence 333222222234568899999999999999999999 889999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=349.25 Aligned_cols=257 Identities=32% Similarity=0.534 Sum_probs=214.9
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC--
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD-- 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded-- 759 (1091)
...++|++.+.||.|+||.||+|.++.+++.||+|++.... .....+.+|+.++.++ .||||++++++|....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 34589999999999999999999999999999999987533 2346788999999998 6999999999997644
Q ss_pred ----eeEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecC
Q 001370 760 ----NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 760 ----~LYLVMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
.+|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998653 479999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHH
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDIWSLGVILYEM 906 (1091)
++..... .........||+.|+|||++.. ..++.++|+|||||+||+|
T Consensus 159 ~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l 211 (275)
T cd06608 159 VSAQLDS---------------------------TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211 (275)
T ss_pred cceeccc---------------------------chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHH
Confidence 9874210 0111234569999999999854 3467899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 907 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 907 LTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
++|.+||...........+.....+....+..++.++++||.+||..||++||+ +.++++|||+
T Consensus 212 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~ll~~~~~ 275 (275)
T cd06608 212 ADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF---MEELLEHPFI 275 (275)
T ss_pred HhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC---HHHHhcCCCC
Confidence 999999987766666555555432211122347889999999999999999999 8899999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=353.21 Aligned_cols=258 Identities=32% Similarity=0.504 Sum_probs=212.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeec----
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFT---- 756 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfq---- 756 (1091)
....++|++++.||+|+||+||+|.++.+++.||+|++++.. .....+.+|+.++..+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 346789999999999999999999999999999999886532 2235677899999998 6999999999873
Q ss_pred -cCCeeEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecC
Q 001370 757 -CRDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 757 -ded~LYLVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
..+.+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 45679999999999999988753 3468899999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHH
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDIWSLGVILYEM 906 (1091)
+++.... .........||+.|+|||++.. ..|+.++|||||||++|||
T Consensus 170 ~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el 222 (286)
T cd06638 170 VSAQLTS---------------------------TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222 (286)
T ss_pred ceeeccc---------------------------CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence 9874210 0011234569999999999853 4578999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 907 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 907 LTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
++|..||...........+..........+...+.++.+||.+||+.||++||+ +.++++|+||
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~~~~ 286 (286)
T cd06638 223 GDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQHVFI 286 (286)
T ss_pred hcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC---HHHHhhcccC
Confidence 999999988766544444333221111123456889999999999999999999 8899999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=355.80 Aligned_cols=255 Identities=23% Similarity=0.375 Sum_probs=216.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TG-----k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
+..++|++++.||+|+||.||+|.....+ ..||+|.++... .......+.+|+.++..++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34678999999999999999999976555 689999886432 23445678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 821 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~ 821 (1091)
....|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45788899999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhh
Q 001370 822 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 901 (1091)
Q Consensus 822 nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGV 901 (1091)
++.+||+|||+++...... .........+|+.|+|||.+.+..++.++|||||||
T Consensus 160 ~~~~~L~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~ 214 (283)
T cd05048 160 GLTVKISDFGLSRDIYSAD-------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214 (283)
T ss_pred CCcEEECCCcceeeccccc-------------------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHH
Confidence 9999999999987431100 001122345789999999999889999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 902 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 902 ILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
++|||++ |..||.+.+..++...+..... +..+..++.++.+|+.+||..||.+||+ +.+|++
T Consensus 215 il~el~~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp~---~~~i~~ 278 (283)
T cd05048 215 VLWEIFSYGLQPYYGFSNQEVIEMIRSRQL--LPCPEDCPARVYALMIECWNEIPARRPR---FKDIHT 278 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCcccCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 9999998 9999999998888888766543 2345789999999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=344.35 Aligned_cols=254 Identities=33% Similarity=0.574 Sum_probs=220.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLV 764 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd--ed~LYLV 764 (1091)
+|++++.||.|+||.||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||+++++.+.. ...+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999876443 34456778999999999999999999987754 4568999
Q ss_pred EeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 765 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLH-----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLH-----s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
|||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999975 357899999999999999999999 89999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
... .........|++.|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus 160 ~~~---------------------------~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGH---------------------------DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccC---------------------------CcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 210 01112235689999999999988899999999999999999999999998
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+...+...+..+.. +.++..++.++.+|+.+||..+|.+||+ +.+|++|||+
T Consensus 213 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCCcccCCC---HHHHhhCCCC
Confidence 887777777665543 4456788999999999999999999999 8899999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=359.17 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=206.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~----------------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN 747 (1091)
..++|++.+.||+|+||.||+|.+.. ++..||+|+++... .......+.+|+.+|.+++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35689999999999999999998642 34579999987532 3445677899999999999999
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 001370 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-------------------CLEEDVARIYIAELVLALEYLHSLGIV 808 (1091)
Q Consensus 748 IVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g-------------------~LsE~~ar~yaaQIa~ALeYLHs~GII 808 (1091)
|+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 356778889999999999999999999
Q ss_pred ecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC
Q 001370 809 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT 888 (1091)
Q Consensus 809 HRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~ 888 (1091)
||||||+|||++.++.+||+|||+++...... .........+|+.|||||++.+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGD-------------------------YYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCc-------------------------eeEecCcCCCCccccCHHHHhcC
Confidence 99999999999999999999999987421100 00111234568899999999988
Q ss_pred CCCccceeechhhhHHHHHh--CCCCCCCCChHHHHHHHhh---c--CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc
Q 001370 889 EHGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDNILN---R--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 961 (1091)
Q Consensus 889 ~Ys~ksDIWSLGVILYEMLT--GkpPF~~~s~~ei~~kIl~---~--~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa 961 (1091)
.++.++|||||||++|||++ |..||...+..+....+.. . ...++..+..++..+.+||.+||..||.+||++
T Consensus 216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 99999999999999999986 6789988776665544322 1 111222346788999999999999999999995
Q ss_pred ccHHH
Q 001370 962 NGAAE 966 (1091)
Q Consensus 962 ~gA~E 966 (1091)
.++..
T Consensus 296 ~~i~~ 300 (304)
T cd05096 296 SDIHA 300 (304)
T ss_pred HHHHH
Confidence 44433
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.04 Aligned_cols=258 Identities=32% Similarity=0.520 Sum_probs=214.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC---
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR--- 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqde--- 758 (1091)
...++|++.+.||.|+||.||+|..+.+++.||+|++.+.. .....+.+|+.++.++ +||||++++++|...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34688999999999999999999999999999999987532 2235677899999988 799999999988754
Q ss_pred --CeeEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCC
Q 001370 759 --DNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 759 --d~LYLVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998863 35689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-----CCCccceeechhhhHHHHH
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-----~Ys~ksDIWSLGVILYEML 907 (1091)
+..... ........+|++.|+|||++... .++.++|||||||++|||+
T Consensus 175 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 175 SAQLTS---------------------------TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred chhccc---------------------------ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 874210 00111235689999999998643 3688999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 908 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 908 TGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
+|++||...........+..........+...+..+.+||.+||..+|++||+ +.++++||||+
T Consensus 228 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~ 291 (291)
T cd06639 228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLLEHPFIK 291 (291)
T ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC---HHHHhcCcccC
Confidence 99999988877666555544432211123457789999999999999999999 88999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=355.10 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=214.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||.||+|.++.+++.||+|++.+.... ....+.+.+|++++..++||||++++++|.....+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999999999999998764332 234566889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++++.|..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~------ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP------ 153 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC------
Confidence 99999999888776667999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
........|+..|+|||++.+ ..++.++|||||||++|||++|.+||...+..+....
T Consensus 154 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 154 ---------------------GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred ---------------------ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 011123568999999999876 4578899999999999999999999987765444333
Q ss_pred Hhhc-------------------CCCCCC---------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 925 ILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 925 Il~~-------------------~l~fP~---------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+... ....|. ....++..+.+||.+||..+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~~~~ 286 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLHHEFF 286 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh---HHHHhcCCCC
Confidence 3321 011111 12357889999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=360.43 Aligned_cols=258 Identities=34% Similarity=0.550 Sum_probs=218.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
..+|++++.||.|+||.||+|....+|+.||+|.+..... ...+.+.+|+.+++.++||||++++++|...+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3689999999999999999999999999999999875332 3346788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||++||+|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~------ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 167 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC------
Confidence 999999999999865 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|.+||...++......
T Consensus 168 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~ 226 (297)
T cd06656 168 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (297)
T ss_pred ---------------------CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence 00111234689999999999998899999999999999999999999987765443333
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+.....+....+..++..+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 275 (297)
T cd06656 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS---AKELLQHPFLKLA 275 (297)
T ss_pred eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhccc
Confidence 332222222234678899999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.98 Aligned_cols=255 Identities=34% Similarity=0.566 Sum_probs=219.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i--~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.|+..+.||+|+||+||+|....+++.||+|.+..... ........+.+|+.++..++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36778899999999999999998999999999875432 2234567889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~------ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE------ 154 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
........|++.|+|||.+.... ++.++|+|||||++|+|++|.+||..........
T Consensus 155 ----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~ 212 (258)
T cd06632 155 ----------------------FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212 (258)
T ss_pred ----------------------cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH
Confidence 00123456899999999998766 8999999999999999999999998776555444
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+... ...+.++..++.++.+||.+||..+|.+||+ +.+++.|||+
T Consensus 213 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 258 (258)
T cd06632 213 KIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPT---AAELLEHPFV 258 (258)
T ss_pred HHHhc-ccCCCcCCCcCHHHHHHHHHHhhcCcccCcC---HHHHhcCCCC
Confidence 44331 2334456788999999999999999999999 8899999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=352.76 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=213.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..++|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4568999999999999999999875 346789999987532 23445678999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
+|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999764 57899999999999999999999999999999999999999999999999987531100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||...+.
T Consensus 161 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 161 --------------------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred --------------------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 0001123346788999999999999999999999999999775 9999999888
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.++...+..+. ..| .+..++..+.+++.+||..+|.+||++.++.+++
T Consensus 215 ~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 215 QDVIKAVEDGF-RLP-APRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred HHHHHHHHCCC-CCC-CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 88777765442 223 3577899999999999999999999955444443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=358.97 Aligned_cols=257 Identities=35% Similarity=0.565 Sum_probs=221.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 56999999999999999999999999999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||+++|+|..++.. ..+++..+..++.+++.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~------- 167 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP------- 167 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc-------
Confidence 99999999998865 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++......+
T Consensus 168 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~ 227 (296)
T cd06655 168 --------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (296)
T ss_pred --------------------ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001112356899999999999888999999999999999999999999988776555555
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.....+....+..+++.+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~il~~~~~~~~ 275 (296)
T cd06655 228 ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKLA 275 (296)
T ss_pred HhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhhc
Confidence 44333222234678999999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=374.10 Aligned_cols=284 Identities=30% Similarity=0.508 Sum_probs=235.1
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeecCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+.||.|+||.|--+....||..||||++.|.. -....++++|++++.++. |+||++|+.+|+++.++|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 47999999999999999999999999998853 355688999999999996 99999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---cEEEEecCCcccccccccccCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINNTIDLSGP 847 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~~~~~~s~dls~~ 847 (1091)
|.|..+|++...|++.++..++.+|+.||.|||.+||.||||||+|||-..-. -||||||.|......++. ++ +
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~--~s-p 237 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND--CS-P 237 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC--CC-C
Confidence 99999999999999999999999999999999999999999999999987654 489999999764322221 11 1
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCC-----
Q 001370 848 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES----- 917 (1091)
Q Consensus 848 ~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s----- 917 (1091)
.......+.||+..|||||++. ...|+++||.||||||+|-||.|++||.+.-
T Consensus 238 -----------------astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 238 -----------------ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred -----------------CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 0112235789999999999863 3579999999999999999999999996531
Q ss_pred ----------hHHHHHHHhhcCCCCCCCC-CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccC
Q 001370 918 ----------PEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA 986 (1091)
Q Consensus 918 ----------~~ei~~kIl~~~l~fP~ip-~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~p 986 (1091)
...++..|..+.+.||.-. ..+|.+++|||+.+|.+|+..|++ |..+++|||++.+.-+.-. ..|
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls---a~~vlnhPw~~~~~~ekal-ptp 376 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS---AAQVLNHPWVQRCAPEKAL-PTP 376 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh---hhhccCCccccccchhccC-CCC
Confidence 4678999999999999632 458999999999999999999999 8899999999987654222 233
Q ss_pred CccCCCCCCCCccccc
Q 001370 987 VFVPQPESVDDTSYFL 1002 (1091)
Q Consensus 987 PfiP~~~s~~Dts~Fd 1002 (1091)
+.+-...+-.+.+.|.
T Consensus 377 ~v~~r~~s~~~lslfa 392 (463)
T KOG0607|consen 377 QVLQRNSSTMDLSLFA 392 (463)
T ss_pred cccccCccchhhHHHH
Confidence 3333333333555554
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.47 Aligned_cols=249 Identities=28% Similarity=0.522 Sum_probs=216.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||.|+||.||+++++.+++.||+|.++... .....+.+.+|+.++..++||||+++++.|.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999987532 23456778899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~------ 152 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS------ 152 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc------
Confidence 99999999988643 4589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 153 ---------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 153 ---------------------PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ---------------------cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 01112245789999999999998899999999999999999999999999888777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+..+... .++..++..+.+||.+||..||.+||+ +.+++.
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~ 251 (255)
T cd08219 212 VCQGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPS---ATTILS 251 (255)
T ss_pred HhcCCCC--CCCcccCHHHHHHHHHHHhCCcccCCC---HHHHhh
Confidence 7655432 235678999999999999999999999 667764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.00 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=213.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc----
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC---- 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqd---- 757 (1091)
...+.|++.+.||.|+||.||+|+++.+++.||+|++... ......+..|+.++.++ +||||++++++|..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 4557899999999999999999999999999999998653 23446688899999988 69999999999853
Q ss_pred --CCeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 758 --RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 758 --ed~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 45789999999999999999753 35888889999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHh
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFIT 908 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLT 908 (1091)
..... ........+|++.|+|||++. +..|+.++|+|||||++|||++
T Consensus 169 ~~~~~---------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~ 221 (282)
T cd06636 169 AQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221 (282)
T ss_pred hhhhc---------------------------cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh
Confidence 74210 001123467999999999986 3568889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 909 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 909 GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
|.+||....+......+..... .......++.++.+||.+||..||.+||+ +.+|+.||||
T Consensus 222 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~ell~~~~~ 282 (282)
T cd06636 222 GAPPLCDMHPMRALFLIPRNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRPS---TEQLLKHPFI 282 (282)
T ss_pred CCCCccccCHHhhhhhHhhCCC-CCCcccccCHHHHHHHHHHhCCChhhCcC---HHHHhcCCCC
Confidence 9999987765544444333221 11123568899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=391.82 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=219.8
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..+.+....+++++.||+|-||+||+|.+.. ...||+|.++...+ ..+.|.+|++||.+++|++||+||+++..+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 4455666678888999999999999999974 34799999986543 345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k--~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+.+|||||||+.|+|.++|+. ...+...+...+++|||.||+||+++++|||||-..||||++++.+||+|||||+..
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999999987 456999999999999999999999999999999999999999999999999999953
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
..+.+.. .....-...|.|||.+....++.++|||||||+||||+| |+.||.+
T Consensus 354 ~d~~Y~~--------------------------~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 354 GDDEYTA--------------------------SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred CCCceee--------------------------cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 2211110 001112457999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
.+..++.+.+-.+ .++|. |..+|+++.+++..||..+|++|||++.....+.
T Consensus 408 msn~ev~~~le~G-yRlp~-P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 408 MSNEEVLELLERG-YRLPR-PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred CCHHHHHHHHhcc-CcCCC-CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence 9999999887655 45553 6899999999999999999999999765554443
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.16 Aligned_cols=253 Identities=30% Similarity=0.502 Sum_probs=220.9
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||.|+||.||+|....+++.||+|.+..... .......+.+|+.+|+.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999976443 33456789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEecCCccccccccccc
Q 001370 767 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~~~s~d 843 (1091)
|++|++|.+++... ..+++..+..++.+++.||.|||++||+|+||||+||+++.++ .+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----- 154 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-----
Confidence 99999999999764 3489999999999999999999999999999999999998654 689999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+......
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 155 -----------------------KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred -----------------------CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 111223568999999999998889999999999999999999999999888877777
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+..... +.++..++.++.++|.+||..||.+||+ +.++++||||
T Consensus 212 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~ll~~p~~ 256 (256)
T cd08220 212 KIMSGTF--APISDRYSPDLRQLILSMLNLDPSKRPQ---LSQIMAQPIC 256 (256)
T ss_pred HHHhcCC--CCCCCCcCHHHHHHHHHHccCChhhCCC---HHHHhhCCCC
Confidence 7765433 2234678999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.00 Aligned_cols=258 Identities=30% Similarity=0.510 Sum_probs=209.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCeeEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieI-LskL~HPNIVkL~gsfqded~LYLV 764 (1091)
++|++.+.||+|+||.||+|+++.+|+.||||.+++... .. ....+..|..+ ++..+||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876422 22 23445556665 5667899999999999999999999
Q ss_pred EeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 765 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
|||++ |+|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99997 588877754 24689999999999999999999997 999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC----CCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g----~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
........|+..|+|||++.+ ..++.++|+|||||++|+|++|..||..
T Consensus 157 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 ---------------------------SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ---------------------------ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 001123468999999999865 5578999999999999999999999975
Q ss_pred C-ChHHHHHHHhhc-CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 916 E-SPEIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 916 ~-s~~ei~~kIl~~-~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
. ...+....+... ...+| ...+|.++.+||.+||..+|.+||+ +.+++.||||....+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~ 270 (283)
T cd06617 210 WKTPFQQLKQVVEEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPN---YPELLQHPFFELHLSK 270 (283)
T ss_pred cccCHHHHHHHHhcCCCCCC--ccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhhhcccc
Confidence 3 233333333333 22222 2457899999999999999999999 7899999999886654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.54 Aligned_cols=258 Identities=35% Similarity=0.593 Sum_probs=223.8
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||.|+||.||+|++..+|+.||+|++...... .....+.+|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4799999999999999999999999999999998764321 45678899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~------ 152 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN------ 152 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 999999999999888889999999999999999999999 9999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC---ChHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEII 921 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~---s~~ei 921 (1091)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+.
T Consensus 153 ---------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 211 (264)
T cd06623 153 ---------------------TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211 (264)
T ss_pred ---------------------CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH
Confidence 011112456899999999999989999999999999999999999999877 44555
Q ss_pred HHHHhhcCCCCCCCCCC-CCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~-lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
...+..... +..+.. ++..+.++|.+||..+|.+||+ +.++++||||+.++
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~ll~~~~~~~~~ 263 (264)
T cd06623 212 MQAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHhcCCC--CCCCcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCHHHHhcc
Confidence 555554322 223455 8899999999999999999999 88999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=375.06 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=203.9
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
....+|++++.||+|+||.||+|++..+++.||+|+..+. ....|+.++..++||||+++++++......|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3456799999999999999999999999999999976442 2356899999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
+||||+. |+|.+++.+ ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 9999996 588888865 45699999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC-CCCCCCCh--
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI-PPFTAESP-- 918 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGk-pPF~~~s~-- 918 (1091)
........||+.|+|||++.+..|+.++|||||||++|||+++. ++|.....
T Consensus 210 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~ 264 (357)
T PHA03209 210 -------------------------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264 (357)
T ss_pred -------------------------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcH
Confidence 01123457999999999999999999999999999999999854 44443211
Q ss_pred -------HHHHHHHhhc----CCCCCC---------------------------CCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 919 -------EIIFDNILNR----KIPWPC---------------------------VPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 919 -------~ei~~kIl~~----~l~fP~---------------------------ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
......++.. ...+|. ....++.++.+||.+||+.||.+||+
T Consensus 265 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt 344 (357)
T PHA03209 265 EEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS 344 (357)
T ss_pred HHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC
Confidence 0111111110 001110 01245778889999999999999999
Q ss_pred cccHHHHHcCCCCCCC
Q 001370 961 ANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 961 a~gA~EIL~HPFFkgI 976 (1091)
|.|+++||||+.+
T Consensus 345 ---a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 ---AEEILNYPMFAQL 357 (357)
T ss_pred ---HHHHhcCchhccC
Confidence 8899999999864
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.56 Aligned_cols=256 Identities=31% Similarity=0.472 Sum_probs=211.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...+++.....||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++..++||||+++++++...+..|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34556666678999999999999999999999999886532 345667899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRKV-GCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~-g~L--sE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~ 838 (1091)
+||||+++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999999764 455 88889999999999999999999999999999999986 67999999999864210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
. ........|++.|+|||++.+. .++.++|+||||+++|+|++|.+||...
T Consensus 162 ~---------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 162 I---------------------------NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred C---------------------------CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 0 0111234589999999998764 4789999999999999999999999764
Q ss_pred ChHH--HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 917 SPEI--IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 917 s~~e--i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.... .+...... ..+.++..+++++++||.+||..+|.+||+ +.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 268 (268)
T cd06624 215 GEPQAAMFKVGMFK--IHPEIPESLSAEAKNFILRCFEPDPDKRAS---AHDLLQDPFL 268 (268)
T ss_pred cChhhhHhhhhhhc--cCCCCCcccCHHHHHHHHHHcCCCchhCCC---HHHHHhCCCC
Confidence 3221 22111111 223455788999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=396.37 Aligned_cols=261 Identities=33% Similarity=0.590 Sum_probs=234.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
+-|+|+..||-|+||+||+|..+.++-.-|-|+|. .....+.+.++-|++||..++||+||+|++.|..++.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 34688999999999999999999999989999885 345678899999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||.||-+..++-..+ .|++.+++.+++|++.||.|||+++|||||||..|||++.+|.|+|+|||.+....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------- 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------- 181 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-------
Confidence 9999999988887665 59999999999999999999999999999999999999999999999999875311
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.......++.|||+|||||++. ..+|++++||||||++|.||.-+.||-...++.
T Consensus 182 --------------------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 182 --------------------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred --------------------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence 1234556899999999999874 478999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
.+..+|.....+--..|..++..+.||+.+||.+||..||+ +.+|++||||.++.-+
T Consensus 242 RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~---aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 242 RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP---AAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC---HHHHhhCcccccCCcc
Confidence 99999988766554457899999999999999999999999 8899999999976543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=347.01 Aligned_cols=259 Identities=32% Similarity=0.530 Sum_probs=215.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-------RKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~-------~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
.|.+.+.||.|+||.||+|....+|+.||+|.++..... .....+.+.+|+.++..++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999999999999988642111 1223457888999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC--CCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
..........|+..|+|||++.... ++.++|+||||+++|+|++|..||....
T Consensus 162 -------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 162 -------------------------YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred -------------------------ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 0011123456899999999998754 8899999999999999999999997766
Q ss_pred hHHHHHHHhhcCC--CCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 918 PEIIFDNILNRKI--PWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 918 ~~ei~~kIl~~~l--~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.......+..... .++. ....++.++.+||.+||..||.+||+ +.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~ 272 (272)
T cd06629 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT---ARELLQHPFI 272 (272)
T ss_pred hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC---HHHHhhCCCC
Confidence 5544444333221 2221 22356899999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=374.88 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=212.7
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 752 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TG-----k~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~ 752 (1091)
..+....++|++.+.||+|+||.||+|++..+| ..||||+++... .......+.+|+.+++.+ +|||||+++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 344566789999999999999999999865443 579999997533 233456789999999999 899999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhc----------------------------------------------------
Q 001370 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKV---------------------------------------------------- 780 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GGSL~dlL~k~---------------------------------------------------- 780 (1091)
++|.....+|+||||+++|+|.+++.+.
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999999998642
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 781 ------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 781 ------------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~-- 266 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-- 266 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc--
Confidence 136788899999999999999999999999999999999999999999999987421000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei 921 (1091)
.........+++.|||||++.+..|+.++|||||||++|||++ |+.||........
T Consensus 267 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~ 323 (374)
T cd05106 267 -----------------------NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323 (374)
T ss_pred -----------------------ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH
Confidence 0001112345678999999999999999999999999999997 9999988765554
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+..+.......+ .+..+++++.+||.+||+.||.+||++.++.+++
T Consensus 324 ~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 324 FYKMVKRGYQMS-RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHHHHHcccCcc-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 545544433322 3456789999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.06 Aligned_cols=257 Identities=36% Similarity=0.580 Sum_probs=215.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||.|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999976432 23345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 767 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
|+ +++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~------ 152 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE------ 152 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC------
Confidence 99 99999998654 56899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........||..|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+..
T Consensus 153 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 153 --------------------EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred --------------------CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 00112235799999999998754 468999999999999999999999988776666555
Q ss_pred HhhcC-------------------CCCC--------CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 925 ILNRK-------------------IPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 925 Il~~~-------------------l~fP--------~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
++..- ..++ ......+.++.+||.+||..||.+||+ +.+++.||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~~l~h~~~~ 286 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS---AAEALRHPYFT 286 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC---HHHHhhCcCcC
Confidence 44310 0111 011346789999999999999999999 88999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.76 Aligned_cols=259 Identities=34% Similarity=0.521 Sum_probs=215.5
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~--~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+|++.+.||.|+||.||+|.++.+|+.||||.++..... .......+..|+.++..++||||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999865432 122345677899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS----- 154 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC-----
Confidence 9999 899999998766 799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.........+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||.+.+..+.+
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~ 212 (298)
T cd07841 155 ----------------------PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212 (298)
T ss_pred ----------------------CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence 0011123457889999999865 46789999999999999999999999887766655
Q ss_pred HHHhhcCC-----CC---------------C-----CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 923 DNILNRKI-----PW---------------P-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 923 ~kIl~~~l-----~f---------------P-----~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.++..... .+ + ......+.++.+||.+||..||.+||+ +.+++.||||++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~e~l~~~~~~~~ 288 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT---ARQALEHPYFSND 288 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC---HHHHhhCccccCC
Confidence 55532100 00 0 011345788999999999999999999 8899999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=349.04 Aligned_cols=254 Identities=34% Similarity=0.576 Sum_probs=218.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||.|+||.||+|.++.+++.||+|.+.+... ......+.+|+++++.++||||+++++.+.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478899999999999999999999999999999876432 245577889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 766 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.+|.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~----- 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----- 153 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH-----
Confidence 999999999999876 789999999999999999999999 9999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC-----Ch
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-----SP 918 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~-----s~ 918 (1091)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ..
T Consensus 154 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (265)
T cd06605 154 ------------------------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209 (265)
T ss_pred ------------------------HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH
Confidence 0011267899999999999999999999999999999999999999764 23
Q ss_pred HHHHHHHhhcCCCCCCCCCC-CCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 919 EIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~-lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.+..+.+..... |..+.. ++.++.+||.+||..||.+||+ +.+++.||||+.
T Consensus 210 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~~~ 262 (265)
T cd06605 210 FELLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPS---YKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcC---HHHHhhCchhhc
Confidence 344444444322 222333 8899999999999999999999 889999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=350.95 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=214.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++++.. .......+.+|+++|..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998753 36789999987532 233457899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 824 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g--------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~ 824 (1091)
..+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997643 3788899999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHH
Q 001370 825 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 904 (1091)
Q Consensus 825 VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILY 904 (1091)
+||+|||+++...... .........+++.|+|||++.+..++.++|||||||++|
T Consensus 161 ~kl~d~g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 161 VKIGDFGMSRDVYTTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred EEECCcccceecccCc-------------------------ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 9999999987421000 001112345688999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 905 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 905 EMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
||++ |..||...+..+....+..+.... .+..++..+.+||.+||..||.+||++.++.+
T Consensus 216 e~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 216 EIFTYGKQPWYGLSNEEVIECITQGRLLQ--RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9998 999999888888888777655433 24678999999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=370.77 Aligned_cols=255 Identities=32% Similarity=0.535 Sum_probs=222.2
Q ss_pred ccCCCeEEE-EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc---
Q 001370 683 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--- 757 (1091)
Q Consensus 683 ~~iddFeil-r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqd--- 757 (1091)
..+++|.+- ++||-|-.|.|..|.++.||+.+|+|++.. ....++|+++.-... |||||.+++.|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 356777765 579999999999999999999999998853 345678998877765 9999999987754
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CCcEEEEecC
Q 001370 758 -RDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 831 (1091)
Q Consensus 758 -ed~LYLVMEYm~GGSL~dlL~k~g~--LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFG 831 (1091)
...+.+|||+|.||+|++.++..+. |+|.++..++.||..|+.|||+.+|.||||||+|+|... |..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 4578999999999999999988765 999999999999999999999999999999999999975 4579999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
+|+... ......+.|-||.|.|||++...+|+..||+||+||+||-||+|+|
T Consensus 210 FAK~t~----------------------------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyP 261 (400)
T KOG0604|consen 210 FAKETQ----------------------------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_pred cccccC----------------------------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCC
Confidence 998521 1223456789999999999999999999999999999999999999
Q ss_pred CCCCCC----hHHHHHHHhhcCCCCCCCC-CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 912 PFTAES----PEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 912 PF~~~s----~~ei~~kIl~~~l~fP~ip-~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
||+... ...+..+|..+.+.||.-+ ..+|.+++|+|++||..+|.+|++ +.+++.|||..+.
T Consensus 262 PFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT---I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 262 PFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT---IEEVMDHPWINQY 328 (400)
T ss_pred cccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee---HHHhhcCchhccc
Confidence 999865 4578889999999998622 457899999999999999999999 8899999998753
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=391.42 Aligned_cols=260 Identities=33% Similarity=0.575 Sum_probs=239.3
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
.......|.+.++||+|.|++|.++++..||..||||++.|..... ....++.+|+++|..++|||||++|.+......
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 4456789999999999999999999999999999999999866543 344568999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+||||+.+|++++++.+++.+.+..++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++.++.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998642
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
......++||+|.|.|||++.+..| +..+|+||+|+++|-|+.|..||.+.+-.
T Consensus 207 -------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk 261 (596)
T KOG0586|consen 207 -------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK 261 (596)
T ss_pred -------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence 1334567899999999999999888 68999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
++-.+.+.+++.+| ..++.++++||+++|..+|.+|++ ..+|..|.|...
T Consensus 262 ~Lr~rvl~gk~rIp---~~ms~dce~lLrk~lvl~Pskr~~---~dqim~~~W~n~ 311 (596)
T KOG0586|consen 262 ELRPRVLRGKYRIP---FYMSCDCEDLLRKFLVLNPSKRGP---CDQIMKDRWRND 311 (596)
T ss_pred cccchheeeeeccc---ceeechhHHHHHHhhccCccccCC---HHHhhhhcccch
Confidence 99999998888876 689999999999999999999999 889999999863
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.55 Aligned_cols=258 Identities=33% Similarity=0.544 Sum_probs=215.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||.|+||.||+|.++.+++.||+|+++.... .......+.+|+++++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999875332 2334577899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++++.+..++.+...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~------ 153 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR------ 153 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC------
Confidence 99999888777776677999999999999999999999999999999999999999999999999998753110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........|++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+....
T Consensus 154 --------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 154 --------------------PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred --------------------ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00112345789999999999887 889999999999999999999999987765443333
Q ss_pred Hhhc-------------------CCCCCC----------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 925 ILNR-------------------KIPWPC----------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 925 Il~~-------------------~l~fP~----------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+... ...++. .+..++.++.+||.+||..+|++||+ +.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~f 288 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT---CDELLQHPYF 288 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc---HHHHhcCCCC
Confidence 2210 000110 12345889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=351.98 Aligned_cols=255 Identities=33% Similarity=0.534 Sum_probs=210.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++++.||.|+||.||+|+++.+|+.||||.++... ........+.+|++++.+++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999886532 222334578899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|+. ++|..++... ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~------ 152 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV------ 152 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhccc------
Confidence 996 5898888653 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
.........+++.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+......
T Consensus 153 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 153 ---------------------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred ---------------------CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 001112335789999999987644 6889999999999999999999998877654444
Q ss_pred HHhhcC------------------CCCCC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRK------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~------------------l~fP~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
++.... ..++. +...++.++++||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~f 284 (284)
T cd07860 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS---AKAALAHPFF 284 (284)
T ss_pred HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC---HHHHhcCCCC
Confidence 333210 00110 11357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.22 Aligned_cols=251 Identities=28% Similarity=0.481 Sum_probs=211.4
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||+|+||.||+|+.+.+++.||||.++............+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765555566677889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 765 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~-- 158 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-- 158 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc--
Confidence 999999999988853 34588999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC--h
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--P 918 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s--~ 918 (1091)
.........|++.|+|||.+.+..++.++|+||||+++|||++|..||.... .
T Consensus 159 -------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~ 213 (267)
T cd08228 159 -------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred -------------------------hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH
Confidence 0011123568999999999999889999999999999999999999997654 2
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
......+.....+ +..+...+..+.+||.+||..+|.+||++..
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 257 (267)
T cd08228 214 FSLCQKIEQCDYP-PLPTEHYSEKLRELVSMCIYPDPDQRPDIGY 257 (267)
T ss_pred HHHHHHHhcCCCC-CCChhhcCHHHHHHHHHHCCCCcccCcCHHH
Confidence 3444444333221 2122467889999999999999999999443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=341.10 Aligned_cols=259 Identities=38% Similarity=0.630 Sum_probs=216.5
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||+|+||.||+|....+++.||+|+++.... .......+.+|+.++..++||||+++++.+...+.+|+|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 48899999999999999999998999999999976543 24577889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|+++++|.+++.+.+.+++..++.++.+++.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~----- 154 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT----- 154 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC-----
Confidence 999999999998877899999999999999999999999999999999999999999999999999875311000
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC---CCccceeechhhhHHHHHhCCCCCCCCChH-HHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESPE-IIF 922 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~---Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~-ei~ 922 (1091)
..........|++.|+|||++.+.. ++.++||||||+++|+|++|..||...... ...
T Consensus 155 ------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~ 216 (264)
T cd06626 155 ------------------TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216 (264)
T ss_pred ------------------cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH
Confidence 0000022356899999999998766 889999999999999999999999765332 222
Q ss_pred HHHhhc-CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 923 DNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 923 ~kIl~~-~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..+... ...+|. ...++..+.+||.+||+.+|.+||+ +.+++.|||+
T Consensus 217 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~---~~~i~~~~~~ 264 (264)
T cd06626 217 FHVGAGHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPT---ASELLQHPFV 264 (264)
T ss_pred HHHhcCCCCCCCc-ccccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 222222 222221 1234899999999999999999999 8899999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.99 Aligned_cols=257 Identities=32% Similarity=0.519 Sum_probs=209.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe----
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN---- 760 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~---- 760 (1091)
++|++.+.||.|+||.||+|.+..+|+.||+|+++... ........+.+|+.++..+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999886532 22233467888999999995 6999999999987776
Q ss_pred -eEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEecCCc
Q 001370 761 -LYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLS 833 (1091)
Q Consensus 761 -LYLVMEYm~GGSL~dlL~k~-----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLA 833 (1091)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 888887643 35799999999999999999999999999999999999998 899999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
+.... .........+++.|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 159 ~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCC---------------------------CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 74210 0011122357899999999875 4679999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcC-----CCC------------CC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 913 FTAESPEIIFDNILNRK-----IPW------------PC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~-----l~f------------P~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
|.+.+.......+...- ..+ +. ....++.++.+||.+||.+||.+||+ +.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~---~~ei 288 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---AKAA 288 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC---HHHH
Confidence 99877665555443310 000 10 01357889999999999999999999 8899
Q ss_pred HcCCCCC
Q 001370 968 KAHPFFK 974 (1091)
Q Consensus 968 L~HPFFk 974 (1091)
+.||||+
T Consensus 289 l~~~~~~ 295 (295)
T cd07837 289 LTHPYFD 295 (295)
T ss_pred hcCCCcC
Confidence 9999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=353.92 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=218.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++++.||+|+||+||++.+..+|+.||+|++.... .......+.+|++++..++||||+++++++.....+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999999999999986532 23345778999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||+++|+|.+++.+.+.+++..++.++.+++.||.|||+ .||+||||||+||+++.++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~----- 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----- 155 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh-----
Confidence 99999999999999888889999999999999999999997 599999999999999999999999999986321
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH---
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE--- 919 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~--- 919 (1091)
.......+||..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 156 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~ 211 (284)
T cd06620 156 ------------------------NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211 (284)
T ss_pred ------------------------hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh
Confidence 00112357999999999998888999999999999999999999999865542
Q ss_pred --------HHHHHHhhcCCCCCCCC-CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 920 --------IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 920 --------ei~~kIl~~~l~fP~ip-~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+....+..... +.++ ..++.++.+||.+||..||.+||+ +.++++||||..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~e~~~~~~~~~ 271 (284)
T cd06620 212 QDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPT---PQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccc
Confidence 23333333221 1112 237889999999999999999999 889999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.95 Aligned_cols=257 Identities=30% Similarity=0.551 Sum_probs=207.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++.+.||.|+||.||+|..+.+++.||||.+..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875321 1223456789999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||+.+ +|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 155 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---- 155 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC----
Confidence 9999985 999988764 4689999999999999999999999999999999999999999999999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC-hHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES-PEI 920 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s-~~e 920 (1091)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|++||.... ..+
T Consensus 156 -----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 212 (291)
T cd07844 156 -----------------------PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212 (291)
T ss_pred -----------------------CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 0001122357899999999876 568999999999999999999999997665 222
Q ss_pred HHHHHhhc-------------------CCCCCC--------CCCCCC--HHHHHHHhhhccCCCCCCCCcccHHHHHcCC
Q 001370 921 IFDNILNR-------------------KIPWPC--------VPSDMS--FEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971 (1091)
Q Consensus 921 i~~kIl~~-------------------~l~fP~--------ip~~lS--~eakDLI~rcL~kDPeKRpSa~gA~EIL~HP 971 (1091)
....+... ...++. ....++ .++.++|.+||+.||.+||+ +.+++.||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps---~~e~l~~~ 289 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS---AAEAMKHP 289 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC---HHHHhcCC
Confidence 22222110 000000 001344 88999999999999999999 88999999
Q ss_pred CC
Q 001370 972 FF 973 (1091)
Q Consensus 972 FF 973 (1091)
||
T Consensus 290 ~f 291 (291)
T cd07844 290 YF 291 (291)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.53 Aligned_cols=250 Identities=52% Similarity=0.959 Sum_probs=223.2
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001370 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 773 (1091)
Q Consensus 694 LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL 773 (1091)
||.|+||.||++.+..+++.||+|++++...........+..|+.+++.++||||+++++.+.....+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887665566778899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001370 774 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853 (1091)
Q Consensus 774 ~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~l 853 (1091)
.+++.....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-------------- 146 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-------------- 146 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--------------
Confidence 999988888999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC
Q 001370 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 933 (1091)
Q Consensus 854 ps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP 933 (1091)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+...+...+......+|
T Consensus 147 -------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 213 (250)
T cd05123 147 -------------GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP 213 (250)
T ss_pred -------------CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 0122345689999999999988889999999999999999999999988888788888777655544
Q ss_pred CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 934 ~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..++..+.++|.+||..||.+||++..+.++++||||
T Consensus 214 ---~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 214 ---EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 6779999999999999999999995445899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=355.39 Aligned_cols=261 Identities=33% Similarity=0.486 Sum_probs=214.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 761 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~L 761 (1091)
..++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+.+|+.++.+++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 56789999999999999999999999999999999875332 122233567899999999999999999998765 568
Q ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~- 161 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP- 161 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc-
Confidence 999999975 888888753 56899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
........+++.|+|||++.+ ..++.++|||||||++|||++|.+||...+..
T Consensus 162 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 162 --------------------------AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred --------------------------cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 011122346889999999876 56899999999999999999999999998887
Q ss_pred HHHHHHhhcC-------------------CCCCCC--------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 920 IIFDNILNRK-------------------IPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 920 ei~~kIl~~~-------------------l~fP~i--------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
+.+..+.+.. ...+.. ...+++++.+||.+||+.||++||+ +.+++.|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~~il~h~~ 292 (309)
T cd07845 216 EQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT---AEEALESSY 292 (309)
T ss_pred HHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC---HHHHhcChh
Confidence 7777665421 011100 0235889999999999999999999 889999999
Q ss_pred CCCC
Q 001370 973 FKGV 976 (1091)
Q Consensus 973 FkgI 976 (1091)
|++.
T Consensus 293 f~~~ 296 (309)
T cd07845 293 FKEK 296 (309)
T ss_pred hccC
Confidence 9753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=370.87 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=210.0
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 753 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~g 753 (1091)
.+....++|++.+.||+|+||+||+|++ ..++..||+|+++... .....+.+.+|+.+|..+ +|||||++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 3445567899999999999999999974 3457789999987533 223456788999999999 8999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhcC----------------------------------------------------
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------------------------------------------- 781 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~g---------------------------------------------------- 781 (1091)
+|...+..|+||||++||+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986421
Q ss_pred -----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 782 -----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 782 -----------------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 367788899999999999999999999999999999999999999999999874311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s 917 (1091)
.. .........++..|+|||++.+..++.++|||||||++|||++ |.+||....
T Consensus 267 ~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 267 DS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred cc-------------------------cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 00 0001112345778999999999999999999999999999998 999998766
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
....+.+++...... ..+...+.++.+||.+||..||++||++.++.+.+
T Consensus 322 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 322 VDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred chHHHHHHHHhCccC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 544444444433322 23456789999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.98 Aligned_cols=255 Identities=21% Similarity=0.361 Sum_probs=216.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+...+|.+.+.||.|+||.||+|.++.+++.||+|++.+.. .....+.+|++++..++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45678999999999999999999999999999999987532 34567889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999999754 358899999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..
T Consensus 159 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 159 --------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred --------------------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 000112234678999999999999999999999999999998 99999998888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+.+..+.... . +..+..++.++.+||.+||..||++||++.++.+.++
T Consensus 213 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 213 QVYELLEKGY-R-MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred HHHHHHHCCC-C-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 8777765532 2 2235778999999999999999999999665555543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=340.52 Aligned_cols=254 Identities=29% Similarity=0.520 Sum_probs=219.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||+|+||.||+|..+.+|..||+|.+..... ...+.+.+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999876432 22345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc-EEEEecCCccccccccccc
Q 001370 767 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~-VKLsDFGLAk~~~~~~s~d 843 (1091)
|+++++|.+++.+.. .+++..+..++.|++.||.|||+++|+|+||||+||+++.++. +||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND----- 154 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC-----
Confidence 999999999997643 4789999999999999999999999999999999999998865 69999998874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
.........|++.|+|||++.+..++.++|+|||||++|||++|..||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 155 ----------------------SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred ----------------------CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 0111123468999999999998889999999999999999999999999888777776
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+..... +.++..++.++.++|.+||..+|++||+ +.++++||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~~~~~ 257 (257)
T cd08225 213 KICQGYF--APISPNFSRDLRSLISQLFKVSPRDRPS---ITSILKRPFL 257 (257)
T ss_pred HHhcccC--CCCCCCCCHHHHHHHHHHhccChhhCcC---HHHHhhCCCC
Confidence 6665543 2334678899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.30 Aligned_cols=250 Identities=33% Similarity=0.539 Sum_probs=203.7
Q ss_pred CCCeEEEEee--ccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCCee
Q 001370 685 IDDFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 685 iddFeilr~L--GkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILsk-L~HPNIVkL~gsfqded~L 761 (1091)
.++|++.+.+ |.|+||.||+++.+.+|..||+|++.+..... .|..+... .+||||++++++|...+.+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3466666665 99999999999999999999999987643211 12222222 2699999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||+++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~--- 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG--- 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC---
Confidence 99999999999999998877899999999999999999999999999999999999999998 99999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 162 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 162 ----------------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred ----------------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 0112468999999999999999999999999999999999999998654433
Q ss_pred HHHH-HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 921 IFDN-ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 921 i~~k-Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+... +.......+..+..+++.+.+||.+||+.||.+||+ .+.++++||||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 2111 111111111233578999999999999999999996 2589999999974
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=362.98 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=211.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
..++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.++..++||||++++++|....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3578999999999999999999999999999999986532 23334567788999999999999999999886543
Q ss_pred --eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+.+ +|.+.+... +++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 57999999965 888887654 8999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 170 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 170 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred C----------------------------CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 0 011223568999999999999999999999999999999999999998877
Q ss_pred hHHHHHHHhhcC----------------------C-----C---------CCC----CCCCCCHHHHHHHhhhccCCCCC
Q 001370 918 PEIIFDNILNRK----------------------I-----P---------WPC----VPSDMSFEAQDLINRFLIHDPNQ 957 (1091)
Q Consensus 918 ~~ei~~kIl~~~----------------------l-----~---------fP~----ip~~lS~eakDLI~rcL~kDPeK 957 (1091)
....+..+...- . . ++. .+...+..+.+||.+||+.||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 222 HIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 655444443210 0 0 000 01234667899999999999999
Q ss_pred CCCcccHHHHHcCCCCCC
Q 001370 958 RLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 958 RpSa~gA~EIL~HPFFkg 975 (1091)
||+ +.+++.||||+.
T Consensus 302 R~t---~~eiL~~~~~~~ 316 (353)
T cd07850 302 RIS---VDDALQHPYINV 316 (353)
T ss_pred CcC---HHHHhcChhHhh
Confidence 999 889999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=335.38 Aligned_cols=254 Identities=36% Similarity=0.658 Sum_probs=224.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||.|+||.||++.+..++..||+|++..... .......+.+|++++..++|||++++++.+......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999999999999999876432 33556778999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 767 YLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
|+++++|.+++.+. ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~---- 155 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---- 155 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc----
Confidence 99999999999764 6799999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...+.
T Consensus 156 -----------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 156 -----------------------TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred -----------------------CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 001123457899999999999989999999999999999999999999988887777
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..+.... ++.++..++.++.++|.+||..+|.+||+ +.++++||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQ--YPPIPSQYSSELRNLVSSLLQKDPEERPS---IAQILQSPFI 258 (258)
T ss_pred HHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCCCC
Confidence 7776554 33445788999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=340.42 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=214.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++.+.||.|+||.||+|....+|+.||+|.++............+.+|+.++.+++|+||+++++++...+..|+||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999998655555556788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 766 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 766 EYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||+++|+|..++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.+|.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~--- 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--- 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC---
Confidence 99999999999864 24589999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC--hH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PE 919 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s--~~ 919 (1091)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||.... ..
T Consensus 159 ------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 159 ------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred ------------------------CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 0111233568999999999999999999999999999999999999997653 33
Q ss_pred HHHHHHhhcCCCCCCCCC-CCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~-~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.....+..+.. +..+. .++.++.++|.+||..+|.+||++.++.+.+
T Consensus 215 ~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 215 SLCKKIEKCDY--PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred HHHhhhhcCCC--CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 44444444322 22233 6888999999999999999999965554444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=354.26 Aligned_cols=249 Identities=24% Similarity=0.427 Sum_probs=192.3
Q ss_pred EeeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeEEEEee
Q 001370 692 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVMEY 767 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~--TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd--ed~LYLVMEY 767 (1091)
..||+|+||+||+|+.+. ++..||+|.+.... ....+.+|+.+|..++||||++++++|.. ...+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999764 56899999887532 22457789999999999999999998854 5678999999
Q ss_pred cCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe----cCCCcEEEEecCCcc
Q 001370 768 LNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLSK 834 (1091)
Q Consensus 768 m~GGSL~dlL~k~---------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKLsDFGLAk 834 (1091)
+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 875 788777522 248899999999999999999999999999999999999 567899999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
...... .........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||
T Consensus 161 ~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 161 LFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCc------------------------ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 521000 00111234679999999999987 45899999999999999999999999
Q ss_pred CCCChH---------HHHHHHhhc--------------CCCC---------------------CCCCCCCCHHHHHHHhh
Q 001370 914 TAESPE---------IIFDNILNR--------------KIPW---------------------PCVPSDMSFEAQDLINR 949 (1091)
Q Consensus 914 ~~~s~~---------ei~~kIl~~--------------~l~f---------------------P~ip~~lS~eakDLI~r 949 (1091)
...... .....+... ...+ +......+..+.+||.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 296 (317)
T cd07867 217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296 (317)
T ss_pred ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHH
Confidence 754321 111111100 0000 00012345678999999
Q ss_pred hccCCCCCCCCcccHHHHHcCCCC
Q 001370 950 FLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 950 cL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
||+.||.+||| +.|+++||||
T Consensus 297 ~l~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07867 297 LLTMDPTKRIT---SEQALQDPYF 317 (317)
T ss_pred HhccCcccccC---HHHHhcCCCC
Confidence 99999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=354.37 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=210.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~--VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded 759 (1091)
+..++|++.+.||+|+||.||+|.++.++.. +|+|.++. .........+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 5678999999999999999999999888765 46666543 23345567888999999999 8999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 823 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG 823 (1091)
.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997543 478899999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001370 824 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903 (1091)
Q Consensus 824 ~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVIL 903 (1091)
.+||+|||++..... ........+++.|+|||++.+..++.++|||||||++
T Consensus 162 ~~kl~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 162 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred cEEeCccccCcccch----------------------------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 999999999863100 0001122356789999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 904 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 904 YEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
|||++ |.+||...+..+.+..+... .. +..+..++.++.+||.+||..+|.+||+ +.+++.+
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~ 276 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQG-YR-LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 276 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcC-Cc-CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99998 99999988887777766443 11 1223567899999999999999999999 5555543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=342.19 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=209.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||+|+||.||+++++. +..+|+|.+++... ....+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4679999999999999999998864 56799998865432 235688899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~---- 153 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD---- 153 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC----
Confidence 9999999999998753 56899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~ 922 (1091)
.........++..|+|||++.+..++.++|+||||+++|||++ |++||...+..+..
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~ 211 (256)
T cd05114 154 ----------------------EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV 211 (256)
T ss_pred ----------------------ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 0001112346678999999998899999999999999999999 99999999888888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
..+..+... ..+...+.++.+||.+||..||.+||++.+
T Consensus 212 ~~i~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~ 250 (256)
T cd05114 212 EMISRGFRL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAE 250 (256)
T ss_pred HHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 888765432 224567889999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=349.68 Aligned_cols=256 Identities=31% Similarity=0.551 Sum_probs=220.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|...+.||.|+||.||++..+.+++.||+|.+... .....+.+.+|+.++..++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455567999999999999999989999999988642 23345668899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~-------- 167 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-------- 167 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc--------
Confidence 9999999999877 6799999999999999999999999999999999999999999999999998764210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 926 (1091)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...++......+.
T Consensus 168 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 168 -------------------EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred -------------------CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 0011123568999999999998889999999999999999999999999888877777776
Q ss_pred hcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 927 ~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
....+....+..++..+.+||.+||..+|.+||+ +.+++.||||+..
T Consensus 229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 275 (285)
T cd06648 229 DNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT---AAELLNHPFLAKA 275 (285)
T ss_pred hcCCCCCcccccCCHHHHHHHHHHcccChhhCcC---HHHHccCcccccC
Confidence 5533332223447899999999999999999999 8899999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.70 Aligned_cols=259 Identities=29% Similarity=0.488 Sum_probs=219.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 761 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~--i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~L 761 (1091)
.+|++.+.||+|+||.||+|.++.+|+.||+|.+.... .........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999885421 12234567889999999999999999999998764 468
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
++||||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-- 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
...........||+.|+|||++.+..++.++|+|||||++|+|++|++||........
T Consensus 160 ----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 160 ----------------------CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred ----------------------cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 0001111235689999999999998899999999999999999999999988776665
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..++..... .+.+|..+++++.++|.+||. +|.+||+ +.+++.|||.
T Consensus 218 ~~~~~~~~~-~~~~p~~~~~~~~~~i~~~l~-~~~~r~~---~~~~~~~~~~ 264 (264)
T cd06653 218 IFKIATQPT-KPMLPDGVSDACRDFLKQIFV-EEKRRPT---AEFLLRHPFV 264 (264)
T ss_pred HHHHHcCCC-CCCCCcccCHHHHHHHHHHhc-CcccCcc---HHHHhcCCCC
Confidence 555543322 244568899999999999999 6899999 7899999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.33 Aligned_cols=261 Identities=31% Similarity=0.486 Sum_probs=212.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||+|+||+||+|.++.+|+.||+|.++.... .......+.+|+++++.++||||+++++++.+...+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999865432 223346688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEecCCccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~--LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~~~s 841 (1091)
|||++ ++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~--- 155 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--- 155 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC---
Confidence 99996 488888765443 578888999999999999999999999999999999985 55799999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+
T Consensus 156 ------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~ 211 (294)
T PLN00009 156 ------------------------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211 (294)
T ss_pred ------------------------CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0011123467899999999876 457899999999999999999999999877665
Q ss_pred HHHHHhhcC-C--------------------CCCC-----CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 921 IFDNILNRK-I--------------------PWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 921 i~~kIl~~~-l--------------------~fP~-----ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
...++.... . .++. ....+++++.++|.+||+.||++||+ +.+++.||||.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~~l~~~~~~ 288 (294)
T PLN00009 212 ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT---ARAALEHEYFK 288 (294)
T ss_pred HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC---HHHHhcCchHh
Confidence 555543210 0 0000 11357889999999999999999999 88999999998
Q ss_pred CCC
Q 001370 975 GVN 977 (1091)
Q Consensus 975 gId 977 (1091)
+++
T Consensus 289 ~~~ 291 (294)
T PLN00009 289 DLG 291 (294)
T ss_pred HHh
Confidence 753
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=385.99 Aligned_cols=253 Identities=32% Similarity=0.535 Sum_probs=214.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C-----CceEEEeeeeccCCe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N-----PFVVRFFYSFTCRDN 760 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-H-----PNIVkL~gsfqded~ 760 (1091)
.|+++++||+|+||.|.+|.+..|++.||||++++.. .-..+...|+.||..++ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 7999999999999999999999999999999998733 45567788999999997 3 489999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC--cEEEEecCCcccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIG 836 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG--~VKLsDFGLAk~~ 836 (1091)
+|||+|++.. +|+++|+.. ..|+...++.++.||+.||.+||++||||+|||||||||..-+ .|||+|||.|...
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999965 999999865 4699999999999999999999999999999999999997644 7999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
....++.+-+..|.|||+|+|.+|+.+.|+||||||++||++|.|.|.+.
T Consensus 342 ------------------------------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 ------------------------------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ------------------------------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 12233567788999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhc--------------------C-CCCCC----------------------------CC-----------
Q 001370 917 SPEIIFDNILNR--------------------K-IPWPC----------------------------VP----------- 936 (1091)
Q Consensus 917 s~~ei~~kIl~~--------------------~-l~fP~----------------------------ip----------- 936 (1091)
+..+.+..|+.- . ..+|. .|
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 988777766531 0 00000 01
Q ss_pred CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 937 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 937 ~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
..-...+.|||.+||..||.+|+| +.+.|+||||.+..
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~t---p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERIT---PAQALNHPFLTGTS 509 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCC---HHHHhcCccccccc
Confidence 011245789999999999999999 78999999998653
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.18 Aligned_cols=257 Identities=38% Similarity=0.614 Sum_probs=220.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLV 764 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~LYLV 764 (1091)
+|++.+.||+|+||.||+|....+++.|++|++..... .......+.+|+.++++++||||+++++.+... ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 48889999999999999999999999999999876443 245678899999999999999999999999988 899999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||+++++|.+++.+...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET--- 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-hHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s-~~ei~~ 923 (1091)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ......
T Consensus 157 ----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (260)
T cd06606 157 ----------------------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214 (260)
T ss_pred ----------------------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 001234568999999999998889999999999999999999999998766 223333
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+.. ....+.++..++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 215 ~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 260 (260)
T cd06606 215 KIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT---ADELLQHPFL 260 (260)
T ss_pred hccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCC---HHHHhhCCCC
Confidence 3322 22334456788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.07 Aligned_cols=258 Identities=31% Similarity=0.527 Sum_probs=221.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|+.++.||.|+||.||+|.++.++..||+|++.... .......+.+|+.++..++||||+++++++.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999999999999999987532 2345678899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||++||+|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~------- 153 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD------- 153 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC-------
Confidence 99999999999865 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.........|+..|+|||++.+..++.++|+|||||++|||++|.+||...++......+
T Consensus 154 --------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 154 --------------------TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred --------------------CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 001112346899999999999888999999999999999999999999988776665554
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
.... .|.++..++..+.+||.+||..+|.+||+ +.+++.||||.....
T Consensus 214 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06640 214 PKNN--PPTLTGEFSKPFKEFIDACLNKDPSFRPT---AKELLKHKFIVKNAK 261 (277)
T ss_pred hcCC--CCCCchhhhHHHHHHHHHHcccCcccCcC---HHHHHhChHhhhcch
Confidence 3332 23345677889999999999999999999 889999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=345.08 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=214.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++.+.||+|+||.||+|+.+.+|+.||||.+.+...........+.+|+.++..++||||++++++|...+.+|+|
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 36799999999999999999999999999999998876555556667889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 765 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|||++|++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999998864 345899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh--
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-- 918 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~-- 918 (1091)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||.+...
T Consensus 160 --------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 213 (267)
T cd08229 160 --------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred --------------------------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH
Confidence 0111235689999999999998999999999999999999999999976543
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
......+.....+ +..+..++.++++||.+||..||.+||++..+.+++
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 214 YSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred HHHhhhhhcCCCC-CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 3444444433221 112346889999999999999999999955444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=346.17 Aligned_cols=254 Identities=30% Similarity=0.507 Sum_probs=212.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||.|+||.||+|+++.+|..||||+++.... ......+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999876432 2234667889999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 767 YLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g---~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|+++ +|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++.....
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~----- 152 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI----- 152 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC-----
Confidence 9985 8988886543 589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+
T Consensus 153 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 153 ----------------------PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred ----------------------CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 0011123467899999999876 45789999999999999999999999988776666
Q ss_pred HHHhhcC------------------CCCCC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 923 DNILNRK------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 923 ~kIl~~~------------------l~fP~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..+.... ..+|. +...++..+.++|.+||+.||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~f 284 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS---AHDALQHPWF 284 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 6554310 00110 11246788999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=346.63 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=211.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
...++|++.+.||+|+||.||+|.++. ++..||+|++.... .......+.+|+.++..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998652 35689999886532 22345668899999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEE
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 827 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g----------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKL 827 (1091)
....|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999997532 3567788889999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001370 828 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 828 sDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEML 907 (1091)
+|||+++....... ........+++.|||||++.+..++.++|||||||++|||+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCcce-------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 99999874210000 00011235688999999999989999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 908 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 908 T-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+ |..||.+.+.......+..... +..+..++..+.+||.+||+.||.+||+ +.+++.
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~ 273 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPS---FLEIIS 273 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 9 7999999888888777766543 2335778999999999999999999999 545543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=346.80 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=211.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
..++|++.+.||+|+||+||+|... .++..||+|.++... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999863 356789999987532 3345577889999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV-----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 822 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~-----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n 822 (1091)
..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 237788889999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001370 823 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902 (1091)
Q Consensus 823 G~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVI 902 (1091)
+.+||+|||+++...... .........++..|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSAD-------------------------YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCc-------------------------ceecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 999999999987531100 0011233456788999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 903 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 903 LYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
+|||++ |.+||.+.+...+...+..... +..+..++..+.++|.+||+.||.+||+++++.+
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 216 LWEIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 999998 9999998887777666655432 2235678999999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=341.24 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=213.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++++.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++..++||||+++++.+...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 55689999999999999999999865 56779999876532 23567899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999753 458888999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
........++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 158 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 158 --------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred --------------------------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 001112346788999999998889999999999999999998 99999988887
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.....+... ..+|. +..++.++.+||.+||..+|++||+++.+.+++
T Consensus 212 ~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 212 DVMSALQRG-YRMPR-MENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred HHHHHHHcC-CCCCC-CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 777776554 23332 356889999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=347.91 Aligned_cols=263 Identities=34% Similarity=0.572 Sum_probs=226.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|++++..++||||+++++++......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 44678999999999999999999998899999999975332 45678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~---- 168 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK---- 168 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc----
Confidence 999999999999998876 899999999999999999999999999999999999999999999999998763210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...++....
T Consensus 169 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 169 -----------------------EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred -----------------------chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 001122346889999999999888999999999999999999999999988776666
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
..+..........+..++.++++||.+||+.+|.+||+ +.+++.||||+...|..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS---AEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC---HHHHhhChHhhccCchH
Confidence 66554433221122347899999999999999999999 88999999999876653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=345.97 Aligned_cols=256 Identities=29% Similarity=0.559 Sum_probs=216.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~---HPNIVkL~gsfqded~LYL 763 (1091)
.|++++.||.|+||.||+|.+..+|+.||+|.++... .......+.+|+.+++.+. ||||+++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987532 2345667889999999987 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.+|.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~----- 153 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ----- 153 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC-----
Confidence 9999999999999865 4789999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.........|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.........
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 154 ----------------------NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred ----------------------CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 0011233569999999999875 45789999999999999999999999887765554
Q ss_pred HHHhhcCCCCCCCCC-CCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 923 DNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~-~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
..+... ..|.++. .++.++.++|.+||..||.+||+ +.+++.||||+...
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~il~~~~~~~~~ 262 (277)
T cd06917 212 MLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLS---AEELLKSKWIKAHS 262 (277)
T ss_pred hccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcC---HHHHhhChHhhccc
Confidence 443332 2233333 37889999999999999999999 88999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=342.57 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=212.9
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq 756 (1091)
++..++|++.+.||+|+||.||+|..+.. +..||+|.+.... .......+.+|+.+|..++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 34567899999999999999999988644 4789999986532 2334567889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEE
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~----------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 826 (1091)
.....|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 999999999999999999999653 2367788999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEM 906 (1091)
|+|||+++...... .........||..|+|||.+.+..++.++|+|||||++|||
T Consensus 160 l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 214 (277)
T cd05032 160 IGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214 (277)
T ss_pred ECCcccchhhccCc-------------------------ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHh
Confidence 99999987431100 00111234578899999999988899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 907 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 907 LT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
++ |.+||...+.......+.... .+..+..++.++.+||.+||+.+|.+||++.++.
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 215 ATLAEQPYQGLSNEEVLKFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred hccCCCCCccCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 98 999999888888877776443 2334567899999999999999999999944433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=349.01 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=215.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.-++|.+.+.||.|+||+||++... .++..||+|.+.+.. ......+.+|+.++.+++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3468999999999999999999853 345679999887532 34566789999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcE
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG-------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 825 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g-------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~V 825 (1091)
+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999997553 38999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001370 826 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905 (1091)
Q Consensus 826 KLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYE 905 (1091)
||+|||+++...... .........|++.|+|||++.+..++.++|||||||++|+
T Consensus 160 kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 160 KIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred EeccCCccccccCCc-------------------------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 999999987421000 0011123456889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 906 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 906 MLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
|++ |.+||...+..+....+..+... ..+..++.++.+||.+||+.||.+||++.++...++
T Consensus 215 l~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 215 IFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 998 99999998888888888776532 234678899999999999999999999665554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=344.18 Aligned_cols=251 Identities=31% Similarity=0.498 Sum_probs=206.0
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC--CeeEEE
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR--DNLYLV 764 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqde--d~LYLV 764 (1091)
|++++.||+|+||.||+|..+.+++.||+|.+++... . .......+|+.++.++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-S-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-C-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6889999999999999999999999999999876321 1 22234467888888885 99999999999988 889999
Q ss_pred EeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++. |.+||+|||+++....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~----- 151 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS----- 151 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc-----
Confidence 999975 888887653 57899999999999999999999999999999999999999 9999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
........||+.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+..
T Consensus 152 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~ 208 (282)
T cd07831 152 -----------------------KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208 (282)
T ss_pred -----------------------CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH
Confidence 001122458899999998754 45688999999999999999999999988776655
Q ss_pred HHHhhc------------------CCCCCC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 923 DNILNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 923 ~kIl~~------------------~l~fP~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..+... ...+|. ....++.++.+||.+||.+||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~~~~ 282 (282)
T cd07831 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT---AKQALRHPYF 282 (282)
T ss_pred HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC---HHHHhhCCCC
Confidence 544321 111111 11356899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=381.57 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=206.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
....|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++++|||||++++++......|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 34579999999999999999999999999999995321 235689999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
|||++. |+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 999995 6898888654 469999999999999999999999999999999999999999999999999997521100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-----
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 917 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s----- 917 (1091)
........+||+.|||||++.+..|+.++|||||||+||||++|..|+....
T Consensus 315 -----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~ 371 (461)
T PHA03211 315 -----------------------STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371 (461)
T ss_pred -----------------------ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccccc
Confidence 0011234679999999999999999999999999999999999886654321
Q ss_pred ---hHHHHHHHhhcCCC---CCCC----------------------------CCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 918 ---PEIIFDNILNRKIP---WPCV----------------------------PSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 918 ---~~ei~~kIl~~~l~---fP~i----------------------------p~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
...+.+.|...... ++.. ...++.++.+||.+||+.||.+||+
T Consensus 372 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs--- 448 (461)
T PHA03211 372 RPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS--- 448 (461)
T ss_pred CCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC---
Confidence 22333333222111 1100 0135668999999999999999999
Q ss_pred HHHHHcCCCCCC
Q 001370 964 AAEVKAHPFFKG 975 (1091)
Q Consensus 964 A~EIL~HPFFkg 975 (1091)
+.|+|+||||+.
T Consensus 449 a~elL~hp~f~~ 460 (461)
T PHA03211 449 AAELLRLPLFQS 460 (461)
T ss_pred HHHHhhCcccCC
Confidence 889999999974
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=355.88 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=218.5
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|+....||.|+||.||+|....+++.||+|++..... .....+.+|+.++..++||||++++++|...+..|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 34455679999999999999998999999999865332 234668899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~-------- 169 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------- 169 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc--------
Confidence 9999999987754 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 926 (1091)
........+|++.|+|||++.+..++.++|+|||||++|||++|+.||...+..+....+.
T Consensus 170 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 170 -------------------DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred -------------------ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 0011234579999999999999899999999999999999999999999887777666665
Q ss_pred hcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 927 ~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
............++..+.++|.+||+.+|.+||+ +.++++||||...
T Consensus 231 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps---~~~ll~~~~~~~~ 277 (297)
T cd06659 231 DSPPPKLKNAHKISPVLRDFLERMLTREPQERAT---AQELLDHPFLLQT 277 (297)
T ss_pred ccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC---HHHHhhChhhccC
Confidence 4433333334567899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.35 Aligned_cols=257 Identities=31% Similarity=0.534 Sum_probs=217.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
+.|.....||.|+||.||++....++..||||.+.... ....+.+.+|+.++..++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 44555678999999999999999999999999886422 344567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~------- 170 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK------- 170 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc-------
Confidence 99999999998754 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.........||+.|+|||++.+..++.++|+|||||++|||++|..||...+....+..+
T Consensus 171 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 230 (292)
T cd06658 171 --------------------EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230 (292)
T ss_pred --------------------ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001113356899999999999889999999999999999999999999988776666555
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..............+..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~~~~ 278 (292)
T cd06658 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT---AQELLQHPFLKLA 278 (292)
T ss_pred HhcCCCccccccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhhcc
Confidence 43221111122457889999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=333.25 Aligned_cols=254 Identities=31% Similarity=0.611 Sum_probs=222.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||+|+||.||++++..+++.||+|.+.+... .......+.+|++++.+++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999987543 23466789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------- 152 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV------- 152 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC-------
Confidence 9999999999988888999999999999999999999999999999999999999999999999998753100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 926 (1091)
........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.
T Consensus 153 --------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 153 --------------------SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred --------------------cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 011234568999999999988889999999999999999999999998776655554444
Q ss_pred hcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 927 ~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.. ..+.++..++..+.++|.+||..+|++||+ +.+++.||||
T Consensus 213 ~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~~ 254 (254)
T cd06627 213 QD--DHPPLPEGISPELKDFLMQCFQKDPNLRPT---AKQLLKHPWI 254 (254)
T ss_pred cc--CCCCCCCCCCHHHHHHHHHHHhCChhhCcC---HHHHhcCCCC
Confidence 32 233455788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=404.16 Aligned_cols=264 Identities=31% Similarity=0.520 Sum_probs=219.3
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-- 758 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde-- 758 (1091)
.....++|++++.||+|+||+||+|+++.++..||+|++..... .......+..|+.+|..++|||||+++++|...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34567899999999999999999999999999999999976433 344567889999999999999999999988554
Q ss_pred CeeEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-------CCeecccCCCceEecC------
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSL-------GIVHRDLKPDNLLIAH------ 821 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~-------GIIHRDLKPeNILLD~------ 821 (1091)
..+||||||+++|+|.++|... +.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5699999999999999998753 5799999999999999999999985 4999999999999964
Q ss_pred -----------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--C
Q 001370 822 -----------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--T 888 (1091)
Q Consensus 822 -----------nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~ 888 (1091)
.+.+||+|||+++.... .......+||+.|+|||++.+ .
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~----------------------------~s~~~s~vGTp~YmAPEvL~ge~~ 218 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGI----------------------------ESMAHSCVGTPYYWSPELLLHETK 218 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccc----------------------------cccccccCCCccccCHHHHhccCC
Confidence 34599999999874210 011234579999999999965 4
Q ss_pred CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 889 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 889 ~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.|+.++||||||||||||++|.+||...+....+..++.....+|. ...+.++.+||.+||..+|.+||+ +.++|
T Consensus 219 ~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi--~~~S~eL~dLI~~~L~~dPeeRPS---a~QlL 293 (1021)
T PTZ00266 219 SYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI--KGKSKELNILIKNLLNLSAKERPS---ALQCL 293 (1021)
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCc--CCCCHHHHHHHHHHhcCChhHCcC---HHHHh
Confidence 5889999999999999999999999876554444444444333332 457899999999999999999999 88999
Q ss_pred cCCCCCCCCc
Q 001370 969 AHPFFKGVNW 978 (1091)
Q Consensus 969 ~HPFFkgIdW 978 (1091)
.||||+.+..
T Consensus 294 ~h~~ik~i~~ 303 (1021)
T PTZ00266 294 GYQIIKNVGP 303 (1021)
T ss_pred ccHHHhhcCC
Confidence 9999987643
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=346.89 Aligned_cols=256 Identities=29% Similarity=0.497 Sum_probs=205.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||+|+||.||+|..+.+|+.||+|++..... ......+.+|+.++..++|+||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875332 22334667899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----- 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI----- 155 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC-----
Confidence 99996 577776654 35688889999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChH-HH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE-II 921 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~-ei 921 (1091)
.........+++.|+|||++.+ ..++.++|||||||++|||++|.+||...+.. +.
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 156 ----------------------PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred ----------------------CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 0011123467999999999876 45888999999999999999999999865432 22
Q ss_pred HHHHhhc-CCC------------------CCC--------C--CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 922 FDNILNR-KIP------------------WPC--------V--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 922 ~~kIl~~-~l~------------------fP~--------i--p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
...+... ..+ ++. + ....+.++.+||.+||..||.+||+ +.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t---~~~~l~h~~ 290 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS---AQDALLHPY 290 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC---HHHHhcCCC
Confidence 2221110 000 000 0 0123578999999999999999999 889999999
Q ss_pred C
Q 001370 973 F 973 (1091)
Q Consensus 973 F 973 (1091)
|
T Consensus 291 ~ 291 (291)
T cd07870 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=347.17 Aligned_cols=263 Identities=30% Similarity=0.452 Sum_probs=208.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded--- 759 (1091)
..+++|++.+.||+|+||.||+|+++.+++.||||++..... .......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 346789999999999999999999999999999999865322 2223345678999999999999999999887654
Q ss_pred -----eeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 760 -----NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 760 -----~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
..|+||||+.+ +|.+++.+.. .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 35999999975 8888886653 6899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
........ ..........|+..|+|||++.+. .++.++|+||||+++|||++|++|
T Consensus 167 ~~~~~~~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 167 RAFSLSKN-----------------------SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred ccccCCcc-----------------------cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 75311000 001112235688999999998764 478899999999999999999999
Q ss_pred CCCCChHHHHHHHhh--cCC-----------------CCCCC----------CCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 913 FTAESPEIIFDNILN--RKI-----------------PWPCV----------PSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~--~~l-----------------~fP~i----------p~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
|.+.+.......+.. +.. .+|.. +...+..+.+||.+||..||.+||+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t--- 300 (310)
T cd07865 224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID--- 300 (310)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC---
Confidence 988776544333222 110 01100 0123567889999999999999999
Q ss_pred HHHHHcCCCC
Q 001370 964 AAEVKAHPFF 973 (1091)
Q Consensus 964 A~EIL~HPFF 973 (1091)
+.++++||||
T Consensus 301 ~~e~l~h~~f 310 (310)
T cd07865 301 ADTALNHDFF 310 (310)
T ss_pred HHHHhcCCCC
Confidence 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=349.06 Aligned_cols=257 Identities=33% Similarity=0.501 Sum_probs=212.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 762 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~LY 762 (1091)
.++|++.+.||.|+||.||+|.++.+++.||+|.++..... ......+.+|+.++.+++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999999754322 22334577899999999999999999998887 8899
Q ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~--- 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS--- 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC---
Confidence 99999975 9999887654 589999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.........|++.|+|||++.+. .++.++|+||||+++|+|++|.+||...+..+
T Consensus 159 ------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~ 214 (293)
T cd07843 159 ------------------------PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214 (293)
T ss_pred ------------------------CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 00111234578999999998764 46899999999999999999999999887766
Q ss_pred HHHHHhhcCC-------------------CC---------CCCCCC-CCHHHHHHHhhhccCCCCCCCCcccHHHHHcCC
Q 001370 921 IFDNILNRKI-------------------PW---------PCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971 (1091)
Q Consensus 921 i~~kIl~~~l-------------------~f---------P~ip~~-lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HP 971 (1091)
...++...-. .+ ..++.. +++.+.+||.+||+.||++||+ +.|++.||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t---~~ell~~~ 291 (293)
T cd07843 215 QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS---AEDALKHP 291 (293)
T ss_pred HHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC---HHHHhcCC
Confidence 6555432100 00 001222 5889999999999999999999 88999999
Q ss_pred CC
Q 001370 972 FF 973 (1091)
Q Consensus 972 FF 973 (1091)
||
T Consensus 292 ~f 293 (293)
T cd07843 292 YF 293 (293)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=359.71 Aligned_cols=263 Identities=29% Similarity=0.441 Sum_probs=214.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNL 761 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd----ed~L 761 (1091)
++|++.+.||.|+||.||+|..+.+|+.||+|++.+.. ........+.+|+.+|..++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 68999999999999999999999999999999987532 223345678889999999999999999988763 3468
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 59999998777899999999999999999999999999999999999999999999999999874211000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.........+||..|+|||++.+ ..++.++|||||||++|||++|++||.+.+...
T Consensus 163 -----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 219 (334)
T cd07855 163 -----------------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219 (334)
T ss_pred -----------------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence 00111234579999999999876 568999999999999999999999998876544
Q ss_pred HHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 921 IFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 921 i~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
....+... ..++.......+.++.+||.+||+.||.+||+ +.+++.|||
T Consensus 220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~ 296 (334)
T cd07855 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT---VEQALQHPF 296 (334)
T ss_pred HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC---HHHHHhChh
Confidence 33322210 00111112456899999999999999999999 889999999
Q ss_pred CCCC
Q 001370 973 FKGV 976 (1091)
Q Consensus 973 FkgI 976 (1091)
|.+.
T Consensus 297 ~~~~ 300 (334)
T cd07855 297 LAQY 300 (334)
T ss_pred hhhc
Confidence 9854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.80 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=215.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|++.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.++..++||||++++++|.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45999999999999999999999999999999997654444555678899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||+.| +|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.+||+|||++....
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------- 166 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------- 166 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC-------
Confidence 99975 77777654 4568999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
......|++.|+|||++. ...++.++||||||+++|||++|.+||...+....
T Consensus 167 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~ 222 (307)
T cd06607 167 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (307)
T ss_pred ------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence 012346889999999985 35688999999999999999999999988876665
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
...+.....+ ...+..++.++.+||.+||..||.+||+ +.+++.||||..
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 272 (307)
T cd06607 223 LYHIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRPS---SEELLKHRFVLR 272 (307)
T ss_pred HHHHhcCCCC-CCCchhhCHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcc
Confidence 5554433221 1112457889999999999999999999 889999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.21 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=206.7
Q ss_pred eEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe----
Q 001370 688 FEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN---- 760 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~T---Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~---- 760 (1091)
|++.+.||+|+||.||+|....+ +..||+|.++.. .........+.+|+.++..++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC-cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999987653 478999998753 3334556789999999999999999999998766554
Q ss_pred --eEEEEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCC
Q 001370 761 --LYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 761 --LYLVMEYm~GGSL~dlL~k~------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999998543 2589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 911 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-Gkp 911 (1091)
++....... ........++..|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeecccccc-------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 875321100 001112335778999999988899999999999999999999 999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 912 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 912 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
||.+.+..+++..+..+.. +..+..++.++.++|.+||..||.+||++.++
T Consensus 215 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~ 265 (273)
T cd05035 215 PYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFTKL 265 (273)
T ss_pred CCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9999888888877765432 23457889999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=353.22 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=208.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~----VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
+...+|++.+.||+|+||+||+|++..+|.. ||+|+++... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4457899999999999999999998776664 8999886422 234456788999999999999999999998764
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999874 468889999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
... .........++..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 161 ADE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred CCC-------------------------cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 100 0001112335778999999999999999999999999999997 99999988
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
...++... +.....+| .+...+.++.++|.+||..||.+||+ +.+++.+
T Consensus 216 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps---~~~l~~~ 264 (316)
T cd05108 216 PASEISSI-LEKGERLP-QPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 264 (316)
T ss_pred CHHHHHHH-HhCCCCCC-CCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 77665543 34333333 24667899999999999999999999 4455543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.74 Aligned_cols=247 Identities=29% Similarity=0.428 Sum_probs=212.7
Q ss_pred EeeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001370 692 KPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 768 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~T---Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm 768 (1091)
+.||+|+||.||+|..... +..||+|+++..... .....+.+|+.++..++||||+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 889999999764332 25678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 769 NGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 769 ~GGSL~dlL~k~---------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 67999999999999999999999999999999999999999999999999998753210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
. .........+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+.
T Consensus 159 ~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 D-------------------------YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred c-------------------------ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 0011234568899999999998899999999999999999999 6999999988
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.++...+..... +..+..++.++.++|.+||+.||.+||+ +.+++.|
T Consensus 214 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~l~~~ 260 (262)
T cd00192 214 EEVLEYLRKGYR--LPKPEYCPDELYELMLSCWQLDPEDRPT---FSELVER 260 (262)
T ss_pred HHHHHHHHcCCC--CCCCccCChHHHHHHHHHccCCcccCcC---HHHHHHh
Confidence 888888776321 2235678999999999999999999999 6666643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.33 Aligned_cols=258 Identities=31% Similarity=0.486 Sum_probs=213.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYL 763 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~LYL 763 (1091)
++|+..+.||.|+||.||+|.+..+++.||+|.+.+... ......+.+|+++++.++||||++++++|.+. ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999875322 24457789999999999999999999988654 46899
Q ss_pred EEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 764 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
||||++||+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999988753 34589999999999999999999999999999999999999999999999999864210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC---
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 916 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~--- 916 (1091)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 158 ----------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 158 ----------------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred ----------------------------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 0011345788999999999999999999999999999999999999865
Q ss_pred --ChHHHHHHHhhcCC-CCCCCC---CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 917 --SPEIIFDNILNRKI-PWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 917 --s~~ei~~kIl~~~l-~fP~ip---~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
...+....+..... .++..+ ..+++.+.+||.+||..||.+||+ +.|++.||||+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~~ 273 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT---PWDMLEHPWIKAQM 273 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC---HHHHHhCccccccc
Confidence 33444444444221 111111 235678999999999999999999 88999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=347.64 Aligned_cols=263 Identities=26% Similarity=0.439 Sum_probs=212.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYL 763 (1091)
.++|+..+.||+|+||.||++.+..+|+.||+|.+.+... ......+.+|+.++.++. ||||+++++++..+...|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3577888999999999999999999999999999876432 245667889999999996 9999999999999999999
Q ss_pred EEeecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 764 VMEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~-----k~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+|||+.+ +|.++.. ....+++..+..++.+++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999865 5544332 235799999999999999999999975 99999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---CCCccceeechhhhHHHHHhCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|++||.
T Consensus 160 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 160 D----------------------------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred c----------------------------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 0 0111234689999999999875 68999999999999999999999997
Q ss_pred CCCh-HHHHHHHhhcCC-CCC-CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchh
Q 001370 915 AESP-EIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 915 ~~s~-~ei~~kIl~~~l-~fP-~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
.... .+....+..... .++ ..+..++.++.+||.+||..||.+||+ +.+++.||||+...|...
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~i~~~~~~~~~~~~~~ 278 (288)
T cd06616 212 KWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK---YKELLEHPFIKDYEERNV 278 (288)
T ss_pred hcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcChhhhchhhcch
Confidence 6542 222233322221 111 112357899999999999999999999 889999999998766543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.87 Aligned_cols=257 Identities=31% Similarity=0.536 Sum_probs=219.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|+.++.||+|+||.||+|.+..++..||+|++..... ......+.+|+.++..++||||++++++|.....+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 46777889999999999999999999999999875332 2345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|+++|+|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~------- 154 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------- 154 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-------
Confidence 9999999998864 56899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 926 (1091)
........|+..|+|||++.+..++.++|+|||||++|||++|.+||....+......+.
T Consensus 155 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 214 (277)
T cd06642 155 --------------------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP 214 (277)
T ss_pred --------------------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh
Confidence 011123468999999999999899999999999999999999999998776665554443
Q ss_pred hcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 927 ~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
... .+..+..++.++.+||.+||..+|.+||+ +.++++||||....+
T Consensus 215 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06642 215 KNS--PPTLEGQYSKPFKEFVEACLNKDPRFRPT---AKELLKHKFITRYTK 261 (277)
T ss_pred cCC--CCCCCcccCHHHHHHHHHHccCCcccCcC---HHHHHHhHHHHHHhh
Confidence 332 23344678899999999999999999999 889999999976544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=328.08 Aligned_cols=250 Identities=38% Similarity=0.647 Sum_probs=215.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||+|+||.||++....+++.|++|++..... .....+.+|+.++..++||+|+++++.+......|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999976432 356788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 767 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
|++|++|.+++... ..+++..+..++.|++.||.|||.+|++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~------- 150 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------- 150 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccc-------
Confidence 99999999999776 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 151 ---------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 151 ---------------------TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred ---------------------cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 00023457899999999999888999999999999999999999999887655444443
Q ss_pred hhcCCCCCCCCC--CCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 926 LNRKIPWPCVPS--DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 926 l~~~l~fP~ip~--~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
.... .+..+. .++..+.++|.+||..||.+||+ +.+++.|||
T Consensus 210 ~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~~~l~~~~ 253 (253)
T cd05122 210 ATNG--PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLKHPF 253 (253)
T ss_pred HhcC--CCCcCcccccCHHHHHHHHHHccCChhhCCC---HHHHhcCCC
Confidence 3322 222222 34889999999999999999999 889999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=348.89 Aligned_cols=259 Identities=28% Similarity=0.481 Sum_probs=207.0
Q ss_pred CeEEEEeeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 762 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~--TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~LY 762 (1091)
.|++.+.||+|+||.||+|..+. +++.||+|.+.+...........+.+|+.++..++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 8999999999874332333456778899999999999999999999988 7899
Q ss_pred EEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC----CCcEEEEecCCc
Q 001370 763 LVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLS 833 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~-----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~----nG~VKLsDFGLA 833 (1091)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 777766432 36899999999999999999999999999999999999999 999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
+...... .........+||+.|+|||++.+ ..++.++|||||||++|+|++|++|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPL------------------------KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCc------------------------ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 7531100 00111234578999999999876 4589999999999999999999999
Q ss_pred CCCCChHH---------HHHHHhh--------------------------cCCCCCC------CC--CCCCHHHHHHHhh
Q 001370 913 FTAESPEI---------IFDNILN--------------------------RKIPWPC------VP--SDMSFEAQDLINR 949 (1091)
Q Consensus 913 F~~~s~~e---------i~~kIl~--------------------------~~l~fP~------ip--~~lS~eakDLI~r 949 (1091)
|.+..... ....++. ....++. .+ ...+.++.++|.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 98654322 1111110 0011110 00 1567789999999
Q ss_pred hccCCCCCCCCcccHHHHHcCCCC
Q 001370 950 FLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 950 cL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
||..||++||+ +.+++.||||
T Consensus 296 ~l~~~P~~Rps---~~eil~~~~f 316 (316)
T cd07842 296 LLEYDPTKRIT---AEEALEHPYF 316 (316)
T ss_pred HhcCCcccCcC---HHHHhcCCCC
Confidence 99999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.96 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=207.6
Q ss_pred eeccCCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 693 PISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~--k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
.||+|+||.||+|.+ +.++..||+|+++... ......+.+.+|+.++..++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 4568899999986432 33445678899999999999999999999875 4567999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 771 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 771 GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
|+|.+++.+...+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~---------- 149 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---------- 149 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 929 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~ 929 (1091)
..........+++.|+|||++....++.++|+|||||++|||++ |.+||...+..++...+.++.
T Consensus 150 --------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~ 215 (257)
T cd05116 150 --------------NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215 (257)
T ss_pred --------------CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence 00001122345789999999988889999999999999999998 999999888888777776543
Q ss_pred CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 930 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 930 l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
. +..+..++.++++||.+||+.||++||++..+.+.|+
T Consensus 216 ~--~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 216 R--MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 2 3345789999999999999999999999665555554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.99 Aligned_cols=255 Identities=31% Similarity=0.534 Sum_probs=219.9
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
-|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||+++++++...+.+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47788999999999999999998999999998865332 2345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|+++|+|..++.. +.+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~-------- 153 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------- 153 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc--------
Confidence 9999999998864 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 926 (1091)
.........|+..|+|||.+.+..++.++|+|||||++|+|++|.+||...+.......+.
T Consensus 154 -------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (277)
T cd06641 154 -------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214 (277)
T ss_pred -------------------chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence 0011123568999999999988888999999999999999999999998877766666654
Q ss_pred hcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 927 ~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
... .+.++..++.++.++|.+||+.+|.+||+ +.++++||||...
T Consensus 215 ~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~~~~ 259 (277)
T cd06641 215 KNN--PPTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFIVRF 259 (277)
T ss_pred cCC--CCCCCcccCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhhh
Confidence 433 23345678899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.39 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=210.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCC----------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTG----------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TG----------------k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN 747 (1091)
...+|++++.||+|+||.||+|....++ ..||+|.+.... .......+.+|++++.+++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 4568999999999999999999876544 468999987533 2345678899999999999999
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCc
Q 001370 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 816 (1091)
Q Consensus 748 IVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g-----------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeN 816 (1091)
|+++++++...+.+|+||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001370 817 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896 (1091)
Q Consensus 817 ILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDI 896 (1091)
||++.++.++|+|||+++...... .........+|+.|||||++.+..++.++||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD-------------------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeecCCCceEEccccceeecccCc-------------------------ceeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 999999999999999987421100 0011224457889999999998889999999
Q ss_pred echhhhHHHHHh--CCCCCCCCChHHHHHHHhhc-----CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 897 WSVGIILFEFIT--GIPPFTAESPEIIFDNILNR-----KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 897 WSLGVILYEMLT--GkpPF~~~s~~ei~~kIl~~-----~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
|||||++|||++ |..||...+..+++..+... .......+..++.++.+||.+||+.||.+||++.++
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 999999999998 78999887777766665432 111111235678999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.50 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=212.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
...++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.++..++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345789999999999999999999987 7789999988642 223345678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---cEEE
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKL 827 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g-------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKL 827 (1091)
....|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999997653 488999999999999999999999999999999999998765 5999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001370 828 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 828 sDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEML 907 (1091)
+|||+++...... + ........+++.|+|||++.+..++.++|||||||++|||+
T Consensus 161 ~dfg~~~~~~~~~------------------~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 161 ADFGMARDIYRAS------------------Y-------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred ccCccccccCCcc------------------c-------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence 9999987421000 0 00011223457899999999889999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 908 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 908 T-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+ |..||.+.+...+...+..... +..+..++..+.+||.+||+.+|++||+ +.++++|
T Consensus 216 ~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps---~~~vl~~ 274 (277)
T cd05036 216 SLGYMPYPGRTNQEVMEFVTGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRPN---FATILER 274 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 7 9999998888777766654321 2234678999999999999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=342.66 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=214.5
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 753 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TG-----k~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~g 753 (1091)
.+....++|++.+.||+|+||.||++.++..+ ..+|+|.+.... .......+.+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 44566789999999999999999999986443 789999987532 234556788999999999 7999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCce
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNI 817 (1091)
++.....+|+||||+++|+|..++... +.+++..+..++.|++.||.|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999642 3588899999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001370 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 897 (1091)
Q Consensus 818 LLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIW 897 (1091)
|++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 218 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY-------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218 (293)
T ss_pred EEcCCCeEEeCccccccccccccc-------------------------eeccCCCCCCccccCHHHhccCCcCccccee
Confidence 999999999999999874211000 0001122356789999999999999999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 898 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 898 SLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
||||++|||++ |..||...+..+++..+..... +..+...+.++.+||.+||..||.+||+ +.++++
T Consensus 219 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~eil~ 286 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRPT---FKQLVE 286 (293)
T ss_pred ehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcC---HHHHHH
Confidence 99999999997 9999999888888777655432 2234678899999999999999999999 556554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=350.45 Aligned_cols=258 Identities=33% Similarity=0.550 Sum_probs=218.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||.|+||.||++....+++.||+|.+.... ....+.+.+|+.++..++||||+++++.|...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 478999999999999999999998899999999986432 23456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||+++|+|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~------ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 167 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc------
Confidence 999999999999865 3588999999999999999999999999999999999999999999999998864210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......
T Consensus 168 ---------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~ 226 (293)
T cd06647 168 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (293)
T ss_pred ---------------------cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence 00111234689999999999988899999999999999999999999988766544333
Q ss_pred Hhhc-CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 925 ILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 925 Il~~-~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
+... ...++ .+..++..+.+||.+||..+|.+||+ +.+++.||||+..+
T Consensus 227 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~h~~~~~~~ 276 (293)
T cd06647 227 IATNGTPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKIAK 276 (293)
T ss_pred hhcCCCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhcCc
Confidence 3222 22222 23457889999999999999999999 88999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=357.21 Aligned_cols=257 Identities=31% Similarity=0.478 Sum_probs=213.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
..++|++++.||+|+||.||+|....+|..||||++.+.. ........+.+|+.+|+.++||||++++++|....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567999999999999999999999999999999986532 22334567889999999999999999999988765
Q ss_pred --eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 358999999 7799888764 579999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.......|++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 170 ------------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ------------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 01123467999999999876 45889999999999999999999999887
Q ss_pred ChHHHHHHHhhcCCC----------------------------CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 917 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~----------------------------fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+....+..++..... +......+++++.++|.+||+.||.+||+ +.+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t---~~~~l 296 (343)
T cd07880 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT---AAEAL 296 (343)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 765555444332111 01112467889999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001370 969 AHPFFKGV 976 (1091)
Q Consensus 969 ~HPFFkgI 976 (1091)
.||||+..
T Consensus 297 ~~~~~~~~ 304 (343)
T cd07880 297 AHPYFEEF 304 (343)
T ss_pred cCccHhhh
Confidence 99999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.13 Aligned_cols=247 Identities=28% Similarity=0.400 Sum_probs=204.8
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GG 771 (1091)
+.||+|+||.||+|+++.+|+.||+|.+.+. ........+.+|+++++.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3699999999999999999999999988642 23445577899999999999999999999999999999999999999
Q ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 772 DLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 772 SL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
+|.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~---------- 147 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED-G---------- 147 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccc-c----------
Confidence 9999997654 589999999999999999999999999999999999999999999999999864210 0
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 929 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~ 929 (1091)
. . ........++..|+|||.+.+..++.++|||||||++|||++ |.+||...+.......+....
T Consensus 148 -~------~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~ 213 (252)
T cd05084 148 -V------Y-------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213 (252)
T ss_pred -c------c-------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 0 0 000011123567999999998889999999999999999997 999998877776666655432
Q ss_pred CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 930 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 930 l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
.. ..+...+..+.+||.+||+.||++||++.++.+.
T Consensus 214 -~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 214 -RL-PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred -CC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21 2346778999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.69 Aligned_cols=253 Identities=33% Similarity=0.525 Sum_probs=209.9
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccCCe----
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDN---- 760 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL---~HPNIVkL~gsfqded~---- 760 (1091)
|++.+.||.|+||.||+|+++.+++.||+|+++.... .......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999998999999999975332 222344566788877666 59999999999998887
Q ss_pred -eEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 761 -LYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 761 -LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+|++|||+.+ +|.+++.+.. .+++..++.++.|++.||.|||+.||+|+||+|+|||++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 58999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. ........|++.|+|||++.+..++.++|||||||++|||++|.+||...+
T Consensus 159 ~----------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 159 F----------------------------EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred C----------------------------CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 0 011123458899999999999999999999999999999999999999988
Q ss_pred hHHHHHHHhhcC-----CCCC-----------C--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 918 PEIIFDNILNRK-----IPWP-----------C--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 918 ~~ei~~kIl~~~-----l~fP-----------~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..+.+.++...- ..++ . ....++..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~il~~~~~ 287 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS---AFEALQHPYF 287 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC---HHHHhcCcCC
Confidence 877776665410 1111 0 01245678899999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=383.23 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=202.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCC-cEEEEEE--------------eecccccchhHHHHHHHHHHHHHhcCCCce
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKV--------------LKKLDMIRKNDIERILAERNILITVRNPFV 748 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TG-k~VAIKi--------------LkK~~i~~~~eie~~l~EieILskL~HPNI 748 (1091)
..++|++++.||+|+||+||+|..+... ..++.|. +.+...........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999999765432 2222221 111111122345668899999999999999
Q ss_pred EEEeeeeccCCeeEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC
Q 001370 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 823 (1091)
Q Consensus 749 VkL~gsfqded~LYLVMEYm~GGSL~dlL~k~-----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG 823 (1091)
|++++++...+..|+||+++. ++|..++... .......++.++.||+.||.|||++|||||||||+||||+.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999995 4787777542 2234567888999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001370 824 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903 (1091)
Q Consensus 824 ~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVIL 903 (1091)
.+||+|||+++.... .........+||+.|+|||++.+..|+.++|||||||+|
T Consensus 305 ~vkL~DFGla~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 358 (501)
T PHA03210 305 KIVLGDFGTAMPFEK--------------------------EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358 (501)
T ss_pred CEEEEeCCCceecCc--------------------------ccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHH
Confidence 999999999974210 001122346899999999999999999999999999999
Q ss_pred HHHHhCCCC-CCCC--ChHHHHHHHhhc----CCCCCC----------------C---------CCCCCHHHHHHHhhhc
Q 001370 904 FEFITGIPP-FTAE--SPEIIFDNILNR----KIPWPC----------------V---------PSDMSFEAQDLINRFL 951 (1091)
Q Consensus 904 YEMLTGkpP-F~~~--s~~ei~~kIl~~----~l~fP~----------------i---------p~~lS~eakDLI~rcL 951 (1091)
|||++|..| |... ++...+.+++.. ...+|. . ...++.++.++|.+||
T Consensus 359 ~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL 438 (501)
T PHA03210 359 LDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKML 438 (501)
T ss_pred HHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHh
Confidence 999998754 4322 222222222210 001110 0 1235678889999999
Q ss_pred cCCCCCCCCcccHHHHHcCCCCCCCCcchh
Q 001370 952 IHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 952 ~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
++||.+||+ +.|++.||||.+..++.+
T Consensus 439 ~~DP~~Rps---a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 439 TFDWHLRPG---AAELLALPLFSAEEEEEI 465 (501)
T ss_pred ccCcccCcC---HHHHhhChhhhcCCchHH
Confidence 999999999 889999999998776654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=356.69 Aligned_cols=261 Identities=30% Similarity=0.506 Sum_probs=209.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----C
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----D 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde-----d 759 (1091)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.++..++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 368999999999999999999999999999999986422 233456788999999999999999999876544 3
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||+.+ +|..++.. ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999975 88887754 56999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
. .........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 160 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 160 H------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred c------------------------cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 00111234578999999998765 5689999999999999999999999987654
Q ss_pred HHHHHHHhh---------------c-------------CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILN---------------R-------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~---------------~-------------~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
......+.. . ..+++......+.++.+||.+||+.||.+||+ +.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~e~l~h 292 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT---VEEALAH 292 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC---HHHHhcC
Confidence 333322211 0 00000011346788999999999999999999 8899999
Q ss_pred CCCCCC
Q 001370 971 PFFKGV 976 (1091)
Q Consensus 971 PFFkgI 976 (1091)
|||+..
T Consensus 293 p~~~~~ 298 (336)
T cd07849 293 PYLEQY 298 (336)
T ss_pred cccccc
Confidence 999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=332.29 Aligned_cols=252 Identities=30% Similarity=0.521 Sum_probs=221.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+|++.+.||.|+||.||+++++.+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999976443 23456778899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 767 YLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 767 Ym~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
|+++++|..++.+ ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.+||+|||+++....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~---- 155 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK---- 155 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc----
Confidence 9999999999866 35689999999999999999999999999999999999999999999999999875210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 156 -------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 156 -------------------------NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred -------------------------CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112346889999999999999999999999999999999999999998887777
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..+.... ++.++..++.++.++|.+||..+|.+||+ +.++++||+.
T Consensus 211 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~p~~ 256 (256)
T cd08530 211 YKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPN---CDKILASPAV 256 (256)
T ss_pred HHHhcCC--CCCCchhhCHHHHHHHHHHcCCCcccCCC---HHHHhcCCCC
Confidence 6665544 34445678999999999999999999999 8899999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.96 Aligned_cols=260 Identities=30% Similarity=0.462 Sum_probs=213.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded----- 759 (1091)
.+.|++++.||+|+||+||+|++..+|+.||||.+++.. ........+.+|+.++..++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357999999999999999999999999999999987532 23334567788999999999999999999886543
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~- 160 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE- 160 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC-
Confidence 4899999996 68999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.........||..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 161 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 161 --------------------------KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred --------------------------CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 0011223568999999999875 5689999999999999999999999987664
Q ss_pred HHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
......+... ...+......+++++.+||.+||+.||.+||+ +.++++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps---~~ell~h 291 (337)
T cd07858 215 VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT---VEEALAH 291 (337)
T ss_pred HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC---HHHHHcC
Confidence 4333322210 00011112467899999999999999999999 8899999
Q ss_pred CCCCCC
Q 001370 971 PFFKGV 976 (1091)
Q Consensus 971 PFFkgI 976 (1091)
|||+.+
T Consensus 292 ~~~~~~ 297 (337)
T cd07858 292 PYLASL 297 (337)
T ss_pred cchhhh
Confidence 999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.07 Aligned_cols=254 Identities=31% Similarity=0.530 Sum_probs=210.8
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999875432 223346688999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 768 LNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 768 m~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~------- 151 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV------- 151 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC-------
Confidence 95 69999997765 689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
.........+++.|+|||++.+. .++.++|+|||||++|+|++|.+||...+.......
T Consensus 152 --------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 152 --------------------PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred --------------------CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00111223578999999998764 578899999999999999999999988776544443
Q ss_pred HhhcC--------------------------CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 925 ILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 925 Il~~~--------------------------l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+.... .........++.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS---AKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC---HHHHhcCCCC
Confidence 32210 0001112467789999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=337.33 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=212.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.++|++.+.||+|+||.||+|+++.+ ...||||+++... .......+.+|+.++..++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46899999999999999999998654 4589999887532 334456788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS- 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc-
Confidence 9999999999999999764 46899999999999999999999999999999999999999999999999999853100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 160 ------------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 160 ------------------------EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred ------------------------ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 00001112345788999999999899999999999999999998 99999888877
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
.....+..... .| .+...+..+.+|+.+||+.+|++||++.++.+.
T Consensus 216 ~~~~~~~~~~~-~~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 216 DVIKAVEDGYR-LP-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHcCCC-CC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 77777765422 22 246789999999999999999999995444333
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.46 Aligned_cols=254 Identities=21% Similarity=0.329 Sum_probs=213.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
...+|++.+.||+|+||.||+|....+ +..||||+++... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456788999999999999999987543 5789999987532 233456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 822 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n 822 (1091)
..+++++||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 247888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001370 823 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902 (1091)
Q Consensus 823 G~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVI 902 (1091)
+.+||+|||+++...... .........+++.|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 215 (283)
T cd05091 161 LNVKISDLGLFREVYAAD-------------------------YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVV 215 (283)
T ss_pred CceEecccccccccccch-------------------------heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHH
Confidence 999999999987421100 0011123456889999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 903 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 903 LYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+|||++ |.+||.+....+....+...... ..+..++.++.+|+.+||+.+|.+||+ +.+|+.
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~---~~~i~~ 278 (283)
T cd05091 216 LWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPR---FKDIHS 278 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCC---HHHHHH
Confidence 999998 99999998888888888776543 235789999999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=340.08 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=209.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk----~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
+..++|++++.||.|+||+||+|++..+|+ .||+|+++... .......+.+|+.++..+.||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456789999999999999999999887776 48999886532 33445678899999999999999999998875
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
...+++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 4578999999999999999764 569999999999999999999999999999999999999999999999999987531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.... ........+++.|+|||.+.+..++.++|||||||++|||++ |.+||...
T Consensus 161 ~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 161 IDET-------------------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred cccc-------------------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1000 000112245788999999999999999999999999999998 99999887
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
....+...+.... ..+ .+...+.++.++|.+||..||++||+ +.+++
T Consensus 216 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~l~ 262 (279)
T cd05109 216 PAREIPDLLEKGE-RLP-QPPICTIDVYMIMVKCWMIDSECRPR---FRELV 262 (279)
T ss_pred CHHHHHHHHHCCC-cCC-CCccCCHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 7766666554432 222 24678899999999999999999999 44554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=375.81 Aligned_cols=257 Identities=35% Similarity=0.597 Sum_probs=226.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GG 771 (1091)
++||.|.||+||-|+++.+|+.||||+|.|.++..+. ...+++|+.||+.+.||.||.|-..|++.+.+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 6899999999999999999999999999998776554 48899999999999999999999999999999999999965
Q ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---cEEEEecCCcccccccccccCCC
Q 001370 772 DLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 772 SL~dlL~--k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|+..++- +.++|++...+|++.||+.||.|||-+||+|+||||+||||.... .+||||||+|+++.+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-------- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-------- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--------
Confidence 7766663 568899999999999999999999999999999999999997643 699999999997431
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 926 (1091)
.....+.+|||.|+|||++..++|+..-|+||.|||+|.-|.|..||..+ +++-++|.
T Consensus 720 --------------------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQ 777 (888)
T KOG4236|consen 720 --------------------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQ 777 (888)
T ss_pred --------------------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhh
Confidence 23346789999999999999999999999999999999999999999754 56677788
Q ss_pred hcCCCCCCCC-CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC-Ccchhhc
Q 001370 927 NRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV-NWDSLAL 983 (1091)
Q Consensus 927 ~~~l~fP~ip-~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI-dWd~L~~ 983 (1091)
+..+.||.-| ..+++++.|||..+|++.-.+|.+ +...+.|||+++. -|-.|+.
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys---vdk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS---VDKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc---hHhhccchhhhcchHHHHHHH
Confidence 8777776533 568999999999999999999999 7788999999874 4655543
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.00 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=215.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
...+|++.+.||.|+||.||+|.++. +..+|+|++.+.. ......+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 45679999999999999999999987 8999999987643 2235568899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~--- 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE--- 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC---
Confidence 99999999999999753 4589999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~e 920 (1091)
.........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+
T Consensus 157 ------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 157 ------------------------DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred ------------------------ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 0001113346788999999998899999999999999999998 899999988888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
++..+... ...+ .+..+++.+.++|.+||+.||.+||++.++.+.|
T Consensus 213 ~~~~~~~~-~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 213 VYDQITAG-YRMP-CPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHHHHhC-CcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 88877654 2222 3467899999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.21 Aligned_cols=262 Identities=31% Similarity=0.471 Sum_probs=220.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----ee
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 761 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded-----~L 761 (1091)
+|++.+.||.|+||.||+|+...+|+.||||++.+.. ........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999999999999987632 22345677899999999999999999999998876 79
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||+++ +|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~- 157 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE- 157 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc-
Confidence 999999985 899999887789999999999999999999999999999999999999999999999999987531100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
..........||+.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+
T Consensus 158 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~ 214 (330)
T cd07834 158 -----------------------DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214 (330)
T ss_pred -----------------------cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 000112335689999999999887 88999999999999999999999999988777
Q ss_pred HHHHHhhcCCC----------------------------CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 921 IFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 921 i~~kIl~~~l~----------------------------fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
.+..+...... +......++.++.+||.+||++||.+||+ +.+++.|||
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~~~ 291 (330)
T cd07834 215 QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT---ADEALAHPY 291 (330)
T ss_pred HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCcc
Confidence 76665542110 01112347889999999999999999999 889999999
Q ss_pred CCCCC
Q 001370 973 FKGVN 977 (1091)
Q Consensus 973 FkgId 977 (1091)
|+++.
T Consensus 292 ~~~~~ 296 (330)
T cd07834 292 LAQLH 296 (330)
T ss_pred HHhhc
Confidence 98653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=355.82 Aligned_cols=257 Identities=32% Similarity=0.481 Sum_probs=210.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded----- 759 (1091)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|+.++..++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 368999999999999999999999999999999987632 22233456889999999999999999999887553
Q ss_pred -eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 -~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+|+||||+.+ +|..++. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~- 168 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD- 168 (342)
T ss_pred ceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC-
Confidence 46999999965 7776652 368999999999999999999999999999999999999999999999999987310
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 169 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 169 -----------------------------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred -----------------------------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123468999999999876 468899999999999999999999999887
Q ss_pred hHHHHHHHhhcC-----------------------CCCC-----CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 918 PEIIFDNILNRK-----------------------IPWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 918 ~~ei~~kIl~~~-----------------------l~fP-----~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
....+..+.... ..++ ......+.++.+||.+||+.||.+||+ +.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~---~~e~l~ 296 (342)
T cd07879 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT---ATEALE 296 (342)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC---HHHHhc
Confidence 655554443310 0000 011246788999999999999999999 889999
Q ss_pred CCCCCCCCc
Q 001370 970 HPFFKGVNW 978 (1091)
Q Consensus 970 HPFFkgIdW 978 (1091)
||||+++.+
T Consensus 297 h~~f~~~~~ 305 (342)
T cd07879 297 HPYFDSFRD 305 (342)
T ss_pred Ccchhhccc
Confidence 999988754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=337.30 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=204.8
Q ss_pred eEEEEeeccCCceEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------C
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------D 759 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk--~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde------d 759 (1091)
|.+.+.||+|+||.||+|+...++. .||+|.++.. .......+.+.+|..++..++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999887775 6999988653 23455678899999999999999999999876332 2
Q ss_pred eeEEEEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 478999999999999887422 34789999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpP 912 (1091)
+....... ........+++.|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 75311000 001122346788999999999999999999999999999999 8999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 913 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
|.+.....++..+.++... ..+..++..+.++|.+||+.||.+||++.++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~ 265 (272)
T cd05075 215 YPGVENSEIYDYLRQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLR 265 (272)
T ss_pred CCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 9988888887777665431 22467889999999999999999999944443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=336.55 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=208.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
..+|++.+.||+|+||.||+|+++ ++..+|+|++.+... ....+.+|+.++..++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 357899999999999999999886 467899999875432 234678899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--- 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--- 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc---
Confidence 9999999999999764 468999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~ 922 (1091)
........++..|+|||++.+..++.++|||||||++|||++ |.+||...+..+..
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05059 155 -----------------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211 (256)
T ss_pred -----------------------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence 000111234568999999999999999999999999999999 89999988887777
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..+.... . +..+...+.++.+|+.+||..+|++||+ +.++++
T Consensus 212 ~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~~~l~ 253 (256)
T cd05059 212 ESVSAGY-R-LYRPKLAPTEVYTIMYSCWHEKPEDRPA---FKKLLS 253 (256)
T ss_pred HHHHcCC-c-CCCCCCCCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 7765442 2 1224568999999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.72 Aligned_cols=269 Identities=30% Similarity=0.479 Sum_probs=210.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
.+++|++.+.||.|+||.||+|+++.+++.||||++..... .......+.+|++++..++||||+++++.+....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 36899999999999999999999999999999999875432 1222345678999999999999999998875433
Q ss_pred ----eeEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 760 ----NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 760 ----~LYLVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
.+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 47999999975 67777664 3479999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
........ ....+ ...........||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 164 ~~~~~~~~-----------~~~~~-----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPN-----------PKGGG-----GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCcc-----------cccCC-----cccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 43211000 00000 001112234678999999999875 45889999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCC-----CC------C---------CC-------CCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 914 TAESPEIIFDNILNRKI-----PW------P---------CV-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 914 ~~~s~~ei~~kIl~~~l-----~f------P---------~i-------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
.+.+.......+..... .+ + .. ...++.++.+||.+||..||.+||+ +.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~e 304 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT---ASD 304 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC---HHH
Confidence 98877666555443100 00 0 00 0234578899999999999999999 889
Q ss_pred HHcCCCC
Q 001370 967 VKAHPFF 973 (1091)
Q Consensus 967 IL~HPFF 973 (1091)
++.||||
T Consensus 305 ll~~~~f 311 (311)
T cd07866 305 ALEHPYF 311 (311)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=358.09 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=206.6
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 754 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gs 754 (1091)
|.+.-++|++.+.||.|+||.||+|.... +++.||+|+++... .......+..|+.++.++ +||||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 44556789999999999999999997543 45789999987432 234456788999999999 79999999998
Q ss_pred eccC-CeeEEEEeecCCCcHHHHHHhc-----------------------------------------------------
Q 001370 755 FTCR-DNLYLVMEYLNGGDLYSLLRKV----------------------------------------------------- 780 (1091)
Q Consensus 755 fqde-d~LYLVMEYm~GGSL~dlL~k~----------------------------------------------------- 780 (1091)
+... ..+|+||||+++|+|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 7654 5689999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCC
Q 001370 781 --------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852 (1091)
Q Consensus 781 --------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~ 852 (1091)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~------------ 227 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------ 227 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc------------
Confidence 257888999999999999999999999999999999999999999999999997531100
Q ss_pred CCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCC
Q 001370 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIP 931 (1091)
Q Consensus 853 lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~ 931 (1091)
.........|+..|||||++.+..++.++|||||||++|||++ |..||.+....+.+...+.....
T Consensus 228 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 294 (337)
T cd05054 228 -------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294 (337)
T ss_pred -------------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC
Confidence 0011123456788999999999999999999999999999998 99999876655444444443322
Q ss_pred CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 932 fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
+..+...++++.+++.+||+.+|++||++.++
T Consensus 295 -~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 295 -MRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred -CCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 22346788999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=366.58 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=212.6
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeee
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYS 754 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gs 754 (1091)
+....++|++++.||+|+||.||+|.+... +..||||+++... .....+.+++|+.+|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 445678899999999999999999987533 3479999996532 3344578999999999996 9999999999
Q ss_pred eccCCeeEEEEeecCCCcHHHHHHhc------------------------------------------------------
Q 001370 755 FTCRDNLYLVMEYLNGGDLYSLLRKV------------------------------------------------------ 780 (1091)
Q Consensus 755 fqded~LYLVMEYm~GGSL~dlL~k~------------------------------------------------------ 780 (1091)
+.....+|||||||++|+|.++|.+.
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 99999999999999999999988642
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceE
Q 001370 781 ------------------------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 818 (1091)
Q Consensus 781 ------------------------------------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNIL 818 (1091)
..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 13677888899999999999999999999999999999
Q ss_pred ecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeec
Q 001370 819 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 898 (1091)
Q Consensus 819 LD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWS 898 (1091)
++.++.+||+|||+++...... .........|++.|||||++.+..++.++||||
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 324 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDS-------------------------NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324 (400)
T ss_pred EeCCCEEEEEeCCcceeccccc-------------------------cccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence 9999999999999987421100 001122346788999999999999999999999
Q ss_pred hhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 899 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 899 LGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
|||++|||++ |..||........+...+.....++ .+..++.++.+||.+||..||++||++.++.+++.
T Consensus 325 lGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 325 YGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 9999999997 9999987655444433344333332 34678999999999999999999999766666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=335.58 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=209.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++.+.||+|+||.||+|... .+..||+|.++.... ....+.+|+.++++++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999876 567799999876432 2356889999999999999999998875 45689
Q ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||+++|+|.+++... ..+++..++.++.+++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc-
Confidence 999999999999999763 35899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
.........++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 156 -------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred -------------------------ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0001112345678999999998889999999999999999999 99999988888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
++...+... ...+ .+...+..+.+||.+||.+||.+||+++.+.+++
T Consensus 211 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 211 EVLEQVERG-YRMP-CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 877777653 2222 3467889999999999999999999955444443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=334.15 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=207.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee-ccCCee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRDNL 761 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsf-qded~L 761 (1091)
+...+|++.+.||+|+||.||++... |..||+|.++.. .....+.+|+.+++.++||||+++++++ .....+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999765 788999988642 2345788999999999999999999875 455679
Q ss_pred EEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
|+||||+++|+|.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999997654 488999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
......++..|+|||++.+..++.++|||||||++|||++ |++||...+.
T Consensus 155 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 155 -----------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred -----------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0112335678999999999899999999999999999997 9999998887
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.++...+..+. . +..+..+++.+.+||.+||..+|.+||++.++.+.|
T Consensus 206 ~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 206 KDVVPRVEKGY-K-MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred HHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 77777665442 2 223467899999999999999999999955554444
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=334.95 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=211.9
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++.+.||+|+||.||+|... +++.||+|.++.... ....+.+|+.++.+++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45578999999999999999999875 457899999875432 2456889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 156 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED- 156 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC-
Confidence 9999999999999997654 6899999999999999999999999999999999999999999999999998753100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
.........++..|+|||++.+..++.++|+||||+++|||++ |++||.+.+..
T Consensus 157 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 157 -------------------------IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred -------------------------cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0000111223568999999999899999999999999999999 99999998887
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.+...+.... ..+ .+...+..+.+++.+||..+|.+||++..+...+
T Consensus 212 ~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 212 EVLQQVDQGY-RMP-CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred HHHHHHHcCC-CCC-CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 7777765442 222 2467889999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.38 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=212.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
...+|.+.+.||+|+||.||+|... .++..+|+|.+.+. .......+.+|++++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3468899999999999999999753 34678999988653 234567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG---------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 823 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g---------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG 823 (1091)
...|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997653 478899999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001370 824 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903 (1091)
Q Consensus 824 ~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVIL 903 (1091)
.+||+|||+++...... .........+++.|+|||++.+..++.++|||||||++
T Consensus 160 ~~kL~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05092 160 VVKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214 (280)
T ss_pred CEEECCCCceeEcCCCc-------------------------eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHH
Confidence 99999999987421000 00111234467899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 904 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 904 YEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
|||++ |.+||......+....+..+... ..+..+++.+.+||.+||+.||.+||+++++.+.
T Consensus 215 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~ 277 (280)
T cd05092 215 WEIFTYGKQPWYQLSNTEAIECITQGREL--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSR 277 (280)
T ss_pred HHHHcCCCCCCccCCHHHHHHHHHcCccC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 99998 99999888877777776655322 2346788999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=343.45 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=206.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk--~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LY 762 (1091)
++|++.+.||+|+||.||+|..+.++. .+|+|.++. .........+.+|+.++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999887765 468887763 22334456789999999999 7999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEE
Q 001370 763 LVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 826 (1091)
+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997542 478889999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEM 906 (1091)
|+|||++..... ........++..|+|||++.+..++.++|||||||++|||
T Consensus 160 l~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCccccc----------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 999999863100 0001112235679999999998999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 907 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 907 LT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
++ |.+||...+..+.+..+..+. . +..+..++.++.+||.+||..+|.+||++.+
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 267 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGY-R-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQ 267 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 97 999999998888887776542 1 2234678999999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=335.78 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=210.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++++.||+|+||+||+|++.. +..||+|.++.... ....+.+|+.++.+++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4689999999999999999998764 45699998875332 235688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~---- 153 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD---- 153 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC----
Confidence 9999999999999764 46899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~ 922 (1091)
. ........++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+..
T Consensus 154 -----------------~-----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05113 154 -----------------E-----YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211 (256)
T ss_pred -----------------c-----eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 0 000112346678999999998889999999999999999998 99999988888888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..+.+..... .+...+..+.+++.+||..||.+||+ +.+|+.
T Consensus 212 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~---~~~ll~ 253 (256)
T cd05113 212 EKVSQGLRLY--RPHLASEKVYAIMYSCWHEKAEERPT---FQQLLS 253 (256)
T ss_pred HHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 8877654332 24567899999999999999999999 556654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=342.17 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=212.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
...+|.+.+.||+|+||.||+|+... ++..+|+|.+.... ......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45689999999999999999998643 45679999876432 23446788999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 822 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n 822 (1091)
+.+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997543 37889999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001370 823 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902 (1091)
Q Consensus 823 G~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVI 902 (1091)
+.+||+|||+++...... .........|++.|+|||++.+..++.++|||||||+
T Consensus 160 ~~~~l~dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 214 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214 (291)
T ss_pred CcEEECCCCcccccCCCc-------------------------eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHH
Confidence 999999999987421100 0011123457899999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 903 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 903 LYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+|||++ |.+||...+..+....+..+... ..+...+..+.+||.+||+.||.+||++.++.+.+
T Consensus 215 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 215 LWEIFTYGKQPWFQLSNTEVIECITQGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhCCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 999998 99999988888777776655432 23466789999999999999999999965554444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=346.19 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=217.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|+..+.||+|+||.||+|++..+|..||+|++.+...........+.+|+.+++.++|||++++++++...+..|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999999999999999997654444455678899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||++| +|.+++.. ...+++..+..++.+++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 99975 78777754 4568999999999999999999999999999999999999999999999999876311
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
......|++.|+|||++. +..++.++|||||||++|||++|.+||...+....
T Consensus 177 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 177 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred ------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 012346899999999984 35688999999999999999999999988877776
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
...+........ ....++..+.+||.+||+.+|.+||+ +.+++.|+|+..
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~ 282 (317)
T cd06635 233 LYHIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRPT---SEELLKHMFVLR 282 (317)
T ss_pred HHHHHhccCCCC-CCccccHHHHHHHHHHccCCcccCcC---HHHHHhChhhhc
Confidence 666665543322 23567889999999999999999999 889999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.75 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=212.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk---~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..++|+..+.||+|+||.||+|+.+.++. .+|+|.++... .......+.+|+.++..++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45689999999999999999999876665 79999886532 23345678899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.|+||||+++|+|.+++.+. +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999764 57899999999999999999999999999999999999999999999999998743110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
.. .........+++.|+|||++.+..++.++|||||||++|||++ |+.||...+.
T Consensus 161 ~~------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 161 PE------------------------GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred cc------------------------cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 00 0000111223568999999998889999999999999999997 9999998888
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
.++...+.... ..| .+...+.++.+|+.+||..+|.+||++.++.+.
T Consensus 217 ~~~~~~i~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 217 HEVMKAINDGF-RLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88777776542 323 235678999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=339.95 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=213.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.++..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999998753 67899999987532 233456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 816 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g----------------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeN 816 (1091)
..+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997432 36788889999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001370 817 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896 (1091)
Q Consensus 817 ILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDI 896 (1091)
||++.++.+||+|||++....... .........+++.|+|||++.+..++.++||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSAD-------------------------YYKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCc-------------------------cccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 999999999999999987421000 0001112235678999999999999999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 897 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 897 WSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
|||||++|||++ |..||.+.+..+....+..+... ..+..++.++.+||.+||+.||.+||++.++...|+
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 999999999997 88999988888888777665432 234678899999999999999999999665555554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.40 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=205.8
Q ss_pred EeeccCCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001370 692 KPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 768 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TG---k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm 768 (1091)
+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.++|||||++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876655 78999998765432 35567899999999999999999999876 45689999999
Q ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001370 769 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848 (1091)
Q Consensus 769 ~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~ 848 (1091)
++|+|.+++.+...+++..+..++.|++.||.|||..||+||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~------- 150 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD------- 150 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc-------
Confidence 9999999998888899999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhh
Q 001370 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 927 (1091)
Q Consensus 849 t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~ 927 (1091)
.........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..++...+..
T Consensus 151 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 151 -----------------YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred -----------------ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 0000111224578999999999999999999999999999998 9999998888777776655
Q ss_pred cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 928 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 928 ~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
... ...+..++..+++||.+||..+|.+||++.++.+++
T Consensus 214 ~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 214 GER--LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred CCc--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 432 223567889999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=342.87 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=208.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCC--------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTG--------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV 749 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TG--------------k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIV 749 (1091)
..++|++.+.||+|+||.||+|++..++ ..||+|.++.. ........+.+|++++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3468999999999999999999875432 35999998753 2344566789999999999999999
Q ss_pred EEeeeeccCCeeEEEEeecCCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCce
Q 001370 750 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817 (1091)
Q Consensus 750 kL~gsfqded~LYLVMEYm~GGSL~dlL~k~g------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNI 817 (1091)
++++++.....+|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 367888899999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001370 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 897 (1091)
Q Consensus 818 LLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIW 897 (1091)
|++.++.+||+|||++....... .........+++.|+|||++.+..++.++|||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 215 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVW 215 (295)
T ss_pred EEcCCCcEEecccccccccccCc-------------------------ceeccCcCcCceeecChhhhccCCcCchhhHH
Confidence 99999999999999987421100 00111234567899999999998999999999
Q ss_pred chhhhHHHHHh--CCCCCCCCChHHHHHHHhh-----cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 898 SVGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 898 SLGVILYEMLT--GkpPF~~~s~~ei~~kIl~-----~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
||||++|+|++ |..||...+..+....+.. ....+...+..+++.+.+||.+||..||.+||+++++.+.|
T Consensus 216 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 216 AFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99999999988 7789988777666555432 12222333456789999999999999999999955544433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=335.43 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=212.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk---~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
..+|++.+.||+|+||.||+|.++.++. .||+|.++... .......+.+|+.++..++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865543 79999886532 233456889999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||+++|+|.+++.+. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
..........++..|+|||++.+..++.++|+|||||++|||++ |..||...+..
T Consensus 161 ------------------------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 161 ------------------------EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred ------------------------ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 00001112234678999999998899999999999999999886 99999988877
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+....+... ...| .+..++..+.+++.+||+++|.+||+++++.+++
T Consensus 217 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 263 (267)
T cd05066 217 DVIKAIEEG-YRLP-APMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263 (267)
T ss_pred HHHHHHhCC-CcCC-CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence 777776654 2223 2456889999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=335.83 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=209.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++.+.||+|+||.||+|++..+ ..||+|++++... ....+.+|++++..++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 3456799999999999999999988765 4599999875332 2356889999999999999999998875 45689
Q ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~- 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc-
Confidence 999999999999999763 35789999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
.........|+..|+|||++.+..++.++|+|||||++|||++ |.+||.+....
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 156 -------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred -------------------------ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 0001123346788999999998899999999999999999999 89999988888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.+...+.... ..+ .+..++..+.+||.+||++||.+||++.++.+.+
T Consensus 211 ~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l 257 (262)
T cd05071 211 EVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257 (262)
T ss_pred HHHHHHhcCC-CCC-CccccCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 7777765542 222 2457889999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.15 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=207.1
Q ss_pred eeccCCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 693 PISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k--~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
.||+|+||.||+|.++ .++..||+|++.... .....+.+.+|+.++++++||||+++++++. .+.+|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999775 445679999986532 3344567899999999999999999999886 4578999999999
Q ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001370 771 GDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 849 (1091)
Q Consensus 771 GSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t 849 (1091)
|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 150 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS-------- 150 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc--------
Confidence 999999874 45789999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 001370 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 928 (1091)
Q Consensus 850 ~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~ 928 (1091)
.........+++.|+|||++.+..++.++|+|||||++|||++ |.+||......+....+..+
T Consensus 151 ----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05115 151 ----------------YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214 (257)
T ss_pred ----------------ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 0000111234678999999998889999999999999999996 99999988887777666554
Q ss_pred CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 929 ~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.. +..+...++++.+||.+||..||++||++.++.+.++.-||
T Consensus 215 ~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 215 KR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred CC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhcC
Confidence 32 22456789999999999999999999997777777766654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.51 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=215.2
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
|...+.||+|+||+||+|++..+|+.||+|++.............+.+|+.++..++||||+++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999999765544455667789999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 768 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 768 m~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
+.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--------- 172 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------- 172 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---------
Confidence 964 78777765 4568999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
......|++.|+|||++. ...++.++|+|||||++|+|++|.+||...+......
T Consensus 173 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 173 ----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred ----------------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 112356899999999984 3567889999999999999999999998877666555
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
.+.....+.. ....++..+++||.+||+++|.+||+ +.+++.||||+...
T Consensus 231 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~---~~~~l~~~~~~~~~ 280 (313)
T cd06633 231 HIAQNDSPTL-QSNEWTDSFRGFVDYCLQKIPQERPA---SAELLRHDFVRRDR 280 (313)
T ss_pred HHHhcCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 5544332211 12457788999999999999999999 88999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=334.88 Aligned_cols=255 Identities=35% Similarity=0.579 Sum_probs=212.2
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeEEEE
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLVM 765 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~LYLVM 765 (1091)
|++.+.||.|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.++..++||||+++++.+... ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998643 2333456788999999999999999999999988 8899999
Q ss_pred eecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.+|.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~---- 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---- 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC----
Confidence 99975 899888765 579999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
........++..|+|||.+.+ ..++.++||||||+++|||++|++||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~ 212 (287)
T cd07840 155 ----------------------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212 (287)
T ss_pred ----------------------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 001123457889999998775 467899999999999999999999999888766666
Q ss_pred HHhhcC-----CCCCCC-----------------------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRK-----IPWPCV-----------------------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~-----l~fP~i-----------------------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+.... ..++.. ...++.++.++|.+||..+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~~~~ 287 (287)
T cd07840 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS---ADQALQHEYF 287 (287)
T ss_pred HHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC---HHHHhhCcCC
Confidence 554311 011110 0113889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=343.47 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=209.4
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 753 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~-------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~g 753 (1091)
....++|.+.+.||+|+||.||+|++.. ++..||+|.+++.. .......+.+|+.++..+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3455789999999999999999998643 23579999987532 234556788999999999 7999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCce
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNI 817 (1091)
++...+.+|+||||+++|+|.+++.... .++...+..++.|++.||+|||++||+||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997642 478888999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001370 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 897 (1091)
Q Consensus 818 LLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIW 897 (1091)
|++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 226 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226 (307)
T ss_pred EEcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHHH
Confidence 999999999999999874210000 0001112345789999999998999999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 898 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 898 SLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
||||++|||++ |.+||.+.+..+++..+..... +..+..++.++++||.+||..+|.+||++.++
T Consensus 227 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 99999999998 9999998887777776654432 22346789999999999999999999995433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.36 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=212.8
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 752 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~-------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~ 752 (1091)
+....++|.+.+.||+|+||.||+|++.. .+..||+|++++.. .......+.+|+.++..+ +||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34556789999999999999999998642 34579999987532 234567789999999999 599999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCc
Q 001370 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 816 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GGSL~dlL~k~----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeN 816 (1091)
+++.....+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999999999999999999999999753 247888899999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001370 817 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896 (1091)
Q Consensus 817 ILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDI 896 (1091)
||++.++.+||+|||+++....... ........+++.|||||++.+..++.++||
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDY-------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred EEEcCCCcEEEcccccccccccccc-------------------------ccccccCCCCccccCHHHHccCCcCccchh
Confidence 9999999999999999974210000 000111234578999999999999999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 897 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 897 WSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
|||||++|||++ |..||.+.+..+++..+..... +..+..++.++++||.+||..||.+||++.++.+.+
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 999999999999 9999999888888887765432 223467889999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.62 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=214.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
.++|++++.||.|+||+||+|+.+.+ .+.||+|.+.... .......+.+|+.++.+++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 46899999999999999999997643 4679999876532 2234677899999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEec
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG---------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 830 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g---------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDF 830 (1091)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999998665 6899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-C
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 909 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-G 909 (1091)
|+++..... .........+++.|+|||.+.+..++.++|||||||++|+|++ |
T Consensus 162 ~~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 162 SLSKDVYNS--------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred ccccccCcc--------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 998632100 0011123456788999999988889999999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..||...........+..+...++. +..++..+.++|.+||..||.+||+ +.+++.
T Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~~l~ 271 (275)
T cd05046 216 ELPFYGLSDEEVLNRLQAGKLELPV-PEGCPSRLYKLMTRCWAVNPKDRPS---FSELVS 271 (275)
T ss_pred CCCccccchHHHHHHHHcCCcCCCC-CCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 9999888777777777766665553 4578899999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=344.34 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=213.1
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 753 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~g 753 (1091)
.+....++|++.+.||+|+||.||+|.. ..++..||+|++++.. .....+.+.+|+.++.++ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 3446667899999999999999999975 3345689999987532 234457789999999999 7999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecC
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
++...+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999999997543 38999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 910 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-Gk 910 (1091)
+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 187 ~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 187 LARDIMNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred ccccccCCCc-------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 9874211000 001122346789999999999999999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 911 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 911 pPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
+||........+..........+ .+...+.++.+||.+||.++|++||++.++.+
T Consensus 242 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 242 NPYPGMPVDSKFYKLIKEGYRMA-QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCcCCCCchHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99988776666555555443322 34567899999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.05 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=211.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++.+.||.|+||.||+|... |+.||+|.++.... ...++.+|+.++..++||||+++++++.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 35678999999999999999999864 89999999875332 5678999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~-- 154 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ-- 154 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc--
Confidence 9999999999999998765 699999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
......++..|+|||++.+..++.++|+||||+++|||++ |..||...+..
T Consensus 155 ----------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 155 ----------------------------GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred ----------------------------ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0012234668999999988889999999999999999997 99999988877
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
++...+.... . +..+..+++++.+||.+||..+|.+||++.++.+.+
T Consensus 207 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 207 DVVPHVEKGY-R-MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHHHHHhcCC-C-CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 7766655432 2 223467889999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=352.09 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=206.7
Q ss_pred EeeccC--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001370 692 KPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 692 r~LGkG--gFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~ 769 (1091)
..||+| +||+||++++..+|+.||+|++..... .....+.+.+|+.++..++||||++++++|...+.+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 999999999999999999999875432 23456788999999999999999999999999999999999999
Q ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCC
Q 001370 770 GGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 847 (1091)
Q Consensus 770 GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~ 847 (1091)
+|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~------ 156 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ------ 156 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc------
Confidence 999999998643 489999999999999999999999999999999999999999999999986542110000
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 848 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 848 ~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
+.... ........++..|||||++.+ ..|+.++|||||||++|||++|.+||...........+
T Consensus 157 ------~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 157 ------KAKVV--------YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred ------ccccc--------ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 00000 000112346778999999976 35789999999999999999999999887655544443
Q ss_pred hhcCCCCC--------------------------------------------CCCCCCCHHHHHHHhhhccCCCCCCCCc
Q 001370 926 LNRKIPWP--------------------------------------------CVPSDMSFEAQDLINRFLIHDPNQRLGA 961 (1091)
Q Consensus 926 l~~~l~fP--------------------------------------------~ip~~lS~eakDLI~rcL~kDPeKRpSa 961 (1091)
+......| ..+..+++.+.+||.+||+.||.+||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt- 301 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS- 301 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC-
Confidence 33211100 011235678999999999999999999
Q ss_pred ccHHHHHcCCCCCCC
Q 001370 962 NGAAEVKAHPFFKGV 976 (1091)
Q Consensus 962 ~gA~EIL~HPFFkgI 976 (1091)
+.++++||||+.+
T Consensus 302 --a~e~l~~~~~~~~ 314 (328)
T cd08226 302 --ASSLLSHAFFKQV 314 (328)
T ss_pred --HHHHhhCHHHHHH
Confidence 8899999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.63 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=209.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+.-++|++++.||+|+||.||+|..+ +++.||+|.+.+... ....+.+|+.+++.++||||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999865 578899999875432 3457889999999999999999998874 45789
Q ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC-
Confidence 999999999999998754 35889999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
.........++..|+|||++.+..++.++||||||+++|||++ |++||.+.+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 156 -------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred -------------------------CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 0001123346789999999998889999999999999999999 99999988877
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+....+... ...+ .+...+.++.+||.+||..+|++||++..+..++
T Consensus 211 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 211 EVIQNLERG-YRMP-RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred HHHHHHHcC-CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 777666443 2222 3467889999999999999999999965555444
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=339.58 Aligned_cols=260 Identities=33% Similarity=0.500 Sum_probs=212.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded--- 759 (1091)
...++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+.+|+.++..++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456889999999999999999999999999999999875432 2233456778999999999999999999987765
Q ss_pred -------eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecC
Q 001370 760 -------NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 760 -------~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
.+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999986 777777653 469999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGk 910 (1091)
++....... ........+++.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 162 ~~~~~~~~~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSEE--------------------------SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCCc--------------------------ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 987431100 001122356889999999875 45789999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhc---CC--CCCC----------------------CCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 911 PPFTAESPEIIFDNILNR---KI--PWPC----------------------VPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 911 pPF~~~s~~ei~~kIl~~---~l--~fP~----------------------ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
+||...+..+....+... .. .+|. ....++..+.+||.+||..||.+||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~--- 292 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT--- 292 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC---
Confidence 999987766655554431 00 0110 01246889999999999999999999
Q ss_pred HHHHHcCCCC
Q 001370 964 AAEVKAHPFF 973 (1091)
Q Consensus 964 A~EIL~HPFF 973 (1091)
+.+++.||||
T Consensus 293 ~~~il~~~~~ 302 (302)
T cd07864 293 AEEALNSPWL 302 (302)
T ss_pred HHHHhcCCCC
Confidence 8899999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=332.87 Aligned_cols=254 Identities=28% Similarity=0.493 Sum_probs=215.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i--~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.|.+.+.||+|+||.||++.+..++..+++|+++.... ........+..|+.++..++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48899999999999999999988888888888765332 1233445677899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 765 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|||+++++|.+++.+ ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999998864 346899999999999999999999999999999999999975 6799999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus 158 -------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 158 -------------------------SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred -------------------------CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 0011223568999999999988889999999999999999999999998877777
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
....+..+. .|..+..++.++.++|.+||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 260 (260)
T cd08222 213 VVLRIVEGP--TPSLPETYSRQLNSIMQSMLNKDPSLRPS---AAEILRNPFI 260 (260)
T ss_pred HHHHHHcCC--CCCCcchhcHHHHHHHHHHhcCChhhCcC---HHHHhhCCCC
Confidence 666665543 33445778899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.97 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=212.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++.+.||+|+||.||+|... .+..||||.+..... ....+.+|+.+++.++||||+++++++.....+|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 56689999999999999999999976 457899999875432 3456889999999999999999999999989999
Q ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||+++++|.+++.... .+++..+..++.+++.||.|||++||+|+||||+||+++.++.+||+|||+++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997653 68999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
........++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+..
T Consensus 158 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 158 --------------------------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred --------------------------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 000112235678999999999899999999999999999998 99999988888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.....+.... ..+ .+...+.++.+++.+||+.+|.+||+++.+.+.+
T Consensus 212 ~~~~~~~~~~-~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 212 EVLEQVERGY-RMP-RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred HHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 7777776542 222 2356789999999999999999999955554443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.41 Aligned_cols=261 Identities=31% Similarity=0.449 Sum_probs=209.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc----CC
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC----RD 759 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~T--Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqd----ed 759 (1091)
+|++.+.||+|+||.||+|+...+ +..||+|.+.... ........+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999988 8999999986422 2233456788899999999 59999999986432 24
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|++|||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5889999986 599999988888999999999999999999999999999999999999999999999999999743110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.
T Consensus 159 ~~-----------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 159 PG-----------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred cc-----------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 00 00111234679999999998865 5789999999999999999999999987665
Q ss_pred HHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
...+..++.. ...++......+..+.+||.+||+.||.+||+ +.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~ll~~ 292 (332)
T cd07857 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS---VEEALEH 292 (332)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC---HHHHhcC
Confidence 4443332221 01112122346889999999999999999999 8899999
Q ss_pred CCCCC
Q 001370 971 PFFKG 975 (1091)
Q Consensus 971 PFFkg 975 (1091)
|||+.
T Consensus 293 ~~~~~ 297 (332)
T cd07857 293 PYLAI 297 (332)
T ss_pred hhhhh
Confidence 99964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.59 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=224.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
+-|.++..||.|+||.||++.++.+|+.+|||.+.- ..+.+.+..|+.||++++.|+||++|++|.....+|+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 458899999999999999999999999999997753 346788999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||..|++.+.++- ...|++.++..+++..++||+|||...-||||||..||||+.+|+.||+|||.|....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------- 180 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------- 180 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh-------
Confidence 99999999999974 4579999999999999999999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
......++..|||.|||||++..-+|+.++||||||++..||.-|+|||....+....-.
T Consensus 181 --------------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 181 --------------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred --------------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 112345678999999999999999999999999999999999999999988777554444
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
|-....+--.-|..+|.++.|||++||.+.|++|-+ |.++++|||.++.
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA 289 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNA 289 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCC
Confidence 433332211134678999999999999999999998 8999999999864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.85 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=211.6
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 752 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k-------~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~ 752 (1091)
+....++|++.+.||+|+||.||+|++. .++..||+|.++.. ........+.+|+.++..+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3466789999999999999999999753 23457999988643 2334567889999999999 799999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCc
Q 001370 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 816 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GGSL~dlL~k~----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeN 816 (1091)
+++.....+|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999999763 236777888999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001370 817 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896 (1091)
Q Consensus 817 ILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDI 896 (1091)
||++.++.+||+|||+++...... .........+++.|+|||++.+..|+.++||
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222 (304)
T ss_pred EEEcCCCcEEECCCccceeccccc-------------------------ccccccCCCCCceeeCchhhccCCCCchhhH
Confidence 999999999999999987531100 0011122346788999999999899999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 897 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 897 WSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
|||||++|+|++ |..||.+.+..++...+..... +..+..++.++++||.+||..+|.+||++.++
T Consensus 223 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 999999999998 8999999888888887755432 12346788999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.60 Aligned_cols=257 Identities=30% Similarity=0.454 Sum_probs=210.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde---- 758 (1091)
...++|++.+.||+|+||.||+|....+|+.||+|++.+.. ......+.+.+|+.++.+++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 34588999999999999999999999999999999987532 2233456788999999999999999999988643
Q ss_pred --CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 --DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 --d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
...|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478889887 7799888754 46999999999999999999999999999999999999999999999999998631
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 171 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 D------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred c------------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0 01123468999999999876 5688999999999999999999999987
Q ss_pred CChHHHHHHHhhcCC-----------------------CCC-----CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 916 ESPEIIFDNILNRKI-----------------------PWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l-----------------------~fP-----~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
.+.......+..... ..| ......++++.+||.+||+.||.+||+ +.++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~ 297 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQA 297 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC---HHHH
Confidence 765544443322110 001 011245788999999999999999999 8899
Q ss_pred HcCCCCCC
Q 001370 968 KAHPFFKG 975 (1091)
Q Consensus 968 L~HPFFkg 975 (1091)
+.||||+.
T Consensus 298 l~h~~f~~ 305 (345)
T cd07877 298 LAHAYFAQ 305 (345)
T ss_pred hcChhhhh
Confidence 99999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=351.44 Aligned_cols=257 Identities=32% Similarity=0.483 Sum_probs=215.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe---
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--- 760 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~--- 760 (1091)
..++|++.+.||.|+||.||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4578999999999999999999999999999999986532 223345678889999999999999999998877665
Q ss_pred ---eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 761 ---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 761 ---LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999998 6699998865 569999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 170 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ------------------------------ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 01123468899999999875 46789999999999999999999999888
Q ss_pred ChHHHHHHHhhcCCC----------------------------CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 917 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~----------------------------fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+....+..+.+.... ++......+.++.+||.+||..||.+||+ +.+++
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt---~~ell 296 (343)
T cd07851 220 DHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT---AAEAL 296 (343)
T ss_pred ChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC---HHHHh
Confidence 776666655442110 00111246889999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001370 969 AHPFFKGV 976 (1091)
Q Consensus 969 ~HPFFkgI 976 (1091)
+||||+..
T Consensus 297 ~h~~~~~~ 304 (343)
T cd07851 297 AHPYLAEY 304 (343)
T ss_pred cCCCcccc
Confidence 99999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.61 Aligned_cols=250 Identities=19% Similarity=0.304 Sum_probs=204.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~----VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
+..++|++++.||+|+||+||+|.+..+|+. ||+|.+... ........+..|+.++..++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3457899999999999999999999888874 566665421 12234466778888999999999999999875 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
...++||||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 5678999999999999999764 568999999999999999999999999999999999999999999999999987531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
... .........|+..|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 161 PDD-------------------------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCC-------------------------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 100 0011123457789999999998899999999999999999998 99999988
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
....+...+.++... ..+...+.++.+++.+||..||.+||++.
T Consensus 216 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~ 259 (279)
T cd05111 216 RPHEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENVRPTFK 259 (279)
T ss_pred CHHHHHHHHHCCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence 777665555444322 22456788999999999999999999944
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.60 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=210.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk---~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
..+|++.+.||+|+||.||+|..+.+++ .||||++++. ........+..|+.++..++||||+++++++.....+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999887765 6999998753 2344567899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||+++|+|.+++... +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999999764 568999999999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
. .+.+ .......++..|+|||++.+..++.++|||||||++|||++ |..||...+..
T Consensus 161 ~-----------------~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 161 S-----------------DPTY-----TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred c-----------------cccc-----ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 0 0000 00011123567999999999999999999999999999886 99999988887
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
.....+... ..+| .+..++..+.+++.+||..+|.+||+++++
T Consensus 219 ~~~~~i~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 261 (269)
T cd05065 219 DVINAIEQD-YRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQI 261 (269)
T ss_pred HHHHHHHcC-CcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 777776443 2333 235778999999999999999999995433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.16 Aligned_cols=261 Identities=28% Similarity=0.503 Sum_probs=211.9
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded 759 (1091)
.....++|++.+.||.|+||+||+|.+..+++.||||.+++... ......+..|+.++.+.. ||||+++++++.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 35677899999999999999999999999999999999976432 233455667777676665 999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 88 ~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999999854 77777765 3568999999999999999999997 599999999999999999999999999986421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeechhhhHHHHHhCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
. ........|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus 167 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 218 (296)
T cd06618 167 D----------------------------SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218 (296)
T ss_pred C----------------------------CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCC
Confidence 0 00112235889999999987553 788999999999999999999999
Q ss_pred CCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 914 TAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 914 ~~~s~-~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
..... .+....+.............++.++.+||.+||..||.+||+ +.+++.||||..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 278 (296)
T cd06618 219 KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK---YRELLQHPFIRR 278 (296)
T ss_pred CcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhc
Confidence 76433 345555554432211112347889999999999999999999 889999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.96 Aligned_cols=274 Identities=28% Similarity=0.410 Sum_probs=215.9
Q ss_pred CCeE-EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchh-----------HHHHHHHHHHHHHhcCCCceEEEee
Q 001370 686 DDFE-IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-----------DIERILAERNILITVRNPFVVRFFY 753 (1091)
Q Consensus 686 ddFe-ilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~-----------eie~~l~EieILskL~HPNIVkL~g 753 (1091)
+.|. +.+.||.|+||+||+|.++.+|+.||+|++++....... ....+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 457799999999999999999999999998764322110 0124778999999999999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
+|...+.+|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999997 599999988788999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
........... .... .. ...........+++.|+|||++.+. .++.++|+|||||++|||++|.+|
T Consensus 167 ~~~~~~~~~~~--------~~~~-~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 167 RRYGYPPYSDT--------LSKD-ET----MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred eeccccccccc--------cccc-cc----ccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 75321110000 0000 00 0011122334679999999999764 468999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcC-----CCCCC--------------------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 913 FTAESPEIIFDNILNRK-----IPWPC--------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~-----l~fP~--------------------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
|.+.+..+....+.... ..||. .....+.++.+||.+||..+|.+||+ +.++
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~ 310 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS---AKEA 310 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC---HHHH
Confidence 99888777666554310 00110 11345788999999999999999999 8899
Q ss_pred HcCCCCCCC
Q 001370 968 KAHPFFKGV 976 (1091)
Q Consensus 968 L~HPFFkgI 976 (1091)
+.||||++.
T Consensus 311 l~~~~~~~~ 319 (335)
T PTZ00024 311 LKHEYFKSD 319 (335)
T ss_pred hcCcccCCC
Confidence 999999853
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.64 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=207.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 446799999999999999999988654 4699998865332 2356888999999999999999998875 456899
Q ss_pred EEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||+++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence 999999999999997643 47889999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~e 920 (1091)
........++..|+|||++.+..++.++|+|||||++|||++ |.+||.+....+
T Consensus 157 -------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 211 (260)
T cd05069 157 -------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211 (260)
T ss_pred -------------------------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 001112346788999999998889999999999999999999 999999988887
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
....+... ...+ .+..++..+.+||.+||.+||.+||+++.+.+.+
T Consensus 212 ~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 212 VLEQVERG-YRMP-CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHHHHHcC-CCCC-CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 77776554 2222 3467889999999999999999999955554443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=374.86 Aligned_cols=250 Identities=34% Similarity=0.526 Sum_probs=214.2
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCc
Q 001370 693 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 772 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGS 772 (1091)
+||+|.||+||.|++..|....|||.+... .....+-+..|+.+.+.++|.|||++++++..++.+-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999999999999999988643 23456778899999999999999999999999999999999999999
Q ss_pred HHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEecCCcccccccccccCCCCC
Q 001370 773 LYSLLRK-VGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPE 848 (1091)
Q Consensus 773 L~dlL~k-~g~L--sE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~~~s~dls~~~ 848 (1091)
|.++|+. .|++ +|...-+|.+||+.||.|||.+.|||||||-+|+||+. .|.+||+|||-++..-
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA----------- 727 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA----------- 727 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc-----------
Confidence 9999974 5778 88899999999999999999999999999999999975 7999999999988531
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCC-hHHHHHHH
Q 001370 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNI 925 (1091)
Q Consensus 849 t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s-~~ei~~kI 925 (1091)
| -+..+.++.||..|||||++-. .+|+.++|||||||++.||.||+|||.... ++..+-++
T Consensus 728 --g--------------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV 791 (1226)
T KOG4279|consen 728 --G--------------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV 791 (1226)
T ss_pred --c--------------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh
Confidence 1 1223467889999999999975 579999999999999999999999997543 33322222
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
---+ .-|.+|..+|.+++.||.+|+..||..||+ |.++|..||++.-
T Consensus 792 GmyK-vHP~iPeelsaeak~FilrcFepd~~~R~s---A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 792 GMYK-VHPPIPEELSAEAKNFILRCFEPDPCDRPS---AKDLLQDPFLQHN 838 (1226)
T ss_pred ccee-cCCCCcHHHHHHHHHHHHHHcCCCcccCcc---HHHhccCcccccC
Confidence 1111 235567899999999999999999999999 8899999999743
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.87 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=199.1
Q ss_pred EeeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001370 692 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~--TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~ 769 (1091)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 369999999999997543 34568888765422 23345678899999999999999999999999999999999999
Q ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 770 GGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 770 GGSL~dlL~k~g-----~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---- 154 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED---- 154 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch----
Confidence 999999997643 24677888999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.........+++.|+|||++.. ..++.++|||||||++|||++ |.+||...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 155 ---------------------YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ---------------------heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 0001123456788999999753 456889999999999999999 88999887
Q ss_pred ChHHHHHHHhhc-CCC--CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 917 SPEIIFDNILNR-KIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 917 s~~ei~~kIl~~-~l~--fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
...+....+... ... -|.++..++....+++..||. ||.+||+++++.+++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l~~ 269 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhc-CcccccCHHHHHHHhcC
Confidence 776666555443 222 233456788999999999995 99999997777777654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.08 Aligned_cols=254 Identities=36% Similarity=0.561 Sum_probs=212.7
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
|++.+.||.|+||.||+|+...+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998643 2233456778899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 768 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 768 m~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
++ ++|.+++.+. ..+++..+..++.+++.||.|||++||+||||+|+||+++.++.+||+|||+++....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~-------- 150 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI-------- 150 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC--------
Confidence 98 4999999876 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.........++..|+|||++.+. .++.++|+|||||++|||++|.+||...+..+.+.++
T Consensus 151 -------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 151 -------------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred -------------------CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 00011234567889999999876 7899999999999999999999999988766655544
Q ss_pred hhc------------------CCCCCC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 926 LNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 926 l~~------------------~l~fP~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
... ...++. ....++..+.++|.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~p~~ 282 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS---AKEALKHPYF 282 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC---HHHHhhCcCC
Confidence 321 011111 01235788999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.34 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=206.4
Q ss_pred EeeccCCceEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001370 692 KPISRGAFGRVFLARKRT-TGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 768 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~-TGk--~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm 768 (1091)
+.||+|+||.||+|.+.. .++ .||||.+.+.... .....+.+|+.++.+++||||+++++.+.. ..+|+||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999999764432 567789999999999999999999999988 8899999999
Q ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 769 NGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 769 ~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
++|+|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~------ 151 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE------ 151 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc------
Confidence 9999999997754 68999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kI 925 (1091)
. .+ .......++..|+|||++.+..++.++|+|||||++|||++ |..||...+..++...+
T Consensus 152 ----------~---~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 152 ----------D---HY-----VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred ----------c---ce-----ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 0 00 01113457889999999999999999999999999999998 99999988888877776
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
......++ .+...+..+.+++.+||+.+|++||++.++.+
T Consensus 214 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 214 DKEGERLE-RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HhcCCcCC-CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 65333322 34678899999999999999999999544443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.05 Aligned_cols=254 Identities=34% Similarity=0.563 Sum_probs=212.2
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
|++.+.||.|++|.||+|....+|+.+|+|.++.... .......+.+|+.+|+.++||||+++++.+.+...+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999999999999999875432 223456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 768 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 768 m~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
+++ +|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~------- 151 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP------- 151 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC-------
Confidence 976 888888764 57999999999999999999999999999999999999999999999999988742100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
........++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+.+.++
T Consensus 152 --------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 152 --------------------VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred --------------------cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011224588999999999876 7899999999999999999999999888766655554
Q ss_pred hhcC-------------------CCCC--------CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 926 LNRK-------------------IPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 926 l~~~-------------------l~fP--------~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
...- ..++ .....++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~ll~~~~~ 283 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---AEQALAHPYF 283 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC---HHHHhhCCCC
Confidence 3210 0000 112346889999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=324.93 Aligned_cols=249 Identities=28% Similarity=0.433 Sum_probs=212.2
Q ss_pred eEEEEeeccCCceEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TG----k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
|++.+.||.|+||.||++++..++ ..||+|+++.... ......+..|+.++..++||||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467789999999999999998766 8999999965422 2256789999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~--LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||||+++++|.+++..... +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD- 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc-
Confidence 9999999999999976544 9999999999999999999999999999999999999999999999999987532100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~e 920 (1091)
.+. .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+...
T Consensus 158 -------------------~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 158 -------------------YYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred -------------------ccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 000 001227889999999988889999999999999999998 899999988888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+...+...... ..+...+.++.+++.+||..||.+||+ +.+++.
T Consensus 213 ~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~ 256 (258)
T smart00219 213 VLEYLKKGYRL--PKPENCPPEIYKLMLQCWAEDPEDRPT---FSELVE 256 (258)
T ss_pred HHHHHhcCCCC--CCCCcCCHHHHHHHHHHCcCChhhCcC---HHHHHh
Confidence 88877665432 234668999999999999999999999 556553
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.04 Aligned_cols=254 Identities=31% Similarity=0.544 Sum_probs=213.4
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 768 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm 768 (1091)
+....||+|+||.||++..+.+|+.||||.+... .......+.+|+.++..++||||+++++.|...+..|+||||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 3346799999999999999999999999987532 2334567889999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001370 769 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848 (1091)
Q Consensus 769 ~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~ 848 (1091)
++++|.+++.. +.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~---------- 168 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK---------- 168 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc----------
Confidence 99999988754 5689999999999999999999999999999999999999999999999998764210
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhc
Q 001370 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 928 (1091)
Q Consensus 849 t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~ 928 (1091)
.........||+.|+|||.+.+..++.++|+|||||++|+|++|.+||.+.........+...
T Consensus 169 -----------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~ 231 (292)
T cd06657 169 -----------------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231 (292)
T ss_pred -----------------ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Confidence 001112356899999999998888899999999999999999999999987776655554332
Q ss_pred CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 929 ~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..........++..+.++|.+||..||.+||+ +.+++.||||...
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~---~~~ll~~~~~~~~ 276 (292)
T cd06657 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 276 (292)
T ss_pred CCcccCCcccCCHHHHHHHHHHHhCCcccCcC---HHHHhcChHHhcc
Confidence 21111112457899999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.78 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=205.3
Q ss_pred eeccC--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 693 PISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 693 ~LGkG--gFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
+||+| ++|.||+++.+.+|+.||||+++... ........+.+|+.++..++||||++++++|...+..|++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34444 55667777777799999999997642 3345678899999999999999999999999999999999999999
Q ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001370 771 GDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848 (1091)
Q Consensus 771 GSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~ 848 (1091)
|+|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~------- 156 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK------- 156 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc-------
Confidence 9999999764 4589999999999999999999999999999999999999999999999998874311000
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001370 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926 (1091)
Q Consensus 849 t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 926 (1091)
.............++..|+|||++.+ ..|+.++|+|||||++|||++|..||.............
T Consensus 157 -------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~ 223 (314)
T cd08216 157 -------------RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV 223 (314)
T ss_pred -------------cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 00001112234568899999999976 468899999999999999999999998766544332222
Q ss_pred hcCCC-------CCC------------------------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 927 NRKIP-------WPC------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 927 ~~~l~-------fP~------------------------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.+..+ +|. ....++.++.+||.+||+.||++||+ +.++++||||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~p~~~~ 300 (314)
T cd08216 224 RGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS---ASQLLNHSFFKQ 300 (314)
T ss_pred hccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC---HHHHhcCchHhh
Confidence 11100 000 11234568899999999999999999 889999999986
Q ss_pred CC
Q 001370 976 VN 977 (1091)
Q Consensus 976 Id 977 (1091)
+.
T Consensus 301 ~~ 302 (314)
T cd08216 301 CK 302 (314)
T ss_pred hc
Confidence 63
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=337.31 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=206.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 748 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~----------------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNI 748 (1091)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++... .......+.+|+.+|..++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986543 34579999987532 23445788999999999999999
Q ss_pred EEEeeeeccCCeeEEEEeecCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCce
Q 001370 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817 (1091)
Q Consensus 749 VkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g-----------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNI 817 (1091)
+++++++...+..|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997643 366778999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001370 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 897 (1091)
Q Consensus 818 LLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIW 897 (1091)
|++.++.++|+|||+++....... ........+++.|+|||+..+..++.++|+|
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc-------------------------eeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 999999999999999874211000 0011223457889999999888899999999
Q ss_pred chhhhHHHHHh--CCCCCCCCChHHHHHHHhh-----cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 898 SVGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 898 SLGVILYEMLT--GkpPF~~~s~~ei~~kIl~-----~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
||||++|||++ |..||...+..+....... ........+..++..+.+||.+||+.||.+||++.++.++|
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 99999999998 7899988776665543321 11111112456789999999999999999999965554444
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=326.21 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=209.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
..+|++.+.||.|+||.||+|.+. .+..+|+|.+.+... ....+.+|++++..++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999999875 477899998875332 234688899999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+++|+|.+++... +.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc---
Confidence 9999999999999764 568999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~ 922 (1091)
........++..|+|||++.+..++.++|+|||||++|||++ |.+||.......+.
T Consensus 155 -----------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 211 (256)
T cd05112 155 -----------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211 (256)
T ss_pred -----------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 001112345678999999998889999999999999999998 99999988877777
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..+..+...+ .+...+..+.+|+.+||+.+|++||+ +.++++
T Consensus 212 ~~~~~~~~~~--~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~~l~ 253 (256)
T cd05112 212 ETINAGFRLY--KPRLASQSVYELMQHCWKERPEDRPS---FSLLLH 253 (256)
T ss_pred HHHhCCCCCC--CCCCCCHHHHHHHHHHcccChhhCCC---HHHHHH
Confidence 7765543222 23567899999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.73 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=207.6
Q ss_pred CeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 687 DFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
+|++.+.||+|+||.||+|.... ....+|+|.+.+.. .......+.+|+.++..++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 23579999886532 233457789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCce
Q 001370 762 YLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~------------------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNI 817 (1091)
|+||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2477888999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001370 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 897 (1091)
Q Consensus 818 LLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIW 897 (1091)
|++.++.+||+|||+++...... .........++..|+|||++.+..++.++|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEED-------------------------SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCcc-------------------------chhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 99999999999999987421100 00011233567889999999988899999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 898 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 898 SLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
|||+++|||++ |.+||.+..+..+...+... ..++ .+..++.++.+||.+||+.+|.+||++.++.+.
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 99999999998 99999988887777655433 2222 356789999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=331.93 Aligned_cols=252 Identities=35% Similarity=0.528 Sum_probs=207.9
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEe
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLVME 766 (1091)
|++.+.||.|+||+||+|+...+++.||||.+.+... ........+|+..+.+++ ||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6789999999999999999999999999999875322 122334567899999999 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 767 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|+ +|+|.+++.... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||+++....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~------ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS------ 151 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC------
Confidence 99 789999987764 789999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
........|+..|+|||++.+ ..++.++|+||||+++|||++|++||...+..+.+.
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 152 ----------------------RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred ----------------------CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 001123468999999998854 567899999999999999999999998877665554
Q ss_pred HHhhcC-------------------CCCCC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 924 NILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 924 kIl~~~-------------------l~fP~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
++...- ..++. .....+.++.+||.+||+.||.+||+ +.|++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei~~~~~~ 283 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT---ASQALQHPYF 283 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC---HHHHhhCCCC
Confidence 443210 00000 01123688999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=343.98 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=212.6
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 750 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~T-------Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVk 750 (1091)
.++.+...+|++.+.||+|+||.||+|++... +..||+|+++.. ........+.+|+.++.++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34455667899999999999999999986432 236999988742 2334567889999999999 7999999
Q ss_pred EeeeeccCCeeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCC
Q 001370 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 814 (1091)
Q Consensus 751 L~gsfqded~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKP 814 (1091)
++++|...+.+|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999997532 367788888999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001370 815 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 894 (1091)
Q Consensus 815 eNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 894 (1091)
+|||++.++.+||+|||+++....... ........++..|||||++.+..++.++
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQS 217 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccc-------------------------cccccCCCcCceEcCHHHhccCCcCchh
Confidence 999999999999999999874211000 0011123346789999999999999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 895 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 895 DIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
|||||||++|||++ |.+||.+.+..+.+..+..... +..+...+.++.+||.+||..+|.+||+ +.+++.+
T Consensus 218 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~ell~~ 289 (334)
T cd05100 218 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPT---FKQLVED 289 (334)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHHH
Confidence 99999999999998 8999999888888877765432 2234678899999999999999999999 5555543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=346.78 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=209.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-------
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------- 758 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde------- 758 (1091)
.+|++.+.||.|+||.||+|..+.+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 689999999999999999999999999999999865432 4567788999999999999999999776654
Q ss_pred -------CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEec
Q 001370 759 -------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDF 830 (1091)
Q Consensus 759 -------d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDF 830 (1091)
..+|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35899999997 489888754 56999999999999999999999999999999999999984 567899999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhC
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
|++..... .. ..........||..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 160 g~~~~~~~--~~----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 160 GLARIVDP--HY----------------------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred ccceecCC--cc----------------------ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhC
Confidence 99874210 00 00001122368999999998765 5688999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcC----------------------CC-----CCCCCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 910 IPPFTAESPEIIFDNILNRK----------------------IP-----WPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~----------------------l~-----fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
..||...+..+....++... .. +......++.++.+||.+||+.||.+||+
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-- 293 (342)
T cd07854 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT-- 293 (342)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC--
Confidence 99998877655554443211 00 00012357889999999999999999999
Q ss_pred cHHHHHcCCCCCCC
Q 001370 963 GAAEVKAHPFFKGV 976 (1091)
Q Consensus 963 gA~EIL~HPFFkgI 976 (1091)
+.+++.||||+.+
T Consensus 294 -~~ell~h~~~~~~ 306 (342)
T cd07854 294 -AEEALMHPYMSCY 306 (342)
T ss_pred -HHHHhCCCccccc
Confidence 8899999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=331.66 Aligned_cols=240 Identities=25% Similarity=0.394 Sum_probs=199.8
Q ss_pred eeccCCceEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecC
Q 001370 693 PISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TGk--~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~ 769 (1091)
.||+|+||.||+|+.+.+|. .+|+|.++.. ........+.+|+.++.++ +||||+++++++.....+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 68999999999999988876 4688877642 2334556788999999999 79999999999999999999999999
Q ss_pred CCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 770 GGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 770 GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
+|+|.+++.+.. .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997543 4788899999999999999999999999999999999999999999999997
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpP 912 (1091)
..... ........+++.|+|||++.+..++.++|+|||||++|||++ |..|
T Consensus 160 ~~~~~----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 160 RGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred cccch----------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 52100 000111234678999999998899999999999999999997 9999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 913 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
|.+.+..+.+..+.... . +..+..++.++.+|+.+||..||.+||++.++
T Consensus 212 f~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 212 YCGMTCAELYEKLPQGY-R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred ccccCHHHHHHHHhCCC-C-CCCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 99888877777765432 1 12345678999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.85 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=205.1
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 754 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gs 754 (1091)
+....++|++.+.||+|+||+||+|++ ..+++.||||+++... .......+.+|+.+|..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 345567899999999999999999984 3467899999997532 234466788999999999 68999999988
Q ss_pred eccC-CeeEEEEeecCCCcHHHHHHhc-----------------------------------------------------
Q 001370 755 FTCR-DNLYLVMEYLNGGDLYSLLRKV----------------------------------------------------- 780 (1091)
Q Consensus 755 fqde-d~LYLVMEYm~GGSL~dlL~k~----------------------------------------------------- 780 (1091)
+... ..+|+||||+++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 7654 4689999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 781 --------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 781 --------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------ 233 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------ 233 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc------
Confidence 136777888899999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kI 925 (1091)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 234 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 294 (343)
T cd05103 234 -------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294 (343)
T ss_pred -------------------chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence 0001112346778999999999999999999999999999997 99999876543333333
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+..... +..+...++++.+++.+||+.||.+||+ +.+|++|
T Consensus 295 ~~~~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rps---~~eil~~ 335 (343)
T cd05103 295 LKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 335 (343)
T ss_pred HhccCC-CCCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 332222 2234567889999999999999999999 5566654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=386.19 Aligned_cols=266 Identities=26% Similarity=0.393 Sum_probs=208.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++.+.||+|+||.||+|++..+|+.||||++++..........++.+|+.++..++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999764333344567799999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 765 MEYLNGGDLYSLLRKV-----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-----------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
|||++||+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 23455667888999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
+........ ........+.............+||+.|||||++.+..++.++|||||||++|||++|.+||
T Consensus 161 k~i~~~~~~---------~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 161 IFKKLEEED---------LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred eeccccccc---------ccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 853111000 00000000000000111223468999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHH-HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 914 TAESPEIIFDN-ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 914 ~~~s~~ei~~k-Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
.......+... .......+.. ...+++.+.+++.+||..||++|++
T Consensus 232 ~~~~~~ki~~~~~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 232 RRKKGRKISYRDVILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred CCcchhhhhhhhhccChhhccc-cccCCHHHHHHHHHHccCChhhCcC
Confidence 87665433322 1111111111 1467899999999999999999998
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.53 Aligned_cols=256 Identities=33% Similarity=0.527 Sum_probs=210.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd-ed~LY 762 (1091)
..++|++.+.||.|+||.||+|..+.+|+.||+|++.+.. ........+.+|+.++..++||||++++++|.. ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 5678999999999999999999999999999999886532 223345678899999999999999999999876 56799
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 999998 5689888764 468889999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||........
T Consensus 160 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~ 214 (328)
T cd07856 160 -------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214 (328)
T ss_pred -------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01123467899999999876 6789999999999999999999999987765333
Q ss_pred HHHHhh----------------------------cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 922 FDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 922 ~~kIl~----------------------------~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
+..+.+ ...++......++.++.++|.+||+.+|++||+ +.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~ell~~~~~ 291 (328)
T cd07856 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS---AAEALAHPYL 291 (328)
T ss_pred HHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcCCcc
Confidence 222111 001111112357889999999999999999999 8899999999
Q ss_pred CC
Q 001370 974 KG 975 (1091)
Q Consensus 974 kg 975 (1091)
..
T Consensus 292 ~~ 293 (328)
T cd07856 292 AP 293 (328)
T ss_pred cc
Confidence 63
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=340.69 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=215.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|+..+.||.|+||.||+|+++.++..||+|.+.............+.+|+.+++.++|||++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44788899999999999999999999999999987543334445667889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------- 166 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec-------
Confidence 9997 588777754 4468999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
......||+.|+|||++. ...++.++|||||||++|+|++|..||...+....
T Consensus 167 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 222 (308)
T cd06634 167 ------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (308)
T ss_pred ------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH
Confidence 012346899999999985 34678899999999999999999999988766555
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
...+.....+.. .+..++..+.+||.+||..+|.+||+ +.+++.||||...
T Consensus 223 ~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~---~~~ll~~~~~~~~ 273 (308)
T cd06634 223 LYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 273 (308)
T ss_pred HHHHhhcCCCCc-CcccccHHHHHHHHHHhhCCcccCCC---HHHHhhCcccccc
Confidence 555544433221 13568899999999999999999999 8899999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=330.24 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=195.6
Q ss_pred EeeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001370 692 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~--TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~ 769 (1091)
+.||+|+||.||+|.... ++..+|+|.++... .......+.+|+.++..++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999998653 45689999886533 22334578899999999999999999999999999999999999
Q ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 770 GGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 770 GGSL~dlL~k~g-----~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
+|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 999999997532 35667788899999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-------CCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-------~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.........|++.|+|||++.+. .++.++|||||||++|||++ |.+||...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 155 ---------------------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ---------------------eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 00011235678999999998642 35789999999999999996 99999877
Q ss_pred ChHHHHHHHhhc-CC--CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 917 SPEIIFDNILNR-KI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 917 s~~ei~~kIl~~-~l--~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
...+........ .. +.|.+....+..+.++|.+|+ .+|++||+++++...|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 766554443332 22 223333467889999999999 5899999955444443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.47 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=209.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.+..++|++.+.||+|+||.||+|... .+..+|+|.+.+. ......+.+|+.+++.++|+||+++++.+.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 355688999999999999999999865 4567999988653 2245678899999999999999999999888 788
Q ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999764 35788889999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
. ........++..|+|||++.+..++.++|+|||||++|+|++ |++||...+.
T Consensus 156 ~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 156 E--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred C--------------------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 001112346678999999998889999999999999999998 9999998887
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
..+...+.... ..+ .+...+.++.+++.+||+.+|++||+...+.++|
T Consensus 210 ~~~~~~~~~~~-~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 210 PEVIRALERGY-RMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred HHHHHHHhCCC-CCC-CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 77776665442 222 3467889999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.33 Aligned_cols=266 Identities=33% Similarity=0.527 Sum_probs=214.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC--
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD-- 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded-- 759 (1091)
...++|++.+.||+|+||.||+|.+..+|+.||||.+.+.. ........+.+|+.++.++ +||||++++++|...+
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 34678999999999999999999999899999999886532 2233456678899999999 9999999999886543
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||+++ +|..++.+. .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 68999999974 999988765 7889999999999999999999999999999999999999999999999998753210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.. ...........||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+...
T Consensus 161 ~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 161 EE----------------------NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred cc----------------------cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 00 000112234579999999998865 5578999999999999999999999987765
Q ss_pred HHHHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~~~----------------------------l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.+...++.... ..+......++.++.+||.+||+.||.+||+ +.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~~il~~ 295 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT---AEEALEH 295 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC---HHHHhhC
Confidence 55444332211 0011112347889999999999999999999 8899999
Q ss_pred CCCCCC
Q 001370 971 PFFKGV 976 (1091)
Q Consensus 971 PFFkgI 976 (1091)
|||+..
T Consensus 296 ~~~~~~ 301 (337)
T cd07852 296 PYVAQF 301 (337)
T ss_pred hhhhhh
Confidence 999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.38 Aligned_cols=232 Identities=34% Similarity=0.542 Sum_probs=195.0
Q ss_pred CCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHH
Q 001370 697 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 776 (1091)
Q Consensus 697 GgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL~dl 776 (1091)
|.||.||+|+++.+|+.||+|.+++.. .+.+|...+....||||+++++++...+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997632 123445555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 001370 777 LRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856 (1091)
Q Consensus 777 L~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~ 856 (1091)
+.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~------------------- 136 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE------------------- 136 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccc-------------------
Confidence 9888889999999999999999999999999999999999999999999999999876321
Q ss_pred CCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCC
Q 001370 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 936 (1091)
Q Consensus 857 ~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip 936 (1091)
.......++..|+|||.+.+..++.++|+|||||++|||++|+.||...... + ..... ..++
T Consensus 137 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~-~~~~ 198 (237)
T cd05576 137 -----------DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTT-LNIP 198 (237)
T ss_pred -----------cccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccc-cCCc
Confidence 0112245678899999998888999999999999999999999998643221 0 11111 1234
Q ss_pred CCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCC
Q 001370 937 SDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 973 (1091)
Q Consensus 937 ~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFF 973 (1091)
..++..+++||.+||+.||.+||++ ..+.++++||||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 6789999999999999999999995 346899999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=329.98 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=209.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk----~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
...+|++.+.||+|+||+||+|.++.+|+ .||+|.+.+.. .......+.+|+.++..++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999887765 58999886543 23456778899999999999999999999887 7
Q ss_pred eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..++||||+++|+|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999999764 4689999999999999999999999999999999999999999999999999875310
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s 917 (1091)
.. . ........++..|+|||.+....++.++|+|||||++|||++ |..||.+..
T Consensus 162 ~~----------------~---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 162 DE----------------K---------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cc----------------c---------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 00 0 000111234678999999988899999999999999999998 999999988
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
..++...+..+.. ++ .+...+.++.+++.+||..||.+||++..
T Consensus 217 ~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~ 260 (279)
T cd05057 217 AVEIPDLLEKGER-LP-QPPICTIDVYMVLVKCWMIDAESRPTFKE 260 (279)
T ss_pred HHHHHHHHhCCCC-CC-CCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 8888777765432 22 24567899999999999999999999543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=330.48 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=198.3
Q ss_pred eEEEEeeccCCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 001370 688 FEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 761 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~L 761 (1091)
|++++.||+|+||+||++.. ..++..||+|+++... .......+.+|+++|+.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 48999999999999988753 3568899999987532 223456788999999999999999999987654 458
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~- 161 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH- 161 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc-
Confidence 9999999999999999764 59999999999999999999999999999999999999999999999999987431100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH--
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 919 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~-- 919 (1091)
..........++..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 162 -----------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 218 (283)
T cd05080 162 -----------------------EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218 (283)
T ss_pred -----------------------hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 0000111234567899999999888999999999999999999999998653321
Q ss_pred HH------------HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 II------------FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei------------~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
++ ........... ..+..++.++.+|+.+||..||++||++.++.+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 219 EMIGPKQGQMTVVRLIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hhhcccccccchhhhhhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 11 11111111111 23467889999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=323.05 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=204.3
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GG 771 (1091)
+.||.|+||.||+|.+.. ++.||+|.++.... ......+.+|++++++++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999887 99999998876432 245678899999999999999999999999999999999999999
Q ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 772 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 772 SL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
+|.+++.+. ..+++..+..++.+++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~---------- 147 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI---------- 147 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc----------
Confidence 999999764 468899999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 929 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~ 929 (1091)
+ ........++..|+|||++.+..++.++|||||||++|||++ |..||...........+....
T Consensus 148 -----------~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~ 212 (251)
T cd05041 148 -----------Y----TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212 (251)
T ss_pred -----------c----eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC
Confidence 0 000012234678999999998899999999999999999998 899998888777666665432
Q ss_pred CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 930 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 930 l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
..+ .+..++.++.+||.+||+.+|.+||+ +.+++
T Consensus 213 -~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~---~~ell 246 (251)
T cd05041 213 -RMP-APQLCPEEIYRLMLQCWAYDPENRPS---FSEIY 246 (251)
T ss_pred -CCC-CCccCCHHHHHHHHHHhccChhhCcC---HHHHH
Confidence 222 34678899999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.31 Aligned_cols=242 Identities=25% Similarity=0.365 Sum_probs=201.3
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GG 771 (1091)
++||+|+||.||+|... ++..||+|+++... .......+.+|++++..++||||+++++.+......|+||||+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36999999999999865 68899999887532 2333457889999999999999999999999999999999999999
Q ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 001370 772 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850 (1091)
Q Consensus 772 SL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~ 850 (1091)
+|.+++... ..+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~----------- 146 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG----------- 146 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc-----------
Confidence 999998754 46889999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 001370 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 929 (1091)
Q Consensus 851 g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~ 929 (1091)
. ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......+...+....
T Consensus 147 -~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~ 211 (250)
T cd05085 147 -I--------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211 (250)
T ss_pred -c--------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 0 000112234678999999998889999999999999999998 999999888777776665432
Q ss_pred CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 930 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 930 l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
. +..+..++..+.+|+.+||..+|++||+..++
T Consensus 212 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 244 (250)
T cd05085 212 -R-MSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244 (250)
T ss_pred -C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 1 22346789999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=329.58 Aligned_cols=257 Identities=20% Similarity=0.314 Sum_probs=211.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC- 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd- 757 (1091)
+..++|++.+.||+|+||.||+|.+.. ++..||+|.++.. ........+.+|..++..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999876 3578999988642 344567888999999999999999999997655
Q ss_pred CCeeEEEEeecCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEe
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 829 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~--------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsD 829 (1091)
....++++||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56789999999999999999753 3588999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 908 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT- 908 (1091)
||+++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 161 ~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 161 NALSRDLFPMDY-------------------------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCCcccccCCce-------------------------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 999874211000 000112346778999999999899999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 909 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 909 GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
|++||...++.++...+... ..++ .+..+++++.+++.+||..||++||++..+.+.+
T Consensus 216 g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLKDG-YRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred CCCCcCcCCHHHHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999988887777665543 2322 2356789999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=328.65 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=203.6
Q ss_pred EeeccCCceEEEEEEECCCC------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 692 KPISRGAFGRVFLARKRTTG------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TG------k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
+.||+|+||.||+|+.+..+ ..||+|.+.+.. .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36999999999999986544 689999886532 2234567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-----cEEEEecCCc
Q 001370 766 EYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLS 833 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~-------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-----~VKLsDFGLA 833 (1091)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+++|+||||+|||++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999743 2478889999999999999999999999999999999999888 8999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpP 912 (1091)
+....... ........++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 159 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 159 RDIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred cccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 74211000 001122356789999999999899999999999999999998 9999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 913 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
|...+..+....+..... +..+..++..+.+||.+||..+|.+||+++.+.+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 214 YPALNNQEVLQHVTAGGR--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred CcccCHHHHHHHHhcCCc--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 998887777766654322 123467889999999999999999999965555444
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=326.01 Aligned_cols=246 Identities=25% Similarity=0.406 Sum_probs=205.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++..++||||+++++++... .+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 3457899999999999999999864 68899999886421 345788999999999999999999998764 579
Q ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.+|.+||+|||++.....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~-- 152 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-- 152 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc--
Confidence 9999999999999997654 478999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
......++..|+|||++.+..++.++|+|||||++|||++ |++||...+..
T Consensus 153 ----------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 204 (254)
T cd05083 153 ----------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204 (254)
T ss_pred ----------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 0011234567999999998899999999999999999997 99999988887
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+....+..+. ..+ .+..++..+.+||.+||..+|.+||+++++.+.+
T Consensus 205 ~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 205 EVKECVEKGY-RME-PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred HHHHHHhCCC-CCC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7776665442 222 2467889999999999999999999955554444
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=365.38 Aligned_cols=261 Identities=27% Similarity=0.467 Sum_probs=212.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~ 760 (1091)
.+.-..|++++.||+||.+.||+|...+ ...||+|.+.- .......+.-+.+|+..|.+++ |.+||+||++-..++.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 4556789999999999999999998654 46677775543 2334556788999999999997 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~-LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
+||||||=. -||..+|++... ++...+++|..|++.|+.++|..||||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus 435 lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 999999864 499999987765 44468999999999999999999999999999999995 699999999999864221
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-----------CCccceeechhhhHHHHHh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEFIT 908 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-----------Ys~ksDIWSLGVILYEMLT 908 (1091)
. -.....+.+||+.||+||.+.... .+.++||||||||||+|++
T Consensus 513 T-------------------------TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 513 T-------------------------TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred c-------------------------cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 1 122345789999999999996533 4578999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 909 GIPPFTAES-PEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 909 GkpPF~~~s-~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
|++||..-. ...-+..|.+- .++||.++.. .++.++++.||.+||.+||+ +.++|+|||+..+
T Consensus 568 gktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~s---i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 568 GKTPFGQIINQIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWS---IPELLQHPFLQIQ 633 (677)
T ss_pred cCCchHHHHHHHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCC---cHHHhcCcccccc
Confidence 999997643 33334445443 4577765543 34999999999999999999 8899999999753
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=326.22 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=198.4
Q ss_pred EeeccCCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec-cCCeeEEEEee
Q 001370 692 KPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDNLYLVMEY 767 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~---TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq-ded~LYLVMEY 767 (1091)
+.||+|+||.||+|.+.. .+..||+|.+... ........+.+|+.+++.++||||+++++.+. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 3457999987542 23345678889999999999999999999765 45568999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 768 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 768 m~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
+++|+|.+++.+. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~----- 153 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY----- 153 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc-----
Confidence 9999999999764 3467777888999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kI 925 (1091)
..........+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..++...+
T Consensus 154 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05058 154 ------------------YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215 (262)
T ss_pred ------------------eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 00011123456789999999998899999999999999999999 57888888877777766
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
..+.. +..+..++..+.+++.+||..+|++||++.++..
T Consensus 216 ~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 216 LQGRR--LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred hcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 55432 2234567899999999999999999999544333
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=356.64 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=210.5
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFY 753 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~g 753 (1091)
.+.+..++|.+.+.||+|+||.||+|++. .+++.||+|+++... .......+++|+.+|..+. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 35677788999999999999999999864 345689999997532 2334557889999999998 999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhcC----------------------------------------------------
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------------------------------------------- 781 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~g---------------------------------------------------- 781 (1091)
++.....+|+||||+++|+|.+++.+.+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999996531
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCC
Q 001370 782 ----------------------------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 815 (1091)
Q Consensus 782 ----------------------------------------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPe 815 (1091)
.++...+..|+.||+.||.|||+.||+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2566678889999999999999999999999999
Q ss_pred ceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001370 816 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 895 (1091)
Q Consensus 816 NILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 895 (1091)
|||++.++.+||+|||+++...... .........|++.|||||++.+..++.++|
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 323 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDS-------------------------NYISKGSTFLPLKWMAPESIFNNLYTTLSD 323 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccc-------------------------ccccCCCcCCCCceeChHHhcCCCCCcHhH
Confidence 9999999999999999987421100 000112346789999999999988999999
Q ss_pred eechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 896 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 896 IWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
||||||++|||++ |..||......+.....+...... ..+..++.++.+||.+||..+|.+||++.++.
T Consensus 324 vwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell 393 (401)
T cd05107 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393 (401)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999999999998 899998766555544444443332 23567899999999999999999999944333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=373.05 Aligned_cols=343 Identities=29% Similarity=0.436 Sum_probs=252.6
Q ss_pred hhhhhhhhhhhhhhhhccchhhHhhhccchHHHHhhcccceEeccchhHHHHHHhhhhHHhhh----------hhcccCC
Q 001370 578 IELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILAC----------ELLDEKS 647 (1091)
Q Consensus 578 ~~~~~~~~~~~~~~~~ke~~~~l~~~~~~~~~~~~~~kl~~lvid~~g~rI~kllr~k~~l~~----------~lL~~ks 647 (1091)
.++.+.|+..+...+++--.-||.+-.....++.+|.-...+-.+.+.. +.....+.... ..+....
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~---r~~~~~fkp~~~~e~~~~~fd~eft~~~ 284 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEA---RSRPPPFKPGSITERDVAQFDPEFTSQV 284 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhh---cCCCCCCCCcccchhhhhhcCchhccCC
Confidence 3577888888888888887777777777778888888777664332111 11111110000 0000011
Q ss_pred CCcc---cccccchhhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc
Q 001370 648 PTSF---SKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 724 (1091)
Q Consensus 648 p~s~---Sk~~ensrllldsvs~ssg~~tpl~ss~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i 724 (1091)
|... +...++.++..+-.- .....-...+.....++|++...+|.|+|+.|..+.+..+++.+|+|++.+..
T Consensus 285 P~dsp~~~~~~s~~~if~g~sf----va~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~- 359 (612)
T KOG0603|consen 285 PADSPLLSASGSDHTIFSGPSF----VAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA- 359 (612)
T ss_pred cccCCCCCCCccccchhcCCCc----cChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccc-
Confidence 1000 000000000000000 00000000111235778999999999999999999999999999999998752
Q ss_pred cchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 001370 725 IRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803 (1091)
Q Consensus 725 ~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLH 803 (1091)
....+|+.++... +||||+++++.+.+..+.|+|||++.||.|.+.+.....+. ..+..|+++|+.|+.|||
T Consensus 360 ------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH 432 (612)
T KOG0603|consen 360 ------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLH 432 (612)
T ss_pred ------cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHH
Confidence 2234566565555 69999999999999999999999999999999988776666 788889999999999999
Q ss_pred HcCCeecccCCCceEe-cCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCh
Q 001370 804 SLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 882 (1091)
Q Consensus 804 s~GIIHRDLKPeNILL-D~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAP 882 (1091)
.+|||||||||+|||+ +..|+++|+|||.++... ....+.|-|..|.||
T Consensus 433 ~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~------------------------------~~~~tp~~t~~y~AP 482 (612)
T KOG0603|consen 433 EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE------------------------------RSCDTPALTLQYVAP 482 (612)
T ss_pred hcCeeecCCChhheeecCCCCcEEEEEechhhhCc------------------------------hhhcccchhhcccCh
Confidence 9999999999999999 699999999999987421 113456789999999
Q ss_pred hhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH-HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc
Q 001370 883 EILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 961 (1091)
Q Consensus 883 EVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~-ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa 961 (1091)
|++...+|+.+|||||||++||+||+|+.||...... ++..+|..+. +...+|++++|||++||+.||.+||+
T Consensus 483 Evl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~-----~s~~vS~~AKdLl~~LL~~dP~~Rl~- 556 (612)
T KOG0603|consen 483 EVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK-----FSECVSDEAKDLLQQLLQVDPALRLG- 556 (612)
T ss_pred hhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc-----cccccCHHHHHHHHHhccCChhhCcC-
Confidence 9999999999999999999999999999999876655 6666654443 23789999999999999999999999
Q ss_pred ccHHHHHcCCCC
Q 001370 962 NGAAEVKAHPFF 973 (1091)
Q Consensus 962 ~gA~EIL~HPFF 973 (1091)
+.+++.||||
T Consensus 557 --~~~i~~h~w~ 566 (612)
T KOG0603|consen 557 --ADEIGAHPWF 566 (612)
T ss_pred --hhhhccCcch
Confidence 8899999999
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=368.64 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=221.8
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
|.-++.||.|+||-||-|++..+.+.||||.+.-...........++.|+.+|.+++|||+|.+-+||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 67788999999999999999999999999999766555666778899999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 768 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 768 m~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|-| +-.++|.-+ .++-+..+..++.+.+.||.|||+.+.||||||..||||.+.|.|||+|||.|...
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---------- 176 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---------- 176 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc----------
Confidence 966 777777543 46899999999999999999999999999999999999999999999999988642
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
..+.+++|||.||||||++. +.|+-++||||||++..||.-.+||+...+.....-
T Consensus 177 ---------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 177 ---------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred ---------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 23568999999999999974 679999999999999999999999998888766665
Q ss_pred HHhhcC-CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 924 NILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 924 kIl~~~-l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
-|..+. ..++ .+.+|..+..||..||++-|..||| .++++.|+|...
T Consensus 236 HIAQNesPtLq--s~eWS~~F~~Fvd~CLqKipqeRpt---se~ll~H~fv~R 283 (948)
T KOG0577|consen 236 HIAQNESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPT---SEELLKHRFVLR 283 (948)
T ss_pred HHHhcCCCCCC--CchhHHHHHHHHHHHHhhCcccCCc---HHHHhhcchhcc
Confidence 665543 3333 3679999999999999999999999 889999999853
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.53 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=206.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..++|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.++..++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 446799999999999999999987654 3468999876432 23456788999999999999999999998876 45
Q ss_pred eEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.|+||||+++|+|.+++.+.. .+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997644 5899999999999999999999999999999999999999999999999998743110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
. ........+++.|+|||.+....++.++|+|||||++|||++ |..||...+.
T Consensus 161 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 161 S--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred c--------------------------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 0 000112235678999999998899999999999999999996 9999998887
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
.+....+.++.. +..+..++.++.+||.+||..+|.+||++.+
T Consensus 215 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 257 (270)
T cd05056 215 NDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTE 257 (270)
T ss_pred HHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 777766655432 1234788999999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.41 Aligned_cols=236 Identities=24% Similarity=0.392 Sum_probs=193.8
Q ss_pred eeccCCceEEEEEEECCCCcE-------EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 693 PISRGAFGRVFLARKRTTGDL-------FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TGk~-------VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
.||+|+||.||+|.++.++.. ||+|.+.+.. ....+.+.+|..++..++||||+++++++......|+||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 699999999999998765543 8888775422 344567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc--------EEEEecCCcccc
Q 001370 766 EYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSKIG 836 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~--------VKLsDFGLAk~~ 836 (1091)
||+++|+|..++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999997654 5899999999999999999999999999999999999988765 689999987531
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhC-CCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG-IPPFT 914 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTG-kpPF~ 914 (1091)
. ......|++.|+|||++.+ ..++.++|||||||++|||++| .+||.
T Consensus 159 ~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 159 L-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred C-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 0 1123568899999999986 4589999999999999999998 57777
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 915 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 915 ~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..+...... +......+| ...+.++.+||.+||+.||++||+ +.+|++
T Consensus 208 ~~~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 255 (258)
T cd05078 208 ALDSQKKLQ-FYEDRHQLP---APKWTELANLINQCMDYEPDFRPS---FRAIIR 255 (258)
T ss_pred hccHHHHHH-HHHccccCC---CCCcHHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 666554433 333333333 567789999999999999999999 556654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.61 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=201.3
Q ss_pred CCeEEEEeeccCCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 001370 686 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 759 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d 759 (1091)
.-|++++.||+|+||.||+|+. +.++..||+|.++... .......+.+|+.+++.+.||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3578999999999999999984 4578899999986532 234456789999999999999999999988875 5
Q ss_pred eeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 6899999999999999997653 589999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s- 917 (1091)
.. ..........|+..|+|||++.+..++.++|||||||++|||+++..|+....
T Consensus 162 ~~------------------------~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 162 DK------------------------EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred Cc------------------------cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 00 00011123557888999999998889999999999999999999877653311
Q ss_pred -------------hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 918 -------------PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 918 -------------~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
........+......+ .+..++..+.+||.+||+.||.+||+ +.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~ 278 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTT---FQNLIE 278 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCccCC-CCCCCCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 0111111222222222 34678999999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=331.65 Aligned_cols=248 Identities=32% Similarity=0.508 Sum_probs=204.0
Q ss_pred EEEEeeccCCceEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 689 EIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
++.+.||.|.||.||+|.+. ..+..|+||+++. .......+.+.+|++++.+++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 57789999999999999998 3467899999954 23344578899999999999999999999999988889999
Q ss_pred EeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
|||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|++|+|.|||++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~--- 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK--- 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999998753100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei 921 (1091)
..........+...|+|||++.+..++.++||||||++||||++ |+.||...+..++
T Consensus 157 ----------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 157 ----------------------SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp ----------------------SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ----------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 00111233457788999999998889999999999999999999 7899999988888
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
...+..... +..+..++..+.++|.+||..||.+||+ +.+|+
T Consensus 215 ~~~~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs---~~~i~ 256 (259)
T PF07714_consen 215 IEKLKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPS---FQEIL 256 (259)
T ss_dssp HHHHHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS-----HHHHH
T ss_pred ccccccccc--ceeccchhHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 888855433 2235778999999999999999999999 44544
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=362.96 Aligned_cols=259 Identities=29% Similarity=0.461 Sum_probs=224.7
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCc---E-EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD---L-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 755 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk---~-VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsf 755 (1091)
.|.+.-++-.+.+.||+|+||+||+|+.+..+. . ||+|..+......+.++..+++|.++|.+++|||||++||+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456677788888999999999999999876533 3 899998765556778899999999999999999999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 756 TCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 756 qded~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
.....+|+|||+|+||+|.++|++.+ .++..+...|+.+.+.||+|||++++|||||-..|+|++.++.+||+||||++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999999999887 49999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF 913 (1091)
... .|... .....-...|+|||.+...-|+.++|||||||++||+++ |..||
T Consensus 311 ~~~-----------------------~~~~~----~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 311 AGS-----------------------QYVMK----KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred CCc-----------------------ceeec----cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCC
Confidence 531 00000 001124578999999999999999999999999999998 89999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 914 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 914 ~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
.+.+..++..+|....++.+ .+...+.++..++.+||..||+.||++..+.+
T Consensus 364 ~g~~~~~v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 364 PGMKNYEVKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCHHHHHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 99999999999977666655 35688899999999999999999999654443
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.88 Aligned_cols=251 Identities=28% Similarity=0.446 Sum_probs=198.3
Q ss_pred CCeEEEEeeccCCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CC
Q 001370 686 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RD 759 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd--ed 759 (1091)
.+|++++.||+|+||.||+|.. ..++..||+|.+... .......+.+|++++..++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5799999999999999999984 457889999998653 23456788999999999999999999987644 34
Q ss_pred eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999764 4689999999999999999999999999999999999999999999999999875311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
... . ........++..|+|||++.+..++.++|||||||++|||++|..|+.....
T Consensus 161 ~~~--------------------~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 161 DKE--------------------Y----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred CCc--------------------c----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 000 0 0001112345569999999988999999999999999999998877643321
Q ss_pred HH---------------HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 919 EI---------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 919 ~e---------------i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
.. ....++.....++ .+..++.++.+||.+||..+|++||++.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 276 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSEL 276 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 10 0111222222222 346788999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=364.89 Aligned_cols=256 Identities=20% Similarity=0.340 Sum_probs=214.3
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..|.+..+++.+...||+|.||+||+|+|-. .||||+++.... ...+.+.|++|+.++++-+|-||+-+.|++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 5677888999999999999999999999964 499999986554 455889999999999999999999999999887
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.. .||+.+|.|-+|+.+|+-. ..|....++.|+.||++|+.|||.++|||||||..||+|.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 9999999999999999744 469999999999999999999999999999999999999999999999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
. | .........-|...|||||++.. .+|++.+|||||||++|||++|..||.
T Consensus 540 --------------~---------w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 540 --------------R---------W--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred --------------e---------e--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 0 1 11223344568899999999974 478999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 915 AESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 915 ~~s~~ei~~kIl~~~l--~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
..+.+.+.-.+-.+.+ ....+....+.++++|+..||.+++++||.+..+
T Consensus 595 i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~i 646 (678)
T KOG0193|consen 595 IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQL 646 (678)
T ss_pred CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence 7666666555444421 1122335677899999999999999999994433
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=398.31 Aligned_cols=259 Identities=35% Similarity=0.569 Sum_probs=220.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+++....||.|.||.||-|.+.+||...|||-++-.... ......+.+|..+|..++|||+|++|+.-...+.+||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 345566899999999999999999999999988754433 4556778899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
||.||+|.+++...+..++...+.|..|++.|+.|||+.|||||||||+||||+.+|.+|++|||.|+.+.. +..++
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~-~~~~~-- 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN-NAQTM-- 1391 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC-chhcC--
Confidence 999999999999888899999999999999999999999999999999999999999999999999986421 11010
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCCCh-HHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 922 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~-~ei~ 922 (1091)
.......+|||.|||||++.+ .+.+.++|||||||++.||+||+.||...+. -.++
T Consensus 1392 --------------------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM 1451 (1509)
T KOG4645|consen 1392 --------------------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM 1451 (1509)
T ss_pred --------------------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH
Confidence 122346789999999999986 4678899999999999999999999976543 2333
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
-.+-.+. -|.+|..+|.+.+|||.+||+.||++|++ +.+|+.|.|-+
T Consensus 1452 y~V~~gh--~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~---~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1452 YHVAAGH--KPQIPERLSSEGRDFLEHCLEQDPKMRWT---ASQLLEHAFGK 1498 (1509)
T ss_pred hHHhccC--CCCCchhhhHhHHHHHHHHHhcCchhhhH---HHHHHHhhccc
Confidence 3333332 25566889999999999999999999998 77999999865
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=365.63 Aligned_cols=248 Identities=26% Similarity=0.424 Sum_probs=214.4
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
+.|.+.++...-++-||.|+-|-||+|+.+ ++.||||.++.. + ..++.-|++|+||||+.+.++|...
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---k-------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---K-------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---h-------hhhHHHHHhccCcceeeEeeeecCC
Confidence 344556666667788999999999999986 789999976531 1 2456678899999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..+|||||||+.|-|+..|+....++......+..+|+.||.|||.+.|||||||.-||||..+..|||+|||-++..
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~-- 262 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL-- 262 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999988742
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.+.....+++||..|||||++...+.+.|+|||||||+|||||||..||...+.
T Consensus 263 --------------------------~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 263 --------------------------SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred --------------------------hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 112345679999999999999999999999999999999999999999988776
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
..++--+-.+.+.+| .|..+++-++=||+.||.-.|..||+ ..+|+.|
T Consensus 317 sAIIwGVGsNsL~Lp-vPstcP~GfklL~Kqcw~sKpRNRPS---Frqil~H 364 (904)
T KOG4721|consen 317 SAIIWGVGSNSLHLP-VPSTCPDGFKLLLKQCWNSKPRNRPS---FRQILLH 364 (904)
T ss_pred heeEEeccCCccccc-CcccCchHHHHHHHHHHhcCCCCCcc---HHHHHHH
Confidence 655544444545544 46889999999999999999999999 5666766
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.03 Aligned_cols=251 Identities=21% Similarity=0.339 Sum_probs=204.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk----~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
+..++|+.++.||+|+||.||+|++..+|. .||+|.+.... .......+.+|+.++..++||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999999987776 46888776432 233345688999999999999999999988754
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..++|+||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 5789999999999999997654 58999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
... .........++..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 161 GDE-------------------------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred Ccc-------------------------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 000 0001122346789999999999999999999999999999997 99999887
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
........+..+ ..++ .+...+..+.++|.+||..+|++||++.+
T Consensus 216 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~ 260 (303)
T cd05110 216 PTREIPDLLEKG-ERLP-QPPICTIDVYMVMVKCWMIDADSRPKFKE 260 (303)
T ss_pred CHHHHHHHHHCC-CCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 766655544333 2222 23567889999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.50 Aligned_cols=250 Identities=31% Similarity=0.512 Sum_probs=208.5
Q ss_pred CeEEEEeeccCCceEEEEEEECC-CCcEEEEEEeeccc-------ccchhHHHHHHHHHHHHHh-cCCCceEEEeeeecc
Q 001370 687 DFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLD-------MIRKNDIERILAERNILIT-VRNPFVVRFFYSFTC 757 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~-TGk~VAIKiLkK~~-------i~~~~eie~~l~EieILsk-L~HPNIVkL~gsfqd 757 (1091)
+|++.+.||+|+||.||+|.++. +++.+|+|.+.... .........+.+|+.++.+ ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 68899999886422 1233445667889888865 799999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCC
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .||+|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
+..... ........|+..|+|||++.+..++.++|+||||+++|+|++|.+|
T Consensus 161 ~~~~~~----------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQP----------------------------ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccc----------------------------ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 874210 0012345689999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 913 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
|...........+...... |......+.++.+||.+||+.||++||++.++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~ 264 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264 (269)
T ss_pred ccccCHHHHHHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHH
Confidence 9888777777666654432 222346789999999999999999999944433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.26 Aligned_cols=238 Identities=22% Similarity=0.280 Sum_probs=192.3
Q ss_pred EeeccCCceEEEEEEECCC------------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 692 KPISRGAFGRVFLARKRTT------------GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~T------------Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
+.||+|+||.||+|..... ...+|+|++.... ......+.+|..++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999986422 2358888876432 334557888999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc-------EEEEecC
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-------IKLTDFG 831 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~-------VKLsDFG 831 (1091)
..|+||||+++|+|..++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999888754 56899999999999999999999999999999999999987764 8999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHH-hC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFI-TG 909 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDIWSLGVILYEML-TG 909 (1091)
++.... ......||..|||||++. +..++.++|||||||++|||+ .|
T Consensus 158 ~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 158 IPITVL-------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred CCcccc-------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 886321 012346889999999987 467899999999999999998 58
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
..||......+... +........ ...+.++.+||.+||+.||.+||+ ..+|+.+
T Consensus 207 ~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rp~---~~~il~~ 260 (262)
T cd05077 207 EIPLKDKTLAEKER-FYEGQCMLV---TPSCKELADLMTHCMNYDPNQRPF---FRAIMRD 260 (262)
T ss_pred CCCCCCcchhHHHH-HHhcCccCC---CCChHHHHHHHHHHcCCChhhCcC---HHHHHHh
Confidence 99998766544432 223322221 345678999999999999999999 5666643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.77 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=204.2
Q ss_pred eEEEEeeccCCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001370 688 FEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 759 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~---TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded----- 759 (1091)
|++.++||+|+||.||+|..+. ++..||||++... .......+.+.+|+.++..++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc-cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6778899999999999998653 5789999998653 334445778899999999999999999999886543
Q ss_pred -eeEEEEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCC
Q 001370 760 -NLYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 760 -~LYLVMEYm~GGSL~dlL~k~------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
..+++++|+.+|+|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999999887532 2478889999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 911 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-Gkp 911 (1091)
++...... .........+++.|++||.+.+..++.++|||||||++|||++ |.+
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGD-------------------------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCc-------------------------ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 87421100 0001122346788999999999999999999999999999999 999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 912 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 912 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
||.+.+..+.+..+...... ..+...+..+.+++.+||..+|.+||++.++.+
T Consensus 215 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 215 PYAGVENSEIYNYLIKGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99988888777776654321 123567899999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=319.42 Aligned_cols=234 Identities=24% Similarity=0.310 Sum_probs=192.1
Q ss_pred EeeccCCceEEEEEEECCCC----------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 692 KPISRGAFGRVFLARKRTTG----------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TG----------k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36999999999999998777 347778765432 125778899999999999999999999888 778
Q ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-------cEEEEecCCc
Q 001370 762 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-------HIKLTDFGLS 833 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-------~VKLsDFGLA 833 (1091)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 789999999999999999999999999999999999999888 8999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeechhhhHHHHHh-CC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFIT-GI 910 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Ys~ksDIWSLGVILYEMLT-Gk 910 (1091)
..... .....++..|+|||++.+. .++.++|+|||||++|||++ |.
T Consensus 156 ~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 156 ITVLS-------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred ccccc-------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 74210 1234577889999999876 78999999999999999999 68
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 911 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 911 pPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.||...+......... ....+| ......+.+||.+||..+|.+||+ +.+++
T Consensus 205 ~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt---~~~il 255 (259)
T cd05037 205 EPLSTLSSSEKERFYQ-DQHRLP---MPDCAELANLINQCWTYDPTKRPS---FRAIL 255 (259)
T ss_pred CCcccCCchhHHHHHh-cCCCCC---CCCchHHHHHHHHHhccChhhCCC---HHHHH
Confidence 8897776444333322 222222 223478999999999999999999 44554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.10 Aligned_cols=237 Identities=25% Similarity=0.335 Sum_probs=192.1
Q ss_pred eeccCCceEEEEEEECCCC------------------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce
Q 001370 693 PISRGAFGRVFLARKRTTG------------------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 748 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TG------------------------k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNI 748 (1091)
.||+|+||.||+|....++ ..||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 5999999999999854321 358888886432 2334678889999999999999
Q ss_pred EEEeeeeccCCeeEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC----
Q 001370 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---- 823 (1091)
Q Consensus 749 VkL~gsfqded~LYLVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---- 823 (1091)
+++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..|
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999875 46789999999999999999999999999999999999998654
Q ss_pred ---cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeech
Q 001370 824 ---HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSV 899 (1091)
Q Consensus 824 ---~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSL 899 (1091)
.+||+|||++.... ......|++.|+|||.+.+ ..++.++|+|||
T Consensus 159 ~~~~~kl~d~g~~~~~~-------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL-------------------------------SREERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred ccceeeecCCccccccc-------------------------------cccccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 48999999875311 0012357888999999875 568999999999
Q ss_pred hhhHHHHH-hCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 900 GIILFEFI-TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 900 GVILYEML-TGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
||++|||+ +|.+||....+.+... .......+| ...++++.+||.+||+.+|.+||+ +.+++++
T Consensus 208 G~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps---~~~il~~ 272 (274)
T cd05076 208 GTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLP---EPSCKELATLISQCLTYEPTQRPS---FRTILRD 272 (274)
T ss_pred HHHHHHHHhCCCCCccccChHHHHH-HHHhccCCC---CCCChHHHHHHHHHcccChhhCcC---HHHHHHh
Confidence 99999995 6999998877655433 233333333 446678999999999999999999 6666643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=321.71 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=205.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--C
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--R 758 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd--e 758 (1091)
..+|++++.||+|+||.||+|++.. +++.||+|++++.... .....+.+|+.++..+.||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3578899999999999999998653 4789999999764322 356789999999999999999999998877 5
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
...|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 57999999999999999997654 58999999999999999999999999999999999999999999999999987531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
.... .........++..|+|||.+.+..++.++|||||||++|||++|..||....
T Consensus 161 ~~~~------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 161 EDKD------------------------YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred cCCc------------------------ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 0000 0000112345667999999998899999999999999999999999987543
Q ss_pred hHH--------------HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 918 PEI--------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 918 ~~e--------------i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
... ....++.....++ .+..++.++.+|+.+||..+|.+||++.++.+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred chhccccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 221 1122233333333 2456788999999999999999999955444443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=321.93 Aligned_cols=248 Identities=19% Similarity=0.285 Sum_probs=195.1
Q ss_pred eeccCCceEEEEEEECCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 001370 693 PISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TG--k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
.||+|+||.||+++....+ ..+++|.++... .......+.+|+.++..++||||+++++.|......|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5999999999999764332 345566554322 234567899999999999999999999999999999999999999
Q ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 771 GDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 771 GSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|+|.+++.+. ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~------- 152 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE------- 152 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc-------
Confidence 9999999764 23566778889999999999999999999999999999999999999999997631100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
.........+|++.|+|||++.. ..++.++|||||||++|||++ |.+||...+.
T Consensus 153 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 153 ------------------DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred ------------------hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 00011124578999999999853 245789999999999999997 6789988887
Q ss_pred HHHHHHHhhcCC---CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 919 EIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 919 ~ei~~kIl~~~l---~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.+.+..+..... .-|.++..+++.+.+++..|| .+|.+||+++++.+.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 215 REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 777776655421 224445668899999999999 5899999955444433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=350.65 Aligned_cols=265 Identities=27% Similarity=0.351 Sum_probs=207.4
Q ss_pred CCCCCCccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEe
Q 001370 673 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 752 (1091)
Q Consensus 673 tpl~ss~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~ 752 (1091)
...++..+...++++|..-..||+|+||.||+|.... |..||||.+....... ...|.+|+.+|.+++|||+|+|+
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence 3345556677888999999999999999999999864 5899999776533211 34599999999999999999999
Q ss_pred eeeccCC-eeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CeecccCCCceEecCCCcEE
Q 001370 753 YSFTCRD-NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 753 gsfqded-~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~G---IIHRDLKPeNILLD~nG~VK 826 (1091)
|+|.+.+ ..+||+|||++|+|.++|.... .++|.....|+.+++.||+|||... ||||||||+|||||+++.+|
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999999 5999999999999999998655 8999999999999999999999864 99999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCc-cCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~-vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYE 905 (1091)
|+|||||+..... .....+. .||.+|+|||++..+..+.++|||||||+|.|
T Consensus 218 lsDFGLa~~~~~~---------------------------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllE 270 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG---------------------------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLE 270 (361)
T ss_pred ccCccCcccCCcc---------------------------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHH
Confidence 9999999753210 0001112 79999999999998889999999999999999
Q ss_pred HHhCCCCCCCCC---h---HHHHHHHhh-cCC---CCCCCC-CCCC--HH---HHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 906 FITGIPPFTAES---P---EIIFDNILN-RKI---PWPCVP-SDMS--FE---AQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 906 MLTGkpPF~~~s---~---~ei~~kIl~-~~l---~fP~ip-~~lS--~e---akDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
|++|+.|..... . .+.....+. +.+ --|.+. ...+ .+ +..+..+|++.+|.+||++.++.+.|
T Consensus 271 litgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 271 LITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 999998887432 1 111111221 111 001111 1222 23 45677899999999999976655555
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=335.38 Aligned_cols=260 Identities=29% Similarity=0.521 Sum_probs=219.9
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~ 760 (1091)
...+++.+++..||.|+.|+|++++.+.+|...|||.+.+.. ++++..+++..++++.+.. +|+||+.|++|..+..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 345678889999999999999999999999999999998744 5667788999999887765 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+++.||.|.. -+..+|++ .++++|..+-.+...++.||.||..+ ||||||+||+|||+|..|++||||||++-...
T Consensus 166 V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv- 243 (391)
T KOG0983|consen 166 VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV- 243 (391)
T ss_pred HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee-
Confidence 9999999854 55556654 46799999999999999999999864 89999999999999999999999999987532
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
+........|-+.|||||-+. ...|+..+||||||++++||.||..||.+
T Consensus 244 ---------------------------dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 244 ---------------------------DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ---------------------------cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 112223457999999999985 35799999999999999999999999988
Q ss_pred C-ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 916 E-SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 916 ~-s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
. ..-++..+|++...+.-.....+|+++++|+..||++|+.+||. ..++|+|||...
T Consensus 297 c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~---Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 297 CKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK---YNKLLEHPFIKR 354 (391)
T ss_pred CCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc---hHHHhcCcceee
Confidence 5 45678888888554322222458999999999999999999998 679999999964
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=364.19 Aligned_cols=253 Identities=26% Similarity=0.483 Sum_probs=219.1
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe--eEEEE
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--LYLVM 765 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i-~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~--LYLVM 765 (1091)
++..+||+|+|-+||+|.+..+|..||--.++-.++ ......+++..|+.+|+.|+|||||++|+++.+..+ +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 555689999999999999999999888554432222 244567899999999999999999999999998876 88999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEecC-CCcEEEEecCCcccccccccc
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
|++..|+|..|+++++.++...++.|++||++||.|||++. |||||||-+||+|+. -|.|||+|+|||+...
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----- 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----- 197 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh-----
Confidence 99999999999999999999999999999999999999984 999999999999985 4899999999998631
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC-CCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT-AESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~-~~s~~ei 921 (1091)
...+.+.+|||.|||||++. ..|+..+||||||++|.||+|+..||. ..++.++
T Consensus 198 ------------------------~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI 252 (632)
T KOG0584|consen 198 ------------------------KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI 252 (632)
T ss_pred ------------------------ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence 22344589999999999998 789999999999999999999999996 5678999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
|+++..+..+-. +..--.+++++||.+||.. ...||+ |.|+|.||||..-
T Consensus 253 YKKV~SGiKP~s-l~kV~dPevr~fIekCl~~-~~~R~s---a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 253 YKKVTSGIKPAA-LSKVKDPEVREFIEKCLAT-KSERLS---AKELLKDPFFDED 302 (632)
T ss_pred HHHHHcCCCHHH-hhccCCHHHHHHHHHHhcC-chhccC---HHHHhhChhhccc
Confidence 999988765421 1223368999999999997 999999 8999999999753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=369.43 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=224.4
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 754 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gs 754 (1091)
...+...+.++.+.||+|+||+||+|+... ....||||.++... ..+....|.+|+++|..++|||||+|+|.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 345677888999999999999999998642 33589999998643 34467899999999999999999999999
Q ss_pred eccCCeeEEEEeecCCCcHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec
Q 001370 755 FTCRDNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA 820 (1091)
Q Consensus 755 fqded~LYLVMEYm~GGSL~dlL~k~g--------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD 820 (1091)
|..++.+|||+|||..|||..+|+... .|+..+...++.||+.||+||-++.+|||||-..|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 999999999999999999999997432 278888999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechh
Q 001370 821 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 900 (1091)
Q Consensus 821 ~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLG 900 (1091)
++-.|||+||||++......+. + ......-...||+||.++..+|+.++||||||
T Consensus 638 e~l~VKIsDfGLsRdiYssDYY---------------------k----~~~~t~lPIRWMppEsIly~kFTteSDVWs~G 692 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYY---------------------K----VRGNTLLPIRWMPPESILYGKFTTESDVWSFG 692 (774)
T ss_pred cceEEEecccccchhhhhhhhh---------------------c----ccCCceeeeecCCHHHhhcCcccchhhhhhhh
Confidence 9999999999999964321111 0 00112235789999999999999999999999
Q ss_pred hhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 901 IILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 901 VILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
|+|||+++ |+.||++.+.++....|.++++ ++ .|..+|.++.+|+..||+.+|.+||++.++..+|+
T Consensus 693 VvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~-~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 693 VVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LS-CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred hhhhhhhccccCcccccchHHHHHHHHcCCc-cc-CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 99999998 9999999999999999999887 55 47899999999999999999999999665555553
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.52 Aligned_cols=258 Identities=16% Similarity=0.235 Sum_probs=192.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccchhH--------HHHHHHHHHHHHhcCCCceEEE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKND--------IERILAERNILITVRNPFVVRF 751 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKiLkK~~i~~~~e--------ie~~l~EieILskL~HPNIVkL 751 (1091)
..-+.|++.+.||+|+||+||+|++..+ +..+|+|+..........+ ......+...+..+.|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999999887 6678887643211110001 0112233344556789999999
Q ss_pred eeeeccCC----eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEE
Q 001370 752 FYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 827 (1091)
Q Consensus 752 ~gsfqded----~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKL 827 (1091)
++++.... ..|++|+++.. ++.+.+.....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98766554 34788888754 77777766666788999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001370 828 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 828 sDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEML 907 (1091)
+|||+|+....+.. .. . ..........||+.|+|||++.+..|+.++|||||||+||||+
T Consensus 168 ~DFGla~~~~~~~~----------------~~-~---~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 168 IDYGIASHFIIHGK----------------HI-E---YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred EEcCCceeeccCCc----------------cc-c---cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999985321100 00 0 0011223457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-H--------HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 908 TGIPPFTAESP-E--------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 908 TGkpPF~~~s~-~--------ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
+|.+||.+.+. . +...++......+ ...+.++.+++..||..+|.+||+.+.+.
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 99999987632 1 2233344343332 34678999999999999999999954333
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=367.15 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=208.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC--
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR-- 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqde-- 758 (1091)
.+.-..+++.+.|.+|||+.||+|+....|..||+|.+-. ..+...+.+.+|+++|++|+ |||||.++++....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 3455677899999999999999999998889999998754 25678889999999999998 99999999943221
Q ss_pred -----CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEecCCCcEEEEe
Q 001370 759 -----DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTD 829 (1091)
Q Consensus 759 -----d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsD 829 (1091)
-.++|.||||.||.|-+++.+. ..|++.++..|++++++|+.+||... |||||||-|||||+.+|+.||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 2378999999999999999743 46999999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHH
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEM 906 (1091)
||.|...... + ...+ ...-.+..-...-|+.|+|||++. +.+.+.|+|||+|||+||-|
T Consensus 190 FGSatt~~~~-------~-------~~~~----e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 190 FGSATTKILS-------P-------TSAQ----EVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred ccccccccCC-------C-------ccHH----HHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 9988742100 0 0000 000001111234699999999874 67789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 907 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 907 LTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
+....||+.... ..|+++.+.||.. +..+..+++||+.||+.||.+||+
T Consensus 252 Cy~t~PFe~sg~----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPn 300 (738)
T KOG1989|consen 252 CYFTTPFEESGK----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPN 300 (738)
T ss_pred HHhCCCcCcCcc----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCC
Confidence 999999987643 3688999999964 578899999999999999999999
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=363.28 Aligned_cols=276 Identities=41% Similarity=0.734 Sum_probs=249.6
Q ss_pred eeccCCceEEEEEEE---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec
Q 001370 693 PISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 768 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~---k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLVMEYm 768 (1091)
++|.|+||.|++++. .+.|..||||++++......... +...|+.++..++ ||++|++++.|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999999864 34578999999998766555444 7888999999998 999999999999999999999999
Q ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001370 769 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848 (1091)
Q Consensus 769 ~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~ 848 (1091)
.||+|+..+.+...+.+...++|.++++.|++++|+.||||||+|++||+++.+||+++.|||+++.....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~--------- 150 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE--------- 150 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhc
Q 001370 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 928 (1091)
Q Consensus 849 t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~ 928 (1091)
...|||..|||||++. ++...+||||||+++|||++|..||.+ ++...|+..
T Consensus 151 ----------------------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~ 202 (612)
T KOG0603|consen 151 ----------------------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA 202 (612)
T ss_pred ----------------------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh
Confidence 1129999999999998 788999999999999999999999988 888889888
Q ss_pred CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCccccccc
Q 001370 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSR 1004 (1091)
Q Consensus 929 ~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~ 1004 (1091)
.+.+| ..++..+++++..++.++|.+|++. .++.+|++|+||..++|+.+..+ +|||+|....+.|+.+|+.+
T Consensus 203 ~~~~p---~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~e 279 (612)
T KOG0603|consen 203 ELEMP---RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPE 279 (612)
T ss_pred ccCCc---hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCch
Confidence 87777 7899999999999999999999995 68999999999999999988766 78999999999999999998
Q ss_pred cccCC
Q 001370 1005 FSQIS 1009 (1091)
Q Consensus 1005 fs~~~ 1009 (1091)
|+...
T Consensus 280 ft~~~ 284 (612)
T KOG0603|consen 280 FTSQV 284 (612)
T ss_pred hccCC
Confidence 87763
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=370.66 Aligned_cols=273 Identities=31% Similarity=0.484 Sum_probs=209.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 757 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd------ 757 (1091)
-..+|+.++.||+||||.||+|+++-+|+.||||.|.-.. .......+.+|+.+|++++|||||++|.++..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4678999999999999999999999999999999987533 45567889999999999999999999864300
Q ss_pred --------------------------------------------------------------------------------
Q 001370 758 -------------------------------------------------------------------------------- 757 (1091)
Q Consensus 758 -------------------------------------------------------------------------------- 757 (1091)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeeEEEEeecCCCcHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHH
Q 001370 758 -------------------------R--------DNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLH 803 (1091)
Q Consensus 758 -------------------------e--------d~LYLVMEYm~GGSL~dlL~k~g~L-sE~~ar~yaaQIa~ALeYLH 803 (1091)
+ ..+||-||||+.-.|.+++.+.... ....++.+++||+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1268999999997777776654433 47788899999999999999
Q ss_pred HcCCeecccCCCceEecCCCcEEEEecCCccccccc-ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCh
Q 001370 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN-NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 882 (1091)
Q Consensus 804 s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~-~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAP 882 (1091)
++|||||||||.||+||.++.|||+|||+|+....+ ..++.. ..+ .............+.+||..|+||
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~-~~~---------~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQD-LSF---------STNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhc-cCc---------cccccCCCCcccccccceeeeecH
Confidence 999999999999999999999999999999852211 011000 000 000011122244678999999999
Q ss_pred hhhcCCC---CCccceeechhhhHHHHHhCCCCCCCC-ChHHHHHHHhhcCCCCC-CCCCCCCHHHHHHHhhhccCCCCC
Q 001370 883 EILLGTE---HGYAADWWSVGIILFEFITGIPPFTAE-SPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQ 957 (1091)
Q Consensus 883 EVL~g~~---Ys~ksDIWSLGVILYEMLTGkpPF~~~-s~~ei~~kIl~~~l~fP-~ip~~lS~eakDLI~rcL~kDPeK 957 (1091)
|++.+.. |+.|+|+||||||+|||+. ||... ....+...+-++.++.| .+...--+....+|++||..||.+
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence 9998754 9999999999999999984 67543 34445555555555555 112233356778999999999999
Q ss_pred CCCcccHHHHHcCCCCC
Q 001370 958 RLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 958 RpSa~gA~EIL~HPFFk 974 (1091)
||| |.|+|++.||-
T Consensus 862 RPt---A~eLL~s~llp 875 (1351)
T KOG1035|consen 862 RPT---ATELLNSELLP 875 (1351)
T ss_pred CCC---HHHHhhccCCC
Confidence 999 99999999997
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=364.70 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=214.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk-----~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
......++.+.||+|+||.||.|....-.. .||||.+++ ..+..++..|++|..+|+.++|||||++.+.+.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 445677899999999999999999875433 399998876 4456788999999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEec
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 830 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~-------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDF 830 (1091)
....+|++|||.||||..+|++. ..++......++.+|++|++||+++++|||||-..|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999876 24889999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-C
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 909 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-G 909 (1091)
|||+.+....+. . .... ..-...|||||.|....++.++|||||||+|||+++ |
T Consensus 847 GlArDiy~~~yy--------------------r-~~~~----a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 847 GLARDIYDKDYY--------------------R-KHGE----AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred chhHhhhhchhe--------------------e-ccCc----cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 999953321111 0 0011 122357999999999999999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 961 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa 961 (1091)
..||.+.+..+++...+.+. +++ .|..++..+.++|..||+.+|++||++
T Consensus 902 ~~PY~~~~n~~v~~~~~~gg-RL~-~P~~CP~~ly~lM~~CW~~~pe~RP~F 951 (1025)
T KOG1095|consen 902 ATPYPSRSNFEVLLDVLEGG-RLD-PPSYCPEKLYQLMLQCWKHDPEDRPSF 951 (1025)
T ss_pred CCCCCCcchHHHHHHHHhCC-ccC-CCCCCChHHHHHHHHHccCChhhCccH
Confidence 99999999999988666654 333 258999999999999999999999994
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=296.59 Aligned_cols=243 Identities=50% Similarity=0.851 Sum_probs=209.2
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHH
Q 001370 698 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 777 (1091)
Q Consensus 698 gFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL~dlL 777 (1091)
+||.||+|.+..+|+.+|+|++........ ...+.+|+.++.+++|+||+++++.+......++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998999999999976443221 678899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001370 778 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857 (1091)
Q Consensus 778 ~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~ 857 (1091)
.....++...+..++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~------------------- 139 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP------------------- 139 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecc-------------------
Confidence 8766689999999999999999999999999999999999999999999999999875310
Q ss_pred CCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC-CChHHHHHHHhhcCCCCCCCC
Q 001370 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWPCVP 936 (1091)
Q Consensus 858 ~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~-~s~~ei~~kIl~~~l~fP~ip 936 (1091)
........|++.|++||.+.+..++.++|+||||+++|+|++|..||.. .....+...+.......+...
T Consensus 140 ---------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (244)
T smart00220 140 ---------GGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE 210 (244)
T ss_pred ---------ccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccc
Confidence 0022345688999999999988899999999999999999999999988 666666666555544433211
Q ss_pred CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 937 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 937 ~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..++.++.+++.+||..+|.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~~~~~~~ 244 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLT---AEEALQHPFF 244 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccC---HHHHhhCCCC
Confidence 228899999999999999999999 8899999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=347.85 Aligned_cols=264 Identities=25% Similarity=0.346 Sum_probs=184.6
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee--
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTT----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS-- 754 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~T----Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gs-- 754 (1091)
.....++|++.+.||+|+||.||+|++..+ +..||+|.+.... ..+...++. +....+.+++.+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e~--l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNER--VRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHHH--HHhhchhhHHHHHHhhh
Confidence 345778999999999999999999999988 8999999876422 111112221 112222222222222
Q ss_pred ----eccCCeeEEEEeecCCCcHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 001370 755 ----FTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------------LEEDVARIYIAELVLALEYLHSLGIVHR 810 (1091)
Q Consensus 755 ----fqded~LYLVMEYm~GGSL~dlL~k~g~--------------------LsE~~ar~yaaQIa~ALeYLHs~GIIHR 810 (1091)
......+|+||||+.+|+|.+++..... ..+..++.++.||+.||.|||++|||||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2455679999999999999999875321 1234466789999999999999999999
Q ss_pred ccCCCceEecC-CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-
Q 001370 811 DLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT- 888 (1091)
Q Consensus 811 DLKPeNILLD~-nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~- 888 (1091)
||||+|||++. ++.+||+|||+|+..... ........+||+.|||||.+...
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~--------------------------~~~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVG--------------------------INYIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccc--------------------------cccCCcccccCCCccChHHhhccC
Confidence 99999999986 689999999999742100 01122356899999999976432
Q ss_pred ---------------------CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhh-cCCCC------------CC
Q 001370 889 ---------------------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN-RKIPW------------PC 934 (1091)
Q Consensus 889 ---------------------~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~-~~l~f------------P~ 934 (1091)
.++.++|||||||+||||+++..|+.. ....+..++. ....+ +.
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 411 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchh
Confidence 244567999999999999997666432 2222222211 11100 00
Q ss_pred ------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001370 935 ------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 982 (1091)
Q Consensus 935 ------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~ 982 (1091)
+....+..++|||.+||++||.+||+ +.++|+||||.+..+..+.
T Consensus 412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t---a~e~L~Hpff~~~~~~~~~ 462 (566)
T PLN03225 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS---AKAALAHPYFDREGLLGLS 462 (566)
T ss_pred hhhhhhhccccchHHHHHHHHHccCCcccCCC---HHHHhCCcCcCCCCccccc
Confidence 01112345679999999999999999 8899999999998776443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=306.88 Aligned_cols=259 Identities=30% Similarity=0.538 Sum_probs=217.8
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|.-++.||.|.||+||+++++.+++.||+|.++-.+ ..+.--...++|+-+|+.++|.|||++++....+..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35677789999999999999999999999999987533 22333467899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||.. +|..+.... |.++.+.++.++.|+++||.|+|+.++.||||||.|+||+.+|.+||+|||+++.+..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi------ 153 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI------ 153 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC------
Confidence 99976 887777653 6799999999999999999999999999999999999999999999999999985320
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~ 922 (1091)
+.+-....+.|.+|.+|.++.+. -|+.+.|+||.|||+.|+.. |+|.|.+.+..+..
T Consensus 154 ---------------------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql 212 (292)
T KOG0662|consen 154 ---------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_pred ---------------------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence 11122345789999999999884 58999999999999999987 89999999998888
Q ss_pred HHHhhc-----CCCCCC------------CC---------CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 923 DNILNR-----KIPWPC------------VP---------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 923 ~kIl~~-----~l~fP~------------ip---------~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.+|... .-.||. +| +.++...+||++++|..+|.+|++ |++.++||||.+.
T Consensus 213 krif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris---aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 213 KRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS---AEAALQHPYFSDF 289 (292)
T ss_pred HHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC---HHHHhcCcccccc
Confidence 888641 112222 22 345567889999999999999999 7888999999764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=333.76 Aligned_cols=256 Identities=30% Similarity=0.529 Sum_probs=211.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--C----ceEEEeeeec
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--P----FVVRFFYSFT 756 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H--P----NIVkL~gsfq 756 (1091)
...+.|+++..+|+|.||.|..+.+..++..||||+++... ...+..+-|+++|.++.+ | .+|++.++|.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 34678999999999999999999999999999999998643 234556779999999842 3 4889999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-------------
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH------------- 821 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~------------- 821 (1091)
-.++.|+|+|.+ |-+++++|.+.. +|+...++.+++||+.+++|||+++++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999988 559999998754 6899999999999999999999999999999999999842
Q ss_pred -------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001370 822 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 894 (1091)
Q Consensus 822 -------nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 894 (1091)
+-+|||+|||.|++.. +...+.+-|..|.|||++++-+++..|
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~------------------------------e~hs~iVsTRHYRAPEViLgLGwS~pC 290 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDH------------------------------EHHSTIVSTRHYRAPEVILGLGWSQPC 290 (415)
T ss_pred ceeccCCCcceEEEecCCcceec------------------------------cCcceeeeccccCCchheeccCcCCcc
Confidence 3368999999988521 222567899999999999999999999
Q ss_pred eeechhhhHHHHHhCCCCCCCCChHH---HHHHHhh------------------cCCCCCCCC-----------------
Q 001370 895 DWWSVGIILFEFITGIPPFTAESPEI---IFDNILN------------------RKIPWPCVP----------------- 936 (1091)
Q Consensus 895 DIWSLGVILYEMLTGkpPF~~~s~~e---i~~kIl~------------------~~l~fP~ip----------------- 936 (1091)
||||+||||+|+.+|...|...+..+ ++++|+. +.+.||...
T Consensus 291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~ 370 (415)
T KOG0671|consen 291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK 370 (415)
T ss_pred CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH
Confidence 99999999999999999998876544 5555543 223333210
Q ss_pred -----CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 937 -----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 937 -----~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..-..++.|||++||.+||.+|+| +.|+|.||||+..
T Consensus 371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiT---l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 371 YMLQDDLEHVQLFDLLRRMLEFDPARRIT---LREALSHPFFARL 412 (415)
T ss_pred HhccCcHHHhHHHHHHHHHHccCcccccc---HHHHhcCHHhhcC
Confidence 001235779999999999999999 8899999999864
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=317.16 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=212.8
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe-
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN- 760 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~- 760 (1091)
.+.-++|++.+.||.|||+-||+|+...+++.||+|.+.... .++++..++|++.-++++||||++++++...+..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 456788999999999999999999999999999999886533 5678899999999999999999999988765544
Q ss_pred ----eEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEecCCCcEEEEec
Q 001370 761 ----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDF 830 (1091)
Q Consensus 761 ----LYLVMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsDF 830 (1091)
.||+++|...|+|.+.+... ..+++.++..|+.+|++||++||... ++||||||.|||+...+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 99999999999999998643 36999999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHH
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEML 907 (1091)
|.++..... +.+. .....+.+| .....|..|.|||.+.- ...+.++|||||||+||+|+
T Consensus 174 GS~~~a~i~----i~~~------~~a~~lQe~--------a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m 235 (302)
T KOG2345|consen 174 GSATQAPIQ----IEGS------RQALRLQEW--------AEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM 235 (302)
T ss_pred cCccccceE----eech------HHHHHHHHH--------HHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH
Confidence 998753210 0000 000001111 22346889999999964 44588999999999999999
Q ss_pred hCCCCCCCCC--hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 908 TGIPPFTAES--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 908 TGkpPF~~~s--~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
.|..||...- ...+.-.+.+.++.||.- ...|..+..||+.||++||.+||+ +.+++.
T Consensus 236 f~~sPfe~~~~~GgSlaLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~---i~~ll~ 295 (302)
T KOG2345|consen 236 FGESPFERIYQQGGSLALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPT---IPELLS 295 (302)
T ss_pred HcCCcchHHhhcCCeEEEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCC---HHHHHH
Confidence 9999996421 122233455677888863 458999999999999999999999 556654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.65 Aligned_cols=264 Identities=29% Similarity=0.489 Sum_probs=209.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-C
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-R 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk----~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd-e 758 (1091)
....|+.+..||+|+||.||+|..+.++. .||||.++...- ...-.....+|+.+++.++|||||.|..+|.. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 35679999999999999999997665543 799998865321 11223457889999999999999999999988 7
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC----CcEEEEe
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTD 829 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n----G~VKLsD 829 (1091)
..+||++||.+. ||...++-+ ..++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 789999999988 999988633 358999999999999999999999999999999999999877 8999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHh
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 908 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLT 908 (1091)
|||++... +. + . +-......+.|.+|.|||.++| ..|+.++|+||+|||+.|||+
T Consensus 180 lGlaR~~~--~p----------l-------k-----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 180 LGLARLFN--NP----------L-------K-----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccHHHHhh--cc----------c-------c-----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 99999632 10 0 0 0112245788999999999998 568999999999999999999
Q ss_pred CCCCCCCCCh---------HHHHHHHhhc-----CCCCCCC---C--------------------------CCCCHHHHH
Q 001370 909 GIPPFTAESP---------EIIFDNILNR-----KIPWPCV---P--------------------------SDMSFEAQD 945 (1091)
Q Consensus 909 GkpPF~~~s~---------~ei~~kIl~~-----~l~fP~i---p--------------------------~~lS~eakD 945 (1091)
-.|-|.+... .+...+|++- .-.||.+ | ..-++.+.+
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 9999976431 2344555441 1123221 0 113556889
Q ss_pred HHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 946 LINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 946 LI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
|+.+||++||.+|++ +.+.++|+||..-
T Consensus 316 LL~klL~yDP~kRIt---a~qAleh~yF~~d 343 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRIT---AEQALEHPYFTED 343 (438)
T ss_pred HHHHHhccCchhhcc---HHHHhcccccccC
Confidence 999999999999999 8889999999754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=346.40 Aligned_cols=259 Identities=32% Similarity=0.539 Sum_probs=223.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc----
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC---- 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqd---- 757 (1091)
...+-|++..+||.|.+|.||+++++.+|+..|+|++... .+..+.+..|.+||+.. +|||++.+||+|.-
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 4457799999999999999999999999999999998653 23456678899999877 49999999998854
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 758 -RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 758 -ed~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
.+.+|||||||.||+.-+++++. ..+.|+.+..++++++.|+.+||.+.+||||||-.|||++.+|.|||+|||++.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 45799999999999999999754 569999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
... ....+..+.+|||.|||||++.- ..|+..+|+||||++..||.-|
T Consensus 172 Qld---------------------------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG 224 (953)
T KOG0587|consen 172 QLD---------------------------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEG 224 (953)
T ss_pred eee---------------------------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCC
Confidence 421 12445678999999999999953 3578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.||+....+...+-.|-....+-..-|..++.++.|||..||.+|-.+||+ ..+++.|||.+.
T Consensus 225 ~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~---~~~ll~hpFi~e 287 (953)
T KOG0587|consen 225 APPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS---TEELLKHPFITE 287 (953)
T ss_pred CCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc---hhhhccCCcccc
Confidence 999999988877777665543332235778999999999999999999999 889999999984
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=346.20 Aligned_cols=242 Identities=35% Similarity=0.490 Sum_probs=195.8
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC------e
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD------N 760 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded------~ 760 (1091)
.+..-+.||+||||.||+++++.||+.||||.+++.. .....+...+|+++|++++|||||++++.-.+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4566788999999999999999999999999998744 3445678889999999999999999998876654 4
Q ss_pred eEEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC--CC--cEEEEecCCc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DG--HIKLTDFGLS 833 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~---g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~--nG--~VKLsDFGLA 833 (1091)
..+|||||+||||+..|.+. ..|++.+.+.++..++.||.|||++|||||||||.||++-. +| .-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999999753 46999999999999999999999999999999999999853 34 3699999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
+... +.....+++||+.|.+||++. .+.|+..+|.|||||++|+++||..|
T Consensus 172 rel~----------------------------d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 172 RELD----------------------------DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCC----------------------------CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 9532 223456789999999999999 48899999999999999999999999
Q ss_pred CCCCCh-----HHHHHHHhh--------------cCCC----CCCCCCCCCHHHH----HHHhhhccCCCCCCC
Q 001370 913 FTAESP-----EIIFDNILN--------------RKIP----WPCVPSDMSFEAQ----DLINRFLIHDPNQRL 959 (1091)
Q Consensus 913 F~~~s~-----~ei~~kIl~--------------~~l~----fP~ip~~lS~eak----DLI~rcL~kDPeKRp 959 (1091)
|..... +-++..+.. +.+. +|. |..++.... ..+..+|..+|++|.
T Consensus 224 F~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 224 FIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 964321 233333322 1222 232 455555433 456678899999998
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.79 Aligned_cols=267 Identities=29% Similarity=0.467 Sum_probs=218.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc----ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD----MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~----i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde- 758 (1091)
--+.|-++..||+|||++||+|.+...+++||+|+-.-.. ..+.+..++..+|.+|.+.++||.||++|++|.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3467888999999999999999999999999999754221 22344567899999999999999999999999754
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CCeecccCCCceEecC---CCcEEEEecCCc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--GIVHRDLKPDNLLIAH---DGHIKLTDFGLS 833 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~--GIIHRDLKPeNILLD~---nG~VKLsDFGLA 833 (1091)
+.+|-|+|||+|.+|..+|+.+..+++.+++.|+.||+.||.||... .|||-||||.||||-. .|.+||+||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 56899999999999999999999999999999999999999999976 5999999999999954 578999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC----CCCccceeechhhhHHHHHhC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~----~Ys~ksDIWSLGVILYEMLTG 909 (1091)
+.+... +.+ .......+....||.+|++||.|.-. +.+.++||||+|||+|.+|+|
T Consensus 621 KIMddd-Sy~-------------------~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 621 KIMDDD-SYN-------------------SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred hhccCC-ccC-------------------cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence 964321 110 00122345567899999999998632 457899999999999999999
Q ss_pred CCCCCCCCh-HHHHH--HHhh-cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 910 IPPFTAESP-EIIFD--NILN-RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 910 kpPF~~~s~-~ei~~--kIl~-~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
+.||..... .++.. .|++ ..+.||. .+.++.++++||++||++.-+.|+. +.++..||||.
T Consensus 681 rKPFGhnqsQQdILqeNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~D---V~qLA~dpyll 745 (775)
T KOG1151|consen 681 RKPFGHNQSQQDILQENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRID---VQQLACDPYLL 745 (775)
T ss_pred CCCCCCchhHHHHHhhhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhh---HHHHccCcccc
Confidence 999976543 33332 2333 3556774 3578999999999999999999987 88999999995
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=328.38 Aligned_cols=265 Identities=23% Similarity=0.306 Sum_probs=192.5
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEEC----------------CCCcEEEEEEeecccccc-----------hhHHHHH
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKR----------------TTGDLFAIKVLKKLDMIR-----------KNDIERI 733 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k----------------~TGk~VAIKiLkK~~i~~-----------~~eie~~ 733 (1091)
.+...++|++.++||+|+||+||+|... ..++.||||.++...... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3567889999999999999999999752 235679999886422100 0111233
Q ss_pred HHHHHHHHhcCCCce-----EEEeeeecc--------CCeeEEEEeecCCCcHHHHHHhcC-------------------
Q 001370 734 LAERNILITVRNPFV-----VRFFYSFTC--------RDNLYLVMEYLNGGDLYSLLRKVG------------------- 781 (1091)
Q Consensus 734 l~EieILskL~HPNI-----VkL~gsfqd--------ed~LYLVMEYm~GGSL~dlL~k~g------------------- 781 (1091)
..|+.++.+++|.++ ++++++|.. ....||||||+++|+|.+++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 456777777776554 566666543 356899999999999999886421
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 001370 782 -----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856 (1091)
Q Consensus 782 -----~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~ 856 (1091)
.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~----------------- 362 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG----------------- 362 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-----------------
Confidence 2356678889999999999999999999999999999999999999999998642100
Q ss_pred CCCCcccccCcCCccCccCCCCCCChhhhcCCC--------------------CC--ccceeechhhhHHHHHhCCC-CC
Q 001370 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--------------------HG--YAADWWSVGIILFEFITGIP-PF 913 (1091)
Q Consensus 857 ~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--------------------Ys--~ksDIWSLGVILYEMLTGkp-PF 913 (1091)
.........+|+.|+|||++.... |+ .+.||||+||++|+|++|.. ||
T Consensus 363 ---------~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 363 ---------INFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred ---------CccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 000111234589999999986422 22 34799999999999999875 77
Q ss_pred CCCC-----------hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCC---CCCCCcccHHHHHcCCCCCC
Q 001370 914 TAES-----------PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP---NQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 914 ~~~s-----------~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDP---eKRpSa~gA~EIL~HPFFkg 975 (1091)
.... ....++.+....+.++. ....++.++|||.+||.++| .+|+| +.|+|+||||..
T Consensus 434 ~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlS---a~eaL~Hp~f~~ 505 (507)
T PLN03224 434 ANIRLFNTELRQYDNDLNRWRMYKGQKYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLS---VGQALSHRFFLP 505 (507)
T ss_pred cchhhhhhHHhhccchHHHHHhhcccCCCccc-ccccChHHHHHHHHHhccCCCCcccCCC---HHHHhCCCCcCC
Confidence 5422 11222333334445542 35678999999999999876 68999 889999999953
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.19 Aligned_cols=261 Identities=26% Similarity=0.453 Sum_probs=213.7
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCC
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILsk-L~HPNIVkL~gsfqded 759 (1091)
.....++.+-+..||.|+||+|++-.++.+|+..|||.|+.... +.+..+++.|.+...+ -+.||||++|+..-.+.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 34566778888899999999999999999999999999986443 4567788888876544 56999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 760 NLYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~-----k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
..|+.||+|.- +|..+-+ +...++|..+-.+....+.||+||-. ..||||||||+|||||..|.|||||||+|
T Consensus 137 dcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 99999999964 5543332 34579999999999999999999985 58999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--CCCCCccceeechhhhHHHHHhCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~--g~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
..... ......-+|-..|||||-+. +.+|+.++|+||||++|||+.||+.
T Consensus 216 GqLv~----------------------------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~f 267 (361)
T KOG1006|consen 216 GQLVD----------------------------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNF 267 (361)
T ss_pred HhHHH----------------------------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCC
Confidence 64210 11123357889999999996 3579999999999999999999999
Q ss_pred CCCCCC-hHHHHHHHhhcCCCCCCCCC---CCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 912 PFTAES-PEIIFDNILNRKIPWPCVPS---DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 912 PF~~~s-~~ei~~kIl~~~l~fP~ip~---~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
||..-+ ..+....++.+..+.-..+. ..+..+..+|.-||.+|-..||. ..+++.+||++-
T Consensus 268 Pyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk---y~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 268 PYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK---YDDLKKFPFYRM 332 (361)
T ss_pred CcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc---hhhhhcCchhhh
Confidence 998754 34555566666654333233 37899999999999999999999 679999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.33 Aligned_cols=263 Identities=31% Similarity=0.447 Sum_probs=211.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 758 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde------ 758 (1091)
.+.|+-+..||+|.||+||+|+.+.+|+.||+|++--. -.+..--...++|+++|..++|+|++.+...|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 45678888999999999999999999999999854211 11222235578999999999999999998777543
Q ss_pred --CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 759 --DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 759 --d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
..+|+||.+|+. ||.-+|.+. .+|+...++.++.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 248999999987 999999766 5799999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
+.... ..........+.|.+|.+||.++| ..|+.+.|+|+.||||.||.+|.+-|.
T Consensus 174 fs~~~-----------------------n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 174 FSTSK-----------------------NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred eeccc-----------------------ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 42110 001112344678999999999987 679999999999999999999999999
Q ss_pred CCChHHHHHHHhh--c---CCCCCCC---------------------------CCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 915 AESPEIIFDNILN--R---KIPWPCV---------------------------PSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 915 ~~s~~ei~~kIl~--~---~l~fP~i---------------------------p~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
+.+.......|.. + +-.||.. |-.-.+++.||+.+||..||.+|+.
T Consensus 231 gnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~-- 308 (376)
T KOG0669|consen 231 GNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID-- 308 (376)
T ss_pred CChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc--
Confidence 9887766655532 1 1122221 1112468999999999999999999
Q ss_pred cHHHHHcCCCCCC
Q 001370 963 GAAEVKAHPFFKG 975 (1091)
Q Consensus 963 gA~EIL~HPFFkg 975 (1091)
+.++++|.||..
T Consensus 309 -ad~alnh~~F~k 320 (376)
T KOG0669|consen 309 -ADQALNHDFFWK 320 (376)
T ss_pred -hHhhhchhhhhc
Confidence 789999999953
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=349.77 Aligned_cols=270 Identities=51% Similarity=0.865 Sum_probs=231.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
-.-++|+.++.|..|+||-||+++++.+.+.+|+| ++|..++-++ ||.....|++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn----------ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN----------ILTFAGNPFVV------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc----------cccccCCccee-------------
Confidence 34579999999999999999999999999999995 4443322111 56666677777
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||=..+++..+.++.+. +.+++|||+.||+|||+||+|.||+.-||+|++|||+++.+.+..++
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 67777888878777554 88999999999999999999999999999999999999987655443
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.+.. + ++.. ..+.......||||.|+||||+..++|++.+|||++|+|+||.|.|..||.++++++++
T Consensus 200 nl~e----g------~I~k--~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 200 NLKE----G------HIEK--DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhhh----c------chHH--HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 2211 1 1110 11223345679999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCCCCCCCCccccc
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFL 1002 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~~~s~~Dts~Fd 1002 (1091)
..++...+.||.-...++++++++|.+||+.+|..|++..++.++++|+||+.+||..|..+++.|+|+....+|++||+
T Consensus 268 g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfd 347 (1205)
T KOG0606|consen 268 GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFD 347 (1205)
T ss_pred hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchhhc
Confidence 99999999999877789999999999999999999999889999999999999999999999999999999999999999
Q ss_pred cc
Q 001370 1003 SR 1004 (1091)
Q Consensus 1003 s~ 1004 (1091)
.+
T Consensus 348 TR 349 (1205)
T KOG0606|consen 348 TR 349 (1205)
T ss_pred cc
Confidence 75
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=322.30 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=218.3
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
++|.+.-.+..+-..||.|.||.||.|.|+.-.-.||||.++... .+++.|+.|..+|+.++|||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 677788888889999999999999999999999999999997644 3688999999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~--LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
..+|||+|||..|+|.+||++..+ ++.-....++.||..||+||..+++|||||-..|+|+.++..|||+||||++++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999999987653 566666667779999999999999999999999999999999999999999975
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
..+.++ ++ ....-...|.|||-|....++.++|||+|||+|||+.| |..||.+
T Consensus 416 tgDTYT--------------AH------------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 416 TGDTYT--------------AH------------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred cCCcee--------------cc------------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 321110 00 01112467999999998899999999999999999998 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
.+..++|..+-+ .+++. -|..+++.+.+|++.||+..|..||++.++
T Consensus 470 idlSqVY~LLEk-gyRM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 470 IDLSQVYGLLEK-GYRMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred ccHHHHHHHHhc-ccccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 999888876544 44443 358999999999999999999999995433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=320.19 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=209.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
..-+...+.+.||+|-||+|.+|... .+..||+|+++... ..+....|..|+++|.+++|||||.|+++|..++.++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 44556788899999999999999864 36899999998643 3455688999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|||||.+|+|.+++.++. .+.......++.||+.||+||.+.+||||||.+.|+|+|.++++||+|||+++-.....
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999999998873 33455566789999999999999999999999999999999999999999998432211
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH--hCCCCCCCCCh
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI--TGIPPFTAESP 918 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEML--TGkpPF~~~s~ 918 (1091)
+. ......+-...|||||.+.-.+++.++|+|+||++||||+ +...||...+.
T Consensus 692 yy-------------------------~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 692 YY-------------------------RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ce-------------------------eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 11 1112245578999999999999999999999999999975 47899998887
Q ss_pred HHHHHHHhh-----cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 919 EIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 919 ~ei~~kIl~-----~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
++..+..-. +...++..|.-++..+.+||.+||.+|-.+||+++
T Consensus 747 e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe 795 (807)
T KOG1094|consen 747 EQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFE 795 (807)
T ss_pred HHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHH
Confidence 777665432 22233445678999999999999999999999954
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=346.76 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=186.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|...+.||+|+||.||+|+.+.+|..||+|.++..... ...|+.++.+++|||||++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3466677899999999999999999999999988653321 124578899999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLH---s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||+++|+|.++++. +++..+..++.|++.||+||| +.+|+||||||+|||++.++..++. ||......
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----- 833 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----
Confidence 99999999999964 888999999999999999999 6699999999999999999988876 66543210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh----
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---- 918 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~---- 918 (1091)
......||+.|||||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 834 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~ 887 (968)
T PLN00113 834 --------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887 (968)
T ss_pred --------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc
Confidence 01123689999999999999999999999999999999999999954321
Q ss_pred -HHHHHHHhhc-CC---CCCCC------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 919 -EIIFDNILNR-KI---PWPCV------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 919 -~ei~~kIl~~-~l---~fP~i------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
.+..+..... .. .-|.+ +.....++.+++.+||+.||++||++.++.+.
T Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1111111100 00 00111 11122357789999999999999995544433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=330.33 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=219.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk---~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
++..+...|-++||.|-||+||.|+.+..|+ .||||.++... .+.+...|+.|..||-+++||||++|-++....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 3556778899999999999999999988774 79999998643 456778899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..+.||+|||++|+|..+|++. +.|+..+..-+++.|+.||.||-++|+|||||-..|||++.+-.+|++||||+++..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999999865 569999999999999999999999999999999999999999999999999999642
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCcc---CCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV---GTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~v---GTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF 913 (1091)
.+ . ...++.. -...|.|||.+...+++.++||||+|++|||.+. |..||
T Consensus 783 dd-~--------------------------~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 783 DD-P--------------------------EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred cC-C--------------------------CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 11 0 1111222 2468999999999999999999999999999665 99999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 914 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 914 ~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
...+.++....|..+ +.+|. |.+++..+..|+..||++|-.+||.+.++..
T Consensus 836 WdmSNQdVIkaIe~g-yRLPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 836 WDMSNQDVIKAIEQG-YRLPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred cccchHHHHHHHHhc-cCCCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 999999999888654 44443 5789999999999999999999999554433
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=319.25 Aligned_cols=256 Identities=31% Similarity=0.525 Sum_probs=213.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC------CceEEEeeeec
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN------PFVVRFFYSFT 756 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H------PNIVkL~gsfq 756 (1091)
+--+.|.+....|+|-|++|..|.+..-|..||||+|+..++.. ..=+.|++||++|+. -++++||..|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 34568999999999999999999999999999999999865543 345679999999962 48999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEecCC
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGL 832 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g---~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGL 832 (1091)
..+++|||+|-+.- +|..+|++.| .|....++.|+.|+..||..|-..||+|.||||+|||+++.. .+||||||.
T Consensus 505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 99999999998854 9999999887 478889999999999999999999999999999999999754 689999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
|.....+. ......+..|.|||+++|-+|++..|+||+||+||||.||+..
T Consensus 584 A~~~~ene-----------------------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 584 ASFASENE-----------------------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred cccccccc-----------------------------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 87542211 1123456789999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCC--------------------------------------C-C-----------------
Q 001370 913 FTAESPEIIFDNILNRKIPWPC--------------------------------------V-P----------------- 936 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l~fP~--------------------------------------i-p----------------- 936 (1091)
|.+.+...|++..+.-+-+||. + |
T Consensus 635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de 714 (752)
T KOG0670|consen 635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE 714 (752)
T ss_pred cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence 9999888777655543333332 0 0
Q ss_pred -CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 937 -SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 937 -~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
..+-..+++|+.+||..||++|++ +.+.|+||||.+
T Consensus 715 q~~~~~~~rdLLdkml~LdP~KRit---~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 715 QPKIVQQLRDLLDKMLILDPEKRIT---VNQALKHPFITE 751 (752)
T ss_pred hHHHHHHHHHHHHHHhccChhhcCC---HHHHhcCCcccC
Confidence 011235789999999999999999 778899999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=292.51 Aligned_cols=253 Identities=32% Similarity=0.547 Sum_probs=207.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC--e
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD--N 760 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded--~ 760 (1091)
..++|++.+.+|+|-|++||.|.+..+++.++||+++.. ..+.+.+|+.||..+. ||||++|++...+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 678999999999999999999999999999999999752 3467899999999998 999999999998865 4
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC-CcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~~~~~ 839 (1091)
..||+||+.+.+...+- ..|+...+++|+.|++.||.|+|++||+|||+||.|++||.. -.++|+|+|||.+-.
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-- 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-- 184 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC--
Confidence 78999999998776654 458888999999999999999999999999999999999964 479999999998631
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCC-CCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT-AES 917 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~-~~s 917 (1091)
++....-.+.+..|--||.+.. +.|+.+.|+|||||++..|+..+-||. +.+
T Consensus 185 --------------------------p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 185 --------------------------PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred --------------------------CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 1223345677888999999975 678999999999999999999998874 444
Q ss_pred hHHHHHHHhh-------------cC----------------CCCCC-----CCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 918 PEIIFDNILN-------------RK----------------IPWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 918 ~~ei~~kIl~-------------~~----------------l~fP~-----ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
..+..-+|.. -. .+|.. -..-.++++.|||.++|.+|.++|||
T Consensus 239 N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT--- 315 (338)
T KOG0668|consen 239 NYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT--- 315 (338)
T ss_pred CHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc---
Confidence 3333333221 01 11111 01235799999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 001370 964 AAEVKAHPFFKGV 976 (1091)
Q Consensus 964 A~EIL~HPFFkgI 976 (1091)
|.|.+.||||..+
T Consensus 316 akEam~HpyF~~~ 328 (338)
T KOG0668|consen 316 AKEAMAHPYFAPV 328 (338)
T ss_pred hHHHhcCchHHHH
Confidence 8899999999754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=300.76 Aligned_cols=257 Identities=29% Similarity=0.481 Sum_probs=211.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
....|.-++.+|.|+- .|..+-+.-+++.||+|.+... ........+..+|..++..++|+||++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3457888899999998 7888888889999999988664 444555678899999999999999999999997654
Q ss_pred --eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..|+|||||.. +|...+. -.++...+++++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+.-.
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 47999999976 8888876 347788899999999999999999999999999999999999999999999998410
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
........+.|..|.|||++.+.+|...+||||+||++.||++|..-|.+.+
T Consensus 170 ----------------------------~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 170 ----------------------------TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred ----------------------------cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 0112345789999999999999999999999999999999999999999887
Q ss_pred hHHHHHHHhhc---------------------------CCC----CCC--C------CCCCCHHHHHHHhhhccCCCCCC
Q 001370 918 PEIIFDNILNR---------------------------KIP----WPC--V------PSDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 918 ~~ei~~kIl~~---------------------------~l~----fP~--i------p~~lS~eakDLI~rcL~kDPeKR 958 (1091)
..+.+.+|... ... ||. + +..-+..++||+.+||..||++|
T Consensus 222 ~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~R 301 (369)
T KOG0665|consen 222 HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKR 301 (369)
T ss_pred HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhc
Confidence 66555554320 000 111 0 01224568999999999999999
Q ss_pred CCcccHHHHHcCCCCCCCCc
Q 001370 959 LGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkgIdW 978 (1091)
++ +.++|.||||+ -|
T Consensus 302 is---v~daL~HPY~~--vw 316 (369)
T KOG0665|consen 302 IS---VDDALRHPYIK--VW 316 (369)
T ss_pred cc---HHHHhcCCeee--ee
Confidence 99 88999999998 46
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=318.51 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=213.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCC-c--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTG-D--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TG-k--~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
+..++..+++.||.|.||.|++|.|+..+ + .||||+++..... .....|++|+.+|.+++|||+++||+...+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 45567788899999999999999997643 3 6999999864432 267889999999999999999999999988 7
Q ss_pred eeEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k--~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+.||||++++|+|.+.|++ .+.|.......|+.||+.||.||..+++|||||-..||||...-.|||+||||.+...
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78899999999999999987 3568889999999999999999999999999999999999999999999999998542
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.+.. . |.+ .....-...|.|||.|....++.++|+|+|||+||||++ |..||.+.
T Consensus 264 ~ned----------------~---Yvm-----~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 264 ENED----------------M---YVM-----APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred CCCc----------------c---eEe-----cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 2110 0 000 111223568999999999999999999999999999998 89999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
...++.++|-.+ -.+| .|..++.++.+++..||..+|..||++..+
T Consensus 320 ~g~qIL~~iD~~-erLp-RPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 320 RGIQILKNIDAG-ERLP-RPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CHHHHHHhcccc-ccCC-CCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 999999998743 2333 258999999999999999999999995433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=326.09 Aligned_cols=245 Identities=32% Similarity=0.433 Sum_probs=197.3
Q ss_pred EEeeccCCceE-EEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec
Q 001370 691 IKPISRGAFGR-VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 768 (1091)
Q Consensus 691 lr~LGkGgFGt-VyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLVMEYm 768 (1091)
-+++|.|+-|+ ||+|... |+.||||.+-. .-...+.+|+..|+..+ |||||++|+.-++...+||+.|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35689999985 8999875 88999996632 34456789999999886 999999999999999999999999
Q ss_pred CCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CC--cEEEEecCCccccccc
Q 001370 769 NGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DG--HIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 769 ~GGSL~dlL~k~g~----LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG--~VKLsDFGLAk~~~~~ 839 (1091)
.. +|.+++...+. ......+..+.|++.||++||+.+||||||||.||||+. +| .++|+|||+|+....+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 76 99999987411 111345778899999999999999999999999999986 34 6899999999964211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC-CCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTG-kpPF~~~s~ 918 (1091)
.. .-....+..||-+|+|||++....-+.++|||||||++|+.++| ..||...-.
T Consensus 665 ~s------------------------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 665 KS------------------------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred cc------------------------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 10 11224567899999999999998888899999999999999985 999976433
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
-...|+++....-.+......++.|||.+||..||..||+ |.++|.||||
T Consensus 721 --R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs---a~~VL~HPlF 770 (903)
T KOG1027|consen 721 --RQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS---ATDVLNHPLF 770 (903)
T ss_pred --hhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC---HHHHhCCCcc
Confidence 3345666655443333333339999999999999999999 8999999999
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=312.87 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=206.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTT----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~T----Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....+.+.||.|-||.||.|....- .-.||||..++.. ..+..+.|+.|.-+|+.++|||||+|+|.+.+. ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 3445567899999999999987532 2369999887633 344578999999999999999999999999764 57
Q ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|||||+++-|.|..+|+.. ..++......|+.||+.||.|||+..+|||||-..|||+...-.|||+||||++.+....
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999754 568999999999999999999999999999999999999999999999999998642111
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
. ..+....-...|||||-++-..++.++|||-|||+|||+|. |..||.+....
T Consensus 546 y--------------------------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 546 Y--------------------------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred h--------------------------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 1 01112223567999999999999999999999999999987 99999998888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
+..-.|-++. +.| .|+.+++.+..|+.+||.+||.+||.+..
T Consensus 600 DVI~~iEnGe-RlP-~P~nCPp~LYslmskcWayeP~kRPrfte 641 (974)
T KOG4257|consen 600 DVIGHIENGE-RLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTE 641 (974)
T ss_pred ceEEEecCCC-CCC-CCCCCChHHHHHHHHHhccCcccCCcHHH
Confidence 8877776653 223 35899999999999999999999999543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=300.31 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=201.4
Q ss_pred cCCCCCCCCCCCccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH--hcC
Q 001370 667 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVR 744 (1091)
Q Consensus 667 ~ssg~~tpl~ss~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILs--kL~ 744 (1091)
..+|...|+ ...++...+..+.+.||+|.||+||+|+|+ |+.||||++... +.....+|.+|-+ .++
T Consensus 195 SGSGSGlpl---LVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLR 263 (513)
T KOG2052|consen 195 SGSGSGLPL---LVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLR 263 (513)
T ss_pred CCCCCCchh---HhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhc
Confidence 344555555 455677789999999999999999999998 899999999753 3456777887765 469
Q ss_pred CCceEEEeeeeccCC----eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccc
Q 001370 745 NPFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDL 812 (1091)
Q Consensus 745 HPNIVkL~gsfqded----~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~--------GIIHRDL 812 (1091)
|+||+.++++-..++ .+|||++|.+.|+|+|+|.+ ..++.+....++..++.||+|||.. .|.||||
T Consensus 264 HENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 264 HENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred cchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 999999997765443 49999999999999999987 6788899999999999999999953 4999999
Q ss_pred CCCceEecCCCcEEEEecCCccccccc-ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-
Q 001370 813 KPDNLLIAHDGHIKLTDFGLSKIGLIN-NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH- 890 (1091)
Q Consensus 813 KPeNILLD~nG~VKLsDFGLAk~~~~~-~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y- 890 (1091)
|..|||+.++|.+-|+|+|||...... +.+ ....+..|||..|||||+|...-.
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~i------------------------di~~N~rVGTKRYMAPEvLdetin~ 398 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTI------------------------DIPPNPRVGTKRYMAPEVLDETINM 398 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccCCcc------------------------cCCCCCccceeeccChHHhhhhcCh
Confidence 999999999999999999999753211 111 122356799999999999965321
Q ss_pred -----CccceeechhhhHHHHHhC----------CCCCCCCC-----hHHHHHHHhhcCCCCCCCCCCCCH-----HHHH
Q 001370 891 -----GYAADWWSVGIILFEFITG----------IPPFTAES-----PEIIFDNILNRKIPWPCVPSDMSF-----EAQD 945 (1091)
Q Consensus 891 -----s~ksDIWSLGVILYEMLTG----------kpPF~~~s-----~~ei~~kIl~~~l~fP~ip~~lS~-----eakD 945 (1091)
-..+||||||.+|||++.. .+||++.. .+++.+-+.-.+++ |.+|+.+.. .+-.
T Consensus 399 ~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~R-P~ipnrW~s~~~l~~m~k 477 (513)
T KOG2052|consen 399 KHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLR-PNIPNRWKSDPALRVMAK 477 (513)
T ss_pred hhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccC-CCCCcccccCHHHHHHHH
Confidence 2468999999999999763 47987532 23444333333333 545555432 3567
Q ss_pred HHhhhccCCCCCCCCcccHHHHH
Q 001370 946 LINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 946 LI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
|++.||..+|.-|++ |..|+
T Consensus 478 lMkeCW~~Np~aRlt---ALriK 497 (513)
T KOG2052|consen 478 LMKECWYANPAARLT---ALRIK 497 (513)
T ss_pred HHHHhhcCCchhhhH---HHHHH
Confidence 899999999999999 55544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=318.73 Aligned_cols=261 Identities=31% Similarity=0.506 Sum_probs=226.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
-..++|+++..+|.|+||.||+++++.+++..|+|+++- .......-+..|+-+++.++|||||.+|+.+.-.+.+|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL---ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL---EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeec---cCCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 345799999999999999999999999999999999863 23455677888999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
++||||.||+|.+.-+-.+.+++.++.+..++.+.||+|||+.|=+|||||-.|||+++.|.+||+|||.+....
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit----- 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT----- 163 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-----
Confidence 999999999999998888999999999999999999999999999999999999999999999999999875321
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh---cCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL---~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.--.+..++.|||.|||||+. ...+|+..||+|++|+...|+---.+|-....+.
T Consensus 164 ----------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 164 ----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 012234678999999999986 3578999999999999999999888998777776
Q ss_pred HHHHHHhhcCCCCCCC--CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 920 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~i--p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.....+.+..+.-|.. +..+++.+.+|++.+|.++|++||+ ++.+|.|||....
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt---aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT---AEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC---hhhheeceeeccc
Confidence 6665555555443432 3568899999999999999999999 7788999998754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=295.78 Aligned_cols=261 Identities=29% Similarity=0.491 Sum_probs=214.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----e
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----N 760 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded-----~ 760 (1091)
-+.+--+.||-|+||.||-+.+..+|+.||+|.+... ..+-...+++.+|..+|.-++|.|++..++..+-.. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 4556668899999999999999999999999987642 223345678999999999999999999988877654 4
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+|+|+|.. ||..++-.-..++.+.++-+++||++||+|||+.||.||||||.|+|++.|..+|||||||++.-.
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee--- 207 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD--- 207 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc---
Confidence 7899999976 898888888889999999999999999999999999999999999999999999999999998521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
..........+.|..|.|||+++| ..|+..+||||.|||+.|||..+..|...++.
T Consensus 208 -----------------------~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 208 -----------------------QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred -----------------------hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 111222334578999999999998 57899999999999999999999999988876
Q ss_pred HHHHHHhh-----------------------cCCCCCCCC--------CCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 920 IIFDNILN-----------------------RKIPWPCVP--------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 920 ei~~kIl~-----------------------~~l~fP~ip--------~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+..+.|.. +...-|.++ ..-..++.+++..+|..||.+|++ ..+.+
T Consensus 265 qQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris---~~~A~ 341 (449)
T KOG0664|consen 265 EQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS---VEEAL 341 (449)
T ss_pred HHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc---Hhhhc
Confidence 66555432 222223221 233457889999999999999998 77889
Q ss_pred cCCCCCCCC
Q 001370 969 AHPFFKGVN 977 (1091)
Q Consensus 969 ~HPFFkgId 977 (1091)
.|+|.....
T Consensus 342 ~~~~~~e~R 350 (449)
T KOG0664|consen 342 QHRYLEEGR 350 (449)
T ss_pred ccccccccc
Confidence 999986543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=309.26 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=211.8
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEE
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRF 751 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~-------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL 751 (1091)
.+.+..++..+.+.||.|.||.|++|.... ....||||.++.... ..+...+..|+++|+.+. ||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 455666667788899999999999997431 135799999876443 367888999999999985 9999999
Q ss_pred eeeeccCCeeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCC
Q 001370 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 815 (1091)
Q Consensus 752 ~gsfqded~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPe 815 (1091)
.+++.....+++|+||+..|+|..+|+... .++......++.||+.|++||++..+|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998765 4888899999999999999999999999999999
Q ss_pred ceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccC--CCCCCChhhhcCCCCCcc
Q 001370 816 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG--TPDYLAPEILLGTEHGYA 893 (1091)
Q Consensus 816 NILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vG--Tp~YmAPEVL~g~~Ys~k 893 (1091)
||||..+..+||+|||||+....... .......| ...|||||.+....|+.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~--------------------------y~~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDY--------------------------YRTKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCc--------------------------eEecCCCCccceeecCHHHhccCccccc
Confidence 99999999999999999985321100 00011122 234999999999999999
Q ss_pred ceeechhhhHHHHHh-CCCCCCCCC-hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 894 ADWWSVGIILFEFIT-GIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 894 sDIWSLGVILYEMLT-GkpPF~~~s-~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+|||||||+||||++ |..||.+.. ..++++.+..+. .. ..|..+++++.++++.||..+|++||++.+..+.+
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~-r~-~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN-RM-EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC-CC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 999999999999998 999999865 666776555543 22 23578899999999999999999999965554433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=308.70 Aligned_cols=206 Identities=29% Similarity=0.521 Sum_probs=183.2
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchh-----HHHHHHHHHHHHHhcC---CCceEEEe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-----DIERILAERNILITVR---NPFVVRFF 752 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~-----eie~~l~EieILskL~---HPNIVkL~ 752 (1091)
......+|..++.+|.|+||.|++|.++.+...|+||.|.|.++.... ..-.+-.|+.||..++ |+||++++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 345678899999999999999999999999999999999987654322 2334678999999998 99999999
Q ss_pred eeeccCCeeEEEEeec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecC
Q 001370 753 YSFTCRDNLYLVMEYL-NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 753 gsfqded~LYLVMEYm-~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
++|++++++||+||-. +|-||++++..+..++|.+++.++.|++.|+++||+.||||||||-+|+.++.+|.+||+|||
T Consensus 636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 9999999999999975 456999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGk 910 (1091)
.|.... ...-..++||.+|.|||++.|.+| +..-|||+||++||.++...
T Consensus 716 saa~~k-----------------------------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke 766 (772)
T KOG1152|consen 716 SAAYTK-----------------------------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE 766 (772)
T ss_pred chhhhc-----------------------------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence 886421 122346899999999999999988 78899999999999999999
Q ss_pred CCCCC
Q 001370 911 PPFTA 915 (1091)
Q Consensus 911 pPF~~ 915 (1091)
.||+.
T Consensus 767 npyyn 771 (772)
T KOG1152|consen 767 NPYYN 771 (772)
T ss_pred CCCcC
Confidence 99975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=255.99 Aligned_cols=214 Identities=46% Similarity=0.752 Sum_probs=185.0
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
|.+.+.||.|+||.||+|....+++.+|+|.+...... .....+.+|++.+..++|+|++++++++......|+++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999764322 2567888999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 768 LNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 768 m~GGSL~dlL~k~g~-LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
+++++|.+++..... +++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------ 152 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence 999999999987766 8999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh-cCCCCCccceeechhhhHHHHHhCCCCCCC--CChHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFITGIPPFTA--ESPEIIFD 923 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL-~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~--~s~~ei~~ 923 (1091)
........|+..|++||.+ ....++.++|+|+||+++|+|++|++||.. .+...+.+
T Consensus 153 --------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 153 --------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred --------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 0012345688999999999 667788899999999999999999999987 44457777
Q ss_pred HHhhcC
Q 001370 924 NILNRK 929 (1091)
Q Consensus 924 kIl~~~ 929 (1091)
.|..+.
T Consensus 213 ~~~~~~ 218 (225)
T smart00221 213 VWSFGV 218 (225)
T ss_pred HHhcCC
Confidence 777665
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=246.20 Aligned_cols=212 Identities=44% Similarity=0.742 Sum_probs=185.7
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcH
Q 001370 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 773 (1091)
Q Consensus 694 LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL 773 (1091)
||.|++|.||++....+|+.+++|++....... ....+.+|+.++..+.|++|+++++++......+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987643211 357799999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEecCCcccccccccccCCCCCCCC
Q 001370 774 YSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDG 851 (1091)
Q Consensus 774 ~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~~~s~dls~~~t~g 851 (1091)
.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||++......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~------------ 146 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD------------ 146 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC------------
Confidence 9999876 57899999999999999999999999999999999999999 899999999998742100
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 001370 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930 (1091)
Q Consensus 852 ~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l 930 (1091)
........+...|++||.+... .++.+.|+|+||++||+|
T Consensus 147 ---------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------ 187 (215)
T cd00180 147 ---------------KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187 (215)
T ss_pred ---------------cchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------
Confidence 0012335688999999999887 888999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCC
Q 001370 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971 (1091)
Q Consensus 931 ~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HP 971 (1091)
..+.+++.+||..||.+||+ +.++++|+
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~---~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPS---AKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcC---HHHHhhCC
Confidence 57899999999999999999 77888774
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=293.85 Aligned_cols=133 Identities=29% Similarity=0.485 Sum_probs=115.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----C---CceEEEeee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----N---PFVVRFFYS 754 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-----H---PNIVkL~gs 754 (1091)
+....|-+.++||.|-|++||+|.+..+.+.||||+.+... ...+..+.|+.+|++++ | .+||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 34478999999999999999999999999999999998754 34566788999999874 2 379999999
Q ss_pred eccC----CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEec
Q 001370 755 FTCR----DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIA 820 (1091)
Q Consensus 755 fqde----d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD 820 (1091)
|... .++|||+|++ |-+|..+|.+. ..++...++.|++||+.||.|||.. ||||-||||+||||-
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9764 4799999999 66999999765 4699999999999999999999965 999999999999994
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=270.54 Aligned_cols=218 Identities=28% Similarity=0.517 Sum_probs=182.4
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~ 760 (1091)
....++..-+..||+|+||.|-+.++..+|...|+|.++. ....++..+.++|+++..+. .+|++|.+|+.+.....
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~--tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA--TVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehh--hcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3556677788899999999999999999999999999875 33456678888999887654 69999999999999999
Q ss_pred eEEEEeecCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 761 LYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL----~k~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
+++.||.|.. +|..+- .+.+.++|..+-.++..++.||.|||++ .+||||+||+||||+.+|+||+||||++-.
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999965 775443 4557899999999999999999999975 899999999999999999999999999864
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC----CCCCccceeechhhhHHHHHhCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g----~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
... ........|-..|||||.+.. .+|+.++||||||++|+||.+++.
T Consensus 199 L~d----------------------------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~ 250 (282)
T KOG0984|consen 199 LVD----------------------------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF 250 (282)
T ss_pred ehh----------------------------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc
Confidence 210 111122568889999999853 589999999999999999999999
Q ss_pred CCCC-CChHHHHHHHhhcCC
Q 001370 912 PFTA-ESPEIIFDNILNRKI 930 (1091)
Q Consensus 912 PF~~-~s~~ei~~kIl~~~l 930 (1091)
||.. .++-+..++++....
T Consensus 251 PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 251 PYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred cccccCCHHHHHHHHhcCCC
Confidence 9974 567788888877643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=289.18 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=191.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeeccCC---
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD--- 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILsk--L~HPNIVkL~gsfqded--- 759 (1091)
....++++.||+|.||.||+|+.. ++.||||++.- .+.+.+.+|.+|.+. +.|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 567788899999999999999875 69999998863 466789999998765 57999999998766555
Q ss_pred -eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecccCCCceEecCCCcEEEEe
Q 001370 760 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHDGHIKLTD 829 (1091)
Q Consensus 760 -~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~---------GIIHRDLKPeNILLD~nG~VKLsD 829 (1091)
.++||++|.+.|+|.++|.. ..+++.....++..+++||+|||.. .|+|||||..||||..++++.|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 68999999999999999976 4689999999999999999999963 599999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CC-----ccceeechhhhH
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HG-----YAADWWSVGIIL 903 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys-----~ksDIWSLGVIL 903 (1091)
||||..... . .....+...+||..|||||+|.+.- .. ...||||+|.+|
T Consensus 360 FGLAl~~~p----------------~---------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 360 FGLALRLEP----------------G---------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred cceeEEecC----------------C---------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 999986320 0 0112233479999999999998742 21 468999999999
Q ss_pred HHHHhCC------------CCCCC-----CChHHHHHHHhhcCCCCCCCCCCC-----CHHHHHHHhhhccCCCCCCCCc
Q 001370 904 FEFITGI------------PPFTA-----ESPEIIFDNILNRKIPWPCVPSDM-----SFEAQDLINRFLIHDPNQRLGA 961 (1091)
Q Consensus 904 YEMLTGk------------pPF~~-----~s~~ei~~kIl~~~l~fP~ip~~l-----S~eakDLI~rcL~kDPeKRpSa 961 (1091)
|||++.- +||.. .+.+++...++..+.+ |.++..+ -.-+++.|..||..||+.|+|+
T Consensus 415 WEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~R-P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 415 WEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQR-PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccC-CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 9998853 24431 2334555555554332 3333322 3458899999999999999995
Q ss_pred c
Q 001370 962 N 962 (1091)
Q Consensus 962 ~ 962 (1091)
.
T Consensus 494 ~ 494 (534)
T KOG3653|consen 494 G 494 (534)
T ss_pred H
Confidence 4
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=282.83 Aligned_cols=283 Identities=27% Similarity=0.427 Sum_probs=207.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~---TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded 759 (1091)
..+.|..+..||.|+|++||++.... .++.||+|.+.... ...++.+|+++|..+. +.||+++.+++...+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44678999999999999999998877 78899999886533 3467999999999986 899999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~ 838 (1091)
...+||||++..+..++... ++-..++.|++.++.||.++|.+|||||||||.|+|.+. -+.-.|+|||||.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999999988888765 668899999999999999999999999999999999985 46789999999972110
Q ss_pred cccccCC----CCCC---CCCCCC-----CCCCC-ccc----ccCcCCccCccCCCCCCChhhhcCC-CCCccceeechh
Q 001370 839 NNTIDLS----GPET---DGIMPS-----DAHYP-EYQ----QTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVG 900 (1091)
Q Consensus 839 ~~s~dls----~~~t---~g~lps-----~~~~~-~~~----~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLG 900 (1091)
..-.+-+ .+.. .|.... ....| -+. ..........+||++|.|||++... ..+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0000000 0000 010000 00000 011 1223345567899999999999874 458899999999
Q ss_pred hhHHHHHhCCCCCCCCCh--------------HHHHHH-HhhcC------CCCCC-------------------------
Q 001370 901 IILFEFITGIPPFTAESP--------------EIIFDN-ILNRK------IPWPC------------------------- 934 (1091)
Q Consensus 901 VILYEMLTGkpPF~~~s~--------------~ei~~k-Il~~~------l~fP~------------------------- 934 (1091)
||+.-+++++.||..... .++.+- .+.+. ..+|.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999854221 000000 00011 00000
Q ss_pred ---CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 935 ---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 935 ---ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
.....+..+.||+.+||..||.+|+| |++.|+||||...+
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRit---AEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRIT---AEDALKHPFFDEAD 388 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhccc---HHHHhcCcCCcchh
Confidence 01234568999999999999999999 88999999998543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=296.75 Aligned_cols=246 Identities=22% Similarity=0.335 Sum_probs=207.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk----~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
..+..++||.|+||+||+|.+...|+ +||||++.... .......++.|.-+|.+++|||+++|++++.... +-
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34567899999999999999876665 78999887643 3344577999999999999999999999998877 88
Q ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||++||++|.|.++++.+ +.+-......|..||++||.|||.++++||||-..|+|+..-.++||+|||+++....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~--- 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP--- 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc---
Confidence 999999999999999865 5688888999999999999999999999999999999999999999999999985321
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~e 920 (1091)
... ...+....-.+.|||=|.+....|+.++|||||||++||++| |..|+.+....+
T Consensus 851 -------------d~~---------ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 851 -------------DEK---------EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred -------------ccc---------cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 000 111122334678999999999999999999999999999998 999999998888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
+-..+-.+. +++ .|+..+-++.-++.+||..|+..||++.
T Consensus 909 I~dlle~ge-RLs-qPpiCtiDVy~~mvkCwmid~~~rp~fk 948 (1177)
T KOG1025|consen 909 IPDLLEKGE-RLS-QPPICTIDVYMVMVKCWMIDADSRPTFK 948 (1177)
T ss_pred hhHHHhccc-cCC-CCCCccHHHHHHHHHHhccCcccCccHH
Confidence 776655443 344 3578999999999999999999999943
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-27 Score=235.04 Aligned_cols=260 Identities=40% Similarity=0.709 Sum_probs=208.6
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeccCCeeEEEEe
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HP-NIVkL~gsfqded~LYLVME 766 (1091)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...........+.+|..++..+.|+ +|++++..+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 78999999876554444578899999999999988 79999999988888899999
Q ss_pred ecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEecCCcccccccccc
Q 001370 767 YLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g---~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~~~s~ 842 (1091)
|+.++++.+++.... .+++.....++.|++.++.|+|..|++||||||+|||++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998877665 799999999999999999999999999999999999999998 7999999998742110000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCCCh-
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESP- 918 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~- 918 (1091)
. .........+||+.|+|||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 159 ----------------~-----~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~ 217 (384)
T COG0515 159 ----------------S-----SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217 (384)
T ss_pred ----------------c-----cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 0 00013456789999999999988 5788999999999999999999999887763
Q ss_pred ---HHHHHHHhhcCCC-CCC-CCCCC----CHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 919 ---EIIFDNILNRKIP-WPC-VPSDM----SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 919 ---~ei~~kIl~~~l~-fP~-ip~~l----S~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
......+.....+ ... ..... ...+.+++.+++..+|..|.+ ..+...++|..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~ 279 (384)
T COG0515 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLA 279 (384)
T ss_pred ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhh
Confidence 4555555444432 111 11111 257899999999999999998 44555554443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=303.99 Aligned_cols=224 Identities=16% Similarity=0.182 Sum_probs=154.7
Q ss_pred cCC-CceEEEeeee-------ccCCeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccC
Q 001370 743 VRN-PFVVRFFYSF-------TCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 813 (1091)
Q Consensus 743 L~H-PNIVkL~gsf-------qded~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLK 813 (1091)
+.| +||++++++| .....++++|||+ +++|.++|... ..+++..++.|+.||+.||.|||++||||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 5777788877 3334678889988 55999999753 469999999999999999999999999999999
Q ss_pred CCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCC-----C---CCCcccc-cCcCCccCccCCCCCCChhh
Q 001370 814 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD-----A---HYPEYQQ-TDNRNRHSAVGTPDYLAPEI 884 (1091)
Q Consensus 814 PeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~-----~---~~~~~~~-~~~~~~~s~vGTp~YmAPEV 884 (1091)
|+||||+..|.+|++|||++..........+.... -|..... . ....... .........+||+.|||||+
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~D-fG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSRE-IGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccc-cccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999988888888888877642111000000000 0000000 0 0000000 00011223579999999999
Q ss_pred hcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 885 LLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 885 L~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
+.+..|+.++|||||||+||||++|.+||.... .....+..... |.....-.+.+.+++.+||++||.+||+ +
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~L~~~P~~Rps---~ 259 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILLNWPKEASFCLWLLHPEPSCRPS---M 259 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--ChhhhhcCHHHHHHHHHhCCCChhhCcC---h
Confidence 999999999999999999999999999986432 12222222211 1111122456789999999999999999 8
Q ss_pred HHHHcCCCCCC
Q 001370 965 AEVKAHPFFKG 975 (1091)
Q Consensus 965 ~EIL~HPFFkg 975 (1091)
.++++||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 89999999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=253.80 Aligned_cols=240 Identities=27% Similarity=0.394 Sum_probs=190.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe-eeeccCCee
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF-YSFTCRDNL 761 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~-gsfqded~L 761 (1091)
-.+.|.+.+.||.|-||.+.+|+++.++..+++|.+.+.. ..++.|.+|..---.+ .|.||+.-| ..|+..+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3578999999999999999999999999999999998743 3456788887654445 489999988 568999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC--CCcEEEEecCCccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~~~~ 839 (1091)
.++|||++.|||..-+.. ..+-|...+.+++|++.||.|||+.++||||||.+||||-. ...|||||||+.+...
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 999999999999988755 44889999999999999999999999999999999999953 3489999999987421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC---C--CCccceeechhhhHHHHHhCCCCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---E--HGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~--Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
.......-+..|-|||+.... . .....|+|.||+++|.+|+|.+||.
T Consensus 175 ----------------------------~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 175 ----------------------------TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred ----------------------------ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 000112245679999987532 2 3678999999999999999999997
Q ss_pred CCC----hHHHHHHHhhc-CCCCCCCCCCCCHHHHHHHhhhccCCCCCC
Q 001370 915 AES----PEIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 915 ~~s----~~ei~~kIl~~-~l~fP~ip~~lS~eakDLI~rcL~kDPeKR 958 (1091)
... +.--+.+...+ ....|.....+++.+..+.++-|..+|++|
T Consensus 227 ka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 227 KASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 432 22222232322 234455557789999999999999999998
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=232.99 Aligned_cols=161 Identities=25% Similarity=0.281 Sum_probs=129.9
Q ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001370 771 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 849 (1091)
Q Consensus 771 GSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t 849 (1091)
|+|.+++... ..+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~----------- 61 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP----------- 61 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----------
Confidence 7899999874 45999999999999999999999998 999999999999999 999875210
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh-HHHHHHHhhc
Q 001370 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNILNR 928 (1091)
Q Consensus 850 ~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~-~ei~~kIl~~ 928 (1091)
....||+.|||||++.+..|+.++|||||||++|||++|.+||..... ......+...
T Consensus 62 ---------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 120 (176)
T smart00750 62 ---------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120 (176)
T ss_pred ---------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH
Confidence 112589999999999999999999999999999999999999976543 2333343332
Q ss_pred CCCC-C---CCCCCCCH--HHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 929 KIPW-P---CVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 929 ~l~f-P---~ip~~lS~--eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
.... + ..+..++. ++++||.+||..||.+||+ +.+++.|+|+.
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~---~~~ll~~~~~~ 169 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA---ANHYLAHCRAL 169 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC---HHHHHHHHHHH
Confidence 2111 0 01123333 6999999999999999999 88999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=272.25 Aligned_cols=265 Identities=27% Similarity=0.388 Sum_probs=207.5
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL---DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~---~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
....++|.|+||.|+.+......+.++.|..+.. ..........+..|.-+-..+.|||++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999999999888877777777765421 1111222223666777777889999999888888887777779
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
|||++ ||+.++...+.+....+..++.|++.|+.|||..||.||||||+|+|++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~------ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP------ 473 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC------
Confidence 99999 99999998888999999999999999999999999999999999999999999999999998764210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC-ccceeechhhhHHHHHhCCCCCCCCChHHHH--
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEIIF-- 922 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys-~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~-- 922 (1091)
|. ........++|+..|+|||++.+..|+ ..+||||.|++++.|++|+.||......+..
T Consensus 474 ----------------~e-~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~ 536 (601)
T KOG0590|consen 474 ----------------WE-KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK 536 (601)
T ss_pred ----------------cc-hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh
Confidence 00 112345678999999999999999996 5789999999999999999999764433221
Q ss_pred HHHhhcCC----CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 923 DNILNRKI----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 923 ~kIl~~~l----~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
........ ..-.+...++...+.+|.+||+.||.+|.+ +.+|++.+||+.+.-..
T Consensus 537 ~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t---i~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 537 TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT---IEQILNDEWIRSIECCH 595 (601)
T ss_pred hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec---HHHHhhChHhhhcceEE
Confidence 11111110 001123567889999999999999999999 88999999999886443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=240.47 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=205.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec-c
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-C 757 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk-----~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq-d 757 (1091)
...++++...+-+|.||.||.|.+++... .|-+|.++. -...-++..++.|.-.|..+.|||+..+.+... +
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 34567888889999999999998875432 345565543 224556788999999999999999999987764 4
Q ss_pred CCeeEEEEeecCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEe
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 829 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~--------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsD 829 (1091)
....+.++.++.-|+|..+|... ..++..+...++.|++.|++|||+.||||.||-..|.+||+.-.|||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 45688899999999999999721 2467778888899999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 908 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT- 908 (1091)
=.|++... |.+-++ .. ..-.....||+||.+.+..|+..+|+|||||+||||+|
T Consensus 440 saLSRDLF----------------P~DYhc--LG-------DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtl 494 (563)
T KOG1024|consen 440 SALSRDLF----------------PGDYHC--LG-------DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTL 494 (563)
T ss_pred chhccccC----------------cccccc--cC-------CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhc
Confidence 99988432 111111 00 01123567999999999999999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 909 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 909 GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
|+.||...++.++...+..+. ++- .|.++|+++..++--||..+|++||+..+....|
T Consensus 495 g~~PyaeIDPfEm~~ylkdGy-Rla-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 495 GKLPYAEIDPFEMEHYLKDGY-RLA-QPFNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred CCCCccccCHHHHHHHHhccc-eec-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 999999999999998887653 222 2578999999999999999999999966554443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=241.26 Aligned_cols=177 Identities=23% Similarity=0.180 Sum_probs=133.9
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECC-CCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEE-Eeeeec
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVR-FFYSFT 756 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~-TGk~VAIKiLkK~~i--~~~~eie~~l~EieILskL~HPNIVk-L~gsfq 756 (1091)
.+...++|++.+.||+|+||+||+|+++. +++.||||++..... ........+.+|+++|.+++|+||+. ++..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34567889999999999999999999876 688889998753211 12234567899999999999999985 4432
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccc-CCCceEecCCCcEEEEecCCccc
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDL-KPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
...|+||||++|++|.. +.. .. ...++.+++.||.|||++||+|||| ||+|||++.+|.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 45899999999999963 211 11 1467889999999999999999999 99999999999999999999986
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 887 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g 887 (1091)
..... .. +...........+|++.|+|||++..
T Consensus 162 ~~~~~--------~~-----------~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRG--------AL-----------YRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCc--------ch-----------hhhhhhhhhhhhhccCccCCcccCCh
Confidence 32100 00 00000111236789999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=224.43 Aligned_cols=259 Identities=22% Similarity=0.292 Sum_probs=192.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcC----CCceEEEeeee-ccCCe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVR----NPFVVRFFYSF-TCRDN 760 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TG-k~VAIKiLkK~~i~~~~eie~~l~EieILskL~----HPNIVkL~gsf-qded~ 760 (1091)
.|.+.+.||+|+||.||+|....++ ..+|+|+........ ...+..|+.++..+. .+++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988774 689999876532211 115677888888876 36899999988 57778
Q ss_pred eEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC-----CcEEEEecCCc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-----GHIKLTDFGLS 833 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n-----G~VKLsDFGLA 833 (1091)
-|+||+.+ |-+|.++.... +.|+...+..++.|++.+|++||+.|+|||||||+|+++... -.+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 77999988654 479999999999999999999999999999999999999865 36999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
+....... .+ .. ....+.....+.||..|.++.+-.+...+.+-|+||++.++.||+.|..||
T Consensus 175 r~~~~~~~--------~~-----~~----~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 175 RRFKYVGD--------SG-----GN----LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred ccccccCC--------CC-----cc----cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 83210000 00 00 000111124567999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhh---cCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 914 TAESPEIIFDNILN---RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 914 ~~~s~~ei~~kIl~---~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
..........++.. .... .......+.+...+...+-..+...+|.......+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 238 EALEMTDLKSKFEKDPRKLLT-DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccccccchHHHHHHHhhhhcc-ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 77653222222221 1111 10123445677777777776788888885444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=205.88 Aligned_cols=141 Identities=24% Similarity=0.200 Sum_probs=111.0
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhH-----------------------HHHHHHHHHHHHhcCCCc
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-----------------------IERILAERNILITVRNPF 747 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~e-----------------------ie~~l~EieILskL~HPN 747 (1091)
...||+|+||.||+|... +|+.||||+++......... .....+|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999987 89999999998643211110 123345999999998776
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecccCCCceEecCCCcEE
Q 001370 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 748 IVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYL-Hs~GIIHRDLKPeNILLD~nG~VK 826 (1091)
+...+... .. ..||||||++|++|...+.+.+.+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~-~~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPIL-LK-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEE-ec-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 53322221 12 2389999999988876655567899999999999999999999 799999999999999998 58899
Q ss_pred EEecCCccc
Q 001370 827 LTDFGLSKI 835 (1091)
Q Consensus 827 LsDFGLAk~ 835 (1091)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-21 Score=197.04 Aligned_cols=141 Identities=25% Similarity=0.169 Sum_probs=112.0
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhcCCCc
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----------------------NDIERILAERNILITVRNPF 747 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~-----------------------~eie~~l~EieILskL~HPN 747 (1091)
.+.||+|+||.||+|.+. +|+.||||+++....... .....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 899999999986421100 00223467899999999988
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEE
Q 001370 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 748 IVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VK 826 (1091)
|......... ..||||||++|+++.........++...+..++.|++.+|.+||. .||+||||||+|||++ +|.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7443332222 248999999998665443344668888999999999999999999 9999999999999999 89999
Q ss_pred EEecCCccc
Q 001370 827 LTDFGLSKI 835 (1091)
Q Consensus 827 LsDFGLAk~ 835 (1091)
|+|||+|+.
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=209.52 Aligned_cols=219 Identities=24% Similarity=0.410 Sum_probs=179.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LY 762 (1091)
.--.|++.+.||.|+||++++|++.-++++||||.=.. +.+.-.+..|...-+.|. .+.|...|++.+...+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 33579999999999999999999999999999996443 223445666777666664 799999999999999989
Q ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-----cEEEEecCCcccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIG 836 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-----~VKLsDFGLAk~~ 836 (1091)
||||++ |-+|.|+..-.+ .|+...+..++.|++.-|+|+|++.+|+|||||+|+||..-| .|.|+|||+|+.-
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999998 668888887554 599999999999999999999999999999999999998644 5899999999952
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
..|.+....|.. ...+..||..||+--.-+|...+..-|+=|||-++++.|-|..||.+.
T Consensus 180 --------rDp~TkqHIPYr------------E~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 180 --------RDPKTKQHIPYR------------EHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred --------cCccccccCccc------------cccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 234444333332 234677999999998888988999999999999999999999999874
Q ss_pred ---ChHHHHHHHhhc
Q 001370 917 ---SPEIIFDNILNR 928 (1091)
Q Consensus 917 ---s~~ei~~kIl~~ 928 (1091)
+..+-|++|-..
T Consensus 240 KA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 240 KADTNKEKYEKIGET 254 (449)
T ss_pred cCcchHHHHHHhccc
Confidence 456667776543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=205.91 Aligned_cols=175 Identities=17% Similarity=0.183 Sum_probs=136.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhcCCCceEEEeeeec
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER------ILAERNILITVRNPFVVRFFYSFT 756 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~------~l~EieILskL~HPNIVkL~gsfq 756 (1091)
.-.++|+++++||.|+||.||++.. ++..||+|+++......+..... +.+|+..+.++.||+|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3457899999999999999999755 47789999997644333333334 578999999999999999988866
Q ss_pred cC--------CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEE
Q 001370 757 CR--------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 828 (1091)
Q Consensus 757 de--------d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLs 828 (1091)
+. ...||||||++|.+|.++. .+++. ...+++.+|..||..|++||||||+||+++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 54 3589999999999998773 23332 356999999999999999999999999999999 9999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001370 829 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 829 DFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEML 907 (1091)
|||..+...... + -..+++...|+.++|+||||+++.-..
T Consensus 177 Dfg~~~~~~e~~-----------------------------a----------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRK-----------------------------A----------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchh-----------------------------h----------HHHHHHHhHhcccccccceeEeehHHH
Confidence 999876321000 0 011556667888999999999987543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=202.13 Aligned_cols=279 Identities=23% Similarity=0.320 Sum_probs=208.3
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCR 758 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H-PNIVkL~gsfqde 758 (1091)
++.+..+.|++++.||.|+||.+|+|....+|+.||||+=.+.. ...++.-|..+-..+.+ ..|..+..++...
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 34467789999999999999999999999999999999765422 22346678888777764 6788888888999
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC---CcEEEEecCCcc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSK 834 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n---G~VKLsDFGLAk 834 (1091)
.+-.+|||++ |-+|.++..-. ..|+...+...+-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 9999999998 67998887643 468999999999999999999999999999999999999754 358999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
..... .+ ..++| -.......||..|.+--...+...+..-|+=|+|.+|.++..|..||.
T Consensus 163 ky~d~--------~t------~~HIp------yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 163 KYRDI--------RT------RQHIP------YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred hhccc--------cc------cccCc------cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 63211 11 11222 122345679999998888777777889999999999999999999998
Q ss_pred CCC---hHHHHHHHhhcCCCCCC--CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH-------HcCCCCCCCCcchhh
Q 001370 915 AES---PEIIFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-------KAHPFFKGVNWDSLA 982 (1091)
Q Consensus 915 ~~s---~~ei~~kIl~~~l~fP~--ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI-------L~HPFFkgIdWd~L~ 982 (1091)
+.. ..+-+++|...+...|. +-..+|.++.-.+.-|=..-=++-|...-+.++ |+|.+=--.||+.+.
T Consensus 223 glka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 223 GLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred ccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 864 45667778776554332 235678888877777654444444542112222 233332336898886
Q ss_pred cc
Q 001370 983 LQ 984 (1091)
Q Consensus 983 ~~ 984 (1091)
.+
T Consensus 303 qk 304 (341)
T KOG1163|consen 303 QK 304 (341)
T ss_pred HH
Confidence 54
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=208.18 Aligned_cols=234 Identities=27% Similarity=0.381 Sum_probs=152.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-----------CceEE-----
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-----------PFVVR----- 750 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H-----------PNIVk----- 750 (1091)
.+...+.||.|+|+.||.+++..||+.+|+|++.-.........+.+.+|.-....+.+ ..++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45777899999999999999999999999999876554445566777766644433221 12221
Q ss_pred Ee---eeeccCC--------eeEEEEeecCCCcHHHHHH---hcCCC---CHHHHHH-HHHHHHHHHHHHHHcCCeeccc
Q 001370 751 FF---YSFTCRD--------NLYLVMEYLNGGDLYSLLR---KVGCL---EEDVARI-YIAELVLALEYLHSLGIVHRDL 812 (1091)
Q Consensus 751 L~---gsfqded--------~LYLVMEYm~GGSL~dlL~---k~g~L---sE~~ar~-yaaQIa~ALeYLHs~GIIHRDL 812 (1091)
+- .++.... +.+++|+-+.+ ||.+++. ..... ....++. +..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 0111111 34778888754 8887764 22222 1233433 3479999999999999999999
Q ss_pred CCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----
Q 001370 813 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----- 887 (1091)
Q Consensus 813 KPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g----- 887 (1091)
||+|+|++.+|.++|+||+..... +........+..|.+||....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~------------------------------g~~~~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRA------------------------------GTRYRCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEET------------------------------TEEEEGGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeec------------------------------CceeeccCCCcccCChhhhhhhcccC
Confidence 999999999999999999976531 011111345578999998744
Q ss_pred ---CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCC
Q 001370 888 ---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 888 ---~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKR 958 (1091)
..++.+.|.|+||+++|.|.||..||....+...... .|.... .+|+.+++||.+||++||.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 2468899999999999999999999987654322221 233333 788999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=208.48 Aligned_cols=273 Identities=28% Similarity=0.419 Sum_probs=189.4
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCc-----------------------------------EEEEEEeecccc
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----------------------------------LFAIKVLKKLDM 724 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk-----------------------------------~VAIKiLkK~~i 724 (1091)
..++.+++|+|...||+|.-+.||.++....|. +.|||.+-.-+.
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 345788999999999999999999987653210 345665543222
Q ss_pred cchhHHHHHHH----HH------HHH----------------HhcCCCceEEEeeeeccC--------------------
Q 001370 725 IRKNDIERILA----ER------NIL----------------ITVRNPFVVRFFYSFTCR-------------------- 758 (1091)
Q Consensus 725 ~~~~eie~~l~----Ei------eIL----------------skL~HPNIVkL~gsfqde-------------------- 758 (1091)
.+ ...++++ |. ..+ ...+|||||+++.+|.+.
T Consensus 231 ~s--~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~ 308 (598)
T KOG4158|consen 231 DS--GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWY 308 (598)
T ss_pred CC--chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceec
Confidence 21 1122221 11 011 013699999999988652
Q ss_pred -------CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe--cCCC--cEEE
Q 001370 759 -------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDG--HIKL 827 (1091)
Q Consensus 759 -------d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL--D~nG--~VKL 827 (1091)
..+|+||..++. +|..++-.. ..+....+.+++|+++|+.|||++||.|||+|.+|||| |.++ .+.|
T Consensus 309 p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 309 PSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred ccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 238999998876 899998654 35677788899999999999999999999999999998 4444 5789
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC------CCccceeechhh
Q 001370 828 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGI 901 (1091)
Q Consensus 828 sDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~------Ys~ksDIWSLGV 901 (1091)
+|||.|-.. .+....+ | |.. .....-|...-||||+....+ .-.++|.|+.|.
T Consensus 387 aDFGCcLAd-~~hGlql---------p----y~S-------~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~Ga 445 (598)
T KOG4158|consen 387 ADFGCCLAD-DNHGLQL---------P----YES-------DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGA 445 (598)
T ss_pred cccceeeec-ccccccc---------c----ccc-------ccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhh
Confidence 999987531 1111110 1 111 112344778889999987532 124899999999
Q ss_pred hHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 902 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 902 ILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
+.||+++...||++.....+-.+.. ..-..|..|..+++.+++|+..+|++||.+|++.+=|..+++--.|..-+|
T Consensus 446 laYEIfg~~NPFY~rGem~L~~r~Y-qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 446 LAYEIFGRSNPFYKRGEMLLDTRTY-QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGED 521 (598)
T ss_pred hHHHHhccCCcccccchheechhhh-hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchH
Confidence 9999999999999854332222211 122456678999999999999999999999999776666665444443333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-20 Score=194.34 Aligned_cols=202 Identities=21% Similarity=0.257 Sum_probs=143.5
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchh-HHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEe
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~-eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLVME 766 (1091)
.+...|++|+||+|+++.. .+..++.+.+.-....... ....+.+|+++|.++. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998865 5777887766543332221 2235789999999996 5789998875 45799999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccc-CCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDL-KPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
|+.|.+|...+.. . ...++.|++.+|.++|.+||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~---- 147 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR---- 147 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch----
Confidence 9999998755422 1 1346789999999999999999999 79999999999999999999984211000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. ...+ ...........-..+++.|++|+.-.- ..--...+|++.|+-+|.|+|+..|+.+++
T Consensus 148 ------~---~r~L-~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 ------W---MRLL-AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ------H---HHHH-HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0000 000000001112347899999986432 223356799999999999999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-20 Score=223.51 Aligned_cols=244 Identities=27% Similarity=0.404 Sum_probs=183.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~-i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ...-....+-+.|++ ...+++||++.+--.-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78899999999999999998763 44 8899987654 223333344444555 56678999999988888888899999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
+|+.. +|+|.|.....+..-+.+.|+.||+.||.-+|..||+|+|||.+||||+.=+-+.|+||-.-|...
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY-------- 171 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY-------- 171 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc--------
Confidence 99977 999999888888889999999999999999999999999999999999998899999998655311
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-----------CCccceeechhhhHHHHHh-CCCCC
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEFIT-GIPPF 913 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-----------Ys~ksDIWSLGVILYEMLT-GkpPF 913 (1091)
.|+. .|.+ +..|-... .--..|+|||-|.... .+.+-||||+||+++||++ |+|||
T Consensus 172 LPeD---NPad--f~fFFDTS-------rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 172 LPED---NPAD--FTFFFDTS-------RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred CCCC---Cccc--ceEEEecC-------CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 0110 0111 11111111 1123599999986522 4568899999999999988 89999
Q ss_pred CC-----------CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 914 TA-----------ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 914 ~~-----------~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.- .+++...++|- +..++.||..|++.||.+|++ |++.|+.
T Consensus 240 ~LSQL~aYr~~~~~~~e~~Le~Ie-------------d~~~Rnlil~Mi~rdPs~RlS---AedyL~~ 291 (1431)
T KOG1240|consen 240 TLSQLLAYRSGNADDPEQLLEKIE-------------DVSLRNLILSMIQRDPSKRLS---AEDYLQK 291 (1431)
T ss_pred cHHHHHhHhccCccCHHHHHHhCc-------------CccHHHHHHHHHccCchhccC---HHHHHHh
Confidence 52 22333333321 225789999999999999999 6677754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.5e-20 Score=196.94 Aligned_cols=250 Identities=20% Similarity=0.330 Sum_probs=198.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+...+..++.+|.....|+.|+|++. |..++.|+++-.+. .....+.|..|.-.|+-+.||||+.+++.|....++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 45567778888999999999999997 44566787764332 2233456778888888899999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~--LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+|..||+.|+|+..|+.... .+..++..++.+++.|+.|||+.. |----|....++||++.+.+|+ .+-+++.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs-- 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS-- 340 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee--
Confidence 99999999999999987643 677889999999999999999974 3344688889999998877765 1111110
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC---ccceeechhhhHHHHHhCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys---~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
| ......-.|.||+||.+...+-+ ..+|+|||.+++|||.|...||..
T Consensus 341 -----------------------f------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 341 -----------------------F------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred -----------------------e------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 0 01123457899999999876543 589999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.++.+.--+|.-..+. +.+|+.++..+..|+.-|+..||.+||.++.+.-||
T Consensus 392 lspmecgmkialeglr-v~ippgis~hm~klm~icmnedpgkrpkfdmivpil 443 (448)
T KOG0195|consen 392 LSPMECGMKIALEGLR-VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPIL 443 (448)
T ss_pred CCchhhhhhhhhcccc-ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhH
Confidence 9998887777666555 456799999999999999999999999966554444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.6e-19 Score=186.15 Aligned_cols=136 Identities=18% Similarity=0.204 Sum_probs=108.7
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-----CCCceEEEeeeeccCC---ee
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-----RNPFVVRFFYSFTCRD---NL 761 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-----~HPNIVkL~gsfqded---~L 761 (1091)
-.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.++..+ +||||+++|++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 346899999999995 6666665 688886532 22456789999999999 6799999999999874 33
Q ss_pred E-EEEee--cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCeecccCCCceEecCC----CcEEEEecCCc
Q 001370 762 Y-LVMEY--LNGGDLYSLLRKVGCLEEDVARIYIAELVLAL-EYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLS 833 (1091)
Q Consensus 762 Y-LVMEY--m~GGSL~dlL~k~g~LsE~~ar~yaaQIa~AL-eYLHs~GIIHRDLKPeNILLD~n----G~VKLsDFGLA 833 (1091)
| +|||| +.+|+|.+++.+ +.+++. ..++.+++.++ +|||+++||||||||+|||++.. +.++|+||+-+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 558999999976 457666 35678888888 99999999999999999999753 37999995444
Q ss_pred c
Q 001370 834 K 834 (1091)
Q Consensus 834 k 834 (1091)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=9e-19 Score=179.64 Aligned_cols=137 Identities=31% Similarity=0.373 Sum_probs=114.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~-----~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+.||+|++|.||+|.+ +|..+++|+....... .......+.+|+.++..+.|++|+....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 5788999976532211 11223567889999999999988776666777788999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
|++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865432 6778899999999999999999999999999999 88999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-20 Score=220.10 Aligned_cols=263 Identities=27% Similarity=0.399 Sum_probs=209.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~-TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LY 762 (1091)
...|.+.+.||+|+|+.|-+..... +...+|+|.+.... .......++..|..+-..+. |+|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5678899999999999999887643 34567888765433 23445566777888887887 999999999999999999
Q ss_pred EEEeecCCCcHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCeecccCCCceEecCCC-cEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLL-RKVG-CLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL-~k~g-~LsE~~ar~yaaQIa~ALeYLH-s~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~ 838 (1091)
++++|..||+++..+ .... ..+...+.+|+.|+..++.|+| ..++.||||||+|.+++.++ .++++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5544 6788889999999999999999 99999999999999999999 999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccC-CCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG-TPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vG-Tp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
. ..........+| ++.|+|||.+.+..| ....|+||.|+++.-|++|..||...
T Consensus 178 ~------------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 178 K------------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred c------------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 0 112233455678 999999999998654 78899999999999999999999765
Q ss_pred ChHHH--HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 917 SPEII--FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 917 s~~ei--~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
..... ...+-+....-......++..+.+++.++|..+|..|.+ ..++..+||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s---~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 234 SRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS---IEELKLDNWLSS 291 (601)
T ss_pred ccccccceeecccccccccCccccCChhhhhcccccccCCchhccc---cccccccccccc
Confidence 43321 111111111001123678999999999999999999999 779999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=184.46 Aligned_cols=144 Identities=24% Similarity=0.144 Sum_probs=114.6
Q ss_pred CeEEEEeeccCCceEEEEEE-ECCCCcEEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhcC
Q 001370 687 DFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIR---------------------KNDIERILAERNILITVR 744 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar-~k~TGk~VAIKiLkK~~i~~---------------------~~eie~~l~EieILskL~ 744 (1091)
.|++.+.||+|+||.||+|. +..+|+.||||+++...... ......+..|..++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 66789999999997532110 001134568999999997
Q ss_pred CC--ceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecccCCCceEecC
Q 001370 745 NP--FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAH 821 (1091)
Q Consensus 745 HP--NIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~G-IIHRDLKPeNILLD~ 821 (1091)
+. .+.+++.. ...|+||||++|++|...+.....+....+..++.||+.+|.+||+.| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34445442 235899999999888776544456677778899999999999999999 99999999999999
Q ss_pred CCcEEEEecCCccc
Q 001370 822 DGHIKLTDFGLSKI 835 (1091)
Q Consensus 822 nG~VKLsDFGLAk~ 835 (1091)
++.++|+|||+|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.6e-18 Score=208.27 Aligned_cols=198 Identities=24% Similarity=0.387 Sum_probs=159.4
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeecc
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTC 757 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~---HPNIVkL~gsfqd 757 (1091)
..+....|.|-+.||+|+||+||+|.... |+.||+|+=+....+. |.--.+++.+|+ -+-|..++.++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34667789999999999999999999877 9999999866543321 222223344444 2456666777777
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-------CCcEEEEec
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDF 830 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-------nG~VKLsDF 830 (1091)
.+.-+||+||.+.|+|.+++...+.+++..+.+++.|++.-|+.||..+|||+||||+|+||.. +--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 7788999999999999999998888999999999999999999999999999999999999953 335899999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGk 910 (1091)
|-+--+. ..| ++..-...++|-.+--+|+..|..+++.+|.|.|..+++-||.|+
T Consensus 846 G~siDm~--------------lfp-----------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMK--------------LFP-----------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeee--------------EcC-----------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 9875321 111 112234568899999999999999999999999999999999985
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=168.96 Aligned_cols=133 Identities=29% Similarity=0.322 Sum_probs=107.0
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 693 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~-----~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
.||+|+||.||+|.+ +|..+++|+....... ......++.+|++++..+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 5788999986542211 112346778999999999887654444444556678999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 768 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 768 m~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||+++.
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 7788999999999999999999999999999 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=170.13 Aligned_cols=137 Identities=21% Similarity=0.205 Sum_probs=107.7
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch-------------------hHHHHHHHHHHHHHhcCCC--
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-------------------NDIERILAERNILITVRNP-- 746 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~-------------------~eie~~l~EieILskL~HP-- 746 (1091)
|.+.+.||.|+||.||++... +|+.||||+++....... ........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 677789999999999999875 799999999765321000 0112367788889888877
Q ss_pred ceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEE
Q 001370 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 747 NIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 826 (1091)
.++..+. ....++||||++|++|..+... .....++.+++.++.++|..||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4444443 2456999999999998765431 34567788999999999999999999999999999999999
Q ss_pred EEecCCccc
Q 001370 827 LTDFGLSKI 835 (1091)
Q Consensus 827 LsDFGLAk~ 835 (1091)
|+|||++..
T Consensus 166 liDfg~~~~ 174 (198)
T cd05144 166 IIDWPQMVS 174 (198)
T ss_pred EEECCcccc
Confidence 999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-17 Score=191.46 Aligned_cols=140 Identities=26% Similarity=0.235 Sum_probs=112.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i-----~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
...|...+.||+|+||+||+|.+.. ..+++|+...... ......+++.+|++++..++|++|+..+.++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445667899999999999998754 3344443322111 11123467889999999999999988777777777
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
..++||||++|++|.+++. ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8899999999999999885 346788999999999999999999999999999 678999999999985
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=161.17 Aligned_cols=137 Identities=23% Similarity=0.275 Sum_probs=98.9
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHH---------------------HHHHHHHHHHhcCCC--c
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE---------------------RILAERNILITVRNP--F 747 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie---------------------~~l~EieILskL~HP--N 747 (1091)
.+.||+|+||+||+|.+. +|+.||||+++........... ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 7999999998753221111111 113556666666543 2
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcE
Q 001370 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSL-LRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHI 825 (1091)
Q Consensus 748 IVkL~gsfqded~LYLVMEYm~GGSL~dl-L~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~V 825 (1091)
+.+.++. ...++||||++||.+... +.... .. ..++.++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 236899999999654321 21111 11 6678899999999999999 9999999999999999 9999
Q ss_pred EEEecCCccc
Q 001370 826 KLTDFGLSKI 835 (1091)
Q Consensus 826 KLsDFGLAk~ 835 (1091)
+|+|||++..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.7e-17 Score=188.85 Aligned_cols=182 Identities=27% Similarity=0.402 Sum_probs=135.1
Q ss_pred eeEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g---~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
++|+.|++|.-++|.++|.... ..+......++.|++.|++| +|.||||+||.||+...+..+||.||||....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5899999999999999997443 35667788899999999999 99999999999999999999999999997642
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
.... ... .........+||..||+||.+.+..|+.++||||||+||||++. =..+|+.
T Consensus 407 ~~~~----------~~~-----------~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er 465 (516)
T KOG1033|consen 407 DKDE----------TVA-----------PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER 465 (516)
T ss_pred ccCC----------ccc-----------chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH
Confidence 1100 000 11223455789999999999999999999999999999999997 2233321
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..++..+-.+.+ |.....--++-.+|+.+||...|.+||+ +.+.--|+|.
T Consensus 466 ---~~t~~d~r~g~i--p~~~~~d~p~e~~ll~~lls~~p~~RP~---~~~~~~~~~~ 515 (516)
T KOG1033|consen 466 ---IATLTDIRDGII--PPEFLQDYPEEYTLLQQLLSPSPEERPS---AIEVALHEFL 515 (516)
T ss_pred ---HHhhhhhhcCCC--ChHHhhcCcHHHHHHHHhcCCCcccCch---HHHHhhhhhc
Confidence 223333333433 2111111245669999999999999996 5566556653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=143.25 Aligned_cols=132 Identities=23% Similarity=0.304 Sum_probs=112.4
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCCeeEEEEee
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H--PNIVkL~gsfqded~LYLVMEY 767 (1091)
+++.||.|.++.||++... +..+++|.+.+... ...+.+|..++..+.+ +++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999975 37899998865322 4568889999999976 5899999988888889999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 768 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 768 m~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~---GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
++|+.+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++++|||++..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 4456667788999999999985 799999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.9e-15 Score=159.00 Aligned_cols=137 Identities=21% Similarity=0.353 Sum_probs=105.8
Q ss_pred Eeec-cCCceEEEEEEECCCCcEEEEEEeeccccc----------chhHHHHHHHHHHHHHhcCCCce--EEEeeeeccC
Q 001370 692 KPIS-RGAFGRVFLARKRTTGDLFAIKVLKKLDMI----------RKNDIERILAERNILITVRNPFV--VRFFYSFTCR 758 (1091)
Q Consensus 692 r~LG-kGgFGtVyLar~k~TGk~VAIKiLkK~~i~----------~~~eie~~l~EieILskL~HPNI--VkL~gsfqde 758 (1091)
..|| .||.|+||.+... +..++||.+.+.... ......++.+|..++..+.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888888888764 788999988643211 11234678899999999998774 6666554332
Q ss_pred Ce----eEEEEeecCC-CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 759 DN----LYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 759 d~----LYLVMEYm~G-GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
.. .++||||++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999998 689888765 4566543 568999999999999999999999999999999999999988
Q ss_pred cc
Q 001370 834 KI 835 (1091)
Q Consensus 834 k~ 835 (1091)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.4e-15 Score=173.43 Aligned_cols=205 Identities=24% Similarity=0.309 Sum_probs=156.7
Q ss_pred HHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCC-eecccCCCce
Q 001370 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGI-VHRDLKPDNL 817 (1091)
Q Consensus 740 LskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GI-IHRDLKPeNI 817 (1091)
|+.+.|.|+.++++.+.+....+.|.+||..|+|.+.+... -.++.-....++++|+.||.|||.-.| .|+-+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999999999874 357777777788999999999998866 9999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-------C
Q 001370 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------H 890 (1091)
Q Consensus 818 LLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-------Y 890 (1091)
++|....+||+|||+...... . . .........-...|.|||.+.+.. -
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~--------------~---~--------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~ 135 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE--------------T---A--------EPEAHHPIRKALLWTAPELLRGALSQSLESAL 135 (484)
T ss_pred eeeeeEEEEechhhhcccccc--------------c---c--------cccccchhHHHHhccCHHHhcccccccccccc
Confidence 999999999999999764210 0 0 000001111345799999997642 3
Q ss_pred CccceeechhhhHHHHHhCCCCCCCC----ChHHHHHHHhh-cC-CCCCCCC--CCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 891 GYAADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILN-RK-IPWPCVP--SDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 891 s~ksDIWSLGVILYEMLTGkpPF~~~----s~~ei~~kIl~-~~-l~fP~ip--~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
+.+.|+||||+++||+++..-||... .+.++..++.+ +. ...|.+. ..+.+++..++.+||..+|.+||+..
T Consensus 136 ~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 136 TQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred cccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 56799999999999999999999763 23455555555 22 1223332 14566899999999999999999966
Q ss_pred cHHHHHc
Q 001370 963 GAAEVKA 969 (1091)
Q Consensus 963 gA~EIL~ 969 (1091)
.+...+.
T Consensus 216 ~i~~~~~ 222 (484)
T KOG1023|consen 216 QIRSKLL 222 (484)
T ss_pred HHHhhhh
Confidence 5554443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-13 Score=162.73 Aligned_cols=141 Identities=23% Similarity=0.400 Sum_probs=96.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc--------------------------c-----hhHHHHH
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--------------------------R-----KNDIERI 733 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~--------------------------~-----~~eie~~ 733 (1091)
..+|+. +.||.|++|+||.|+.+.+|+.||||++++.-.. + .+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456777 7999999999999999988999999999753100 0 0112333
Q ss_pred HHHHHHHHhcCCCceEEEeeeecc-------------CCeeEEEEeecCCCcHHHH--HHhcC----CCCHHHHHHHHHH
Q 001370 734 LAERNILITVRNPFVVRFFYSFTC-------------RDNLYLVMEYLNGGDLYSL--LRKVG----CLEEDVARIYIAE 794 (1091)
Q Consensus 734 l~EieILskL~HPNIVkL~gsfqd-------------ed~LYLVMEYm~GGSL~dl--L~k~g----~LsE~~ar~yaaQ 794 (1091)
.+|++++... +|+.++...|.+ ....+|||||+.|+.+.++ +...+ .+.+..+..++.|
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 4444444333 233333322222 2335699999999999774 33333 2444445555555
Q ss_pred HHHHHHHHHHcCCeecccCCCceEecCCC----cEEEEecCCccc
Q 001370 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKI 835 (1091)
Q Consensus 795 Ia~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~ 835 (1091)
++ ..|++|+|+||.||+++.+| .++++|||++..
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 54 58999999999999999988 999999999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.5e-12 Score=148.37 Aligned_cols=138 Identities=24% Similarity=0.319 Sum_probs=94.4
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccc--------------------------h-h----HHH------HHH
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR--------------------------K-N----DIE------RIL 734 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~--------------------------~-~----eie------~~l 734 (1091)
+.||.|++|.||+|+.+ +|+.||||+.+..-... . . -.. .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999975 69999999986421000 0 0 000 234
Q ss_pred HHHHHHHhcC-----CCceE--EEeeeeccCCeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHc
Q 001370 735 AERNILITVR-----NPFVV--RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL-ALEYLHSL 805 (1091)
Q Consensus 735 ~EieILskL~-----HPNIV--kL~gsfqded~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~-ALeYLHs~ 805 (1091)
+|...+.++. +++|. ++|..+ ....+|||||++|++|.++.... ..+. ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555444442 34332 233222 33468999999999998876532 1222 2334455555 46789999
Q ss_pred CCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 806 GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
|++|+|+||.||+++.+|.++|+|||++..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 999999999999999999999999999875
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8e-13 Score=155.19 Aligned_cols=261 Identities=26% Similarity=0.261 Sum_probs=191.2
Q ss_pred CCeEEEEeecc--CCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 001370 686 DDFEIIKPISR--GAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 686 ddFeilr~LGk--GgFGtVyLar~--k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~ 760 (1091)
..|.+...+|. |.+|.||.+.. ..++..+|+|.=+. .......-.+-++|..-...++ |++.|+.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 34566777888 99999999998 88899999996322 1111122233345665555665 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCeecccCCCceEecCC-CcEEEEecCCcc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSK 834 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~-LsE~~ar~yaaQIa~----ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk 834 (1091)
+|+-+|++. .+|..+...... +++..++.+..+... ||.++|..+++|-|+||.||++..+ ..++++|||+..
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 999999985 688888877665 888889999999988 9999999999999999999999999 889999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
.+...+. .. . .......-|...|++||++.+ -++...|+|+||.++.+-.+|..++.
T Consensus 272 ~i~~~~~------------------~~---~-~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 272 KISDGNF------------------SS---V-FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred EccCCcc------------------cc---c-eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 5321110 00 0 011122357888999999875 48889999999999999988876554
Q ss_pred CC-ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 915 AE-SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 915 ~~-s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
.. +.. +..+-+..++ ..+-...+.++...+..|+..+|..|++ +..+++|++.....
T Consensus 329 ~g~~~~--W~~~r~~~ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~---~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 329 VGKNSS--WSQLRQGYIP-LEFCEGGSSSLRSVTSQMLDEDPRLRLT---AQILTALNVIHSKL 386 (524)
T ss_pred CCCCCC--ccccccccCc-hhhhcCcchhhhhHHHHhcCcchhhhhH---HHHHhccccccchh
Confidence 32 110 0011111111 1122455667777999999999999999 78899999987543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.4e-12 Score=126.17 Aligned_cols=128 Identities=18% Similarity=0.290 Sum_probs=96.0
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeccCCeeEEEEeecC
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNI-VkL~gsfqded~LYLVMEYm~ 769 (1091)
++.|+.|.++.||+++.. |+.|++|+...... ....+..|..++..+.+.++ .++++... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999864 78899998754321 12235678888888765443 34544433 34589999999
Q ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eecccCCCceEecCCCcEEEEecCCccc
Q 001370 770 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI-----VHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 770 GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GI-----IHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
|.++... . .....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 0 1123456799999999999985 9999999999999 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.7e-12 Score=152.49 Aligned_cols=250 Identities=26% Similarity=0.246 Sum_probs=187.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k-~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~ 760 (1091)
....+|..+..||.|.|+.|+.+..+ .++..|++|.+.+...... +...-+.|+.+...+. |.+++.++..+...++
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 45678999999999999999998876 6788999998876443332 2333456666666664 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC-CcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~~~~~ 839 (1091)
.|+=.|||.++++...+.-...+.+...+....|++.++.++|+..++|+|+||+||++..+ +..++.|||..+.....
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 99999999999987777555568888899999999999999999999999999999999886 77899999987621100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCC--ChhhhcCCCCCccceeechhhhHHHHHhCCCC-CCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL--APEILLGTEHGYAADWWSVGIILFEFITGIPP-FTAE 916 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~Ym--APEVL~g~~Ys~ksDIWSLGVILYEMLTGkpP-F~~~ 916 (1091)
.....++-+++ +|+......+..++|++|||..+++.++|.+- ..+.
T Consensus 421 ------------------------------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~ 470 (524)
T KOG0601|consen 421 ------------------------------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV 470 (524)
T ss_pred ------------------------------cccccccccccccchhhccccccccccccccccccccccccCcccCcccc
Confidence 01122333444 45455567788999999999999999998642 2221
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
. ...|..+..+.. .....+++.+.+.++..++..|+. +.++..|.=|
T Consensus 471 ~----~~~i~~~~~p~~---~~~~~~~q~~~kv~~~~~~~~~~l---~~~l~~~~~~ 517 (524)
T KOG0601|consen 471 Q----SLTIRSGDTPNL---PGLKLQLQVLLKVMINPDRKRRPS---AVELSLHSEF 517 (524)
T ss_pred c----ceeeecccccCC---CchHHhhhhhhhhhcCCccccchh---hhhhcccchh
Confidence 1 222333333222 234488999999999999999998 6666666655
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.8e-11 Score=123.60 Aligned_cols=139 Identities=22% Similarity=0.166 Sum_probs=100.2
Q ss_pred EeeccCCceEEEEEEECC------CCcEEEEEEeecccc-------------------cchhHHHHH----HHHHHHHHh
Q 001370 692 KPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDM-------------------IRKNDIERI----LAERNILIT 742 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~------TGk~VAIKiLkK~~i-------------------~~~~eie~~----l~EieILsk 742 (1091)
..||.|--+.||.|.... .+..+|||+.+-... .+.+....+ .+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 357999998753110 011112233 378999988
Q ss_pred cCC--CceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecccCCCceEe
Q 001370 743 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLI 819 (1091)
Q Consensus 743 L~H--PNIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYL-Hs~GIIHRDLKPeNILL 819 (1091)
+.. -++.+.+++ ..-+|||||+.++.+..-..+...+++..+..+..+++.+|..| |+.||||+||+|.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 752 345555543 45689999998765533222333466666777789999999999 89999999999999999
Q ss_pred cCCCcEEEEecCCccc
Q 001370 820 AHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 820 D~nG~VKLsDFGLAk~ 835 (1091)
+ +|.+.|+|||.+..
T Consensus 159 ~-~~~v~iIDF~qav~ 173 (197)
T cd05146 159 H-DGKVWFIDVSQSVE 173 (197)
T ss_pred E-CCcEEEEECCCcee
Confidence 7 57899999998863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=137.67 Aligned_cols=169 Identities=21% Similarity=0.362 Sum_probs=128.2
Q ss_pred EEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCC
Q 001370 704 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 783 (1091)
Q Consensus 704 Lar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~L 783 (1091)
.|..+.++.+|.+.+.+...- .....+.+-+.-|+.++||||++++..+..+..+|||+|-+. .|..++.+.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 456677889999998875332 335667788889999999999999999999999999999884 6777777654
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcc
Q 001370 784 EEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862 (1091)
Q Consensus 784 sE~~ar~yaaQIa~ALeYLH-s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~ 862 (1091)
......-+.||+.||.||| +.+++|++|.-+-|+++..|+.||.+|-++.... +..+
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~-------------~~~~-------- 160 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS-------------GFNA-------- 160 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc-------------cCCc--------
Confidence 5666677889999999998 5689999999999999999999999999875311 0000
Q ss_pred cccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001370 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 863 ~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
......---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 161 ------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 ------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 000011112355666543322 567999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.8e-10 Score=116.42 Aligned_cols=140 Identities=20% Similarity=0.256 Sum_probs=105.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccC---CeeEEEEe
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCR---DNLYLVME 766 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H--PNIVkL~gsfqde---d~LYLVME 766 (1091)
+.||.|.++.||++.... |+.|++|+....... .....+.+|..++..+.+ ..+.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998753 688999987654321 134567889999999875 3456666666554 36789999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS------------------------------------------ 804 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs------------------------------------------ 804 (1091)
|++|+++.+.+.. +.+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 346666666677777777777773
Q ss_pred --------------cCCeecccCCCceEecC--CCcEEEEecCCccc
Q 001370 805 --------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 --------------~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~ 835 (1091)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 67789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-10 Score=127.48 Aligned_cols=211 Identities=24% Similarity=0.340 Sum_probs=149.0
Q ss_pred HHHHhcCCCceEEEeeeeccCC-----eeEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc--C
Q 001370 738 NILITVRNPFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSL--G 806 (1091)
Q Consensus 738 eILskL~HPNIVkL~gsfqded-----~LYLVMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~--G 806 (1091)
.-|-++.|.|||+++.++.+.. ...+++|||..|+|..+|++. ..+.....+.++-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3445667999999998876654 478999999999999999864 3577888889999999999999987 4
Q ss_pred CeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc
Q 001370 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 886 (1091)
Q Consensus 807 IIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~ 886 (1091)
|||+.+..+-|++..+|-+|+.---... .+.. .............|-++|.|||.=.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s----------------------~h~s-~~~~~~~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS----------------------THPS-VNSTREAEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc----------------------cchh-hhhhhHhhhhccccCCccccCCcCc
Confidence 9999999999999999988875211110 0100 0011111222345778999999766
Q ss_pred CCCCCccceeechhhhHHHHHhCCCC-CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 887 GTEHGYAADWWSVGIILFEFITGIPP-FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 887 g~~Ys~ksDIWSLGVILYEMLTGkpP-F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
....+-.+|||+||....||..|..- -.+.+....-..|.+..+... +. --+++|.+||+-.|..||+ +.
T Consensus 256 ~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le---n~---lqr~~i~kcl~~eP~~rp~---ar 326 (458)
T KOG1266|consen 256 TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE---NG---LQRGSITKCLEGEPNGRPD---AR 326 (458)
T ss_pred ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc---Cc---cccCcCcccccCCCCCCcc---hh
Confidence 66677899999999999999987653 333332222222222111111 11 2357899999999999999 88
Q ss_pred HHHcCCCCCCCCcch
Q 001370 966 EVKAHPFFKGVNWDS 980 (1091)
Q Consensus 966 EIL~HPFFkgIdWd~ 980 (1091)
+++.||..-++--..
T Consensus 327 ~llfHpllfeVhslk 341 (458)
T KOG1266|consen 327 LLLFHPLLFEVHSLK 341 (458)
T ss_pred hhhcCceeeecchHH
Confidence 999999986654433
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.8e-09 Score=111.89 Aligned_cols=134 Identities=29% Similarity=0.315 Sum_probs=98.1
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEe-ecc----cccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVL-KKL----DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiL-kK~----~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
..+++|+-+.+|.+.+. |..+.+|.= +|. .+..+-...+..+|..+|.++.--.|..-+-++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999774 555666642 221 12222234567889999988864433333334556677789999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
|++|-.|.+.+... . -.++..+-.-+.-||..||||+||.++||++...+ +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888765 1 34566677778889999999999999999997654 99999999985
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.5e-09 Score=130.09 Aligned_cols=170 Identities=21% Similarity=0.342 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCcc
Q 001370 793 AELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871 (1091)
Q Consensus 793 aQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~ 871 (1091)
.+++.|+.|+|.. ++||+.|.|++|.++.+|.+||+-|+++...... ....+..| +.....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~---------------~~~p~~~y---d~~lp~ 167 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGP---------------TEYPFSEY---DPPLPL 167 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCC---------------CccccccC---CCCCCh
Confidence 3556999999965 8999999999999999999999999988632110 01111111 111122
Q ss_pred CccCCCCCCChhhhcCCCCCccceeechhhhHHHHH-hCCCCCCCCChHHHHHHHhh-cCCCCCCCCCCCCHHHHHHHhh
Q 001370 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI-TGIPPFTAESPEIIFDNILN-RKIPWPCVPSDMSFEAQDLINR 949 (1091)
Q Consensus 872 s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEML-TGkpPF~~~s~~ei~~kIl~-~~l~fP~ip~~lS~eakDLI~r 949 (1091)
...-...|.|||++.+.-.+.++|+|||||++|-+. .|+.-|...+....+..-.+ .....-.....++.++++-|.+
T Consensus 168 ~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 168 LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred hhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHH
Confidence 233467899999999988899999999999999998 56666666544333332221 1222222347899999999999
Q ss_pred hccCCCCCCCCcccHHHHHcCCCCCCCCcchhhc
Q 001370 950 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 983 (1091)
Q Consensus 950 cL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~ 983 (1091)
+|..++..||+ +..++..|||.+..-..|..
T Consensus 248 ~l~~~~~~rp~---~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 248 LLNGDSAVRPT---LDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred HhcCCcccCcc---hhhhhcccccCCchhhhhhh
Confidence 99999999997 88999999999876555543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.9e-08 Score=105.77 Aligned_cols=144 Identities=24% Similarity=0.253 Sum_probs=105.5
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEe-----ecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVL-----KKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiL-----kK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.+..|-+|+-+.|+++.+. |+.+.||.= +...+..+-...+.++|.++|.++.--.|.--.-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 6778999999999999875 888888842 122222233456788999999888643333333345566667899
Q ss_pred EeecCC-CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---cEEEEecCCccc
Q 001370 765 MEYLNG-GDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 835 (1091)
Q Consensus 765 MEYm~G-GSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~ 835 (1091)
|||++| -++.+++.... .........++..|-..|.-||.++|||+||..+||+|..+| .+.|+||||+..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 47788876543 223333367788899999999999999999999999998766 358999999863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.5e-07 Score=102.04 Aligned_cols=131 Identities=15% Similarity=0.140 Sum_probs=90.4
Q ss_pred EEEEEECCCCcEEEEEEeecccc---cch-----hHHHHHHHHHHHHHhcC-----CCceEEEeeeecc--CCeeEEEEe
Q 001370 702 VFLARKRTTGDLFAIKVLKKLDM---IRK-----NDIERILAERNILITVR-----NPFVVRFFYSFTC--RDNLYLVME 766 (1091)
Q Consensus 702 VyLar~k~TGk~VAIKiLkK~~i---~~~-----~eie~~l~EieILskL~-----HPNIVkL~gsfqd--ed~LYLVME 766 (1091)
|+.+.. .|+.|.||....... .+. .-...+.+|...+..+. -|.+|-+...-.. ...-|||||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 445543 367788886532211 000 11124678888877763 3444433211111 234789999
Q ss_pred ecCCC-cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-------CCcEEEEecCCcc
Q 001370 767 YLNGG-DLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDFGLSK 834 (1091)
Q Consensus 767 Ym~GG-SL~dlL~k--~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-------nG~VKLsDFGLAk 834 (1091)
++++- +|.+++.. ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99986 79888864 234566778889999999999999999999999999999985 4689999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.4e-07 Score=97.45 Aligned_cols=127 Identities=25% Similarity=0.280 Sum_probs=81.9
Q ss_pred EEEEEEECCCCcEEEEEEeecccc-----------------------cchhHHHHHHHHHHHHHhcCCC--ceEEEeeee
Q 001370 701 RVFLARKRTTGDLFAIKVLKKLDM-----------------------IRKNDIERILAERNILITVRNP--FVVRFFYSF 755 (1091)
Q Consensus 701 tVyLar~k~TGk~VAIKiLkK~~i-----------------------~~~~eie~~l~EieILskL~HP--NIVkL~gsf 755 (1091)
.||.|... .|..+|||+.+.... ..........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888864 578999998753110 0111234678899999999754 455665442
Q ss_pred ccCCeeEEEEeecC--CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecccCCCceEecCCCcEEEEecCC
Q 001370 756 TCRDNLYLVMEYLN--GGDLYSLLRKVGCLEEDVARIYIAELVLALEY-LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 756 qded~LYLVMEYm~--GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeY-LHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
.-+|||||+. |..+..+... . ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~-~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV-D-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC-G-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc-c-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 6555443322 1 2244556667788886655 579999999999999999876 899999998
Q ss_pred ccc
Q 001370 833 SKI 835 (1091)
Q Consensus 833 Ak~ 835 (1091)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 863
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.3e-07 Score=103.89 Aligned_cols=202 Identities=19% Similarity=0.229 Sum_probs=145.6
Q ss_pred ceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----CeeEEEEeecCC-CcH
Q 001370 699 FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----DNLYLVMEYLNG-GDL 773 (1091)
Q Consensus 699 FGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde----d~LYLVMEYm~G-GSL 773 (1091)
-.+.|++....+|..|++|.++-.+.... .....-+++++++.|+|||++..+|.+. ..++||++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789999999999999999843332222 2233456789999999999999999843 358999999987 577
Q ss_pred HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 774 YSLLRK---------------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 774 ~dlL~k---------------~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+++... ....+|..++.|+.||..||.++|+.|+.-+-|.|.+||++.+-.++|+--|...+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 776531 12467899999999999999999999999999999999999888888887776543210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC-CCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-FTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpP-F~~~s 917 (1091)
+ . + |-+.+. .+-|.=.||.+++.|.||..- +....
T Consensus 446 d---------------------------~-------~-------~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~~~d~ 481 (655)
T KOG3741|consen 446 D---------------------------P-------T-------EPLESQ---QQNDLRDLGLLLLALATGTENSNRTDS 481 (655)
T ss_pred C---------------------------C-------C-------cchhHH---hhhhHHHHHHHHHHHhhcccccccccc
Confidence 0 0 1 112111 245777899999999998532 33333
Q ss_pred hHHH-HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCC
Q 001370 918 PEII-FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 957 (1091)
Q Consensus 918 ~~ei-~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeK 957 (1091)
.+.. .+.| ....|.+++++|.-+..-+++.
T Consensus 482 ~~~s~~~~I----------~~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 482 TQSSHLTRI----------TTTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred hHHHHHHHh----------hhhhhHHHHHHHHHHHhcCccc
Confidence 3333 2222 2456778899999888888873
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.9e-07 Score=94.59 Aligned_cols=106 Identities=29% Similarity=0.364 Sum_probs=82.0
Q ss_pred HHHHHHHHHHHHhcC-----CCceEEEeeeecc-CCeeEEEEeecCCC-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 001370 730 IERILAERNILITVR-----NPFVVRFFYSFTC-RDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYL 802 (1091)
Q Consensus 730 ie~~l~EieILskL~-----HPNIVkL~gsfqd-ed~LYLVMEYm~GG-SL~dlL~k~g~LsE~~ar~yaaQIa~ALeYL 802 (1091)
.....+|...+..+. -|-.|-+...-.. ...-|||||+++|- +|.+++.....++......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 345777777776654 3444433221111 12458999999984 8999998755577788889999999999999
Q ss_pred HHcCCeecccCCCceEecCCC---cEEEEecCCccc
Q 001370 803 HSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 835 (1091)
Q Consensus 803 Hs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~ 835 (1091)
|..||+|+|++|.|||++.++ .+.|+||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.3e-08 Score=121.24 Aligned_cols=244 Identities=23% Similarity=0.217 Sum_probs=165.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN-IVkL~gsfqded~LY 762 (1091)
....+....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++.++.++..+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW 310 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence 3445666777899999999998876655444 5554321 34556889999999999 888888888899999
Q ss_pred EEEeecCCC-cHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 763 LVMEYLNGG-DLYSLL-RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GG-SL~dlL-~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
++|+++.+| +..... ...-.|.+-+.....+.-+++++|||+.-=+||| |||..+ +..|+.||+.....
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L---- 381 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL---- 381 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc----
Confidence 999999987 221111 1111233444445566778899999998778998 888765 77899999976521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.+.....+..||+.++|||+.....|....|.|++|+--.+|.-|-+|-... ..
T Consensus 382 ------------------------~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~ 435 (829)
T KOG0576|consen 382 ------------------------TRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PA 435 (829)
T ss_pred ------------------------CcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--cc
Confidence 1111346778999999999999999999999999999777888887775441 11
Q ss_pred HHHHHhhcCCCCCCCC--CCCCH-HHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 921 IFDNILNRKIPWPCVP--SDMSF-EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip--~~lS~-eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
....+-++.- -|.+. ...++ .-.++...|+..-|..|+. +...+.|.+|.+
T Consensus 436 ~~~~~g~~p~-s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---~mgacfsKvfng 489 (829)
T KOG0576|consen 436 VLPMIGNGPN-SPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---HMGACFSKVFNG 489 (829)
T ss_pred ccCCCCCCCC-ccccchhhhcCcccccCCcccccCCCCCCCcc---hhhHHHHHHhcc
Confidence 1111111110 00000 00011 1114667788888888877 667788888876
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=6e-06 Score=95.37 Aligned_cols=229 Identities=17% Similarity=0.253 Sum_probs=148.1
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE--------EeeeeccCCee
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR--------FFYSFTCRDNL 761 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVk--------L~gsfqded~L 761 (1091)
.+.||+|+-+.+|-.-.- +. .+-|++.+...-. -...+..|... .||-+-. |++. .....+
T Consensus 16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i 85 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVI 85 (637)
T ss_pred CccccCCccceeeecchh--hc-hhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence 467999999999965322 22 3457776643211 11122233333 3553322 2221 112237
Q ss_pred EEEEeecCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 762 YLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~-------k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
-+.|..++|-.--..+. ....+.+..+...+++|+.+...||..|.+-+|+.++|+|+.+++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 78898888753222221 12346788889999999999999999999999999999999999999999744211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
.. .........+|.+.|.+||.-. +.+-+...|-|.|||++|++|.|
T Consensus 166 i~----------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 166 IN----------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred ec----------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 10 1122234578999999999765 33446788999999999999986
Q ss_pred -CCCCCCCC-------hHHHHHHHhhcCC---------------CCCCCCCCCCHHHHHHHhhhccCC--CCCCCCc
Q 001370 910 -IPPFTAES-------PEIIFDNILNRKI---------------PWPCVPSDMSFEAQDLINRFLIHD--PNQRLGA 961 (1091)
Q Consensus 910 -kpPF~~~s-------~~ei~~kIl~~~l---------------~fP~ip~~lS~eakDLI~rcL~kD--PeKRpSa 961 (1091)
+.||.+.. +-++ .|-.+.+ .+|. .-++++++.|..+|+..- +.-||++
T Consensus 218 grHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~--~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPL--SMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred CCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCCh--hhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 99997632 2221 2222111 1111 347889999999999842 4579994
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.3e-05 Score=78.32 Aligned_cols=138 Identities=28% Similarity=0.380 Sum_probs=82.2
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeeee---ccCCeeEEEE
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSF---TCRDNLYLVM 765 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HP--NIVkL~gsf---qded~LYLVM 765 (1091)
++.|+.|..+.||++.... ..|++|+.... .....+.+|..++..+... .+.+++... ......|++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998764 58999986542 3456677888888777522 244555433 2233479999
Q ss_pred eecCCCcHHH----------------HHH---hc--C--CCCHHH------HHHH---------------HHHHHH-HHH
Q 001370 766 EYLNGGDLYS----------------LLR---KV--G--CLEEDV------ARIY---------------IAELVL-ALE 800 (1091)
Q Consensus 766 EYm~GGSL~d----------------lL~---k~--g--~LsE~~------ar~y---------------aaQIa~-ALe 800 (1091)
++++|..+.. .+. .. . .+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 111 11 0 011000 0000 111222 233
Q ss_pred HHHH-------cCCeecccCCCceEec-CCCcEEEEecCCccc
Q 001370 801 YLHS-------LGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKI 835 (1091)
Q Consensus 801 YLHs-------~GIIHRDLKPeNILLD-~nG~VKLsDFGLAk~ 835 (1091)
.++. ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 4599999999999999 667778999998864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.8e-05 Score=83.75 Aligned_cols=139 Identities=14% Similarity=0.203 Sum_probs=100.1
Q ss_pred ccCCceEEEEEEECCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccC----CeeEEEE
Q 001370 695 SRGAFGRVFLARKRTTGDLFAIKVLKKL---DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCR----DNLYLVM 765 (1091)
Q Consensus 695 GkGgFGtVyLar~k~TGk~VAIKiLkK~---~i~~~~eie~~l~EieILskL~H--PNIVkL~gsfqde----d~LYLVM 765 (1091)
|+||-+-|+..... |+.|-+|.-... ..........|.+|...|..+.. -.+.+....-... -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 67888889887654 446778865410 11113356778999999988752 2244443221111 2368999
Q ss_pred eecCC-CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc--EEEEecCCccc
Q 001370 766 EYLNG-GDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKI 835 (1091)
Q Consensus 766 EYm~G-GSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~--VKLsDFGLAk~ 835 (1091)
|-+.| -+|.+++.+. ...+......++.+++..|.-||..|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98764 4888888663 34567777889999999999999999999999999999987777 99999987663
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.9e-05 Score=84.23 Aligned_cols=141 Identities=22% Similarity=0.318 Sum_probs=90.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhcC---CCceEEEe-
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER------ILAERNILITVR---NPFVVRFF- 752 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~------~l~EieILskL~---HPNIVkL~- 752 (1091)
....+|++++++-......|.+..- +|+.|.+|..+......+..... ..+++..+..+. --.+..+|
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4457889999998888777877754 47889999876532211111111 122333233332 11222222
Q ss_pred ----eeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEE
Q 001370 753 ----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 828 (1091)
Q Consensus 753 ----gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLs 828 (1091)
-.+.-....+|||||++|..|.++.. +++. +...++.+|.-||+.|+.|+|..|.|++++.++ +++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 22222334568999999988766532 3332 345677889999999999999999999998655 9999
Q ss_pred ecCCcc
Q 001370 829 DFGLSK 834 (1091)
Q Consensus 829 DFGLAk 834 (1091)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.4e-05 Score=88.61 Aligned_cols=136 Identities=24% Similarity=0.247 Sum_probs=96.7
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecc-------ccc----------c--hhHHHHHHHHHHHHHhcCCC--c
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-------DMI----------R--KNDIERILAERNILITVRNP--F 747 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~-------~i~----------~--~~eie~~l~EieILskL~HP--N 747 (1091)
.+...||-|--+.||.|... .|..+|||.=+-. ... . .-......+|.++|.++... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999875 6899999963211 000 0 01123457788888888643 4
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEE
Q 001370 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 827 (1091)
Q Consensus 748 IVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKL 827 (1091)
|.+.++ -+.-.+||||+.|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+-|||++.+|.+.+
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 444433 24567999999997665432 234445555666666666666899999999999999999999999
Q ss_pred EecCCcc
Q 001370 828 TDFGLSK 834 (1091)
Q Consensus 828 sDFGLAk 834 (1091)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.0001 Score=79.05 Aligned_cols=128 Identities=27% Similarity=0.390 Sum_probs=91.9
Q ss_pred CCeEEEEeeccCCc-eEEEEEEECCCCcEEEEEEeeccccc---------ch---------hHHHHHHHHHHHHHhcC--
Q 001370 686 DDFEIIKPISRGAF-GRVFLARKRTTGDLFAIKVLKKLDMI---------RK---------NDIERILAERNILITVR-- 744 (1091)
Q Consensus 686 ddFeilr~LGkGgF-GtVyLar~k~TGk~VAIKiLkK~~i~---------~~---------~eie~~l~EieILskL~-- 744 (1091)
.+++.++.||.|.- |.||+++.. |+.||+|+++.-... .. ....-|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 79999999999999 999999875 889999994321110 00 12335677777655554
Q ss_pred -CCce--EEEeeeeccC------------------CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 001370 745 -NPFV--VRFFYSFTCR------------------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803 (1091)
Q Consensus 745 -HPNI--VkL~gsfqde------------------d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLH 803 (1091)
+..+ |++|++..-. ....||.||++... .+.. .-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4455 9999887332 12468899887743 1222 23567888899999
Q ss_pred HcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 804 s~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
..||+-+|+|+.|.. +| ||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---CC--EEEecccC
Confidence 999999999999987 33 89999954
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.2e-05 Score=80.96 Aligned_cols=134 Identities=16% Similarity=0.121 Sum_probs=83.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeeeeccCCeeEEEEeecC
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HP--NIVkL~gsfqded~LYLVMEYm~ 769 (1091)
..||.|..+.||+. .|..+++|...... ....+.+|.+++..+..- .+.+.+++..+.+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999974 25567788875421 234468899999887632 24566677777777899999999
Q ss_pred CCc-HH--------------HHH-------Hhc--CCCCHHH-HHHHHH----------HHHH-HHHHHHH----cCCee
Q 001370 770 GGD-LY--------------SLL-------RKV--GCLEEDV-ARIYIA----------ELVL-ALEYLHS----LGIVH 809 (1091)
Q Consensus 770 GGS-L~--------------dlL-------~k~--g~LsE~~-ar~yaa----------QIa~-ALeYLHs----~GIIH 809 (1091)
|.+ +. ..+ +.. ....... ...+.. .+.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 964 11 111 110 0011000 001100 0111 1222321 24789
Q ss_pred cccCCCceEecCCCcEEEEecCCccc
Q 001370 810 RDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 810 RDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
+|+.|.||+++.+| +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999988 99999998875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.6e-05 Score=100.53 Aligned_cols=203 Identities=25% Similarity=0.289 Sum_probs=145.5
Q ss_pred HHHHHHHHHHHHHhcCCCceEEEeeeeccCCe----eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 001370 729 DIERILAERNILITVRNPFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804 (1091)
Q Consensus 729 eie~~l~EieILskL~HPNIVkL~gsfqded~----LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs 804 (1091)
++....-|...+.++.|+|++.++.+-..... +.+..++++.-++...+...+..+.+.++.+..++++||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 44455567777888899999999877655432 34556889999999999999999999999999999999999999
Q ss_pred cCCeecccCCC---ceEecCCCcEEEE--ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCC
Q 001370 805 LGIVHRDLKPD---NLLIAHDGHIKLT--DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 879 (1091)
Q Consensus 805 ~GIIHRDLKPe---NILLD~nG~VKLs--DFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~Y 879 (1091)
....|.-+... +-..+..+.+.++ ||+..+.... ........-+..|
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d----------------------------~~~~~~~~~~~~~ 356 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD----------------------------NEKSFSDLLAEIR 356 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCC----------------------------cccchhhcCcccc
Confidence 96666555444 4445556677766 8887664211 1112233445678
Q ss_pred CChhhhcCCCCCcc--ceeechhhhHHHHHhCCCCCC-CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCC
Q 001370 880 LAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFT-AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPN 956 (1091)
Q Consensus 880 mAPEVL~g~~Ys~k--sDIWSLGVILYEMLTGkpPF~-~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPe 956 (1091)
.|||......+..+ .|+|.+|.....+..|..+-. ...+. +..+.....+..+++.+|+..+++
T Consensus 357 ~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~-------------~~l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 357 NADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV-------------SLLDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred ccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh-------------hhhccccchhhhhhhhhhcchhhh
Confidence 88998887666544 799999999999988754321 11111 111122222678899999999999
Q ss_pred CCCCcccHHHHHcCCCCCC
Q 001370 957 QRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 957 KRpSa~gA~EIL~HPFFkg 975 (1091)
+|++ +.+++.|||.+-
T Consensus 424 ~Rl~---~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 424 ERLS---ALELLTHPFLRF 439 (1351)
T ss_pred hccc---hhhhhhchhccc
Confidence 9999 889999999864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.4e-05 Score=92.49 Aligned_cols=139 Identities=25% Similarity=0.316 Sum_probs=87.1
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccc--------------------------cch-hH----HHH------HH
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------------------------IRK-ND----IER------IL 734 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i--------------------------~~~-~e----ie~------~l 734 (1091)
..|+.++-|+||.|+.+. |+.||||+.+..-. ... .- .+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999875 99999999753100 000 00 111 23
Q ss_pred HHHHHHHhcC-----CCceEEEeeeeccCCeeEEEEeecCCCcHHHHH--HhcCCCCHHHHHHHHHHHHHH-HHHHHHcC
Q 001370 735 AERNILITVR-----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLA-LEYLHSLG 806 (1091)
Q Consensus 735 ~EieILskL~-----HPNIVkL~gsfqded~LYLVMEYm~GGSL~dlL--~k~g~LsE~~ar~yaaQIa~A-LeYLHs~G 806 (1091)
+|..-+.++. .|+|.--.-+.+-...-.|+|||+.|-.+.+.. .. ..++...+ +..++.+ +.-+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 3444343332 343322111222234457999999998888774 44 34553222 2222222 22333479
Q ss_pred CeecccCCCceEecCCCcEEEEecCCccc
Q 001370 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 807 IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
++|.|.+|.||+++.+|.+-+.|||+...
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceec
Confidence 99999999999999999999999998764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=1.8e-06 Score=110.29 Aligned_cols=255 Identities=19% Similarity=0.124 Sum_probs=163.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCC-cEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-- 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TG-k~VAIKiLkK~~i--~~~~eie~~l~EieILskL~HPNIVkL~gsfqded-- 759 (1091)
...+++.--+|-|.+++ +++.... .-+.+|+.+..+. ..+...+....|++-++...|++++..+.-.....
T Consensus 1228 ~e~~EV~l~i~~~~~~R---~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFR---NKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hhhhheeeecccceeec---cchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 45566665666655543 3332111 1234555443221 22334566677777778889999998776655443
Q ss_pred eeEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecccCCCceEecCCCcEEEEec
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDF 830 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~G-----IIHRDLKPeNILLD~nG~VKLsDF 830 (1091)
..|.+++|+.+|.+++.|.+. ..+.+..+.....+.+.+..-+|... .+|++||+-|.+|..+..+|+.++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 479999999999999999764 23444444444445578888877652 689999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGk 910 (1091)
|+.+.- + .........++++.||+|++.+.-.++.++|+|..|+-+|+.-.|.
T Consensus 1385 gLdKIk--n-------------------------p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1385 GLDKIK--N-------------------------PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred cccccc--C-------------------------chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 999831 0 1112234567899999999999999999999999999999999998
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 911 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 911 pPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
+||.......+...|.++. +-.++.--|.++-.....+|-..-..||+ ...++.-+.|.
T Consensus 1438 ~~fi~flq~~Lkgiidn~t--f~sIe~l~pgdaNve~~~~Ll~K~~~rp~---q~isls~d~~a 1496 (2724)
T KOG1826|consen 1438 AYFIFFLQPALKGIIDNHT--FFSIEKLKPGDANVEALHRLLWKYMERPG---QYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHHHHHcCcccccc--cccccccCCCcccHHHHHHHHHHhhhcch---hhhhccccccc
Confidence 8885433322222222221 11122222333333333333334556887 44566666664
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00011 Score=78.39 Aligned_cols=135 Identities=15% Similarity=0.121 Sum_probs=82.5
Q ss_pred eeccCCc-eEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeecCC
Q 001370 693 PISRGAF-GRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNG 770 (1091)
Q Consensus 693 ~LGkGgF-GtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLVMEYm~G 770 (1091)
.|-.|.. ..||++... +..+.+|+..... ...+.+|+.++..+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444555 789998653 4678888775432 234667888887764 33455677777766778999999999
Q ss_pred CcHHHHH----------------HhcCCC-------CHH------HHHHHHH----------------HHHHHHHHHH--
Q 001370 771 GDLYSLL----------------RKVGCL-------EED------VARIYIA----------------ELVLALEYLH-- 803 (1091)
Q Consensus 771 GSL~dlL----------------~k~g~L-------sE~------~ar~yaa----------------QIa~ALeYLH-- 803 (1091)
.+|.... .+...+ ... .....+. .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7765331 110011 100 0000000 0111112221
Q ss_pred -----HcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 804 -----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 804 -----s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
...++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00026 Score=89.30 Aligned_cols=145 Identities=20% Similarity=0.355 Sum_probs=90.6
Q ss_pred EEEeeccCCceEEEEEEECCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCce--EEEeeeeccC---Cee
Q 001370 690 IIKPISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFV--VRFFYSFTCR---DNL 761 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TG--k~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNI--VkL~gsfqde---d~L 761 (1091)
.++.|+.|.+..+|+......+ ..|++|+....... .....+.+|..+|..+. |++| .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3577899999999998865432 46777765432211 12346779999999885 6554 7777777664 468
Q ss_pred EEEEeecCCCcHHH--------------------HHH---hcC----CC---------CHHHHHHHHH------------
Q 001370 762 YLVMEYLNGGDLYS--------------------LLR---KVG----CL---------EEDVARIYIA------------ 793 (1091)
Q Consensus 762 YLVMEYm~GGSL~d--------------------lL~---k~g----~L---------sE~~ar~yaa------------ 793 (1091)
|+||||++|..+.+ .|. ... .+ ...++..+..
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 99999999864211 111 100 01 0112221111
Q ss_pred ---HHHHHHHHHHH-----------cCCeecccCCCceEecCC-Cc-EEEEecCCcccc
Q 001370 794 ---ELVLALEYLHS-----------LGIVHRDLKPDNLLIAHD-GH-IKLTDFGLSKIG 836 (1091)
Q Consensus 794 ---QIa~ALeYLHs-----------~GIIHRDLKPeNILLD~n-G~-VKLsDFGLAk~~ 836 (1091)
.+...+.+|.. ..+||+|++|.|||++.+ +. +-|.||+++..+
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12233556632 249999999999999853 33 579999999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00021 Score=78.76 Aligned_cols=138 Identities=25% Similarity=0.240 Sum_probs=91.8
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchh-------------------H--HHHHHHHHHHHHhcC--CCc
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-------------------D--IERILAERNILITVR--NPF 747 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~-------------------e--ie~~l~EieILskL~--HPN 747 (1091)
...|+.|--+.||+|.. .++..+|+|+++......+. . ......|..-|.++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34788888889999975 45889999998643221111 1 122345666666653 222
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcE
Q 001370 748 VVRFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHI 825 (1091)
Q Consensus 748 IVkL~gsfqded~LYLVMEYm~GGSL-~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~V 825 (1091)
+.+-+.++ .-.|||||+....+ .-.|.. -.+....+..+..+++..+.-|-. .|+||+||..=|||+. +|.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 23333222 23689999965311 111211 123444688888899999998877 8999999999999999 8999
Q ss_pred EEEecCCccc
Q 001370 826 KLTDFGLSKI 835 (1091)
Q Consensus 826 KLsDFGLAk~ 835 (1091)
.|+|||-|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00014 Score=87.55 Aligned_cols=138 Identities=25% Similarity=0.371 Sum_probs=85.4
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccc-----------------------------hhHHHH------HHHH
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----------------------------KNDIER------ILAE 736 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~-----------------------------~~eie~------~l~E 736 (1091)
+.||.-+.|.||+|+.+. |+.||||+-+.. +.. .+-.+. |.+|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 469999999999999886 999999986531 000 000111 2233
Q ss_pred HHHH----HhcCCCc------eEEEeeeeccCCeeEEEEeecCCCcHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 001370 737 RNIL----ITVRNPF------VVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALEYLHS 804 (1091)
Q Consensus 737 ieIL----skL~HPN------IVkL~gsfqded~LYLVMEYm~GGSL~dl--L~k~g~LsE~~ar~yaaQIa~ALeYLHs 804 (1091)
.+-. ..+.|-+ |.++|..+.. .-.|+||||+|.-+.++ |.+.+ ++...+...+.++.. +-|=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHHh
Confidence 3222 2223433 4455544432 35799999999866544 44444 444433332222211 12234
Q ss_pred cCCeecccCCCceEecC----CCcEEEEecCCcccc
Q 001370 805 LGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIG 836 (1091)
Q Consensus 805 ~GIIHRDLKPeNILLD~----nG~VKLsDFGLAk~~ 836 (1091)
.|++|.|-.|.|||+.. ++.+.+-|||+....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 68999999999999994 568999999998753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00043 Score=73.20 Aligned_cols=131 Identities=24% Similarity=0.336 Sum_probs=93.1
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 767 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEY 767 (1091)
.+..+.||+|.+|.||+|.+. |..+|+|+-+... -...+..|.++|..+.--++..=.+.+- ..++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhh
Confidence 356678999999999999986 6789999765422 3456788999999888655544322221 22455999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccC-CCceEecCCCcEEEEecCCccc
Q 001370 768 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK-PDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 768 m~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLK-PeNILLD~nG~VKLsDFGLAk~ 835 (1091)
+.|-.|.++-... + +.-+..++.+---|-..||-|..|. |..++|..++.+.|+||.-|++
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998887765421 1 2223345555445667899999995 7777777777999999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00049 Score=73.42 Aligned_cols=73 Identities=16% Similarity=0.165 Sum_probs=44.8
Q ss_pred EEeeccCCce-EEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---ceEEEeeeeccC---CeeEE
Q 001370 691 IKPISRGAFG-RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFTCR---DNLYL 763 (1091)
Q Consensus 691 lr~LGkGgFG-tVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HP---NIVkL~gsfqde---d~LYL 763 (1091)
++.|+.|+.. .||+. +..+++|+.+.. .....+.+|..+|..+... -+.+.++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567877776 58876 234677865431 1234688899888776521 233344433332 23589
Q ss_pred EEeecCCCcH
Q 001370 764 VMEYLNGGDL 773 (1091)
Q Consensus 764 VMEYm~GGSL 773 (1091)
||++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0029 Score=67.61 Aligned_cols=133 Identities=24% Similarity=0.281 Sum_probs=91.8
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccc-------------cchhHHHHHHHHHHHHHhcC------CCceEEEe
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-------------IRKNDIERILAERNILITVR------NPFVVRFF 752 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i-------------~~~~eie~~l~EieILskL~------HPNIVkL~ 752 (1091)
..||+|+.=.||.- . .+....||+++.... ..........+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46999999999853 3 244467898876440 01112344555665444443 78999999
Q ss_pred eeeccCCeeEEEEeecCCC------cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---
Q 001370 753 YSFTCRDNLYLVMEYLNGG------DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--- 823 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GG------SL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG--- 823 (1091)
|..+++..+-+|+|.+... +|.+++.+ +.+++ ..+ ..+-.-..||-..+|+.+||+|.||++..++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999987542 57888854 44665 222 2334455688899999999999999997533
Q ss_pred -cEEEEe-cCC
Q 001370 824 -HIKLTD-FGL 832 (1091)
Q Consensus 824 -~VKLsD-FGL 832 (1091)
.+.|+| ||-
T Consensus 159 ~~lvlIDG~G~ 169 (199)
T PF10707_consen 159 FRLVLIDGLGE 169 (199)
T ss_pred eEEEEEeCCCC
Confidence 577887 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0018 Score=68.39 Aligned_cols=137 Identities=18% Similarity=0.238 Sum_probs=80.1
Q ss_pred EEeeccCCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec
Q 001370 691 IKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 768 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~-TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLVMEYm 768 (1091)
++.|..|-...||++.... .++.|++|+...... ..-...+|..++..+. +....++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888889999997543 356888997754211 1112246788887774 3334455544432 4799999
Q ss_pred CCCcHHH--------------HHHh---cC-CC----------C-HHHHHHHHHH----------------------HHH
Q 001370 769 NGGDLYS--------------LLRK---VG-CL----------E-EDVARIYIAE----------------------LVL 797 (1091)
Q Consensus 769 ~GGSL~d--------------lL~k---~g-~L----------s-E~~ar~yaaQ----------------------Ia~ 797 (1091)
+|-++.. .|.+ .. .. . ...+..|... +..
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 9866521 1111 00 11 0 1122222111 111
Q ss_pred HHHHH----H----HcCCeecccCCCceEecC-CCcEEEEecCCccc
Q 001370 798 ALEYL----H----SLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 835 (1091)
Q Consensus 798 ALeYL----H----s~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~ 835 (1091)
.+..| - ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11111 1 236999999999999998 57899999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0011 Score=69.73 Aligned_cols=98 Identities=23% Similarity=0.263 Sum_probs=78.8
Q ss_pred HHHHHHHHhcCC-CceEEEeeeeccCCeeEEEEeecCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 001370 734 LAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL---LRKVGCLEEDVARIYIAELVLALEYLHS---LG 806 (1091)
Q Consensus 734 l~EieILskL~H-PNIVkL~gsfqded~LYLVMEYm~GGSL~dl---L~k~g~LsE~~ar~yaaQIa~ALeYLHs---~G 806 (1091)
.+|.-+|+.+.+ +++.+++|+|- -++|.||...+++... +......++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888875 69999999983 3679999988766421 2222346888899999999999999997 35
Q ss_pred CeecccCCCceEecCCCcEEEEecCCccc
Q 001370 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 807 IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
+.-.|++|+|+-++++|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 78899999999999999999999997653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0085 Score=70.35 Aligned_cols=80 Identities=18% Similarity=0.163 Sum_probs=54.8
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccc-cc---hhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEE
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IR---KNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i-~~---~~eie~~l~EieILskL~---HPNIVkL~gsfqded~LYL 763 (1091)
.+.||.|.+..||++.....++.|+||.-..... .. .-..++...|.+.|..+. ..++.++|.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864335899997431100 00 124567778888887753 3456777766 4466789
Q ss_pred EEeecCCCc
Q 001370 764 VMEYLNGGD 772 (1091)
Q Consensus 764 VMEYm~GGS 772 (1091)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0067 Score=67.96 Aligned_cols=78 Identities=13% Similarity=0.040 Sum_probs=54.2
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---CceEEEeeeecc---CCeeE
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC---RDNLY 762 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H---PNIVkL~gsfqd---ed~LY 762 (1091)
.-.+.||.|..+.||..... ++ .+.+|..+. . .....+.+|...|+.+.- ..+.++++.+.+ .+..|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARS-F----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecc-c----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34567999999999998643 23 466776432 1 123568889998887752 356777776654 35689
Q ss_pred EEEeecCCCcH
Q 001370 763 LVMEYLNGGDL 773 (1091)
Q Consensus 763 LVMEYm~GGSL 773 (1091)
||||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0034 Score=67.80 Aligned_cols=133 Identities=20% Similarity=0.226 Sum_probs=75.8
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeccCCeeEEEEeecCCC
Q 001370 693 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYLNGG 771 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNI-VkL~gsfqded~LYLVMEYm~GG 771 (1091)
.+..|-.+.+|++. .+|+.|++|+....... -.+ ...+|..++..+..-.+ .++++.+. -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35567778899886 34677888875432110 001 24668888877753222 33333332 36899999986
Q ss_pred cHHH--------------HHHh---cC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCCeeccc
Q 001370 772 DLYS--------------LLRK---VG----CLEE-DVARIYIAEL---------VLALEYLHS--------LGIVHRDL 812 (1091)
Q Consensus 772 SL~d--------------lL~k---~g----~LsE-~~ar~yaaQI---------a~ALeYLHs--------~GIIHRDL 812 (1091)
.+.. .+.+ .. .++. ..+..|..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5421 1111 11 1111 1222332222 111222221 24899999
Q ss_pred CCCceEecCCCcEEEEecCCccc
Q 001370 813 KPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 813 KPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.|.|||++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999887 78999998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.016 Score=64.51 Aligned_cols=142 Identities=20% Similarity=0.232 Sum_probs=82.9
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeee------eccC
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYS------FTCR 758 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H--PNIVkL~gs------fqde 758 (1091)
....++.++.|....||++.. . +..|++|+.+... ....+..|.+++..+.. -.+.+++.. ....
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred CceeccccCCccccceEEEEe-C-CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 344567788888889999864 2 3457789775421 12334556666666532 113333332 1224
Q ss_pred CeeEEEEeecCCCcHH-----------HH---HHhc-CCCC--------HHH-----HH----------HHHHHHHHHHH
Q 001370 759 DNLYLVMEYLNGGDLY-----------SL---LRKV-GCLE--------EDV-----AR----------IYIAELVLALE 800 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~-----------dl---L~k~-g~Ls--------E~~-----ar----------~yaaQIa~ALe 800 (1091)
+..|+||+|++|..+. .. ++.. ..++ ... .. .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 5678999999985431 11 1110 0110 000 00 00112334555
Q ss_pred HHHH-------cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 801 YLHS-------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 801 YLHs-------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
++.. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5643 5899999999999999988779999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.019 Score=63.86 Aligned_cols=31 Identities=32% Similarity=0.430 Sum_probs=26.8
Q ss_pred cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 ~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.++||+|+.|.|||++.+...-|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999998665568999998864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.01 Score=65.09 Aligned_cols=139 Identities=19% Similarity=0.169 Sum_probs=83.1
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeee------eccCCe
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYS------FTCRDN 760 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HP--NIVkL~gs------fqded~ 760 (1091)
.-++.|..|....+|++.. .+..+++|+... .....+..|..++..+.+- .+.+++.. ....+.
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 3366788888889999864 345788998764 1123456677777666421 24444332 123456
Q ss_pred eEEEEeecCCCcHHH----H-------H---Hhc-CCCCH--------HHHH------------HHHHHHHHHHHHHHH-
Q 001370 761 LYLVMEYLNGGDLYS----L-------L---RKV-GCLEE--------DVAR------------IYIAELVLALEYLHS- 804 (1091)
Q Consensus 761 LYLVMEYm~GGSL~d----l-------L---~k~-g~LsE--------~~ar------------~yaaQIa~ALeYLHs- 804 (1091)
.|+||+|++|..+.. . | +.. ..+.. .... .....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999999866421 1 1 110 00100 0000 011123334555543
Q ss_pred ------cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 ------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 ------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.+++|+|+.|.|||++.++.+.|.||+.|..
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999887789999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0057 Score=67.43 Aligned_cols=75 Identities=12% Similarity=0.109 Sum_probs=47.3
Q ss_pred EEeeccCCceEEEEEEECC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeccCCeeEE
Q 001370 691 IKPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HP-NIVkL~gsfqded~LYL 763 (1091)
++.|..|-...||++.... +++.|++|+..... .......+|..++..+... ...++++.+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4566677777899887543 25789999876532 1123456777777776522 23445555542 36
Q ss_pred EEeecCCCcH
Q 001370 764 VMEYLNGGDL 773 (1091)
Q Consensus 764 VMEYm~GGSL 773 (1091)
||||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.042 Score=63.99 Aligned_cols=77 Identities=21% Similarity=0.201 Sum_probs=49.3
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeec-ccc---cchhHHHHHHHHHHHHHhcC--CC-ceEEEeeeeccCCeeEEEE
Q 001370 693 PISRGAFGRVFLARKRTTGDLFAIKVLKK-LDM---IRKNDIERILAERNILITVR--NP-FVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 693 ~LGkGgFGtVyLar~k~TGk~VAIKiLkK-~~i---~~~~eie~~l~EieILskL~--HP-NIVkL~gsfqded~LYLVM 765 (1091)
.||-|....||++.....++.++||.-.. ... .-+-...+..-|...|.... -| .+.++|+ .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57999999999999754346899985321 111 11234566677888887654 34 4555543 3455566999
Q ss_pred eecCCC
Q 001370 766 EYLNGG 771 (1091)
Q Consensus 766 EYm~GG 771 (1091)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.06 Score=61.72 Aligned_cols=140 Identities=19% Similarity=0.248 Sum_probs=79.1
Q ss_pred CeEEEEeeccCCceEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCee
Q 001370 687 DFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNL 761 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN-IVkL~gsfqded~L 761 (1091)
...+ ..|-.|-.-.+|++.... +++.|.+|+..... ...+.+ .+|..++..+..-. -.++++.+...
T Consensus 38 ~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g--- 109 (344)
T PLN02236 38 ALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG--- 109 (344)
T ss_pred cEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc---
Confidence 3444 445457778899987532 34688999876532 112222 56787877775322 23445555432
Q ss_pred EEEEeecCCCcHHHH--------------HH---hcC----C-C-CHHHHHHHHHHH-----------------HHHHHH
Q 001370 762 YLVMEYLNGGDLYSL--------------LR---KVG----C-L-EEDVARIYIAEL-----------------VLALEY 801 (1091)
Q Consensus 762 YLVMEYm~GGSL~dl--------------L~---k~g----~-L-sE~~ar~yaaQI-----------------a~ALeY 801 (1091)
.|++|++|.+|... |. ... . + ....+..++.++ ...+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 58999987665211 11 111 0 1 112222332111 111222
Q ss_pred HH--------HcCCeecccCCCceEecC-CCcEEEEecCCccc
Q 001370 802 LH--------SLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 835 (1091)
Q Consensus 802 LH--------s~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~ 835 (1091)
|. ...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 21 225899999999999986 47899999998864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.065 Score=61.43 Aligned_cols=124 Identities=19% Similarity=0.273 Sum_probs=73.3
Q ss_pred CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCC--eeEEEEeecCCCcHH------------
Q 001370 711 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRD--NLYLVMEYLNGGDLY------------ 774 (1091)
Q Consensus 711 Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H--PNIVkL~gsfqded--~LYLVMEYm~GGSL~------------ 774 (1091)
++.+++. ... ............+|..+|..+.- .-+...++.+.++. ..|.||+|+.|..+.
T Consensus 48 ~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~ 125 (321)
T COG3173 48 GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQF 125 (321)
T ss_pred CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHH
Confidence 7777777 321 12222344556677777777653 23445566666665 679999999984221
Q ss_pred ------HHHHh---c--------C---CCCHHHHHHHHHH--------------HHHHHHHHHHc--------CCeeccc
Q 001370 775 ------SLLRK---V--------G---CLEEDVARIYIAE--------------LVLALEYLHSL--------GIVHRDL 812 (1091)
Q Consensus 775 ------dlL~k---~--------g---~LsE~~ar~yaaQ--------------Ia~ALeYLHs~--------GIIHRDL 812 (1091)
+.|.. . + .+...+...+..+ ...-..+|+.+ .++|+|+
T Consensus 126 ~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~ 205 (321)
T COG3173 126 ALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDY 205 (321)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCc
Confidence 11111 0 0 0011111112212 22234455543 3899999
Q ss_pred CCCceEecCCCcEEEEecCCcccc
Q 001370 813 KPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 813 KPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
.+.||+|+..+-+=|.||+++..+
T Consensus 206 ~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 206 RPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ccCCEEEeCCCeeEEEeccccccC
Confidence 999999999999999999999864
|
|
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.012 Score=50.51 Aligned_cols=35 Identities=37% Similarity=0.702 Sum_probs=28.8
Q ss_pred CCCCcchhhcc--cCCccCCCCCCCCccccccccccC
Q 001370 974 KGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 1008 (1091)
Q Consensus 974 kgIdWd~L~~~--~pPfiP~~~s~~Dts~Fds~fs~~ 1008 (1091)
++++|+.|..+ +|||+|...+..|+++|+..+...
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~ 37 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEE 37 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCC
Confidence 47999999755 799999999999999998754443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.27 Score=54.21 Aligned_cols=30 Identities=27% Similarity=0.522 Sum_probs=26.5
Q ss_pred cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 ~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.019 Score=66.07 Aligned_cols=136 Identities=16% Similarity=0.180 Sum_probs=90.2
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-----------------cchhH--HHHHHHHHHHHHhcC-CCc
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----------------IRKND--IERILAERNILITVR-NPF 747 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i-----------------~~~~e--ie~~l~EieILskL~-HPN 747 (1091)
+.+...||-|--+.||.+-+. .|.++++|+=+-... ..... .-...+|...|+.+. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456788999999999999865 588999995321000 00001 112456777777764 322
Q ss_pred -eEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEE
Q 001370 748 -VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 748 -IVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 826 (1091)
|.+.+ +-+.-++|||++.|-.|...-+- .+ +..+...+..-|--|...|+||+|..-=||+++.+++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 22222 23457899999999777544321 11 223334455556778899999999999999999999999
Q ss_pred EEecCCcc
Q 001370 827 LTDFGLSK 834 (1091)
Q Consensus 827 LsDFGLAk 834 (1091)
++||--+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99998654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.12 Score=57.59 Aligned_cols=30 Identities=37% Similarity=0.626 Sum_probs=25.8
Q ss_pred CCeecccCCCceEecCCCc-EEEEecCCccc
Q 001370 806 GIVHRDLKPDNLLIAHDGH-IKLTDFGLSKI 835 (1091)
Q Consensus 806 GIIHRDLKPeNILLD~nG~-VKLsDFGLAk~ 835 (1091)
.++|+|++|.|||++.++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 56999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.14 Score=60.04 Aligned_cols=141 Identities=28% Similarity=0.253 Sum_probs=90.4
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchh---------------------HH--HHHHHHHHHHHhcCCC
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---------------------DI--ERILAERNILITVRNP 746 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~---------------------ei--e~~l~EieILskL~HP 746 (1091)
+-..|..|--+-||.|.. .+|..+|||+++-.-+.-++ .. -....|++-|.+++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345688888899999985 46888999998642211110 01 1233455666666532
Q ss_pred ceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecccCCCceEecCCCcE
Q 001370 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHI 825 (1091)
Q Consensus 747 NIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLH-s~GIIHRDLKPeNILLD~nG~V 825 (1091)
.|..- ..... ..-.|||+|+.+.....=.-+.-.++...++.+-.+++.-|.-|- ..++||.||.--|+|+. +|.+
T Consensus 227 GIP~P-ePIlL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 227 GIPCP-EPILL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCC-Cceee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 22100 00000 123689999964222111123345777788888888888888775 56999999999999995 6899
Q ss_pred EEEecCCcc
Q 001370 826 KLTDFGLSK 834 (1091)
Q Consensus 826 KLsDFGLAk 834 (1091)
.|+|-+-+.
T Consensus 304 yiIDVSQSV 312 (520)
T KOG2270|consen 304 YIIDVSQSV 312 (520)
T ss_pred EEEEccccc
Confidence 999998765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.28 Score=58.25 Aligned_cols=77 Identities=21% Similarity=0.168 Sum_probs=51.1
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeE
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRK---NDIERILAERNILITVR---NPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i-~~~---~eie~~l~EieILskL~---HPNIVkL~gsfqded~LY 762 (1091)
..+.||.|.-..||++... ++.|+||.-..... ... ....+...|...|..+. ...+.++|.++. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678999999999999863 45688886431111 111 23455566677776654 247777887776 4467
Q ss_pred EEEeecCC
Q 001370 763 LVMEYLNG 770 (1091)
Q Consensus 763 LVMEYm~G 770 (1091)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.31 Score=55.12 Aligned_cols=75 Identities=21% Similarity=0.301 Sum_probs=47.5
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEEEE
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~---HPNIVkL~gsfqded~LYLVM 765 (1091)
+-.+.||.|....+|+.. .+++.|.+|+-.. .....+..|..-|+.+. .-.+.+.+.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 455679999999999987 6688899997653 22356777888777773 345777888777777779999
Q ss_pred eecCCC
Q 001370 766 EYLNGG 771 (1091)
Q Consensus 766 EYm~GG 771 (1091)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.17 Score=57.64 Aligned_cols=142 Identities=17% Similarity=0.186 Sum_probs=77.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeccCCe
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDN 760 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNI-VkL~gsfqded~ 760 (1091)
.+++++.. |..|=...+|++..... +..|.+|+...... ..+ .-.+|..++..+..-.+ .++++++...
T Consensus 14 ~~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~G-- 86 (330)
T PLN02421 14 DSDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVI-DRERELQAIKYLSAAGFGAKLLGVFGNG-- 86 (330)
T ss_pred cCceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEe-chHHHHHHHHHHHhcCCCCceeEEeCCc--
Confidence 34555544 44477778998875432 23788998754211 111 12467777777753333 3455555322
Q ss_pred eEEEEeecCCCcHHH--------------HHHh---cC-C----C-CHHHHHHHHHHH----------------------
Q 001370 761 LYLVMEYLNGGDLYS--------------LLRK---VG-C----L-EEDVARIYIAEL---------------------- 795 (1091)
Q Consensus 761 LYLVMEYm~GGSL~d--------------lL~k---~g-~----L-sE~~ar~yaaQI---------------------- 795 (1091)
+|.+|++|-.|.. .|.+ .. . + ....+..|..++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 5899998765411 1111 11 0 1 112233332221
Q ss_pred HHHHHHHH----Hc----CCeecccCCCceEecC-CCcEEEEecCCccc
Q 001370 796 VLALEYLH----SL----GIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 835 (1091)
Q Consensus 796 a~ALeYLH----s~----GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~ 835 (1091)
..-+..+. .. -+.|.|+.|.|||+++ ++.++++||..|..
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11122221 11 2799999999999975 57899999999863
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.45 Score=53.26 Aligned_cols=30 Identities=17% Similarity=0.204 Sum_probs=28.1
Q ss_pred CCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 806 GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.21 Score=59.03 Aligned_cols=78 Identities=22% Similarity=0.164 Sum_probs=51.9
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeec-cc--ccchhHHHHHHHHHHHHHhcC--CC-ceEEEeeeeccCCeeEEE
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK-LD--MIRKNDIERILAERNILITVR--NP-FVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK-~~--i~~~~eie~~l~EieILskL~--HP-NIVkL~gsfqded~LYLV 764 (1091)
++.||-|.-..||++.....++.++||.-.. .. ..-.-..++..-|.++|+... .| .+.++|+ .+++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 6789999999999999744456788885321 11 111234677788888887764 34 4555654 345566789
Q ss_pred EeecCC
Q 001370 765 MEYLNG 770 (1091)
Q Consensus 765 MEYm~G 770 (1091)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999865
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.53 Score=55.19 Aligned_cols=30 Identities=27% Similarity=0.309 Sum_probs=25.1
Q ss_pred cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 ~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
..+.|.|+-+.|||.+. +.+.++||-.|..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 46799999999999764 5599999998863
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.14 E-value=2.4 Score=55.69 Aligned_cols=31 Identities=32% Similarity=0.518 Sum_probs=26.4
Q ss_pred cCCeecccCCCceEecCCC--cEE-EEecCCccc
Q 001370 805 LGIVHRDLKPDNLLIAHDG--HIK-LTDFGLSKI 835 (1091)
Q Consensus 805 ~GIIHRDLKPeNILLD~nG--~VK-LsDFGLAk~ 835 (1091)
.++||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999876 565 999998763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.61 E-value=0.3 Score=57.30 Aligned_cols=72 Identities=26% Similarity=0.400 Sum_probs=52.0
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
..++|++|++. |+.+.- + ..-..+++..++.+.+.-+.-+... .+=|||+...||||+ +|+|-|+||-+|+.
T Consensus 298 ~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34678888876 445432 1 1123455566666666666666644 688999999999999 99999999999985
|
|
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=91.52 E-value=0.07 Score=44.59 Aligned_cols=22 Identities=27% Similarity=0.193 Sum_probs=15.5
Q ss_pred CCCCCCccccccccccCCCCCC
Q 001370 992 PESVDDTSYFLSRFSQISSGLP 1013 (1091)
Q Consensus 992 ~~s~~Dts~Fds~fs~~~s~l~ 1013 (1091)
+.+..|++||+..|+.+.....
T Consensus 2 v~~~~DtsnFD~eFt~~~~~~t 23 (48)
T PF00433_consen 2 VKSETDTSNFDPEFTEEPPVDT 23 (48)
T ss_dssp -SSTT-GTTSCHHHHTSSSSS-
T ss_pred CCchhhhhhcCcccccCCCCCC
Confidence 5678999999999988865443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.57 E-value=0.38 Score=58.41 Aligned_cols=163 Identities=21% Similarity=0.276 Sum_probs=99.9
Q ss_pred HHHHHHHHHHHhcCCCceEEEeeeeccC-CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 001370 731 ERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 809 (1091)
Q Consensus 731 e~~l~EieILskL~HPNIVkL~gsfqde-d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIH 809 (1091)
..++--..+++.+.|+|...+.+.-... ....+|||++. -+|.+++.... +-.. ++. .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~-------s~~-------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDE-------SLL-------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchh-------hhc-------ccccce
Confidence 3456667788999999999988766543 35889999995 49999887643 2111 111 122222
Q ss_pred cccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC
Q 001370 810 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 889 (1091)
Q Consensus 810 RDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ 889 (1091)
-| .++.+| -++. +. .+..|
T Consensus 91 -----~~-------~~~~td-~~~t---------------------------~~-------~~~~~-------------- 109 (725)
T KOG1093|consen 91 -----LN-------IIYITD-HFLT---------------------------KY-------PSPIG-------------- 109 (725)
T ss_pred -----eh-------hhhccc-cccc---------------------------cC-------CCCCC--------------
Confidence 11 223333 1110 00 01112
Q ss_pred CCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC----------CCCCCCHHHHHHHhhhccCCCCCCC
Q 001370 890 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC----------VPSDMSFEAQDLINRFLIHDPNQRL 959 (1091)
Q Consensus 890 Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~----------ip~~lS~eakDLI~rcL~kDPeKRp 959 (1091)
.++||||+|.++.|+..|..-|......+..+.|..-... +. +.-.++.....+..+|+...|..||
T Consensus 110 --pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~-d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 110 --PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTD-DQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred --cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccC-chhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 3999999999999999998877766555555544432110 10 0112445567888999999999999
Q ss_pred CcccHHHHHcCCCCCCC
Q 001370 960 GANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 960 Sa~gA~EIL~HPFFkgI 976 (1091)
. ..++.+|+-|..+
T Consensus 187 l---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 L---PMELSKRCSFTEV 200 (725)
T ss_pred c---hhHHhcCccHHHH
Confidence 7 5577777777543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=89.66 E-value=1.1 Score=49.75 Aligned_cols=101 Identities=16% Similarity=0.153 Sum_probs=66.3
Q ss_pred EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHH
Q 001370 713 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 792 (1091)
Q Consensus 713 ~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~ya 792 (1091)
...+|.++.....- ...-+.++.+++.++. .|++|..- ....+-+|+|+|-.-.. . ..-++.
T Consensus 87 ~L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~---~~N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------N---FSNFIT 148 (308)
T ss_pred hhhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------c---hhHHHH
Confidence 34466665433321 2345678889998876 47888732 33456789999843211 0 111222
Q ss_pred HHHHHHHHHHHH--cCCeecccCCCceEecCCCcEEEEecCC
Q 001370 793 AELVLALEYLHS--LGIVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 793 aQIa~ALeYLHs--~GIIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
-=+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 149 -agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 -AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 12466777884 4799999999999999999999999874
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.98 E-value=10 Score=43.29 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=24.7
Q ss_pred cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 ~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.++||+|+.+.|||++ + .+.|+||+-|..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 4 578999998874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=88.39 E-value=0.098 Score=62.83 Aligned_cols=75 Identities=28% Similarity=0.476 Sum_probs=61.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
...++|+....+|.|+||+|+-++.+.++..||||.|.-.. ......+.++|..-+.++.|++|+.++..|....
T Consensus 46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn--~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~ 120 (516)
T KOG1033|consen 46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN--REESRSRVLREVSSLAEFEHPGIKRYFHAWYERP 120 (516)
T ss_pred hhhccccccccccccCccccCCccccccchhhHHHHhcccc--hhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence 35688999999999999999999999888899999875322 2334567888999999999999999998886544
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.52 E-value=4.2 Score=48.79 Aligned_cols=29 Identities=28% Similarity=0.495 Sum_probs=24.7
Q ss_pred CCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 806 GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.+.|.|+-+.|||.+.++ ++|+||-.|..
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeeccccc
Confidence 479999999999986554 99999998863
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1091 | ||||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-65 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-65 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-59 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-59 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-59 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-59 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-59 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-58 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-58 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-58 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-58 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-58 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-58 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-58 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-58 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-58 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-58 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-58 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-58 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-58 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-58 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-58 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-58 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-58 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-58 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-58 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-58 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-58 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-58 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-58 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-58 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-58 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-58 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-58 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-58 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-58 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-58 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-58 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-57 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-57 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-57 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-57 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-57 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-57 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-57 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-57 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-57 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-57 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-57 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-57 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-57 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-57 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-57 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-57 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-57 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-57 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-57 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-57 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-57 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-57 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-57 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-57 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-57 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-57 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-57 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-57 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-57 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-57 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-57 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-57 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-57 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-57 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-56 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-56 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-56 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-56 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-56 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-56 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-55 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-55 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-55 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-54 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-54 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-53 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-53 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-52 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-52 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-52 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-51 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-51 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-51 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-50 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-50 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-50 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-50 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-50 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-50 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-50 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-50 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-50 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-50 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-50 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-50 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-50 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-50 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-50 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-50 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-50 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-50 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-50 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-50 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-50 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-41 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-41 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-41 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-41 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-41 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-41 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-41 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-40 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-40 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-40 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-40 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-40 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-40 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-40 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-40 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-40 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-39 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-39 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-39 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-39 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-39 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-39 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-39 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-39 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-39 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-39 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-39 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-39 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-39 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-39 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-38 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-38 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-38 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-38 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-38 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-38 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-38 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-37 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-37 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-35 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-35 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-34 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-34 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-34 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-34 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-34 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-34 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-33 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-33 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-33 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-33 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-33 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-33 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-32 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-32 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-31 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-31 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-31 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-31 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-31 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-31 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-31 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-31 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-31 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-31 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-31 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-31 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-31 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-31 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-30 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-30 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-30 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-30 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-30 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-30 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-30 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-30 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-30 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-30 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-30 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-30 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-30 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-29 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-29 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-29 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-29 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-29 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-29 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-28 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-28 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-28 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-27 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-27 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-27 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-27 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-27 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-27 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-26 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-26 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-26 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-26 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-26 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-26 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-26 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-25 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-25 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-25 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-25 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-24 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-24 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-24 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-24 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-24 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-24 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-24 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-24 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-24 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-24 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-24 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-24 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-24 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-24 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-24 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-23 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-23 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-23 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-22 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-22 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-22 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-22 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-21 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-20 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-20 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-19 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-19 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-18 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-18 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-18 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-14 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-08 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 7e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-08 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 7e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 |
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1091 | |||
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-143 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-139 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-135 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-134 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-132 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-131 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-131 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-130 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-130 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-129 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-128 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-127 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-126 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-126 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-124 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-123 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-122 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-121 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-117 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-115 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-113 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-112 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-105 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-105 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-91 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-90 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-85 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-85 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 6e-83 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-82 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-78 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-76 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-74 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-73 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 6e-73 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-72 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-72 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-72 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-71 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-71 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-71 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-70 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-70 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-70 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-70 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-70 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-69 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 6e-69 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 6e-69 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-69 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 7e-69 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-69 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-68 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-68 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-68 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-68 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-68 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-68 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-68 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-68 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-67 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-67 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-67 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-67 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 9e-67 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-66 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-66 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-66 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-65 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-65 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-65 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-65 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-65 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-64 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-64 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-64 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-64 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-64 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-63 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-63 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-63 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-63 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-63 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-63 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-62 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-62 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-62 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-62 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 8e-62 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-61 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-61 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-60 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-59 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-58 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-57 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-57 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-56 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-56 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 8e-56 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-55 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-55 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-55 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-54 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 7e-54 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-52 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-52 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 9e-52 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-51 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-51 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-50 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-50 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-50 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-50 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-49 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-45 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-45 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-44 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-44 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-44 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-43 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-43 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-43 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-43 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-43 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-43 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-43 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-43 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-43 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 6e-43 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-43 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-42 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-42 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-42 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-42 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-42 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-41 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-41 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-41 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-40 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-40 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-40 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 6e-40 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-39 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-39 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-39 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 8e-38 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 9e-38 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-37 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 6e-37 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-37 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-36 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-36 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-36 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-36 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 8e-36 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-35 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-35 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-35 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 7e-35 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-34 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-34 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-34 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-34 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-34 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-34 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-33 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-33 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-33 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-33 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-32 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-31 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-26 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-25 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 8e-25 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-24 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-24 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-24 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-23 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-23 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-23 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-22 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-22 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-21 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-21 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-21 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-21 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-21 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-21 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-21 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-20 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-20 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-20 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-20 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-20 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-19 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-19 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-19 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-19 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-19 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-19 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-19 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-19 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 9e-19 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-18 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-18 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-18 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-18 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-18 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-18 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-18 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-18 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-18 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-18 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-17 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-17 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-17 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-17 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-17 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 7e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-16 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-16 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-16 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-16 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-16 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-16 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-16 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-16 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-16 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-16 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-16 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-13 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 7e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 2e-07 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 1e-04 |
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 435 bits (1120), Expect = e-143
Identities = 133/462 (28%), Positives = 212/462 (45%), Gaps = 68/462 (14%)
Query: 616 LKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPL 675
++ LV+D +E LL L + E + ++ K + + +
Sbjct: 2 MQQLVLDPGFLGLEPLLD----LLLGVHQELGASELAQDKYVADFL-------QWAEPIV 50
Query: 676 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 735
+ R DDFEI+K I RGAF V + + + TG ++A+K++ K DM+++ ++
Sbjct: 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 736 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAE 794
ER++L+ ++ + ++F + LYLVMEY GGDL +LL K G + ++AR Y+AE
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+V+A++ +H LG VHRD+KPDN+L+ GHI+L DFG + T+
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV------------ 218
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------HGYAADWWSVGIILFEFI 907
AVGTPDYL+PEIL +G DWW++G+ +E
Sbjct: 219 --------------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 908 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965
G PF A+S + I++ K + P V + EA+D I R L P RLG GA
Sbjct: 265 YGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAG 323
Query: 966 EVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADT 1025
+ + HPFF G++WD L F P E DT F ++ G + +D
Sbjct: 324 DFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLT---AMVSGGGETLSDI 380
Query: 1026 CDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLAS 1067
+ + L + +S+ ++ S
Sbjct: 381 REGAPLGV-----------------HLPFVGYSYSCMALRDS 405
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-139
Identities = 134/423 (31%), Positives = 213/423 (50%), Gaps = 46/423 (10%)
Query: 614 SKLKALVIDTFGSRIEKLLREKYIL--ACELLDEKSPTSFSKYKENSRLILDSVSQSSGV 671
+L+ ++D + + +L L DE + + + K +
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYL-------EWA 59
Query: 672 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 731
+ R +DFEI+K I RGAFG V + + + +FA+K+L K +M+++ +
Sbjct: 60 KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119
Query: 732 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARI 790
ER++L+ + ++ Y+F +NLYLVM+Y GGDL +LL K L E++AR
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179
Query: 791 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850
Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG + + T+
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ------- 232
Query: 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFE 905
AVGTPDY++PEIL E +G DWWS+G+ ++E
Sbjct: 233 -------------------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 906 FITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963
+ G PF AES + I+N K +P +D+S A+DLI R LI RLG NG
Sbjct: 274 MLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNG 332
Query: 964 AAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRF--SQISSGLPDDQNGSYS 1021
+ K HPFF G++WD++ +A ++P+ S DTS F + S +P + ++S
Sbjct: 333 IEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFS 392
Query: 1022 DAD 1024
Sbjct: 393 GHH 395
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 409 bits (1055), Expect = e-135
Identities = 117/326 (35%), Positives = 186/326 (57%), Gaps = 40/326 (12%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
+ S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
V +PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEY
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LHS I++RDLKP+N+L+ +GHIK+TDFG +K + + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVT-------------------- 160
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
++ GTPDY+APE++ + + DWWS GI+++E + G PF +
Sbjct: 161 ---------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 979
++ ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W+
Sbjct: 212 YEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268
Query: 980 SLALQKAV---FVPQPESVD-DTSYF 1001
L L + + + P + DTS F
Sbjct: 269 KL-LSRNIETPYEPPIQQGQGDTSQF 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-134
Identities = 101/327 (30%), Positives = 172/327 (52%), Gaps = 31/327 (9%)
Query: 663 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 722
+ + + + +DF+ K + G+F V LAR+ T +AIK+L+K
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR 66
Query: 723 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 782
+I++N + + ER+++ + +PF V+ +++F + LY + Y G+L +RK+G
Sbjct: 67 HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 126
Query: 783 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842
+E R Y AE+V ALEYLH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS----- 181
Query: 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902
++ +S VGT Y++PE+L ++D W++G I
Sbjct: 182 --------------------PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 221
Query: 903 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962
+++ + G+PPF A + +IF I+ + + P +A+DL+ + L+ D +RLG
Sbjct: 222 IYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCE 278
Query: 963 ---GAAEVKAHPFFKGVNWDSLALQKA 986
G +KAHPFF+ V W++L Q
Sbjct: 279 EMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 402 bits (1036), Expect = e-132
Identities = 134/345 (38%), Positives = 198/345 (57%), Gaps = 40/345 (11%)
Query: 670 GVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR 726
G S + E+ + FE+++ + +G +G+VF RK T TG +FA+KVLKK ++R
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 727 K-NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE 785
D AERNIL V++PF+V Y+F LYL++EYL+GG+L+ L + G E
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 786 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845
D A Y+AE+ +AL +LH GI++RDLKP+N+++ H GH+KLTDFGL K +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-------- 172
Query: 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905
D H+ GT +Y+APEIL+ + H A DWWS+G ++++
Sbjct: 173 -------------------HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 906 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NG 963
+TG PPFT E+ + D IL K+ P ++ EA+DL+ + L + RLGA
Sbjct: 214 MLTGAPPFTGENRKKTIDKILKCKLNL---PPYLTQEARDLLKKLLKRNAASRLGAGPGD 270
Query: 964 AAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1005
A EV+AHPFF+ +NW+ L L + V F P +S +D S F S+F
Sbjct: 271 AGEVQAHPFFRHINWEEL-LARKVEPPFKPLLQSEEDVSQFDSKF 314
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 404 bits (1039), Expect = e-131
Identities = 127/338 (37%), Positives = 183/338 (54%), Gaps = 37/338 (10%)
Query: 672 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 731
++ R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D
Sbjct: 55 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 732 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 791
ER+I+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFY 173
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851
AE+VLAL+ +HS+G +HRD+KPDN+L+ GH+KL DFG
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------------- 216
Query: 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFI 907
+ + +AVGTPDY++PE+L +G DWWSVG+ L+E +
Sbjct: 217 ---------KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
Query: 908 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965
G PF A+S + I+N K + +P D+S EA++LI FL D RLG NG
Sbjct: 268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDN-DISKEAKNLICAFL-TDREVRLGRNGVE 325
Query: 966 EVKAHPFFKGVNWDSLALQKAV--FVPQPESVDDTSYF 1001
E+K H FFK W L+ V VP S DTS F
Sbjct: 326 EIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 363
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-131
Identities = 117/327 (35%), Positives = 185/327 (56%), Gaps = 39/327 (11%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 739
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
EYLHSL +++RDLKP+NLLI G+I++TDFG +K + T
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRT------------------ 195
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 196 -----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 977
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F +
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
Query: 978 WDSLALQKAV---FVPQPESVDDTSYF 1001
W ++ Q+ V F+P+ + DTS F
Sbjct: 302 WIAI-YQRKVEAPFIPKFKGPGDTSNF 327
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-130
Identities = 121/348 (34%), Positives = 186/348 (53%), Gaps = 36/348 (10%)
Query: 663 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 722
+ + L S DF +K I +G+FG+V LAR + +A+KVL+K
Sbjct: 15 PAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKK 74
Query: 723 DMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 781
+++K + + I++ERN+L+ V++PF+V +SF D LY V++Y+NGG+L+ L++
Sbjct: 75 AILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 134
Query: 782 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841
C E AR Y AE+ AL YLHSL IV+RDLKP+N+L+ GHI LTDFGL K +
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI---- 190
Query: 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 901
N + GTP+YLAPE+L + DWW +G
Sbjct: 191 -----------------------EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 902 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 961
+L+E + G+PPF + + ++DNILN+ + +++ A+ L+ L D +RLGA
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---KPNITNSARHLLEGLLQKDRTKRLGA 284
Query: 962 -NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1005
+ E+K+H FF +NWD L + K + F P +D +F F
Sbjct: 285 KDDFMEIKSHVFFSLINWDDL-INKKITPPFNPNVSGPNDLRHFDPEF 331
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-130
Identities = 122/337 (36%), Positives = 185/337 (54%), Gaps = 40/337 (11%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERI 733
E+ FE++K + +G+FG+VFL +K + L+A+KVLKK ++ D R
Sbjct: 15 KEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-ATLKVRDRVRT 73
Query: 734 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 793
ER+IL+ V +PF+V+ Y+F LYL++++L GGDL++ L K E+ + Y+A
Sbjct: 74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 133
Query: 794 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
EL LAL++LHSLGI++RDLKP+N+L+ +GHIKLTDFGLSK +
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI---------------- 177
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913
+ +S GT +Y+APE++ H +ADWWS G+++FE +TG PF
Sbjct: 178 -----------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 914 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHP 971
+ + IL K+ P +S EAQ L+ +P RLGA +G E+K H
Sbjct: 227 QGKDRKETMTMILKAKLGM---PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283
Query: 972 FFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1005
FF ++W+ L ++ + F P +DT YF F
Sbjct: 284 FFSTIDWNKL-YRREIHPPFKPATGRPEDTFYFDPEF 319
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-129
Identities = 127/357 (35%), Positives = 193/357 (54%), Gaps = 37/357 (10%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LHS +V+RD+K +NL++ DGHIK+TDFGL K G+
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI------------------------ 156
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 157 ---SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 979
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 980 SLALQKAV---FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDSSSNS 1032
+ +QK + F PQ S DT YF F+ S + P D+ S +
Sbjct: 271 DV-VQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQE 326
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-128
Identities = 129/374 (34%), Positives = 200/374 (53%), Gaps = 46/374 (12%)
Query: 644 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVF 703
S + + ++ + T + H E+ I++FE++K + GA+G+VF
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 704 LARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILITVRN-PFVVRFFYSFTCR 758
L RK + TG L+A+KVLKK +++K E ER +L +R PF+V Y+F
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131
Query: 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 818
L+L+++Y+NGG+L++ L + E +IY+ E+VLALE+LH LGI++RD+K +N+L
Sbjct: 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 819 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 878
+ +GH+ LTDFGLSK + + + + GT +
Sbjct: 192 LDSNGHVVLTDFGLSKEFVAD--------------------------ETERAYDFCGTIE 225
Query: 879 YLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKIPW 932
Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT + S I IL + P+
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 933 PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV--- 987
P +MS A+DLI R L+ DP +RLG A E+K H FF+ +NWD L K V
Sbjct: 286 ---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL-AAKKVPAP 341
Query: 988 FVPQPESVDDTSYF 1001
F P D S F
Sbjct: 342 FKPVIRDELDVSNF 355
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 391 bits (1007), Expect = e-127
Identities = 125/347 (36%), Positives = 195/347 (56%), Gaps = 38/347 (10%)
Query: 666 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 725
+SS + + R ID+FE I+ + +G+FG+V LAR + TGDL+A+KVLKK ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 726 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 784
+ +D+E + E+ IL RN PF+ + F F D L+ VME++NGGDL ++K +
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 785 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844
E AR Y AE++ AL +LH GI++RDLK DN+L+ H+GH KL DFG+ K G+
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI------- 175
Query: 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 904
+ + GTPDY+APEIL +G A DWW++G++L+
Sbjct: 176 --------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 905 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--- 961
E + G PF AE+ + +F+ ILN ++ + P+ + +A ++ F+ +P RLG+
Sbjct: 216 EMLCGHAPFEAENEDDLFEAILNDEVVY---PTWLHEDATGILKSFMTKNPTMRLGSLTQ 272
Query: 962 NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1005
G + HPFFK ++W L + + F P+ +S +D S F F
Sbjct: 273 GGEHAILRHPFFKEIDWAQL-NHRQIEPPFRPRIKSREDVSNFDPDF 318
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-126
Identities = 117/333 (35%), Positives = 185/333 (55%), Gaps = 37/333 (11%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
S + + I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E
Sbjct: 8 PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 737 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 795
+ +L +PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE+
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
+L L++LHS GIV+RDLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------------------ 169
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF
Sbjct: 170 ---------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
Query: 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ E +F +I + P + EA+DL+ + + +P +RLG G +++ HP F+
Sbjct: 221 QDEEELFHSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFRE 275
Query: 976 VNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1005
+NW+ L +K + F P+ +S D S F F
Sbjct: 276 INWEEL-ERKEIDPPFRPKVKSPFDCSNFDKEF 307
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-126
Identities = 106/344 (30%), Positives = 182/344 (52%), Gaps = 38/344 (11%)
Query: 668 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 727
++ VS ++ +++R + DF + + +G+FG+V L+ ++ T +L+A+K+LKK +I+
Sbjct: 2 TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 728 NDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 786
+D+E + E+ +L PF+ + F D LY VMEY+NGGDL +++VG +E
Sbjct: 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121
Query: 787 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846
A Y AE+ + L +L S GI++RDLK DN+++ +GHIK+ DFG+ K +
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--------- 172
Query: 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906
D + GTPDY+APEI+ +G + DWW+ G++L+E
Sbjct: 173 ------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 907 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGA 964
+ G PF E + +F +I+ + + P MS EA + + P +RLG G
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGE 271
Query: 965 AEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1005
++K H FF+ ++W+ L +K + + P+ + F F
Sbjct: 272 RDIKEHAFFRYIDWEKL-ERKEIQPPYKPKACG-RNAENFDRFF 313
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-124
Identities = 115/343 (33%), Positives = 181/343 (52%), Gaps = 47/343 (13%)
Query: 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 738
+ + DF++++ I RG++ +V L R + T ++A+KV+KK + DI+ + E++
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 739 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
+ N PF+V F L+ V+EY+NGGDL +++ L E+ AR Y AE+ L
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
AL YLH GI++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-------------------- 161
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT--- 914
+ GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF
Sbjct: 162 -------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 915 ------AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAA 965
+ + +F IL ++I P +S +A ++ FL DP +RLG G A
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFA 271
Query: 966 EVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 1005
+++ HPFF+ V+WD + QK V F P F S+F
Sbjct: 272 DIQGHPFFRNVDWDMM-EQKQVVPPFKPNISGEFGLDNFDSQF 313
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-123
Identities = 129/379 (34%), Positives = 198/379 (52%), Gaps = 38/379 (10%)
Query: 633 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIK 692
RE++ A + + + + + S + + L + K R ++++FE +K
Sbjct: 96 REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSL-AKPKHRVTMNEFEYLK 154
Query: 693 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 752
+ +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRD 811
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 871
LK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATMK 307
Query: 872 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 931
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 987
+ P + EA+ L++ L DP QRLG A E+ H FF G+ W + +K +
Sbjct: 368 F---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV-YEKKLSP 423
Query: 988 -FVPQPESVDDTSYFLSRF 1005
F PQ S DT YF F
Sbjct: 424 PFKPQVTSETDTRYFDEEF 442
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-122
Identities = 119/381 (31%), Positives = 193/381 (50%), Gaps = 48/381 (12%)
Query: 641 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 700
D PT+ + Y + + + + ++T + DF++++ I RG++
Sbjct: 8 HHHDYDIPTTENLYFQGA-MGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 701 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 759
+V L R + T ++A++V+KK + DI+ + E+++ N PF+V F
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 819
L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDLK DN+L+
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 820 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 879
+GHIKLTD+G+ K GL + GTP+Y
Sbjct: 187 DSEGHIKLTDYGMCKEGL---------------------------RPGDTTSTFCGTPNY 219
Query: 880 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---------AESPEIIFDNILNRKI 930
+APEIL G ++G++ DWW++G+++FE + G PF + + +F IL ++I
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKAV 987
P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD + QK V
Sbjct: 280 RIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM-EQKQV 335
Query: 988 ---FVPQPESVDDTSYFLSRF 1005
F P F S+F
Sbjct: 336 VPPFKPNISGEFGLDNFDSQF 356
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 377 bits (969), Expect = e-121
Identities = 101/413 (24%), Positives = 187/413 (45%), Gaps = 53/413 (12%)
Query: 672 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 731
S P E + D FEI++ I +G+FG+V + +K T ++A+K + K + +N++
Sbjct: 1 SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 732 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 791
+ E I+ + +PF+V +YSF +++++V++ L GGDL L++ +E+ +++
Sbjct: 61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851
I ELV+AL+YL + I+HRD+KPDN+L+ GH+ +TDF ++ +
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML--------------- 165
Query: 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFIT 908
+ GT Y+APE+ G + +A DWWS+G+ +E +
Sbjct: 166 -------------PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 909 GIPPF---TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965
G P+ ++ S + I + + PS S E L+ + L +P+QR +
Sbjct: 213 GRRPYHIRSSTSSKEIVHTFETTVVTY---PSAWSQEMVSLLKKLLEPNPDQRFS--QLS 267
Query: 966 EVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF---SQISSGLPDDQNG- 1018
+V+ P+ +NWD++ QK + F+P F I P +
Sbjct: 268 DVQNFPYMNDINWDAV-FQKRLIPGFIPNK----GRLNCDPTFELEEMILESKPLHKKKK 322
Query: 1019 --SYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1069
+ + D S+ + E D + + +N F ++
Sbjct: 323 RLAKKEKDMRKCDSSQTCLLQEHLDSVQKEFIIFNREKVNRDFNKRQPNLALE 375
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 375 bits (964), Expect = e-117
Identities = 109/371 (29%), Positives = 189/371 (50%), Gaps = 38/371 (10%)
Query: 641 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 700
+E+ F + K ++ +S ++ +++R + DF + + +G+FG
Sbjct: 296 SEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFG 355
Query: 701 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 759
+V L+ ++ T +L+A+K+LKK +I+ +D+E + E+ +L PF+ + F D
Sbjct: 356 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 819
LY VMEY+NGGDL +++VG +E A Y AE+ + L +L S GI++RDLK DN+++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 820 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 879
+GHIK+ DFG+ K + D + GTPDY
Sbjct: 476 DSEGHIKIADFGMCKENI---------------------------WDGVTTKTFCGTPDY 508
Query: 880 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDM 939
+APEI+ +G + DWW+ G++L+E + G PF E + +F +I+ + + P M
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---PKSM 565
Query: 940 SFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPES 994
S EA + + P +RLG G ++K H FF+ ++W+ L +K + + P+ S
Sbjct: 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL-ERKEIQPPYKPKA-S 623
Query: 995 VDDTSYFLSRF 1005
+ F F
Sbjct: 624 GRNAENFDRFF 634
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-115
Identities = 98/381 (25%), Positives = 170/381 (44%), Gaps = 46/381 (12%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 739
+ D F + + RG FG VF + + TG L+A K L K + ++ + + E+ I
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAEL 795
L V + F+V Y+F + +L LVM +NGGD+ Y++ +E A Y A++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
V LE+LH I++RDLKP+N+L+ DG+++++D GL+
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK------------------ 340
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915
GTP ++APE+LLG E+ ++ D++++G+ L+E I PF A
Sbjct: 341 ---------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
Query: 916 E----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKA 969
+ + +L + + + P S ++D L DP +RLG ++
Sbjct: 392 RGEKVENKELKQRVLEQAVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 970 HPFFKGVNWDSLALQK--AVFVPQPESVDDTSYF-LSRFSQI--SSGLPDDQNGSYSDAD 1024
HP F+ ++W L FVP +V + + FS + + D + +
Sbjct: 449 HPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTE-FFQEFA 507
Query: 1025 TCDSSSNSRTEMDECGDLAEF 1045
+ + EM E G +
Sbjct: 508 SGTCPIPWQEEMIETGVFGDL 528
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-113
Identities = 113/393 (28%), Positives = 175/393 (44%), Gaps = 56/393 (14%)
Query: 641 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 700
E+ F K+ E+ + + + +++DF + + I RG FG
Sbjct: 152 EICQNLRGDVFQKFIESDK--------FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFG 203
Query: 701 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC 757
V+ RK TG ++A+K L K + K L ER +L V PF+V Y+F
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263
Query: 758 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817
D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+RDLKP N+
Sbjct: 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323
Query: 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP 877
L+ GH++++D GL+ H++VGT
Sbjct: 324 LLDEHGHVRISDLGLACDFSKKKP-----------------------------HASVGTH 354
Query: 878 DYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNILNRKIPWP 933
Y+APE+L G + +ADW+S+G +LF+ + G PF I L +
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL- 413
Query: 934 CVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK--AVFV 989
P S E + L+ L D N+RLG GA EVK PFF+ ++W + LQK +
Sbjct: 414 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 471
Query: 990 PQPESVD-----DTSYFLSRFSQISSGLPDDQN 1017
P V+ D F ++ L DQ
Sbjct: 472 PPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQE 504
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 360 bits (925), Expect = e-112
Identities = 126/489 (25%), Positives = 197/489 (40%), Gaps = 64/489 (13%)
Query: 632 LREKYILACELLDEKSPTSFSKYKENSRLILDSVSQ--------SSGVSTPLHSSHKERT 683
+ + + C E+ P ++E +RL + +S S + L ER
Sbjct: 121 VPRQLVTNCTQRLEQGPCK-DLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ 179
Query: 684 --SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
+ + F + + +G FG V + R TG ++A K L+K + ++ L E+ IL
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLAL 799
V + FVV Y++ +D L LV+ +NGGDL + +G E A Y AE+ L
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
E LH IV+RDLKP+N+L+ GHI+++D GL+ TI
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----------------- 342
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 916
VGT Y+APE++ + ++ DWW++G +L+E I G PF
Sbjct: 343 -----------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391
Query: 917 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 973
E + + + S +A+ L ++ L DP +RLG A EVK HP F
Sbjct: 392 IKREEVERLVKEVPEEY---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 974 KGVNWDSLALQKAV--FVPQPESVD--DTSYFLSRFSQISSGL-PDDQNGSYSDADTCDS 1028
K +N+ L F P P+++ D + L P DQ+ Y T
Sbjct: 449 KKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTDQD-FYQKFATGSV 507
Query: 1029 SSNSRTEMDECGDLAEF------GSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTR 1082
+ EM E E GS P DL + + +
Sbjct: 508 PIPWQNEMVETECFQELNVFGLDGSVPPDLDWKGQP--PAPPKKGLLQRLFSRQDSSGNS 565
Query: 1083 SSPAKDAGT 1091
S ++ T
Sbjct: 566 SDSEEELPT 574
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-105
Identities = 95/308 (30%), Positives = 152/308 (49%), Gaps = 35/308 (11%)
Query: 678 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 737
S K + +++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 738 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
I +R+P ++R + F +YL++EY G +Y L+K+ +E YI EL
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
AL Y HS ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------- 157
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917
+ R GT DYL PE++ G H D WS+G++ +EF+ G PPF A +
Sbjct: 158 ------HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ + I + + P ++ A+DLI+R L H+P+QR EV HP+ +
Sbjct: 212 YQETYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITANS 265
Query: 978 WDSLALQK 985
Q
Sbjct: 266 SKPSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 329 bits (847), Expect = e-105
Identities = 94/302 (31%), Positives = 153/302 (50%), Gaps = 35/302 (11%)
Query: 673 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 732
T L K + +IDDF+I +P+ +G FG V+LAR++ + A+KVL K + ++ +
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 733 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 792
+ E I +R+P ++R + F R +YL++E+ G+LY L+K G +E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 793 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
EL AL Y H ++HRD+KP+NLL+ + G +K+ DFG S
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912
+ R + GT DYL PE++ G H D W G++ +EF+ G+PP
Sbjct: 163 -----------HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
Query: 913 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
F + S I+N + + P +S ++DLI++ L + P QRL V HP+
Sbjct: 212 FDSPSHTETHRRIVNVDLKF---PPFLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPW 265
Query: 973 FK 974
K
Sbjct: 266 VK 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 5e-91
Identities = 72/361 (19%), Positives = 141/361 (39%), Gaps = 76/361 (21%)
Query: 663 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 722
D +S S + ++ I+D+ II+ +++G F ++ L K +A+K +K
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKS 65
Query: 723 DMIRK--------------NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 768
+ +K + + E I+ ++N + + T D +Y++ EY+
Sbjct: 66 LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125
Query: 769 NGGDLYSLLRKVGCLE--------EDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLI 819
+ L+ V + I ++ + Y+H+ I HRD+KP N+L+
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185
Query: 820 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 879
+G +KL+DFG S+ ++ + GT ++
Sbjct: 186 DKNGRVKLSDFGESEY-----------------------------MVDKKIKGSRGTYEF 216
Query: 880 LAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAE-SPEIIFDNILNRKIPWPCVP 936
+ PE +G D WS+GI L+ + PF+ + S +F+NI + I +P
Sbjct: 217 MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276
Query: 937 SD----------------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980
+ +S E D + FL +P +R+ + + H + N +
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIED 333
Query: 981 L 981
L
Sbjct: 334 L 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 4e-90
Identities = 89/312 (28%), Positives = 146/312 (46%), Gaps = 38/312 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DFE I + +GAFG+V AR +AIK ++ + + IL+E +L ++ +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNH 61
Query: 746 PFVVRFFYSFTCRDN-------------LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 791
+VVR++ ++ R N L++ MEY G LY L+ + D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851
+++ AL Y+HS GI+HRDLKP N+ I ++K+ DFGL+K ++ ++D+ ++
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN--VHRSLDILKLDSQN 179
Query: 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 910
+ S N SA+GT Y+A E+L GT H D +S+GII FE I
Sbjct: 180 LPGSS-----------DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226
Query: 911 PPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969
P T I + + I +P + + +I + HDPN+R GA +
Sbjct: 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GARTLLN 283
Query: 970 HPFFKGVNWDSL 981
+ + D +
Sbjct: 284 SGWLPVKHQDEV 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-85
Identities = 86/336 (25%), Positives = 131/336 (38%), Gaps = 43/336 (12%)
Query: 643 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHS-SHKERTSIDDFEIIKPISRGAFGR 701
L ++ S ++ R + S + +P + S E F+ + + G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 702 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 760
VF R + G L+A+K K D R LAE V ++P VR ++
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 761 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 819
LYL E G L G L E Y+ + +LAL +LHS G+VH D+KP N+ +
Sbjct: 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190
Query: 820 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 879
G KL DFGL L G P Y
Sbjct: 191 GPRGRCKLGDFGLLVE--------LGTAGA--------------------GEVQEGDPRY 222
Query: 880 LAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFTAESPEIIFDNILNRKIPWPCVPSD 938
+APE+L G +G AAD +S+G+ + E + P E + + L P +
Sbjct: 223 MAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP-----PEFTAG 276
Query: 939 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+S E + ++ L DP R A + A P +
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAE---ALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 5e-85
Identities = 81/298 (27%), Positives = 148/298 (49%), Gaps = 34/298 (11%)
Query: 678 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 737
+ I+DF++ + +G+F V+ A TG AIK++ K M + ++R+ E
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 738 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 796
I +++P ++ + F + +YLV+E + G++ L+ +V E+ AR ++ +++
Sbjct: 63 KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
+ YLHS GI+HRDL NLL+ + +IK+ DFGL+
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA----------------------- 159
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916
+ + ++ GTP+Y++PEI + HG +D WS+G + + + G PPF +
Sbjct: 160 TQL----KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215
Query: 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ + + ++ +PS +S EA+DLI++ L +P RL + V HPF
Sbjct: 216 TVKNTLNKVVLADYE---MPSFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMS 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 6e-83
Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 33/295 (11%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 739
+ S + + + +G F + F T ++FA K++ K +++ + E++ E +I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
++ + VV F F D +++V+E L L ++ L E AR Y+ ++VL
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV----------------- 165
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
+ D + GTP+Y+APE+L H + D WS+G I++ + G PPF +
Sbjct: 166 ----EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ I + P ++ A LI + L DP R E+ FF
Sbjct: 222 ETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---TINELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 1e-82
Identities = 75/311 (24%), Positives = 133/311 (42%), Gaps = 33/311 (10%)
Query: 664 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 723
++ + + + S + + + +G F + F T ++FA K++ K
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 724 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 783
+++ + E++ E +I ++ + VV F F D +++V+E L L ++ L
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL 138
Query: 784 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843
E AR Y+ ++VL +YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV- 191
Query: 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903
+ D + GTP+Y+APE+L H + D WS+G I+
Sbjct: 192 --------------------EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
Query: 904 FEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963
+ + G PPF + + I + P ++ A LI + L DP R
Sbjct: 232 YTLLVGKPPFETSCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---T 285
Query: 964 AAEVKAHPFFK 974
E+ FF
Sbjct: 286 INELLNDEFFT 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 3e-78
Identities = 79/310 (25%), Positives = 149/310 (48%), Gaps = 37/310 (11%)
Query: 667 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 726
SSGV + + + S++ + ++ I G+FG+ L + G + IK + M
Sbjct: 7 HSSGVDLGTENLYFQ--SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 727 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLE 784
K + E E +L +++P +V++ SF +LY+VM+Y GGDL+ + +K +
Sbjct: 65 K-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 785 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844
ED + ++ LAL+++H I+HRD+K N+ + DG ++L DFG++++ +N+T++L
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVEL 181
Query: 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 904
+ + +GTP YL+PEI + +D W++G +L+
Sbjct: 182 A-------------------------RACIGTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 905 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964
E T F A S + + I++ P V S++ + L+++ +P R N
Sbjct: 217 ELCTLKHAFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPSVN-- 272
Query: 965 AEVKAHPFFK 974
+ F
Sbjct: 273 -SILEKGFIA 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-76
Identities = 80/325 (24%), Positives = 131/325 (40%), Gaps = 49/325 (15%)
Query: 666 SQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 723
SSGV + + + S+ + I+K I G +VF ++AIK + +
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-E 63
Query: 724 MIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 781
++ E L ++ + ++R + +Y+VME DL S L+K
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122
Query: 782 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841
++ + Y ++ A+ +H GIVH DLKP N LI DG +KL DFG++
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIAN------- 174
Query: 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----------EH 890
M D T + + S VGT +Y+ PE + +
Sbjct: 175 ----------QMQPD--------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 891 GYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINR 949
+D WS+G IL+ G PF +I I++ P + QD++
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKC 275
Query: 950 FLIHDPNQRLGANGAAEVKAHPFFK 974
L DP QR+ E+ AHP+ +
Sbjct: 276 CLKRDPKQRISIP---ELLAHPYVQ 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 6e-74
Identities = 83/303 (27%), Positives = 142/303 (46%), Gaps = 44/303 (14%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 742
+ +D+E++ I G++GR R+++ G + K L M + + +++E N+L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 743 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELV 796
+++P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 797 LALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851
LAL+ H ++HRDLKP N+ + ++KL DFGL++I +N+ +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA------ 173
Query: 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 911
+ VGTP Y++PE + + +D WS+G +L+E +P
Sbjct: 174 -------------------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
Query: 912 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
PFTA S + + I K +P S E ++I R L R E+ +P
Sbjct: 215 PFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILENP 269
Query: 972 FFK 974
Sbjct: 270 LIL 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 4e-73
Identities = 95/298 (31%), Positives = 146/298 (48%), Gaps = 47/298 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
F ++ + GAF VFL ++R TG LFA+K +KK R + +E E +L +++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+V + + YLVM+ ++GG+L+ + + G E A + I +++ A++YLH
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 806 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
GIVHRDLKP+NLL + I +TDFGLSK+ E +GIM
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM------------EQNGIM--------- 164
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
+A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 165 --------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216
Query: 923 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ I W + S A+D I L DPN+R + +HP+ G
Sbjct: 217 EKIKEGYYEFESPFWDDI----SESAKDFICHLLEKDPNERY---TCEKALSHPWIDG 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 6e-73
Identities = 75/302 (24%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-- 744
+ I+K I G +VF ++AIK + + ++ E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQH 67
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+ ++R + +Y+VME DL S L+K ++ + Y ++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
GIVH DLKP N LI DG +KL DFG++ M D
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIAN-----------------QMQPD-------- 160
Query: 865 TDNRNRHSAVGTPDYLAPEILLGT-----------EHGYAADWWSVGIILFEFITGIPPF 913
T + + S VGT +Y+ PE + + +D WS+G IL+ G PF
Sbjct: 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220
Query: 914 TAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+I I++ P + QD++ L DP QR+ E+ AHP+
Sbjct: 221 QQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIP---ELLAHPY 276
Query: 973 FK 974
+
Sbjct: 277 VQ 278
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-72
Identities = 82/344 (23%), Positives = 134/344 (38%), Gaps = 49/344 (14%)
Query: 647 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFL 704
S + + R +DS + SS E S+ + I+K I G +VF
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ 74
Query: 705 ARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLY 762
++AIK + + ++ E L ++ + ++R + +Y
Sbjct: 75 VLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132
Query: 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 822
+VME DL S L+K ++ + Y ++ A+ +H GIVH DLKP N LI D
Sbjct: 133 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VD 190
Query: 823 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 882
G +KL DFG++ M D T + + S VG +Y+ P
Sbjct: 191 GMLKLIDFGIAN-----------------QMQPD--------TTSVVKDSQVGAVNYMPP 225
Query: 883 EILLGT-----------EHGYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKI 930
E + + +D WS+G IL+ G PF +I I++
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
P + QD++ L DP QR+ E+ AHP+ +
Sbjct: 286 EIE-FPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 325
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 1e-72
Identities = 69/308 (22%), Positives = 130/308 (42%), Gaps = 39/308 (12%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
+ DFE I+ + RG FG VF A+ + +AIK ++ + + E+++ E L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE 61
Query: 745 NPFVVRFFYSFTCRDN------------LYLVMEYLNGGDLYSLLRK---VGCLEEDVAR 789
+P +VR+F ++ ++ LY+ M+ +L + + E V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 790 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 849
++ A+E+LHS G++HRDLKP N+ D +K+ DFGL ++
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQD-------- 171
Query: 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909
+ VGT Y++PE + G + + D +S+G+ILFE +
Sbjct: 172 -----EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225
Query: 910 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969
P T ++ R + +P + + ++ L P +R A +
Sbjct: 226 -PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI---NIIE 279
Query: 970 HPFFKGVN 977
+ F+ ++
Sbjct: 280 NAVFEDLD 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 2e-72
Identities = 82/310 (26%), Positives = 140/310 (45%), Gaps = 44/310 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D ++ + + +G+FG V L + + TG A+KV+ K + +K D E +L E +L + +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +++ + F + YLV E GG+L+ + E A I +++ + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 806 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
IVHRDLKP+NLL+ D +I++ DFGLS
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--------------------------- 178
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
++ +GT Y+APE+L G + D WS G+IL+ ++G PPF + I
Sbjct: 179 -FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 923 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ K W V S A+DLI + L + P+ R+ A + H + +
Sbjct: 237 KKVEKGKYTFELPQWKKV----SESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYT 289
Query: 978 WDSLALQKAV 987
+ +++
Sbjct: 290 KEQISVDVPS 299
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-71
Identities = 83/319 (26%), Positives = 141/319 (44%), Gaps = 50/319 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D++++ + + +GAF V +TTG FA K++ + D +++ E I +++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 806 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
GIVHR+LKP+NLL+A +KL DFGL+ ++
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE------VN------------------- 159
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
D+ H GTP YL+PE+L + D W+ G+IL+ + G PPF E ++
Sbjct: 160 ---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 216
Query: 923 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
I W V + EA+ LI+ L +P +R+ A + P+
Sbjct: 217 AQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN-- 267
Query: 978 WDSLALQKAVFVPQPESVD 996
+ A + + ++VD
Sbjct: 268 ----RERVASAIHRQDTVD 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-71
Identities = 81/356 (22%), Positives = 137/356 (38%), Gaps = 74/356 (20%)
Query: 667 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KKLD 723
S L+ + + + I +G++G V +A + T + AIK++ K+
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 724 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 783
I D+ERI E ++ + +P + R + + + LVME +GG L L
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 784 E----------------------------------------EDVARIYIAELVLALEYLH 803
E + + ++ AL YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 804 SLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
+ GI HRD+KP+N L + + IKL DFGLSK + +
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE-----------------------FYK 222
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 919
+ + GTP ++APE+L T Y D WS G++L + G PF +
Sbjct: 223 LNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282
Query: 920 IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+LN+K+ + + +S A+DL++ L + ++R A HP+
Sbjct: 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF---DAMRALQHPWIS 335
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-71
Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 45/298 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + I+ + +G+FG V + R T +A+KV+ K + D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLDH 80
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 806 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
N +GT Y+APE+L GT + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 923 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ K W + S +A+DLI + L P+ R+ A + HP+ +
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQK 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-70
Identities = 82/321 (25%), Positives = 137/321 (42%), Gaps = 45/321 (14%)
Query: 664 SVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 722
S++ + T D +++ + + +GAF V +TTG FA K++
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT- 64
Query: 723 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 782
+ D +++ E I +++P +VR S YLV + + GG+L+ +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 783 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLIN 839
E A I +++ ++ Y HS GIVHR+LKP+NLL+A +KL DFGL+
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---- 180
Query: 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 899
++ D+ H GTP YL+PE+L + D W+
Sbjct: 181 --VN----------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216
Query: 900 GIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHD 954
G+IL+ + G PPF E ++ I W V + EA+ LI+ L +
Sbjct: 217 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVN 272
Query: 955 PNQRLGANGAAEVKAHPFFKG 975
P +R+ A + P+
Sbjct: 273 PKKRI---TADQALKVPWICN 290
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 1e-70
Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 45/300 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + I+ + +G+FG V + R T +A+KV+ K K D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 806 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
N +GT Y+APE+L G + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 923 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ K W + S +A+DLI + L P+ R+ A + HP+ + +
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYS 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 2e-70
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 41/296 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D F + + GAFG V L +R++G IK + K + +E+I AE +L ++ +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLLRKVGCLEEDVARIYIAELVLALEY 801
P +++ F F N+Y+VME GG+L S + L E + +++ AL Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 802 LHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
HS +VH+DLKP+N+L IK+ DFGL+++
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL----------------------- 176
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918
+ + +A GT Y+APE+ + + D WS G++++ +TG PFT S
Sbjct: 177 -----FKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
E + ++ + ++ +A DL+ + L DP +R AA+V H +FK
Sbjct: 231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFK 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-70
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 36/300 (12%)
Query: 666 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 725
++ +F I K I RG F V+ A G A+K ++ D++
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 726 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---- 781
+ E ++L + +P V++++ SF + L +V+E + GDL +++
Sbjct: 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 782 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841
+ E Y +L ALE++HS ++HRD+KP N+ I G +KL D GL + ++
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSK 189
Query: 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 901
HS VGTP Y++PE + + + +D WS+G
Sbjct: 190 TTA-------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 224
Query: 902 ILFEFITGIPPFTAESPEI--IFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQR 958
+L+E PF + + + I P +PSD S E + L+N + DP +R
Sbjct: 225 LLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 6e-70
Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 47/298 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + I RG++G V +A ++ T A K + K + D++R E I+ ++ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P ++R + +F ++YLVME GG+L+ + E A + +++ A+ Y H L
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 806 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
+ HRDLKP+N L D +KL DFGL+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--------------------------- 158
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
+ + VGTP Y++P++L G +G D WS G++++ + G PPF+A + +
Sbjct: 159 -FKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216
Query: 923 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
I W V S +A+ LI R L P QR+ + + H +F+
Sbjct: 217 LKIREGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 3e-69
Identities = 89/342 (26%), Positives = 152/342 (44%), Gaps = 49/342 (14%)
Query: 663 DSVSQSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 721
+ Q +TP ++ + + ++ +K + GA+G V L R + T AIK+++K
Sbjct: 13 NLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK 72
Query: 722 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 781
+ + ++L E +L + +P +++ + F + N YLVME GG+L+ +
Sbjct: 73 -TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131
Query: 782 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLI 838
E A + I +++ + YLH IVHRDLKP+NLL+ D IK+ DFGLS +
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--- 188
Query: 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 898
+ + +GT Y+APE+L ++ D WS
Sbjct: 189 -------------------------FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWS 222
Query: 899 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 953
+G+ILF + G PPF ++ + I + K W V S A+DLI + L
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----SEGAKDLIKQMLQF 278
Query: 954 DPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESV 995
D +R+ A + HP+ K + + +P +
Sbjct: 279 DSQRRI---SAQQALEHPWIKE---MCSKKESGIELPSLANA 314
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 6e-69
Identities = 63/312 (20%), Positives = 122/312 (39%), Gaps = 63/312 (20%)
Query: 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
++ DF+ I+ I G FG+VF A+ R G + IK ++ N+ E+ E L
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYNN-EKAEREVKAL 58
Query: 741 ITVRNPFVVRFFYSF----------------TCRDNLYLVMEYLNGGDLYSLL--RKVGC 782
+ + +V + + + L++ ME+ + G L + R+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 783 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842
L++ +A ++ ++Y+HS +++RDLKP N+ + +K+ DFGL + N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDG 176
Query: 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902
R + GT Y++PE + ++G D +++G+I
Sbjct: 177 K--------------------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210
Query: 903 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962
L E + TA F ++ + I + + L+ + L P R +
Sbjct: 211 LAELLH--VCDTAFETSKFFTDLRDGII-----SDIFDKKEKTLLQKLLSKKPEDRPNTS 263
Query: 963 GAAEVKAHPFFK 974
E+
Sbjct: 264 ---EILRTLTVW 272
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 6e-69
Identities = 81/306 (26%), Positives = 138/306 (45%), Gaps = 48/306 (15%)
Query: 683 TSIDDF-EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERN 738
+ ++D E+ + + G F V R++ TG +A K +KK + E I E N
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 739 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 798
IL +R+P ++ F + ++ L++E ++GG+L+ L + L ED A ++ +++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 799 LEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ YLHS I H DLKP+N+++ + IKL DFG++ I +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKN-------- 170
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914
GTP+++APEI+ G AD WS+G+I + ++G PF
Sbjct: 171 ------------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212
Query: 915 AESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969
E+ + NI + S A+D I R L+ DP +R+ A+
Sbjct: 213 GETKQETLTNISAVNYDFDEEYFSNT----SELAKDFIRRLLVKDPKRRM---TIAQSLE 265
Query: 970 HPFFKG 975
H + K
Sbjct: 266 HSWIKA 271
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 7e-69
Identities = 77/320 (24%), Positives = 138/320 (43%), Gaps = 54/320 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----------KNDIERILA 735
+ + ++ + GA+G V L +++ AIKV+KK + + E I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 736 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 795
E ++L ++ +P +++ F F + YLV E+ GG+L+ + +E A + ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
+ + YLH IVHRD+KP+N+L+ + +IK+ DFGLS
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF----------------- 198
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912
+ + +GT Y+APE+L ++ D WS G+I++ + G PP
Sbjct: 199 -----------FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 913 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967
F ++ + I + K W + S EA++LI L +D N+R A E
Sbjct: 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNI----SDEAKELIKLMLTYDYNKRC---TAEEA 299
Query: 968 KAHPFFKGVNWDSLALQKAV 987
+ K + +
Sbjct: 300 LNSRWIKKYANNINKSDQKT 319
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 7e-69
Identities = 85/326 (26%), Positives = 137/326 (42%), Gaps = 49/326 (15%)
Query: 664 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 723
S S G L + + D +E+ + I +G F V R TG FA+K++
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 724 MIRKN--DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLL 777
E + E +I +++P +V +++ LY+V E+++G DL
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 778 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSK 834
E VA Y+ +++ AL Y H I+HRD+KP +L+A +KL FG++
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 894
+ SG G VGTP ++APE++ +G
Sbjct: 182 Q------LGESGLVAGGR---------------------VGTPHFMAPEVVKREPYGKPV 214
Query: 895 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINR 949
D W G+ILF ++G PF +F+ I+ K W + S A+DL+ R
Sbjct: 215 DVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI----SESAKDLVRR 269
Query: 950 FLIHDPNQRLGANGAAEVKAHPFFKG 975
L+ DP +R+ E HP+ K
Sbjct: 270 MLMLDPAERI---TVYEALNHPWLKE 292
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 8e-69
Identities = 85/299 (28%), Positives = 145/299 (48%), Gaps = 36/299 (12%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
S E+ I ++ ++K I +G F +V LAR TG AIK++ K + ++++ E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFRE 64
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
I+ + +P +V+ F LYL+MEY +GG+++ L G ++E AR ++V
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
A++Y H IVHRDLK +NLL+ D +IK+ DFG S
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---------------------- 162
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 915
+ T + G P Y APE+ G + G D WS+G+IL+ ++G PF
Sbjct: 163 ------EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
Query: 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
++ + + + +L K +P MS + ++L+ RFL+ +P +R ++ +
Sbjct: 217 QNLKELRERVLRGKYR---IPFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWIN 269
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-68
Identities = 77/298 (25%), Positives = 136/298 (45%), Gaps = 43/298 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+++++ + + +GAF V K G +A ++ + D +++ E I +++
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +VR S + + YL+ + + GG+L+ + E A I +++ A+ + H +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 806 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
G+VHR+LKP+NLL+A +KL DFGL+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAI---------------------------E 162
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
+ + + GTP YL+PE+L +G D W+ G+IL+ + G PPF E ++
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 923 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
I W V + EA+DLIN+ L +P++R+ AAE HP+
Sbjct: 223 QQIKAGAYDFPSPEWDTV----TPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-68
Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 47/316 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 742
D ++I + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 802
V + V+ + R ++ L++E ++GG+L+ L + L E+ A +I +++ + YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 803 HSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
H+ I H DLKP+N+++ HIKL DFGL+ I
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE----------------IEDGVEF 175
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 176 K------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223
Query: 919 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ NI + + S A+D I + L+ + +RL E HP+
Sbjct: 224 QETLANITSVSYDFDEEFFSHT----SELAKDFIRKLLVKETRKRL---TIQEALRHPWI 276
Query: 974 KGVNWDSLALQKAVFV 989
V+ +++ V
Sbjct: 277 TPVDNQQAMVRRESVV 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-68
Identities = 69/337 (20%), Positives = 121/337 (35%), Gaps = 76/337 (22%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 739
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEV 60
Query: 740 LITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAE 794
L + + +V+ F T + L+ME+ G LY++L + L E I + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETD 850
+V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------------- 165
Query: 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGII 902
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 -------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 903 LFEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVP 936
+ TG PF ++ + I +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 937 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ ++ L D + G + + A
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGFD---QFFAETSD 306
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-68
Identities = 81/314 (25%), Positives = 131/314 (41%), Gaps = 53/314 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDI----ERILAERNI 739
+++E + + RG V + T +A+K++ ++ E L E +I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 740 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 798
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ----------------------- 173
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 912
GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 174 -----LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 913 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967
F ++ I++ W S +DL++RFL+ P +R A E
Sbjct: 229 FWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKDLVSRFLVVQPQKRY---TAEEA 281
Query: 968 KAHPFFKGVNWDSL 981
AHPFF+ + +
Sbjct: 282 LAHPFFQQYVVEEV 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 3e-68
Identities = 79/316 (25%), Positives = 140/316 (44%), Gaps = 47/316 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 742
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 802
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 803 HSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
HSL I H DLKP+N+++ IK+ DFGL+ I +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK----------------IDFGNEF 174
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 175 ------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222
Query: 919 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ N+ + S A+D I R L+ DP +R+ + HP+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNT----SALAKDFIRRLLVKDPKKRM---TIQDSLQHPWI 275
Query: 974 KGVNWDSLALQKAVFV 989
K + +KA V
Sbjct: 276 KPKDTQQALSRKASAV 291
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 4e-68
Identities = 87/303 (28%), Positives = 145/303 (47%), Gaps = 45/303 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 740
D++ + K + GA G V LA +R T AI+++ K + + E IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 800
+ +P +++ F ++ Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 195 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 801 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 291
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFT 914
+ + GTP YLAPE+L+ A D WS+G+ILF ++G PPF+
Sbjct: 292 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 915 AES-PEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ D I + K + +++S +A DL+ + L+ DP R E HP+
Sbjct: 346 EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPW 402
Query: 973 FKG 975
+
Sbjct: 403 LQD 405
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 5e-68
Identities = 92/326 (28%), Positives = 146/326 (44%), Gaps = 60/326 (18%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--------- 727
S + ++ + + I +G++G V LA +A+KVL K +IR+
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 728 --------------NDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGG 771
IE++ E IL + +P VV+ D+LY+V E +N G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 772 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831
+ + L ED AR Y +L+ +EYLH I+HRD+KP NLL+ DGHIK+ DFG
Sbjct: 124 PVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 891
+S + + + VGTP ++APE L T
Sbjct: 183 VSNE---------------------------FKGSDALLSNTVGTPAFMAPESLSETRKI 215
Query: 892 Y---AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLIN 948
+ A D W++G+ L+ F+ G PF E + I ++ + +P P D++ + +DLI
Sbjct: 216 FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-DIAEDLKDLIT 274
Query: 949 RFLIHDPNQRLGANGAAEVKAHPFFK 974
R L +P R+ E+K HP+
Sbjct: 275 RMLDKNPESRI---VVPEIKLHPWVT 297
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 6e-68
Identities = 91/316 (28%), Positives = 144/316 (45%), Gaps = 53/316 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 740
D++ + K + GA G V LA +R T AIK++ K + + E IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 800
+ +P +++ F D Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 801 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 166
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFT 914
+ + GTP YLAPE+L+ + A D WS+G+ILF ++G PPF+
Sbjct: 167 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220
Query: 915 AES-PEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968
+ D I + K W V S +A DL+ + L+ DP R E
Sbjct: 221 EHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVDPKARF---TTEEAL 273
Query: 969 AHPFFKGVNWDSLALQ 984
HP+ + +
Sbjct: 274 RHPWLQDEDMKRKFQD 289
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-67
Identities = 95/301 (31%), Positives = 143/301 (47%), Gaps = 49/301 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D FE+ + RGA V+ +++ T +A+KVLKK D + + E +L+ + +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSH 107
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +++ F + LV+E + GG+L+ + + G E A + +++ A+ YLH
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 806 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
GIVHRDLKP+NLL A D +K+ DFGLSKI E +M
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-----------EHQVLM--------- 207
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-II 921
+ GTP Y APEIL G +G D WSVGII + + G PF E + +
Sbjct: 208 --------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
Query: 922 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
F ILN + W V S A+DL+ + ++ DP +RL + HP+ G
Sbjct: 260 FRRILNCEYYFISPWWDEV----SLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTGK 312
Query: 977 N 977
Sbjct: 313 A 313
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 1e-67
Identities = 79/299 (26%), Positives = 139/299 (46%), Gaps = 35/299 (11%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
S H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
L R+P +++ + + + ++VMEY++GG+L+ + K G +EE AR +++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
A++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 160
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 915
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 161 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
Query: 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
E +F I +P ++ L+ L DP +R +++ H +FK
Sbjct: 214 EHVPTLFKKIRGGVFY---IPEYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFK 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-67
Identities = 70/298 (23%), Positives = 131/298 (43%), Gaps = 47/298 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHS 804
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 805 LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
I H D++P+N++ IK+ +FG ++ + P D
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----------------LKPGDNF---- 160
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 923 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+NI+N + + + S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-67
Identities = 81/324 (25%), Positives = 143/324 (44%), Gaps = 47/324 (14%)
Query: 678 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERIL 734
+ K++ D ++I + + G F V R+++TG +A K +KK E I
Sbjct: 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 735 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 794
E +IL V +P ++ + R ++ L++E ++GG+L+ L + L E+ A +I +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETD 850
++ + YLH+ I H DLKP+N+++ HIKL DFGL+
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------------- 168
Query: 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910
I + GTP+++APEI+ G AD WS+G+I + ++G
Sbjct: 169 -IEDGVEFK------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 911 PPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965
PF ++ + NI + S A+D I + L+ + +RL
Sbjct: 216 SPFLGDTKQETLANITAVSYDFDEEFFSQT----SELAKDFIRKLLVKETRKRL---TIQ 268
Query: 966 EVKAHPFFKGVNWDSLALQKAVFV 989
E HP+ V+ +++ V
Sbjct: 269 EALRHPWITPVDTQQAMVRRESVV 292
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 9e-67
Identities = 88/347 (25%), Positives = 136/347 (39%), Gaps = 52/347 (14%)
Query: 645 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFL 704
+ + + QS G L + ++ I RG V
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 705 ARKRTTGDLFAIKVLKKLDMIRKND-----IERILAERNILITVRN-PFVVRFFYSFTCR 758
R TG FA+K+++ + E E +IL V P ++ S+
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 818
++LV + + G+L+ L + L E R + L+ A+ +LH+ IVHRDLKP+N+L
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 819 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 878
+ + I+L+DFG S + P + GTP
Sbjct: 233 LDDNMQIRLSDFGFSCH----------------LEPGEKLR------------ELCGTPG 264
Query: 879 YLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-- 930
YLAPEIL + +G D W+ G+ILF + G PPF ++ I+ +
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324
Query: 931 ---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
W S +DLI+R L DP RL A + HPFF+
Sbjct: 325 SSPEWDDR----SSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-66
Identities = 45/352 (12%), Positives = 100/352 (28%), Gaps = 87/352 (24%)
Query: 669 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 728
+G + S ER + + A + TG+ F + V + N
Sbjct: 58 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115
Query: 729 DIE-------------------------RILAERNILITVRNPFVVRFFYSFTCRD--NL 761
I+ R + +++ + ++R +
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 762 YLVMEYLN------GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 815
+ + + G L S L +++ L LH G+VH L+P
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 816 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 875
++++ G + LT F + R +
Sbjct: 236 DIVLDQRGGVFLTGFEHLV-------------------------------RDGARVVSSV 264
Query: 876 TPDYLAPEILL-----------GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
+ + PE+ T ++ D W++G++++ P T ++ +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW 324
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
I ++ + L+ FL + RL + P ++ +
Sbjct: 325 IFRS-------CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQL 366
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-66
Identities = 84/323 (26%), Positives = 139/323 (43%), Gaps = 55/323 (17%)
Query: 667 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 725
Q+ GV + + H+ D +E+ + I G++ + T FA+K++ K
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---- 57
Query: 726 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 784
K D E IL+ P ++ + +Y+V E + GG+L + +
Sbjct: 58 SKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114
Query: 785 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINN 840
E A + + +EYLH+ G+VHRDLKP N+L + I++ DFG +K
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---- 170
Query: 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 900
+ +N + T +++APE+L + A D WS+G
Sbjct: 171 -----------------------RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 901 IILFEFITGIPPFTA---ESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLI 952
++L+ +TG PF ++PE I I + K W V S A+DL+++ L
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDLVSKMLH 263
Query: 953 HDPNQRLGANGAAEVKAHPFFKG 975
DP+QRL AA V HP+
Sbjct: 264 VDPHQRL---TAALVLRHPWIVH 283
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-66
Identities = 82/328 (25%), Positives = 134/328 (40%), Gaps = 48/328 (14%)
Query: 666 SQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 724
S + T + + + K + RG F V ++TG +A K LKK
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK-RR 66
Query: 725 IRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVG 781
++ IL E +L + P V+ + + L++EY GG+++SL
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 782 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLI 838
+ E+ I +++ + YLH IVH DLKP N+L++ G IK+ DFG+S+
Sbjct: 127 MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--- 183
Query: 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 898
I +GTP+YLAPEIL A D W+
Sbjct: 184 ---IG----------------------HACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 899 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 953
+GII + +T PF E + + NI + + V S A D I L+
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV----SQLATDFIQSLLVK 274
Query: 954 DPNQRLGANGAAEVKAHPFFKGVNWDSL 981
+P +R A +H + + ++++L
Sbjct: 275 NPEKRP---TAEICLSHSWLQQWDFENL 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 1e-65
Identities = 68/325 (20%), Positives = 119/325 (36%), Gaps = 73/325 (22%)
Query: 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 741 ITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAEL 795
+ + +V+ F T + L+ME+ G LY++L + L E I + ++
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851
V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---------------- 165
Query: 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGIIL 903
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 ------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 904 FEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVPS 937
+ TG PF ++ + I +
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 938 DMSFEAQDLINRFLIHDPNQRLGAN 962
+ ++ L D + G +
Sbjct: 274 GLQVLLTPVLANILEADQEKCWGFD 298
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-65
Identities = 82/334 (24%), Positives = 135/334 (40%), Gaps = 56/334 (16%)
Query: 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 750
KP+ G+F + + FA+K+ I K E L P +V+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 810
F + + +LVME LNGG+L+ ++K E A + +LV A+ ++H +G+VHR
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 811 DLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
DLKP+NLL + IK+ DFG +++ + DN
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL---------------------------KPPDN 163
Query: 868 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEI 920
+ + T Y APE+L + + D WS+G+IL+ ++G PF + S
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223
Query: 921 IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
I I W V S EA+DLI L DPN+RL + ++ + + +
Sbjct: 224 IMKKIKKGDFSFEGEAWKNV----SQEAKDLIQGLLTVDPNKRL---KMSGLRYNEWLQD 276
Query: 976 VNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 1009
+ S + + + F +
Sbjct: 277 GSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFN 310
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 4e-65
Identities = 74/295 (25%), Positives = 136/295 (46%), Gaps = 39/295 (13%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 922
+ GT Y+APE+L E H D WS GI+L + G P+ +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 923 DNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ +K PW + L+++ L+ +P+ R+ ++K ++
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 5e-65
Identities = 71/340 (20%), Positives = 138/340 (40%), Gaps = 47/340 (13%)
Query: 645 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVF 703
KY D + ++ S+ D ++I++ + GAFG V
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 704 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763
++ TG +F K + + K ++ E +I+ + +P ++ +F + + L
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINLHDAFEDKYEMVL 125
Query: 764 VMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH- 821
++E+L+GG+L+ + + + E Y+ + L+++H IVH D+KP+N++
Sbjct: 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185
Query: 822 -DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 880
+K+ DFGL+ + P + T ++
Sbjct: 186 KASSVKIIDFGLATK----------------LNPDEIV------------KVTTATAEFA 217
Query: 881 APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCV 935
APEI+ G+ D W++G++ + ++G+ PF E N+ + V
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 936 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
S EA+D I L +P +RL + HP+ KG
Sbjct: 278 ----SPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKG 310
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-64
Identities = 83/339 (24%), Positives = 133/339 (39%), Gaps = 52/339 (15%)
Query: 668 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDM 724
G TP ++ + + +G FG VF + T AIKV+ + L
Sbjct: 13 PPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW 72
Query: 725 IRKNDIERILAERNILITVRN----PFVVRFFYSFTCRDNLYLVMEY-LNGGDLYSLLRK 779
+D E +L V P V+R F ++ LV+E L DL+ + +
Sbjct: 73 SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE 132
Query: 780 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 838
G L E +R + ++V A+++ HS G+VHRD+K +N+LI G KL DFG +
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--- 189
Query: 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 897
D Y GT Y PE + + H A W
Sbjct: 190 ---------------LHDEPY-----------TDFDGTRVYSPPEWISRHQYHALPATVW 223
Query: 898 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 957
S+GI+L++ + G PF + IL ++ P+ +S + LI R L P+
Sbjct: 224 SLGILLYDMVCGDIPFERD------QEILEAELH---FPAHVSPDCCALIRRCLAPKPSS 274
Query: 958 RLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 996
R E+ P+ + + + L + P P +
Sbjct: 275 RP---SLEEILLDPWMQ-TPAEDVPLNPSKGGPAPLAWS 309
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-64
Identities = 77/339 (22%), Positives = 136/339 (40%), Gaps = 48/339 (14%)
Query: 664 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-- 721
++ + + E + + P+ GAFG V+ A + +K +KK
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 722 ---LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME-YLNGGDLYSLL 777
I + ++ E IL V + +++ F + LVME + +G DL++ +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 778 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837
+ L+E +A +LV A+ YL I+HRD+K +N++IA D IKL DFG +
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-- 179
Query: 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADW 896
+ ++ GT +Y APE+L+G G +
Sbjct: 180 --------------------------LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 897 WSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPN 956
WS+G+ L+ + PF + + I P +S E L++ L P
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIH---PPYLVSKELMSLVSGLLQPVPE 264
Query: 957 QRLGANGAAEVKAHPFF-KGVNWDSLALQKAVFVPQPES 994
+R ++ P+ + VN ++ V +PES
Sbjct: 265 RRT---TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-64
Identities = 75/343 (21%), Positives = 140/343 (40%), Gaps = 47/343 (13%)
Query: 644 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRV 702
D + K D+ + + D ++I + + GAFG V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 703 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762
+R TG+ FA K + ++D E + E + +R+P +V +F + +
Sbjct: 174 HRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 763 LVMEYLNGGDLYS-LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 821
++ E+++GG+L+ + + + ED A Y+ ++ L ++H VH DLKP+N++
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 822 --DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 879
+KL DFGL+ ++ GT ++
Sbjct: 291 KRSNELKLIDFGLTA----------------------------HLDPKQSVKVTTGTAEF 322
Query: 880 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPC 934
APE+ G GY D WSVG++ + ++G+ PF E+ + N+ + +
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382
Query: 935 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ S + +D I + L+ DPN R+ + HP+ N
Sbjct: 383 I----SEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGN 418
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-64
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 36/300 (12%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
++ R + + RG+FG V + + TG A+K ++ L++ R ++
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEELV----- 102
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
+ +P +V + + + + ME L GG L L++++GCL ED A Y+ + +
Sbjct: 103 --ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
LEYLH+ I+H D+K DN+L++ DG L DFG + L +
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC--------LQPDGLGKSLL- 211
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915
GT ++APE+++G D WS ++ + G P+T
Sbjct: 212 -------------TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258
Query: 916 ESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ I + P +P + I L +P R A E++
Sbjct: 259 YFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA---SAMELRRKVGKA 314
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 9e-64
Identities = 81/348 (23%), Positives = 150/348 (43%), Gaps = 42/348 (12%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF--TAESPEII 921
+ GT Y+APE+L E H D WS GI+L + G P+ ++S +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 922 FDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF-KGVNW 978
D PW + L+++ L+ +P+ R+ ++K ++ K +
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKPLKK 271
Query: 979 DSL--ALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 1024
+ + P FS ++S +G +
Sbjct: 272 GAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHH 319
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-63
Identities = 69/302 (22%), Positives = 138/302 (45%), Gaps = 46/302 (15%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+ + G FG+V + TG A K++K D E + E +++ + +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT---RGMKDKEEVKNEISVMNQLDHA 146
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+++ + +F ++++ LVMEY++GG+L+ ++ + L E +++ ++ + ++H +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 806 GIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
I+H DLKP+N+L + IK+ DFGL++
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARR---------------------------- 238
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923
GTP++LAPE++ + D WSVG+I + ++G+ PF ++ +
Sbjct: 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
Query: 924 NILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978
NIL + + + S EA++ I++ LI + + R+ A+E HP+
Sbjct: 299 NILACRWDLEDEEFQDI----SEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKL 351
Query: 979 DS 980
S
Sbjct: 352 HS 353
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-63
Identities = 77/320 (24%), Positives = 133/320 (41%), Gaps = 49/320 (15%)
Query: 666 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---L 722
+ +T L ++ +++ + G FG V+ + + AIK ++K
Sbjct: 23 PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 82
Query: 723 DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEYLNG-GDLYSLLRK 779
D + R+ E +L V + V+R F D+ L++E DL+ + +
Sbjct: 83 DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 142
Query: 780 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 838
G L+E++AR + +++ A+ + H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--- 199
Query: 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 897
D Y GT Y PE + HG +A W
Sbjct: 200 ---------------LKDTVY-----------TDFDGTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 898 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 957
S+GI+L++ + G PF E E I + +S E Q LI L P+
Sbjct: 234 SLGILLYDMVCGDIPF--EHDEEIIRGQVF-------FRQRVSSECQHLIRWCLALRPSD 284
Query: 958 RLGANGAAEVKAHPFFKGVN 977
R E++ HP+ + V
Sbjct: 285 RP---TFEEIQNHPWMQDVL 301
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-63
Identities = 83/296 (28%), Positives = 143/296 (48%), Gaps = 36/296 (12%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 739
+ I + I + + G+FG+V LA T A+K + + + + + R+ E +
Sbjct: 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
L +R+P +++ + T ++ +V+EY GG+L+ + + + ED R + +++ A+
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
EY H IVHRDLKP+NLL+ + ++K+ DFGLS I
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI------------------------ 157
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 918
TD ++ G+P+Y APE++ G G D WS GI+L+ + G PF E
Sbjct: 158 ----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213
Query: 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+F + + +P +S AQ LI R ++ DP QR+ E++ P+F
Sbjct: 214 PNLFKKVNSCVYV---MPDFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFN 263
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-63
Identities = 68/300 (22%), Positives = 117/300 (39%), Gaps = 37/300 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 744
+F ++ I G FG VF KR G ++AIK KK D + L E + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQ 69
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 800
+ VVR+F ++ D++ + EY NGG L + R + +E + + ++ L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPS 855
Y+HS+ +VH D+KP N+ I+ + +N + DL G +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL------GHV-- 181
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 914
T + G +LA E+L H AD +++ + + P
Sbjct: 182 ---------TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
Query: 915 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ I R+ P +P +S E +L+ + DP +R A + H
Sbjct: 233 NGDQ---WHEI--RQGRLPRIPQVLSQEFTELLKVMIHPDPERRP---SAMALVKHSVLL 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-63
Identities = 103/394 (26%), Positives = 165/394 (41%), Gaps = 52/394 (13%)
Query: 665 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 724
+ ++ + PL D ++ +K I G FG L R + T +L A+K +++
Sbjct: 1 MDRAPVTTGPLDMPIMHD--SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA 58
Query: 725 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 784
I +N ++R E ++R+P +VRF +L ++MEY +GG+LY + G
Sbjct: 59 IDEN-VQR---EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS 114
Query: 785 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTI 842
ED AR + +L+ + Y HS+ I HRDLK +N L+ + +K+ DFG SK
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS------- 167
Query: 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGI 901
P S VGTP Y+APE+LL E G AD WS G+
Sbjct: 168 -----SVLHSQP----------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 902 ILFEFITGIPPFTAESPEIIFDNILNR------KIPWPCVPSDMSFEAQDLINRFLIHDP 955
L+ + G PF + + R IP +S E LI+R + DP
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADP 263
Query: 956 NQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS--GLP 1013
R+ E+K H +F N + + ++ Q + + L QI S +P
Sbjct: 264 ATRI---SIPEIKTHSWFL-KNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319
Query: 1014 DDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGS 1047
+N D T + + + + + S
Sbjct: 320 AVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDS 353
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-63
Identities = 63/378 (16%), Positives = 105/378 (27%), Gaps = 77/378 (20%)
Query: 641 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID----DFEIIKPISR 696
+LL + +E + V + P ++ + + ++++P+
Sbjct: 13 DLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRV 72
Query: 697 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF---- 752
G VFL R + FA+KV ++++ER+ +
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 753 ----------------------YSFTCRDNLYLVMEYLNG--GDLYSLLRKV----GCLE 784
N L+M + L+S L V G
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 785 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844
I A+L+ L S G+VH PDNL I DG + L D
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---------- 242
Query: 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGII 902
++ Y E L +A + W +G+
Sbjct: 243 --------------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 903 LFEFITGIPPFTAESPEIIFDNILN-----RKIPWP-CVPSDMSFEAQDLINRFLIHDPN 956
++ PF +P I + + + LI RFL D
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342
Query: 957 QRLGANGAAEVKAHPFFK 974
+RL E P F
Sbjct: 343 RRL---LPLEAMETPEFL 357
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-62
Identities = 75/299 (25%), Positives = 138/299 (46%), Gaps = 35/299 (11%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
L R+P +++ + + ++++VMEY++GG+L+ + K G L+E +R +++
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 165
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 915
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 166 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
Query: 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ +F I + P ++ L+ L DP +R +++ H +FK
Sbjct: 219 DHVPTLFKKICDGIFY---TPQYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFK 271
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-62
Identities = 82/320 (25%), Positives = 139/320 (43%), Gaps = 60/320 (18%)
Query: 686 DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
D +++ + + GA RV T +A+K+++K ++ + R E +L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQ 68
Query: 745 N-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803
V+ F D YLV E + GG + S + K E A + + ++ AL++LH
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 804 SLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
+ GI HRDLKP+N+L H +K+ DF L I L+G +
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG------IKLNGDCSP---------- 172
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTA 915
+ G+ +Y+APE++ + + D WS+G+IL+ ++G PPF
Sbjct: 173 ----ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 916 E---------------SPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDP 955
++F++I K W + S A+DLI++ L+ D
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SCAAKDLISKLLVRDA 284
Query: 956 NQRLGANGAAEVKAHPFFKG 975
QRL AA+V HP+ +G
Sbjct: 285 KQRL---SAAQVLQHPWVQG 301
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 224 bits (571), Expect = 4e-62
Identities = 77/335 (22%), Positives = 124/335 (37%), Gaps = 66/335 (19%)
Query: 676 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 735
S + +E+ + + G FG V + TG+ AIK ++ ++ KN ER
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKN-RERWCL 61
Query: 736 ERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEED 786
E I+ + +P VV D L MEY GGDL L + L+E
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 787 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTID 843
R ++++ AL YLH I+HRDLKP+N+++ K+ D G +K
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-------- 173
Query: 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903
VGT YLAPE+L ++ D+WS G +
Sbjct: 174 --------------------LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
Query: 904 FEFITGIPPFTAESPEIIFDNILNRK--------------------IPWPC-VPSDMSFE 942
FE ITG PF + + + K +P P + ++ +
Sbjct: 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK 273
Query: 943 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ + L+ QR + F+ ++
Sbjct: 274 LERWLQCMLMWHQRQR---GTDPQNPNVGCFQALD 305
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-62
Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 39/297 (13%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE-RILAERNILITV 743
I + + + G++G+V T A+K+LKK + R + E + E +L +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 744 RNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLAL 799
R+ V++ + +Y+VMEY G + +L V A Y +L+ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
EYLHS GIVH+D+KP NLL+ G +K++ G++ +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA------EALH---------------- 160
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 917
+ ++ G+P + PEI G + G+ D WS G+ L+ TG+ PF ++
Sbjct: 161 ---PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
Query: 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+F+NI +P D DL+ L ++P +R +++ H +F+
Sbjct: 218 IYKLFENIGKGSYA---IPGDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 216 bits (550), Expect = 8e-62
Identities = 50/368 (13%), Positives = 102/368 (27%), Gaps = 76/368 (20%)
Query: 669 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 728
+G + S ER + + A + TG+ F + V + N
Sbjct: 63 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 120
Query: 729 DIERILAERNI---LITVRNP------------------------FVVRFFYSFTCRDNL 761
I+++ E L ++N VR +
Sbjct: 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180
Query: 762 YLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 815
+ + + L S L +++ L LH G+VH L+P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 816 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 875
++++ G + LT F + P
Sbjct: 241 DIVLDQRGGVFLTGFEHLVR-----------DGASAVSPI---------------GRGFA 274
Query: 876 TPDYLAPEILLGTEHG-----YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 930
P+ A +L +H +A D W++G+ ++ P T ++ + I
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-- 332
Query: 931 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVP 990
++ + L+ FL + RL + P ++ + + A
Sbjct: 333 -----CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLRTELSAALPLYQTD 384
Query: 991 QPESVDDT 998
+ +
Sbjct: 385 GEPTREGG 392
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-61
Identities = 57/299 (19%), Positives = 103/299 (34%), Gaps = 37/299 (12%)
Query: 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+ I+ + G F V L G +A+K + + D E E ++ +P
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHP 86
Query: 747 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLA 798
++R +L++ + G L++ + ++ L ED + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
LE +H+ G HRDLKP N+L+ +G L D G + +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ---------------ACIHVEGS 191
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFTA 915
D + T Y APE+ H D WS+G +L+ + G P+
Sbjct: 192 RQALTLQDWAAQR---CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 916 ESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ + ++ P S L+N + DP+QR + +
Sbjct: 249 VFQKGDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIP---LLLSQLEA 303
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 6e-61
Identities = 83/330 (25%), Positives = 136/330 (41%), Gaps = 67/330 (20%)
Query: 668 SSGVSTPLHSSHKERTSI-DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 725
SSG+ ++ ++ DD+++ K + G G+V R TG A+K+L
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68
Query: 726 RKNDIERILAERNILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLR 778
R+ E + P +V + + L ++ME + GG+L+S R
Sbjct: 69 RQ--------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 779 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKI 835
E A + ++ A+++LHS I HRD+KP+NLL D +KLTDFG +K
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 895
T + TP Y+APE+L ++ + D
Sbjct: 181 -----------------------------TTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 896 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI----------PWPCVPSDMSFEAQD 945
WS+G+I++ + G PPF + + + I + R+I W V S +A+
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMK-RRIRLGQYGFPNPEWSEV----SEDAKQ 266
Query: 946 LINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
LI L DP +RL + HP+
Sbjct: 267 LIRLLLKTDPTERL---TITQFMNHPWINQ 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 8e-60
Identities = 86/289 (29%), Positives = 134/289 (46%), Gaps = 43/289 (14%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
+ +G +G V+ R + AIK + + D + + E + +++ +V++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 754 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 810
SF+ + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 811 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 869
D+K DN+LI + G +K++DFG SK L+G N
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKR--------LAG-------------------INPC 179
Query: 870 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFT--AESPEIIFDNI 925
+ GT Y+APEI+ GY AAD WS+G + E TG PPF E +F +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KV 238
Query: 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
K+ P +P MS EA+ I + DP++R A ++ F K
Sbjct: 239 GMFKVH-PEIPESMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLK 283
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-59
Identities = 47/336 (13%), Positives = 94/336 (27%), Gaps = 76/336 (22%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
+ + GAF +V+ A + F +KV K + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERL 121
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----CLEEDVARIYIAEL 795
++F+ + ++ LV E + G L + + + + + + +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAH-----------DGHIKLTDFGLSKIGLINNTIDL 844
+ +E +H I+H D+KPDN ++ + + L D G S ID+
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--------IDM 233
Query: 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 904
I + T + E+L Y D++ V ++
Sbjct: 234 KLFPKGTIF-----------------TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVY 276
Query: 905 EFITGIPPFTAESPEI------------------IFDNILNRKIPWPCVPSDMSFEAQDL 946
+ G F +LN +P + DL
Sbjct: 277 CMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN-------IPDCHHLPSLDL 329
Query: 947 INRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 982
+ + L Q + + +
Sbjct: 330 LRQKLKKVFQQHYTNKI--RALRNRLIVLLLECKRS 363
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-58
Identities = 84/349 (24%), Positives = 138/349 (39%), Gaps = 63/349 (18%)
Query: 647 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLA 705
P + + ++ Q K+ IDD+++ + + G G+V
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 706 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRF--FY--SFTCRDN 760
+ T + FA+K+L+ R+ E + P +VR Y + R
Sbjct: 82 FNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 761 LYLVMEYLNGGDLYS--LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 818
L +VME L+GG+L+S R E A + + A++YLHS+ I HRD+KP+NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 819 IAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 875
+ +KLTDFG +K + + +
Sbjct: 194 YTSKRPNAILKLTDFGFAKE-----------TTSHNSL-----------------TTPCY 225
Query: 876 TPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----IFDNILNRKI- 930
TP Y+APE+L ++ + D WS+G+I++ + G PPF + + I +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
Query: 931 ----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
W V S E + LI L +P QR+ E HP+
Sbjct: 286 FPNPEWSEV----SEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 327
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-57
Identities = 59/288 (20%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753
I RG+F V+ T A L+ + K++ +R E +L +++P +VRF+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 754 SFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--I 807
S+ + + LV E + G L + L++ ++ V R + +++ L++LH+ I
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 808 VHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
+HRDLK DN+ I G +K+ D GL+
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLAT-----------------------------LKR 183
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
+ +GTP+++APE + ++ + D ++ G+ + E T P++ +
Sbjct: 184 ASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ E +++I + + ++R ++ H FF+
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 4e-57
Identities = 66/349 (18%), Positives = 123/349 (35%), Gaps = 80/349 (22%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFA-------------------IKVLKKLD--- 723
DFE I+ + RG FG VF A+ + +A +K L KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 724 ---------------------------------MIRKNDIERILAERNILITVRNPFVVR 750
+ + ++ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLGI 807
+ + LY+ M+ +L + + + E V ++ A+E+LHS G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
+HRDLKP N+ D +K+ DFGL ++ + T
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEEEQTVLTP-------------MPAY 230
Query: 868 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 927
VGT Y++PE + G + + D +S+G+ILFE + T I ++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV-- 286
Query: 928 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
R + +P + + + ++ L P +R A ++ + F+ +
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT---DIIENAIFENL 332
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-56
Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 43/314 (13%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
S+ + DD+E+ + I GA V A + AIK + L+ + ++ +L E
Sbjct: 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQ-TSMDELLKE 63
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--------KVGCLEEDVA 788
+ +P +V ++ SF +D L+LVM+ L+GG + +++ K G L+E
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 789 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848
+ E++ LEYLH G +HRD+K N+L+ DG +++ DFG+S + D
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGD----- 176
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFI 907
T N+ R + VGTP ++APE + + + AD WS GI E
Sbjct: 177 ---------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 908 TGIPPFTAESPEIIFDNILNRKIP-------WPCVPSDMSFEAQDLINRFLIHDPNQRLG 960
TG P+ P + L P + + +I+ L DP +R
Sbjct: 222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP- 280
Query: 961 ANGAAEVKAHPFFK 974
AAE+ H FF+
Sbjct: 281 --TAAELLRHKFFQ 292
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 7e-56
Identities = 67/310 (21%), Positives = 103/310 (33%), Gaps = 46/310 (14%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 736
+ F + GA G + A+K I E
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKR------ILPECFSFADRE 67
Query: 737 RNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAE 794
+L P V+R+F + R Y+ +E L + +K + +
Sbjct: 68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQ 126
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPET 849
L +LHSL IVHRDLKP N+LI+ ++DFGL K
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK--------------- 171
Query: 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEF 906
+ + +R R GT ++APE+L Y D +S G + +
Sbjct: 172 --------KLAVGRHSFSR-RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 907 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965
I+ G PF + + A++LI + + DP +R A
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAK 279
Query: 966 EVKAHPFFKG 975
V HPFF
Sbjct: 280 HVLKHPFFWS 289
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-56
Identities = 81/291 (27%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ I G+ G V LAR++ +G A+K++ D+ ++ E + E I+ ++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
VV + S+ + L+++ME+L GG L ++ +V EE +A + ++ AL YLH+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV-CEAVLQALAYLHAQ 160
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
G++HRD+K D++L+ DG +KL+DFG Q +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA----------------------------QIS 192
Query: 866 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFD 923
+ R S VGTP ++APE++ + + D WS+GI++ E + G PP+ ++SP + +
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK- 251
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ + P +S +D + R L+ DP +R A E+ HPF
Sbjct: 252 RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-55
Identities = 89/290 (30%), Positives = 139/290 (47%), Gaps = 36/290 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKN 76
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +V + S+ D L++VMEYL GG L ++ + E +A + E + ALE+LHS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSN 135
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
++HRD+K DN+L+ DG +KLTDFG Q T
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------------------------QIT 167
Query: 866 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
++ R + VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
I P P +S +D +NR L D +R A E+ H F K
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHQFLK 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-55
Identities = 70/323 (21%), Positives = 124/323 (38%), Gaps = 65/323 (20%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ K + G+ G V G A+K + + + L E +L +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKR------MLIDFCDIALMEIKLLTESDD 67
Query: 746 -PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-------ARIYIAELVL 797
P V+R++ S T LY+ +E +L L+ +E++ + ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAH-------------DGHIKLTDFGLSKIGLINNTIDL 844
+ +LHSL I+HRDLKP N+L++ + I ++DFGL K
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--------- 177
Query: 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-------GYAADWW 897
Q + N ++ GT + APE+L + + + D +
Sbjct: 178 --------------LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 898 SVGIILFEFIT-GIPPFTAESPEI--IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 954
S+G + + ++ G PF + I I + + EA DLI++ + HD
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283
Query: 955 PNQRLGANGAAEVKAHPFFKGVN 977
P +R A +V HP F +
Sbjct: 284 PLKRP---TAMKVLRHPLFWPKS 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-55
Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 37/290 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ F ++ I +G+FG VF T + AIK++ L+ +++IE I E +L +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEA-EDEIEDIQQEITVLSQCDS 79
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P+V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE 138
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
+HRD+K N+L++ G +KL DFG++ G + +T
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQI---------------------- 174
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 924
R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F
Sbjct: 175 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-- 229
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
L K P + + S ++ + L +P+ R A E+ H F
Sbjct: 230 -LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIL 275
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-54
Identities = 76/321 (23%), Positives = 135/321 (42%), Gaps = 43/321 (13%)
Query: 662 LDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 721
S + +G T + + I+D E + + G G+V+ R R TG + A+K ++
Sbjct: 3 SGSSGKQTGYLTI--GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR- 59
Query: 722 LDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 780
K + +RIL + ++++ + P++V+ F +F ++++ ME + R
Sbjct: 60 RS-GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118
Query: 781 GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839
G + E + +V AL YL G++HRD+KP N+L+ G IKL DFG+S
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG----- 173
Query: 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 894
+ D++ + + G Y+APE + ++ A
Sbjct: 174 -----------------------RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210
Query: 895 DWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 953
D WS+GI L E TG P+ + + +L + P S + Q + L
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTK 270
Query: 954 DPNQRLGANGAAEVKAHPFFK 974
D +R ++ H F K
Sbjct: 271 DHRKRP---KYNKLLEHSFIK 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-54
Identities = 84/298 (28%), Positives = 145/298 (48%), Gaps = 41/298 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ +EI+ + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDH 75
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 804
P++V+ ++ L++++E+ GG + +++ ++ L E ++ +++ AL +LHS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
I+HRDLK N+L+ +G I+L DFG+S T+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQ--------------------- 172
Query: 865 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP- 918
R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P
Sbjct: 173 ----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
Query: 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
++ I P PS S E +D + L +P R AA++ HPF +
Sbjct: 229 RVLL-KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQLLEHPFVSSI 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-52
Identities = 76/316 (24%), Positives = 120/316 (37%), Gaps = 84/316 (26%)
Query: 680 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 738
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 62
Query: 739 ILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLRKVGCLEEDVARIY 791
+ P +VR + R L +VME L+GG+L+S R E A
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 848
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------- 165
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
A E G ++ + D WS+G+I++ +
Sbjct: 166 -------------------------------FAKET-TGEKYDKSCDMWSLGVIMYILLC 193
Query: 909 GIPPFTAESPEI----IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRL 959
G PPF + + I + W V S E + LI L +P QR+
Sbjct: 194 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----SEEVKMLIRNLLKTEPTQRM 249
Query: 960 GANGAAEVKAHPFFKG 975
E HP+
Sbjct: 250 ---TITEFMNHPWIMQ 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 82/292 (28%), Positives = 138/292 (47%), Gaps = 40/292 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ F++++ + G++G V+ A + TG + AIK + ++D++ I+ E +I+ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-----VPVESDLQEIIKEISIMQQCDS 83
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 804
P VV+++ S+ +L++VMEY G + ++R L ED + + LEYLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+ +HRD+K N+L+ +GH KL DFG++ Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAG----------------------------QL 175
Query: 865 TDNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 922
TD R++ +GTP ++APE++ + AD WS+GI E G PP+ P IF
Sbjct: 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235
Query: 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
I P P S D + + L+ P QR A ++ HPF +
Sbjct: 236 -MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVR 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-52
Identities = 87/335 (25%), Positives = 138/335 (41%), Gaps = 80/335 (23%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
DDFE I + G G VF + +G + A K++ L+ I+ +I+ E +L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LE-IKPAIRNQIIRELQVLHEC 88
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803
+P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 804 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
I+HRD+KP N+L+ G IKL DFG+S G + +++
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSM-------------------- 186
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 917
+S VGT Y++PE L GT + +D WS+G+ L E G P
Sbjct: 187 -------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239
Query: 918 ----------------------------------PEIIFD---NILNRKIP-WPCVPSDM 939
P IF+ I+N P P
Sbjct: 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVF 297
Query: 940 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
S E QD +N+ LI +P +R ++ H F K
Sbjct: 298 SLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIK 329
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-51
Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 46/302 (15%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-T 742
DD E I + RGA+G V R +G + A+K ++ + + +R+L + +I + T
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-AT-VNSQEQKRLLMDLDISMRT 62
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLY-SLLRKVGCLEEDVARIYIAELVLAL 799
V PF V F+ + ++++ ME ++ Y ++ K + ED+ +V AL
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 800 EYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
E+LHS L ++HRD+KP N+LI G +K+ DFG+S
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG------------------------ 158
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILFEFITGIPPFT 914
D+ + G Y+APE + + +D WS+GI + E P+
Sbjct: 159 ----YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
Query: 915 A-ESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
+ +P ++ P P +P+D S E D ++ L + +R E+ HPF
Sbjct: 215 SWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTSQCLKKNSKERP---TYPELMQHPF 269
Query: 973 FK 974
F
Sbjct: 270 FT 271
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 7e-51
Identities = 67/313 (21%), Positives = 130/313 (41%), Gaps = 46/313 (14%)
Query: 675 LHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 734
+ + +D + + I RGA+G V + +G + A+K ++ + + + +++L
Sbjct: 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-ST-VDEKEQKQLL 68
Query: 735 AERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKV--GCLEEDVAR 789
+ ++++ + P++V+F+ + + ++ ME ++ Y + V + E++
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 790 IYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848
V AL +L L I+HRD+KP N+L+ G+IKL DFG+S
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG-------------- 174
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILF 904
Q D+ + G Y+APE + + +D WS+GI L+
Sbjct: 175 --------------QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 905 EFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGA 961
E TG P+ + ++ P + F + +N L D ++R
Sbjct: 221 ELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-- 278
Query: 962 NGAAEVKAHPFFK 974
E+ HPF
Sbjct: 279 -KYKELLKHPFIL 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-50
Identities = 66/301 (21%), Positives = 111/301 (36%), Gaps = 42/301 (13%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 746
+ + ++ G F V+ A+ +G +A+K L + + I + E + + P
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKKLSGHP 86
Query: 747 FVVRFFYSFTCRDN--------LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 796
+V+F + + L+ E G + L + G L D +
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 797 LALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
A++++H I+HRDLK +NLL+++ G IKL DFG + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT------------TISHYPDY 194
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIP 911
S + + R+ TP Y PEI+ G D W++G IL+
Sbjct: 195 SWSAQRRALVEEEITRN---TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
Query: 912 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
PF + I+N K P + LI L +P +RL EV
Sbjct: 252 PFEDGAKL----RIVNGKYSIPPHDT-QYTVFHSLIRAMLQVNPEERLSIA---EVVHQL 303
Query: 972 F 972
Sbjct: 304 Q 304
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-50
Identities = 71/293 (24%), Positives = 111/293 (37%), Gaps = 40/293 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
++HRD+K N+L++ G +KL DFG +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA-----------------------------SIM 204
Query: 866 DNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP-EII 921
N S VGTP ++APE IL E Y D WS+GI E PP + +
Sbjct: 205 APAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ +I + P S ++ ++ L P R + + H F
Sbjct: 263 Y-HIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 310
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-50
Identities = 62/338 (18%), Positives = 119/338 (35%), Gaps = 73/338 (21%)
Query: 686 DDFEIIKPISRGA--FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
+E++ I +G V LAR + TG+ ++ + L+ + + E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEY 801
+P +V + +F + L++V ++ G L+ + + E + ++ AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
+H +G VHR +K ++LI+ DG + L+ + + +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSN--LSMISHGQ------------------ 183
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF------ 913
Q+ + +V +L+PE+L GY +D +SVGI E G PF
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 914 -------------------------------------TAESPEIIFDNILNRKIPWPCVP 936
++S N P
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 937 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
S + + L +P+ R A+ + H FFK
Sbjct: 304 RTFSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFK 338
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-49
Identities = 77/304 (25%), Positives = 134/304 (44%), Gaps = 51/304 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 744
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 745 NPFVVRFFYSF------TCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELV 796
+ + ++ +F D L+LVME+ G + L++ K L+E+ E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
L +LH ++HRD+K N+L+ + +KL DFG+S ++ T+
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVG------------- 184
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-----GYAADWWSVGIILFEFITGIP 911
R++ +GTP ++APE++ E+ + +D WS+GI E G P
Sbjct: 185 ------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 912 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970
P P +F I P S + Q I L+ + +QR ++ H
Sbjct: 233 PLCDMHPMRALF-LIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKH 287
Query: 971 PFFK 974
PF +
Sbjct: 288 PFIR 291
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-45
Identities = 62/274 (22%), Positives = 115/274 (41%), Gaps = 17/274 (6%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D + + +G FG+ R TG++ +K L + D + L E ++ + +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH 66
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALEYLHS 804
P V++F L + EY+ GG L +++ + R+ A+ + + YLHS
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+ I+HRDL N L+ + ++ + DFGL+++ + + P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKP---------- 174
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
D + R++ VG P ++APE++ G + D +S GI+L E I + P +
Sbjct: 175 -DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ R P + + R DP +R
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 80/326 (24%), Positives = 136/326 (41%), Gaps = 70/326 (21%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITV 743
+ +E I I G++G VF R R TG + AIK K + + + +A R +L +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 802
++P +V F + L+LV EY + + L + + E + + + + A+ +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
H +HRD+KP+N+LI IKL DFG +++ L+GP +Y +
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARL--------LTGP--------SDYYDDE 162
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 920
V T Y +PE+L+G G D W++G + E ++G+P + +S ++
Sbjct: 163 -----------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-DVD 210
Query: 921 ----IFDNIL------------------NRKIPWPCVPSD-------MSFEAQDLINRFL 951
I L KIP P +S+ A L+ L
Sbjct: 211 QLYLIR-KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCL 269
Query: 952 IHDPNQRLGANGAAEVKAHPFFKGVN 977
DP +RL HP+F+ +
Sbjct: 270 HMDPTERLTCEQLLH---HPYFENIR 292
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-44
Identities = 81/352 (23%), Positives = 142/352 (40%), Gaps = 75/352 (21%)
Query: 666 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 725
+Q+ G + S+ TSID + I + G +G V+ A T + AIK ++ L+
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LE-- 70
Query: 726 RKNDIERI----LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 781
++ E + + E ++L +++ ++ L+L+ EY DL + K
Sbjct: 71 --HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 782 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIG 836
+ V + ++ +L+ + + HS +HRDLKP NLL+ + +K+ DFGL++
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-- 185
Query: 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 895
+ + H + T Y PEILLG+ H + D
Sbjct: 186 ------------------------AFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVD 220
Query: 896 WWSVGIILFEFITGIPPFTAESPEI-----IFD-----------------NILNRKIPWP 933
WS+ I E + P F +S EI IF+ + +
Sbjct: 221 IWSIACIWAEMLMKTPLFPGDS-EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR 279
Query: 934 ------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979
+ + + E DL+ L DP +R+ A A E HP+F ++D
Sbjct: 280 GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE---HPYFSHNDFD 328
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 43/308 (13%)
Query: 663 DSVSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFA 715
+ T + + DD +I + I G+FG V A G A
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVA 64
Query: 716 IKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS 775
+K+L + D + L E I+ +R+P +V F + T NL +V EYL+ G LY
Sbjct: 65 VKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 776 LLRKVGCLEE--DVARIYIA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDF 830
LL K G E+ + R+ +A ++ + YLH+ IVHR+LK NLL+ +K+ DF
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183
Query: 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 890
GLS++ + + + SA GTP+++APE+L
Sbjct: 184 GLSRL---------------------------KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 891 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 950
+D +S G+IL+E T P+ +P + + + +P +++ + +I
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGC 275
Query: 951 LIHDPNQR 958
++P +R
Sbjct: 276 WTNEPWKR 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 85/326 (26%), Positives = 139/326 (42%), Gaps = 71/326 (21%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 740
++ + ++ I G +G V+ A+ G+ FA+K ++ L+ + E I + E +IL
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIR-LE----KEDEGIPSTTIREISIL 54
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 799
+++ +V+ + + L LV E+L+ DL LL LE A+ ++ +L+ +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
Y H ++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------------------------- 148
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 918
+ + H V T Y AP++L+G++ D WSVG I E + G P F S
Sbjct: 149 -AFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS- 205
Query: 919 EI-----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFL 951
E IF + +P + DL+++ L
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 952 IHDPNQRLGANGAAEVKAHPFFKGVN 977
DPNQR+ A A E H +FK N
Sbjct: 266 KLDPNQRITAKQALE---HAYFKENN 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 47/288 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILI 741
++ E K I +G FG V R + AIK L D + ++ E I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALE 800
+ +P +V+ + + +VME++ GDLY L + ++ + ++ L +E
Sbjct: 79 NLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 801 YLHSLG--IVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
Y+ + IVHRDL+ N+ + K+ DFGLS+ +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------------SVHSVS 184
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIP 911
+G ++APE + E Y AD +S +IL+ +TG
Sbjct: 185 ------------------GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 912 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
PF S +I F N++ + P +P D +++I DP +R
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-43
Identities = 77/314 (24%), Positives = 118/314 (37%), Gaps = 56/314 (17%)
Query: 688 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 746
+E+ I+ G G ++LA + G +K L + +AER L V +P
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL--VHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 747 FVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
+V+ F Y+VMEY+ G L L A Y+ E++ AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSY 197
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LHS+G+V+ DLKP+N+++ + +KL D G I+ G
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS------RINSFG--------------- 235
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
GTP + APEI+ A D ++VG L +P +
Sbjct: 236 ----------YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-- 282
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981
L P S+ L+ R + DP QR A E+ A GV + +
Sbjct: 283 ---GLPEDDPVLKTYD--SYGR--LLRRAIDPDPRQRFTT--AEEMSAQ--LTGVLREVV 331
Query: 982 ALQKAVFVPQPESV 995
A V P ++
Sbjct: 332 AQDTGVPRPGLSTI 345
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-43
Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 86/335 (25%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NI 739
++ +E + + G F V+ AR + T + AIK +K D A R +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 798
L + +P ++ +F + N+ LV +++ DL +++ L + Y+ +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
LEYLH I+HRDLKP+NLL+ +G +KL DFGL+K
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK------------------------ 160
Query: 859 YPEYQQTDNRNRHSAVGTPD-----------YLAPEILLGTEH-GYAADWWSVGIILFEF 906
+ G+P+ Y APE+L G G D W+VG IL E
Sbjct: 161 --------------SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206
Query: 907 ITGIPPFTAESPEI-----IFDNIL---NRKI--------------PWPCVP-----SDM 939
+ +P +S ++ IF+ L + +P +P S
Sbjct: 207 LLRVPFLPGDS-DLDQLTRIFE-TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 264
Query: 940 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ DLI + +P R+ A A + +F
Sbjct: 265 GDDLLDLIQGLFLFNPCARITATQALK---MKYFS 296
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 70/292 (23%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ E+ + + RGAFG V A+ R AIK ++ +++ + + E L V +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVNH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-----------DVARIYIAE 794
P +V+ + + C + + LVMEY GG LY++L L ++
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ----- 113
Query: 795 LVLALEYLHSL---GIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETD 850
+ YLHS+ ++HRDLKP NLL+ G +K+ DFG + +
Sbjct: 114 ---GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------------DIQ 157
Query: 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910
M T + G+ ++APE+ G+ + D +S GIIL+E IT
Sbjct: 158 THM-----------T------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 911 PPF--TAESPEIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
PF I + N R P + ++ + L+ R DP+QR
Sbjct: 201 KPFDEIGGPAFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 46/311 (14%)
Query: 665 VSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIK 717
+S S S P +S + + +++I + I +G FG+V+ R G++ AI+
Sbjct: 6 LSLLSARSFPRKAS-QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEV-AIR 61
Query: 718 VLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 777
++ ++ ++ E R+ VV F + +L ++ G LYS++
Sbjct: 62 LIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 778 RKVGCLEEDVARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836
R + + IA E+V + YLH+ GI+H+DLK N+ +G + +TDFGL I
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSIS 179
Query: 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---- 892
+ G +LAPEI+
Sbjct: 180 GVLQAGRREDKLR----------------------IQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 893 -----AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 947
+D +++G I +E PF + E I + P M E D++
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-NLSQIGMGKEISDIL 276
Query: 948 NRFLIHDPNQR 958
+ +R
Sbjct: 277 LFCWAFEQEER 287
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 77/345 (22%), Positives = 135/345 (39%), Gaps = 70/345 (20%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILI 741
S++ +E + + G++G V R + TG + A +KK + + + +A R +L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVA---IKKFLESDDDKMVKKIAMREIKLLK 79
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALE 800
+R+ +V + YLV E+++ + L L+ V + Y+ +++ +
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
+ HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAP-----GEVYDDE- 184
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 919
V T Y APE+L+G G A D W++G ++ E G P F +S +
Sbjct: 185 -------------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS-D 230
Query: 920 I-----IFDNILNRKIP--WPCVPS-----------------------DMSFEAQDLINR 949
I I L IP +S DL +
Sbjct: 231 IDQLYHIM-MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289
Query: 950 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPES 994
L DP++R H FF+ + Q+ Q ++
Sbjct: 290 CLHIDPDKRPFCAELLH---HDFFQMDGFAERFSQELQLKVQKDA 331
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 83/340 (24%), Positives = 133/340 (39%), Gaps = 91/340 (26%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERIL 734
+S F+ ++ + G + V+ +TTG A+K +K LD IR
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIR-------- 52
Query: 735 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------LEEDVA 788
E +++ +++ +VR + + L LV E+++ DL + LE ++
Sbjct: 53 -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 789 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848
+ + +L+ L + H I+HRDLKP NLLI G +KL DFGL++
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-------------- 156
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFI 907
GI P + E V T Y AP++L+G+ + D WS G IL E I
Sbjct: 157 AFGI-PVNTFSSE------------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 908 TGIPPFTAESPEI-----IFD----------------------------NILNRKIPWPC 934
TG P F + + IFD L + +
Sbjct: 204 TGKPLFPGTN-DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262
Query: 935 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ D ++ L +P+ RL A A HP+F
Sbjct: 263 KEP-LDGNLMDFLHGLLQLNPDMRLSAKQALH---HPWFA 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 83/330 (25%), Positives = 139/330 (42%), Gaps = 72/330 (21%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAER 737
+ ++ ++ ++ + G +G V+ A+ G + A+K ++ LD + E I + E
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIR-LD----AEDEGIPSTAIREI 70
Query: 738 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELV 796
++L + +P +V L LV E++ DL +L + L++ +IY+ +L+
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
+ + H I+HRDLKP NLLI DG +KL DFGL++
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR---------------------- 167
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTA 915
+ H V T Y AP++L+G++ + D WS+G I E ITG P F
Sbjct: 168 ----AFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 916 ESPEI-----IFD-----------------NILNRKIP-WPCVP-----SDMSFEAQDLI 947
+ + IF R + P E DL+
Sbjct: 223 VT-DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLL 281
Query: 948 NRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ L DPN+R+ A A HP+FK ++
Sbjct: 282 SNMLCFDPNKRISARDAMN---HPYFKDLD 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-43
Identities = 80/332 (24%), Positives = 124/332 (37%), Gaps = 78/332 (23%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL---AERNI- 739
+ +E + I GA+G V+ AR +G A LK + + L R +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGGGGGGGLPISTVREVA 63
Query: 740 ----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVA 788
L +P VVR + LV E+++ DL + L K L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 789 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848
+ + + + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR------IYSYQMAL 176
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
T V T Y APE+LL + + D WSVG I E
Sbjct: 177 T----------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
Query: 909 GIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDMSFE 942
P F S E IFD ++ + +P P +M
Sbjct: 215 RKPLFCGNS-EADQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES 272
Query: 943 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
L+ L +P++R+ A A + H +
Sbjct: 273 GAQLLLEMLTFNPHKRISAFRALQ---HSYLH 301
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 82/329 (24%), Positives = 134/329 (40%), Gaps = 75/329 (22%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 740
+ +E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLL 55
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 799
+++ +VR L LV E+ + DL L+ ++ + ++ +L+ L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+ HS ++HRDLKP NLLI +G +KL +FGL++ GI P +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR--------------AFGI-PVRCYS 159
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFIT-GIPPFTAES 917
E V T Y P++L G + + D WS G I E G P F
Sbjct: 160 AE------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 918 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 948
IF +L + WP + ++ +DL+
Sbjct: 208 -VDDQLKRIFR-LLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ 264
Query: 949 RFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
L +P QR+ A A + HP+F
Sbjct: 265 NLLKCNPVQRISAEEALQ---HPYFSDFC 290
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 86/335 (25%), Positives = 142/335 (42%), Gaps = 88/335 (26%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DD+++++ + RG + VF A T + +K+LK + ++I E IL +R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRG 89
Query: 746 -PFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 798
P ++ S LV E++N D L + L + R Y+ E++ A
Sbjct: 90 GPNIITLADIVKDPVSR----TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 142
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
L+Y HS+GI+HRD+KP N++I H+ ++L D+GL++ P +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---------HPGQE------- 186
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF--- 913
Y V + + PE+L+ + Y+ D WS+G +L I PF
Sbjct: 187 -YNVR-----------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 914 ---------------TAESPEII----------FDNILNR--KIPW-PCVPSD----MSF 941
T + + I F++IL R + W V S+ +S
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 942 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
EA D +++ L +D RL A A E HP+F V
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAME---HPYFYTV 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 65/297 (21%), Positives = 125/297 (42%), Gaps = 44/297 (14%)
Query: 676 HSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 728
H H R + DD+EI + I G+FG V+ + GD+ A+K+L
Sbjct: 7 HHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAP-TPQ 62
Query: 729 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 788
++ E +L R+ ++ F ++ L +V ++ G LY L E
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 789 RIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 847
I IA + ++YLH+ I+HRDLK +N+ + D +K+ DFGL+
Sbjct: 122 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE------------ 169
Query: 848 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILF 904
+ + + + G+ ++APE++ + + +D ++ GI+L+
Sbjct: 170 -------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 905 EFITGIPPFTAESP-EIIFDNIL--NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
E +TG P++ + + I + + + V S+ + L+ L ++R
Sbjct: 217 ELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 80/330 (24%), Positives = 129/330 (39%), Gaps = 84/330 (25%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERILAE 736
++ + + + G + V+ + + T +L A+K ++ L+ IR E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIR---------E 50
Query: 737 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAEL 795
++L +++ +V +L LV EYL+ DL L G + ++++ +L
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
+ L Y H ++HRDLKP NLLI G +KL DFGL++ S P
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA--------KSIP-------- 153
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFT 914
+ + V T Y P+ILLG+ D W VG I +E TG P F
Sbjct: 154 -----------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
Query: 915 AESPEI-----IFDNIL---NRKIPWPCVPS----------------------DMSFEAQ 944
+ IF IL + WP + S + +
Sbjct: 203 GST-VEEQLHFIFR-ILGTPTEET-WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259
Query: 945 DLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
DL+ + L + R+ A A + HPFF
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMK---HPFFL 286
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 30/278 (10%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILI 741
T + + + + RG G V+ A + A+K++ + R+ E
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAG 89
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
++ P VV LY+ M +NG DL ++LR+ G L A + ++ AL+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
H+ G HRD+KP+N+L++ D L DFG++ + + T
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKL------T------------ 190
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
Q + VGT Y+APE + Y AD +++ +L+E +TG PP+ + ++
Sbjct: 191 --QLG-----NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243
Query: 922 FDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQR 958
+ +N+ IP P V + +I R + +P R
Sbjct: 244 GAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-42
Identities = 86/335 (25%), Positives = 134/335 (40%), Gaps = 86/335 (25%)
Query: 684 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIER----ILAERN 738
+ +E + I GA+G+VF AR + G A LK++ + + R
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRV----QTGEEGMPLSTIRE 61
Query: 739 I-----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEED 786
+ L T +P VVR F L LV E+++ DL + L KV + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 787 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846
+ + +L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I S
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI--------YSF 172
Query: 847 PETDGIMPSDAHY-PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905
V T Y APE+LL + + D WSVG I E
Sbjct: 173 QMA---------LTSV------------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211
Query: 906 FITGIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDM 939
P F S ++ I D ++ + +P +D+
Sbjct: 212 MFRRKPLFRGSS-DVDQLGKILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 269
Query: 940 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+DL+ + L +P +R+ A A HP+F+
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALS---HPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-41
Identities = 89/337 (26%), Positives = 131/337 (38%), Gaps = 81/337 (24%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----------IRKNDIER 732
+ +E + I +G FG VF AR R TG A LKK+ M +R+ I +
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQ 71
Query: 733 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 791
+L N+ + + + C+ ++YLV ++ DL LL V +
Sbjct: 72 LLKHENV-VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETD 850
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL+ L
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL------------- 176
Query: 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 909
++ Y T NR V T Y PE+LLG G D W G I+ E T
Sbjct: 177 ---AKNSQPNRY--T-NR-----VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
Query: 910 IPPFTAESPEI-----IFDNIL---NRKIPWPCVPS------------------------ 937
P + E I + ++ WP V +
Sbjct: 226 SPIMQGNT-EQHQLALIS-QLCGSITPEV-WPNVDNYELYEKLELVKGQKRKVKDRLKAY 282
Query: 938 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
A DLI++ L+ DP QR+ ++ A H FF
Sbjct: 283 VRDPYALDLIDKLLVLDPAQRIDSDDALN---HDFFW 316
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 30/274 (10%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 746
++I+ + G V+LA AIK + + K + ++R E + + +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
+V D YLVMEY+ G L + G L D A + +++ +++ H +
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
IVHRD+KP N+LI + +K+ DFG++K L ++ +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTN-------------------- 170
Query: 867 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926
+GT Y +PE G D +S+GI+L+E + G PPF E+ I +
Sbjct: 171 -----HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225
Query: 927 NRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 958
+P V D+ ++I R D R
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-41
Identities = 84/340 (24%), Positives = 140/340 (41%), Gaps = 82/340 (24%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERN 738
+ R +D F++ + +G FG V L ++++TG AIK V+ D +N R L
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPRFRN---RELQIMQ 71
Query: 739 ILITVRNPFVVR---FFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC----LEEDV 787
L + +P +V+ +FY+ RD L +VMEY+ L+ R +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 788 ARIYIAELVLALEYLH--SLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDL 844
++++ +L+ ++ LH S+ + HRD+KP N+L+ DG +KL DFG +K
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK---------- 180
Query: 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIIL 903
+ Y + + Y APE++ G + A D WSVG I
Sbjct: 181 -------KLSPSEPNVAY-----------ICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 904 FEFITGIPPFTAESP-----EII----------FDNILN----------RKIPW----PC 934
E + G P F ++ EI+ + + IPW
Sbjct: 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282
Query: 935 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ EA DL++ L + P +R+ E HP+F
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYFD 319
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-40
Identities = 89/334 (26%), Positives = 132/334 (39%), Gaps = 81/334 (24%)
Query: 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
+R + K I G+FG V+ A+ +G+L AIK K+ D E I+
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KV----LQDKRFKNRELQIM 101
Query: 741 ITVRNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGC----LEEDVARI 790
+ + +VR FFYS + + L LV++Y+ +Y + R L ++
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 791 YIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPET 849
Y+ +L +L Y+HS GI HRD+KP NLL+ +KL DFG +K
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------------- 205
Query: 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 908
+ Y + + Y APE++ G T++ + D WS G +L E +
Sbjct: 206 --QLVRGEPNVSY-----------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252
Query: 909 GIPPFTAESP-----EII----------------------FDNILNRKIPWP-CVPSDMS 940
G P F +S EII F I + PW
Sbjct: 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI--KAHPWTKVFRPRTP 310
Query: 941 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
EA L +R L + P RL E AH FF
Sbjct: 311 PEAIALCSRLLEYTPTARL---TPLEACAHSFFD 341
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 45/285 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-LDMIRKNDIERILAERNILITVR 744
+ + + I G FG+V+ A GD A+K + D IE + E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+P ++ NL LVME+ GG L +L + D+ + ++ + YLH
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHD 123
Query: 805 LG---IVHRDLKPDNLLIAHDGH--------IKLTDFGLSKIGLINNTIDLSGPETDGIM 853
I+HRDLK N+LI +K+TDFGL++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------------------ 165
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913
+ SA G ++APE++ + +D WS G++L+E +TG PF
Sbjct: 166 -----------WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 914 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ + K+ +PS L+ DP+ R
Sbjct: 215 RGIDGLAVAYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 746
+E+ + + G V LAR A+KVL+ D+ R R E + +P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHP 72
Query: 747 FVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 802
+V + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
H GI+HRD+KP N++I+ +K+ DFG+++ + ++ ++
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVT----------------- 174
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 921
QT + +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 175 -QTA-----AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ ++ IP +S + ++ + L +P R
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 79/326 (24%), Positives = 133/326 (40%), Gaps = 61/326 (18%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 744
DF++ + GA+G V A + TG++ AIK K++ K R L E IL +
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFK 67
Query: 745 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
+ ++ F +N +Y++ E + DL+ ++ L +D + +I + + A+
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAV 125
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+ LH ++HRDLKP NLLI + +K+ DFGL++I + + M
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM------ 179
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES- 917
E+ V T Y APE++L ++ A D WS G IL E P F
Sbjct: 180 VEF-----------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 918 ---------------PEIIFDNILN-------------RKIPWPCVPSDMSFEAQDLINR 949
+ I + P + ++ + DL+ R
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 950 FLIHDPNQRLGANGAAEVKAHPFFKG 975
L+ DP +R+ A E HP+ +
Sbjct: 289 MLVFDPAKRI---TAKEALEHPYLQT 311
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 56/296 (18%)
Query: 677 SSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 734
+ H ID + ++ G ++ R + G+ +KVLK D
Sbjct: 2 NKHSG---IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFN 55
Query: 735 AERNILITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA-RIY 791
E L +P V+ + + L+ ++ G LY++L + D + +
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115
Query: 792 IA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848
A ++ + +LH+L I L +++I D +++ +
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------------- 161
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFE 905
+Q + P ++APE L +AD WS ++L+E
Sbjct: 162 ------------SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203
Query: 906 FITGIPPFTAESP-EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+T PF S EI L R P +P +S L+ + DP +R
Sbjct: 204 LVTREVPFADLSNMEIGMKVALEGLR----PTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-39
Identities = 93/327 (28%), Positives = 137/327 (41%), Gaps = 82/327 (25%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+ K I G+FG VF A+ + + AIK K+ D E I+ V++P
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIK---KV----LQDKRFKNRELQIMRIVKHPN 93
Query: 748 VVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 797
VV FFYS + + L LV+EY+ +Y R + + ++Y+ +L+
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 798 ALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
+L Y+HS+GI HRD+KP NLL+ G +KL DFG +KI ++ +
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI----------------LIAGE 196
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 915
Y + + Y APE++ G T + D WS G ++ E + G P F
Sbjct: 197 P-NVSY-----------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 916 ESP-----EII----------------------FDNILNRKIPWP-CVPSDMSFEAQDLI 947
ES EII F I R P+ +A DLI
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI--RPHPFSKVFRPRTPPDAIDLI 302
Query: 948 NRFLIHDPNQRLGANGAAEVKAHPFFK 974
+R L + P+ RL A E HPFF
Sbjct: 303 SRLLEYTPSARL---TAIEALCHPFFD 326
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-38
Identities = 81/358 (22%), Positives = 134/358 (37%), Gaps = 113/358 (31%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+ + K + G+FG V +G FA+K K+ D E +I+ + +
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK---KV----LQDPRYKNRELDIMKVLDHVN 61
Query: 748 VVRFFYSFTCRDN--------------------------------------LYLVMEYLN 769
+++ F + L ++MEY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120
Query: 770 GGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGH 824
L+ +L+ + ++ IYI +L A+ ++HSLGI HRD+KP NLL+ + D
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 825 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 884
+KL DFG +K + Y + + Y APE+
Sbjct: 181 LKLCDFGSAK-----------------KLIPSEPSVAY-----------ICSRFYRAPEL 212
Query: 885 LLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-----EII----------------- 921
+LG TE+ + D WS+G + E I G P F+ E+ II
Sbjct: 213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH 272
Query: 922 -----FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
F + + W + P A DL+ + L ++P+ R+ E AHPFF
Sbjct: 273 YTEVRFPTL--KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFF 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 83/331 (25%), Positives = 130/331 (39%), Gaps = 75/331 (22%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---------RN 738
+ +KP+ G G VF A AIK K+ + ++ L E N
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 739 I-----LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 793
I ++ + S T +++Y+V EY+ DL ++L + G L E+ AR+++
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARLFMY 127
Query: 794 ELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
+L+ L+Y+HS ++HRDLKP NL I D +K+ DFGL++I D
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI-------------MDPH 174
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 911
H E + T Y +P +LL + A D W+ G I E +TG
Sbjct: 175 YSHKGHLSEG-----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
Query: 912 PFTAESP----EIIFD-------------------NILN----RKIPWPCVPSDMSFEAQ 944
F ++I + I N P + +S EA
Sbjct: 224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283
Query: 945 DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
D + + L P RL A E +HP+
Sbjct: 284 DFLEQILTFSPMDRL---TAEEALSHPYMSI 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-37
Identities = 81/327 (24%), Positives = 132/327 (40%), Gaps = 76/327 (23%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 743
+ + GA+G V A + +G+ AIK KL +++I R E +L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 744 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
++ V+ F + N YLVM ++ DL ++ E+ + + +++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLK 137
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
L+Y+HS G+VHRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADA 178
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 916
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 179 EMTGY-----------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 917 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 948
I + + + + + S +A DL+
Sbjct: 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 287
Query: 949 RFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ L D ++RL AA+ HPFF+
Sbjct: 288 KMLELDVDKRL---TAAQALTHPFFEP 311
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 79/354 (22%), Positives = 127/354 (35%), Gaps = 74/354 (20%)
Query: 647 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLAR 706
S T + LI S S SG PL +RT +++K I +G +G V++ +
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLV---QRTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 707 KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFF----YSFTCRDN 760
R G+ A+KV + E I TV R+ ++ F
Sbjct: 58 WR--GEKVAVKVFFT------TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109
Query: 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDL 812
LYL+ +Y G LY L+ + + ++ V L +LH+ I HRDL
Sbjct: 110 LYLITDYHENGSLYDYLKSTTLDAKSMLKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 813 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 872
K N+L+ +G + D GL+ E D ++
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVK------FISDTNEVDIPP-----------------NT 205
Query: 873 AVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGI----------PPFTAE 916
VGT Y+ PE+L + + AD +S G+IL+E P+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 917 SP-----EIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 961
P E + + + +K P + + L+ H+P RL A
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-37
Identities = 79/325 (24%), Positives = 131/325 (40%), Gaps = 67/325 (20%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 744
+ + I GA+G V A AIK K+ +R L E IL+ R
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFR 83
Query: 745 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
+ ++ + +Y+V + + DLY LL+ L D ++ +++ L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQILRGL 141
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+Y+HS ++HRDLKP NLL+ +K+ DFGL+++ D
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-------------ADPDHDHTGFL 188
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 918
EY V T Y APEI+L ++ + D WSVG IL E ++ P F +
Sbjct: 189 TEY-----------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 919 ----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRF 950
I I+N K+PW + + +A DL+++
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 951 LIHDPNQRLGANGAAEVKAHPFFKG 975
L +P++R+ + AHP+ +
Sbjct: 298 LTFNPHKRI---EVEQALAHPYLEQ 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 66/334 (19%), Positives = 114/334 (34%), Gaps = 77/334 (23%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--------DIERILAER 737
+ + + IS G++G V + G AIK + + +R+L E
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 738 NILITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSLLR-KVGCLEEDVARIY 791
+L +P ++ F + LYLV E + DL ++ + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851
+ ++L L LH G+VHRDL P N+L+A + I + DF L++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----------EDTADA 188
Query: 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 910
Y V Y APE+++ + D WS G ++ E
Sbjct: 189 NK------THY-----------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 911 PPFTAESP----EIIFD-----------NILN--------------RKIPWPCVPSDMSF 941
F + I + + W V
Sbjct: 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADP 291
Query: 942 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
A DLI + L +P +R+ + HP+F+
Sbjct: 292 VALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-36
Identities = 83/326 (25%), Positives = 134/326 (41%), Gaps = 75/326 (23%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 743
+ ++ + P+ GA+G V A TG A+K KL ++ I R E +L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 744 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
++ V+ F + +YLV + G DL ++++ L +D + I +++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ T M
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTADEM---- 186
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 916
Y V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 187 --TGY-----------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 917 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 948
++I I + K+ + V + A DL+
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293
Query: 949 RFLIHDPNQRLGANGAAEVKAHPFFK 974
+ L+ D ++R+ AA+ AH +F
Sbjct: 294 KMLVLDSDKRI---TAAQALAHAYFA 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-36
Identities = 83/327 (25%), Positives = 135/327 (41%), Gaps = 75/327 (22%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 743
+ ++P+ GA+G V A TG AIK KL ++++ R E +L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 744 RNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
R+ V+ + + YLVM ++ G DL L++ L ED + + +++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLK 139
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
L Y+H+ GI+HRDLKP NL + D +K+ DFGL++ +D+
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------QADS 180
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 916
Y V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 181 EMTGY-----------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 917 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 948
+ I + + K + + ++ S A +L+
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289
Query: 949 RFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ L+ D QR+ A E AHP+F+
Sbjct: 290 KMLVLDAEQRV---TAGEALAHPYFES 313
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-36
Identities = 75/354 (21%), Positives = 123/354 (34%), Gaps = 104/354 (29%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 744
+E++K I +G+FG+V A A+K+++ + E IL +R
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ----AAEEIRILEHLRKQD 154
Query: 745 ---NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLAL 799
V+ +FT R+++ + E L +LY L++K + R + ++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
+ LH I+H DLKP+N+L+ G IK+ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS------------------CYEHQR 255
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 913
Y Y Q+ R Y APE++LG +G D WS+G IL E +TG P
Sbjct: 256 VYT-YIQS----RF-------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303
Query: 914 ------------------------------------------TAESPEIIFDNILNRKIP 931
T ++ + +R+
Sbjct: 304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGK 363
Query: 932 WPCVPSDMSFEAQ----------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
P + D + + L DP R+ A HP+ +
Sbjct: 364 LRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA---LRHPWLRR 414
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-36
Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 68/322 (21%)
Query: 643 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 702
LD + + K+ LI D + SG PL +RT + + I +G FG V
Sbjct: 5 LDRPFISEGTTLKD---LIYDMTTSGSGSGLPLLV---QRTIARTIVLQESIGKGRFGEV 58
Query: 703 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRDN 760
+ + R G+ A+K+ + E I T +R+ ++ F + +
Sbjct: 59 WRGKWR--GEEVAVKIF------SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110
Query: 761 ----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIV 808
L+LV +Y G L+ L + E + ++ L +LH I
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 809 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 868
HRDLK N+L+ +G + D GL+ + T +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVR-----------------------HDSATDTIDI 206
Query: 869 NRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
+ VGT Y+APE+L + E AD +++G++ +E
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--- 263
Query: 923 DNILNRKIPWP-CVPSDMSFEA 943
++P+ VPSD S E
Sbjct: 264 ------QLPYYDLVPSDPSVEE 279
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 62/283 (21%), Positives = 107/283 (37%), Gaps = 62/283 (21%)
Query: 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
+RT D +++ + +G +G V+ + G+ A+K+ D + E +
Sbjct: 3 QRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIF------SSRDEKSWFRETELY 54
Query: 741 ITV--RNPFVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 794
TV R+ ++ F S L+L+ Y G LY L+ RI +
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLS 113
Query: 795 LVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846
+ L +LH I HRDLK N+L+ +G + D GL+ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----------- 162
Query: 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVG 900
+ + + + VGT Y+APE+L T + D W+ G
Sbjct: 163 ------------HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210
Query: 901 IILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 942
++L+E + + + K P+ VP+D SFE
Sbjct: 211 LVLWEVARRMVS---------NGIVEDYKPPFYDVVPNDPSFE 244
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-35
Identities = 87/358 (24%), Positives = 134/358 (37%), Gaps = 74/358 (20%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 743
D +EI I G++G V A + + AIK K+ + ++ I+ RIL E IL +
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRL 109
Query: 744 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 798
+ VV+ D LY+V+E D L R L E + + L++
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
++Y+HS GI+HRDLKP N L+ D +K+ DFGL++ + P + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 917
+ + R V T Y APE++L E+ A D WS+G I E + I A
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 918 P-----------------------------------EIIFD------------------- 923
+IF+
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 924 NILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
+ S +A L+ R L+ +PN+R+ N HPFFK V
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA---HPFFKEV 403
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-35
Identities = 75/363 (20%), Positives = 137/363 (37%), Gaps = 101/363 (27%)
Query: 677 SSHKERTSIDDFEIIKP-ISRGAFGRVFLARKR--TTGDLFAIKVLKKLDM----IRKND 729
SS +ER D FE + RG +G V+ A+++ +A+K ++ + R+
Sbjct: 12 SSERER-VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA 70
Query: 730 IERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------- 782
+ R L N+ I+++ F+ ++L+ +Y DL+ +++
Sbjct: 71 LLRELKHPNV-ISLQKVFLSH------ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 783 --LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIG 836
L + + + +++ + YLH+ ++HRDLKP N+L+ + G +K+ D G +++
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL- 181
Query: 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 895
+ P D V T Y APE+LLG H A D
Sbjct: 182 --------------------FNSPLKPLADLDPV---VVTFWYRAPELLLGARHYTKAID 218
Query: 896 WWSVGIILFEFITGIPPFTAESPEIIFDNILNR----KI------P----WPCVPS---- 937
W++G I E +T P F +I N + +I P W +
Sbjct: 219 IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH 278
Query: 938 --------------------------DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
+A L+ + L DP +R+ + A + P
Sbjct: 279 STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ---DP 335
Query: 972 FFK 974
+F
Sbjct: 336 YFL 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 72/346 (20%), Positives = 120/346 (34%), Gaps = 81/346 (23%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 744
F +I+ + G FGRV L + +A+KV++ + E +IL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKIEADILKKIQNDD 92
Query: 745 --NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 800
N +V++ F D++ L+ E L G LY ++ + + ++Y E++ AL
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI-------- 852
YL + + H DLKP+N+L+ K I + ++ GI
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD--GKKIQIYRTKSTGIKLIDFGCA 209
Query: 853 -MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 911
SD H T R Y APE++L ++D WS G +L E TG
Sbjct: 210 TFKSDYHGS-IINT----RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 912 PFTAES----------------PEII----------FDNILNRKIPWPCVPSDMSF---- 941
F ++ + N K+ WP S ++
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 942 -------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
D + L DP R + H F +
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK---HKFLE 360
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 74/337 (21%), Positives = 129/337 (38%), Gaps = 84/337 (24%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 743
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 744 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
+ ++ FT + + +Y+VME + +L +++ L+ + + +++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 138
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 183
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 913
Y V T Y APE++LG + D WSVG I+ E I G F
Sbjct: 184 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
Query: 914 ---------------TAESPEIIFDNILN--------RKIPW------------PCVPSD 938
E + + + +
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290
Query: 939 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ +A+DL+++ L+ D ++R+ E HP+
Sbjct: 291 KASQARDLLSKMLVIDASKRI---SVDEALQHPYINV 324
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-34
Identities = 84/356 (23%), Positives = 142/356 (39%), Gaps = 78/356 (21%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 743
D++ I I RG++G V+LA + T AIK K++ + ++ I+ RIL E IL +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRL 82
Query: 744 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 798
++ +++R + D LY+V+E DL L + L E+ + + L+L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
++H GI+HRDLKP N L+ D +K+ DFGL++ ++ + P +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 859 YPEYQQ-TDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 916
+Q T + V T Y APE++L E+ + D WS G I E + + +
Sbjct: 202 KNLKKQLTSH------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 917 SP--------------------------------EIIFD-----------NILN------ 927
IIF+ NI
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315
Query: 928 -------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
+ I +S + +L+ L +PN+R+ + HP+ K V
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDV 368
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 74/357 (20%), Positives = 123/357 (34%), Gaps = 107/357 (29%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP- 746
+ +++ + G F V+LA+ A+K+++ K E E +L V +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDAD 76
Query: 747 ----------FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 790
+++ F + + +V E L G +L +L++K + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 791 YIAELVLALEYLHS-LGIVHRDLKPDNLLIAH------DGHIKLTDFGLSKIGLINNTID 843
+L+L L+Y+H GI+H D+KP+N+L+ IK+ D G +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------- 185
Query: 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903
D HY QT R Y +PE+LLG G AD WS ++
Sbjct: 186 ---------CWYDEHYTNSIQT----RE-------YRSPEVLLGAPWGCGADIWSTACLI 225
Query: 904 FEFITGIPPFTAESPEI-------------------------------IFDNILNRKI-- 930
FE ITG F + F++ +
Sbjct: 226 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS 285
Query: 931 ---PWP---CVPSDMSFEAQ------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
WP + F D ++ L DP +R A G HP+ K
Sbjct: 286 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN---HPWLKD 339
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 87/340 (25%), Positives = 149/340 (43%), Gaps = 64/340 (18%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 743
+E++K + +GA+G V+ + R TG++ A+K K+ +N + R E IL +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTEL 65
Query: 744 RN-PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 800
+V ++ +YLV +Y+ DL++++R LE + + +L+ ++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIKVIK 123
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
YLHS G++HRD+KP N+L+ + H+K+ DFGLS+ + + + P + +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP- 918
+ TD V T Y APEILLG T++ D WS+G IL E + G P F S
Sbjct: 184 QPILTD------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 919 ---EIIFD-------------------NILNRKIPWPCVP-------------------- 936
E I ++ +
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297
Query: 937 -SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+D + EA DL+++ L +PN+R+ A + HPF
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSI 334
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 33/286 (11%), Positives = 70/286 (24%), Gaps = 60/286 (20%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 747
+ ++ + + A A+ + ++ + ++ L+ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 807
V R R +V E++ GG L + R + L A + H G+
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRA-MQSLAAAADAAHRAGV 150
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
P + ++ DG + L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------------ 174
Query: 868 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 927
+ D +G L+ + P
Sbjct: 175 -----------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 928 RKIPWPCVPS----DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969
P P+ D+ F+ + R + D R + ++
Sbjct: 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 75/337 (22%), Positives = 131/337 (38%), Gaps = 84/337 (24%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 743
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 744 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
+ ++ FT + +YLVME + +L +++ L+ + + +++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 175
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 220
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 913
Y V T Y APE++LG + D WSVG I+ E + F
Sbjct: 221 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
Query: 914 ---------------TAESPEIIFDNILN--------RKIPWPCV------------PSD 938
E + + + N + +P +
Sbjct: 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 327
Query: 939 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 328 KASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 361
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 74/238 (31%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIE-RILAERNILITVRN 745
+EI I +G+FG+V A R + AIK++K K + + IE R+L N T
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLH 803
++V F R++L LV E L +LY LLR + ++ R + ++ AL +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 804 S--LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+ L I+H DLKP+N+L+ + IK+ DFG S Y
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS------------------CQLGQRIY 216
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917
Y Q+ R Y +PE+LLG + A D WS+G IL E TG P F+ +
Sbjct: 217 Q-YIQS----RF-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 71/352 (20%), Positives = 108/352 (30%), Gaps = 95/352 (26%)
Query: 688 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 732
+EI+ + G FG+V A+K+++ L I++ D E
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 733 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 790
+ V F ++ + E L G + + L++ R
Sbjct: 81 ---KFLC---------VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH 127
Query: 791 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 845
+L AL +LH + H DLKP+N+L + L + S D
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905
+ H T RH Y PE++L D WS+G ILFE
Sbjct: 188 S----ATFDHEHHTT-IVAT----RH-------YRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 906 FITGIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSD------ 938
+ G F P + +K + W SD
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291
Query: 939 --------------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
+ DL+ R L DP QR+ A HPFF G+
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL---HPFFAGL 340
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 70/354 (19%), Positives = 116/354 (32%), Gaps = 99/354 (27%)
Query: 688 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 732
+EI+ + GAFG+V + G A+K++K L+ + D
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 733 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 790
V+ F ++ +V E L G Y +++ G D R
Sbjct: 76 ---TFRC---------VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK 122
Query: 791 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 845
++ ++ +LHS + H DLKP+N+L + + + + + +D
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF- 181
Query: 846 GPETDG--IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903
G + H T RH Y APE++L D WS+G IL
Sbjct: 182 -----GSATYDDEHHST-LVST----RH-------YRAPEVILALGWSQPCDVWSIGCIL 224
Query: 904 FEFITGIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSDMSF- 941
E+ G F P+ + RK + W S +
Sbjct: 225 IEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284
Query: 942 -------------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
DLI + L +DP +R+ A + HPFF +
Sbjct: 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK---HPFFDLL 335
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 59/282 (20%), Positives = 103/282 (36%), Gaps = 58/282 (20%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-- 742
+D+ ++++ I RG +G V+ A+KV + + + E+NI
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR------QNFINEKNIYRVPL 63
Query: 743 VRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
+ + + RF + R LVMEY G L L R+ +
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTR 122
Query: 798 ALEYLHS---------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848
L YLH+ I HRDL N+L+ +DG ++DFGLS
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR------------- 169
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGI 901
+ ++ S VGT Y+APE+L G D +++G+
Sbjct: 170 ------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 902 ILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 942
I +E + +++ ++ + V + +FE
Sbjct: 224 IYWEIFMR------CTDLFPGESVPEYQMAFQTEVGNHPTFE 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 53/300 (17%), Positives = 107/300 (35%), Gaps = 69/300 (23%)
Query: 666 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-- 723
SSGV + ++ ++++ +RG FG V+ A+ + A+K+ D
Sbjct: 7 HHSSGVDLGT-ENLYFQS--MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ 61
Query: 724 -MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLR 778
+ ++ L +++ +++F + + L+L+ + G L L+
Sbjct: 62 SWQNEYEVY-------SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 779 KVGCLEEDVARIYIAELVLALEYLHS----------LGIVHRDLKPDNLLIAHDGHIKLT 828
++ I + L YLH I HRD+K N+L+ ++ +
Sbjct: 115 ANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 829 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--- 885
DFGL+ + + H VGT Y+APE+L
Sbjct: 174 DFGLALKFEAGKSAG-------------------------DTHGQVGTRRYMAPEVLEGA 208
Query: 886 LGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 942
+ + D +++G++L+E + E +P+ + S E
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--------YMLPFEEEIGQHPSLE 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 49/276 (17%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-- 745
+ +I+ + G F V+L+ A+KV+K ++ E L E +L +VRN
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSD 94
Query: 746 ------PFVVRFFYSFT---------CRDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVA 788
VV+ F C +V E L G L + K L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 789 RIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 847
+ I +++ L+YLH+ I+H D+KP+N+L++ + + + SG
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 848 ETDGIM------------PSDAHYPEYQQTD-------NRNRHSAVGTPDYLAPEILLGT 888
P +A + + D +++ + T Y + E+L+G+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 889 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
+ AD WS + FE TG F S E +
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 38/254 (14%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 746
F + K I G FG + L + T + AIK+ K+ ++ E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 804
+ + +Y C +V+E L G L L + V I I +L+ +EY+HS
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAI-QLISRMEYVHS 123
Query: 805 LGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+++RD+KP+N LI G+ I + DF L+K ID + H
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE-----YIDPETKK---------HI 169
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 916
P R S GT Y++ LG E D ++G + F+ G P A+
Sbjct: 170 PY------REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223
Query: 917 SPEIIFDNILNRKI 930
+ + + I + K
Sbjct: 224 TLKERYQKIGDTKR 237
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 38/257 (14%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 746
+++ + I G+FG +F AIK R++D ++ E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 66
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 804
+ +Y + LV++ L G L LL G + VA +++ ++ +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAK-QMLARVQSIHE 124
Query: 805 LGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
+V+RD+KPDN LI + I + DFG+ K T H
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--------------KQHI 170
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 916
P R + + GT Y++ LG E D ++G + F+ G P A
Sbjct: 171 PY------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224
Query: 917 SPEIIFDNILNRKIPWP 933
+ + ++ I +K P
Sbjct: 225 TNKQKYERIGEKKQSTP 241
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/252 (23%), Positives = 96/252 (38%), Gaps = 36/252 (14%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 746
+ + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGGV 65
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 804
+ + D +VME L G L L + V + +++ +EY+HS
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD-QMISRIEYIHS 123
Query: 805 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
+HRD+KPDN L+ + + DFGL+K D + H P
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-----KYRDARTHQ---------HIP- 168
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAESP 918
R + GT Y + LG E D S+G +L F G P A +
Sbjct: 169 -----YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223
Query: 919 EIIFDNILNRKI 930
++ I +K+
Sbjct: 224 RQKYERISEKKM 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+D + + I RG FG VF R R L A+K ++ + + L E IL +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSH 171
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 804
P +VR T + +Y+VME + GGD + LR G + + + +EYL S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+HRDL N L+ +K++DFG+S+ +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR-----------------EEADGVYAA---- 270
Query: 865 TDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913
P + APE L + +D WS GI+L+E + G P+
Sbjct: 271 -----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 49/257 (19%)
Query: 667 QSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLK 720
G L + T + I+ + G FG+V L T D + A+K LK
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69
Query: 721 KLDMIRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLR 778
E +IL T+ + ++++ +L LVMEY+ G L L
Sbjct: 70 --ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP 127
Query: 779 KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831
+ I +A+L+L + YLH+ +HRDL N+L+ +D +K+ DFG
Sbjct: 128 R--------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 891
L+K + + DG P + APE L +
Sbjct: 180 LAK--AVPEGHEYYRVREDGDSPV----------------------FWYAPECLKEYKFY 215
Query: 892 YAADWWSVGIILFEFIT 908
YA+D WS G+ L+E +T
Sbjct: 216 YASDVWSFGVTLYELLT 232
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 48/237 (20%)
Query: 686 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 66
Query: 742 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 797
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYT 120
Query: 798 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 163
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
+P D + ++ + +P + APE L ++ A+D WS G++L+E T
Sbjct: 164 LPQDKEF--FKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 49/254 (19%)
Query: 671 VSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDM 724
VS ++ + T + + I+ + G FG+V L R GD A+K LK
Sbjct: 4 VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PE 61
Query: 725 IRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 782
N I + E IL + + +V++ + + + L+ME+L G L L K
Sbjct: 62 SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--- 118
Query: 783 LEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
+ +I + + + ++YL S VHRDL N+L+ + +K+ DFGL+K
Sbjct: 119 ---NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK- 174
Query: 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAA 894
+ +D Y Y D+R+ +P + APE L+ ++ A+
Sbjct: 175 ----------------AIETDKEY--YTVKDDRD------SPVFWYAPECLMQSKFYIAS 210
Query: 895 DWWSVGIILFEFIT 908
D WS G+ L E +T
Sbjct: 211 DVWSFGVTLHELLT 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 51/262 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 97
Query: 742 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 797
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------HKERIDHIKLLQYT 151
Query: 798 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 194
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 911
+P D Y Y+ + +P + APE L ++ A+D WS G++L+E T I
Sbjct: 195 LPQDKEY--YKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246
Query: 912 PFTAESPEIIFDNILNRKIPWP 933
++SP F ++
Sbjct: 247 K--SKSPPAEFMRMIGN-DKQG 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 57/253 (22%), Positives = 91/253 (35%), Gaps = 45/253 (17%)
Query: 680 KERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK------------- 721
E +DD + + K I G FG ++LA + A V+K
Sbjct: 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELK 85
Query: 722 -LDMIRKNDIERILAERNILITVRNPFVVRF-FYSFTCRDNLYLVMEYLNGGDLYSLLRK 779
+ K D + ER L + P F R ++VME L G DL + +
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 780 VGCL-EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIG 836
G + V ++ I ++ LEY+H VH D+K NLL+ + + L D+GLS
Sbjct: 145 NGTFKKSTVLQLGI-RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896
N Y E R GT ++ + + G +D
Sbjct: 204 CPNGN--------------HKQYQE------NPRKGHNGTIEFTSLDAHKGVALSRRSDV 243
Query: 897 WSVGIILFEFITG 909
+G + ++ G
Sbjct: 244 EILGYCMLRWLCG 256
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 68/265 (25%), Positives = 106/265 (40%), Gaps = 49/265 (18%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 741
+ I + +G FG V L R GD L A+K L+ ++ D E IL
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF---QREIQILK 79
Query: 742 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 797
+ + F+V++ R +L LVMEYL G L L++ AR+ + L+L
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRLLLYS 133
Query: 798 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 852
+EYL S VHRDL N+L+ + H+K+ DFGL+K +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK-----------------L 176
Query: 853 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 910
+P D Y Y + +P + APE L +D WS G++L+E T
Sbjct: 177 LPLDKDY--YVVREPG------QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228
Query: 911 PPFTAESPEIIFDNILNRKIPWPCV 935
+ + + +
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSRL 253
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-21
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 238
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 798
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 292
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 331
Query: 859 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913
EY P + APE L +D WS GI+L E T G P+
Sbjct: 332 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 48/241 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 741
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 797
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 798 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 855 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 912
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 913 F 913
+
Sbjct: 220 Y 220
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 2e-21
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 36/255 (14%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 746
F + + I G+FG ++L T + AIK+ K ++L E I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRILQGGT 63
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 804
+ + D LVM+ L G L L + V + +++ +E++HS
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD-QMINRVEFVHS 121
Query: 805 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
+HRD+KPDN L+ + + DFGL+K D S + H P
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-----KYRDTSTHQ---------HIPY 167
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---AESP 918
R + GT Y + LG E D S+G +L F+ G P+ A +
Sbjct: 168 ------RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
Query: 919 EIIFDNILNRKIPWP 933
+ ++ I +K+
Sbjct: 222 KQKYEKISEKKVATS 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 35/232 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 803
P +V+ T Y++ E++ G+L LR+ E +Y+A ++ A+EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
+HR+L N L+ + +K+ DFGLS++ D Y
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-----------MTGD----------TYT 374
Query: 864 QTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 375 AHAGAK------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 321
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 798
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 375
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 414
Query: 859 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913
EY P + APE L +D WS GI+L E T G P+
Sbjct: 415 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 61/277 (22%), Positives = 109/277 (39%), Gaps = 57/277 (20%)
Query: 678 SHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRK 727
S + + ++D I + + +G FG V A+ + F A+K+LK D+I
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIAS 66
Query: 728 NDIERILAERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG 781
+DIE L E + +P V + + +++ ++ GDL++ L
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 782 CLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
E + + LV +EYL S +HRDL N ++A D + + DFGLS+
Sbjct: 127 IGENP-FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN---RHSAVGTPDYLAPEILLGTEHG 891
I D Y+Q + +LA E L +
Sbjct: 186 ----------------KIYSGD----YYRQGCASKLPVK--------WLALESLADNLYT 217
Query: 892 YAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 927
+D W+ G+ ++E +T G P+ I++ ++
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 46/276 (16%), Positives = 87/276 (31%), Gaps = 50/276 (18%)
Query: 664 SVSQSSGVSTPLHSSHKERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDL----- 713
+ S L I D +++ PI +G FG ++LA ++ +
Sbjct: 8 QAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAP 67
Query: 714 FAIKVLKK-----------LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762
+KV K + + L + P Y
Sbjct: 68 CVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY-WGSGLHDKNGKSY 126
Query: 763 --LVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 818
++M+ G DL + + V ++ + ++ LEY+H VH D+K NLL
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSL-RILDILEYIHEHEYVHGDIKASNLL 184
Query: 819 I--AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 876
+ + + L D+GL+ Y + GT
Sbjct: 185 LNYKNPDQVYLVDYGLAYRYCPEGV--------------HKAYAA------DPKRCHDGT 224
Query: 877 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912
++ + + G D +G + +++TG P
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 55/242 (22%), Positives = 90/242 (37%), Gaps = 48/242 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 742
D +++ + G+FG V +G A+K LK + + ++ + E N + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 797
+ + ++R Y + +V E G L LRK + L
Sbjct: 78 LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQV 130
Query: 798 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
+ YL S +HRDL NLL+A +K+ DFGL + + +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA----------------LPQN 174
Query: 856 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 911
D HY P + APE L +A+D W G+ L+E T G
Sbjct: 175 DDHY-----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
Query: 912 PF 913
P+
Sbjct: 224 PW 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 18/157 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++ I G FG V L + AIK +++ M E + E +++ + +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 798
P +V+ + + + LV E++ G L LR L+
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEG 116
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
+ YL ++HRDL N L+ + IK++DFG+++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 803
P +V+ T Y++ E++ G+L LR+ E + ++ A+EYL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
+HRDL N L+ + +K+ DFGLS++
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 686 DDFEI--------IKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILA 735
+ + K + G FG V + + A+K+LK + + +LA
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 67
Query: 736 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 795
E N++ + NP++VR ++ LVME G L L++ +++ + ++
Sbjct: 68 EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
+ ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 38/151 (25%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
++ ++K + G FG V L + + D+ A+K++K+ M + E ++ + +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 804
P +V+F+ + +Y+V EY++ G L + LR G E + + ++ + +L S
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
+HRDL N L+ D +K++DFG+++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 48/253 (18%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 741
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 797
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 798 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 855 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 912
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 913 FTAESPEIIFDNI 925
+ I +
Sbjct: 220 YDGIPASEISSIL 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 34/152 (22%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++++ + G FG V++ + A+K LK+ M + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 803
+VR + T ++ +Y++ EY+ G L L+ ++ + + + +A ++ + ++
Sbjct: 68 QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D +K + G FG V + R D+ AIK++K+ M + + E +++ + +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 798
+V+ + T + ++++ EY+ G L + LR++ R +L+ A
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEA 132
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
+EYL S +HRDL N L+ G +K++DFGLS+
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 65/253 (25%), Positives = 100/253 (39%), Gaps = 45/253 (17%)
Query: 674 PLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKN 728
P + I+ I K I G G V R R G AIK LK +
Sbjct: 35 PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ER 92
Query: 729 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 788
L+E +I+ +P ++R T +V EY+ G L + LR
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD------G 146
Query: 789 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841
+ I +LV + YL LG VHRDL N+L+ + K++DFGLS+ ++ +
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--VLEDD 204
Query: 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 901
D + T G +P + T APE + A+D WS G+
Sbjct: 205 PDAAYTTTGGKIP-------IRWT---------------APEAIAFRTFSSASDVWSFGV 242
Query: 902 ILFEFIT-GIPPF 913
+++E + G P+
Sbjct: 243 VMWEVLAYGERPY 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 34/165 (20%), Positives = 69/165 (41%), Gaps = 19/165 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 738
+D + + +G F ++F +R GD +KVL K +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF---FEAAS 64
Query: 739 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVL 797
++ + + +V + C D LV E++ G L + L+K + ++ +A +L
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSK 834
A+ +L ++H ++ N+L+ + IKL+D G+S
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 58/273 (21%), Positives = 102/273 (37%), Gaps = 55/273 (20%)
Query: 658 SRLILDSVSQSSGVSTPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF- 714
+ + + S + + E + + K I G FG V+ +T+
Sbjct: 17 TENLYFQGAMGSDPNQAVLKFTTEIHPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKE 73
Query: 715 ---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 771
AIK LK + L E I+ + ++R + + ++ EY+ G
Sbjct: 74 VPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 131
Query: 772 DLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGH 824
L LR+ + +LV ++YL ++ VHRDL N+L+ +
Sbjct: 132 ALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV 185
Query: 825 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT--P-DYLA 881
K++DFGLS++ D Y + G P + A
Sbjct: 186 CKVSDFGLSRV------------------LEDDPEATY---------TTSGGKIPIRWTA 218
Query: 882 PEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913
PE + + A+D WS GI+++E +T G P+
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-19
Identities = 35/157 (22%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++ K + G FG V++A + A+K +K M +E LAE N++ T+++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 798
+V+ T ++ +Y++ E++ G L L+ ++ ++ + +L+
Sbjct: 243 DKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEG 296
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
+ ++ +HRDL+ N+L++ K+ DFGL+++
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 53/255 (20%)
Query: 674 PLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRK 727
+ + T + +K + G FG V G+ IKV++ D +
Sbjct: 2 AMKVLARIFKETEL---RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGR 56
Query: 728 NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV 787
+ + + ++ + +VR +L LV +YL G L +R+
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQ------HR 109
Query: 788 ARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840
+ L+ + YL G+VHR+L N+L+ +++ DFG++
Sbjct: 110 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD------ 163
Query: 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSV 899
++P D ++ + TP ++A E + ++ + +D WS
Sbjct: 164 -----------LLPPDDKQ--LLYSEAK-------TPIKWMALESIHFGKYTHQSDVWSY 203
Query: 900 GIILFEFIT-GIPPF 913
G+ ++E +T G P+
Sbjct: 204 GVTVWELMTFGAEPY 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 26/197 (13%)
Query: 662 LDSVSQSSGVSTPLHSSHKE--RTSIDDFEI-------IKPISRGAFGRVFLARKRTTGD 712
+ S S+ L E + ++D I K + G FG V +
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 713 LF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-----YSFTCRDNLYLV 764
A+K +K D + +IE L+E + +P V+R S ++
Sbjct: 61 TSLKVAVKTMKL-DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNL 817
+ ++ GDL++ L LE I + L+ +EYL + +HRDL N
Sbjct: 120 LPFMKYGDLHTYLLYSR-LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178
Query: 818 LIAHDGHIKLTDFGLSK 834
++ D + + DFGLSK
Sbjct: 179 MLRDDMTVCVADFGLSK 195
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 46/273 (16%), Positives = 92/273 (33%), Gaps = 52/273 (19%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDL--------FAIKVLKK--------LDMIRKNDIE 731
+++ +R G ++ A +T F++K+ K R
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 732 RILAERNILITVRNPFVVRFFYSFTCRDNL-YLVMEYLNGGDLYSLLRKVGCL---EEDV 787
++ + L + + +D +LV+ L G L S L E V
Sbjct: 104 QVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 788 ARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTIDLS 845
++ L+ ALE+LH VH ++ +N+ + + L +G +
Sbjct: 162 LQVAC-RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR---------- 210
Query: 846 GPETDGIMPSDAH--YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903
PS H Y E +R G ++++ ++ G +D S+G +
Sbjct: 211 ------YCPSGKHVAYVE------GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258
Query: 904 FEFITGIPP---FTAESPEIIFDNILNRKIPWP 933
+++ G P + +I+ P P
Sbjct: 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 57/266 (21%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 740
+ + + + +G+FG V+ K D AIK + + +R + L E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVL 797
VVR + ++ME + GDL S LR +A +++++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 798 -------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850
+ YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---------------- 186
Query: 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYL-----APEILLGTEHGY--AADWWSVGIIL 903
D + +Y + + L +PE L + + +D WS G++L
Sbjct: 187 -----DIYETDYYRKGGKGL---------LPVRWMSPESLK--DGVFTTYSDVWSFGVVL 230
Query: 904 FEFIT-GIPPFTAESPEIIFDNILNR 928
+E T P+ S E + ++
Sbjct: 231 WEIATLAEQPYQGLSNEQVLRFVMEG 256
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 50/242 (20%)
Query: 686 DDFEIIK-PISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 742
D+ I + G FG V R AIKVLK+ K D E ++ E I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQ 66
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 797
+ NP++VR + L LVME GG L+ L I ++ +
Sbjct: 67 LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQV 119
Query: 798 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
++YL VHRDL N+L+ + + K++DFGLSK +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA----------------LGAD 163
Query: 856 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 911
D++Y + P + APE + + +D WS G+ ++E ++ G
Sbjct: 164 DSYY-----------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
Query: 912 PF 913
P+
Sbjct: 213 PY 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 50/256 (19%)
Query: 672 STPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIR 726
+ +H KE T+I I K + G FG V R + AIK LK
Sbjct: 32 TQTVHEFAKELDATNI---SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-- 86
Query: 727 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 786
+ L E +I+ +P ++R T + +V EY+ G L S LRK
Sbjct: 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----- 141
Query: 787 VARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839
A+ + +LV ++YL +G VHRDL N+LI + K++DFGL ++
Sbjct: 142 -AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV---- 196
Query: 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWS 898
D Y + P + +PE + + A+D WS
Sbjct: 197 --------------LEDDPEAAYTTRGGK-------IPIRWTSPEAIAYRKFTSASDVWS 235
Query: 899 VGIILFEFIT-GIPPF 913
GI+L+E ++ G P+
Sbjct: 236 YGIVLWEVMSYGERPY 251
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 742
+D + + + G FG V+ A+K KK + E+ ++E I+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKN 69
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 797
+ +P +V+ + +++ME G+L L + + + LVL
Sbjct: 70 LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQI 122
Query: 798 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
A+ YL S+ VHRD+ N+L+A +KL DFGLS+
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 26/170 (15%)
Query: 683 TSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIER 732
+S D+EI + I G FG V + + AIK K E+
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREK 62
Query: 733 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 792
L E + +P +V+ + ++++ME G+L S L+ + +
Sbjct: 63 FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK------YSLDL 115
Query: 793 AELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
A L+L AL YL S VHRD+ N+L++ + +KL DFGLS+
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++++ I +G FG V L R A+K +K + LAE +++ +R+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRH 73
Query: 746 PFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 802
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
VHRDL N+L++ D K++DFGL+K
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 56/254 (22%), Positives = 98/254 (38%), Gaps = 49/254 (19%)
Query: 689 EIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ I RG FG V+ A+K L ++ I ++ + L E I+ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 85
Query: 746 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAE 794
P V+ + +V+ Y+ GDL + +R +G VA+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK----- 139
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
++YL S VHRDL N ++ +K+ DFGL++ + + +T +P
Sbjct: 140 ---GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 195
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913
V ++A E L + +D WS G++L+E +T G PP+
Sbjct: 196 -------------------V---KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 914 TAESPEIIFDNILN 927
+ I +L
Sbjct: 234 PDVNTFDITVYLLQ 247
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 60/302 (19%)
Query: 646 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 705
K+ + ++ + + +D + + + + S + I RG FG V+
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHG 108
Query: 706 RKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNL 761
A+K L ++ I ++ + L E I+ +P V+ +
Sbjct: 109 TLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166
Query: 762 YLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAELVLALEYLHSLGIVHRD 811
+V+ Y+ GDL + +R +G VA+ +++L S VHRD
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK--------GMKFLASKKFVHRD 217
Query: 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN---- 867
L N ++ +K+ DFGL++ + + +
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARD----------------MYDKE--FDSVHNKTGAKLP 259
Query: 868 -RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 925
+ ++A E L + +D WS G++L+E +T G PP+ + I +
Sbjct: 260 VK----------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 926 LN 927
L
Sbjct: 310 LQ 311
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 6e-18
Identities = 56/246 (22%), Positives = 100/246 (40%), Gaps = 36/246 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 742
+ E+ + I G FG V + + AIK K + E+ L E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQ 447
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEY 801
+P +V+ + ++++ME G+L S L+ L+ +Y +L AL Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
L S VHRD+ N+L++ + +KL DFGLS+ + ++
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDST------------------Y 546
Query: 862 YQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919
Y+ + + P ++APE + A+D W G+ ++E + G+ PF
Sbjct: 547 YKASKGK-------LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 920 IIFDNI 925
+ I
Sbjct: 600 DVIGRI 605
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 740
D + + + GAFG+VFLA + L A+K LK + + D E +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAELL 71
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVARIY 791
+++ +V+F+ D L +V EY+ GDL LR G + +
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 792 IAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833
+++++ + YL S VHRDL N L+ + +K+ DFG+S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 51/296 (17%)
Query: 633 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII- 691
+ + P + + + +D+ S S P K+ D +I
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 692 -KPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 748
+ G FG V R AIKVLK+ K D E ++ E I+ + NP++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYI 398
Query: 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEY 801
VR + L LVME GG L+ L I ++ + ++Y
Sbjct: 399 VRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKY 451
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
L VHR+L N+L+ + + K++DFGLSK + D++Y
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA----------------LGADDSYY-- 493
Query: 862 YQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 913
+ P + APE + + +D WS G+ ++E ++ G P+
Sbjct: 494 ---------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 740
D + + GAFG+VFLA + L A+K LK+ + D E +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELL 97
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYI 792
+++ +VRFF T L +V EY+ GDL LR G + + +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 793 AELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833
+L+ + YL L VHRDL N L+ +K+ DFG+S
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
+ + K + G FG+V A R A+K+LK+ ++ +L+E N+L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 783
V +P V++ + + + L L++EY G L LR+
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 784 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
D + + +L+ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 48/168 (28%), Positives = 70/168 (41%), Gaps = 21/168 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV 743
+D + I G FG+V AR + G AIK +K+ K+D E +L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKL 82
Query: 744 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--- 799
+P ++ + R LYL +EY G+L LRK LE D A L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 800 -------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
+YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 70/281 (24%), Positives = 108/281 (38%), Gaps = 63/281 (22%)
Query: 652 SKYKENSRLILDSVSQSSGVSTPLHS-SHKE-RTSIDDFEIIKPISRGAFGRVFLARKRT 709
SKY + + I D++S S V + + + ++F+ I G FG+V+ R
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 710 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTC--RDNLYLVME 766
G A+K IE E L R+P +V + C R+ + L+ +
Sbjct: 63 -GAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGF---CDERNEMILIYK 115
Query: 767 YLNGGDLYSLLRKVGCLEED---VARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHD 822
Y+ G+L L R+ I L YLH+ I+HRD+K N+L+ +
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175
Query: 823 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH--SAV-GTPDY 879
K+TDFG+SK G E QT H + V GT Y
Sbjct: 176 FVPKITDFGISKKG-----------------------TELDQT-----HLSTVVKGTLGY 207
Query: 880 LAPEILLGTEHGYA--------ADWWSVGIILFEFITGIPP 912
+ PE Y +D +S G++LFE +
Sbjct: 208 IDPE--------YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++++ I +G FG V L R G+ A+K +K + LAE +++ +R+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA-----FLAEASVMTQLRH 245
Query: 746 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 802
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 803 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
VHRDL N+L++ D K++DFGL+K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER-ILAERNILITVRNPFVVRFF 752
+ G FG V+ + A+K L + I ++++ E ++ ++ +V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 753 -YSFTCRDNLYLVMEYLNGGDLYS-LLRKVGCLEED-VARIYIAELVLA--LEYLHSLGI 807
+S D+L LV Y+ G L L G R IA A + +LH
Sbjct: 97 GFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA-QGAANGINFLHENHH 154
Query: 808 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 867
+HRD+K N+L+ K++DFGL++ ++ QT
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARAS-----------------------EKFAQTVM 191
Query: 868 RNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
+R VGT Y+APE L G T +D +S G++L E ITG+P
Sbjct: 192 TSR--IVGTTAYMAPEALRGEITPK---SDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 52/259 (20%), Positives = 95/259 (36%), Gaps = 46/259 (17%)
Query: 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAER 737
ER + I +G FG V+ AIK L ++ ++ +E L E
Sbjct: 19 ERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREG 73
Query: 738 NILITVRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
++ + +P V+ + ++++ Y+ GDL +R + +L+
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ------RNPTVKDLI 127
Query: 797 L-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 849
+EYL VHRDL N ++ +K+ DFGL++ +++
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHR 186
Query: 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 908
+P V + A E L +D WS G++L+E +T
Sbjct: 187 HARLP-------------------V---KWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 909 GIPPFTAESPEIIFDNILN 927
G PP+ P + +
Sbjct: 225 GAPPYRHIDPFDLTHFLAQ 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 738
D + KP+ GAFG+V +A A+K+LK + D+ +++E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 739 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 788
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 789 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 653 KYKENSRLILDSVSQSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLA----- 705
KY+ ++I S P + E+ ++ + K + GAFG+V A
Sbjct: 11 KYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 706 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLV 764
K A+K+LK + E +++E I+ + +V + T + ++
Sbjct: 71 GKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128
Query: 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--------------EYLHSLGIVHR 810
EY GDL + LR+ + E IA + +L S +HR
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188
Query: 811 DLKPDNLLIAHDGHIKLTDFGLS 833
D+ N+L+ + K+ DFGL+
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLA 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 36/169 (21%), Positives = 60/169 (35%), Gaps = 23/169 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNIL 740
++ + FG+V+ AIK LK E E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLR 66
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL- 799
+++P VV T L ++ Y + GDL+ L + + + AL
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 800 ---------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833
EYL S +VH+DL N+L+ ++K++D GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 26/172 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
+ K + GAFG+V A K A+K+LK + + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 741 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------VGCLEEDVA 788
+ N +V + T ++ EY GDL + LR+ +E+D
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 789 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833
+ + +L+ + +L S +HRDL N+L+ H K+ DFGL+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 31/178 (17%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 104
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 783
NP +V+ + L+ EY+ GDL LR
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 784 EEDVARIYIAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
+ AE + + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 738
D + KP+ G FG+V +A K A+K+LK + D+ +++E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 739 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 788
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 789 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 17/164 (10%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 740
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LAL 799
+ +VR +++ME + GGDL S LR+ + + + +L+ +A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 800 ------EYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 834
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 37/164 (22%), Positives = 69/164 (42%), Gaps = 17/164 (10%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 740
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV---- 796
+ +VR ++++E + GGDL S LR+ + + + +L+
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 797 ---LALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 834
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
D ++ KP+ RGAFG+V A K T A+K+LK+ + +++E IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 741 ITV-RNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK---------VGCLEEDVAR 789
I + + VV + T L +++E+ G+L + LR V +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 790 IYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
+ + L+ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 26/173 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 738
D + KP+ GAFG+V LA K A+K+LK + D+ +++E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 739 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 788
++ + ++ + T LY+++EY + G+L L+
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 789 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
++ +LV +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
++ E K + GAFG+V A K A+K+LK+ + E +++E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 102
Query: 741 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCL 783
+ + +V + T +YL+ EY GDL + LR
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 784 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833
EED+ + +L+ +E+L VHRDL N+L+ H +K+ DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 79.5 bits (195), Expect = 4e-15
Identities = 101/726 (13%), Positives = 194/726 (26%), Gaps = 240/726 (33%)
Query: 395 HEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKL--SEIL 452
H +D ++++ E A +C DV + + E +
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILS--VFED-------AFVDNFDCKDVQDMPKSILSKEEI 51
Query: 453 EQISESCNSSSHP------ILGSPENSRTQSMNSAITYDGYSPKISEWRNK-----GVEG 501
+ I S ++ S +L E + + + + Y +S + + +
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTR 110
Query: 502 MFEDIHEM---DTACIDDSHLGS----LNLRGHLGLKLS-----------GYGASSSTGS 543
M+ + + D ++ L LR L L+L G G +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-LELRPAKNVLIDGVLGSGKTWVALD 169
Query: 544 MTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLAC 603
S F FWL ++ C + + + L
Sbjct: 170 --VCLSYKVQCKMDFKIFWL------------------NLKNCNSPETVLEMLQKLLYQI 209
Query: 604 MHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILD 663
+ HS L I + + + +LL+ K Y+ N L+L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-----------------PYE-NCLLVLL 251
Query: 664 SV------------------SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 705
+V ++ V+ L ++ S+D
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS-------MTLT----- 299
Query: 706 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV----RFFYSFTCR--- 758
L K LD R D L + NP +
Sbjct: 300 -PDEVKSLLL----KYLDC-RPQD----LPREVLTT---NPRRLSIIAESIRDGLATWDN 346
Query: 759 ------DNLYLVME----YLNGGDLYSLLRKVGCLEEDVARIYIAELVLA---------- 798
D L ++E L + + ++ +I ++L+
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA---HIPTILLSLIWFDVIKSD 403
Query: 799 ----LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ LH +V + K + I +++L ++ L + +D
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISI-PSIYLELKVKLENEYALHRSIVD----------- 451
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------T 908
HY + D+ D L P Y + I
Sbjct: 452 ---HYNIPKTFDS----------DDLIPP----YLDQY----------FYSHIGHHLKNI 484
Query: 909 GIPPFTAESPEIIFD-NILNRKI-----PWPCVPSDMSFEAQDLIN--RFLI-HDP-NQR 958
P + D L +KI W S ++ Q L ++ +DP +R
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-TLQQLKFYKPYICDNDPKYER 543
Query: 959 LGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQI-SSGLPDDQN 1017
L VN A+ F+P+ E + S+++ + L +
Sbjct: 544 L----------------VN----AILD--FLPKIE----ENLICSKYTDLLRIALMAEDE 577
Query: 1018 GSYSDA 1023
+ +A
Sbjct: 578 AIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 1e-12
Identities = 77/597 (12%), Positives = 166/597 (27%), Gaps = 169/597 (28%)
Query: 605 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDE--KSPTSFSKYKENSRLIL 662
+ +D+L A V + ++ + + IL+ E +D S + + +
Sbjct: 16 YQYKDILSVF-EDAFVDNFDCKDVQDMPKS--ILSKEEIDHIIMSKDA----VSGTLRLF 68
Query: 663 DSV--SQSSGVSTPLHSSHKERTSIDDFEII------KPISRGAFGRVFL-ARKRTTGDL 713
++ Q V + + +++ + + R+++ R R D
Sbjct: 69 WTLLSKQEEMVQKFVEEVLR-----INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND- 122
Query: 714 FAIKVLKKLDMIRKNDIERI-------------------------LAE---RNILITVRN 745
+V K ++ R ++ +A + + +
Sbjct: 123 --NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
F + F+ + ++ V+E L L + D + + L L
Sbjct: 181 DFKI-FWLNLKNCNSPETVLEMLQ--KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 806 GIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI----NNTIDLSGPETDGIMPSDA 857
+ + + LL+ + + KI L+ D T + D
Sbjct: 238 -LKSKPY-ENCLLVLLNVQNAKAWNAFNLS-CKI-LLTTRFKQVTDFLSAATTTHISLDH 293
Query: 858 HYPEYQQTDNRN-------------RHSAVGT-PDYLAPEILLGTE-HGYAADW------ 896
H + ++ + T P L+ ++ A W
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS---IIAESIRDGLATWDNWKHV 350
Query: 897 --WSVGIILFEFITGIPPFTAESPEI-----IFDNILNRKIP-------WP-CVPSDMSF 941
+ I+ + + P AE ++ +F + IP W + SD+
Sbjct: 351 NCDKLTTIIESSLNVLEP--AEYRKMFDRLSVFPP--SAHIPTILLSLIWFDVIKSDVMV 406
Query: 942 EAQDLINRFL-----------IHDPNQRLGANGAAEVKAH-------PFFKGVNWDSLAL 983
L L I L E H K + D L
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI- 465
Query: 984 QKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGS--------YSDAD--------TCD 1027
P +D YF +S I L + ++ + D
Sbjct: 466 --------PPYLDQ--YF---YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 1028 SSSNSRTEMDECGDLAEFG-----SCP----LDLSLINFSFKNLSQLASINHEVLVQ 1075
+ + S + ++ L + + P L ++++F K L + L++
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR 569
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 67/543 (12%), Positives = 137/543 (25%), Gaps = 167/543 (30%)
Query: 38 YGVSRPPQKHKQKTVAQ--------------GHVK--LANSFTEVRKGKKIAQ------- 74
Y VSR K + G K +A +V K+
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL---DVCLSYKVQCKMDFKIF 185
Query: 75 WFT--------SYISKFNIVSPNTENSGSEDKDVDVEDPRRT-----KLRHEGNHLNEKQ 121
W + + + + + + D R +LR +
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 122 SLA--EHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDL--KELLDTLHSRFDAAK 177
L +V ++K +F +L K LL T RF K
Sbjct: 246 CLLVLLNVQNAKA---WNAF---------------------NLSCKILLTT---RF---K 275
Query: 178 EVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQD 237
+V + A + L+ + E+ +L + ++ QD
Sbjct: 276 QVTDFLSAATTTHI--SLDHHSMTLTP-DEVKS---LLL-KYLDCR-----------PQD 317
Query: 238 LTEKRQQCQVG--LVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAV 295
L R+ + ++ + L +K + L +
Sbjct: 318 L--PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC------DKLTTIIESSLNVL--- 366
Query: 296 ETSWVPSPGTAESDLDYASYQK-----ANAKKKISGQQKVSTVPEI----SDCSCSESLD 346
E + + +A I + + + S +
Sbjct: 367 -----------EPAEYRKMFDRLSVFPPSA--HIP-----TILLSLIWFDVIKSDVMVVV 408
Query: 347 HTSENKSVFIEQNFPPQKSQH--YSRMQEQQSHIVE--GRIVEVTKSNCGSPHEQGQSLD 402
+ S+ +Q S Y ++ + + IV+ +
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPP 467
Query: 403 GSDSVICRICEEVVPISHLESHSYICAYADKCEL-NCLDVDERLLKLSEILEQISESCNS 461
D SH+ H + ++ L + +D R L+ ++I
Sbjct: 468 YLDQYFY---------SHIGHHLKNIEHPERMTLFRMVFLDFRFLE-----QKIRHD--- 510
Query: 462 SSHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGV-EGMFEDI----HEMDTACIDD 516
+ N+ +N+ Y P I + N E + I +++ I
Sbjct: 511 ------STAWNASGSILNTLQQLKFYKPYICD--NDPKYERLVNAILDFLPKIEENLICS 562
Query: 517 SHL 519
+
Sbjct: 563 KYT 565
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 4e-13
Identities = 45/219 (20%), Positives = 71/219 (32%), Gaps = 56/219 (25%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL-----KKLDMIRKNDIERILAERN 738
+ + + I G FG VF AIK++ ++ + E IL E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 739 IL-----------------ITVRNPFVVRFFY----------------------SFTCRD 759
I I + + V+ Y F D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 760 NLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNL 817
L++V+E+ GG DL + K+ A+ + +L +L SL HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 818 LIAHDGHIKLTDFGLSKI------GLINNTIDLSGPETD 850
L+ KL K GL + ID + +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-13
Identities = 66/246 (26%), Positives = 100/246 (40%), Gaps = 58/246 (23%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D+F + RG FG+V+ R G L A+K LK+ + + +++ E ++ +
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKE-ERTQGGELQ-FQTEVEMISMAVH 86
Query: 746 PFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLA 798
++R F C LV Y+ G + S LR E R IA L A
Sbjct: 87 RNLLRL-RGF-CMTPTERLLVYPYMANGSVASCLR--ERPESQPPLDWPKRQRIA-LGSA 141
Query: 799 --LEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
L YLH I+HRD+K N+L+ + + DFGL+K+ +T
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------------ 189
Query: 854 PSDAHYPEYQQTDNRNRH--SAV-GTPDYLAPEILLGTEHGYA---ADWWSVGIILFEFI 907
H +AV GT ++APE L G + D + G++L E I
Sbjct: 190 -----------------HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELI 229
Query: 908 TGIPPF 913
TG F
Sbjct: 230 TGQRAF 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 39/186 (20%), Positives = 71/186 (38%), Gaps = 14/186 (7%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
D ++ KP+ RGAFG+V A K T A+K+LK + ++ +++E IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79
Query: 741 ITVRN-PFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 798
I + + VV + T L +++E+ G+L + LR + + Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARF 135
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDA 857
+ +G + DLK I + F K + + D +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 858 HYPEYQ 863
+Q
Sbjct: 196 ICYSFQ 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 28/115 (24%)
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR------------------------- 241
Query: 860 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 912
+ + + R P ++APE + + +D WS G++L+E + G P
Sbjct: 242 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 34/149 (22%), Positives = 57/149 (38%), Gaps = 21/149 (14%)
Query: 694 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRNPF 747
I +GA + + +V K +LD IRK R E L V++
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAREARYLALVKDFG 400
Query: 748 V-VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
+ + + DN ++M Y+NG ++ + + I + LH
Sbjct: 401 IPAPYIFDVD-LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEI--------VGKLHKND 451
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835
++H DL N + D + + DFGL KI
Sbjct: 452 VIHNDLTTSNFIF--DKDLYIIDFGLGKI 478
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 28/169 (16%), Positives = 54/169 (31%), Gaps = 30/169 (17%)
Query: 678 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM------------- 724
+D I K + G VF +K K
Sbjct: 84 RLVRSGKVDA--IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGD 140
Query: 725 IRKNDIERILAER--NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 782
+ + + A L ++ V + + N ++ME ++ +LY +
Sbjct: 141 LHFSVLAIRSARNEFRALQKLQGLAVPKVYA---WEGNA-VLMELIDAKELYRVR----- 191
Query: 783 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831
E+ + ++ + + GIVH DL N+L+ + I + DF
Sbjct: 192 -VENPDEVL-DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFP 237
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1091 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.95 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.97 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.66 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.38 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.26 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.88 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.86 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-66 Score=573.40 Aligned_cols=280 Identities=36% Similarity=0.731 Sum_probs=256.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++|||||++|++|++++.+
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34567899999999999999999999999999999999987666666788999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|||||||+||+|.++|.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~-- 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-- 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999853110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.......+.|||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..++
T Consensus 186 -----------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 242 (311)
T 4aw0_A 186 -----------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242 (311)
T ss_dssp -----------------------TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -----------------------CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 112234578999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc---cHHHHHcCCCCCCCCcchhhcccCCcc
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDSLALQKAVFV 989 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~---gA~EIL~HPFFkgIdWd~L~~~~pPfi 989 (1091)
+.+|++..+.+| ..+|+++++||.+||++||.+|||+. +..+|++||||++++|+.|..+.||.+
T Consensus 243 ~~~i~~~~~~~p---~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 243 FAKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp HHHHHHTCCCCC---TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred HHHHHcCCCCCC---cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 999999988776 68999999999999999999999965 346799999999999999988877654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-66 Score=617.01 Aligned_cols=405 Identities=33% Similarity=0.534 Sum_probs=305.8
Q ss_pred hhhhhhhhhhhhhhhhccchhhHhhhccchH-HH----HhhcccceEeccchhHHHHHH---hhhhHHhhhhhcccCCCC
Q 001370 578 IELADIARCVADTDFSKEGSEFLLACMHDLQ-DV----LQHSKLKALVIDTFGSRIEKL---LREKYILACELLDEKSPT 649 (1091)
Q Consensus 578 ~~~~~~~~~~~~~~~~ke~~~~l~~~~~~~~-~~----~~~~kl~~lvid~~g~rI~kl---lr~k~~l~~~lL~~ksp~ 649 (1091)
.++...|+.|+++|+++| ..+|.+.+. .+ ...........+.|....... +....
T Consensus 99 ~~r~~~~~~i~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~lf~~~~~~~~~~l~~~~------------- 161 (689)
T 3v5w_A 99 EERVARSREIFDSYIMKE----LLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDV------------- 161 (689)
T ss_dssp HHHHHHHHHHHTSHHHHH----HHSSSSCCCHHHHHHHHHHHHTTCCCTTTTHHHHHHHHHHHTTHH-------------
T ss_pred hhHHHHHHHHHHHhcchh----hhhccCccchHHHHHHHHhhhhccCChHHHHHHHHHHHHHhccCc-------------
Confidence 445678999999999999 667777654 21 122223344556665543332 11111
Q ss_pred cccccccchhhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhH
Q 001370 650 SFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND 729 (1091)
Q Consensus 650 s~Sk~~ensrllldsvs~ssg~~tpl~ss~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~e 729 (1091)
|+++...... ....+.... .....+++++|+++++||+|+||+||+|+++.+|+.||||++++..+.....
T Consensus 162 -f~~~~~s~~~--~r~~q~k~~------e~~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~ 232 (689)
T 3v5w_A 162 -FQKFIESDKF--TRFCQWKNV------ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG 232 (689)
T ss_dssp -HHHHHHSHHH--HHHHHHHHH------HTTCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC
T ss_pred -ccccccChhH--HHHHhcccc------ccCCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh
Confidence 1111110000 000000000 0112467889999999999999999999999999999999999876655555
Q ss_pred HHHHHHHHHH---HHhcCCCceEEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 001370 730 IERILAERNI---LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806 (1091)
Q Consensus 730 ie~~l~EieI---LskL~HPNIVkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~G 806 (1091)
...+.+|+.+ +..++|||||+++++|++.+.+|||||||+||+|+++|.+.+.|++..+++|++||+.||+|||++|
T Consensus 233 ~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g 312 (689)
T 3v5w_A 233 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 312 (689)
T ss_dssp HHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6666676554 4566899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc
Q 001370 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 886 (1091)
Q Consensus 807 IIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~ 886 (1091)
||||||||+||||+.+|++||+|||+|+... .....+.||||.|||||++.
T Consensus 313 IiHRDLKPeNILld~~G~vKL~DFGlA~~~~-----------------------------~~~~~t~~GTp~YmAPEvl~ 363 (689)
T 3v5w_A 313 VVYRDLKPANILLDEHGHVRISDLGLACDFS-----------------------------KKKPHASVGTHGYMAPEVLQ 363 (689)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECS-----------------------------SCCCCSCCSCGGGCCHHHHS
T ss_pred ccccCCchHHeEEeCCCCEEecccceeeecC-----------------------------CCCCCCccCCcCccCHHHHh
Confidence 9999999999999999999999999998521 12245689999999999997
Q ss_pred -CCCCCccceeechhhhHHHHHhCCCCCCCC---ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc-
Q 001370 887 -GTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA- 961 (1091)
Q Consensus 887 -g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~---s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa- 961 (1091)
+.+|+.++|||||||+||||++|++||.+. +..+++..+....+.+| ..+|+++++||.+||++||.+|+|.
T Consensus 364 ~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p---~~~S~~a~dLI~~lL~~dP~~Rl~~~ 440 (689)
T 3v5w_A 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCL 440 (689)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCGGGCTTCS
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC---ccCCHHHHHHHHHHccCCHhHCCCCC
Confidence 468999999999999999999999999764 34567778888877766 7899999999999999999999994
Q ss_pred -ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcc-----ccccccccCCCCCCCCCCCCCCCCCCcCCCCCCc
Q 001370 962 -NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTS-----YFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSR 1033 (1091)
Q Consensus 962 -~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts-----~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~ 1033 (1091)
.++.||++||||++++|+.+..+ .|||+|.+..+.+++ +|+.+++. +..+.+.+...+.+|++ ..+..|+
T Consensus 441 ~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~e~~~-~~~~~~~d~~~f~~Fs~-~~~~~~q 518 (689)
T 3v5w_A 441 GRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTK-GIKLLDSDQELYRNFPL-TISERWQ 518 (689)
T ss_dssp SSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC---------C-CCCCCHHHHTTTTTCCE-ECHHHHH
T ss_pred CCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccCCccccC-CCCCCchHHHHHhCCCc-cCccchh
Confidence 57999999999999999999766 799999877665554 44444332 22333344556666665 4445677
Q ss_pred chhhccCCcc
Q 001370 1034 TEMDECGDLA 1043 (1091)
Q Consensus 1034 ~em~et~~f~ 1043 (1091)
.+|.++ .|.
T Consensus 519 ~e~~et-~~~ 527 (689)
T 3v5w_A 519 QEVAET-VFD 527 (689)
T ss_dssp HHHHTT-THH
T ss_pred hhhhhh-hhh
Confidence 777665 444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-65 Score=558.88 Aligned_cols=277 Identities=42% Similarity=0.785 Sum_probs=244.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
...++|++++.||+|+||+||+|++. .+++.||||++++..... ....++.+|+.+|.+++|||||+++++|++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 44578999999999999999999984 468899999998754432 23446889999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|||||||+||+|.++|.+.+.+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-- 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI-- 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..
T Consensus 178 -------------------------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 232 (304)
T 3ubd_A 178 -------------------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232 (304)
T ss_dssp ----------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH
Confidence 0112345689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVP 990 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP 990 (1091)
+++.+|.+..+.+| ..+|+++++||.+||++||.+|||+ ..+.|+++||||++++|+.+..+ +|||+|
T Consensus 233 ~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 233 ETMTMILKAKLGMP---QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred HHHHHHHcCCCCCC---CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 99999999887766 6899999999999999999999995 35789999999999999999766 689987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=527.35 Aligned_cols=301 Identities=40% Similarity=0.772 Sum_probs=267.9
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded 759 (1091)
..+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..+ +||||++++++|++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346789999999999999999999999999999999999986665666778899999999988 6999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||++||+|.+++.+.+.+++..++.|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~-- 175 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI-- 175 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC--
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc--
Confidence 999999999999999999998999999999999999999999999999999999999999999999999999997421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 176 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 176 -------------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp -------------------------C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 0122345678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc---ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 994 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa---~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s 994 (1091)
+++..|.+....+| ..+++++.+||.+||++||.+||++ .++.++++||||++++|+.+..+ .|||+|...+
T Consensus 231 ~~~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~ 307 (353)
T 3txo_A 231 DLFEAILNDEVVYP---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKS 307 (353)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred HHHHHHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCC
Confidence 99999999988776 6799999999999999999999995 45689999999999999998765 7999999999
Q ss_pred CCCccccccccccCCCC
Q 001370 995 VDDTSYFLSRFSQISSG 1011 (1091)
Q Consensus 995 ~~Dts~Fds~fs~~~s~ 1011 (1091)
..|+++|+..|+.....
T Consensus 308 ~~~~~~f~~~~~~~~~~ 324 (353)
T 3txo_A 308 REDVSNFDPDFIKEEPV 324 (353)
T ss_dssp TTCCTTSCHHHHTSCCC
T ss_pred cccccccCcccccCCCc
Confidence 99999999988776443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-61 Score=518.43 Aligned_cols=256 Identities=34% Similarity=0.614 Sum_probs=220.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||+++++|.+++.+||
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999988766666667889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||||| +|+|.+++.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~------ 163 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT------ 163 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC------
Confidence 99999 68999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
......+.+||+.|||||++.+..| +.++|||||||++|||++|++||.+.+...++
T Consensus 164 ----------------------~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~ 221 (275)
T 3hyh_A 164 ----------------------DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF 221 (275)
T ss_dssp ---------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 1122345799999999999999886 58999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
+.|.++...+| ..+|+++++||.+||++||++||| +.|+++||||+
T Consensus 222 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hpw~k 267 (275)
T 3hyh_A 222 KNISNGVYTLP---KFLSPGAAGLIKRMLIVNPLNRIS---IHEIMQDDWFK 267 (275)
T ss_dssp HHHHHTCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHCHHHH
T ss_pred HHHHcCCCCCC---CCCCHHHHHHHHHHccCChhHCcC---HHHHHcCcccc
Confidence 99999887766 689999999999999999999999 88999999996
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-60 Score=534.10 Aligned_cols=303 Identities=37% Similarity=0.739 Sum_probs=269.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~ 760 (1091)
.+..++|+++++||+|+||+||+|+++.+++.||||++++...........+.+|+.+|.++ +|||||+++++|++.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45678999999999999999999999999999999999987666666677889999999887 89999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||||++||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--- 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--- 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC---
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc---
Confidence 99999999999999999998999999999999999999999999999999999999999999999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC----
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---- 916 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~---- 916 (1091)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|++||...
T Consensus 205 ------------------------~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~ 260 (396)
T 4dc2_A 205 ------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260 (396)
T ss_dssp ------------------------CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--
T ss_pred ------------------------cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccc
Confidence 1122345679999999999999999999999999999999999999999642
Q ss_pred -----ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc---ccHHHHHcCCCCCCCCcchhhcc--cC
Q 001370 917 -----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KA 986 (1091)
Q Consensus 917 -----s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa---~gA~EIL~HPFFkgIdWd~L~~~--~p 986 (1091)
....++..+....+.+| ..++.++++||.+||++||.+||++ .++.+|++||||++++|+.+..+ .|
T Consensus 261 ~~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~p 337 (396)
T 4dc2_A 261 NPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 337 (396)
T ss_dssp ----CCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCC
T ss_pred ccchhhHHHHHHHHhccccCCC---CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCC
Confidence 34557788888887766 6899999999999999999999996 36899999999999999998766 79
Q ss_pred CccCCCCCCCCccccccccccCCCCCCC
Q 001370 987 VFVPQPESVDDTSYFLSRFSQISSGLPD 1014 (1091)
Q Consensus 987 PfiP~~~s~~Dts~Fds~fs~~~s~l~~ 1014 (1091)
||+|...+..|+++|++.|+..+..+.+
T Consensus 338 p~~p~~~~~~d~~~fd~~~~~~~~~~~~ 365 (396)
T 4dc2_A 338 PFKPNISGEFGLDNFDSQFTNEPVQLTP 365 (396)
T ss_dssp SCCCCCCSSTTGGGSCHHHHTSCCCCCC
T ss_pred CCcCCCCCccchhhcChhhccCCCccCC
Confidence 9999999999999999998887655443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-60 Score=528.58 Aligned_cols=257 Identities=32% Similarity=0.537 Sum_probs=231.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
..|++++.||+|+||+||+|+++.+|+.||||++++.... ..+.+.+|+.+|+.++|||||++|++|++.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999999865432 3456889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
|||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-------- 221 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------- 221 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC--------
Confidence 99999999999875 679999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.......+.|||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..|
T Consensus 222 -------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 282 (346)
T 4fih_A 222 -------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282 (346)
T ss_dssp -------------------SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -------------------CCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 0112345689999999999999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.....+....+..+|+++++||.+||++||.+||| +.|+|+||||+..
T Consensus 283 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 283 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 330 (346)
T ss_dssp HHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhcCC
Confidence 87644333334679999999999999999999999 8899999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-59 Score=514.71 Aligned_cols=300 Identities=41% Similarity=0.757 Sum_probs=272.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|..++||||++++++|++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45789999999999999999999999999999999998865555567788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~----- 156 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----- 156 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-----
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc-----
Confidence 999999999999999998999999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...++
T Consensus 157 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 214 (337)
T 1o6l_A 157 ----------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214 (337)
T ss_dssp ----------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH
Confidence 0112234678999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCc
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 998 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dt 998 (1091)
..|......+| ..+++++++||.+||++||.+||+. .++.++++||||++++|+.+..+ .|||+|.+.+..|+
T Consensus 215 ~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~ 291 (337)
T 1o6l_A 215 ELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDT 291 (337)
T ss_dssp HHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCC
T ss_pred HHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchh
Confidence 99998887766 6899999999999999999999963 35999999999999999998765 79999999999999
Q ss_pred cccccccccCCCCC
Q 001370 999 SYFLSRFSQISSGL 1012 (1091)
Q Consensus 999 s~Fds~fs~~~s~l 1012 (1091)
++|+..|+......
T Consensus 292 ~~f~~~~~~~~~~~ 305 (337)
T 1o6l_A 292 RYFDDEFTAQSITI 305 (337)
T ss_dssp TTSCHHHHTSCCC-
T ss_pred hcccchhccCccCc
Confidence 99998887765443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=530.82 Aligned_cols=259 Identities=27% Similarity=0.511 Sum_probs=229.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
.+++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||+++++|++.+.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45799999999999999999999999999999999987554 34567889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|||||+||+|.++|... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--- 177 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--- 177 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH---
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC---
Confidence 99999999999999754 3579999999999999999999999999999999999999999999999999985310
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..++
T Consensus 178 ------------------------~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 233 (350)
T 4b9d_A 178 ------------------------TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233 (350)
T ss_dssp ------------------------HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 11223457899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+.+|+++.. |.++..+|+++++||.+||++||.+||| +.|+|+||||+.
T Consensus 234 ~~~i~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~ 282 (350)
T 4b9d_A 234 VLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPS---VNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHT
T ss_pred HHHHHcCCC--CCCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHHhhc
Confidence 999998865 3446789999999999999999999999 889999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=520.69 Aligned_cols=299 Identities=34% Similarity=0.722 Sum_probs=268.0
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded 759 (1091)
.+...++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|..+ +||||++++++|++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 346789999999999999999999999999999999999886655556678899999999887 7999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 172 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999997421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 173 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 227 (353)
T 2i0e_A 173 -------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227 (353)
T ss_dssp -------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH
Confidence 0112335678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 995 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~ 995 (1091)
+++..|....+.+| ..++.++++||.+||++||.+||+. .++.+|++||||++++|+.+..+ .|||+|...+.
T Consensus 228 ~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~ 304 (353)
T 2i0e_A 228 ELFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR 304 (353)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC
T ss_pred HHHHHHHhCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc
Confidence 99999999887776 6899999999999999999999985 46899999999999999999665 79999999888
Q ss_pred CCccccccccccCCC
Q 001370 996 DDTSYFLSRFSQISS 1010 (1091)
Q Consensus 996 ~Dts~Fds~fs~~~s 1010 (1091)
|+++|+.+|+....
T Consensus 305 -~~~~f~~~~~~~~~ 318 (353)
T 2i0e_A 305 -NAENFDRFFTRHPP 318 (353)
T ss_dssp ---CHHHHHHHHSCC
T ss_pred -chhhccchhccCCc
Confidence 99999988776543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-59 Score=520.03 Aligned_cols=300 Identities=39% Similarity=0.756 Sum_probs=250.3
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieI-LskL~HPNIVkL~gsfqde 758 (1091)
......++|++++.||+|+||+||+|+++.+++.||||++++..........++.+|+.+ +..++|||||+++++|++.
T Consensus 32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 345678899999999999999999999999999999999998777666677788888887 4678999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+.+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999984210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 192 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 192 ---------------------------HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp ---------------------------CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred ---------------------------CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 11234567899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc-ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 995 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa-~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~ 995 (1091)
.+++..|+.....+| ..++.++++||.+||++||.+||++ +++.++++||||++++|+.+..+ .|||+|...++
T Consensus 245 ~~~~~~i~~~~~~~~---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~ 321 (373)
T 2r5t_A 245 AEMYDNILNKPLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGP 321 (373)
T ss_dssp HHHHHHHHHSCCCCC---SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC-
T ss_pred HHHHHHHHhcccCCC---CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCc
Confidence 999999999877766 6899999999999999999999996 46889999999999999999665 79999999999
Q ss_pred CCccccccccccCC
Q 001370 996 DDTSYFLSRFSQIS 1009 (1091)
Q Consensus 996 ~Dts~Fds~fs~~~ 1009 (1091)
.|+++|+..|+...
T Consensus 322 ~d~~~f~~~~~~~~ 335 (373)
T 2r5t_A 322 NDLRHFDPEFTEEP 335 (373)
T ss_dssp --------------
T ss_pred chhhhcCccccccc
Confidence 99999998776653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=534.57 Aligned_cols=334 Identities=35% Similarity=0.660 Sum_probs=280.4
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
+...++|+++++||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++|||||+++++|++.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876555555556689999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|||||||+||+|.+++.+ .+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~- 228 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED- 228 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-
Confidence 999999999999999987 468999999999999999999999999999999999999999999999999999753110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
........+||+.|||||++. +..|+.++|||||||+||||++|++||.+
T Consensus 229 -------------------------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 229 -------------------------GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp -------------------------SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -------------------------CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 111234568999999999997 46789999999999999999999999999
Q ss_pred CChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHhhhccCCCCC--CCCcccHHHHHcCCCCCCCCcchhhcccCCccCC
Q 001370 916 ESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQ 991 (1091)
Q Consensus 916 ~s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~rcL~kDPeK--RpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~ 991 (1091)
.+..+++.+|+.. .+.+|.....+++++++||++||+.+|++ |++ +.++++||||++++|+.+....|||+|.
T Consensus 284 ~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~---~~eil~Hpff~~i~w~~l~~~~~p~~P~ 360 (437)
T 4aw2_A 284 ESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNG---IEDFKKHPFFSGIDWDNIRNCEAPYIPE 360 (437)
T ss_dssp SSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTT---THHHHTSGGGTTCCTTTGGGSCCSCCCC
T ss_pred CChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCC---HHHHhCCCccCCCCHHHHhhCCCCCCCc
Confidence 9999999999864 45667655679999999999999988877 776 8899999999999999998889999999
Q ss_pred CCCCCCccccccccccCCCCCCCCCCCCCCCCCCcCCCCCCcchhhccCCccccCCCCCCCcccCceeecchhhhccc
Q 001370 992 PESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 1069 (1091)
Q Consensus 992 ~~s~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~~em~et~~f~e~~~~~~d~~Fig~tyk~~~~~~~~~ 1069 (1091)
..++.|+++|+..+........ ... .. .......+++|.||||++++.+..-+
T Consensus 361 ~~~~~d~~~fd~~~~~~~~~~~------------~~~--~~-----------~~~~~~~~~~f~~~~~~~~~~~~~~~ 413 (437)
T 4aw2_A 361 VSSPTDTSNFDVDDDCLKNSET------------MPP--PT-----------HTAFSGHHLPFVGFTYTSSCVLSDRS 413 (437)
T ss_dssp CSSTTCCTTSCCC-------------------------------------------CCTTGGGTTCCEESSCTTSTTS
T ss_pred CCCccchhhcCCcccccccccC------------CCC--Cc-----------cccccccCccccCCCcCCchhhccCC
Confidence 9999999999875432211000 000 00 01122357899999999999886655
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-59 Score=529.40 Aligned_cols=296 Identities=40% Similarity=0.741 Sum_probs=257.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
+...++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|++.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999886655556667789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
||||||++||+|.+++.+.+ .+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~- 215 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD- 215 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC-
Confidence 99999999999999998765 7999999999999999999999999999999999999999999999999999853110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-------CCCCCccceeechhhhHHHHHhCCCCC
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-------GTEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-------g~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
........+||+.|||||++. +..|+.++|||||||++|||++|++||
T Consensus 216 -------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 216 -------------------------GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp -------------------------SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred -------------------------CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 011234578999999999997 356899999999999999999999999
Q ss_pred CCCChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcccCCccCC
Q 001370 914 TAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQ 991 (1091)
Q Consensus 914 ~~~s~~ei~~kIl~~--~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~~pPfiP~ 991 (1091)
.+.+..+++.+|+.. ...+|..+..+|+++++||.+||+ +|.+|++..++.++++||||++++|+.+....|||+|.
T Consensus 271 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~ 349 (412)
T 2vd5_A 271 YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPD 349 (412)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC
T ss_pred CCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCc
Confidence 999999999999863 355665567899999999999999 99999876679999999999999999998889999999
Q ss_pred CCCCCCccccccc
Q 001370 992 PESVDDTSYFLSR 1004 (1091)
Q Consensus 992 ~~s~~Dts~Fds~ 1004 (1091)
..+..|++||+..
T Consensus 350 ~~~~~d~~~f~~~ 362 (412)
T 2vd5_A 350 FEGATDTCNFDLV 362 (412)
T ss_dssp -----CCSSCC--
T ss_pred CCCcccccccCcc
Confidence 9999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=507.53 Aligned_cols=299 Identities=37% Similarity=0.749 Sum_probs=268.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~ 760 (1091)
....++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.++.++ +|||||+++++|++.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 35678999999999999999999999999999999999987766677788899999999988 89999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~--- 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--- 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC---
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC-----
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA----- 915 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~----- 915 (1091)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||..
T Consensus 162 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 217 (345)
T 3a8x_A 162 ------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217 (345)
T ss_dssp ------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--
T ss_pred ------------------------CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccc
Confidence 011223467899999999999999999999999999999999999999975
Q ss_pred ----CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc---ccHHHHHcCCCCCCCCcchhhcc--cC
Q 001370 916 ----ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KA 986 (1091)
Q Consensus 916 ----~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa---~gA~EIL~HPFFkgIdWd~L~~~--~p 986 (1091)
.....++..+......+| ..++.++++||.+||++||.+||++ .++.++++||||++++|+.+..+ .|
T Consensus 218 ~~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~ 294 (345)
T 3a8x_A 218 NPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 294 (345)
T ss_dssp -----CHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred ccccccHHHHHHHHHcCCCCCC---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCC
Confidence 344567778888777666 6899999999999999999999996 35789999999999999998765 78
Q ss_pred CccCCCCCCCCccccccccccCCC
Q 001370 987 VFVPQPESVDDTSYFLSRFSQISS 1010 (1091)
Q Consensus 987 PfiP~~~s~~Dts~Fds~fs~~~s 1010 (1091)
||+|...+..|+++|+..|+....
T Consensus 295 p~~p~~~~~~~~~~~~~~~~~~~~ 318 (345)
T 3a8x_A 295 PFKPNISGEFGLDNFDSQFTNEPV 318 (345)
T ss_dssp SCCCCCCTTTCGGGSCHHHHTSCS
T ss_pred CcCCCCCCcchhhhcCcccccCcc
Confidence 999999999999999987766543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-59 Score=514.76 Aligned_cols=296 Identities=39% Similarity=0.747 Sum_probs=246.7
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded 759 (1091)
.....++|++++.||+|+||+||+|+++.+|+.||||++++...........+..|+.+|..+ +||||++++++|++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 346789999999999999999999999999999999999886555555678889999999887 8999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999974210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 171 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (345)
T 1xjd_A 171 --------------------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224 (345)
T ss_dssp --------------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH
Confidence 112235678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 997 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~D 997 (1091)
+++..|......+| ..++.++++||.+||+.||.+||++. .+|++||||++++|+.+..+ .|||+|...++.|
T Consensus 225 ~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dp~~R~~~~--~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d 299 (345)
T 1xjd_A 225 ELFHSIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFD 299 (345)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC-----------
T ss_pred HHHHHHHhCCCCCC---cccCHHHHHHHHHHhcCCHhHcCCCh--HHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcch
Confidence 99999998876665 67999999999999999999999943 28999999999999999765 7999999999999
Q ss_pred ccccccccccC
Q 001370 998 TSYFLSRFSQI 1008 (1091)
Q Consensus 998 ts~Fds~fs~~ 1008 (1091)
+++|+..|...
T Consensus 300 ~~~f~~~~~~~ 310 (345)
T 1xjd_A 300 CSNFDKEFLNE 310 (345)
T ss_dssp -----------
T ss_pred hhhcchhhccc
Confidence 99999876554
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=529.21 Aligned_cols=257 Identities=32% Similarity=0.540 Sum_probs=231.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
+.|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++|++|.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999986443 23456889999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
|||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~-------- 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------- 298 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC--------
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC--------
Confidence 99999999999864 679999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.......+.|||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..|
T Consensus 299 -------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 359 (423)
T 4fie_A 299 -------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359 (423)
T ss_dssp -------------------SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -------------------CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 0112345689999999999999999999999999999999999999999999999999998
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.....+....+..+|+++++||.+||++||.+||| +.|+|+||||+..
T Consensus 360 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~ell~Hp~~~~~ 407 (423)
T 4fie_A 360 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 407 (423)
T ss_dssp HHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHHhcCC
Confidence 87654333345689999999999999999999999 8899999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=503.79 Aligned_cols=253 Identities=24% Similarity=0.453 Sum_probs=221.0
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCeeEE
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYL 763 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd----ed~LYL 763 (1091)
|++.+.||+|+||+||+|+++.+|..||+|++.+... .....+.+.+|+.+|++++|||||++|++|.+ ...+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 4778899999999999999999999999999987543 44567889999999999999999999999875 456899
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEecC-CCcEEEEecCCcccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~~~ 840 (1091)
|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--- 183 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC---
Confidence 9999999999999999999999999999999999999999998 999999999999984 8999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-hH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s-~~ 919 (1091)
.....+.+|||.|||||++.+ +|+.++|||||||+||||++|++||.+.+ ..
T Consensus 184 --------------------------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~ 236 (290)
T 3fpq_A 184 --------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 236 (290)
T ss_dssp --------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred --------------------------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH
Confidence 112346799999999999875 69999999999999999999999997654 45
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.++..+..+..+ +.++..+++++++||.+||++||.+||| +.++++||||++
T Consensus 237 ~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 237 QIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred HHHHHHHcCCCC-CCCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccC
Confidence 566666555432 3345678999999999999999999999 889999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=523.43 Aligned_cols=294 Identities=42% Similarity=0.712 Sum_probs=260.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
+...++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++|||||+++++|++.+.+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 45678999999999999999999999999999999999876555555566789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||||||++||+|.+++.+ ..+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~--- 220 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK--- 220 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT---
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc---
Confidence 999999999999999875 5699999999999999999999999999999999999999999999999999975310
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC----CCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
.......+.+||+.|||||++.+.. |+.++|||||||+||||++|++||.+.+
T Consensus 221 -----------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 221 -----------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp -----------------------TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----------------------CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 0111234678999999999998766 8899999999999999999999999999
Q ss_pred hHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCC--CCCcccHHHHHcCCCCCCCCcchhhcc--cCCccCC
Q 001370 918 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 991 (1091)
Q Consensus 918 ~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeK--RpSa~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~ 991 (1091)
...++.+|+... +.+|. ...++.++++||.+||+.+|.+ |++ +.+|++||||++++|+.+..+ .|||+|.
T Consensus 278 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~---~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~ 353 (410)
T 3v8s_A 278 LVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNG---VEEIKRHLFFKNDQWAWETLRDTVAPVVPD 353 (410)
T ss_dssp HHHHHHHHHTHHHHCCCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSC---HHHHHTSGGGCCSSCCSTTGGGSCCSCCCC
T ss_pred hhhHHHHHHhccccccCCC-cccccHHHHHHHHHHccChhhhCCCCC---HHHHhcCccccCCCHHHHhhcccCCCCCCc
Confidence 999999998753 45553 3479999999999999988877 777 899999999999999876554 8999999
Q ss_pred CCCCCCccccccccc
Q 001370 992 PESVDDTSYFLSRFS 1006 (1091)
Q Consensus 992 ~~s~~Dts~Fds~fs 1006 (1091)
+.+..|+++|+..+.
T Consensus 354 ~~~~~d~~~fd~~~~ 368 (410)
T 3v8s_A 354 LSSDIDTSNFDDLEE 368 (410)
T ss_dssp CSSTTCCTTSCCCCS
T ss_pred CCCccchhhcCCccc
Confidence 999999999987643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-59 Score=516.37 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=229.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
+...+.|++.+.||+|+||+||+|+++.+|+.||||++++... ..+|+.+|+.++|||||++|++|++.+.+
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3456789999999999999999999999999999999986432 24699999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~~~ 840 (1091)
|||||||+||+|.++|.+.+.|++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+......
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999998 69999999998532110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
. .........++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+
T Consensus 206 ~----------------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 206 L----------------------GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp ------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred c----------------------ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 0 000112345789999999999999999999999999999999999999999998888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH-------------HcCCCCCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-------------KAHPFFKGV 976 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI-------------L~HPFFkgI 976 (1091)
++.+|.....+++.++..+|+++++||.+||++||.+||| +.|+ ++|||+...
T Consensus 264 ~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 264 LCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS---AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcC---HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 8999998877766677899999999999999999999999 5565 468887654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=549.65 Aligned_cols=302 Identities=34% Similarity=0.724 Sum_probs=272.4
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR 758 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqde 758 (1091)
...+.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|+.+|..+ +||||++++++|++.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3456789999999999999999999999999999999999886555566678899999999987 699999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+.+||||||++||+|.+++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~- 493 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 493 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC-
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc-
Confidence 9999999999999999999998999999999999999999999999999999999999999999999999999998421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+.
T Consensus 494 --------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 494 --------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp --------------------------CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 011234567899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 994 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s 994 (1091)
.+++..|+...+.+| ..+++++++||.+||++||.+||++ +++.+|++||||++++|+.+..+ .|||+|.+..
T Consensus 548 ~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~ 624 (674)
T 3pfq_A 548 DELFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG 624 (674)
T ss_dssp HHHHHHHHSSCCCCC---TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG
T ss_pred HHHHHHHHhCCCCCC---ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC
Confidence 999999999888776 6899999999999999999999995 56799999999999999999766 7999999988
Q ss_pred CCCccccccccccCCCCC
Q 001370 995 VDDTSYFLSRFSQISSGL 1012 (1091)
Q Consensus 995 ~~Dts~Fds~fs~~~s~l 1012 (1091)
.|++||+.+|+.....+
T Consensus 625 -~~~~~f~~~~~~~~~~~ 641 (674)
T 3pfq_A 625 -RNAENFDRFFTRHPPVL 641 (674)
T ss_dssp -GGHHHHTTTTTSSCSSC
T ss_pred -CchhhcCchhccCCCcc
Confidence 89999999887765443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=487.92 Aligned_cols=289 Identities=40% Similarity=0.758 Sum_probs=255.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|..++||||++++++|++...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45789999999999999999999999999999999998765545556788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 999999999999999998899999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...++
T Consensus 158 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 212 (318)
T 1fot_A 158 -------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212 (318)
T ss_dssp -------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -------------------------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1224568999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCC-CCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES-VDD 997 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s-~~D 997 (1091)
.+|++....+| ..+++++++||.+||+.||.+||+. .++.++++||||++++|+.+..+ .|||.|...+ ..|
T Consensus 213 ~~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d 289 (318)
T 1fot_A 213 EKILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGD 289 (318)
T ss_dssp HHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC------
T ss_pred HHHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccc
Confidence 99999887766 6899999999999999999999963 25899999999999999998765 7899999884 889
Q ss_pred ccccccc
Q 001370 998 TSYFLSR 1004 (1091)
Q Consensus 998 ts~Fds~ 1004 (1091)
+++|+..
T Consensus 290 ~~~f~~~ 296 (318)
T 1fot_A 290 TSQFDKY 296 (318)
T ss_dssp -------
T ss_pred hhhcCCC
Confidence 9999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=493.01 Aligned_cols=288 Identities=40% Similarity=0.781 Sum_probs=266.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45689999999999999999999999999999999998866555566788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~----- 192 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----- 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc-----
Confidence 999999999999999998899999999999999999999999999999999999999999999999999998421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++
T Consensus 193 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 247 (350)
T 1rdq_E 193 -------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp -------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred -------------------------CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH
Confidence 1124568999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC--cccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCc
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 998 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS--a~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dt 998 (1091)
..|..+...+| ..++.++.+||.+||+.||.+||+ ..++.+|++||||++++|+.+..+ .|||+|...++.|+
T Consensus 248 ~~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~ 324 (350)
T 1rdq_E 248 EKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDT 324 (350)
T ss_dssp HHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCC
T ss_pred HHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccc
Confidence 99999887766 689999999999999999999998 356899999999999999998765 79999999999999
Q ss_pred ccccc
Q 001370 999 SYFLS 1003 (1091)
Q Consensus 999 s~Fds 1003 (1091)
++|+.
T Consensus 325 ~~f~~ 329 (350)
T 1rdq_E 325 SNFDD 329 (350)
T ss_dssp TTSCC
T ss_pred ccccc
Confidence 99984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=504.04 Aligned_cols=265 Identities=29% Similarity=0.405 Sum_probs=226.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------CC
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------RD 759 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd------ed 759 (1091)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+++|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 57999999999999999999999999999999997643 334556789999999999999999999998754 46
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|||||||. |+|.+++.+.+.+++..++.|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999996 689999999899999999999999999999999999999999999999999999999999999853110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
. ........+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+.
T Consensus 212 ~-----------------------~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~ 268 (398)
T 4b99_A 212 P-----------------------AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268 (398)
T ss_dssp ---------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred c-----------------------cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence 0 0112234568999999999999875 569999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCC--------------------C--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILNRKIPWP--------------------C--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP--------------------~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.+++..|+......+ . +...++++++|||.+||++||.+||| |.|+|+|
T Consensus 269 ~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L~H 345 (398)
T 4b99_A 269 VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS---AAAALRH 345 (398)
T ss_dssp HHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC---HHHHTTS
T ss_pred HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC---HHHHhcC
Confidence 988888865321111 0 11357899999999999999999999 8899999
Q ss_pred CCCCCCCc
Q 001370 971 PFFKGVNW 978 (1091)
Q Consensus 971 PFFkgIdW 978 (1091)
|||+....
T Consensus 346 p~f~~~~~ 353 (398)
T 4b99_A 346 PFLAKYHD 353 (398)
T ss_dssp GGGTTTCC
T ss_pred HhhCcCCC
Confidence 99987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-57 Score=527.50 Aligned_cols=334 Identities=29% Similarity=0.556 Sum_probs=285.4
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.+..++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|++...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35678999999999999999999999999999999999886655556678899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
|+||||++||+|.+++.+. ..+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999764 369999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC-
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE- 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~- 916 (1091)
. ........+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 341 ~---------------------------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 A---------------------------GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp T---------------------------TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred C---------------------------CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 0 011223468999999999999999999999999999999999999999875
Q ss_pred ---ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCcc
Q 001370 917 ---SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFV 989 (1091)
Q Consensus 917 ---s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfi 989 (1091)
...+++..+......+| ..+++++++||.+||++||.+||+.. ++.+|++||||++++|..+..+ .|||+
T Consensus 394 ~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~ 470 (543)
T 3c4z_A 394 EKVENKELKQRVLEQAVTYP---DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFV 470 (543)
T ss_dssp CCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred cchhHHHHHHHHhhcccCCC---cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCC
Confidence 45778888888777666 78999999999999999999999953 5799999999999999999765 79999
Q ss_pred CCCCC-----CCCccccccccccCCCCCCCCCCCCCCCCCCcCCCCCCcchhhccCCccccCCC
Q 001370 990 PQPES-----VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSC 1048 (1091)
Q Consensus 990 P~~~s-----~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~~em~et~~f~e~~~~ 1048 (1091)
|.+.. ..|..+|+. .....++..+..++.+|+++..+.+|+.+|.++++|.+++..
T Consensus 471 P~~~~~~~~~~~d~~~f~~---~~~~~~~~~~~~~f~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (543)
T 3c4z_A 471 PDSRTVYAKNIQDVGAFST---VKGVAFEKADTEFFQEFASGTCPIPWQEEMIETGVFGDLNVW 531 (543)
T ss_dssp CCSSSCCSCC----CCCC------CCCCCHHHHHHHHHHCCEECHHHHHHHHHHTTHHHHHTCS
T ss_pred CCccccccCCchhhhhccc---cCCCCCCcchhhHhhcCCCCCCChhHHHhhhccccHHHhcCC
Confidence 98753 344555543 233444445556777788877788899999999999987754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-56 Score=486.94 Aligned_cols=271 Identities=26% Similarity=0.453 Sum_probs=207.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded----- 759 (1091)
+++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++++|||||++|++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 357999999999999999999999999999999997643 3445678999999999999999999999997654
Q ss_pred -------eeEEEEeecCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEe
Q 001370 760 -------NLYLVMEYLNGGDLYSLLRKVGCL---EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 829 (1091)
Q Consensus 760 -------~LYLVMEYm~GGSL~dlL~k~g~L---sE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsD 829 (1091)
.+|||||||+||+|.+++...+.+ ++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 379999999999999999876543 4567889999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
||+|+......... ... . .........+.+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 162 FGla~~~~~~~~~~-------~~~---~-----~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~- 225 (299)
T 4g31_A 162 FGLVTAMDQDEEEQ-------TVL---T-----PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225 (299)
T ss_dssp CCCC-----------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS-
T ss_pred CccceecCCCcccc-------ccc---c-----ccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc-
Confidence 99998642111000 000 0 0011123356799999999999999999999999999999999996
Q ss_pred CCCCCCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 910 IPPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 910 kpPF~~~s~-~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
||.+... ......+.+. .+|......++.+.+||.+||++||.+||+ +.++++||||++++|..
T Consensus 226 --Pf~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 226 --PFSTQMERVRTLTDVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPE---AINIIENAVFEDLDFPG 290 (299)
T ss_dssp --CCSSHHHHHHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGCCC----
T ss_pred --CCCCccHHHHHHHHHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCCCCCCC
Confidence 8865432 2233333333 344333456778899999999999999999 88999999999999853
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=497.78 Aligned_cols=298 Identities=41% Similarity=0.766 Sum_probs=252.8
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
.+...++|++++.||+|+||.||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999999987655555667788999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+||||+.+|++||+|||+|+....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence 99999999999999999998999999999999999999999998 9999999999999999999999999999974210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
........+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..
T Consensus 302 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 355 (446)
T 4ejn_A 302 --------------------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355 (446)
T ss_dssp -------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 112234578999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 995 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~ 995 (1091)
.++..+......+| ..+++++.+||.+||.+||.+||+. ..+.++++||||++++|+.+..+ .|||+|.+.+.
T Consensus 356 ~~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~ 432 (446)
T 4ejn_A 356 KLFELILMEEIRFP---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSE 432 (446)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSST
T ss_pred HHHHHHHhCCCCCC---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCc
Confidence 99999998887766 6799999999999999999999931 24899999999999999998665 78999999999
Q ss_pred CCccccccccccC
Q 001370 996 DDTSYFLSRFSQI 1008 (1091)
Q Consensus 996 ~Dts~Fds~fs~~ 1008 (1091)
.|+++|+++|+..
T Consensus 433 ~~~~~~~~~~~~~ 445 (446)
T 4ejn_A 433 TDTRYFDEEFTAQ 445 (446)
T ss_dssp TCCTTC-------
T ss_pred cchhhcchhhhcC
Confidence 9999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-55 Score=472.31 Aligned_cols=297 Identities=43% Similarity=0.814 Sum_probs=241.8
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~~-~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
.+..++|++++.||+|+||+||+|++. .+|+.||||++++..... ......+.+|+.+|..++||||++++++|.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456789999999999999999999985 689999999998754322 2345678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. ........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 173 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 173 H---------------------------DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ---------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c---------------------------CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 0 1112345689999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCccCCCC
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPE 993 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~ 993 (1091)
...++..+......+| ..++.++.+||.+||..||.+||++. .+.++++||||++++|+.+... .|||.|...
T Consensus 226 ~~~~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~ 302 (327)
T 3a62_A 226 RKKTIDKILKCKLNLP---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQ 302 (327)
T ss_dssp HHHHHHHHHHTCCCCC---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC--
T ss_pred HHHHHHHHHhCCCCCC---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcC
Confidence 9999999998877665 68999999999999999999999754 6999999999999999988655 789999999
Q ss_pred CCCCccccccccccC
Q 001370 994 SVDDTSYFLSRFSQI 1008 (1091)
Q Consensus 994 s~~Dts~Fds~fs~~ 1008 (1091)
+..|.++|+..|...
T Consensus 303 ~~~~~~~~~~~~~~~ 317 (327)
T 3a62_A 303 SEEDVSQFDSKFTRQ 317 (327)
T ss_dssp ---------------
T ss_pred Chhhhhhcchhhhcc
Confidence 999999998776554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=524.24 Aligned_cols=330 Identities=32% Similarity=0.536 Sum_probs=277.9
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++|||||+++++|++.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 36678999999999999999999999999999999999886655556678899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~--LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
|+||||++||+|.+++...+. +++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 999999999999999987654 99999999999999999999999999999999999999999999999999975210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC--
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-- 917 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s-- 917 (1091)
.......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 339 ---------------------------~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 339 ---------------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp ---------------------------TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred ---------------------------CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence 112234689999999999999999999999999999999999999998763
Q ss_pred --hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cCCccCC
Q 001370 918 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 991 (1091)
Q Consensus 918 --~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~ 991 (1091)
...+...+......+| ..+++++++||.+||++||.+||+.. ++.++++||||++++|+.+..+ .|||+|.
T Consensus 392 ~~~~~i~~~i~~~~~~~p---~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~ 468 (576)
T 2acx_A 392 IKREEVERLVKEVPEEYS---ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPD 468 (576)
T ss_dssp CCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hhHHHHHHHhhcccccCC---ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCC
Confidence 4667777777766655 78999999999999999999999743 6899999999999999999765 7899998
Q ss_pred CCC-----CCCccccccccccCCCCCCCCCCCCCCCCCCcCCCCCCcchhhccCCcccc
Q 001370 992 PES-----VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEF 1045 (1091)
Q Consensus 992 ~~s-----~~Dts~Fds~fs~~~s~l~~~d~~s~s~~st~~sss~~~~em~et~~f~e~ 1045 (1091)
+.. ..|..+|.. ..+..++..+..++.++.++..+.+|+.+|.++++|.++
T Consensus 469 ~~~~~~~~~~d~~~f~~---~~~~~~~~~~~~~f~~f~~~~~~~~~~~e~~~~~~~~~l 524 (576)
T 2acx_A 469 PQAIYCKDVLDIEQFST---VKGVELEPTDQDFYQKFATGSVPIPWQNEMVETECFQEL 524 (576)
T ss_dssp CCCCCC--------------------CHHHHHHHHHHCCEECHHHHHHHHHHTTHHHHH
T ss_pred ccccccCCcccHhhccc---cCCCCCCccHHHHHhhhccCCCCcccchhhhhcchhhhh
Confidence 753 344444432 334455566667777788877788899999999988653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=512.91 Aligned_cols=265 Identities=28% Similarity=0.507 Sum_probs=239.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|++...+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999997643 3456778999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC--CcEEEEecCCcccccccc
Q 001370 764 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n--G~VKLsDFGLAk~~~~~~ 840 (1091)
|||||+||+|+++|.+ .+.|++..++.|++||+.||.|||++|||||||||+|||++.+ |++||+|||+|+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~--- 308 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 308 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC---
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc---
Confidence 9999999999999964 4679999999999999999999999999999999999999854 899999999998531
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
......+.+||+.|||||++.+..|+.++|||||||+|||||+|.+||.+.+..+
T Consensus 309 -------------------------~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~ 363 (573)
T 3uto_A 309 -------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363 (573)
T ss_dssp -------------------------TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred -------------------------CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 1122346789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001370 921 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 982 (1091)
Q Consensus 921 i~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~ 982 (1091)
++..|......++. ....+|+++++||.+||++||.+||| +.|+|+||||+..+|....
T Consensus 364 ~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t---~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 364 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp HHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTSCCCCTTTT
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcCcCCCCCCCch
Confidence 99999988776653 23579999999999999999999999 8899999999998886543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=483.26 Aligned_cols=280 Identities=29% Similarity=0.428 Sum_probs=211.0
Q ss_pred CCeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~L 761 (1091)
+.|++.+.||+|+||+||+|+++ .+++.||||++.+.. ...++.+|+++|..+ +|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 57999999999999999999875 467899999986532 345688999999988 699999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC-CcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLAk~~~~~~ 840 (1091)
|||||||+||+|.+++. .+++..++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999999984 59999999999999999999999999999999999999877 899999999998532111
Q ss_pred cc--cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCC-
Q 001370 841 TI--DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE- 916 (1091)
Q Consensus 841 s~--dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~- 916 (1091)
.. +............... ............+.+||+.|||||++.+. .|+.++||||+||++|||++|++||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNK-CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp CGGGGGC---------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccc-ccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 00 0000000000000000 00001122334567999999999999875 5899999999999999999999999644
Q ss_pred ChHHHHHHHhh--------------------------------------cCCCCC-------------CCCCCCCHHHHH
Q 001370 917 SPEIIFDNILN--------------------------------------RKIPWP-------------CVPSDMSFEAQD 945 (1091)
Q Consensus 917 s~~ei~~kIl~--------------------------------------~~l~fP-------------~ip~~lS~eakD 945 (1091)
+..+....|.. .....| .....+|++++|
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 34444433321 000011 012468999999
Q ss_pred HHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 946 LINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 946 LI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
||.+||++||.+||| |.|+|+||||++++
T Consensus 332 Ll~~lL~~dP~~R~t---a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 332 LLDKLLDLNPASRIT---AEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHTCSCTTTSCC---HHHHHTSGGGTTC-
T ss_pred HHHHHCcCChhHCcC---HHHHhcCcccCCCC
Confidence 999999999999999 88999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=472.35 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=218.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
+..++|.+.+.||+|+||+||+|++. .+|..||||++++. .....+.|.+|+++|++++|||||++|++|.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 45578999999999999999999875 35789999999753 34556789999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVG-------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 824 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g-------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~ 824 (1091)
.+.+|||||||+||+|.++|.+.+ .+++..+..++.||+.||.|||+++||||||||+||||+.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 999999999999999999997643 5999999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHH
Q 001370 825 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 904 (1091)
Q Consensus 825 VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILY 904 (1091)
+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+||
T Consensus 167 ~Ki~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~ 221 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 221 (299)
T ss_dssp EEECCCSCHHHHTGGG-------------------------CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEECCcccceecCCCC-------------------------ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHH
Confidence 9999999998532110 011223467999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 905 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 905 EMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
||+| |++||.+.+..++...+..+.. +..|..+|+++.+||.+||+.||++||++.+
T Consensus 222 Ellt~G~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~ 279 (299)
T 4asz_A 222 EIFTYGKQPWYQLSNNEVIECITQGRV--LQRPRTCPQEVYELMLGCWQREPHMRKNIKG 279 (299)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 9998 9999999999999999888753 2345789999999999999999999999443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-54 Score=470.60 Aligned_cols=265 Identities=21% Similarity=0.315 Sum_probs=218.5
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..|.+..++|++.+.||+|+||+||+|+++ ..||||+++... ......+.|.+|+.+|++++|||||++++++. +
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~ 103 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K 103 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C
Confidence 345677899999999999999999999865 359999997543 34556788999999999999999999999875 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+.+|||||||+||+|.++|... +.+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 6789999999999999999764 579999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
.. .......+.+||+.|||||++.+ ..|+.++|||||||+||||+||++||.
T Consensus 184 ~~-------------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 184 RW-------------------------SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp -----------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cC-------------------------CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 10 01122345789999999999974 358999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCCCC---CCCCCCCCHHHHHHHhhhccCCCCCCCCcccH---HHHHcCCCC
Q 001370 915 AESPEIIFDNILNRKIPW---PCVPSDMSFEAQDLINRFLIHDPNQRLGANGA---AEVKAHPFF 973 (1091)
Q Consensus 915 ~~s~~ei~~kIl~~~l~f---P~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA---~EIL~HPFF 973 (1091)
+.+.......++...... +.++..+++++.+||.+||+.||.+||++.++ .+.++|++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 239 HINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 877666655555544333 34557899999999999999999999995433 355677764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=477.00 Aligned_cols=282 Identities=31% Similarity=0.685 Sum_probs=251.3
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
...+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++|||||+++++|++.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34567889999999999999999999999999999999998866556667788999999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||+.||+|.+++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-- 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999998521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...
T Consensus 167 --------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 167 --------------------------RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp --------------------------TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred --------------------------CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 1122346789999999999974 46899999999999999999999999753
Q ss_pred ---ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc--cCCccCC
Q 001370 917 ---SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 991 (1091)
Q Consensus 917 ---s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~ 991 (1091)
....++..+......+| ..++.++.+||.+||+.||.+||+ .+.++++||||++++|+.+..+ .|||+|.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~ 295 (384)
T 4fr4_A 221 SSTSSKEIVHTFETTVVTYP---SAWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNFPYMNDINWDAVFQKRLIPGFIPN 295 (384)
T ss_dssp TTSCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred CCccHHHHHHHHhhcccCCC---CcCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence 44566666666666655 689999999999999999999998 3789999999999999998766 7899998
Q ss_pred CCC
Q 001370 992 PES 994 (1091)
Q Consensus 992 ~~s 994 (1091)
...
T Consensus 296 ~~~ 298 (384)
T 4fr4_A 296 KGR 298 (384)
T ss_dssp CCS
T ss_pred CCC
Confidence 654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=469.63 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=215.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq 756 (1091)
.+..++|.+.+.||+|+||+||+|+++ .++..||||++++. .....+.|.+|+++|.+++|||||+++++|.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 355678999999999999999999875 36889999999753 3455678999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKV---------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 821 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~---------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~ 821 (1091)
+.+.+|||||||+||+|.++|.+. +.+++..+..|+.||+.||.|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 999999999999999999999754 35899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhh
Q 001370 822 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 901 (1091)
Q Consensus 822 nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGV 901 (1091)
++++||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||
T Consensus 194 ~~~~Ki~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gv 248 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248 (329)
T ss_dssp TTEEEECCCC-----------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCcEEEcccccceeccCCC-------------------------cceecCcccccccccChhhhcCCCCCccccccchHH
Confidence 9999999999998532100 011223568999999999999999999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 902 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 902 ILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+||||+| |++||.+.+..+++..|..+.. +..|..+++++.+||.+||+.||++||+ +.||+
T Consensus 249 vl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs---~~ei~ 311 (329)
T 4aoj_A 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRE--LERPRACPPEVYAIMRGCWQREPQQRHS---IKDVH 311 (329)
T ss_dssp HHHHHHTTSCCTTCSSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHCCSSTTTSCC---HHHHH
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCcccccHHHHHHHHHHcCcChhHCcC---HHHHH
Confidence 9999999 9999999999999988887642 2345789999999999999999999999 44554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=464.36 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=221.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
+..+++++++.||+|+||+||+|++. .+++.||||+++... .....+.|.+|+.+|.+++|||||+++++|.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 56678999999999999999999864 367899999997532 23345789999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 821 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~ 821 (1091)
.+.+|||||||++|+|.++|... ..+++..+..++.||+.||.|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999653 35899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhh
Q 001370 822 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 901 (1091)
Q Consensus 822 nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGV 901 (1091)
++++||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||
T Consensus 181 ~~~~Ki~DFGlar~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGv 235 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAAD-------------------------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235 (308)
T ss_dssp GGCEEECCSCCBCGGGGGG-------------------------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCCEEECCcccceeccCCC-------------------------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHH
Confidence 9999999999998532111 112234568999999999999999999999999999
Q ss_pred hHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 902 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 902 ILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+||||+| |.+||.+.+..++...|.++.. +..|..+|+++.+||.+||+.||.+||++.++.+.|
T Consensus 236 vl~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 236 VLWEVFSYGLQPYCGYSNQDVVEMIRNRQV--LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHHHHTTTCCTTTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999998 8999999999999998877643 234688999999999999999999999955444444
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=465.67 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=217.8
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFY 753 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TG-----k~VAIKiLkK~~i~~~~eie~~l~EieILskL~H-PNIVkL~g 753 (1091)
+|.+..++|++.+.||+|+||+||+|++..++ +.||||++++.. ...+.+.+.+|+.+|.+++| ||||++++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 45677789999999999999999999987543 689999997643 33456789999999999975 99999999
Q ss_pred eeccC-CeeEEEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCc
Q 001370 754 SFTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 816 (1091)
Q Consensus 754 sfqde-d~LYLVMEYm~GGSL~dlL~k~----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeN 816 (1091)
+|... +.+|||||||+||+|.++|++. ..+++..+..|+.||+.||+|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 98664 5799999999999999999753 348999999999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001370 817 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896 (1091)
Q Consensus 817 ILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDI 896 (1091)
|||+.++++||+|||+|+..... .......+.+||+.|||||++.+..|+.++||
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDV 270 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTC-------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred eeeCCCCCEEECcchhhhhcccC-------------------------CCceeeccccccccccCHHHHhcCCCCCcccE
Confidence 99999999999999999853210 00112345789999999999999999999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 897 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 897 WSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
|||||+||||+| |.+||.+.+..+.+.+++..... +..|..+++++.+||.+||+.||.+||| +.+|++|
T Consensus 271 wS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~-~~~p~~~~~~~~~li~~c~~~dP~~RPt---~~eil~~ 341 (353)
T 4ase_A 271 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 341 (353)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCcChhHCcC---HHHHHHH
Confidence 999999999998 99999987755444444443333 2345789999999999999999999999 6666665
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=445.14 Aligned_cols=261 Identities=31% Similarity=0.575 Sum_probs=238.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....++|++++.||+|+||+||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 4567899999999999999999999999999999999987543 445677899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~---- 165 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT---- 165 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS----
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC----
Confidence 9999999999999999998999999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCC-ccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys-~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
........+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..+
T Consensus 166 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 166 ------------------------VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp ------------------------SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 01123457899999999999988875 89999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
+...+..+...+| ..+++++.+||.+||..||.+||| +.++++||||+...
T Consensus 222 ~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 222 LRERVLRGKYRIP---FYMSTDCENLLKRFLVLNPIKRGT---LEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHCCSSTTTSCC---HHHHTTCTTTTTTC
T ss_pred HHHHHHhCCCCCC---CCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCHhhcCCC
Confidence 9999999887766 678999999999999999999999 88999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=454.01 Aligned_cols=269 Identities=29% Similarity=0.485 Sum_probs=240.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~---~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..+.|++.+.||+|+||+||+|+++.+|+.||+|++++...... ...+.+.+|+.+|..++||||++++++|.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 45679999999999999999999999999999999987543221 135678999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC----cEEEEecCCcccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIG 836 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~ 836 (1091)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999999888999999999999999999999999999999999999998877 7999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.. .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.
T Consensus 170 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 170 ED----------------------------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp CT----------------------------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CC----------------------------CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 10 11223568999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhc
Q 001370 917 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 983 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~ 983 (1091)
+..+++..|......++. ....+++++++||.+||..||.+||+ +.++++||||++++|.....
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~~~~~~~~~ 286 (361)
T 2yab_A 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDTQQAMV 286 (361)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSTTTSCSSHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcCcCCCchhhhhh
Confidence 999999999888776652 22578999999999999999999999 88999999999999987544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=443.43 Aligned_cols=292 Identities=42% Similarity=0.795 Sum_probs=244.9
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITV-RNPFVVRFFYSF 755 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~-~~~eie~~l~EieILskL-~HPNIVkL~gsf 755 (1091)
....+++|++++.||+|+||+||+|++. .+|+.||||++++.... .......+.+|+.+|..+ .||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3466789999999999999999999984 58999999999764432 122345677899999999 699999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 756 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 756 qded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.....+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
... .........+||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 209 ~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf 262 (355)
T 1vzo_A 209 FVA--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262 (355)
T ss_dssp CCG--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccc--------------------------CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 311 01122345689999999999986 45789999999999999999999999
Q ss_pred CCC----ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--c
Q 001370 914 TAE----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--K 985 (1091)
Q Consensus 914 ~~~----s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~ 985 (1091)
... ....+...+......+| ..++..+.+||.+||..||.+||+.. .+.++++||||++++|+.+..+ +
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~ 339 (355)
T 1vzo_A 263 TVDGEKNSQAEISRRILKSEPPYP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 339 (355)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred ccCCccchHHHHHHHHhccCCCCC---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCC
Confidence 754 34556666666654444 78999999999999999999999532 4999999999999999998776 6
Q ss_pred CCccCCCCCCCCcccc
Q 001370 986 AVFVPQPESVDDTSYF 1001 (1091)
Q Consensus 986 pPfiP~~~s~~Dts~F 1001 (1091)
+||.|...+..|.++|
T Consensus 340 ~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 340 APFKPVIRDELDVSNF 355 (355)
T ss_dssp CSCCCCCCC-CCC---
T ss_pred CCCCCccccccccccC
Confidence 8999999888888876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=426.25 Aligned_cols=267 Identities=28% Similarity=0.500 Sum_probs=236.5
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~---~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.+.|++.+.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|..++||||++++++|.+...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999987543221 1357789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC----cEEEEecCCccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGL 837 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~~ 837 (1091)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888899999999999999999999999999999999999999888 89999999997521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus 170 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 170 F----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp T----------------------------TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred C----------------------------CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 0 111234679999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001370 918 PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 982 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~ 982 (1091)
..+....+......++. ....++..+++||.+||..||.+||+ +.++++||||++.+|....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~~~~ 284 (326)
T 2y0a_A 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 284 (326)
T ss_dssp HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTSCCSHHHHH
T ss_pred HHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcCCCccCCcchhhh
Confidence 98888888776655542 12568999999999999999999999 8899999999999887643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=422.15 Aligned_cols=258 Identities=34% Similarity=0.543 Sum_probs=227.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.++..++||||++++++|...+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4679999999999999999999999999999999975432 2346788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||++||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 168 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 9999999999999764 699999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.......
T Consensus 169 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 227 (297)
T 3fxz_A 169 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (297)
T ss_dssp ---------------------TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ---------------------cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01123456899999999999999999999999999999999999999999888777776
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+.....+....+..++..+.+||.+||+.||.+||+ +.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~ 276 (297)
T 3fxz_A 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHQFLKIA 276 (297)
T ss_dssp HHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhccc
Confidence 665544333345789999999999999999999999 8899999999854
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=412.35 Aligned_cols=260 Identities=35% Similarity=0.644 Sum_probs=233.8
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
....+++|++.+.||+|+||+||+|+++.++..||+|++.+...........+.+|+.++..++||||++++++|.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 34678899999999999999999999999999999999987554444446778999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+||||+++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~--- 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999886321
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.......+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 161 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 214 (279)
T 3fdn_A 161 --------------------------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214 (279)
T ss_dssp ---------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH
Confidence 111234579999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
....+......+| ..++.++.+||.+||..||.+||+ +.++++||||++
T Consensus 215 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~h~~~~~ 263 (279)
T 3fdn_A 215 TYKRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITA 263 (279)
T ss_dssp HHHHHHHTCCCCC---TTSCHHHHHHHHHHCCSSGGGSCC---HHHHHHCHHHHH
T ss_pred HHHHHHhCCCCCC---CcCCHHHHHHHHHHhccChhhCCC---HHHHhhCccccC
Confidence 9988888776665 678999999999999999999999 889999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=411.98 Aligned_cols=260 Identities=29% Similarity=0.484 Sum_probs=218.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++++.||+|+||+||+|+++.+|+.||||+++... ........+.+|+.++.+++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 368999999999999999999999999999999998644 2344567788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~-k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+.+ +|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~----- 153 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI----- 153 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS-----
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC-----
Confidence 999987 5555554 467899999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCC-CCCCChHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPP-FTAESPEII 921 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDIWSLGVILYEMLTGkpP-F~~~s~~ei 921 (1091)
........+||+.|+|||++.+.. |+.++|||||||++|||++|..| |.+.+..+.
T Consensus 154 ----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~ 211 (292)
T 3o0g_A 154 ----------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp ----------------------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred ----------------------ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 111223467999999999998765 89999999999999999987766 666777776
Q ss_pred HHHHhhcCC-----------------C---------CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 922 FDNILNRKI-----------------P---------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 922 ~~kIl~~~l-----------------~---------fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
...+..... + .......++.++++||.+||+.||.+||| +.|+++||||++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~ 288 (292)
T 3o0g_A 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFSD 288 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGTT
T ss_pred HHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC---HHHHhcCccccc
Confidence 666654100 0 01122357899999999999999999999 889999999986
Q ss_pred C
Q 001370 976 V 976 (1091)
Q Consensus 976 I 976 (1091)
+
T Consensus 289 ~ 289 (292)
T 3o0g_A 289 F 289 (292)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=433.49 Aligned_cols=259 Identities=31% Similarity=0.533 Sum_probs=232.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+|..++|||||+++++|.+.+.+|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999986543 345667899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---cEEEEecCCccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~~~~~~s 841 (1091)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~---- 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---- 182 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT----
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec----
Confidence 99999999999998888899999999999999999999999999999999999998654 59999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...+
T Consensus 183 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 238 (362)
T 2bdw_A 183 ------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238 (362)
T ss_dssp ------------------------TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 01112346899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 922 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 922 ~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+..+..+...+|.. ...+++++++||.+||..||.+||+ +.++++||||.+
T Consensus 239 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~ 290 (362)
T 2bdw_A 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICN 290 (362)
T ss_dssp HHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSHHHHT
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCcccCC
Confidence 99998887776632 1367999999999999999999999 889999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=421.53 Aligned_cols=265 Identities=29% Similarity=0.520 Sum_probs=220.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....++|++++.||+|+||+||+|++. +|+.||+|+++... ........+.+|+.+|..++||||+++++++.+...+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 345689999999999999999999985 59999999997532 2333457788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-- 171 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-- 171 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC--
Confidence 999999985 888887664 4599999999999999999999999999999999999999999999999999975210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..
T Consensus 172 -------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 172 -------------------------PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp -------------------------CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred -------------------------CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 0112234579999999999986 56899999999999999999999999988776
Q ss_pred HHHHHHhhc--CC---CCC----------------------CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 920 IIFDNILNR--KI---PWP----------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 920 ei~~kIl~~--~l---~fP----------------------~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
+....+... .. .++ .+...+++++.+||.+||+.||.+||| +.++++|||
T Consensus 227 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~ 303 (311)
T 3niz_A 227 DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS---ARDAMNHPY 303 (311)
T ss_dssp THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSGG
T ss_pred HHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC---HHHHhcCcc
Confidence 666665431 00 000 012357889999999999999999999 889999999
Q ss_pred CCCCCcc
Q 001370 973 FKGVNWD 979 (1091)
Q Consensus 973 FkgIdWd 979 (1091)
|++++++
T Consensus 304 f~~~~~~ 310 (311)
T 3niz_A 304 FKDLDPQ 310 (311)
T ss_dssp GTTSCTT
T ss_pred cccCCcc
Confidence 9998864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=431.82 Aligned_cols=274 Identities=22% Similarity=0.347 Sum_probs=225.1
Q ss_pred ccCCCeEEEEeeccC--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 683 TSIDDFEIIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 683 ~~iddFeilr~LGkG--gFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
...++|++++.||+| +||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 356789999999999 99999999999999999999998643 344567788999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999876 6799999999999999999999999999999999999999999999999999874321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.... ...........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.
T Consensus 181 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 181 HGQR--------------------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TTEE--------------------CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccc--------------------ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 1000 0001112234589999999999987 67999999999999999999999999887
Q ss_pred ChHHHHHHHhhcCCC-------------------------------------------CCCCCCCCCHHHHHHHhhhccC
Q 001370 917 SPEIIFDNILNRKIP-------------------------------------------WPCVPSDMSFEAQDLINRFLIH 953 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~-------------------------------------------fP~ip~~lS~eakDLI~rcL~k 953 (1091)
+.......++.+..+ ....+..+++++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 320 (389)
T 3gni_B 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320 (389)
T ss_dssp CSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred CHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence 765555544432211 0012356889999999999999
Q ss_pred CCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 954 DPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 954 DPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
||.+||+ +.++++||||+.+.|..
T Consensus 321 dP~~Rpt---a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 321 NPDARPS---ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp CTTTSCC---HHHHTTSGGGGGC---C
T ss_pred CcccCCC---HHHHhcCHHHHHHhhcc
Confidence 9999999 88999999999987754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=437.64 Aligned_cols=258 Identities=32% Similarity=0.571 Sum_probs=228.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
..+++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+...+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45689999999999999999999999999999999998654433344567899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||+ +|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~----- 159 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT----- 159 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT-----
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc-----
Confidence 999999 78999999988999999999999999999999999999999999999999999999999999987421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
........+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.....+
T Consensus 160 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 160 -----------------------DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp -----------------------TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred -----------------------CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence 1122345689999999999998876 7899999999999999999999998776666
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+..+......+| ..+++++.+||.+||..||.+||| +.++++||||+.
T Consensus 217 ~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 264 (336)
T 3h4j_B 217 FKKVNSCVYVMP---DFLSPGAQSLIRRMIVADPMQRIT---IQEIRRDPWFNV 264 (336)
T ss_dssp BCCCCSSCCCCC---TTSCHHHHHHHHTTSCSSGGGSCC---HHHHTTCHHHHT
T ss_pred HHHHHcCCCCCc---ccCCHHHHHHHHHHcCCChhHCcC---HHHHHhChhhcc
Confidence 665555544444 789999999999999999999999 889999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=439.53 Aligned_cols=292 Identities=30% Similarity=0.420 Sum_probs=209.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----C
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-----R 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd-----e 758 (1091)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. ........++.+|+.+|..++|||||+++++|.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 457899999999999999999999999999999999753 3345567889999999999999999999999944 3
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..+|+||||+ +|+|.+++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 5799999998 569999999888899999999999999999999999999999999999999999999999999986421
Q ss_pred cccccCCCCCCCCCCCCC--CCCCcc--cccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHh-----
Q 001370 839 NNTIDLSGPETDGIMPSD--AHYPEY--QQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFIT----- 908 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~--~~~~~~--~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDIWSLGVILYEMLT----- 908 (1091)
....... ....+.. .....+ ...........+||+.|+|||++. +..|+.++|||||||+||||++
T Consensus 209 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 209 PENGNSQ----LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTCCCC----CC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred ccccccc----cccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 1100000 0000000 000000 001112345678999999999874 5679999999999999999998
Q ss_pred ------CCCCCCCCCh--------------------HHHHHHHhh--c--------------------------CCCCCC
Q 001370 909 ------GIPPFTAESP--------------------EIIFDNILN--R--------------------------KIPWPC 934 (1091)
Q Consensus 909 ------GkpPF~~~s~--------------------~ei~~kIl~--~--------------------------~l~fP~ 934 (1091)
|.+||.+.+. .+....|.+ + ...+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 7788876541 122222211 0 001111
Q ss_pred CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc
Q 001370 935 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 984 (1091)
Q Consensus 935 ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~ 984 (1091)
....+++++.+||.+||++||.+||| +.|+|+||||+++.|......
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t---~~e~L~Hp~f~~~~~~~~e~~ 411 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRIT---INECLAHPFFKEVRIAEVETN 411 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGTTTCCGGGCCC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCC---HHHHhcCHhhhhcCCCccCCC
Confidence 12456899999999999999999999 889999999999999877543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=431.38 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=191.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----ee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----NL 761 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded----~L 761 (1091)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... .......+|+.++.+++|||||++++++...+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999987 48999999987532 11222334555567889999999999998764 58
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecccCCCceEecCCCcEEEEecCCc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~--------GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
|||||||+||+|.++|++ ..++++.+..++.|++.||.|||++ +||||||||+||||+.+|++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 4689999999999999999999987 9999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC------CCCccceeechhhhHHHHH
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~------~Ys~ksDIWSLGVILYEML 907 (1091)
+....... .........+||+.|||||++.+. .|+.++|||||||+||||+
T Consensus 156 ~~~~~~~~-----------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~ 212 (303)
T 3hmm_A 156 VRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp EEEETTTT-----------------------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccCCCC-----------------------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence 85321100 001122356899999999999764 3678999999999999999
Q ss_pred hCCCCCCCC---------------ChHHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 908 TGIPPFTAE---------------SPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 908 TGkpPF~~~---------------s~~ei~~kIl~~~l~fP~ip~~-----lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
||.+||... ....+...+....+. |.+|.. .+..+.+||.+||..||.+|||+.++.+
T Consensus 213 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~r-p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HCCCCCCccccccccchhcccccchHHHHHHHHhcccCC-CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 998766321 123444445444432 333332 2357889999999999999999544433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=438.84 Aligned_cols=262 Identities=30% Similarity=0.507 Sum_probs=227.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LY 762 (1091)
..++|++.+.||+|+||+||+|+++.+|+.||||++++... ...+|+++|.++ +||||++++++|.+.+.+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 34679999999999999999999999999999999987432 234678888877 7999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC----CcEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n----G~VKLsDFGLAk~~~~ 838 (1091)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+... +.+||+|||+++....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988899999999999999999999999999999999999998543 3599999999985311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC---
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA--- 915 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~--- 915 (1091)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+
T Consensus 173 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 173 ---------------------------ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp ---------------------------TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred ---------------------------CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 11123456899999999999988899999999999999999999999986
Q ss_pred CChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc
Q 001370 916 ESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 984 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~ 984 (1091)
.+..+++..+..+...++. ....+++++++||.+||..||.+||+ +.++++||||. +|+.+...
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~~--~~~~~~~~ 290 (342)
T 2qr7_A 226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT---AALVLRHPWIV--HWDQLPQY 290 (342)
T ss_dssp SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHH--TGGGSCCS
T ss_pred CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCCeec--Cccccccc
Confidence 4567888888887766543 23578999999999999999999999 88999999995 58766433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=442.73 Aligned_cols=260 Identities=29% Similarity=0.536 Sum_probs=232.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++++.||+|+||+||+|.++.+|+.||+|++.+... .......+.+|+.+|..++|||||+++++|.+.+.+|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999987543 344567889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec---CCCcEEEEecCCccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD---~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~--- 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--- 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT---
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC---
Confidence 99999999999999989999999999999999999999999999999999999998 468899999999974210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++
T Consensus 166 ------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~ 221 (444)
T 3soa_A 166 ------------------------EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221 (444)
T ss_dssp ------------------------TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 01122356899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 922 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 922 ~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+..+..+...+|.. ...+++++++||.+||+.||.+||+ +.++++||||++
T Consensus 222 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~L~hp~~~~ 273 (444)
T 3soa_A 222 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT---AAEALKHPWISH 273 (444)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSCTTHH
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC---HHHHhcCccccC
Confidence 99999887776642 2478999999999999999999999 889999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=410.39 Aligned_cols=260 Identities=35% Similarity=0.654 Sum_probs=234.8
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
.....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 44667899999999999999999999999999999999986544333445778999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~--- 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--- 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS---
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999986421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.......+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 166 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 219 (284)
T 2vgo_A 166 --------------------------SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219 (284)
T ss_dssp --------------------------SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH
Confidence 011234679999999999999999999999999999999999999999999888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
....+......+| ..++.++++||.+||..||.+||+ +.++++||||+.
T Consensus 220 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~h~~~~~ 268 (284)
T 2vgo_A 220 THRRIVNVDLKFP---PFLSDGSKDLISKLLRYHPPQRLP---LKGVMEHPWVKA 268 (284)
T ss_dssp HHHHHHTTCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHHTCHHHHH
T ss_pred HHHHHhccccCCC---CcCCHHHHHHHHHHhhcCHhhCCC---HHHHhhCHHHHh
Confidence 8888888776655 678999999999999999999999 889999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=402.58 Aligned_cols=266 Identities=30% Similarity=0.509 Sum_probs=236.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.++.+++||||+++++++......|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999999976443 44566788999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc---EEEEecCCcccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINN 840 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDFGLAk~~~~~~ 840 (1091)
||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~--- 159 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--- 159 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc---
Confidence 9999999999999998889999999999999999999999999999999999999987665 9999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+...
T Consensus 160 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 214 (284)
T 3kk8_A 160 -------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214 (284)
T ss_dssp -------------------------SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH
Confidence 0111234679999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchh
Q 001370 921 IFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 921 i~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
....+..+...+|.. ...+++++.+||.+||..||.+||+ +.++++||||++..+...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 215 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICNRERVAS 273 (284)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSHHHHSCCCGGG
T ss_pred HHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCC---HHHHhcCccccCChhHHh
Confidence 999888877665532 2478999999999999999999999 889999999988766543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=425.26 Aligned_cols=258 Identities=27% Similarity=0.486 Sum_probs=230.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++.+.||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.+|..++||||++++++|.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 357899999999999999999999999999999998643 2345678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC--CCcEEEEecCCcccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~~~~~ 840 (1091)
||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 999999999999997654 6999999999999999999999999999999999999997 78999999999975210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 157 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 157 --------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp --------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 112234679999999999999889999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 921 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 921 i~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+...+......++. ....++.++++||.+||..||.+||+ +.++++||||+..
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~ 264 (321)
T 1tki_A 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHSC
T ss_pred HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcC---HHHHhcChhhccC
Confidence 99999988776552 12478999999999999999999999 8899999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=410.65 Aligned_cols=259 Identities=30% Similarity=0.514 Sum_probs=216.5
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++++.||+|+||+||+|++ .+|+.||+|+++.... .......+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 6799999999975432 223346788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 152 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI----- 152 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc-----
Confidence 999986 999998764 6799999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+..
T Consensus 153 ----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (288)
T 1ob3_A 153 ----------------------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210 (288)
T ss_dssp -------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ----------------------cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0111234579999999999976 45899999999999999999999999998887777
Q ss_pred HHHhhc--C---CCC---------------------CCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 923 DNILNR--K---IPW---------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 923 ~kIl~~--~---l~f---------------------P~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..+... . ..+ ......+++++.+||.+||+.||.+||+ +.++++||||++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKEN 287 (288)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC-
T ss_pred HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC---HHHHhcCcchhhc
Confidence 666531 0 001 1122458999999999999999999999 8899999999865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=416.19 Aligned_cols=270 Identities=29% Similarity=0.480 Sum_probs=238.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~---~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..+.|++.+.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|..++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34679999999999999999999999999999999987543221 135778999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC----cEEEEecCCcccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIG 836 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~ 836 (1091)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999999888899999999999999999999999999999999999999988 8999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 170 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 170 ED----------------------------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CT----------------------------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred Cc----------------------------cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 10 11123457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc
Q 001370 917 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 984 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~ 984 (1091)
+..+....+......++. .+..++..+.+||.+||..||.+||+ +.++++||||.+++|......
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~hp~~~~~~~~~~~~~ 287 (321)
T 2a2a_A 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDNQQAMVR 287 (321)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC---HHHHHHSTTTSCSSHHHHHHH
T ss_pred CHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhcCccccCCCccccccc
Confidence 999888888877655442 22568899999999999999999999 889999999999998875443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=413.03 Aligned_cols=260 Identities=35% Similarity=0.622 Sum_probs=221.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc-----------------------hhHHHHHHHHHHH
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----------------------KNDIERILAERNI 739 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~-----------------------~~eie~~l~EieI 739 (1091)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45689999999999999999999999999999999998654322 1224568999999
Q ss_pred HHhcCCCceEEEeeeecc--CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCce
Q 001370 740 LITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817 (1091)
Q Consensus 740 LskL~HPNIVkL~gsfqd--ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNI 817 (1091)
|..++||||+++++++.+ ...+|+||||+++|+|.+++. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 568999999999999987653 45799999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC---CCccc
Q 001370 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAA 894 (1091)
Q Consensus 818 LLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~---Ys~ks 894 (1091)
|++.+|.+||+|||+++.... ........+||+.|+|||++.+.. ++.++
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 221 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKG---------------------------SDALLSNTVGTPAFMAPESLSETRKIFSGKAL 221 (298)
T ss_dssp EECTTSCEEECCCTTCEECSS---------------------------SSCEECCCCSCGGGCCGGGCCTTCCCEESHHH
T ss_pred EECCCCCEEEecCCCcccccc---------------------------ccccccCCcCCccccChhhhccCCCCCCCchh
Confidence 999999999999999975210 011123457999999999998765 37889
Q ss_pred eeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 895 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 895 DIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
|||||||++|+|++|..||...+...+...+......+|. ...+++++.+||.+||..||.+||+ +.++++||||+
T Consensus 222 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~R~s---~~e~l~hp~~~ 297 (298)
T 2zv2_A 222 DVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD-QPDIAEDLKDLITRMLDKNPESRIV---VPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-SSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTCHHHH
T ss_pred hhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC-ccccCHHHHHHHHHHhhcChhhCCC---HHHHhcCcccc
Confidence 9999999999999999999999888888888877766663 3578999999999999999999999 88999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=421.34 Aligned_cols=267 Identities=27% Similarity=0.419 Sum_probs=218.2
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
.....++|++++.||+|+||+||+|++..+|+.||||+++... ........+.+|+.+|..++||||+++++++.+.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3456789999999999999999999999999999999997543 233345677899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec-----CCCcEEEEecCCccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-----HDGHIKLTDFGLSKI 835 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD-----~nG~VKLsDFGLAk~ 835 (1091)
+|+||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 9999999988999999999999999999999999999999999999994 555699999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
... ........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.
T Consensus 187 ~~~---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 187 FGI---------------------------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp HC--------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCC---------------------------cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 310 01122345789999999999874 58999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCC-----CCC-------------CC---------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 915 AESPEIIFDNILNRKI-----PWP-------------CV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 915 ~~s~~ei~~kIl~~~l-----~fP-------------~i---------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
+.+..+....+..... .++ .. +..+++++.+||.+||+.||.+||+ +.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~ 316 (329)
T 3gbz_A 240 GDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS---AKNA 316 (329)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC---HHHH
Confidence 9988877777654210 011 00 0117899999999999999999999 8899
Q ss_pred HcCCCCCCCCcc
Q 001370 968 KAHPFFKGVNWD 979 (1091)
Q Consensus 968 L~HPFFkgIdWd 979 (1091)
++||||++++|+
T Consensus 317 l~hp~f~~~~~~ 328 (329)
T 3gbz_A 317 LEHPYFSHNDFD 328 (329)
T ss_dssp HTSGGGSSSCSC
T ss_pred hCCcccCCCCCC
Confidence 999999999996
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=426.31 Aligned_cols=282 Identities=31% Similarity=0.524 Sum_probs=215.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC--
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-- 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded-- 759 (1091)
...++|++++.||+|+||+||+|.++.+|+.||||++.+. .........+.+|+.+|..+. ||||++++++|...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3467899999999999999999999999999999998753 334556778899999999997 999999999997554
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+|||||. |+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999998 599998876 57999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.... ....... .... .............+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.
T Consensus 163 ~~~~--~~~~~~~---~~~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 163 RRVT--NNIPLSI---NENT-ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp CCCC--CCGGGCC---C----------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccc--ccccccc---cccc-cccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0000 0000000 0000 000011223445789999999999987 6799999999999999999999999999998
Q ss_pred HHHHHHHhhcCCCCCC---------------------------------------------CCCCCCHHHHHHHhhhccC
Q 001370 919 EIIFDNILNRKIPWPC---------------------------------------------VPSDMSFEAQDLINRFLIH 953 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~---------------------------------------------ip~~lS~eakDLI~rcL~k 953 (1091)
.+.+..|+.. +.+|. .+..+++++.+||.+||+.
T Consensus 237 ~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 8877777531 11110 0126789999999999999
Q ss_pred CCCCCCCcccHHHHHcCCCCCCCC
Q 001370 954 DPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 954 DPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
||.+||| +.++++||||+.+.
T Consensus 316 dP~~R~t---~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 316 NPNKRIS---ANDALKHPFVSIFH 336 (388)
T ss_dssp SGGGSCC---HHHHTTSTTTTTTC
T ss_pred CcccCCC---HHHHhCCHHHHHhc
Confidence 9999999 88999999998653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=405.94 Aligned_cols=265 Identities=28% Similarity=0.451 Sum_probs=220.4
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++++.||+|+||+||+|++..+|+.||||++.+.. ........+.+|+.++.+++||||+++++++.+.+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 478999999999999999999999999999999987643 2334467788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||+++++|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG------ 154 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (311)
T 4agu_A 155 ---------------------PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY 213 (311)
T ss_dssp --------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ---------------------cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0111234579999999999986 678999999999999999999999999988776655
Q ss_pred HHhhc-------------------CCCCCCC---------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 924 NILNR-------------------KIPWPCV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 924 kIl~~-------------------~l~fP~i---------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.+... ....|.. ...++.++.+||.+||..||.+||| +.++++||||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~ 290 (311)
T 4agu_A 214 LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT---CEQLLHHPYFEN 290 (311)
T ss_dssp HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC---HHHHHTSGGGTT
T ss_pred HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC---HHHHhcChHHHh
Confidence 44321 1111110 1357899999999999999999999 889999999999
Q ss_pred CCcch
Q 001370 976 VNWDS 980 (1091)
Q Consensus 976 IdWd~ 980 (1091)
+.|..
T Consensus 291 ~~~~~ 295 (311)
T 4agu_A 291 IREIE 295 (311)
T ss_dssp CC---
T ss_pred ccCHH
Confidence 87764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=419.95 Aligned_cols=262 Identities=27% Similarity=0.480 Sum_probs=221.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.++..++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35799999999999999999999999999999999975432 2234568899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 158 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN---- 158 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET----
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC----
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999753211
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChH-HH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE-II 921 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~-ei 921 (1091)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.. ..
T Consensus 159 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 217 (323)
T 3tki_A 159 ---------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (323)
T ss_dssp ---------------------TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH
T ss_pred ---------------------CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 01122345689999999999988775 78999999999999999999999876553 33
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+..+.......+ ....++.++.+||.+||..||.+||+ +.|+++||||+..
T Consensus 218 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~ 268 (323)
T 3tki_A 218 YSDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred HHHHhcccccCC-ccccCCHHHHHHHHHHccCChhhCcC---HHHHhhChhhccc
Confidence 333333332222 23568999999999999999999999 8899999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=416.89 Aligned_cols=263 Identities=29% Similarity=0.469 Sum_probs=209.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|..++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 568999999999999999999999999999999997643 223346788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 765 MEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 5999998754 3589999999999999999999999999999999999999999999999999975210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+
T Consensus 161 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 161 ---------------------------PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp ---------------------------CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------------CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0111234579999999999986 468999999999999999999999999998
Q ss_pred hHHHHHHHhhcCC-----CC--------------------------CCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 918 PEIIFDNILNRKI-----PW--------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 918 ~~ei~~kIl~~~l-----~f--------------------------P~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
..+....+..... .| +..+..++.++.+||.+||+.||.+||+ +.+
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e 290 (317)
T 2pmi_A 214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS---AKQ 290 (317)
T ss_dssp HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC---HHH
T ss_pred hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC---HHH
Confidence 8887777654100 00 0012357899999999999999999999 889
Q ss_pred HHcCCCCCCCCcch
Q 001370 967 VKAHPFFKGVNWDS 980 (1091)
Q Consensus 967 IL~HPFFkgIdWd~ 980 (1091)
+++||||++..|..
T Consensus 291 ~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 291 ALHHPWFAEYYHHA 304 (317)
T ss_dssp HTTSGGGGGGCC--
T ss_pred HhCChhhhcccchh
Confidence 99999999876653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=445.11 Aligned_cols=260 Identities=28% Similarity=0.568 Sum_probs=236.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....++|.+.+.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45678999999999999999999999999999999999875544444567899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~---- 167 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---- 167 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999997521
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+...
T Consensus 168 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 223 (476)
T 2y94_A 168 ------------------------DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223 (476)
T ss_dssp ------------------------TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred ------------------------ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence 0112345689999999999998776 789999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
++.++..+....| ..+++++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 224 ~~~~i~~~~~~~p---~~~s~~~~~Li~~~L~~dP~~Rpt---~~eil~hp~~~~ 272 (476)
T 2y94_A 224 LFKKICDGIFYTP---QYLNPSVISLLKHMLQVDPMKRAT---IKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHTTCCCCC---TTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHT
T ss_pred HHHHHhcCCcCCC---ccCCHHHHHHHHHHcCCCchhCcC---HHHHHhCHHhhh
Confidence 9999988876555 678999999999999999999999 889999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=403.95 Aligned_cols=260 Identities=31% Similarity=0.592 Sum_probs=204.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
.+++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45789999999999999999999999999999999986544344446789999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~---- 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM---- 164 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC----
Confidence 99999999999999875 5799999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.....
T Consensus 165 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 221 (278)
T 3cok_A 165 -----------------------PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221 (278)
T ss_dssp --------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred -----------------------CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence 011223467999999999999999999999999999999999999999988777776
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..+......+| ..++.++.+||.+||..||.+||+ +.++++||||...
T Consensus 222 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 269 (278)
T 3cok_A 222 NKVVLADYEMP---SFLSIEAKDLIHQLLRRNPADRLS---LSSVLDHPFMSRN 269 (278)
T ss_dssp --CCSSCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSTTTC--
T ss_pred HHHhhcccCCc---cccCHHHHHHHHHHcccCHhhCCC---HHHHhcCccccCC
Confidence 66665554444 678999999999999999999999 8899999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=425.79 Aligned_cols=264 Identities=30% Similarity=0.505 Sum_probs=226.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~--~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
..+.|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.++..++||||++++++|.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999999999999999997643221 12357789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc---EEEEecCCcc
Q 001370 762 YLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 834 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDFGLAk 834 (1091)
|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999888643 25899999999999999999999999999999999999987665 9999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
.... ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.
T Consensus 182 ~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 182 QLGE---------------------------SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp ECCT---------------------------TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EecC---------------------------CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 5310 0111234689999999999999999999999999999999999999998
Q ss_pred CCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 915 AESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 915 ~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
+. ...++..+..+...++. ....++.++++||.+||..||.+||+ +.++++||||++.++
T Consensus 235 ~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 235 GT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT---VYEALNHPWLKERDR 295 (351)
T ss_dssp SS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHTHHH
T ss_pred Cc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcChhhcCCcc
Confidence 85 45677777777655431 12468999999999999999999999 889999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=420.83 Aligned_cols=257 Identities=34% Similarity=0.564 Sum_probs=215.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.... .+.+.+|+.+++.++||||++++++|.+...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4567899999999999999999999999999999999764332 245789999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc--EEEEecCCcccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINN 840 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~--VKLsDFGLAk~~~~~~ 840 (1091)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++...
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--- 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence 99999999999999998889999999999999999999999999999999999999988775 9999999987321
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc-ceeechhhhHHHHHhCCCCCCCCCh-
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA-ADWWSVGIILFEFITGIPPFTAESP- 918 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k-sDIWSLGVILYEMLTGkpPF~~~s~- 918 (1091)
........+||+.|+|||++.+..|+.+ +|||||||++|+|++|++||.+.+.
T Consensus 170 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 170 -------------------------LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp ------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred -------------------------ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 0112234679999999999998888655 8999999999999999999987543
Q ss_pred ---HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 919 ---EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 919 ---~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
......+......+|. ...+++++.+||.+||..||.+||+ +.++++||||..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~ 280 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIFVADPATRIS---IPEIKTHSWFLK 280 (361)
T ss_dssp CCHHHHHHHHHTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSHHHHT
T ss_pred HHHHHHHHHHhcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCcC---HHHHHhCcchhc
Confidence 4555666666666553 3468999999999999999999999 889999999953
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=440.82 Aligned_cols=266 Identities=30% Similarity=0.522 Sum_probs=236.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|.+++|||||+++++|.+...+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34468999999999999999999999999999999998766555566788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe---cCCCcEEEEecCCccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~~ 839 (1091)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 180 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-- 180 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC--
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc--
Confidence 999999999999999988899999999999999999999999999999999999999 567899999999997521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..
T Consensus 181 --------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 181 --------------------------ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp --------------------------CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 0112234679999999999987 6999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 920 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
++...+..+.+.++. ....+|+++++||.+||++||.+||+ +.++++||||+...++.
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS---ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHHHTC--
T ss_pred HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhhChhhccccccc
Confidence 999999888766542 12468999999999999999999999 88999999998765543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=399.30 Aligned_cols=260 Identities=29% Similarity=0.554 Sum_probs=225.4
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.+..++|++.+.||+|+||.||+|+++.+|+.||||++.............+.+|+.++..++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 45678999999999999999999999999999999999865443444567889999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~--- 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+...
T Consensus 164 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 218 (276)
T 2h6d_A 164 -------------------------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218 (276)
T ss_dssp --------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 111234579999999999988766 689999999999999999999999998888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
++..+......+| ..++.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 219 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps---~~~~l~h~~~~~ 267 (276)
T 2h6d_A 219 LFKKIRGGVFYIP---EYLNRSVATLLMHMLQVDPLKRAT---IKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHT
T ss_pred HHHHhhcCcccCc---hhcCHHHHHHHHHHccCChhhCCC---HHHHHhChhhcc
Confidence 8888877765544 678999999999999999999999 889999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=401.51 Aligned_cols=261 Identities=29% Similarity=0.494 Sum_probs=236.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999998766666667788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---- 167 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY---- 167 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc----
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999875210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
........+||+.|+|||++.+..++.++||||||+++|+|++|..||......+.+
T Consensus 168 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 224 (294)
T 2rku_A 168 -----------------------DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 224 (294)
T ss_dssp -----------------------TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -----------------------CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 011223467999999999999999999999999999999999999999999988888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..+......+| ..++..+.+||.+||+.||.+||+ +.++++||||...
T Consensus 225 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~~~~~~~ 272 (294)
T 2rku_A 225 LRIKKNEYSIP---KHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 272 (294)
T ss_dssp HHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred HHHhhccCCCc---cccCHHHHHHHHHHcccChhhCcC---HHHHhhChheecC
Confidence 88877766555 688999999999999999999999 7799999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=409.46 Aligned_cols=270 Identities=30% Similarity=0.534 Sum_probs=219.1
Q ss_pred CCCeEEE-EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 001370 685 IDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 685 iddFeil-r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LY 762 (1091)
.+.|++. +.||+|+||+||+|+++.+|+.||||++.+.. ......+.+|+.+|.++ +||||+++++++.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4678886 78999999999999999999999999997643 23456789999999885 7999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc---EEEEecCCccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLIN 839 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDFGLAk~~~~~ 839 (1091)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999998889999999999999999999999999999999999999998776 999999998753211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----CCCCccceeechhhhHHHHHhCCCCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
... ...........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 168 ~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 168 GDC--------------------SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp ----------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred Ccc--------------------ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 000 0001112234679999999999975 558899999999999999999999998
Q ss_pred CCC---------------hHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 915 AES---------------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 915 ~~s---------------~~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
+.. ...++..+......+|.. ...++.++++||.+||+.||.+||+ +.++++||||++..|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS---AAQVLQHPWVQGCAP 304 (316)
T ss_dssp CCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSTTCC----
T ss_pred ccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC---HHHHhcChhhcCCCC
Confidence 764 245667777776665521 1368899999999999999999999 889999999998776
Q ss_pred ch
Q 001370 979 DS 980 (1091)
Q Consensus 979 d~ 980 (1091)
..
T Consensus 305 ~~ 306 (316)
T 2ac3_A 305 EN 306 (316)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=399.66 Aligned_cols=269 Identities=30% Similarity=0.487 Sum_probs=232.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc------cchhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM------IRKNDIERILAERNILITVR-NPFVVRFFYSF 755 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i------~~~~eie~~l~EieILskL~-HPNIVkL~gsf 755 (1091)
...++|++.+.||+|+||.||+|+++.+|+.||||+++.... ......+.+.+|+.++.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 346899999999999999999999999999999999975431 11233567889999999996 99999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 756 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 756 qded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.....+|+||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc------CCCCCccceeechhhhHHHHHhC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~------g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
... .......+||+.|+|||++. ...++.++||||||+++|+|++|
T Consensus 174 ~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 225 (298)
T 1phk_A 174 LDP----------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225 (298)
T ss_dssp CCT----------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cCC----------------------------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence 210 11223467999999999985 45688999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 982 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~ 982 (1091)
..||...+.......+..+...++.. ...++.++.+||.+||..||.+||+ +.++++||||++..|+.+.
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 226 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCTTC-----
T ss_pred CCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC---HHHHHhChHhhhccchhhc
Confidence 99999999888888888876665431 2468899999999999999999999 8899999999998887654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=417.92 Aligned_cols=261 Identities=35% Similarity=0.581 Sum_probs=215.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...+.|++.+.||+|+||+||+|+++.+++.||||++++.. ..+.+.+|+.+|.+++||||++++++|.+...+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 44578999999999999999999999999999999997632 3456789999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CCcEEEEecCCccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGLAk~~~~~ 839 (1091)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~-- 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-- 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC--
Confidence 99999999999999998888999999999999999999999999999999999999976 8999999999987421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||......
T Consensus 203 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 203 --------------------------HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp ------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred --------------------------cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 011123467999999999999999999999999999999999999999876654
Q ss_pred -HHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 920 -IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 920 -ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
.++..+.+....++. ....++.++.+||.+||+.||.+||+ +.++++||||.+..+.
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT---TFQALQHPWVTGKAAN 315 (349)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTTSTTCC
T ss_pred HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCccc
Confidence 467777776554432 23578999999999999999999999 8899999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=426.06 Aligned_cols=262 Identities=25% Similarity=0.472 Sum_probs=231.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...+.|++++.||+|+||+||+|.++.+|+.||+|++.+.. ......+.+|+.+|..++||||++++++|.+...+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997643 234567889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC--CCcEEEEecCCccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~~~~ 839 (1091)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 9999999999999997654 6999999999999999999999999999999999999984 57899999999985210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 204 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 256 (387)
T 1kob_A 204 ---------------------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256 (387)
T ss_dssp ---------------------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ---------------------------CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence 11123457999999999999999999999999999999999999999999998
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 920 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
+....+......++. ....+++++++||.+||+.||.+||+ +.++++||||++..+
T Consensus 257 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 257 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSCCT
T ss_pred HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhhCccccCCcc
Confidence 888888877655442 23578999999999999999999999 889999999987644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=401.30 Aligned_cols=259 Identities=32% Similarity=0.535 Sum_probs=223.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++.+.||+|+||+||+|+++.+|..||+|++.+.. .....+.+.+|+.+|..++||||+++++++.+...+|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 34578999999999999999999999999999999998643 2334678899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe---cCCCcEEEEecCCccc
Q 001370 763 LVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~ 835 (1091)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998643 679999999999999999999999999999999999999 4568899999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
... .......+||+.|+|||++. ..++.++|||||||++|||++|..||.+
T Consensus 177 ~~~----------------------------~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 177 FKS----------------------------DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp --------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCC----------------------------cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 210 11123467999999999986 5689999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.+..+....+......++.....+++++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~f~~ 284 (285)
T 3is5_A 228 TSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS---AAQVLHHEWFKQ 284 (285)
T ss_dssp SSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCC---HHHHHTSGGGGC
T ss_pred CCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHhhc
Confidence 998888888777665555444568999999999999999999999 889999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=404.67 Aligned_cols=262 Identities=29% Similarity=0.440 Sum_probs=215.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhc---CCCceEEEeeeecc
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR--KNDIERILAERNILITV---RNPFVVRFFYSFTC 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~--~~eie~~l~EieILskL---~HPNIVkL~gsfqd 757 (1091)
...++|++++.||+|+||+||+|+++.+|+.||||+++...... ......+.+|+.++..+ +||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 44679999999999999999999999999999999997533211 11123456677776665 59999999999987
Q ss_pred CC-----eeEEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEec
Q 001370 758 RD-----NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 830 (1091)
Q Consensus 758 ed-----~LYLVMEYm~GGSL~dlL~k~g~--LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDF 830 (1091)
.. .+|+||||+. |+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 5899999997 599999987654 999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGk 910 (1091)
|+++... ........+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 165 g~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 165 GLARIYS----------------------------YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp SCTTTST----------------------------TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSS
T ss_pred ccccccC----------------------------CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCC
Confidence 9987421 011224568999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCC-----CCCC-------------------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 911 PPFTAESPEIIFDNILNRKI-----PWPC-------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 911 pPF~~~s~~ei~~kIl~~~l-----~fP~-------------------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
+||.+.+..+....+..... .|+. ....+++++.+||.+||+.||.+||+ +.+
T Consensus 217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e 293 (308)
T 3g33_A 217 PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS---AFR 293 (308)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC---HHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC---HHH
Confidence 99999998888877765211 1110 11357899999999999999999999 889
Q ss_pred HHcCCCCCCC
Q 001370 967 VKAHPFFKGV 976 (1091)
Q Consensus 967 IL~HPFFkgI 976 (1091)
+++||||+..
T Consensus 294 ~l~h~~~~~~ 303 (308)
T 3g33_A 294 ALQHSYLHKD 303 (308)
T ss_dssp HHTSTTC---
T ss_pred HhcCccccCC
Confidence 9999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=415.47 Aligned_cols=270 Identities=29% Similarity=0.469 Sum_probs=226.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~--~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
..++|++.+.||+|+||+||+|+++.+++.||+|++.+.... .....+.+.+|+.+|..++||||++++++|.+.+.+
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 346899999999999999999999999999999999864322 345567899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 001370 762 YLVMEYLNGGDLYSLLRKV----------------------------------------GCLEEDVARIYIAELVLALEY 801 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~----------------------------------------g~LsE~~ar~yaaQIa~ALeY 801 (1091)
|+||||++||+|.+++... ..+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999998521 123677888999999999999
Q ss_pred HHHcCCeecccCCCceEecCCC--cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCC
Q 001370 802 LHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 879 (1091)
Q Consensus 802 LHs~GIIHRDLKPeNILLD~nG--~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~Y 879 (1091)
||++||+||||||+|||++.++ .+||+|||+++....... .........+||+.|
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y 240 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-----------------------GEYYGMTTKAGTPYF 240 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-----------------------C--------CCCGGG
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc-----------------------cccccccccCCCccc
Confidence 9999999999999999998777 899999999985321000 011123456799999
Q ss_pred CChhhhcC--CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCC
Q 001370 880 LAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPN 956 (1091)
Q Consensus 880 mAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPe 956 (1091)
+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+......++. ....+++++.+||.+||..||.
T Consensus 241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 99999975 67899999999999999999999999999999999998887765542 1124799999999999999999
Q ss_pred CCCCcccHHHHHcCCCCCCCCcc
Q 001370 957 QRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 957 KRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
+||+ +.++++||||+++.|.
T Consensus 321 ~Rps---~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 321 ERFD---AMRALQHPWISQFSDK 340 (345)
T ss_dssp TSCC---HHHHHHSHHHHTTSSC
T ss_pred HCCC---HHHHhcChhhccChHh
Confidence 9999 8899999999987654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=419.53 Aligned_cols=260 Identities=31% Similarity=0.487 Sum_probs=217.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
..+.|++++.||+|+||.||+|+++.+|+.||||++.+. .........+.+|+.+|..++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 357899999999999999999999999999999998653 234455678899999999999999999999998764
Q ss_pred --eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 8899999876 679999999999999999999999999999999999999999999999999998421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.
T Consensus 180 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 180 ------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01234679999999999987 78999999999999999999999999998
Q ss_pred ChHHHHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 917 SPEIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 917 s~~ei~~kIl~~~----------------------------l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+..+.+..|+... ..+..+....++++.+||.+||+.||.+||| +.+++
T Consensus 230 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t---~~e~l 306 (367)
T 1cm8_A 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEAL 306 (367)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC---HHHHh
Confidence 8877776665411 1122234567999999999999999999999 88999
Q ss_pred cCCCCCCCCcc
Q 001370 969 AHPFFKGVNWD 979 (1091)
Q Consensus 969 ~HPFFkgIdWd 979 (1091)
+||||+.+.+.
T Consensus 307 ~hp~f~~~~~~ 317 (367)
T 1cm8_A 307 AHPYFESLHDT 317 (367)
T ss_dssp HSGGGTTTC--
T ss_pred cChHHHhhcCC
Confidence 99999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=394.25 Aligned_cols=256 Identities=30% Similarity=0.545 Sum_probs=228.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||+|+||+||+|.++.++..||+|++.+... ...+.+.+|+.++..++||||++++++|.+...+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 3579999999999999999999999999999999976432 3456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe---cCCCcEEEEecCCccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~---- 160 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---- 160 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc----
Confidence 9999999999999988899999999999999999999999999999999999999 788999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
........+||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+.
T Consensus 161 ------------------------~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 215 (277)
T 3f3z_A 161 ------------------------PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215 (277)
T ss_dssp ------------------------TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 01122345799999999998765 89999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 922 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 922 ~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
...+..+...+|.. ...+++++.+||.+||+.||.+||+ +.++++||||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~ 267 (277)
T 3f3z_A 216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT---SLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHHH
T ss_pred HHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhc
Confidence 99988887665521 1268999999999999999999999 889999999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=410.29 Aligned_cols=261 Identities=29% Similarity=0.494 Sum_probs=236.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|.+.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 45678999999999999999999999999999999998766666667788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---- 193 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY---- 193 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc----
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999975210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.+
T Consensus 194 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 250 (335)
T 2owb_A 194 -----------------------DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 250 (335)
T ss_dssp -----------------------TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -----------------------CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence 011223467999999999999999999999999999999999999999999988888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..+......+| ..++.++.+||.+||+.||.+||+ +.++++||||...
T Consensus 251 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~ell~~~~~~~~ 298 (335)
T 2owb_A 251 LRIKKNEYSIP---KHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 298 (335)
T ss_dssp HHHHHTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred HHHhcCCCCCC---ccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccCC
Confidence 88887776655 688999999999999999999999 7799999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=436.81 Aligned_cols=263 Identities=31% Similarity=0.540 Sum_probs=231.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+|.+++|||||++++++.+...+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 3457899999999999999999999999999999999764432 234678899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec---CCCcEEEEecCCccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD---~nG~VKLsDFGLAk~~~~~ 839 (1091)
+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-
Confidence 9999999999999999889999999999999999999999999999999999999995 456899999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..
T Consensus 177 ---------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 228 (486)
T 3mwu_A 177 ---------------------------NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (486)
T ss_dssp ---------------------------C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------------------------CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 112234679999999999986 5999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 920 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
++...+..+...++. ....+|+++++||.+||+.||.+||+ +.++++||||+....
T Consensus 229 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHHHCHHHHHTCC
T ss_pred HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCHhhccCcc
Confidence 999999888766542 12468999999999999999999999 889999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=436.29 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=213.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .........+.+|+.+|+.++|||||+++++|....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 467899999999999999999999999999999999864 334556778999999999999999999999997653
Q ss_pred --eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+.+ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 57999999987 56666643 49999999999999999999999999999999999999999999999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
........+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+
T Consensus 216 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 216 ----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp -----------------------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0112345689999999999999999999999999999999999999999998
Q ss_pred hHHHHHHHhhcCC----------------------CCCC------CCCC-----------CCHHHHHHHhhhccCCCCCC
Q 001370 918 PEIIFDNILNRKI----------------------PWPC------VPSD-----------MSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 918 ~~ei~~kIl~~~l----------------------~fP~------ip~~-----------lS~eakDLI~rcL~kDPeKR 958 (1091)
..+.+.+|+.... .+.. ++.. .++++++||.+||++||.+|
T Consensus 268 ~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 347 (464)
T 3ttj_A 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347 (464)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhC
Confidence 8877777654210 0000 0000 15679999999999999999
Q ss_pred CCcccHHHHHcCCCCCC
Q 001370 959 LGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkg 975 (1091)
|| +.|+++||||+.
T Consensus 348 ~t---a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 348 IS---VDDALQHPYINV 361 (464)
T ss_dssp CC---HHHHHTSTTTGG
T ss_pred CC---HHHHhcChhhhh
Confidence 99 889999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=408.94 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=220.9
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----CCceEEEee
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----NPFVVRFFY 753 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-----HPNIVkL~g 753 (1091)
.......++|++++.||+|+||+||+|++..+|+.||||++++. ......+..|+.++..+. |||||++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 33445678999999999999999999999999999999999752 234566788999999986 999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC----------
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---------- 821 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---------- 821 (1091)
+|...+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 899999998754 5999999999999999999999999999999999999975
Q ss_pred ---------------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc
Q 001370 822 ---------------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 886 (1091)
Q Consensus 822 ---------------nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~ 886 (1091)
++.+||+|||+++... ......+||+.|+|||++.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~------------------------------~~~~~~~gt~~y~aPE~~~ 232 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKS------------------------------DYHGSIINTRQYRAPEVIL 232 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETT------------------------------SCCCSCCSCGGGCCHHHHT
T ss_pred hcccccccccccccCCCCEEEEeccCceecC------------------------------CCCcCccCcccccCcHHHc
Confidence 7899999999997421 1123467999999999999
Q ss_pred CCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC--------------------------CC-----
Q 001370 887 GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP--------------------------CV----- 935 (1091)
Q Consensus 887 g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP--------------------------~i----- 935 (1091)
+..|+.++|||||||++|+|++|.+||.+.+..+....+.....++| ..
T Consensus 233 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 312 (360)
T 3llt_A 233 NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312 (360)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHH
T ss_pred CCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchh
Confidence 99999999999999999999999999999887777666654322222 10
Q ss_pred ------------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 936 ------------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 936 ------------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
+...++.+.+||.+||+.||.+||+ +.++++||||+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~ 360 (360)
T 3llt_A 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS---PAELLKHKFLE 360 (360)
T ss_dssp HHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGC
T ss_pred hhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC---HHHHhcCcccC
Confidence 0112377889999999999999999 88999999995
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=408.43 Aligned_cols=257 Identities=30% Similarity=0.534 Sum_probs=225.8
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.++..++||||+++++++...+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4788899999999999999999999999999997533 2345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|++||+|.+++.+ ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-------- 193 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------- 193 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--------
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--------
Confidence 9999999998865 5699999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHh
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 926 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl 926 (1091)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||...+.......+.
T Consensus 194 -------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~ 254 (321)
T 2c30_A 194 -------------------DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254 (321)
T ss_dssp -------------------SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred -------------------CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 0111235689999999999999999999999999999999999999999998888888777
Q ss_pred hcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 927 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 927 ~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
....+....+..+++++.+||.+||+.||.+||+ +.++++||||....
T Consensus 255 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~ 302 (321)
T 2c30_A 255 DSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT---AQELLDHPFLLQTG 302 (321)
T ss_dssp HSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGGGCC
T ss_pred cCCCCCcCccccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhccCC
Confidence 6544322223568999999999999999999999 88999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=424.30 Aligned_cols=290 Identities=28% Similarity=0.435 Sum_probs=219.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde----- 758 (1091)
..++|++++.||+|+||+||+|+++.+|+.||||++++. .........+.+|+.+|..++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 457899999999999999999999999999999999763 33445677899999999999999999999999877
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..+|+||||+. |+|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.+|.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999986 59999999888899999999999999999999999999999999999999999999999999986421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh-cCCCCCccceeechhhhHHHHHh---------
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFIT--------- 908 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL-~g~~Ys~ksDIWSLGVILYEMLT--------- 908 (1091)
........... ...................+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 182 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 182 EKDTNIVNDLE-----ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp ----------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccc-----ccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 11000000000 0000000000111234567999999999987 45679999999999999999998
Q ss_pred --CCCCCCCCCh-----------------HHHHHHHhh------------------------cCCCCC----CCCCCCCH
Q 001370 909 --GIPPFTAESP-----------------EIIFDNILN------------------------RKIPWP----CVPSDMSF 941 (1091)
Q Consensus 909 --GkpPF~~~s~-----------------~ei~~kIl~------------------------~~l~fP----~ip~~lS~ 941 (1091)
|.++|.+.+. .+....|++ .....+ .....+++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 4555554431 111111111 010000 01145899
Q ss_pred HHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhc
Q 001370 942 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 983 (1091)
Q Consensus 942 eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~ 983 (1091)
++.+||.+||+.||.+||| +.|+++||||+++.|.....
T Consensus 337 ~~~dLl~~mL~~dP~~R~t---a~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRIT---IDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCC---HHHHHTCGGGTTTCCTTTC-
T ss_pred HHHHHHHHHhcCCcccCCC---HHHHhcChhhhhccCcccCc
Confidence 9999999999999999999 88999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=399.78 Aligned_cols=264 Identities=31% Similarity=0.539 Sum_probs=230.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~---~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
++|++.+.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.++..++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999987543221 13677899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC----cEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~~~ 838 (1091)
+||||+++++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999999888999999999999999999999999999999999999999877 899999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus 165 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 165 ----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp -----------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ----------------------------CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 0112345799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 919 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
.+....+......++. ....++..+.+||.+||..||.+||+ +.++++||||+.+.|..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT---IAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC---HHHHHHCHHHHHHHHCC
T ss_pred HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC---HHHHHhCHHHHHHHHHh
Confidence 8888888776554431 22568899999999999999999999 88999999998776543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=405.32 Aligned_cols=268 Identities=26% Similarity=0.437 Sum_probs=212.5
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded----- 759 (1091)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|.+++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 467999999999999999999999999999999997543 3345678999999999999999999999986543
Q ss_pred ----------------------------------------------------eeEEEEeecCCCcHHHHHHhcCC---CC
Q 001370 760 ----------------------------------------------------NLYLVMEYLNGGDLYSLLRKVGC---LE 784 (1091)
Q Consensus 760 ----------------------------------------------------~LYLVMEYm~GGSL~dlL~k~g~---Ls 784 (1091)
.+|+||||++||+|.+++.+... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987643 55
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccc
Q 001370 785 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864 (1091)
Q Consensus 785 E~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~ 864 (1091)
+..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......... .... ..
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~-------------~~~~--~~ 227 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ-------------TVLT--PM 227 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhc-------------cccc--cc
Confidence 66788999999999999999999999999999999999999999999998532110000 0000 00
Q ss_pred cCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 001370 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQ 944 (1091)
Q Consensus 865 ~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eak 944 (1091)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..|+.. .......+... .+|......++++.
T Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFPLLFTQKYPQEH 303 (332)
T ss_dssp ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCHHHHHHCHHHH
T ss_pred cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCcccccCChhHH
Confidence 001223456899999999999999999999999999999999999877532 22233333333 23322345678899
Q ss_pred HHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 945 DLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 945 DLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+||.+||..||.+||+ +.++++||||+++
T Consensus 304 ~li~~~l~~~p~~Rps---~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPE---ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHCSSGGGSCC---HHHHHHSTTCCCC
T ss_pred HHHHHHccCCCCcCCC---HHHHhhchhhhcC
Confidence 9999999999999999 8899999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=409.98 Aligned_cols=266 Identities=30% Similarity=0.469 Sum_probs=230.5
Q ss_pred CCCeEEE-EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 001370 685 IDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 685 iddFeil-r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LY 762 (1091)
.+.|.+. +.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.++..+. ||||++++++|.+...+|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 4567777 899999999999999999999999999986443 2334677899999999995 699999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CCcEEEEecCCccccc
Q 001370 763 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGLAk~~~ 837 (1091)
+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999999998653 67999999999999999999999999999999999999998 7899999999997521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+
T Consensus 186 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 186 H----------------------------ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp ------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C----------------------------ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0 111234679999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001370 918 PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 982 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~ 982 (1091)
..+.+..+......++. ....+++.+.+||.+||+.||.+||+ +.++++||||++++|+.+.
T Consensus 238 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT---AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTCGGGCCCCTTCC-
T ss_pred chHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhCCHhhccccccccc
Confidence 98888888776555442 23578999999999999999999999 8899999999999998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=402.30 Aligned_cols=257 Identities=35% Similarity=0.608 Sum_probs=227.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++... .....+.+|+.++..++||||+++++++.+...+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4679999999999999999999999999999999986432 2335688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe---cCCCcEEEEecCCccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~---- 160 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---- 160 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC----
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC----
Confidence 9999999999999988899999999999999999999999999999999999999 788999999999987411
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+...+
T Consensus 161 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 215 (304)
T 2jam_A 161 -------------------------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL 215 (304)
T ss_dssp -------------------------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -------------------------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 0112345799999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 922 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 922 ~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
...+..+...++. ....+++++.+||.+||..||.+||+ +.++++||||++.
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 268 (304)
T 2jam_A 216 FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT---CEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC---HHHHHTSHHHHSS
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCccccCC
Confidence 9888887665542 33578999999999999999999999 8899999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=433.37 Aligned_cols=262 Identities=29% Similarity=0.488 Sum_probs=228.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch----------hHHHHHHHHHHHHHhcCCCceEEEe
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK----------NDIERILAERNILITVRNPFVVRFF 752 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~----------~eie~~l~EieILskL~HPNIVkL~ 752 (1091)
...++|++++.||+|+||+||+|+++.+++.||||++++...... ...+.+.+|+.+|..++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 446789999999999999999999999999999999987543221 3457789999999999999999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---cEEEEe
Q 001370 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTD 829 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsD 829 (1091)
++|.+...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999999999889999999999999999999999999999999999999999876 699999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
||+++.... .......+||+.|+|||++.+ .|+.++|||||||++|+|++|
T Consensus 193 fg~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 243 (504)
T 3q5i_A 193 FGLSSFFSK----------------------------DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243 (504)
T ss_dssp CTTCEECCT----------------------------TSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCEEcCC----------------------------CCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhC
Confidence 999975310 112234679999999999874 699999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.+||.+.+..++...+..+.+.++. ....+|+++++||.+||++||.+||+ +.++++||||+..
T Consensus 244 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT---AEEALNSRWIKKY 308 (504)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCC---HHHHhcCHhhhhc
Confidence 9999999999999999888766542 12568999999999999999999999 8899999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=395.66 Aligned_cols=256 Identities=23% Similarity=0.420 Sum_probs=219.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCe
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDN 760 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd----ed~ 760 (1091)
...|++.+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+|..++||||++++++|.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3458999999999999999999999999999999986443 44567889999999999999999999998865 456
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEec-CCCcEEEEecCCccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD-~nG~VKLsDFGLAk~~~ 837 (1091)
+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999998889999999999999999999999999 99999999999998 78999999999986421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 184 -----------------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 184 -----------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp -----------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred -----------------------------ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 111234579999999998875 59999999999999999999999998854
Q ss_pred h-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 918 P-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 918 ~-~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
. ...+..+..+. ..+..+...++++.+||.+||..||.+||+ +.++++||||++
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~f~~ 288 (290)
T 1t4h_A 234 NAAQIYRRVTSGV-KPASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp SHHHHHHHHTTTC-CCGGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred cHHHHHHHHhccC-CccccCCCCCHHHHHHHHHHccCChhhCCC---HHHHhhCccccc
Confidence 4 44455444433 323345677899999999999999999999 889999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=414.02 Aligned_cols=262 Identities=28% Similarity=0.512 Sum_probs=215.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++++.||+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+|..++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 3689999999999999999999999999999999875321 11122456799999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+.| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~----- 152 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI----- 152 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC-----
Confidence 999985 9999887654 599999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+..
T Consensus 153 ----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (324)
T 3mtl_A 153 ----------------------PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210 (324)
T ss_dssp --------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ----------------------CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112234578999999999987 67899999999999999999999999999888877
Q ss_pred HHHhhcC-----CCCCC----------------------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 923 DNILNRK-----IPWPC----------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 923 ~kIl~~~-----l~fP~----------------------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
..+.... ..||. ....+++++.+||.+||+.||.+||+ +.|+++||||.+
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~ 287 (324)
T 3mtl_A 211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS---AEDAMKHPFFLS 287 (324)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGGG
T ss_pred HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC---HHHHhcChhhhh
Confidence 7665421 11111 11357899999999999999999999 889999999987
Q ss_pred CCcc
Q 001370 976 VNWD 979 (1091)
Q Consensus 976 IdWd 979 (1091)
+...
T Consensus 288 ~~~~ 291 (324)
T 3mtl_A 288 LGER 291 (324)
T ss_dssp GCST
T ss_pred cccc
Confidence 6543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=390.20 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=214.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYL 763 (1091)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4689999999999999999999999999999999986432 334567788999999999 89999999999999999999
Q ss_pred EEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC----------------
Q 001370 764 VMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---------------- 823 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~----g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---------------- 823 (1091)
||||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999765 6799999999999999999999999999999999999998544
Q ss_pred ---cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeech
Q 001370 824 ---HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 899 (1091)
Q Consensus 824 ---~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSL 899 (1091)
.+||+|||++.... ......||+.|+|||++.+. .++.++|||||
T Consensus 169 ~~~~~kl~Dfg~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRIS-------------------------------SPQVEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp -CCCEEECCCTTCEETT-------------------------------CSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred CceEEEEcccccccccC-------------------------------CccccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 79999999987421 01224599999999999875 56789999999
Q ss_pred hhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 900 GIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 900 GVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
||++|+|++|.+||.... ....+..+.. +.++..+++++.+||.+||..||.+||+ +.++++||||.+.
T Consensus 218 G~il~~l~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 218 ALTVVCAAGAEPLPRNGD---QWHEIRQGRL--PRIPQVLSQEFTELLKVMIHPDPERRPS---AMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHTTCCCCCSSSH---HHHHHHTTCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTCTTC---
T ss_pred HHHHHHHhcCCCCCcchh---HHHHHHcCCC--CCCCcccCHHHHHHHHHHhCCCcccCCC---HHHHhhChHhhhh
Confidence 999999999998876543 3344444433 4456789999999999999999999999 8899999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=431.98 Aligned_cols=260 Identities=32% Similarity=0.562 Sum_probs=225.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.+.|++++.||+|+||+||+|+++.++..||||++++.... ......+.+|+.+|..++|||||+++++|.+...+|+|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999875432 23356789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC---CcEEEEecCCccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n---G~VKLsDFGLAk~~~~~~s 841 (1091)
|||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+++...
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~---- 190 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---- 190 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB----
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC----
Confidence 9999999999999988899999999999999999999999999999999999999764 559999999997531
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
........+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..++
T Consensus 191 ------------------------~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 245 (494)
T 3lij_A 191 ------------------------NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245 (494)
T ss_dssp ------------------------TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011223568999999999986 4699999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 922 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 922 ~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
...+..+...++.. ...+++++++||.+||+.||.+||+ +.++++||||+...
T Consensus 246 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 246 LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS---AQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHHHH
T ss_pred HHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCcc---HHHHhcCcccccCc
Confidence 99998887765531 2468999999999999999999999 88999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=413.78 Aligned_cols=264 Identities=31% Similarity=0.509 Sum_probs=226.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++++.||+|+||+||+|++..+|+.||+|+++.. ........+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 4567899999999999999999999999999999999763 23455678999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
+||||++||+|.+++.+.+.+++..+..++.|++.||.|||+. ||+||||||+|||++.+|++||+|||+++...
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---- 183 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 183 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc----
Confidence 9999999999999999988999999999999999999999996 99999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..++
T Consensus 184 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 184 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp -------------------------HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred -------------------------cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112345799999999999999999999999999999999999999987765443
Q ss_pred HH------------------------------------------HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCC
Q 001370 922 FD------------------------------------------NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 959 (1091)
Q Consensus 922 ~~------------------------------------------kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRp 959 (1091)
.. .+.....+ ...+..++.++.+||.+||..||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rp 317 (360)
T 3eqc_A 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERA 317 (360)
T ss_dssp HHHHC------------------------------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCC
Confidence 22 22222211 111245799999999999999999999
Q ss_pred CcccHHHHHcCCCCCCCCcchh
Q 001370 960 GANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 960 Sa~gA~EIL~HPFFkgIdWd~L 981 (1091)
+ +.++++||||++.+|+.+
T Consensus 318 t---~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 318 D---LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp C---HHHHHTSHHHHHHHHSCC
T ss_pred C---HHHHhhChHhhcchHhhh
Confidence 9 889999999998776654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=398.35 Aligned_cols=265 Identities=32% Similarity=0.566 Sum_probs=227.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..+.|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+|+.++..++||||+++++++...+.+|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4578999999999999999999999999999999987532 3346788999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 169 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK---- 169 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH----
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc----
Confidence 9999999999999876 45699999999999999999999999999999999999999999999999998763210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
.........||+.|+|||++. +..++.++|||||||++|+|++|.+||...+
T Consensus 170 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 170 -----------------------TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp -----------------------HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----------------------cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 011123457999999999984 6778999999999999999999999999998
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchh
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
.......+.....+....+..++.++.+||.+||..||.+||+ +.++++||||+++.|...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~ 287 (302)
T 2j7t_A 227 PMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLEHPFVSSITSNKA 287 (302)
T ss_dssp HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCC---HHHHTTSTTTTTCCCCHH
T ss_pred HHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCC---HHHHhcChHHhhhccchh
Confidence 8888877777654433345678999999999999999999999 889999999999988653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=413.06 Aligned_cols=255 Identities=30% Similarity=0.515 Sum_probs=202.9
Q ss_pred CCeEEE---EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001370 686 DDFEII---KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 686 ddFeil---r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~L 761 (1091)
++|++. +.||+|+||+||+|+++.+|+.||||++.+. ....+.+|+.++..+. ||||++++++|.+...+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 456665 7899999999999999999999999999752 3456788999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---cEEEEecCCcccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLI 838 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~~~~ 838 (1091)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999999988999999999999999999999999999999999999998766 899999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s- 917 (1091)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus 162 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 162 ---------------------------DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred ---------------------------CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 1112345679999999999999999999999999999999999999998644
Q ss_pred ------hHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 918 ------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 918 ------~~ei~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..++...+..+...++.. ...+++++++||.+||+.||.+||+ +.++++||||++.
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~h~w~~~~ 277 (325)
T 3kn6_A 215 SLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK---MSGLRYNEWLQDG 277 (325)
T ss_dssp ---CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC---TTTSTTCGGGCTT
T ss_pred ccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC---HHHHhcChhhccC
Confidence 356777777776654421 1358999999999999999999999 7789999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=420.66 Aligned_cols=258 Identities=27% Similarity=0.503 Sum_probs=222.2
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 768 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm 768 (1091)
...+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|+.+|.+++|||||+++++|.+.+.+|+||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 33678999999999999999999999999998643 245677899999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe--cCCCcEEEEecCCcccccccccccCC
Q 001370 769 NGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 769 ~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL--D~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~------- 241 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP------- 241 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT-------
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC-------
Confidence 999999988754 469999999999999999999999999999999999999 5678999999999985210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+
T Consensus 242 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 300 (373)
T 2x4f_A 242 ---------------------REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300 (373)
T ss_dssp ---------------------TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred ---------------------ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11123457999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 926 LNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 926 l~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
+.....++. ....+++++++||.+||+.||.+||+ +.++++||||++..|..
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 301 LACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS---ASEALKHPWLSDHKLHS 353 (373)
T ss_dssp HHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHCHHHHH
T ss_pred HhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCC---HHHHhcCcCcCCCchhh
Confidence 887665442 12568999999999999999999999 88999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=423.60 Aligned_cols=254 Identities=31% Similarity=0.524 Sum_probs=212.0
Q ss_pred ccCCCeEEE-EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCceEEEeeeecc---
Q 001370 683 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTC--- 757 (1091)
Q Consensus 683 ~~iddFeil-r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILs-kL~HPNIVkL~gsfqd--- 757 (1091)
..+++|.+. +.||+|+||+||+|+++.+|+.||||++++. ..+.+|+.++. ..+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 456789887 7999999999999999999999999999642 34667888874 4589999999998875
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CCcEEEEecC
Q 001370 758 -RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 831 (1091)
Q Consensus 758 -ed~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFG 831 (1091)
...+||||||++||+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+||||+. +|.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 667999999999999999998754 5999999999999999999999999999999999999998 7899999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
+++.... .....+.+||+.|+|||++.+..|+.++|||||||+||||++|.+
T Consensus 210 ~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 261 (400)
T 1nxk_A 210 FAKETTS----------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_dssp TCEECC---------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCC----------------------------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 9985210 112235689999999999999999999999999999999999999
Q ss_pred CCCCCChH----HHHHHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 912 PFTAESPE----IIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 912 PF~~~s~~----ei~~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
||.+.+.. .+...+..+.+.+|.. ...++.++++||.+||+.||.+||+ +.++++||||.+
T Consensus 262 pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 327 (400)
T 1nxk_A 262 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 327 (400)
T ss_dssp SCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHT
T ss_pred CCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccccC
Confidence 99876543 2556666666655531 2468999999999999999999999 889999999964
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=408.61 Aligned_cols=265 Identities=26% Similarity=0.389 Sum_probs=223.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe--
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-- 760 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~-- 760 (1091)
...++|++.+.||+|+||+||+|++..+|+.||||+++............+.+|+.++..++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 345789999999999999999999999999999999987655555667789999999999999999999999887654
Q ss_pred --eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 761 --LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 761 --LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 499999999999999999888999999999999999999999999999999999999999999999999999975311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.. .........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.
T Consensus 169 ~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 169 SG------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp -------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc------------------------cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 00 001122346799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 919 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
......+.......+. ....++.++.+||.+||..||.+||+ +.+++.|+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 278 (311)
T 3ork_A 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ---TAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChh---hHHHHHHHHHH
Confidence 8877777665443221 23568999999999999999999999 66888899885
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=413.59 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=211.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
..++|++++.||+|+||+||+|.+..+|+.||||++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4578999999999999999999999999999999997632 33455678899999999999999999999998765
Q ss_pred --eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+.+ +|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 7888885 458999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 179 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 179 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ---------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c----------------------------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0 111234689999999999999999999999999999999999999999998
Q ss_pred hHHHHHHHhhcCCC----------------------CCC-----------CCC------CCCHHHHHHHhhhccCCCCCC
Q 001370 918 PEIIFDNILNRKIP----------------------WPC-----------VPS------DMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~----------------------fP~-----------ip~------~lS~eakDLI~rcL~kDPeKR 958 (1091)
..+.+..++..... +.. .+. ..+.++++||.+||+.||.+|
T Consensus 231 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence 88777776643110 000 000 015689999999999999999
Q ss_pred CCcccHHHHHcCCCCCCC
Q 001370 959 LGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkgI 976 (1091)
|| +.++++||||+..
T Consensus 311 ~t---~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 311 IS---VDEALQHPYINVW 325 (371)
T ss_dssp CC---HHHHHHSHHHHTT
T ss_pred CC---HHHHhCCcchhhh
Confidence 99 8899999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=396.95 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=218.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.++..++||||+++++++.+.+.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 44578999999999999999999999999999999997765556666788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 163 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE---- 163 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc----
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999974210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.....
T Consensus 164 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~ 221 (294)
T 4eqm_A 164 ----------------------TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221 (294)
T ss_dssp ---------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred ----------------------ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 0011223467999999999999999999999999999999999999999999887776
Q ss_pred HHHhhcCCCCC--CCCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 923 DNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 923 ~kIl~~~l~fP--~ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
.+.+....+.. ..+..+++.+.++|.+||..||.+||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp HHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred HHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc
Confidence 66665543321 134678999999999999999999995
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=391.54 Aligned_cols=261 Identities=28% Similarity=0.489 Sum_probs=222.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.++|++++.||+|+||.||+|+++.+|+.||+|++..... ....+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 4679999999999999999999999999999999975432 23457889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---- 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 159 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc----
Confidence 9999999999999877789999999999999999999999999999999999999999999999999987532100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChH-HHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE-IIF 922 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~-ei~ 922 (1091)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.. ..+
T Consensus 160 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 218 (276)
T 2yex_A 160 ---------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218 (276)
T ss_dssp ---------------------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH
T ss_pred ---------------------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 0112235679999999999988765 78999999999999999999999876543 333
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..+.......+ ....++.++.+||.+||..||.+||+ +.++++||||++.
T Consensus 219 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 268 (276)
T 2yex_A 219 SDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred HHhhhcccccC-chhhcCHHHHHHHHHHCCCCchhCCC---HHHHhcCccccCh
Confidence 34433332222 23568999999999999999999999 8899999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=414.78 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=218.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----NDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~-----~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..++|++++.||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|..++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 34689999999999999999999999999999999987543221 2344677899999999999999999999999
Q ss_pred CeeEEEEeecCCC-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GG-SL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+.+|+||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999777 999999988899999999999999999999999999999999999999999999999999997521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 182 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 182 ----------------------------RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp ----------------------------TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred ----------------------------CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 0112234679999999999998877 88999999999999999999999763
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
. .+....... +..+++++.+||.+||..||.+||+ +.++++||||+.
T Consensus 234 ~------~~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps---~~ell~hp~~~~ 280 (335)
T 3dls_A 234 E------ETVEAAIHP---PYLVSKELMSLVSGLLQPVPERRTT---LEKLVTDPWVTQ 280 (335)
T ss_dssp G------GGTTTCCCC---SSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHHCTTTTC
T ss_pred H------HHHhhccCC---CcccCHHHHHHHHHHccCChhhCcC---HHHHhcCccccC
Confidence 2 222333332 3678999999999999999999999 889999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=398.83 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=213.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc--CC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--RD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqd--ed 759 (1091)
...++|++++.||+|+||+||+|++..+|+.||||+++.. ....+.+|+.+|..+. ||||+++++++.+ ..
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 4467899999999999999999999999999999998742 2467889999999997 9999999999988 66
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~ 838 (1091)
..|+||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 79999999999999998853 89999999999999999999999999999999999999777 899999999975210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCC-
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE- 916 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~- 916 (1091)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||...
T Consensus 184 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 184 ----------------------------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp ----------------------------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ----------------------------CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 112234579999999999987 67899999999999999999999999543
Q ss_pred ChHHHHHHH-------------hhcCCCCC---------------------CCCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 917 SPEIIFDNI-------------LNRKIPWP---------------------CVPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 917 s~~ei~~kI-------------l~~~l~fP---------------------~ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
+..+....+ ......++ ..+..+++++.+||.+||+.||.+|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-- 313 (330)
T 3nsz_A 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-- 313 (330)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC--
T ss_pred chHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC--
Confidence 222222211 11111111 011237999999999999999999999
Q ss_pred cHHHHHcCCCCCCCCcc
Q 001370 963 GAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 963 gA~EIL~HPFFkgIdWd 979 (1091)
+.++++||||+++.|+
T Consensus 314 -a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 314 -AREAMEHPYFYTVVKD 329 (330)
T ss_dssp -HHHHHTSGGGTTCC--
T ss_pred -HHHHhcCccHhhhccC
Confidence 8899999999999876
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=407.29 Aligned_cols=267 Identities=29% Similarity=0.417 Sum_probs=220.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde----- 758 (1091)
..++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|..++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 35789999999999999999999999999999999866432 223345678999999999999999999998874
Q ss_pred ---CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 759 ---DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 759 ---d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
+.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999986 777777654 579999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
...... ..........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||
T Consensus 173 ~~~~~~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 173 AFSLAK-----------------------NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp ECCCCS-----------------------SSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccc-----------------------cccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 532100 001122345689999999999986 56899999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCCCCC-CCCC----------------------------CCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 914 TAESPEIIFDNILNRKIPWPC-VPSD----------------------------MSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 914 ~~~s~~ei~~kIl~~~l~fP~-ip~~----------------------------lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
.+.+.......+......++. .... .++++.+||.+||+.||.+||+ +
T Consensus 230 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~ 306 (351)
T 3mi9_A 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---S 306 (351)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC---H
T ss_pred CCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC---H
Confidence 999988877776652211111 0000 2778999999999999999999 8
Q ss_pred HHHHcCCCCCCCCc
Q 001370 965 AEVKAHPFFKGVNW 978 (1091)
Q Consensus 965 ~EIL~HPFFkgIdW 978 (1091)
.++++||||....+
T Consensus 307 ~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 307 DDALNHDFFWSDPM 320 (351)
T ss_dssp HHHHTSGGGGSSSC
T ss_pred HHHhCCCCcCCCCC
Confidence 89999999976543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=401.15 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=210.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~L 761 (1091)
...++|++++.||+|+||+||+|+++.+|+.||||++.+... ..........|+..+..+ .||||++++++|.+.+.+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 344789999999999999999999999999999999865432 233444555666555555 899999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~-- 209 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-- 209 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc--
Confidence 9999999 669998887654 599999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+..
T Consensus 210 --------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--- 259 (311)
T 3p1a_A 210 --------------------------AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--- 259 (311)
T ss_dssp -------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---
T ss_pred --------------------------CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---
Confidence 111234569999999999886 79999999999999999999977765532
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
....+.....+ +.++..+++++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 260 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 310 (311)
T 3p1a_A 260 GWQQLRQGYLP-PEFTAGLSSELRSVLVMMLEPDPKLRAT---AEALLALPVLRQ 310 (311)
T ss_dssp HHHHHTTTCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGSC
T ss_pred HHHHHhccCCC-cccccCCCHHHHHHHHHHcCCChhhCcC---HHHHHhCccccC
Confidence 23333333322 2234678999999999999999999999 889999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=394.94 Aligned_cols=262 Identities=28% Similarity=0.489 Sum_probs=223.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCceEEEeeee--ccCCee
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNPFVVRFFYSF--TCRDNL 761 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~-~~eie~~l~EieILskL~HPNIVkL~gsf--qded~L 761 (1091)
.++|++.+.||+|+||.||+|.+..+++.||+|++++..... ......+.+|+.++..++||||+++++++ .....+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998643321 24567899999999999999999999998 445679
Q ss_pred EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k--~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
|+||||+.+| |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999986 7777765 356999999999999999999999999999999999999999999999999998752100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC--CccceeechhhhHHHHHhCCCCCCCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH--GYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y--s~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
..........||+.|+|||++.+... +.++|||||||++|||++|..||.+.+
T Consensus 163 -------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 163 -------------------------AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp -------------------------CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -------------------------ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 00112234579999999999987543 789999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
...+...+......+| ..+++++.+||.+||..||.+||+ +.++++||||+....
T Consensus 218 ~~~~~~~i~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 218 IYKLFENIGKGSYAIP---GDCGPPLSDLLKGMLEYEPAKRFS---IRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHCCCCCC---SSSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSHHHHSCCC
T ss_pred HHHHHHHHhcCCCCCC---CccCHHHHHHHHHHccCChhhCCC---HHHHhcCcccccCCC
Confidence 9999888888776655 688999999999999999999999 889999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=409.99 Aligned_cols=259 Identities=32% Similarity=0.534 Sum_probs=227.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc-c----hhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-R----KNDIERILAERNILITV-RNPFVVRFFYSFTCR 758 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~-~----~~eie~~l~EieILskL-~HPNIVkL~gsfqde 758 (1091)
.++|++.+.||+|+||.||+|+++.+|+.||||+++..... . ....+.+.+|+.++.++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 46799999999999999999999999999999999764311 1 12246688999999999 799999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999875210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC------CCCCccceeechhhhHHHHHhCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g------~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+|
T Consensus 253 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p 304 (365)
T 2y7j_A 253 ----------------------------GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304 (365)
T ss_dssp ----------------------------TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------------------CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence 112234689999999999963 3688999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 913 FTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
|...+...+...+..+...++. ....++.++.+||.+||+.||.+||+ +.++++||||+
T Consensus 305 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~ 364 (365)
T 2y7j_A 305 FWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT---AEQALQHPFFE 364 (365)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGC
T ss_pred CCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCcccC
Confidence 9999988888888887665442 11467899999999999999999999 88999999996
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=406.73 Aligned_cols=266 Identities=29% Similarity=0.457 Sum_probs=217.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~--~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
...++|++++.||+|+||.||+|+++.+|+.||||+++...... ......+.+|+.++..++||||++++++|.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999999999999999997533221 1123467899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
+|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~- 164 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS- 164 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC-
Confidence 9999999986 898888765 3689999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.
T Consensus 165 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 165 --------------------------PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp --------------------------CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 0112234679999999999976 4589999999999999999999999999998
Q ss_pred HHHHHHHhhcC-----CCCCC---------------C-----CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 919 EIIFDNILNRK-----IPWPC---------------V-----PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 919 ~ei~~kIl~~~-----l~fP~---------------i-----p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+.+..+.... ..||. . ...++.++++||.+||..||.+||+ +.++++||||
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~h~~f 295 (346)
T 1ua2_A 219 LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYF 295 (346)
T ss_dssp HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGG
T ss_pred HHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC---HHHHhcChhh
Confidence 88887776521 11111 0 1456799999999999999999999 8899999999
Q ss_pred CCCCcc
Q 001370 974 KGVNWD 979 (1091)
Q Consensus 974 kgIdWd 979 (1091)
++..|.
T Consensus 296 ~~~~~~ 301 (346)
T 1ua2_A 296 SNRPGP 301 (346)
T ss_dssp TSSSCC
T ss_pred hcCCCC
Confidence 876554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=417.38 Aligned_cols=257 Identities=31% Similarity=0.456 Sum_probs=213.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------C
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------R 758 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd------e 758 (1091)
..+|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+++|..++|||||+++++|.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 4579999999999999999999999999999999875321 23469999999999999999988843 2
Q ss_pred CeeEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC-CcEEEEecCCc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLS 833 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n-G~VKLsDFGLA 833 (1091)
..+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 347899999986 66666542 4679999999999999999999999999999999999999965 67899999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
+.... .......+||+.|+|||++.+. .|+.++|||||||+||||++|++|
T Consensus 205 ~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p 256 (420)
T 1j1b_A 205 KQLVR----------------------------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256 (420)
T ss_dssp EECCT----------------------------TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hhccc----------------------------CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 85210 1112346899999999999764 799999999999999999999999
Q ss_pred CCCCChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 913 FTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
|.+.+..+.+..|+.. .+.+|. ++..+++++.+||.+||++||.+||+ +.+
T Consensus 257 f~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t---~~e 333 (420)
T 1j1b_A 257 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PLE 333 (420)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC---HHH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC---HHH
Confidence 9998877766665531 122332 23467899999999999999999999 889
Q ss_pred HHcCCCCCCCCcch
Q 001370 967 VKAHPFFKGVNWDS 980 (1091)
Q Consensus 967 IL~HPFFkgIdWd~ 980 (1091)
+++||||+++.+..
T Consensus 334 ~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 334 ACAHSFFDELRDPN 347 (420)
T ss_dssp HHTSGGGGGGGCTT
T ss_pred HhCCHhhccccccc
Confidence 99999998776543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=415.93 Aligned_cols=258 Identities=30% Similarity=0.463 Sum_probs=205.4
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 758 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde------ 758 (1091)
.++|++++.||+|+||.||+|.+..+|+.||||++.+. .........+.+|+.+|..++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 47899999999999999999999999999999998753 23345667889999999999999999999998764
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~- 183 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA- 183 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc-
Confidence 5689999999 7899998865 679999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+
T Consensus 184 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 184 -----------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -----------------------------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01234689999999999987 678999999999999999999999999988
Q ss_pred hHHHHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 918 PEIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 918 ~~ei~~kIl~~~----------------------------l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..+....|+... ..++......++++.+||.+||+.||.+||+ +.++++
T Consensus 235 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t---~~e~L~ 311 (367)
T 2fst_X 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALA 311 (367)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHT
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC---HHHHhc
Confidence 877766665410 0011112357899999999999999999999 889999
Q ss_pred CCCCCCCCc
Q 001370 970 HPFFKGVNW 978 (1091)
Q Consensus 970 HPFFkgIdW 978 (1091)
||||+....
T Consensus 312 hp~~~~~~~ 320 (367)
T 2fst_X 312 HAYFAQYHD 320 (367)
T ss_dssp SGGGTTTCC
T ss_pred ChhhhhccC
Confidence 999987654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=407.12 Aligned_cols=267 Identities=28% Similarity=0.441 Sum_probs=224.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 45679999999999999999999999999999999987643 23444567889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||+++++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 176 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA---- 176 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC----
Confidence 9999999999999888778899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 177 -----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (331)
T 4aaa_A 177 -----------------------PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233 (331)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -----------------------CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 01122345799999999999875 789999999999999999999999999887766
Q ss_pred HHHHhhc-------------------CCCCCCC---------CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 922 FDNILNR-------------------KIPWPCV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 922 ~~kIl~~-------------------~l~fP~i---------p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
...+... ...+|.. ...+++++.+||.+||+.||.+||+ +.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f 310 (331)
T 4aaa_A 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF---CAELLHHDFF 310 (331)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHH
T ss_pred HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC---HHHHhcCchh
Confidence 6555421 1111211 1357899999999999999999999 7799999999
Q ss_pred CCCCcch
Q 001370 974 KGVNWDS 980 (1091)
Q Consensus 974 kgIdWd~ 980 (1091)
+...|..
T Consensus 311 ~~~~~~~ 317 (331)
T 4aaa_A 311 QMDGFAE 317 (331)
T ss_dssp HGGGHHH
T ss_pred ccCChhh
Confidence 8766544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=390.83 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=205.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.+..++|++++.||+|+||+||+|++..+|+.||+|+++... ........+..+...+..++||||+++++++.+.+.+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356689999999999999999999999999999999997542 2223334445555567888999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 762 YLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 88777653 46799999999999999999999998 9999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh----cCCCCCccceeechhhhHHHHHhCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL----~g~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
.. ........||+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 161 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 161 VD----------------------------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp -------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred cc----------------------------cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 10 1112234799999999996 456789999999999999999999999
Q ss_pred CCC-CChHHHHHHHhhcCC-CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 913 FTA-ESPEIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 913 F~~-~s~~ei~~kIl~~~l-~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
|.. .........+..... ..+ +..+++++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt---~~e~l~hp~f~~ 272 (290)
T 3fme_A 213 YDSWGTPFQQLKQVVEEPSPQLP--ADKFSAEFVDFTSQCLKKNSKERPT---YPELMQHPFFTL 272 (290)
T ss_dssp SCCCSCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHH
T ss_pred ccccCchHHHHHHHhccCCCCcc--cccCCHHHHHHHHHHhhcChhhCcC---HHHHHhCccccc
Confidence 986 344444444444332 222 3578999999999999999999999 889999999964
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=426.48 Aligned_cols=266 Identities=33% Similarity=0.578 Sum_probs=216.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~-----~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..++|++.+.||+|+||+||+|.++.+++.||||++.+.... .......+.+|+.+|.+++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 357899999999999999999999999999999999875432 11223457899999999999999999999854
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---cEEEEecCCccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 835 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---~VKLsDFGLAk~ 835 (1091)
+.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 55899999999999999998888999999999999999999999999999999999999997654 599999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
.. ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+|
T Consensus 292 ~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p 343 (419)
T 3i6u_A 292 LG----------------------------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343 (419)
T ss_dssp CC---------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cC----------------------------CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 21 0112235689999999999864 6788999999999999999999999
Q ss_pred CCCCCh-HHHHHHHhhcCCCCC-CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchh
Q 001370 913 FTAESP-EIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 913 F~~~s~-~ei~~kIl~~~l~fP-~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
|..... ..+...+..+...++ .....+++++.+||.+||+.||.+||+ +.++++||||++.+|...
T Consensus 344 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 344 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp SCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGCCHHHHHH
T ss_pred CCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcC---HHHHhCCcccCChhHHHH
Confidence 987543 344455555544432 122568999999999999999999999 889999999998877653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=410.10 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=213.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----- 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd----- 757 (1091)
...++|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++|||||+++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 456789999999999999999999999999999999875322 12369999999999999999999843
Q ss_pred ---------------------------------CCeeEEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 001370 758 ---------------------------------RDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALE 800 (1091)
Q Consensus 758 ---------------------------------ed~LYLVMEYm~GGSL~dlL~----k~g~LsE~~ar~yaaQIa~ALe 800 (1091)
...+|+||||++| +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 7776665 3467999999999999999999
Q ss_pred HHHHcCCeecccCCCceEec-CCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCC
Q 001370 801 YLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 879 (1091)
Q Consensus 801 YLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~Y 879 (1091)
|||++||+||||||+|||++ .+|.+||+|||+|+.... .......+||+.|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~----------------------------~~~~~~~~~t~~y 207 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP----------------------------SEPSVAYICSRFY 207 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT----------------------------TSCCCCCCCCSSC
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC----------------------------CCCCcCcccCCCc
Confidence 99999999999999999998 689999999999985310 1122346789999
Q ss_pred CChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhc-----------------CCCCCC-------
Q 001370 880 LAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR-----------------KIPWPC------- 934 (1091)
Q Consensus 880 mAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~-----------------~l~fP~------- 934 (1091)
+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+....++.. ...+|.
T Consensus 208 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (383)
T 3eb0_A 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287 (383)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHH
T ss_pred cCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHH
Confidence 999999875 4899999999999999999999999999888777776541 112222
Q ss_pred --CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 935 --VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 935 --ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
++..+++++.+||.+||+.||.+||| +.|+++||||+.+.
T Consensus 288 ~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 288 KILPEGTPSLAIDLLEQILRYEPDLRIN---PYEAMAHPFFDHLR 329 (383)
T ss_dssp HHSCTTCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSGGGHHHH
T ss_pred hhCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcCHHHHHHH
Confidence 24568999999999999999999999 88999999998653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=401.04 Aligned_cols=273 Identities=27% Similarity=0.416 Sum_probs=221.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 758 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde----- 758 (1091)
..++|++.+.||+|+||+||+|++..+|+.||||+++.. ........+.+|+.+|..++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 357899999999999999999999999999999999653 2344567788999999999999999999887654
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 67999999997 599998876 5799999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
..... .............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+
T Consensus 165 ~~~~~-----------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 165 SAADN-----------------SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccc-----------------cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 10000 000000112335689999999999875 678999999999999999999999999988
Q ss_pred hHHHHHHHhhc--C----------------------CCCCC-----CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 918 PEIIFDNILNR--K----------------------IPWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 918 ~~ei~~kIl~~--~----------------------l~fP~-----ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.......+... . ..++. ....+++++.+||.+||..||.+||+ +.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell 304 (353)
T 2b9h_A 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT---AKEAL 304 (353)
T ss_dssp HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC---HHHHh
Confidence 76655544321 0 00010 12468899999999999999999999 88999
Q ss_pred cCCCCCCCCcch
Q 001370 969 AHPFFKGVNWDS 980 (1091)
Q Consensus 969 ~HPFFkgIdWd~ 980 (1091)
+||||+...+..
T Consensus 305 ~hp~~~~~~~~~ 316 (353)
T 2b9h_A 305 EHPYLQTYHDPN 316 (353)
T ss_dssp TSGGGTTTCCTT
T ss_pred cCccccccCCcc
Confidence 999999887654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=405.78 Aligned_cols=261 Identities=28% Similarity=0.485 Sum_probs=219.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----C
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----D 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde-----d 759 (1091)
.++|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|..++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 368999999999999999999999999999999997532 344567889999999999999999999998765 3
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 68999999975 99999865 56999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
. .........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+.
T Consensus 182 ~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 182 H------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp G------------------------CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred C------------------------CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 0 00112244689999999998765 5589999999999999999999999999887
Q ss_pred HHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.+....+... ..+++.+...+++++.+||.+||+.||.+||+ +.++++|
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~h 314 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAH 314 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTS
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcC
Confidence 7766665431 01111122467899999999999999999999 8899999
Q ss_pred CCCCCC
Q 001370 971 PFFKGV 976 (1091)
Q Consensus 971 PFFkgI 976 (1091)
|||+..
T Consensus 315 p~~~~~ 320 (364)
T 3qyz_A 315 PYLEQY 320 (364)
T ss_dssp GGGTTT
T ss_pred cchhhc
Confidence 999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=406.56 Aligned_cols=268 Identities=25% Similarity=0.504 Sum_probs=232.9
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchh--------------HHHHHHHHHHHHHhcCCCc
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--------------DIERILAERNILITVRNPF 747 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~--------------eie~~l~EieILskL~HPN 747 (1091)
....++|++.+.||+|+||.||+|++ +|+.||||++......... ....+.+|+.++..++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 35578999999999999999999998 8999999999864332211 1278999999999999999
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCcHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceE
Q 001370 748 VVRFFYSFTCRDNLYLVMEYLNGGDLYSL------LRK--VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLL 818 (1091)
Q Consensus 748 IVkL~gsfqded~LYLVMEYm~GGSL~dl------L~k--~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNIL 818 (1091)
|+++++++.+.+.+|+||||++||+|.++ +.+ ...+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 665 5679999999999999999999999 99999999999999
Q ss_pred ecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCc-ccee
Q 001370 819 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGY-AADW 896 (1091)
Q Consensus 819 LD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~-ksDI 896 (1091)
++.+|.+||+|||++..... .......||+.|+|||++.+. .|+. ++||
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 235 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVD-----------------------------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235 (348)
T ss_dssp ECTTSCEEECCCTTCEECBT-----------------------------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHH
T ss_pred EcCCCcEEEecccccccccc-----------------------------ccccCCCCCcCccCchhhcCCCCCCcchhhH
Confidence 99999999999999875210 112345799999999999887 6766 9999
Q ss_pred echhhhHHHHHhCCCCCCCCCh-HHHHHHHhhcCCCCCCC----------------CCCCCHHHHHHHhhhccCCCCCCC
Q 001370 897 WSVGIILFEFITGIPPFTAESP-EIIFDNILNRKIPWPCV----------------PSDMSFEAQDLINRFLIHDPNQRL 959 (1091)
Q Consensus 897 WSLGVILYEMLTGkpPF~~~s~-~ei~~kIl~~~l~fP~i----------------p~~lS~eakDLI~rcL~kDPeKRp 959 (1091)
|||||++|||++|.+||...+. .++...+......+|.. ...++.++.+||.+||+.||.+||
T Consensus 236 ~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 315 (348)
T 2pml_X 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315 (348)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC
Confidence 9999999999999999998877 78888887776665521 156899999999999999999999
Q ss_pred CcccHHHHHcCCCCCCCCcchhhc
Q 001370 960 GANGAAEVKAHPFFKGVNWDSLAL 983 (1091)
Q Consensus 960 Sa~gA~EIL~HPFFkgIdWd~L~~ 983 (1091)
+ +.++++||||++++|..+..
T Consensus 316 s---~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 316 T---SEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp C---HHHHHTSGGGTTCCHHHHHH
T ss_pred C---HHHHhcCccccCCCHHHHHH
Confidence 9 88999999999999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=394.33 Aligned_cols=264 Identities=30% Similarity=0.525 Sum_probs=223.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++++.||+|+||.||+|.++.+|+.||||++.... ....+.+|+.++..++||||+++++++...+.+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997532 3466889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 763 LVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~-k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
+||||+++|+|.+++. ....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--- 177 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT---
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh---
Confidence 9999999999999997 446799999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 178 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 233 (314)
T 3com_A 178 ------------------------TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233 (314)
T ss_dssp ------------------------TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------------------------hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 01122345799999999999999999999999999999999999999998887666
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchh
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
...+..........+..++.++.+||.+||..||.+||+ +.++++||||++..+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~~~~~~~~~~~~ 290 (314)
T 3com_A 234 IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT---ATQLLQHPFVRSAKGVSI 290 (314)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHTCCCGGG
T ss_pred HHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhcCCcchH
Confidence 655554433222234568999999999999999999999 889999999998776654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=395.65 Aligned_cols=274 Identities=30% Similarity=0.498 Sum_probs=201.7
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..+..++|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+|+.++..++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34667899999999999999999999988999999998865322 2345678899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCC
Q 001370 761 LYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k--------~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
.|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999974 35699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
+........ ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 168 ~~~~~~~~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 168 SAFLATGGD----------------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp HHHCC-------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hheeccCCC----------------------ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 875311000 001112235679999999999976 578999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCC-------CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchh
Q 001370 912 PFTAESPEIIFDNILNRKIP-------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 912 PF~~~s~~ei~~kIl~~~l~-------fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
||.................+ .+.....++.++.+||.+||..||.+||+ +.++++||||+...+..+
T Consensus 226 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~ 299 (303)
T 2vwi_A 226 PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRHKFFQKAKNKEF 299 (303)
T ss_dssp TTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSTTC--------
T ss_pred CCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcC---HHHHhhChhhhcCCCCcc
Confidence 99987776655554443221 11233568899999999999999999999 889999999998776544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=424.55 Aligned_cols=251 Identities=16% Similarity=0.200 Sum_probs=208.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHH---HHHHhcCCCceEEEe-------e
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER---NILITVRNPFVVRFF-------Y 753 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~Ei---eILskL~HPNIVkL~-------g 753 (1091)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+ .+|..++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 457899999999999999999999999999999999876555566778899999 455566899999998 5
Q ss_pred eeccCC-----------------eeEEEEeecCCCcHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCee
Q 001370 754 SFTCRD-----------------NLYLVMEYLNGGDLYSLLRKVGCLEE-------DVARIYIAELVLALEYLHSLGIVH 809 (1091)
Q Consensus 754 sfqded-----------------~LYLVMEYm~GGSL~dlL~k~g~LsE-------~~ar~yaaQIa~ALeYLHs~GIIH 809 (1091)
++.+.+ ..||||||+ +|+|.+++.+.+.+++ ..+..++.||+.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 554443 389999999 6799999987666666 777789999999999999999999
Q ss_pred cccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-
Q 001370 810 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT- 888 (1091)
Q Consensus 810 RDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~- 888 (1091)
|||||+||||+.+|.+||+|||+|+.. .......+| +.|+|||++.+.
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~------------------------------~~~~~~~~g-~~y~aPE~~~~~~ 278 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRD------------------------------GARVVSSVS-RGFEPPELEARRA 278 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEET------------------------------TCEEECCCC-TTCCCHHHHHHHT
T ss_pred CCCCHHHEEEcCCCCEEEEechhheec------------------------------CCcccCCCC-cCccChhhhcccc
Confidence 999999999999999999999999741 112235678 999999999987
Q ss_pred ----------CCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCC
Q 001370 889 ----------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 889 ----------~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKR 958 (1091)
.|+.++|||||||+||||++|+.||.+.+.......+... ...+++++.+||.+||+.||.+|
T Consensus 279 ~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS-------CKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp STHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS-------CCCCCHHHHHHHHHHTCSSGGGC
T ss_pred cccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh-------ccCCCHHHHHHHHHHcCCCchhC
Confidence 8999999999999999999999999877655544444332 25678999999999999999999
Q ss_pred CCcccHHHHHcCCCCCCC
Q 001370 959 LGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkgI 976 (1091)
|+ +.++++||||+++
T Consensus 352 pt---~~e~l~hp~f~~~ 366 (377)
T 3byv_A 352 LL---PLQAMETPEYEQL 366 (377)
T ss_dssp CC---HHHHHTSHHHHHH
T ss_pred CC---HHHHhhChHHHHH
Confidence 99 8899999999765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=407.15 Aligned_cols=259 Identities=30% Similarity=0.428 Sum_probs=219.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee---
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL--- 761 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L--- 761 (1091)
.++|.+.+.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.++..++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 478999999999999999999999999999999997633 3445567889999999999999999999999888765
Q ss_pred ---EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 762 ---YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 762 ---YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
|+||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~- 195 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 195 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc-
Confidence 99999997 58888774 359999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+
T Consensus 196 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 196 -----------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ---------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -----------------------------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11234679999999999987 788999999999999999999999999988
Q ss_pred hHHHHHHHhhcCC----------------------------CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 918 PEIIFDNILNRKI----------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 918 ~~ei~~kIl~~~l----------------------------~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..+....++.... .++..+..+++++.+||.+||+.||.+||+ +.++++
T Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~ 323 (371)
T 4exu_A 247 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQALT 323 (371)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC---HHHHHT
T ss_pred hHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC---HHHHhc
Confidence 8777766654110 001112467899999999999999999999 889999
Q ss_pred CCCCCCCCcch
Q 001370 970 HPFFKGVNWDS 980 (1091)
Q Consensus 970 HPFFkgIdWd~ 980 (1091)
||||+.+....
T Consensus 324 hp~f~~~~~~~ 334 (371)
T 4exu_A 324 HPFFEPFRDPE 334 (371)
T ss_dssp SGGGTTTCCGG
T ss_pred CcccccCCCcc
Confidence 99999775443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=402.48 Aligned_cols=260 Identities=28% Similarity=0.430 Sum_probs=214.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCCe
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDN 760 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H--PNIVkL~gsfqded~ 760 (1091)
+..+.|++++.||+|+||+||+|.+. +++.||||++.... ........+.+|+.+|..+.| |||+++++++.+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34567999999999999999999874 68999999997643 344556789999999999986 999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+ +|.+||+|||+++.....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~- 160 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD- 160 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc-
Confidence 999999 56789999999988999999999999999999999999999999999999997 689999999999753110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----------CCCCccceeechhhhHHHHHhC
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----------~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
.........+||+.|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 161 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 216 (343)
T 3dbq_A 161 ------------------------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216 (343)
T ss_dssp ---------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 00112235689999999999975 6789999999999999999999
Q ss_pred CCCCCCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 910 IPPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 910 kpPF~~~s~-~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.+||..... ......++..... ..++...+.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 217 ~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~ 279 (343)
T 3dbq_A 217 KTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQI 279 (343)
T ss_dssp SCTTTTCCSHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHS
T ss_pred CCcchhhhhHHHHHHHHhcCCcc-cCCcccCCHHHHHHHHHHcCCChhHCCC---HHHHHhCccccc
Confidence 999987543 3444444443322 2234677899999999999999999999 889999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=406.74 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=224.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
+.|++++.||+|+||+||+|++..+|+.||||++.............+.+|+.+|..++||||+++++++...+.+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998654444556678999999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------- 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 205 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-------
Confidence 9997 588888754 4679999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+....
T Consensus 206 ------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 261 (348)
T 1u5q_A 206 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261 (348)
T ss_dssp ------------------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------------------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 112457999999999995 46789999999999999999999999999888777
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
...+.....+.. .+..++..+.+||.+||+.||.+||+ +.++++||||...
T Consensus 262 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 262 LYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHSCCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHSC
T ss_pred HHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcC---HHHHhhChhhhcc
Confidence 777766544322 24678999999999999999999999 8899999999654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=387.21 Aligned_cols=259 Identities=31% Similarity=0.538 Sum_probs=225.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec--cCCee
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT--CRDNL 761 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq--ded~L 761 (1091)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.++..++||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 45789999999999999999999999999999999976433 3455678999999999999999999999874 46789
Q ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC-----CeecccCCCceEecCCCcEEEEecCC
Q 001370 762 YLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g----~LsE~~ar~yaaQIa~ALeYLHs~G-----IIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997543 4999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
++.... .........||+.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 163 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 215 (279)
T 2w5a_A 163 ARILNH---------------------------DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215 (279)
T ss_dssp HHHC------------------------------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred heeecc---------------------------ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 874210 00112245799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 913 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
|...+..++...+..+.. +.++..++.++.+||.+||..||.+||+ +.++++|+||.+
T Consensus 216 ~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~~~~~~ 273 (279)
T 2w5a_A 216 FTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLILE 273 (279)
T ss_dssp SCCSSHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTCCG
T ss_pred CcccCHHHHHHHHhhccc--ccCCcccCHHHHHHHHHHcCCCcccCCC---HHHHHhChhhhh
Confidence 999998888888877654 3345789999999999999999999999 889999999964
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=394.25 Aligned_cols=266 Identities=28% Similarity=0.483 Sum_probs=222.5
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc-
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC- 757 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqd- 757 (1091)
......++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 33456789999999999999999999999999999999997532 2346788999999998 79999999999987
Q ss_pred -----CCeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEec
Q 001370 758 -----RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 830 (1091)
Q Consensus 758 -----ed~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDF 830 (1091)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 46799999999999999999864 57999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHH
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFE 905 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYE 905 (1091)
|++..... ........+||+.|+|||++. +..++.++|||||||++|+
T Consensus 174 g~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 174 GVSAQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp TTTC----------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred cCceecCc---------------------------CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence 99874210 011123457999999999997 5678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 906 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 906 MLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
|++|.+||...+.......+.....+. ..+..++..+.+||.+||..||.+||+ +.++++||||++..+..
T Consensus 227 l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 227 MAEGAPPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPA---TEQLMKHPFIRDQPNER 297 (326)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCC-CSCSCSCHHHHHHHHHHCCSSGGGSCC---HHHHHTSHHHHCCTTHH
T ss_pred HHhCCCCCCCCcHHHHHHHhhcCcccc-CCccccCHHHHHHHHHHhccChhhCCC---HHHHhhChHHhhCcccc
Confidence 999999999888877776666554332 124678999999999999999999999 88999999999876654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=392.84 Aligned_cols=264 Identities=32% Similarity=0.484 Sum_probs=220.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeec---
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFT--- 756 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k-~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL---~HPNIVkL~gsfq--- 756 (1091)
..++|++++.||+|+||+||+|++. .+|+.||+|+++..... ......+.+|+.++..+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4478999999999999999999995 67899999999754321 12223456677777665 8999999999987
Q ss_pred --cCCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCC
Q 001370 757 --CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 757 --ded~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
....+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5667999999998 59999998754 499999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
++.... ........||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 167 ~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (326)
T 1blx_A 167 ARIYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218 (326)
T ss_dssp CCCCCG----------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccC----------------------------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 874210 1122346799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcC-----CCC-------------------CCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 913 FTAESPEIIFDNILNRK-----IPW-------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~-----l~f-------------------P~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
|.+.+..+....++... ..| ..+...++.++++||.+||..||.+||+ +.+++
T Consensus 219 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l 295 (326)
T 1blx_A 219 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSAL 295 (326)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred CCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC---HHHHh
Confidence 99998887777765410 001 1123568999999999999999999999 88999
Q ss_pred cCCCCCCCCcch
Q 001370 969 AHPFFKGVNWDS 980 (1091)
Q Consensus 969 ~HPFFkgIdWd~ 980 (1091)
+||||+++++..
T Consensus 296 ~hp~~~~~~~~~ 307 (326)
T 1blx_A 296 SHPYFQDLERCK 307 (326)
T ss_dssp TSGGGTTCCCCC
T ss_pred cCccccccchhh
Confidence 999999887653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=403.11 Aligned_cols=264 Identities=34% Similarity=0.587 Sum_probs=218.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~-----~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.... .......+.+|+.+|..++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999999999999999999764321 1223456889999999999999999999987665
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc---EEEEecCCcccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIG 836 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDFGLAk~~ 836 (1091)
+|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988888999999999999999999999999999999999999987665 999999998752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
.. .......+||+.|+|||++. ...|+.++|||||||++|+|++|.+||
T Consensus 168 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (322)
T 2ycf_A 168 GE----------------------------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219 (322)
T ss_dssp CC----------------------------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cc----------------------------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 10 11123457999999999985 467899999999999999999999999
Q ss_pred CCCChH-HHHHHHhhcCCCCC-CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 914 TAESPE-IIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 914 ~~~s~~-ei~~kIl~~~l~fP-~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
...... .+...+..+...++ .....++.++.+||.+||..||.+||+ +.++++||||++.+|..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 220 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDMKR 285 (322)
T ss_dssp CSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGCCHHHHH
T ss_pred cccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCC---HHHHhhCcCcCCHHHHH
Confidence 875543 34444555544332 223568999999999999999999999 88999999999877653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=395.51 Aligned_cols=256 Identities=30% Similarity=0.461 Sum_probs=213.7
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..+..++|++.+.||+|+||+||+|++ +|+.||||++.+.. ........+.+|+.+|.+++||||+++++++.+...
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 346678999999999999999999987 48899999997643 344556789999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEecCCCcEEEEecCCccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~---LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
+|+||||++||+|.+++.+.+. +++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999987653 999999999999999999999999 99999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 189 ~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 189 KAS---------------------------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp ----------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred ccc---------------------------cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 210 01122356799999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
.+..+....+...... +.++..+++++.+||.+||..||.+||++.++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 292 (309)
T 3p86_A 242 LNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292 (309)
T ss_dssp SCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9888887776543332 23457899999999999999999999995444443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=391.31 Aligned_cols=264 Identities=31% Similarity=0.545 Sum_probs=230.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.++.+++||||+++++++.+...+|
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345689999999999999999999999999999999976443 2345678899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC---CcEEEEecCCccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n---G~VKLsDFGLAk~~~~~ 839 (1091)
+||||+++++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~- 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC-
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC-
Confidence 999999999999999888899999999999999999999999999999999999999764 4799999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
........||+.|+|||++.+. ++.++||||||+++|+|++|.+||.+.+..
T Consensus 177 ---------------------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (287)
T 2wei_A 177 ---------------------------NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (287)
T ss_dssp ---------------------------CSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------------------------CCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 1112345689999999998764 899999999999999999999999999998
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 920 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
++...+..+...++. ....+++++.+||.+||..||.+||+ +.++++||||++..|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHHHCCC
T ss_pred HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC---HHHHhcCHHHhccccC
Confidence 888888887665442 12468999999999999999999999 8899999999876654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=398.98 Aligned_cols=258 Identities=29% Similarity=0.433 Sum_probs=218.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe----
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN---- 760 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~---- 760 (1091)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.++..++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 468999999999999999999999999999999997632 344556788999999999999999999999988764
Q ss_pred --eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 761 --LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 761 --LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+|+||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~- 177 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 177 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC-
Confidence 499999997 58887764 359999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+
T Consensus 178 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 178 -----------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp -----------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred -----------------------------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01124578999999999987 678999999999999999999999999988
Q ss_pred hHHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 918 PEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 918 ~~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..+....+... ...++.....+++++.+||.+||+.||.+||+ +.++++
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~ 305 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQALT 305 (353)
T ss_dssp HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC---HHHHHT
T ss_pred HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC---HHHHhc
Confidence 77666655431 11233344578999999999999999999999 889999
Q ss_pred CCCCCCCCcc
Q 001370 970 HPFFKGVNWD 979 (1091)
Q Consensus 970 HPFFkgIdWd 979 (1091)
||||+.+...
T Consensus 306 hp~f~~~~~~ 315 (353)
T 3coi_A 306 HPFFEPFRDP 315 (353)
T ss_dssp SGGGTTTCCG
T ss_pred CcchhhccCc
Confidence 9999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=410.14 Aligned_cols=259 Identities=31% Similarity=0.451 Sum_probs=212.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded---- 759 (1091)
...+|++.+.||+|+||+||+|++..+++ ||+|++.+.... ..+|+.+|+.++|||||+++++|....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34579999999999999999999987766 888877543221 236999999999999999999985543
Q ss_pred --eeEEEEeecCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec-CCCcEEEEecCCc
Q 001370 760 --NLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLS 833 (1091)
Q Consensus 760 --~LYLVMEYm~GGSL~dlL---~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGLA 833 (1091)
.+|+||||++++.+..+. .....+++..++.|+.||+.||.|||++||+||||||+||||+ .+|.+||+|||+|
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 389999999875443332 2346799999999999999999999999999999999999999 7999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
+.... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++|
T Consensus 190 ~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 241 (394)
T 4e7w_A 190 KILIA----------------------------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241 (394)
T ss_dssp EECCT----------------------------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccC----------------------------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 85310 1122356799999999999765 589999999999999999999999
Q ss_pred CCCCChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 913 FTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
|.+.+..+....|+.. ...+|. ++..+++++.+||.+||++||.+||+ +.+
T Consensus 242 f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e 318 (394)
T 4e7w_A 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT---AIE 318 (394)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC---HHH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC---HHH
Confidence 9999887776666541 111221 22458899999999999999999999 889
Q ss_pred HHcCCCCCCCCcchh
Q 001370 967 VKAHPFFKGVNWDSL 981 (1091)
Q Consensus 967 IL~HPFFkgIdWd~L 981 (1091)
+++||||+++.|...
T Consensus 319 ~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 319 ALCHPFFDELRTGEA 333 (394)
T ss_dssp HHTSGGGSTTTSSCC
T ss_pred HhcChhhhhhccccc
Confidence 999999999988654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=390.75 Aligned_cols=265 Identities=29% Similarity=0.437 Sum_probs=215.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec-------
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT------- 756 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq------- 756 (1091)
..++|++++.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.++..++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 347899999999999999999999999999999998753 3456678899999999999999999998874
Q ss_pred -------cCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec-CCCcEEEE
Q 001370 757 -------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLT 828 (1091)
Q Consensus 757 -------ded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLs 828 (1091)
....+|+||||+. |+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999998 599999864 6799999999999999999999999999999999999997 56799999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHH
Q 001370 829 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 829 DFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEML 907 (1091)
|||+++...... ..........||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 164 Dfg~~~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 164 DFGLARIMDPHY------------------------SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp CCTTCBCC--------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred cCccccccCCCc------------------------ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence 999997521000 00112234578999999999876 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcCCC----------------------CC-----CCCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 908 TGIPPFTAESPEIIFDNILNRKIP----------------------WP-----CVPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 908 TGkpPF~~~s~~ei~~kIl~~~l~----------------------fP-----~ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
+|..||.+.+..+....+...... .+ .....++.++++||.+||+.||.+||+
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 999999998887777666543211 01 112468999999999999999999999
Q ss_pred cccHHHHHcCCCCCCCCcch
Q 001370 961 ANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 961 a~gA~EIL~HPFFkgIdWd~ 980 (1091)
+.++++||||+...|..
T Consensus 300 ---~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 300 ---AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp ---HHHHHTSHHHHTTCC--
T ss_pred ---HHHHhCCcccccccCcc
Confidence 88999999999887754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=403.89 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=209.4
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--------CCceEEEee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--------NPFVVRFFY 753 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~--------HPNIVkL~g 753 (1091)
....++|++++.||+|+||+||+|++..+|+.||||++++. ......+.+|+.+|..+. ||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 34468899999999999999999999999999999999753 344577889999999885 788999999
Q ss_pred eec----cCCeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCC---
Q 001370 754 SFT----CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDG--- 823 (1091)
Q Consensus 754 sfq----ded~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG--- 823 (1091)
+|. ....+|+||||+ +|+|.+++.+. +.+++..++.++.||+.||.|||++ ||+||||||+||||+.+|
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 998 566899999999 55777766554 4699999999999999999999998 999999999999999876
Q ss_pred ----------------------------------------------cEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001370 824 ----------------------------------------------HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857 (1091)
Q Consensus 824 ----------------------------------------------~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~ 857 (1091)
.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~-------------------- 247 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-------------------- 247 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--------------------
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--------------------
Confidence 79999999997521
Q ss_pred CCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh------HHHHHHHhh--cC
Q 001370 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP------EIIFDNILN--RK 929 (1091)
Q Consensus 858 ~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~------~ei~~kIl~--~~ 929 (1091)
......+||+.|+|||++.+..|+.++|||||||+||||++|.+||...+. ......+.. +.
T Consensus 248 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 317 (397)
T 1wak_A 248 ----------KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317 (397)
T ss_dssp ----------BCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS
T ss_pred ----------ccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC
Confidence 112345799999999999999999999999999999999999999986542 222222221 10
Q ss_pred CC-------------------CC------------------CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 930 IP-------------------WP------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 930 l~-------------------fP------------------~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
.+ +. ..+...+.++.+||.+||+.||.+||+ +.++++|||
T Consensus 318 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~ 394 (397)
T 1wak_A 318 VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT---AAECLRHPW 394 (397)
T ss_dssp CCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC---HHHHHTSGG
T ss_pred CChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC---HHHHhhCcc
Confidence 00 00 011234567899999999999999999 889999999
Q ss_pred CCC
Q 001370 973 FKG 975 (1091)
Q Consensus 973 Fkg 975 (1091)
|++
T Consensus 395 ~~~ 397 (397)
T 1wak_A 395 LNS 397 (397)
T ss_dssp GGC
T ss_pred ccC
Confidence 963
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=404.44 Aligned_cols=262 Identities=28% Similarity=0.442 Sum_probs=205.8
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
....+++|++.+.||+|+||+||+|+++.+|+.||||++.+.... .....+++..+..++||||++++++|.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345678999999999999999999999999999999998664322 2345677888889999999999999866443
Q ss_pred -------eEEEEeecCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HcCCeecccCCCceEecC-CCcEE
Q 001370 761 -------LYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALEYLH--SLGIVHRDLKPDNLLIAH-DGHIK 826 (1091)
Q Consensus 761 -------LYLVMEYm~GGSL~dlL----~k~g~LsE~~ar~yaaQIa~ALeYLH--s~GIIHRDLKPeNILLD~-nG~VK 826 (1091)
+|+||||++++ |...+ .....+++..++.++.||+.||.||| ++||+||||||+||||+. +|.+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 89999999874 44433 34567999999999999999999999 999999999999999997 89999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFE 905 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDIWSLGVILYE 905 (1091)
|+|||+++... ........+||+.|+|||++.+.. |+.++|||||||++||
T Consensus 173 l~Dfg~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~e 224 (360)
T 3e3p_A 173 LCDFGSAKKLS----------------------------PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224 (360)
T ss_dssp ECCCTTCBCCC----------------------------TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred EeeCCCceecC----------------------------CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence 99999997421 011223467999999999997654 8999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhcCC-------------------------C----CCCCCCCCCHHHHHHHhhhccCCCC
Q 001370 906 FITGIPPFTAESPEIIFDNILNRKI-------------------------P----WPCVPSDMSFEAQDLINRFLIHDPN 956 (1091)
Q Consensus 906 MLTGkpPF~~~s~~ei~~kIl~~~l-------------------------~----fP~ip~~lS~eakDLI~rcL~kDPe 956 (1091)
|++|.+||.+.+....+..+..... + ++..+...++++.+||.+||+.||.
T Consensus 225 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 304 (360)
T 3e3p_A 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304 (360)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGG
T ss_pred HHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcc
Confidence 9999999999988777777654100 0 1122234678999999999999999
Q ss_pred CCCCcccHHHHHcCCCCCCCCc
Q 001370 957 QRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 957 KRpSa~gA~EIL~HPFFkgIdW 978 (1091)
+||+ +.++++||||+++.+
T Consensus 305 ~Rpt---~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 305 ERMK---PYEALCHPYFDELHD 323 (360)
T ss_dssp GSCC---HHHHTTSGGGGGGGC
T ss_pred ccCC---HHHHhcCccccccCC
Confidence 9999 889999999987654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=393.62 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=216.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEE-CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC------ceEEEeeee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARK-RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP------FVVRFFYSF 755 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~-k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HP------NIVkL~gsf 755 (1091)
...++|++++.||+|+||+||+|.+ +.+|+.||||+++.. ......+.+|+.++..++|+ +|++++++|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 4457999999999999999999998 567899999999753 23456788999999888765 599999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC------------
Q 001370 756 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH------------ 821 (1091)
Q Consensus 756 qded~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~------------ 821 (1091)
...+.+|+||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred -------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001370 822 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 894 (1091)
Q Consensus 822 -------nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 894 (1091)
++.+||+|||+++... ......+||+.|+|||++.+..|+.++
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 215 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDD------------------------------EHHSTLVSTRHYRAPEVILALGWSQPC 215 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETT------------------------------SCCCSSCSCGGGCCHHHHTTSCCCTHH
T ss_pred cccccccCCCceEeeCcccccCc------------------------------cccccccCCccccChHHhhCCCCCcch
Confidence 6789999999987421 112346799999999999999999999
Q ss_pred eeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC-----------------------------------------
Q 001370 895 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP----------------------------------------- 933 (1091)
Q Consensus 895 DIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP----------------------------------------- 933 (1091)
|||||||++|||++|.+||...+..+....+.....++|
T Consensus 216 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (339)
T 1z57_A 216 DVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295 (339)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhc
Confidence 999999999999999999998887665554432111111
Q ss_pred CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 934 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 934 ~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
..+...++++.+||.+||..||.+||+ +.++++||||+.+.
T Consensus 296 ~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~ 336 (339)
T 1z57_A 296 LSQDVEHERLFDLIQKMLEYDPAKRIT---LREALKHPFFDLLK 336 (339)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGGG
T ss_pred ccchhhHHHHHHHHHHHhCcCcccccC---HHHHhcCHHHHHHh
Confidence 001223577899999999999999999 88999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=417.81 Aligned_cols=261 Identities=22% Similarity=0.271 Sum_probs=200.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCceEEEeeeec------
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFFYSFT------ 756 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL--~HPNIVkL~gsfq------ 756 (1091)
..+|++.+.||+|+||+||+|+++.+|+.||||++++...........+.+|+.++..+ +||||++++..|.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 44699999999999999999999999999999999986655556677888886555444 6999988664442
Q ss_pred -cC-----------------CeeEEEEeecCCCcHHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHcCCeecc
Q 001370 757 -CR-----------------DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVA------RIYIAELVLALEYLHSLGIVHRD 811 (1091)
Q Consensus 757 -de-----------------d~LYLVMEYm~GGSL~dlL~k~g-~LsE~~a------r~yaaQIa~ALeYLHs~GIIHRD 811 (1091)
.. ..+||||||++ |+|.+++...+ .+++... ..++.||+.||.|||++||||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 21 34899999999 79999998753 3444444 45569999999999999999999
Q ss_pred cCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CC
Q 001370 812 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TE 889 (1091)
Q Consensus 812 LKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~ 889 (1091)
|||+||||+.+|.+||+|||+|+... .......||+.|+|||++.+ ..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVG------------------------------TRGPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETT------------------------------CEEEGGGSCGGGCCHHHHTCSEEE
T ss_pred CCHHHEEECCCCCEEEEecceeeecC------------------------------CCccCccCCcCCcChhhccCCCCC
Confidence 99999999999999999999998421 11114567799999999987 78
Q ss_pred CCccceeechhhhHHHHHhCCCCCCCCChHHH--HHH-----HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 890 HGYAADWWSVGIILFEFITGIPPFTAESPEII--FDN-----ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 890 Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei--~~k-----Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
|+.++|||||||+||||++|++||.+..+... +.. .......++. ...+++++.+||.+||+.||.+||+
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt-- 346 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLL-- 346 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCC--
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCC--
Confidence 99999999999999999999999987643211 111 1112223332 2578999999999999999999999
Q ss_pred cHHHHHcCCCCCCCCcch
Q 001370 963 GAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 963 gA~EIL~HPFFkgIdWd~ 980 (1091)
+.++++||||+++.|..
T Consensus 347 -~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 347 -PLEAMETPEFLQLQNEI 363 (371)
T ss_dssp -HHHHTTSHHHHHHHHHH
T ss_pred -HHHHhcCHHHHHHHHHH
Confidence 88999999999887764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.98 Aligned_cols=274 Identities=23% Similarity=0.336 Sum_probs=207.6
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk---~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.+..++|++.+.||+|+||+||+|+++.++. .||||+++... ......+.+.+|+.++..++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI-IASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc-cCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 4566789999999999999999999887765 89999997643 2345578899999999999999999999999887
Q ss_pred Cee------EEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEE
Q 001370 759 DNL------YLVMEYLNGGDLYSLLRKVG------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 759 d~L------YLVMEYm~GGSL~dlL~k~g------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 826 (1091)
... |+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 665 99999999999999996543 599999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEM 906 (1091)
|+|||+++...... .........||+.|+|||++.+..|+.++|||||||++|||
T Consensus 178 l~Dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (323)
T 3qup_A 178 VADFGLSRKIYSGD-------------------------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232 (323)
T ss_dssp ECCCCC------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred Eeeccccccccccc-------------------------cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHH
Confidence 99999997531100 01112234578899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc----ccHHHHHcCCCCCCCCcchh
Q 001370 907 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA----NGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 907 LT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa----~gA~EIL~HPFFkgIdWd~L 981 (1091)
++ |.+||.+.+..++...+...... ..+..+++++.+||.+||..||.+||++ ..+.+++.|||+....++.+
T Consensus 233 l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 233 MTRGQTPYAGIENAEIYNYLIGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred HhCCCCCccccChHHHHHHHhcCCCC--CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 99 99999999988888887765432 2347899999999999999999999994 34678999999988776665
Q ss_pred hc
Q 001370 982 AL 983 (1091)
Q Consensus 982 ~~ 983 (1091)
..
T Consensus 311 ~~ 312 (323)
T 3qup_A 311 YI 312 (323)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=395.24 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=218.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc------eEEEeeee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF------VVRFFYSF 755 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TG-k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN------IVkL~gsf 755 (1091)
...++|++++.||+|+||+||+|.+..++ ..||+|++++. ......+.+|+.++..+.|++ ++.+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 44689999999999999999999998877 68999999753 234567888999999887655 99999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe--------------
Q 001370 756 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-------------- 819 (1091)
Q Consensus 756 qded~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL-------------- 819 (1091)
...+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 667777776553 69999999999999999999999999999999999999
Q ss_pred -----cCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001370 820 -----AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 894 (1091)
Q Consensus 820 -----D~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 894 (1091)
+.++.+||+|||+++... ......+||+.|+|||++.+..|+.++
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 220 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDH------------------------------EHHTTIVATRHYRPPEVILELGWAQPC 220 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETT------------------------------SCCCSSCSCGGGCCHHHHTTCCCCTHH
T ss_pred ccccccCCCcEEEeecCcccccc------------------------------ccccCCcCCCcccCCeeeecCCCCCcc
Confidence 668899999999987421 112346799999999999999999999
Q ss_pred eeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC----------------------------------------
Q 001370 895 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC---------------------------------------- 934 (1091)
Q Consensus 895 DIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~---------------------------------------- 934 (1091)
|||||||++|||++|.+||...+..+....+.....++|.
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (355)
T 2eu9_A 221 DVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM 300 (355)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred chHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccc
Confidence 9999999999999999999988876655544332111110
Q ss_pred -CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001370 935 -VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 982 (1091)
Q Consensus 935 -ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~ 982 (1091)
.....+.++.+||.+||..||.+||+ +.++++||||++++|+...
T Consensus 301 ~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 301 LQDSLEHVQLFDLMRRMLEFDPAQRIT---LAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGCCHHHHC
T ss_pred cccchhHHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcCCChhhcc
Confidence 01122457899999999999999999 8899999999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=412.38 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=217.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc------CCCceEEEeeeec
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV------RNPFVVRFFYSFT 756 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL------~HPNIVkL~gsfq 756 (1091)
....+|++++.||+|+||+||+|++..+++.||||+++.. ......+.+|+.++..+ +||||++++++|.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 4457899999999999999999999999999999999753 23445677888888876 5789999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc--EEEEecCC
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGL 832 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~--VKLsDFGL 832 (1091)
....+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++|||||||||+||||+.+|. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999996 59999997654 4999999999999999999999999999999999999999987 99999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
++.. .....+.+||+.|+|||++.+..|+.++|||||||+||||++|.+|
T Consensus 249 a~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p 298 (429)
T 3kvw_A 249 SCYE------------------------------HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298 (429)
T ss_dssp CEET------------------------------TCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceec------------------------------CCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCC
Confidence 8742 1122356899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCC--------------------CCCC------------------------------------CC
Q 001370 913 FTAESPEIIFDNILNRKI--------------------PWPC------------------------------------VP 936 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l--------------------~fP~------------------------------------ip 936 (1091)
|.+.+..+....++.... .+|. ++
T Consensus 299 f~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 378 (429)
T 3kvw_A 299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378 (429)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTT
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcc
Confidence 999988777666553100 0000 11
Q ss_pred CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 937 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 937 ~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
...++++.+||.+||+.||.+||| +.|+++||||+..
T Consensus 379 ~~~~~~~~dli~~~L~~dP~~Rpt---a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 379 GCDDPLFLDFLKQCLEWDPAVRMT---PGQALRHPWLRRR 415 (429)
T ss_dssp TCCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSTTTC--
T ss_pred ccchHHHHHHHHHHCCCChhhCCC---HHHHhCChhhccC
Confidence 234788999999999999999999 8899999999853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=387.21 Aligned_cols=256 Identities=30% Similarity=0.534 Sum_probs=226.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.+.|++++.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.++..++||||+++++++.....+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4569999999999999999999999999999999976432 34567899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||++||+|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~------ 171 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD------ 171 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT------
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc------
Confidence 999999999999865 6799999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~k 924 (1091)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........
T Consensus 172 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 230 (303)
T 3a7i_A 172 ---------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 230 (303)
T ss_dssp ---------------------TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ---------------------cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH
Confidence 01122346799999999999999999999999999999999999999999888777776
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 925 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 925 Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+..... +.++..++..+.+||.+||..||.+||+ +.++++||||..
T Consensus 231 ~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~ 276 (303)
T 3a7i_A 231 IPKNNP--PTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFILR 276 (303)
T ss_dssp HHHSCC--CCCCSSCCHHHHHHHHHHCCSSGGGSCC---HHHHTTCHHHHH
T ss_pred hhcCCC--CCCccccCHHHHHHHHHHcCCChhhCcC---HHHHhhChhhhc
Confidence 665543 3345788999999999999999999999 889999999953
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=408.65 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=217.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccCCee
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~--HPNIVkL~gsfqded~L 761 (1091)
...+|++++.||+|+||+||+|.+.. |+.||||++.+... .......+.+|+.+|..+. |||||++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999865 99999999976433 4456788999999999997 59999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||| +.+|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+||||+ +|.+||+|||+++.....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~-- 207 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD-- 207 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC--
Confidence 99999 56889999999888999999999999999999999999999999999999995 689999999999753110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----------CCCCccceeechhhhHHHHHhCC
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----------~~Ys~ksDIWSLGVILYEMLTGk 910 (1091)
.........+||+.|+|||++.+ ..|+.++|||||||+||||++|.
T Consensus 208 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 208 -----------------------TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp -----------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred -----------------------CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 00112235689999999999975 36899999999999999999999
Q ss_pred CCCCCCC-hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 911 PPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 911 pPF~~~s-~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
+||.... ....+..++.....++ ++...+.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 265 ~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~~ 327 (390)
T 2zmd_A 265 TPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQIQ 327 (390)
T ss_dssp CTTTTCCCHHHHHHHHHCTTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHSC
T ss_pred CcchhhhHHHHHHHHHhCccccCC-CCccchHHHHHHHHHHcccChhhCCC---HHHHhhCcCcccc
Confidence 9998754 3345556655443322 34667899999999999999999999 8899999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=403.06 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=218.2
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 752 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k-------~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~ 752 (1091)
+....++|++.+.||+|+||+||+|++. .++..||||++++. ........+.+|+.+|..+ +||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 4466789999999999999999999975 34568999999764 2345677899999999999 899999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCc
Q 001370 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 816 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeN 816 (1091)
++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999998653 47899999999999999999999999999999999
Q ss_pred eEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001370 817 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896 (1091)
Q Consensus 817 ILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDI 896 (1091)
|||+.+|++||+|||+++...... .........||+.|+|||++.+..|+.++||
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv 288 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCC-------------------------TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHH
T ss_pred EEECCCCCEEEccccCCcccCccc-------------------------ceecccCCCcccceECHhHhcCCCCCcHHHH
Confidence 999999999999999998531100 0111234568899999999999999999999
Q ss_pred echhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 897 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 897 WSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
|||||++|||++ |.+||.+.+..+++..+..+.. +..+..++.++.+||.+||..||.+||++.+
T Consensus 289 wslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e 354 (370)
T 2psq_A 289 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQ 354 (370)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999999999 9999999988888877766542 2345789999999999999999999999443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=394.16 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=213.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--ee
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NL 761 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded--~L 761 (1091)
..+.|++.+.||+|+||+||+|+++.+|+.||||++++... ....+.+.+|+.+|..++||||+++++++.... .+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34679999999999999999999999999999999986443 233567889999999999999999999988765 78
Q ss_pred EEEEeecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe----cCCCcEEEEecCCcc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLSK 834 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~---LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKLsDFGLAk 834 (1091)
|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999986543 9999999999999999999999999999999999999 888899999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--------CCCCCccceeechhhhHHHH
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--------GTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~--------g~~Ys~ksDIWSLGVILYEM 906 (1091)
.... .......+||+.|+|||++. +..|+.++|||||||++|||
T Consensus 165 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el 216 (319)
T 4euu_A 165 ELED----------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (319)
T ss_dssp ECCT----------------------------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred ecCC----------------------------CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence 5210 11223467999999999987 57789999999999999999
Q ss_pred HhCCCCCCCCC----hHHHHHHHhhcCCC-------------------CC---CCCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 907 ITGIPPFTAES----PEIIFDNILNRKIP-------------------WP---CVPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 907 LTGkpPF~~~s----~~ei~~kIl~~~l~-------------------fP---~ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
++|..||.... ..++...++.+... +| .+...++..+.+||.+||+.||.+||+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s 296 (319)
T 4euu_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (319)
T ss_dssp HHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc
Confidence 99999997432 34555555543321 11 112334568899999999999999999
Q ss_pred cccHHHHHcCCC
Q 001370 961 ANGAAEVKAHPF 972 (1091)
Q Consensus 961 a~gA~EIL~HPF 972 (1091)
+.|+++||-
T Consensus 297 ---~~ell~h~~ 305 (319)
T 4euu_A 297 ---FDQFFAETS 305 (319)
T ss_dssp ---HHHHHHHHH
T ss_pred ---HHHhhhccH
Confidence 889998863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=381.27 Aligned_cols=273 Identities=31% Similarity=0.512 Sum_probs=214.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--------
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-------- 757 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd-------- 757 (1091)
++|++++.||+|+||.||+|++..+|+.||||+++.. ......+.+|+.++..++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999999652 3456788999999999999999999998755
Q ss_pred -----CCeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecC
Q 001370 758 -----RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 758 -----ed~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
...+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 456899999999999999998654 57889999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGk 910 (1091)
+++....... ... ...... ..........+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 162 ~~~~~~~~~~--~~~-------~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 162 LAKNVHRSLD--ILK-------LDSQNL----PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp CCSCTTC--------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred chhhcccccc--hhc-------cccccc----cccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 9875321000 000 000000 0011223456899999999999865 68999999999999999998
Q ss_pred CCCCC-CChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchh
Q 001370 911 PPFTA-ESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 911 pPF~~-~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
||.. .+.......+......+|. ++...+..+++||.+||..||.+||+ +.++++||||+...++..
T Consensus 227 -p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~ 295 (303)
T 1zy4_A 227 -PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLNSGWLPVKHQDEV 295 (303)
T ss_dssp -CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC---HHHHHHSSCSCCCCHHHH
T ss_pred -ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC---HHHHhCCCCcCCCChHHH
Confidence 5643 3345555666555444442 34567888999999999999999999 889999999998776654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=398.62 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=215.8
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEE-----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 753 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar-----~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~g 753 (1091)
.+.+..++|++.+.||+|+||.||+|+ ...+++.||||++++.. .....+.+.+|+.+|.++ +|||||++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 345677899999999999999999999 45667899999997632 344567899999999999 7899999999
Q ss_pred eeccCCe-eEEEEeecCCCcHHHHHHhcCC--------------------------------------------------
Q 001370 754 SFTCRDN-LYLVMEYLNGGDLYSLLRKVGC-------------------------------------------------- 782 (1091)
Q Consensus 754 sfqded~-LYLVMEYm~GGSL~dlL~k~g~-------------------------------------------------- 782 (1091)
++.+.+. +|+||||++||+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9887654 9999999999999999976533
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 783 ----------------LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 783 ----------------LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~------- 246 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD------- 246 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC-------
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc-------
Confidence 899999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kI 925 (1091)
..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+..........
T Consensus 247 ------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 308 (359)
T 3vhe_A 247 ------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308 (359)
T ss_dssp ------------------TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred ------------------ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH
Confidence 00112234678999999999999999999999999999999998 99999887755544444
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+..... +..+..+++++.+||.+||..||.+||+ +.++++|
T Consensus 309 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 349 (359)
T 3vhe_A 309 LKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 349 (359)
T ss_dssp HHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHcCCC-CCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHHHH
Confidence 443322 2235789999999999999999999999 5565544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=393.82 Aligned_cols=261 Identities=23% Similarity=0.404 Sum_probs=210.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .......+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4568999999999999999999999999999999988642 3456788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 46799999999999999999999999999999999999999999999999999985321110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
. ..................+||+.|+|||++.+..|+.++|||||||++|||++|..||........
T Consensus 164 ~-------------~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~ 230 (310)
T 3s95_A 164 Q-------------PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230 (310)
T ss_dssp -----------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT
T ss_pred c-------------ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH
Confidence 0 000000111122334467899999999999999999999999999999999999999976432110
Q ss_pred -----HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 922 -----FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 922 -----~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
........ .+..+++++.+||.+||..||.+||++.++
T Consensus 231 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 273 (310)
T 3s95_A 231 DFGLNVRGFLDRY-----CPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273 (310)
T ss_dssp TSSBCHHHHHHHT-----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhhhhhcccccc-----CCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11111111 236778899999999999999999994433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=395.95 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=210.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~----VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
+..++|++++.||+|+||+||+|++..+|+. ||+|.+.... .......+.+|+.++..++||||+++++++. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 4567999999999999999999999988887 5555554321 1223355778999999999999999999886 5
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 6689999999999999999864 579999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
... .........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 167 ~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 167 PDD-------------------------KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp CCT-------------------------TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccc-------------------------ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 100 0111234568899999999999999999999999999999999 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+..++...+...... ..+..++.++.+||.+||..||.+||+ +.++++|
T Consensus 222 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps---~~el~~~ 270 (325)
T 3kex_A 222 RLAEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENIRPT---FKELANE 270 (325)
T ss_dssp CTTHHHHHHHTTCBC--CCCTTBCTTTTHHHHHHTCSCTTTSCC---HHHHHHH
T ss_pred CHHHHHHHHHcCCCC--CCCCcCcHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 888887777665322 234678889999999999999999999 4454443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=383.65 Aligned_cols=262 Identities=30% Similarity=0.417 Sum_probs=214.6
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....++|.....||+|+||.||+|++..+++.||||++.... ......+.+|+.++..++||||+++++++...+.+
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 345566666678999999999999999999999999997643 23456789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEecCCccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g---~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~ 837 (1091)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. +|.+||+|||+++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999999999998652 4678899999999999999999999999999999999998 8999999999987521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeechhhhHHHHHhCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
. .........||+.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 175 ~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 175 G---------------------------INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp C--------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred C---------------------------CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 0 01112345799999999999764 389999999999999999999999976
Q ss_pred CChHH-HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 916 ESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 916 ~s~~e-i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
..... ......... ..+.++..++.++.+||.+||..||.+||+ +.++++||||+...
T Consensus 228 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 228 LGEPQAAMFKVGMFK-VHPEIPESMSAEAKAFILKCFEPDPDKRAC---ANDLLVDEFLKVSS 286 (295)
T ss_dssp GSSHHHHHHHHHHHC-CCCCCCTTSCHHHHHHHHHTTCSSTTTSCC---HHHHHTSGGGCC--
T ss_pred CCchhHHHHhhcccc-ccccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhhcc
Confidence 43322 222211111 123345789999999999999999999999 88999999998543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=406.13 Aligned_cols=261 Identities=21% Similarity=0.314 Sum_probs=223.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq 756 (1091)
.+..++|++++.||+|+||+||+|++ ..+++.||||+++.. ........+.+|+.++..++|||||++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 45568899999999999999999994 456789999999752 23455667899999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC---cEE
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIK 826 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g-------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG---~VK 826 (1091)
+....|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999998653 489999999999999999999999999999999999999665 499
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEM 906 (1091)
|+|||+++...... .........||+.|+|||++.+..|+.++|||||||++|||
T Consensus 225 L~DFG~a~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el 279 (367)
T 3l9p_A 225 IGDFGMARDIYRAG-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279 (367)
T ss_dssp ECCCHHHHHHHHHS-------------------------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ECCCcccccccccc-------------------------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 99999997532110 01122346789999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 907 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 907 LT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
++ |.+||.+.+..++...+..+.... .+..++.++.+||.+||+.||.+||+ +.++++|.++-
T Consensus 280 lt~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps---~~eil~~l~~~ 343 (367)
T 3l9p_A 280 FSLGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPN---FAIILERIEYC 343 (367)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCC--CCccCCHHHHHHHHHHcCCCHhHCcC---HHHHHHHHHHH
Confidence 98 999999999999888887765332 24788999999999999999999999 77888876653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=378.42 Aligned_cols=254 Identities=21% Similarity=0.363 Sum_probs=219.4
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
+.+..++|++++.||+|+||+||+|++. +++.||+|++.+... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3466789999999999999999999987 477899999976432 23568899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
+|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999754 46899999999999999999999999999999999999999999999999999753110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
.........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.
T Consensus 160 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 160 --------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp --------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred --------------------------ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 0112234567889999999999999999999999999999999 9999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.++...+....... .+...++++.+||.+||..||.+||+ +.++++|
T Consensus 214 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~ 260 (269)
T 4hcu_A 214 SEVVEDISTGFRLY--KPRLASTHVYQIMNHCWRERPEDRPA---FSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHhcCccCC--CCCcCCHHHHHHHHHHccCCcccCcC---HHHHHHH
Confidence 98888887663322 34678999999999999999999999 5555543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=389.49 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=221.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq 756 (1091)
....++|++++.||+|+||.||+|++. .+++.||||++++.. .......+.+|+.++..++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456789999999999999999999987 355899999997632 3445678999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccc
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDL 812 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~------------------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDL 812 (1091)
+.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999864 56899999999999999999999999999999
Q ss_pred CCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCc
Q 001370 813 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY 892 (1091)
Q Consensus 813 KPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ 892 (1091)
||+|||++.+|.+||+|||+++...... .........||+.|+|||++.+..|+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~ 255 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYTT 255 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred CcceEEECCCCeEEEeecCCCcccccCc-------------------------cccccCCCcccceecChhhhccCCcCc
Confidence 9999999999999999999997532100 011123456899999999999999999
Q ss_pred cceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 893 AADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 893 ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
++|||||||++|||++ |..||.+.+..++...+..+... ..+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 9999999999999999 99999999988888888776542 34578999999999999999999999955444443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=379.67 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=218.3
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..+.+..++|++++.||+|+||+||+|++. ++..||+|++++... ....+.+|+.++..++||||+++++++.+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 344577889999999999999999999886 577899999976432 235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999999999986 4679999999999999999999999999999999999999999999999999997531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.. .........||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 172 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 172 DD--------------------------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp CH--------------------------HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cc--------------------------ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 10 0111233457889999999999999999999999999999998 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+.......+....... .+...++.+.+||.+||..||.+||+ +.++++|
T Consensus 226 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 274 (283)
T 3gen_A 226 TNSETAEHIAQGLRLY--RPHLASEKVYTIMYSCWHEKADERPT---FKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred ChhHHHHHHhcccCCC--CCCcCCHHHHHHHHHHccCChhHCcC---HHHHHHH
Confidence 9888888887664332 24678999999999999999999999 5565543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=384.49 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=220.9
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 754 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gs 754 (1091)
.+....++|++.+.||+|+||.||+|.+ +.++..||+|+++... .....+.+.+|+.+|..++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 4456678999999999999999999998 3456899999997532 34567889999999999999999999999
Q ss_pred eccCCeeEEEEeecCCCcHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 001370 755 FTCRDNLYLVMEYLNGGDLYSLLRKVGC------------------------LEEDVARIYIAELVLALEYLHSLGIVHR 810 (1091)
Q Consensus 755 fqded~LYLVMEYm~GGSL~dlL~k~g~------------------------LsE~~ar~yaaQIa~ALeYLHs~GIIHR 810 (1091)
+.+.+.+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987543 8999999999999999999999999999
Q ss_pred ccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC
Q 001370 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 890 (1091)
Q Consensus 811 DLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y 890 (1091)
||||+|||++.+|.+||+|||+++...... .........||+.|+|||++.+..|
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEED-------------------------SYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTS-------------------------CEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred ccchheEEEcCCCCEEEccccccccccccc-------------------------cceeccCCCCcccccChhhhcCCCc
Confidence 999999999999999999999997531100 0111234567899999999999999
Q ss_pred CccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 891 GYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 891 s~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+.++|||||||++|||++ |..||.+.+...+...+..... +..+..+++++.+||.+||..||.+||+ +.++++
T Consensus 230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~l~~ 304 (314)
T 2ivs_A 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR--MERPDNCSEEMYRLMLQCWKQEPDKRPV---FADISK 304 (314)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc--CCCCccCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 999999999999999999 9999999988888877765532 2345789999999999999999999999 445543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=387.39 Aligned_cols=273 Identities=21% Similarity=0.297 Sum_probs=228.4
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 753 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~g 753 (1091)
..+.+..++|++.+.||+|+||.||+|+++ .+++.||||++.+.. .......+.+|+.++..++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 445677789999999999999999999876 357899999997532 3345567899999999999999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 823 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~----------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG 823 (1091)
++.+.+..|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999999753 3578999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001370 824 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903 (1091)
Q Consensus 824 ~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVIL 903 (1091)
.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++
T Consensus 176 ~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 230 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230 (322)
T ss_dssp CEEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eEEECcCcccccccccc-------------------------ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHH
Confidence 99999999987532110 01122345689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC---CCCCCCCcc
Q 001370 904 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH---PFFKGVNWD 979 (1091)
Q Consensus 904 YEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H---PFFkgIdWd 979 (1091)
|+|++ |.+||.+.+..++...+...... ..+..++.++.+||.+||..||.+||++.++.+.++. ++|+.++|.
T Consensus 231 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 231 WEIATLAEQPYQGLSNEQVLRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred HHHHhcCCCccccCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence 99999 89999999988888888776542 3357899999999999999999999994433333321 676666554
Q ss_pred h
Q 001370 980 S 980 (1091)
Q Consensus 980 ~ 980 (1091)
.
T Consensus 309 ~ 309 (322)
T 1p4o_A 309 Y 309 (322)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=395.64 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=211.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc--------cchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERILAERNILITVRNPFVVRFFYS 754 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i--------~~~~eie~~l~EieILskL~HPNIVkL~gs 754 (1091)
...++|++.+.||+|+||.||+|.+.. |+.||||++.+... ......+.+.+|+.+|..++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 345789999999999999999999865 99999999865322 122335789999999999999999999999
Q ss_pred ec-----cCCeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEE
Q 001370 755 FT-----CRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 828 (1091)
Q Consensus 755 fq-----ded~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLs 828 (1091)
|. ....+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 84 3446899999998 5888888654 469999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHH
Q 001370 829 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 829 DFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEML 907 (1091)
|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 177 Dfg~~~~~~----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 228 (362)
T 3pg1_A 177 DFNLAREDT----------------------------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228 (362)
T ss_dssp CTTC-------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred ecCcccccc----------------------------cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence 999987421 0112234679999999999987 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcC------------------------CCCC-----CCCCCCCHHHHHHHhhhccCCCCCC
Q 001370 908 TGIPPFTAESPEIIFDNILNRK------------------------IPWP-----CVPSDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 908 TGkpPF~~~s~~ei~~kIl~~~------------------------l~fP-----~ip~~lS~eakDLI~rcL~kDPeKR 958 (1091)
+|.+||.+.+..+....+.... ...+ ..+...++.+.+||.+||+.||.+|
T Consensus 229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (362)
T 3pg1_A 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308 (362)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence 9999999988777776664310 0011 1124568899999999999999999
Q ss_pred CCcccHHHHHcCCCCCCC
Q 001370 959 LGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkgI 976 (1091)
|+ +.++++||||+++
T Consensus 309 pt---~~ell~hp~f~~~ 323 (362)
T 3pg1_A 309 IS---TEQALRHPYFESL 323 (362)
T ss_dssp CC---HHHHHTSGGGTTT
T ss_pred CC---HHHHHcCchhhhc
Confidence 99 8899999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=394.63 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=209.3
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCceE
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----------NPFVV 749 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-----------HPNIV 749 (1091)
.....++|++.+.||+|+||+||+|++..+|+.||||++.+. ......+.+|+.++.++. ||||+
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 345668999999999999999999999999999999999753 234567788999998876 89999
Q ss_pred EEeeeeccCC----eeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEec--
Q 001370 750 RFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIA-- 820 (1091)
Q Consensus 750 kL~gsfqded----~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD-- 820 (1091)
++++++.... .+|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||||+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 9999998755 799999999 88999999864 4599999999999999999999998 999999999999995
Q ss_pred ----CCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001370 821 ----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896 (1091)
Q Consensus 821 ----~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDI 896 (1091)
..+.+||+|||+++... ......+||+.|+|||++.+..|+.++||
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 218 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGADI 218 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHH
T ss_pred CCCcCcceEEEcccccccccC------------------------------CCCCCCCCCccccCcHHHhCCCCCchHhH
Confidence 44589999999997421 01223579999999999999999999999
Q ss_pred echhhhHHHHHhCCCCCCCCCh------HHHHHHHhh------------------------------------------c
Q 001370 897 WSVGIILFEFITGIPPFTAESP------EIIFDNILN------------------------------------------R 928 (1091)
Q Consensus 897 WSLGVILYEMLTGkpPF~~~s~------~ei~~kIl~------------------------------------------~ 928 (1091)
|||||++|||++|.+||.+.+. ......+.. .
T Consensus 219 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (373)
T 1q8y_A 219 WSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 298 (373)
T ss_dssp HHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh
Confidence 9999999999999999986542 222222221 1
Q ss_pred CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 929 ~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
... ++..++.++.+||.+||+.||.+||+ +.++++||||++.
T Consensus 299 ~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 340 (373)
T 1q8y_A 299 KYK---FSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDT 340 (373)
T ss_dssp TTC---CCHHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTC
T ss_pred ccc---CCcchHHHHHHHHHHHhccCccccCC---HHHHhhChhhhcc
Confidence 111 12345678999999999999999999 8899999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=390.57 Aligned_cols=270 Identities=22% Similarity=0.313 Sum_probs=219.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LY 762 (1091)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.++..+ +||||+++++++.+.+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34789999999999999999999999999999999875432 23578899999999 8999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc-----EEEEecCCcccc
Q 001370 763 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIG 836 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~-----VKLsDFGLAk~~ 836 (1091)
+||||+ +|+|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|. +||+|||+++..
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 99999999864 67999999999999999999999999999999999999999987 999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
..... . ...........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 161 ~~~~~--------~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 161 IDPET--------K------------KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp BCTTT--------C------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ecCCC--------C------------ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 21100 0 000111234678999999999999999999999999999999999999999874
Q ss_pred ---ChHHHHHHHhhcCCCCCC--CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc-------CCCCCCCCcch
Q 001370 917 ---SPEIIFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA-------HPFFKGVNWDS 980 (1091)
Q Consensus 917 ---s~~ei~~kIl~~~l~fP~--ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~-------HPFFkgIdWd~ 980 (1091)
...+.+..+.......|. ....++ ++.+||.+||..||.+||++..+.+++. .++...++|+.
T Consensus 221 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 221 KADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp CCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred ccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 444555665543332221 112345 9999999999999999999665555443 34555678873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=391.46 Aligned_cols=259 Identities=24% Similarity=0.319 Sum_probs=219.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk---~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.+..++|++.+.||+|+||+||+|+++.+|+ .||||+++... .......+.+|+.+|..++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567899999999999999999999986665 59999997532 345567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999999755 579999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
... ..........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 203 ~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 203 DDP------------------------DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp ----------------------------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cCc------------------------cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 100 00111223457889999999999999999999999999999999 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+..++...+..+.. .+ .+..+++++.+||.+||..||.+||++.++.+.|
T Consensus 259 ~~~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 259 TNRDVISSVEEGYR-LP-APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp CHHHHHHHHHTTCC-CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHcCCC-CC-CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99888888776532 22 3478999999999999999999999955444433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=375.12 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=218.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.+..++|++++.||+|+||+||+|+++ ++..||+|+++.... ....+.+|+.++..++||||+++++++.+...+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 356689999999999999999999876 577899999976432 235688999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD- 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh-
Confidence 99999999999999998765 4999999999999999999999999999999999999999999999999999753110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
.........||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 158 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (268)
T 3sxs_A 158 -------------------------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212 (268)
T ss_dssp -------------------------CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred -------------------------hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence 0111233457888999999999899999999999999999999 99999999988
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.....+.......+ +...++++.+||.+||+.||.+||+ +.++++|
T Consensus 213 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 258 (268)
T 3sxs_A 213 EVVLKVSQGHRLYR--PHLASDTIYQIMYSCWHELPEKRPT---FQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCCCCC--CTTSCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHcCCCCCC--CCcChHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 88888776654332 4678999999999999999999999 5555543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=400.80 Aligned_cols=259 Identities=32% Similarity=0.469 Sum_probs=215.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CC-----ceEEEeeee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NP-----FVVRFFYSF 755 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HP-----NIVkL~gsf 755 (1091)
....++|++.+.||+|+||+||+|+++.+|+.||||++++. ......+..|+.++..+. |+ +|++++++|
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 45578999999999999999999999999999999999753 234566778888888875 44 599999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCeecccCCCceEec--CCCcEEEEe
Q 001370 756 TCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLH--SLGIVHRDLKPDNLLIA--HDGHIKLTD 829 (1091)
Q Consensus 756 qded~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLH--s~GIIHRDLKPeNILLD--~nG~VKLsD 829 (1091)
...+.+|+||||+.+ +|.+++... +.+++..++.++.||+.||.||| +.|||||||||+||||+ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999999999965 999999865 46999999999999999999999 57999999999999995 478899999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhC
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTG 909 (1091)
||+++... ......+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 205 FG~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 254 (382)
T 2vx3_A 205 FGSSCQLG------------------------------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254 (382)
T ss_dssp CTTCEETT------------------------------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccCceecc------------------------------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99997421 112346899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCC---------------CC------------------CC------------------
Q 001370 910 IPPFTAESPEIIFDNILNRKIPWPC---------------VP------------------SD------------------ 938 (1091)
Q Consensus 910 kpPF~~~s~~ei~~kIl~~~l~fP~---------------ip------------------~~------------------ 938 (1091)
++||.+.+..+....+.......|. ++ ..
T Consensus 255 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 334 (382)
T 2vx3_A 255 EPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334 (382)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGT
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcc
Confidence 9999999888777776542110000 00 00
Q ss_pred ----------CCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 939 ----------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 939 ----------lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
.++++++||.+||+.||.+||| +.++|+||||++..|
T Consensus 335 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt---a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQ---PYYALQHSFFKKTAD 381 (382)
T ss_dssp TTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC---HHHHTTSGGGCC---
T ss_pred ccccccccchhhHHHHHHHHHhcCCChhhCCC---HHHHhcCcccccCCC
Confidence 0147899999999999999999 889999999987654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=393.42 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=221.0
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcC--CCceEEEeeee
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVR--NPFVVRFFYSF 755 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~---~eie~~l~EieILskL~--HPNIVkL~gsf 755 (1091)
.....++|++.+.||+|+||.||+|++..+|+.||||++++...... .....+.+|+.++.++. ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34556889999999999999999999999999999999986543221 12245678999999996 59999999999
Q ss_pred ccCCeeEEEEeecCC-CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec-CCCcEEEEecCCc
Q 001370 756 TCRDNLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLS 833 (1091)
Q Consensus 756 qded~LYLVMEYm~G-GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGLA 833 (1091)
...+..|+||||+.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999999986 89999999888999999999999999999999999999999999999999 7899999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpP 912 (1091)
+... ........||+.|+|||++.+..+ +.++|||||||++|||++|..|
T Consensus 198 ~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 248 (320)
T 3a99_A 198 ALLK-----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248 (320)
T ss_dssp EECC-----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccc-----------------------------cccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCC
Confidence 7521 011234579999999999987665 7889999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 913 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
|.... .+......++ ..+++++.+||.+||..||.+||+ +.++++||||+++.+..
T Consensus 249 f~~~~------~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 249 FEHDE------EIIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp CCSHH------HHHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCCCHH
T ss_pred CCChh------hhhccccccc---ccCCHHHHHHHHHHccCChhhCcC---HHHHhcCHhhcCccCcc
Confidence 97642 2334444433 678999999999999999999999 88999999999886654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=373.78 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=207.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~-~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
+..++|++.+.||+|+||.||+|++. |+.||+|++++..... ....+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45789999999999999999999975 8899999987643222 23457789999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CeecccCCCceEecC--------CCcEEEEec
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAH--------DGHIKLTDF 830 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~G---IIHRDLKPeNILLD~--------nG~VKLsDF 830 (1091)
|+||||++||+|.+++. ...+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999885 457999999999999999999999999 999999999999986 788999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGk 910 (1091)
|+++... ........||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 161 g~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 211 (271)
T 3dtc_A 161 GLAREWH-----------------------------RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211 (271)
T ss_dssp CC------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCC
T ss_pred Ccccccc-----------------------------cccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9987421 01112457999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 911 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 911 pPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
.||.+.+.......+.......+ .+..+++++.+||.+||..||.+||+ +.++++
T Consensus 212 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~ 266 (271)
T 3dtc_A 212 VPFRGIDGLAVAYGVAMNKLALP-IPSTCPEPFAKLMEDCWNPDPHSRPS---FTNILD 266 (271)
T ss_dssp CTTTTSCHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred CCCCCCCHHHHHHhhhcCCCCCC-CCcccCHHHHHHHHHHhcCCcccCcC---HHHHHH
Confidence 99999888887777766655433 45789999999999999999999999 555553
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=372.07 Aligned_cols=249 Identities=19% Similarity=0.304 Sum_probs=216.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 759 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d 759 (1091)
.+..++|++.+.||+|+||+||+|++. |+.||+|+++... ......+.+.+|+.++.+++||||+++++++.+. .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 356789999999999999999999985 8899999997643 2345567899999999999999999999999887 7
Q ss_pred eeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEecCCCcEEEEecCCccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.+|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8999999999999999998765 4899999999999999999999999 99999999999999999999999998652
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCc---cceeechhhhHHHHHhCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~---ksDIWSLGVILYEMLTGkpP 912 (1091)
. .....+||+.|+|||++.+..++. ++|||||||++|||++|..|
T Consensus 163 ~--------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 210 (271)
T 3kmu_A 163 F--------------------------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210 (271)
T ss_dssp T--------------------------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred e--------------------------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 1 112357899999999998766554 79999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 913 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 913 F~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
|.+.+.......+...... +.++..+++++.+||.+||..||.+||++.++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 211 FADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TTTSCHHHHHHHHHHSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999888887777765544 3356789999999999999999999999544433
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=404.32 Aligned_cols=262 Identities=25% Similarity=0.449 Sum_probs=197.4
Q ss_pred CCeEE-EEeeccCCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee--ccCCe
Q 001370 686 DDFEI-IKPISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF--TCRDN 760 (1091)
Q Consensus 686 ddFei-lr~LGkGgFGtVyLar~k--~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsf--qded~ 760 (1091)
+.|++ .++||+|+||+||+|+++ .+++.||||++.+... ...+.+|+.+|..++|||||+++++| .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34665 457999999999999977 4688999999975432 24578999999999999999999999 45778
Q ss_pred eEEEEeecCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe----cCCCcEEE
Q 001370 761 LYLVMEYLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKL 827 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~---------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKL 827 (1091)
+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999999975 888887532 249999999999999999999999999999999999999 77899999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHH
Q 001370 828 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 828 sDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEM 906 (1091)
+|||+|+...... .........+||+.|+|||++.+. .|+.++|||||||+||||
T Consensus 174 ~Dfg~a~~~~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 174 ADMGFARLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp CCTTCCC----------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred EECCCceecCCCC------------------------cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence 9999998531000 001223457899999999999874 589999999999999999
Q ss_pred HhCCCCCCCCCh---------HHHHHHHhhc-CCC----CCC------------------------------CCCCCCHH
Q 001370 907 ITGIPPFTAESP---------EIIFDNILNR-KIP----WPC------------------------------VPSDMSFE 942 (1091)
Q Consensus 907 LTGkpPF~~~s~---------~ei~~kIl~~-~l~----fP~------------------------------ip~~lS~e 942 (1091)
++|.+||.+... .+....|+.. ..+ |+. .....+++
T Consensus 230 l~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (405)
T 3rgf_A 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309 (405)
T ss_dssp HHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSH
T ss_pred HhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHH
Confidence 999999976554 2333343321 000 000 00123778
Q ss_pred HHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcch
Q 001370 943 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 943 akDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
+.+||.+||+.||.+||| +.++|+||||.+..|..
T Consensus 310 ~~~Ll~~~L~~dP~~R~t---a~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 310 AFHLLQKLLTMDPIKRIT---SEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHHHHHHSCSSGGGSCC---HHHHHTSGGGTSSSCCC
T ss_pred HHHHHHHHccCCcccCCC---HHHHhcChhhccCCCCc
Confidence 999999999999999999 88999999999876654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=384.99 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=212.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
....++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.++..++||||+++++++...+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 35678999999999999999999999999999999999875544555568899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+||||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 187 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE-- 187 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc--
Confidence 999999999999999998889999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+...+
T Consensus 188 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 188 ------------------------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp ---------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred ------------------------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 01112345799999999999999999999999999999999999999998877655
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCC-CcccHHHHH
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL-GANGAAEVK 968 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRp-Sa~gA~EIL 968 (1091)
...+..........+..++.++.+||.+||..||.+|| +++++.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 244 GAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp HHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence 54444333222234577899999999999999999999 644444433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=389.20 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=216.3
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 753 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~g 753 (1091)
.+.+..++|++.+.||+|+||+||+|++. .++..||||++++.. .....+.+.+|+.+|.++ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 45567789999999999999999999973 456789999997532 233457889999999999 8999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------------------CLEEDVARIYIAELVLALEYLHSLGIVHR 810 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~g-----------------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHR 810 (1091)
++...+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997653 37899999999999999999999999999
Q ss_pred ccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC
Q 001370 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 890 (1091)
Q Consensus 811 DLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y 890 (1091)
||||+||||+.+|.+||+|||+++...... .........||+.|+|||++.+..|
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDS-------------------------NYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------TSEEETTEEECGGGCCHHHHHHCCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCc-------------------------cceeccCccCccCccCHHHhccCCC
Confidence 999999999999999999999997532100 0111234568999999999999999
Q ss_pred CccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 891 GYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 891 s~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+.++|||||||++|+|++ |..||.+......+..++......+ .+..+++++.+||.+||..||.+||+ +.++++
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps---~~~l~~ 327 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPS---FPNLTS 327 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCCchhCcC---HHHHHH
Confidence 999999999999999998 9999998876666666665544432 35778999999999999999999999 445544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=380.36 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=218.1
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 752 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~ 752 (1091)
..+....++|++.+.||+|+||.||+|++ ..+++.||+|+++... .....+.+.+|+.+|.++ +||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 44556778999999999999999999985 4567899999997643 234567899999999999 899999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCC
Q 001370 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 814 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GGSL~dlL~k~g------------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKP 814 (1091)
+++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 99999999999999999999999998654 489999999999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001370 815 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 894 (1091)
Q Consensus 815 eNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 894 (1091)
+|||++.++.+||+|||+++..... ..........||+.|+|||++.+..++.++
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 228 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCVYTFES 228 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSC-------------------------TTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred ceEEEcCCCCEEEcccccccccccc-------------------------ccceeccCCCCcceeeChHHhcCCCCChHH
Confidence 9999999999999999998742110 001112345688999999999999999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 895 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 895 DIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
|||||||++|||++ |.+||.+.........++......+ .+..++.++.+||.+||..||.+||++.++.
T Consensus 229 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 299 (313)
T 1t46_A 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (313)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 99999999999999 9999998776555555555443322 3467899999999999999999999944333
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=379.91 Aligned_cols=263 Identities=27% Similarity=0.465 Sum_probs=204.6
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
....+++|++++.||+|+||.||+|+++.+|+.||||++..... .......+..+..++..++||||+++++++.+.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34567899999999999999999999999999999999976432 22233444555567888899999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+|+||||+ ++.+..++.. .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.+|.+||+|||++.....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999 5566665544 46799999999999999999999995 999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
........||+.|+|||++. +..++.++|||||||++|||++|..||
T Consensus 178 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (318)
T 2dyl_A 178 ----------------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229 (318)
T ss_dssp -------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ----------------------------CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCC
Confidence 11123457999999999994 467889999999999999999999999
Q ss_pred CC-CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 914 TA-ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 914 ~~-~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.. ....+....+.....+.......++.++.+||.+||..||.+||+ +.++++||||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 230 KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK---YNKLLEHSFIKRY 290 (318)
T ss_dssp TTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHHH
T ss_pred CCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcC---HHHHhhCHHHHhc
Confidence 87 455666666666544322223468999999999999999999999 8899999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=377.00 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=222.6
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..+.+..++|++.+.||+|+||+||+|.++.++..||+|++... ....+.+.+|+.++..++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 35567788999999999999999999999999999999999753 23567789999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
..+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999864 34999999999999999999999999999999999999999999999999998752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
.. ..........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+
T Consensus 162 ~~--------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 162 TG--------------------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp CS--------------------------SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cC--------------------------CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 10 00112234567899999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.+...+...+..... +..+..+++++.+||.+||..||.+||++.++.+.+
T Consensus 216 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 216 IDLSQVYELLEKDYR--MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp CCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHhccCC--CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 888877776655422 223478999999999999999999999955544443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=376.15 Aligned_cols=272 Identities=19% Similarity=0.259 Sum_probs=219.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~L 761 (1091)
...++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+.+|+.++..+ +||+|+++++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45678999999999999999999999999999999987533 224578899999999 799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc-----EEEEecCCccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKI 835 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~-----VKLsDFGLAk~ 835 (1091)
|+||||+ +|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|. +||+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 999999998754 5999999999999999999999999999999999999988776 99999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
...... . ...........+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 161 ~~~~~~--------~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 161 YRDPVT--------K------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp SBCTTT--------C------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccc--------c------------ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 321100 0 00001223457899999999999999999999999999999999999999987
Q ss_pred C---ChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH-------cCCCCCCCCcch
Q 001370 916 E---SPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK-------AHPFFKGVNWDS 980 (1091)
Q Consensus 916 ~---s~~ei~~kIl~~~l--~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL-------~HPFFkgIdWd~ 980 (1091)
. .....+..+..... +.+.....+++++.+||.+||..||.+||++.++.+.+ ........+|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 221 LKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp CCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred hhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 4 34455555443321 22223357899999999999999999999965444333 234455566654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=373.58 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=210.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhH----HHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND----IERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~e----ie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
....++|++.+.||+|+||+||+|++..+++.||+|++.......... .+.+.+|+.++..++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 356789999999999999999999999999999999987644332222 2678999999999999999999999977
Q ss_pred CCeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEecCCCc-----EEEEe
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGH-----IKLTD 829 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD~nG~-----VKLsD 829 (1091)
.. ++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 65 7999999999999888654 46999999999999999999999999 999999999999998886 99999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc--CCCCCccceeechhhhHHHHH
Q 001370 830 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 830 FGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~--g~~Ys~ksDIWSLGVILYEML 907 (1091)
||+++... .......||+.|+|||++. ...|+.++|||||||++|||+
T Consensus 173 fg~~~~~~------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 173 FGLSQQSV------------------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222 (287)
T ss_dssp CTTCBCCS------------------------------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred CCcccccc------------------------------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence 99987321 1123467999999999994 456789999999999999999
Q ss_pred hCCCCCCCCChHHH--HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 908 TGIPPFTAESPEII--FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 908 TGkpPF~~~s~~ei--~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
+|..||...+.... ...+...... +.++..+++++.+||.+||..||.+||++.++.+
T Consensus 223 ~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 223 TGEGPFDEYSYGKIKFINMIREEGLR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HSSCTTTTCCCCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCccccccHHHHHHHHhccCCC-CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999987654333 4444444333 3456789999999999999999999999544433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=378.45 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=208.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 755 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TG-------k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsf 755 (1091)
+..++|++.+.||+|+||+||+|+++.++ ..||+|++.+.. ....+.+.+|+.++..++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45678999999999999999999998877 469999987533 34567899999999999999999999999
Q ss_pred ccCCeeEEEEeecCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc--------EE
Q 001370 756 TCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--------IK 826 (1091)
Q Consensus 756 qded~LYLVMEYm~GGSL~dlL~k~g~-LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~--------VK 826 (1091)
.+.+..|+||||++||+|.+++.+.+. +++..+..++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 999999999999999999999999999999999999999887 99
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFE 905 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYE 905 (1091)
|+|||++.... ......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 162 l~Dfg~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e 210 (289)
T 4fvq_A 162 LSDPGISITVL-------------------------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210 (289)
T ss_dssp ECCCCSCTTTS-------------------------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHH
T ss_pred eccCccccccc-------------------------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHH
Confidence 99999986421 1123468999999999987 779999999999999999
Q ss_pred HHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 906 FITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 906 MLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
|++| .+||...+..... .+......+| ...+.++.+||.+||+.||.+||+ +.++++
T Consensus 211 l~~g~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~ 268 (289)
T 4fvq_A 211 ICSGGDKPLSALDSQRKL-QFYEDRHQLP---APKAAELANLINNCMDYEPDHRPS---FRAIIR 268 (289)
T ss_dssp HHTTTCCTTTTSCHHHHH-HHHHTTCCCC---CCSSCTTHHHHHHHSCSSGGGSCC---HHHHHH
T ss_pred HHcCCCCCccccchHHHH-HHhhccCCCC---CCCCHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 9995 5555555544433 3344443333 567889999999999999999999 555554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=391.66 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=222.0
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 750 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~T-------Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVk 750 (1091)
..+.+..++|++.+.||+|+||+||+|++..+ +..||||++++. ........+.+|+.++..+ +|||||+
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 34456778999999999999999999997543 357999999764 2345668899999999999 8999999
Q ss_pred EeeeeccCCeeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCC
Q 001370 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 814 (1091)
Q Consensus 751 L~gsfqded~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKP 814 (1091)
+++++...+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999998754 499999999999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001370 815 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 894 (1091)
Q Consensus 815 eNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 894 (1091)
+||||+.+|.+||+|||+++..... ..........||+.|+|||++.+..++.++
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 274 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHI-------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCC-------------------------CTTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred ceEEEcCCCcEEEcccCcccccccc-------------------------cccccccCCCCCcceeCHHHhcCCCCCchh
Confidence 9999999999999999999742110 001122345688999999999999999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 895 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 895 DIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
|||||||++|||++ |..||.+.+..++...+..+.. +..+..+++++.+||.+||..||.+||+ +.++++
T Consensus 275 DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~ 345 (382)
T 3tt0_A 275 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPT---FKQLVE 345 (382)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 99999999999999 9999999998888887776543 2235789999999999999999999999 555554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=382.82 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=208.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhc----CCCceEEEeee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITV----RNPFVVRFFYS 754 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~---~eie~~l~EieILskL----~HPNIVkL~gs 754 (1091)
....++|++.+.||+|+||.||+|+++.+|+.||||+++....... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3456789999999999999999999999999999999976443221 1234456799999888 89999999999
Q ss_pred eccCCeeEEEEee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec-CCCcEEEEecCC
Q 001370 755 FTCRDNLYLVMEY-LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGL 832 (1091)
Q Consensus 755 fqded~LYLVMEY-m~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD-~nG~VKLsDFGL 832 (1091)
+...+..|+|||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999999888899999999999999999999999999999999999999 899999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkp 911 (1091)
++... ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.
T Consensus 187 ~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 237 (312)
T 2iwi_A 187 GALLH-----------------------------DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237 (312)
T ss_dssp CEECC-----------------------------SSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred hhhcc-----------------------------cCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence 87521 011234569999999999987666 458999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCC
Q 001370 912 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 912 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgId 977 (1091)
||.... .+......++ ..++.++.+||.+||..||.+||+ +.++++||||+...
T Consensus 238 pf~~~~------~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 238 PFERDQ------EILEAELHFP---AHVSPDCCALIRRCLAPKPSSRPS---LEEILLDPWMQTPA 291 (312)
T ss_dssp SCCSHH------HHHHTCCCCC---TTSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSTTTCC--
T ss_pred CCCChH------HHhhhccCCc---ccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhcCch
Confidence 997632 2334444444 678999999999999999999999 88999999998653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=398.85 Aligned_cols=258 Identities=27% Similarity=0.398 Sum_probs=219.6
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
.+.+..++|++.+.||+|+||+||+|+++.+|+.||||+++.. ........+.+|+.+|..++|||||++++++...+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 4456778999999999999999999999999999999998753 23445567889999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999999998754 599999999999999999999999999999999999999999999999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s 917 (1091)
.. + ........+|+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+
T Consensus 266 ~~---------------------~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 266 GV---------------------Y----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp SE---------------------E----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred Cc---------------------e----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 00 0 001112346788999999998899999999999999999998 999999998
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
..++...+..+. .++ .+..+++++.+||.+||..||.+||++.++.+
T Consensus 321 ~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 321 NQQTREFVEKGG-RLP-CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTTC-CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 888777665543 222 35778999999999999999999999544433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=375.90 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=206.0
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
..+..++|++.+.||+|+||+||+|++..+ +..||+|+++... .....+.+.+|+.++..++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 345668999999999999999999998754 4579999886532 3445678999999999999999999999984
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 567899999999999999998654 6999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
... .........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+
T Consensus 167 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 167 EDS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp --------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred Ccc--------------------------cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 110 0011223457889999999999999999999999999999997 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
.+..++...+..... +..+..+++++.+||.+||..||.+||++.+
T Consensus 221 ~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 266 (281)
T 1mp8_A 221 VKNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 266 (281)
T ss_dssp CCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 888888887766542 2245789999999999999999999999443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=368.07 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=217.8
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
.+..++|++.+.||+|+||.||+|.+. +++.||+|++++... ..+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 455679999999999999999999986 578899999986432 235788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc-
Confidence 9999999999999999865 56899999999999999999999999999999999999999999999999998753110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
.........||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 158 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (267)
T 3t9t_A 158 -------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212 (267)
T ss_dssp -------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred -------------------------cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH
Confidence 0111233567889999999999999999999999999999999 99999999988
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+....+..+... ..+...+.++.+||.+||..||.+||+ +.++++
T Consensus 213 ~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 257 (267)
T 3t9t_A 213 EVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPA---FSRLLR 257 (267)
T ss_dssp HHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHhcCCcC--CCCccCcHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 888887765432 234678999999999999999999999 445543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=387.72 Aligned_cols=267 Identities=23% Similarity=0.397 Sum_probs=199.4
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeecc
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~Eie-ILskL~HPNIVkL~gsfqd 757 (1091)
..+.+..++|++++.||+|+||.||+|.++.+|+.||||+++... .......+..|.. ++..++||||+++++++..
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 445677899999999999999999999999999999999997642 2334455666665 6777899999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecccCCCceEecCCCcEEEEecC
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k-----~g~LsE~~ar~yaaQIa~ALeYLHs~-GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
.+.+|+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999986 88887763 46799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh----cCCCCCccceeechhhhHHHHH
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL----~g~~Ys~ksDIWSLGVILYEML 907 (1091)
+++.... ........||+.|+|||++ .+..|+.++|||||||++|+|+
T Consensus 172 ~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (327)
T 3aln_A 172 ISGQLVD----------------------------SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223 (327)
T ss_dssp SSCC----------------------------------------------------------CCSHHHHHHHHHHHHHHH
T ss_pred Cceeccc----------------------------ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH
Confidence 9874210 0111234799999999999 4567899999999999999999
Q ss_pred hCCCCCCCCCh-HHHHHHHhhcCCC-CCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 908 TGIPPFTAESP-EIIFDNILNRKIP-WPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 908 TGkpPF~~~s~-~ei~~kIl~~~l~-fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
+|..||...+. .+....+..+..+ ++. ....+++++.+||.+||..||.+||+ +.++++||||....+.
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 224 TGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK---YKELLKHPFILMYEER 295 (327)
T ss_dssp HSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHHHHHS
T ss_pred HCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC---HHHHHhChHHHHhHhh
Confidence 99999987543 2333333333221 111 12468999999999999999999999 8899999999765544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=381.79 Aligned_cols=258 Identities=21% Similarity=0.341 Sum_probs=218.5
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 752 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk-----~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~ 752 (1091)
.......++|++.+.||+|+||+||+|.+..+++ .||+|+++... .......+.+|+.+|..+ +||||++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 3456778999999999999999999999987665 79999997633 344567899999999999 899999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceE
Q 001370 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKV--------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 818 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GGSL~dlL~k~--------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNIL 818 (1091)
+++...+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999753 35799999999999999999999999999999999999
Q ss_pred ecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeec
Q 001370 819 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 898 (1091)
Q Consensus 819 LD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWS 898 (1091)
++.++.+||+|||+++...... .........||+.|+|||++.+..++.++||||
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 251 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS-------------------------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT-------------------------TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHH
T ss_pred ECCCCeEEECcccccccccccc-------------------------ceeecCCCCCCccccCHHHhccCCCChHHHHHH
Confidence 9999999999999997432100 011123456789999999999999999999999
Q ss_pred hhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 899 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 899 LGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
|||++|||++ |.+||.+.........+.......+ .+...+.++.+||.+||..||.+||++.++
T Consensus 252 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 317 (333)
T 2i1m_A 252 YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA-QPAFAPKNIYSIMQACWALEPTHRPTFQQI 317 (333)
T ss_dssp HHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 9999999998 9999998776666666655544332 346789999999999999999999994433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=378.21 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=214.9
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccCC
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRD 759 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~--HPNIVkL~gsfqded 759 (1091)
....++|++++.||+|+||.||+|++. +|+.||||++.... ........+.+|+.++..+. ||||+++++++...+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 355678999999999999999999985 58999999997643 23456788999999999997 599999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++.....
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9999999 56889999999888999999999999999999999999999999999999996 599999999998743110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-----------CCCCccceeechhhhHHHHHh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFIT 908 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----------~~Ys~ksDIWSLGVILYEMLT 908 (1091)
. ........+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 180 ~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 234 (313)
T 3cek_A 180 T-------------------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234 (313)
T ss_dssp -----------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH
T ss_pred c-------------------------ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh
Confidence 0 0111234579999999999976 468899999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 909 GIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 909 GkpPF~~~s-~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
|..||.... .......+....... .++...+.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~~~~~ 299 (313)
T 3cek_A 235 GKTPFQQIINQISKLHAIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQIQ 299 (313)
T ss_dssp SSCTTTTCCSHHHHHHHHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHCC
T ss_pred CCCchhhHHHHHHHHHHHHhccccc-CCcccchHHHHHHHHHHccCCcccCcC---HHHHhcCccccCC
Confidence 999998754 334444444433322 234667899999999999999999999 8899999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=379.38 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=214.2
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 754 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~-----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gs 754 (1091)
+....++|++.+.||+|+||+||+|++ ..+++.||||++++.. .......+.+|+.++..+ +||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 345678999999999999999999985 3567899999997643 344567889999999999 69999999999
Q ss_pred eccCC-eeEEEEeecCCCcHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCce
Q 001370 755 FTCRD-NLYLVMEYLNGGDLYSLLRKVGC----------------LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817 (1091)
Q Consensus 755 fqded-~LYLVMEYm~GGSL~dlL~k~g~----------------LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNI 817 (1091)
+...+ .+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87765 49999999999999999987543 89999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001370 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 897 (1091)
Q Consensus 818 LLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIW 897 (1091)
|++.+|.+||+|||+++..... ..........||+.|+|||++.+..++.++|||
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 234 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTC-------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred EECCCCCEEECCCccccccccC-------------------------ccceeccCCCcceeecCchhhccccccchhHHH
Confidence 9999999999999998742110 001122345689999999999999999999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 898 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 898 SLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
||||++|+|++ |..||.+..........+..... +..+..+++++.+||.+||..||.+||+ +.++++|
T Consensus 235 slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~~ 304 (316)
T 2xir_A 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 304 (316)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc-CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99999999998 99999887654444333333222 2234678999999999999999999999 5566554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.54 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=205.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++.+.||+|+||.||+|.+..+|+.||||+++............+.+|+.++..++||||+++++++...+.+|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 35678999999999999999999999999999999998755555667788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999864 35699999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s- 917 (1091)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 189 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 241 (310)
T 2wqm_A 189 ---------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241 (310)
T ss_dssp -------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C
T ss_pred ---------------------------CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 0111234579999999999999999999999999999999999999997653
Q ss_pred -hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 918 -PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 918 -~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
.......+.....+ +.....++.++.+||.+||..||.+||++.++
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~i 288 (310)
T 2wqm_A 242 NLYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288 (310)
T ss_dssp CHHHHHHHHHTTCSC-CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hHHHHHHHhhcccCC-CCcccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 34555555544332 11236789999999999999999999994433
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=390.41 Aligned_cols=254 Identities=30% Similarity=0.511 Sum_probs=185.6
Q ss_pred ccCCCeEEEE-eeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----
Q 001370 683 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC---- 757 (1091)
Q Consensus 683 ~~iddFeilr-~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd---- 757 (1091)
...++|++++ .||+|+||+||+|+++.+|+.||||++.+.. . ........+..+.||||++++++|..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----K---ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----H---HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 4568899965 6999999999999999999999999997522 1 11222234567799999999999876
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CCcEEEEecCC
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGL 832 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGL 832 (1091)
...+|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 456899999999999999998764 6999999999999999999999999999999999999986 45699999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCC
Q 001370 833 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 912 (1091)
Q Consensus 833 Ak~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpP 912 (1091)
++... .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+|
T Consensus 178 ~~~~~-----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (336)
T 3fhr_A 178 AKETT-----------------------------QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228 (336)
T ss_dssp CEEC---------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCC
T ss_pred ceecc-----------------------------ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 87421 1112346789999999999988999999999999999999999999
Q ss_pred CCCCChHHH----HHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 913 FTAESPEII----FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 913 F~~~s~~ei----~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
|........ ...+......+|. ....+++++.+||.+||..||.+||+ +.++++||||++
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 293 (336)
T 3fhr_A 229 FYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT---ITQFMNHPWINQ 293 (336)
T ss_dssp C---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHHSHHHHT
T ss_pred CCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccccc
Confidence 987765443 2233333333332 12468999999999999999999999 889999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=375.10 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=206.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar----~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
.+..++|++++.||+|+||+||+|+ ...+|+.||||++... .....+.+.+|+.+|..++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3556889999999999999999998 4668999999998753 34556789999999999999999999998855
Q ss_pred C--CeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 758 R--DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 758 e--d~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
. ..+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 4 56999999999999999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
...... ..........||+.|+|||++.+..|+.++|||||||++|||++|..||.
T Consensus 163 ~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 163 VLPQDK------------------------EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp -------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred cccCCc------------------------ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 531100 00111223457888999999999999999999999999999999999987
Q ss_pred CCChH----------------HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 915 AESPE----------------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 915 ~~s~~----------------ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
..... .....+. .....+ .+..+++++.+||.+||..||.+||++.++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~el~ 283 (295)
T 3ugc_A 219 SPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283 (295)
T ss_dssp SHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CChHHHHhhhcCccccchhHHHHHHHHh-ccCcCC-CCcCcCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 53221 1122222 222222 3578999999999999999999999954443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=384.53 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=206.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEE----EEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~V----AIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
+..++|++++.||+|+||+||+|++..+|+.+ |+|.++.. ........+.+|+.++.+++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 55678999999999999999999998888765 66665432 2234457899999999999999999999999875
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
. .++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4 78999999999999999874 569999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
... .........||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 169 ~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 169 AEE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp TTC-------------------------C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCc-------------------------ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 100 0111223467889999999999999999999999999999999 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+..++...+..... .+ .+..++.++.+||.+||+.||.+||+ +.+++.+
T Consensus 224 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~ 272 (327)
T 3poz_A 224 PASEISSILEKGER-LP-QPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 272 (327)
T ss_dssp CGGGHHHHHHTTCC-CC-CCTTBCHHHHHHHHHHTCSCGGGSCC---HHHHHHH
T ss_pred CHHHHHHHHHcCCC-CC-CCccCCHHHHHHHHHHcCCChhhCCC---HHHHHHH
Confidence 88777766655432 22 34678999999999999999999999 5555543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=380.34 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=217.3
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 750 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k-------~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVk 750 (1091)
..+.+..++|++.+.||+|+||+||+|++. .++..||||+++... .......+.+|+.++..+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 344566789999999999999999999986 457789999997532 345677899999999999 8999999
Q ss_pred EeeeeccCCeeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCC
Q 001370 751 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 814 (1091)
Q Consensus 751 L~gsfqded~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKP 814 (1091)
+++++...+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999998654 389999999999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001370 815 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 894 (1091)
Q Consensus 815 eNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 894 (1091)
+|||++.+|.+||+|||+++...... .........||+.|+|||++.+..++.++
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 240 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQS 240 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTS-------------------------SEECCSCCCCCGGGCCHHHHHHCEECHHH
T ss_pred ceEEEcCCCCEEEccccccccccccc-------------------------cccccCCCCcccceeChHHhcCCCcChHH
Confidence 99999999999999999997531100 00112334678999999999998999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 895 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 895 DIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
|||||||++|||++ |..||.+.+..++...+..+.. +..+..++.++.+||.+||..||.+||++.
T Consensus 241 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 307 (334)
T 2pvf_A 241 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFK 307 (334)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999999 9999999998888887766542 223578899999999999999999999944
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=382.31 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=214.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEE--EEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~V--AIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded 759 (1091)
+..++|++.+.||+|+||.||+|+++.+|..+ |+|.++.. ........+.+|+.+|.++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55689999999999999999999999888865 99988752 2334556789999999999 8999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 823 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG 823 (1091)
.+|+||||+++|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001370 824 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903 (1091)
Q Consensus 824 ~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVIL 903 (1091)
.+||+|||+++.... ........+|+.|+|||++.+..++.++|||||||++
T Consensus 180 ~~kL~Dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 180 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231 (327)
T ss_dssp CEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred eEEEcccCcCccccc----------------------------cccccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence 999999999873210 1112234678999999999998999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 904 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 904 YEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
|||++ |.+||.+.+..++...+..+.. +..+..+++++.+||.+||..||.+||+ +.++++
T Consensus 232 ~ellt~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~ 293 (327)
T 1fvr_A 232 WEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILV 293 (327)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHcCCCCCCCCCcHHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 99998 9999999998888888766532 2234688999999999999999999999 555554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=381.04 Aligned_cols=260 Identities=21% Similarity=0.318 Sum_probs=218.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEE-----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar-----~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq 756 (1091)
.+..++|++++.||+|+||.||+|+ ...++..||||++... ........+.+|+.++..++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3566899999999999999999999 5567889999999743 23455678899999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC---CcEE
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIK 826 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g-------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n---G~VK 826 (1091)
....+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998753 48999999999999999999999999999999999999954 4699
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEM 906 (1091)
|+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|
T Consensus 184 l~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 238 (327)
T 2yfx_A 184 IGDFGMARDIYRAS-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238 (327)
T ss_dssp ECCCHHHHHHHC-------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ECcccccccccccc-------------------------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHH
Confidence 99999987432100 01112345789999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 907 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 907 LT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
++ |..||...+..+....+..+... ..+..++..+.+||.+||..||.+||+ +.++++|.|+
T Consensus 239 lt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~l~~ 301 (327)
T 2yfx_A 239 FSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPN---FAIILERIEY 301 (327)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHH
T ss_pred HcCCCCCCCCcCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcC---HHHHHHHHHH
Confidence 98 99999999888888877765432 234788999999999999999999999 7788888775
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.87 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=215.7
Q ss_pred ccCCCeEEEE-eeccCCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIK-PISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr-~LGkGgFGtVyLar~--k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
+..++|++.+ .||+|+||+||+|.+ +.+++.||||+++... ......+.+.+|+.++..++||||+++++++ ..+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 4557899998 999999999999954 5668899999997643 2334467899999999999999999999999 567
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 78999999999999999998888999999999999999999999999999999999999999999999999999753110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
. ..........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 171 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 171 E------------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp C------------------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred C------------------------CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 00011223457899999999999889999999999999999999 9999999988
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.++...+..+.. +..+..+++++.+||.+||..||.+||++.++.+.+
T Consensus 227 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 227 SEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp HHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 888877766542 334578999999999999999999999965555444
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=397.49 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=213.0
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD- 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded- 759 (1091)
+.+..++|++.+.||+|+||+||+|.+. |+.||||+++... ..+.+.+|+.+|.+++|||||++++++....
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 4567789999999999999999999885 7899999997532 3467899999999999999999999976665
Q ss_pred eeEEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~--LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+++|+|.+++.+.+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 79999999999999999987654 7999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.......+|+.|+|||++.+..|+.++|||||||+||||++ |..||.+.
T Consensus 341 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 341 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp ------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred ------------------------------ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 00112357899999999999999999999999999999998 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
+..++...+..+. . +..+..+++++.+||.+||..||.+||++.++.+
T Consensus 391 ~~~~~~~~i~~~~-~-~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 391 PLKDVVPRVEKGY-K-MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CTTTHHHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCC-C-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888877776553 2 2235789999999999999999999999554443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=367.56 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=212.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~---TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.+..++|++.+.||+|+||+||+|++.. ++..||+|++++.. .....+.+.+|+.++..++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4567899999999999999999998754 34469999987642 344567899999999999999999999998754
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..|+||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 5799999999999999997654 59999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.. .........||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 165 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 165 DE--------------------------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ----------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cc--------------------------cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 10 0111233467889999999999999999999999999999998 99999988
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
........+...... ..+..+++.+.+||.+||..||.+||+ +.++++
T Consensus 219 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 266 (281)
T 3cc6_A 219 ENKDVIGVLEKGDRL--PKPDLCPPVLYTLMTRCWDYDPSDRPR---FTELVC 266 (281)
T ss_dssp CGGGHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred ChHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccCCchhCcC---HHHHHH
Confidence 777777666554321 234678999999999999999999999 445543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=389.68 Aligned_cols=278 Identities=15% Similarity=0.199 Sum_probs=209.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCC-----CcEEEEEEeecccccchhH--------HHHHHHHHHHHHhcCCCceE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKND--------IERILAERNILITVRNPFVV 749 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~T-----Gk~VAIKiLkK~~i~~~~e--------ie~~l~EieILskL~HPNIV 749 (1091)
...++|++.+.||+|+||+||+|.++.+ ++.||||++.........+ ...+..|...+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4567999999999999999999998765 5889999987643111111 12344566677788899999
Q ss_pred EEeeeeccC----CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec--CC
Q 001370 750 RFFYSFTCR----DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HD 822 (1091)
Q Consensus 750 kL~gsfqde----d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD--~n 822 (1091)
++++++... ..+||||||+ ||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998775 4589999999 99999999876 6799999999999999999999999999999999999999 88
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001370 823 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902 (1091)
Q Consensus 823 G~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVI 902 (1091)
+.+||+|||+++......... ..........+||+.|||||++.+..|+.++|||||||+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHK--------------------AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCC--------------------CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeEEEEECCcceecccCCccc--------------------ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 999999999998532111000 001112245679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhh----cCC------CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH----
Q 001370 903 LFEFITGIPPFTAESPEIIFDNILN----RKI------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK---- 968 (1091)
Q Consensus 903 LYEMLTGkpPF~~~s~~ei~~kIl~----~~l------~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL---- 968 (1091)
||||++|+.||.+......+..... ..+ .++ +..++.++.+||..||..||.+||++.++.+++
T Consensus 251 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 9999999999986432222211111 000 011 256789999999999999999999965544443
Q ss_pred ---cCCCCCCCCcchhhc
Q 001370 969 ---AHPFFKGVNWDSLAL 983 (1091)
Q Consensus 969 ---~HPFFkgIdWd~L~~ 983 (1091)
..++...++|.....
T Consensus 329 ~~~~~~~~~~~dw~~~~~ 346 (364)
T 3op5_A 329 KAIGSKDDGKLDLSVVEN 346 (364)
T ss_dssp HHTTCCCCCCCCC-----
T ss_pred HHcCCCcCCccceEeccC
Confidence 345666677876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=369.01 Aligned_cols=258 Identities=26% Similarity=0.347 Sum_probs=207.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar----~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.....|++++.||+|+||.||+|+ +..+|+.||+|+++... .......+.+|+.+|..++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445679999999999999999999 46689999999997543 234567889999999999999999999999887
Q ss_pred --CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 759 --DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 759 --d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
..+|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 6699999999999999999554 5699999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
..... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 176 ~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 176 IETDK------------------------EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CCTTC------------------------CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccCCC------------------------cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 32100 001122345689999999999999999999999999999999999988643
Q ss_pred C--------------ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 916 E--------------SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 916 ~--------------s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
. .........+......+ .+..+++++.+||.+||..||.+||++.++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 232 PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP-CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp HHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hhhHHhhccCCcccccCHHHHHHHHhccCCCC-CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 2 11112222222222222 357899999999999999999999995544443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=370.84 Aligned_cols=252 Identities=24% Similarity=0.405 Sum_probs=198.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeecc---
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTC--- 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILsk--L~HPNIVkL~gsfqd--- 757 (1091)
...++|++++.||+|+||+||+|++ +|+.||||++... ....+..|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 4567899999999999999999987 5899999998652 34556677888777 789999999988544
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecccCCCceEecCCCcEEEE
Q 001370 758 -RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------SLGIVHRDLKPDNLLIAHDGHIKLT 828 (1091)
Q Consensus 758 -ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLH--------s~GIIHRDLKPeNILLD~nG~VKLs 828 (1091)
...+|+||||+++|+|.+++.. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 4568999999999999999954 57999999999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC------CCCccceeechhhh
Q 001370 829 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGII 902 (1091)
Q Consensus 829 DFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~------~Ys~ksDIWSLGVI 902 (1091)
|||+++....... .........+||+.|+|||++.+. .++.++|||||||+
T Consensus 156 Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~i 212 (301)
T 3q4u_A 156 DLGLAVMHSQSTN-----------------------QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212 (301)
T ss_dssp CCTTCEEEETTTT-----------------------EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHH
T ss_pred eCCCeeecccccc-----------------------cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHH
Confidence 9999975321000 001112345899999999999876 45579999999999
Q ss_pred HHHHHhC----------CCCCCCCC----hHHHHHHHhhcCCCCCCCC-----CCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 903 LFEFITG----------IPPFTAES----PEIIFDNILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 903 LYEMLTG----------kpPF~~~s----~~ei~~kIl~~~l~fP~ip-----~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
+|||++| .+||.... .......+.......+.++ ...+.++.+||.+||..||.+||++.+
T Consensus 213 l~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 213 LWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence 9999999 89996532 2233333333222223222 225578999999999999999999544
Q ss_pred HHH
Q 001370 964 AAE 966 (1091)
Q Consensus 964 A~E 966 (1091)
+.+
T Consensus 293 i~~ 295 (301)
T 3q4u_A 293 IKK 295 (301)
T ss_dssp HHH
T ss_pred HHH
Confidence 433
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=369.55 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=207.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRT-TGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~-TGk--~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
+..++|++.+.||+|+||+||+|++.. +++ .||+|+++..........+.+.+|+.++..++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 456789999999999999999998754 333 69999998654444566788999999999999999999999998765
Q ss_pred eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 89999999999999999765 5699999999999999999999999999999999999999999999999999875311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s 917 (1091)
.. ..........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+
T Consensus 174 ~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 174 ND------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp -C------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc------------------------cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 00 00111234568889999999999889999999999999999999 999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
..++...+......++ .+..++.++.+||.+||..||.+||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 276 (291)
T 1u46_A 230 GSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 276 (291)
T ss_dssp HHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHccCCCCC-CCcCcCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 9888888877655544 3568999999999999999999999944333
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=365.15 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=216.4
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
.+.+..++|++++.||+|+||.||+|++. ++..||+|+++... ...+.+.+|+.+|..++||||+++++++.. +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 45567789999999999999999999975 57789999997643 234678999999999999999999998874 5
Q ss_pred eeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 6899999999999999997543 69999999999999999999999999999999999999999999999999997531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.. .........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.
T Consensus 161 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 161 DN--------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp SS--------------------------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred Cc--------------------------ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 10 0111223467899999999998889999999999999999999 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
+..++...+..+.. +..+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 215 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 215 TNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHhcccC--CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 88888877765532 223478899999999999999999999965555544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.78 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=210.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee-E
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL-Y 762 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk---~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L-Y 762 (1091)
.|++.+.||+|+||+||+|++..++. .||+|++.+. ......+.+.+|+.++..++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57788999999999999999866555 7999998752 3445678899999999999999999999999877765 9
Q ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
+||||+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999986 35689999999999999999999999999999999999999999999999999974311100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~e 920 (1091)
..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+
T Consensus 180 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~ 236 (298)
T 3pls_A 180 -----------------------YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236 (298)
T ss_dssp -----------------------GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG
T ss_pred -----------------------cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH
Confidence 01122334578999999999999999999999999999999999 666777777777
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 921 i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
+...+...... ..+..+++++.+||.+||..||.+||++.++
T Consensus 237 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 278 (298)
T 3pls_A 237 LTHFLAQGRRL--PQPEYCPDSLYQVMQQCWEADPAVRPTFRVL 278 (298)
T ss_dssp HHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHhhcCCCC--CCCccchHHHHHHHHHHccCChhhCcCHHHH
Confidence 77666655422 2357789999999999999999999994433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=366.48 Aligned_cols=244 Identities=24% Similarity=0.414 Sum_probs=208.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-------
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------- 757 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd------- 757 (1091)
..+|++++.||+|+||.||+|++..+|+.||+|+++... ..+.+|+.++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 467999999999999999999999999999999997532 246789999999999999999998864
Q ss_pred ---------CCeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEE
Q 001370 758 ---------RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 758 ---------ed~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VK 826 (1091)
...+|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45589999999999999999754 5799999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHH
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEM 906 (1091)
|+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|
T Consensus 163 l~Dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 214 (284)
T 2a19_B 163 IGDFGLVTSLKN----------------------------DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214 (284)
T ss_dssp ECCCTTCEESSC----------------------------CSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHH
T ss_pred ECcchhheeccc----------------------------cccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHH
Confidence 999999875210 0112345699999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 907 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 907 LTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
++|..||... ......+.... ++..++.++.+||.+||..||.+||+ +.++++|.++
T Consensus 215 ~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~~l~~ 271 (284)
T 2a19_B 215 LHVCDTAFET--SKFFTDLRDGI-----ISDIFDKKEKTLLQKLLSKKPEDRPN---TSEILRTLTV 271 (284)
T ss_dssp HSCCSSHHHH--HHHHHHHHTTC-----CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHH
T ss_pred HhcCCcchhH--HHHHHHhhccc-----ccccCCHHHHHHHHHHccCChhhCcC---HHHHHHHHHH
Confidence 9999988532 23333433332 23678899999999999999999999 7788887654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=395.63 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=219.9
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..+.+..++|++.+.||+|+||+||+|+++ ++..||||+++... ...+.+.+|+.+|..++|||||++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 345677889999999999999999999986 47789999997643 24678999999999999999999999986 6
Q ss_pred CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 6799999999999999999754 36899999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
.... ........+|+.|+|||++.+..|+.++|||||||+||||++ |.+||.+
T Consensus 335 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 335 EDNE--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CCHH--------------------------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCc--------------------------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 1100 011123457889999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
.+..++...+..+. .+| .+..+++++.+||.+||..||.+||++.++.+.|+
T Consensus 389 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~ 440 (454)
T 1qcf_A 389 MSNPEVIRALERGY-RMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440 (454)
T ss_dssp CCHHHHHHHHHHTC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 99888888776652 223 35789999999999999999999999666666554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=367.00 Aligned_cols=257 Identities=26% Similarity=0.338 Sum_probs=216.4
Q ss_pred cccCCCeEEEE-eeccCCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 682 RTSIDDFEIIK-PISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 682 ~~~iddFeilr-~LGkGgFGtVyLar~k--~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.+..++|.+.+ .||+|+||.||+|.++ .++..||+|+++... .....+.+.+|+.++..++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 34567888887 9999999999999864 467889999997642 345677899999999999999999999999 45
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 6799999999999999999754 469999999999999999999999999999999999999999999999999997531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
... ..........||+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 162 ~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 162 ADD------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp TCS------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCc------------------------ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 100 00111233467899999999998899999999999999999998 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+..++...+..+.. +..+..+++++.+||.+||..||.+||+ +.++++|
T Consensus 218 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~~ 266 (287)
T 1u59_A 218 KGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPD---FLTVEQR 266 (287)
T ss_dssp CTHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred CHHHHHHHHhcCCc--CCCCCCcCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 88888877766542 3345789999999999999999999999 4455543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=379.56 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=208.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~--i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
+..++|++++.||+|+||+||+|++..+|+.||+|+..|.. .........+.+|+.++..++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 55689999999999999999999999888876544433211 123345678999999999999999999999998765
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 88999999999999999864 56999999999999999999999999999999999999999999999999999753110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.
T Consensus 171 -------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 171 -------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp ----------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred -------------------------cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 00111223457889999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.++...+..... .+ .+..++.++.+||.+||..||.+||+ +.+++
T Consensus 226 ~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell 270 (327)
T 3lzb_A 226 SEISSILEKGER-LP-QPPICTIDVYMIMRKCWMIDADSRPK---FRELI 270 (327)
T ss_dssp GGHHHHHHTTCC-CC-CCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred HHHHHHHHcCCC-CC-CCccCCHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 877776655432 22 34778999999999999999999999 44554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=390.37 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=208.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k---~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.+..++|++.+.||+|+||+||+|+++ .++..||||+++... .....+.+.+|+.+|.+++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 455678999999999999999999987 457789999997532 345567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
..+|+||||++||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999998764 69999999999999999999999999999999999999999999999999997532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.... .........||+.|+|||++.+..|+.++|||||||++|||++ |..||...
T Consensus 199 ~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 199 DDPE------------------------AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ---------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred cCCc------------------------cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 1000 0011122346889999999999999999999999999999998 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
+..++...+..+. ..+ .+..++.++.+||.+||..||.+||++.++.+.
T Consensus 255 ~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 255 SNQDVIKAVDEGY-RLP-PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp CHHHHHHHHHTTE-ECC-CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCC-CCC-CCccccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 8888887776542 222 246789999999999999999999995544443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.40 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=209.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee-ccCCe
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRDN 760 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TG---k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsf-qded~ 760 (1091)
...|++.+.||+|+||+||+|++..++ ..||+|.+++. ........+.+|+.++++++||||+++++++ ...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 356999999999999999999976443 36899988752 3445677899999999999999999999984 55678
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999999764 45899999999999999999999999999999999999999999999999999753211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
.. ..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.
T Consensus 182 ~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 182 EY-----------------------YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp GG-----------------------CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred ch-----------------------hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 00 01122334578999999999999999999999999999999999 7788888887
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
.+....+....... .+..++.++.+||.+||..||.+||++.++.+
T Consensus 239 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 239 FDITVYLLQGRRLL--QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 77777776665432 24778999999999999999999999544333
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=366.52 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=207.5
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-C
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-D 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde-d 759 (1091)
+.+..++|++.+.||+|+||+||+|++. |+.||||+++... ..+.+.+|+.++..++||||+++++++... +
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 3466789999999999999999999874 8899999987532 456789999999999999999999986554 5
Q ss_pred eeEEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~--LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+++|+|.+++.+.+. +++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 79999999999999999986543 8999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.......||+.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 169 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 169 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp -------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ------------------------------ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123467899999999999999999999999999999998 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
+..++...+..+.. +..+..+++++.+||.+||..||.+||++.++.+.
T Consensus 219 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 219 PLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267 (278)
T ss_dssp CGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCC--CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHH
Confidence 88887777765432 23457889999999999999999999995544443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=381.62 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=202.0
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD- 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded- 759 (1091)
..+..++|++.+.||+|+||+||+|++. |+.||||+++... .......+|+.+|..++|||||++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3466789999999999999999999876 8999999996532 33445667888999999999999999998754
Q ss_pred ---eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeecccCCCceEecCCCcEE
Q 001370 760 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL----------GIVHRDLKPDNLLIAHDGHIK 826 (1091)
Q Consensus 760 ---~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~----------GIIHRDLKPeNILLD~nG~VK 826 (1091)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+|
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 37999999999999999976 4599999999999999999999999 999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-----CCCccceeechhh
Q 001370 827 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGI 901 (1091)
Q Consensus 827 LsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-----~Ys~ksDIWSLGV 901 (1091)
|+|||+++...... ........+||+.|+|||++.+. .++.++|||||||
T Consensus 172 L~DFg~a~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 172 IADFGLALKFEAGK-------------------------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp ECCCTTCEEECTTS-------------------------CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred EccCCccccccccc-------------------------CccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 99999997532100 01122346799999999999873 4567899999999
Q ss_pred hHHHHHhCCCCCCCCC----------------hHHHHHHHhhcCCCCCCCCC-----CCCHHHHHHHhhhccCCCCCCCC
Q 001370 902 ILFEFITGIPPFTAES----------------PEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 902 ILYEMLTGkpPF~~~s----------------~~ei~~kIl~~~l~fP~ip~-----~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
++|||++|.+||.+.. ...+...+..... .|.++. ..+.++.+||.+||+.||.+||+
T Consensus 227 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (322)
T 3soc_A 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK-RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305 (322)
T ss_dssp HHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC-CCCccccccccchHHHHHHHHHHHccCChhhCcC
Confidence 9999999999997642 2233333333322 222222 22456999999999999999999
Q ss_pred cccHHH
Q 001370 961 ANGAAE 966 (1091)
Q Consensus 961 a~gA~E 966 (1091)
+.++.+
T Consensus 306 ~~ell~ 311 (322)
T 3soc_A 306 AGCVGE 311 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 544433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=365.18 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=207.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEe-eeeccCCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~-gsfqded~LY 762 (1091)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.++..+.|++++..+ .++......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 35789999999999999999999999999999999875432 23578999999999987755544 4456677889
Q ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe---cCCCcEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~ 838 (1091)
+||||+ +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 8999999974 4579999999999999999999999999999999999999 5889999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s- 917 (1091)
.... ............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccc--------------------cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 1000 0001112345689999999999999999999999999999999999999998743
Q ss_pred --hHHHHHHHhhcCCCCC--CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 918 --PEIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 918 --~~ei~~kIl~~~l~fP--~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
....+..+.......| ..+..+++++.+||.+||+.||.+||++.++.+.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred hhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence 2334444443322222 123578899999999999999999999665555543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=403.05 Aligned_cols=259 Identities=21% Similarity=0.354 Sum_probs=222.3
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..+.+..++|++.+.||+|+||+||+|+++.++..||||+++... ...+.+.+|+.+|.+++|||||++++++...
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 345567789999999999999999999999999999999997643 2356799999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
..+|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999999999864 35899999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
... .........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+
T Consensus 369 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 369 TGD--------------------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp TTC--------------------------CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCC--------------------------ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 100 0011123457889999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
.+..++...+... ... ..+..+++++.+||.+||+.||.+||++.++.+.++
T Consensus 423 ~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 423 IDLSQVYELLEKD-YRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp CCGGGHHHHHHTT-CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHcC-CCC-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 8888777766543 222 235789999999999999999999999665555554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=376.66 Aligned_cols=268 Identities=25% Similarity=0.377 Sum_probs=215.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec--
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-- 756 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq-- 756 (1091)
+..++|++++.||+|+||.||+|++ ..+++.||||++.+. .....+.+.+|+.++..++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 4567899999999999999999994 668899999999753 3445677999999999999999999999886
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
....+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 456699999999999999999874 5699999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
..... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 177 ~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 177 LPLDK------------------------DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CCTTC------------------------SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCC------------------------ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 31100 001122345689999999999999999999999999999999999999975
Q ss_pred CChH---------------HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 916 ESPE---------------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 916 ~s~~---------------ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
.... .+...+ ...... ..+..+++++.+||.+||..||.+||++.++.+.++..|.....|.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 233 PSAEFLRMMGCERDVPALSRLLELL-EEGQRL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHHHHHHCC----CCHHHHHHHHH-HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred ccchhhhhcccccccccHHHHHHHh-hcccCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 4332 222222 222222 2357899999999999999999999997767666777776554443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=374.41 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=212.4
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TG----k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
.+..++|++.+.||+|+||+||+|.++.++ ..||+|+++... .......+.+|+.++..++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 456789999999999999999999987654 359999997532 34456678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
.+.+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999765 57999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 198 ~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 198 EDDPE------------------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp -------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccc------------------------cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 21000 0011123457889999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
.+..++...+..+. ..+ .+..++.++.+||.+||..||.+||++.++.+
T Consensus 254 ~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 254 LSNHEVMKAINDGF-RLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp CCHHHHHHHHHTTC-CCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHCCC-cCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 98888888776653 222 34688999999999999999999999544433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=370.66 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=206.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~---TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.+..++|++.+.||+|+||+||+|+... ++..||+|+++... ......+.+.+|+.++.+++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3566789999999999999999998765 45689999987543 2345567899999999999999999999999876
Q ss_pred Ce-----eEEEEeecCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEE
Q 001370 759 DN-----LYLVMEYLNGGDLYSLLRK------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 827 (1091)
Q Consensus 759 d~-----LYLVMEYm~GGSL~dlL~k------~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKL 827 (1091)
.. .|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 53 5999999999999999943 346999999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHH
Q 001370 828 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 907 (1091)
Q Consensus 828 sDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEML 907 (1091)
+|||+++...... .........||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 189 ~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 189 ADFGLSKKIYSGD-------------------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp CSCSCC-----------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred eecCcceeccccc-------------------------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 9999987531100 001122346788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 908 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 908 T-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
+ |.+||.+.+...+...+..+.. +..+..+++++.+||.+||..||.+||++.
T Consensus 244 ~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 297 (313)
T 3brb_A 244 TRGMTPYPGVQNHEMYDYLLHGHR--LKQPEDCLDELYEIMYSCWRTDPLDRPTFS 297 (313)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTCC--CCCBTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred hcCCCCCccCCHHHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhhCcCHH
Confidence 9 9999999988888888776542 223578999999999999999999999944
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=369.68 Aligned_cols=245 Identities=29% Similarity=0.449 Sum_probs=200.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++.+.||+|+||+||+|++. ++.||+|++.. ....+.+.+|+.+|.+++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999875 78999999864 2345778999999999999999999999874 489
Q ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCeecccCCCceEecCCCc-EEEEecCCccc
Q 001370 763 LVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHS---LGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKI 835 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g---~LsE~~ar~yaaQIa~ALeYLHs---~GIIHRDLKPeNILLD~nG~-VKLsDFGLAk~ 835 (1091)
+||||++||+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.+|. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998654 47889999999999999999999 89999999999999999886 79999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 156 IQ------------------------------THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp ---------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred cc------------------------------cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 21 011234699999999999999999999999999999999999999986
Q ss_pred CCh--HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 916 ESP--EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 916 ~s~--~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
... ..+...+..+. .+..+..++..+.+||.+||..||.+||++.++.+.+
T Consensus 206 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 206 IGGPAFRIMWAVHNGT--RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp TCSSHHHHHHHHHTTC--CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hCccHHHHHHHHhcCC--CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 432 23333333332 2334578999999999999999999999955444443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.15 Aligned_cols=272 Identities=22% Similarity=0.308 Sum_probs=210.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEe-eeeccCCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~-gsfqded~LY 762 (1091)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.++..+.|++++..+ .++...+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 34789999999999999999999999999999998765332 23478899999999987766555 4456777899
Q ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe---cCCCcEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~ 838 (1091)
+||||+ +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 9999999975 4579999999999999999999999999999999999999 7899999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.... ............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccC--------------------ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 1000 00001223457899999999999999999999999999999999999999987432
Q ss_pred ---HHHHHHHhhcCCCCC--CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH-------cCCCCCCCCcchh
Q 001370 919 ---EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK-------AHPFFKGVNWDSL 981 (1091)
Q Consensus 919 ---~ei~~kIl~~~l~fP--~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL-------~HPFFkgIdWd~L 981 (1091)
...+..+.......| .....+++++.+||.+||..||.+||++.++.+.+ ..++...++|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 233333333222211 12256789999999999999999999965444433 2456666777764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=366.15 Aligned_cols=255 Identities=20% Similarity=0.323 Sum_probs=200.6
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..+..++|++.+.||+|+||+||+|++. ..||+|+++... ......+.+.+|+.+|..++||||+++++++ ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 3567789999999999999999999864 359999997543 3455678899999999999999999999954 5667
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
+|+||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 89999999999999999644 56999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
..........||+.|+|||++. +..++.++|||||||++|+|++|..||...
T Consensus 174 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 174 -------------------------SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -----------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred -------------------------cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 0011223457999999999997 567889999999999999999999999886
Q ss_pred ChHHHHHHHh-hcCC--CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHH
Q 001370 917 SPEIIFDNIL-NRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 965 (1091)
Q Consensus 917 s~~ei~~kIl-~~~l--~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~ 965 (1091)
+..+....++ .... .++.....+++++.+||.+||..||.+||++.++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 280 (289)
T 3og7_A 229 NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280 (289)
T ss_dssp CCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred chHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 6554444443 3322 22333467899999999999999999999944333
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=379.74 Aligned_cols=270 Identities=19% Similarity=0.193 Sum_probs=207.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC---CCcEEEEEEeecccccchh--------HHHHHHHHHHHHHhcCCCceEEE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKN--------DIERILAERNILITVRNPFVVRF 751 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~---TGk~VAIKiLkK~~i~~~~--------eie~~l~EieILskL~HPNIVkL 751 (1091)
...++|++.+.||+|+||+||+|++.. ++..||||++.+....... ....+.+|+.++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445789999999999999999999987 7889999998764321111 12346678889999999999999
Q ss_pred eeeecc----CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC--cE
Q 001370 752 FYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HI 825 (1091)
Q Consensus 752 ~gsfqd----ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG--~V 825 (1091)
++++.. ...+|+||||+ ||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999988 67899999999 999999998888899999999999999999999999999999999999999887 99
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHH
Q 001370 826 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 905 (1091)
Q Consensus 826 KLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYE 905 (1091)
||+|||+++........ ...........+||+.|+|||++.+..|+.++|||||||++||
T Consensus 193 kL~Dfg~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 252 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNH--------------------KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252 (345)
T ss_dssp EECCCTTCEESSGGGCC--------------------CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred EEEeCCCceeccccccc--------------------ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 99999999853211100 0001122245689999999999999999999999999999999
Q ss_pred HHhCCCCCCCC--ChHHHHHHHhhcCCCCCC------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 906 FITGIPPFTAE--SPEIIFDNILNRKIPWPC------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 906 MLTGkpPF~~~--s~~ei~~kIl~~~l~fP~------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
|++|..||.+. +..............+|. ....++.++.+||.+||..||.+||++.++.+.++...+
T Consensus 253 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 253 WLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 99999999653 222222211111111111 012788999999999999999999997766666655443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=368.62 Aligned_cols=262 Identities=26% Similarity=0.362 Sum_probs=189.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeee-----
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSF----- 755 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsf----- 755 (1091)
.+...+|++.+.||+|+||.||+|++..+|+.||||++.+. .......+.+|+.++.++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 45556899999999999999999999999999999998653 2345677899999999996 99999999998
Q ss_pred ---ccCCeeEEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEecCCCcEEE
Q 001370 756 ---TCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKL 827 (1091)
Q Consensus 756 ---qded~LYLVMEYm~GGSL~dlL~k---~g~LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD~nG~VKL 827 (1091)
.....+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.| |+||||||+|||++.+|.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 34456899999996 699998865 456999999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh---cCCCCCccceeechhhhHH
Q 001370 828 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILF 904 (1091)
Q Consensus 828 sDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL---~g~~Ys~ksDIWSLGVILY 904 (1091)
+|||+++......... ...............+||+.|+|||++ .+..++.++|||||||++|
T Consensus 180 ~Dfg~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~ 244 (337)
T 3ll6_A 180 CDFGSATTISHYPDYS---------------WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244 (337)
T ss_dssp CCCTTCBCCSSCC----------------------------------------------CCTTSCSSHHHHHHHHHHHHH
T ss_pred ecCccceeccccCccc---------------ccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHH
Confidence 9999998532110000 000000011122356799999999999 5667899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 905 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 905 EMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+|++|..||.......+. .....++. +...+..+.+||.+||+.||.+||+ +.++++|
T Consensus 245 el~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~ 302 (337)
T 3ll6_A 245 LLCFRQHPFEDGAKLRIV----NGKYSIPP-HDTQYTVFHSLIRAMLQVNPEERLS---IAEVVHQ 302 (337)
T ss_dssp HHHHSSCCC----------------CCCCT-TCCSSGGGHHHHHHHSCSSGGGSCC---HHHHHHH
T ss_pred HHHhCCCCCcchhHHHhh----cCcccCCc-ccccchHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 999999999876544333 33333332 3567788999999999999999999 6666655
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=379.17 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=209.1
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
.....++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.++..++||||+++++++...+.
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3456789999999999999999999964 68999999886532 3456788999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g----~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999999986543 5899999999999999999999999999999999999999999999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
... ..........||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus 190 ~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 190 TEL-------------------------DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp SSS-------------------------SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccc-------------------------cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 100 0011223457999999999999999999999999999999999999999865
Q ss_pred ChHHHH-------HHHhhcCCC---CC----CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 917 SPEIIF-------DNILNRKIP---WP----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 917 s~~ei~-------~kIl~~~l~---fP----~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.+.+.. .......+. -+ .++...+..+.+||.+||..||.+||+ +.++++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 309 (321)
T 2qkw_B 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS---MGDVLWK 309 (321)
T ss_dssp SSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 432211 111111110 01 112334567899999999999999999 5565543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=389.57 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=206.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--ee
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NL 761 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded--~L 761 (1091)
..+.|++.+.||+|+||+||+|+++.+|+.||||++++... ....+.+.+|+.+|..++||||+++++++.... .+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34689999999999999999999999999999999986443 234567789999999999999999999988765 78
Q ss_pred EEEEeecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe----cCCCcEEEEecCCcc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLSK 834 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~---LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL----D~nG~VKLsDFGLAk 834 (1091)
|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999976543 9999999999999999999999999999999999999 788889999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--------CCCCccceeechhhhHHHH
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--------TEHGYAADWWSVGIILFEF 906 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--------~~Ys~ksDIWSLGVILYEM 906 (1091)
.... .......+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 165 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 165 ELED----------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp ECCC----------------------------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred EccC----------------------------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 5210 112234679999999999875 5678899999999999999
Q ss_pred HhCCCCCCC----CChHHHHHHHhhcCCC-------------------CC---CCCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 907 ITGIPPFTA----ESPEIIFDNILNRKIP-------------------WP---CVPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 907 LTGkpPF~~----~s~~ei~~kIl~~~l~-------------------fP---~ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
++|..||.. ....++...++.+... +| .+...++..+.+||.+||..||++||+
T Consensus 217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s 296 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (396)
T ss_dssp HHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc
Confidence 999999964 2334555555554321 11 011234567889999999999999999
Q ss_pred cc
Q 001370 961 AN 962 (1091)
Q Consensus 961 a~ 962 (1091)
+.
T Consensus 297 ~~ 298 (396)
T 4eut_A 297 FD 298 (396)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=388.51 Aligned_cols=261 Identities=24% Similarity=0.382 Sum_probs=216.1
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..+.+..++|++.+.||+|+||+||+|.++. +..||||+++.... ..+.+.+|+.+|.+++||||+++++++..
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 3455677899999999999999999999875 46799999976432 24678999999999999999999999876
Q ss_pred CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 6799999999999999999753 46999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
... .........||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+
T Consensus 331 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 331 EDN--------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp --------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCC--------------------------ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 110 0011123457889999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
.+..++...+..+. ..+ .+..+++++.+||.+||..||.+||++.++.+.|. .+|.
T Consensus 385 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~-~~~~ 440 (452)
T 1fmk_A 385 MVNREVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE-DYFT 440 (452)
T ss_dssp CCHHHHHHHHHTTC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH-TTTS
T ss_pred CCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH-HHhc
Confidence 99888888776543 222 35789999999999999999999999655555443 3443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=376.44 Aligned_cols=243 Identities=15% Similarity=0.212 Sum_probs=199.5
Q ss_pred cccccCCCeEEEEeeccCCceEEEEE-----EECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEE
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLA-----RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRF 751 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLa-----r~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~---HPNIVkL 751 (1091)
......++|++.+.||+|+||+||+| ....+++.||||++++. ....+..|+.++..+. |+||+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 34466788999999999999999999 46778999999998753 2345778888888887 9999999
Q ss_pred eeeeccCCeeEEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-----
Q 001370 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH----- 821 (1091)
Q Consensus 752 ~gsfqded~LYLVMEYm~GGSL~dlL~k-----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~----- 821 (1091)
++++...+..|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred ------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001370 822 ------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 895 (1091)
Q Consensus 822 ------nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 895 (1091)
++.+||+|||+|+..... .........+||+.|||||++.+..|+.++|
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 267 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLF-------------------------PKGTIFTAKCETSGFQCVEMLSNKPWNYQID 267 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGS-------------------------CTTEEECCSSCTTSCCCHHHHTTCCBSTHHH
T ss_pred cccccccCCEEEeeCchhhhhhcc-------------------------CCCceeeeecCCCCCCChHHhcCCCCCcccc
Confidence 899999999999742100 0112234568999999999999999999999
Q ss_pred eechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 896 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 896 IWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
||||||++|||++|+.||....... ......++. ...++...+++.+||..+|.+|++
T Consensus 268 iwslG~il~elltg~~pf~~~~~~~-----~~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 268 YFGVAATVYCMLFGTYMKVKNEGGE-----CKPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp HHHHHHHHHHHHHSSCCCEEEETTE-----EEECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred HHHHHHHHHHHHhCCCccccCCCCc-----eeechhccc--cCcHHHHHHHHHHHcCCCCCCcch
Confidence 9999999999999999996543211 011111221 234678999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=374.77 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=205.4
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.......++|++.+.||+|+||+||+|++. +|+.||||++...... .....+.+|+.++..++||||+++++++.+.
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 444567789999999999999999999854 6899999999764321 2223688999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCeecccCCCceEecCCCcEEEEecC
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g----~LsE~~ar~yaaQIa~ALeYLHs~---GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
...|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999998653 499999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
+++.... .........+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 180 ~~~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (326)
T 3uim_A 180 LAKLMDY--------------------------KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233 (326)
T ss_dssp SCEECCS--------------------------SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCC
T ss_pred cccccCc--------------------------ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCC
Confidence 9985310 01112234569999999999998899999999999999999999999
Q ss_pred CCCCC-----Ch---HHHHHHHhhcC-CC---C----CCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 912 PFTAE-----SP---EIIFDNILNRK-IP---W----PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 912 PF~~~-----s~---~ei~~kIl~~~-l~---f----P~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
||... .. ........... .. . +..+...+.++.+||.+||+.||.+||+ +.++++|
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~ell~~ 305 (326)
T 3uim_A 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK---MSEVVRM 305 (326)
T ss_dssp SBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC---HHHHHHH
T ss_pred cccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCC---HHHHHHH
Confidence 99521 11 11111111110 00 0 0111223467999999999999999999 4455544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=394.59 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=203.9
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~L 761 (1091)
....+|++.+.||+|+||+|+.. ...+|+.||||++.+... ..+.+|+.+|..+ +|||||++++++.+...+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 44457999999999999997643 345799999999865332 2356799999999 799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---C--CcEEEEecCCccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---D--GHIKLTDFGLSKI 835 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---n--G~VKLsDFGLAk~ 835 (1091)
|+||||+. |+|.+++.... .+.+..+..++.||+.||.|||++|||||||||+||||+. + ..+||+|||+|+.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999996 59999997654 4566677889999999999999999999999999999953 2 3588999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc---CCCCCccceeechhhhHHHHHh-CCC
Q 001370 836 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFIT-GIP 911 (1091)
Q Consensus 836 ~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~Ys~ksDIWSLGVILYEMLT-Gkp 911 (1091)
..... .........+||+.|+|||++. +..++.++|||||||++|||++ |.+
T Consensus 173 ~~~~~------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~ 228 (432)
T 3p23_A 173 LAVGR------------------------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228 (432)
T ss_dssp C------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCB
T ss_pred ccCCC------------------------cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 31100 0011224568999999999998 4567889999999999999999 999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcc
Q 001370 912 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 912 PF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd 979 (1091)
||...........+..........+...+..+.+||.+||+.||.+||+ +.++++||||.+++|.
T Consensus 229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS---AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp TTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC---HHHHHTSTTTCCHHHH
T ss_pred CcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCC---HHHHHhCccccChHHH
Confidence 9976655544433322222222222344667899999999999999999 8899999999998874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=368.69 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=206.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec----c
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT----C 757 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq----d 757 (1091)
.+..++|++++.||+|+||.||+|+++.+|+.||||++... .......+.+|+.++..++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 35567899999999999999999999999999999998653 3456678899999999999999999999987 3
Q ss_pred CCeeEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCc
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
...+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 4578999999999999999976 367999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC---CCccceeechhhhHHHHHhCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~---Ys~ksDIWSLGVILYEMLTGk 910 (1091)
......... ..............||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 182 ~~~~~~~~~------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 243 (317)
T 2buj_A 182 NQACIHVEG------------------SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243 (317)
T ss_dssp EESCEEEES------------------HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSS
T ss_pred hhccccccc------------------ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCC
Confidence 742100000 00000001112356899999999998654 688999999999999999999
Q ss_pred CCCCCCC--hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 911 PPFTAES--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 911 pPF~~~s--~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.||.... ....... ......+|. +..++.++.+||.+||..||.+||+ +.++++|
T Consensus 244 ~p~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 300 (317)
T 2buj_A 244 GPYDMVFQKGDSVALA-VQNQLSIPQ-SPRHSSALWQLLNSMMTVDPHQRPH---IPLLLSQ 300 (317)
T ss_dssp CTTHHHHHTTSCHHHH-HHCC--CCC-CTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CChhhhhcccchhhHH-hhccCCCCc-cccCCHHHHHHHHHHhhcChhhCCC---HHHHHHH
Confidence 9995421 1111222 222333332 3578999999999999999999999 5566543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=386.26 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=196.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~LYLV 764 (1091)
+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+|.++ +|||||++++++.+...+|+|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 445667899999999998764 457999999998652 235678899999876 899999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC-------------Cc
Q 001370 765 MEYLNGGDLYSLLRKVGCLE-------EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-------------GH 824 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~Ls-------E~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n-------------G~ 824 (1091)
|||+. |+|.+++....... +..+..++.||+.||.|||++|||||||||+||||+.+ ++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 59999998755332 22356799999999999999999999999999999754 48
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceee
Q 001370 825 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWW 897 (1091)
Q Consensus 825 VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Ys~ksDIW 897 (1091)
+||+|||+++....... .........+||+.|+|||++.+ ..++.++|||
T Consensus 167 ~kL~DFG~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 223 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQS-----------------------SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223 (434)
T ss_dssp EEECCCTTCEECCC-------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHH
T ss_pred EEEcccccceecCCCCc-----------------------cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhH
Confidence 99999999985321000 00111234689999999999976 6789999999
Q ss_pred chhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCC----CCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 898 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVP----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 898 SLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip----~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
||||++|||++ |.+||....... ..++.+...++..+ ..+++++.+||.+||+.||.+||+ +.++++|||
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~hp~ 298 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT---AMKVLRHPL 298 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC---HHHHHTSGG
T ss_pred hHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC---HHHHHhCCc
Confidence 99999999999 999998765443 34444444433321 234688999999999999999999 889999999
Q ss_pred CCCC
Q 001370 973 FKGV 976 (1091)
Q Consensus 973 FkgI 976 (1091)
|...
T Consensus 299 f~~~ 302 (434)
T 2rio_A 299 FWPK 302 (434)
T ss_dssp GSCH
T ss_pred cCCc
Confidence 9653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=367.51 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=194.8
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH--HhcCCCceEEEeeee---
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL--ITVRNPFVVRFFYSF--- 755 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieIL--skL~HPNIVkL~gsf--- 755 (1091)
..+..++|++++.||+|+||+||+|+. +|+.||||+++... ...+..|.+++ ..++||||+++++.+
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 346789999999999999999999976 58999999987532 23444555554 458999999999743
Q ss_pred --ccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecccCCCceEecCCCc
Q 001370 756 --TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHDGH 824 (1091)
Q Consensus 756 --qded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~---------GIIHRDLKPeNILLD~nG~ 824 (1091)
.....+|+||||+++|+|.+++... .+++..+..++.||+.||.|||+. ||+||||||+||||+.+|.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 3344689999999999999999664 458889999999999999999999 9999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-------CCCCccceee
Q 001370 825 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWW 897 (1091)
Q Consensus 825 VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~Ys~ksDIW 897 (1091)
+||+|||+++......... ...........+||+.|+|||++.+ ..++.++|||
T Consensus 159 ~kL~DFG~a~~~~~~~~~~-------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 219 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVR-------------------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219 (336)
T ss_dssp EEECCCTTCEECSSSSCC----------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred EEEeeccceeecccccccC-------------------ccccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence 9999999998532110000 0001122345689999999999987 3566789999
Q ss_pred chhhhHHHHHhCCCCCCCCCh-----------------HHHHHHHhhcCCCCCCCCCC------CCHHHHHHHhhhccCC
Q 001370 898 SVGIILFEFITGIPPFTAESP-----------------EIIFDNILNRKIPWPCVPSD------MSFEAQDLINRFLIHD 954 (1091)
Q Consensus 898 SLGVILYEMLTGkpPF~~~s~-----------------~ei~~kIl~~~l~fP~ip~~------lS~eakDLI~rcL~kD 954 (1091)
||||++|||++|..||..... ......+.......|.++.. .++++.+||.+||..|
T Consensus 220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence 999999999999766543211 11122222222222333333 3458999999999999
Q ss_pred CCCCCCcccHHHH---HcCCCCCC
Q 001370 955 PNQRLGANGAAEV---KAHPFFKG 975 (1091)
Q Consensus 955 PeKRpSa~gA~EI---L~HPFFkg 975 (1091)
|.+||++.++.+. +.++|-++
T Consensus 300 P~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 300 AEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp GGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhhCcchHHHHHHHHHHHHHHHhc
Confidence 9999995443332 33566543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=375.21 Aligned_cols=254 Identities=18% Similarity=0.215 Sum_probs=202.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCC--------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEE------
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTT--------GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR------ 750 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~T--------Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVk------ 750 (1091)
.++|++.+.||+|+||.||+|+++.+ ++.||||++.+. ..+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47899999999999999999999874 889999998753 35788999999999999988
Q ss_pred ---------Eeeeecc-CCeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceE
Q 001370 751 ---------FFYSFTC-RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 818 (1091)
Q Consensus 751 ---------L~gsfqd-ed~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNIL 818 (1091)
+++++.. ...+|+||||+ +|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 4555554 67899999999 99999999876 78999999999999999999999999999999999999
Q ss_pred ecCCC--cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcccee
Q 001370 819 IAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896 (1091)
Q Consensus 819 LD~nG--~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDI 896 (1091)
++.++ .+||+|||+++........ ............||+.|+|||++.+..|+.++||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 251 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKH--------------------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCC--------------------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCcc--------------------ccccccccccccCCccccCHHHHccCCCCchhhH
Confidence 99998 9999999999753211100 0000112234589999999999999999999999
Q ss_pred echhhhHHHHHhCCCCCCCCC--hHHHHHHHh---hcCCCCCC---CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 897 WSVGIILFEFITGIPPFTAES--PEIIFDNIL---NRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 897 WSLGVILYEMLTGkpPF~~~s--~~ei~~kIl---~~~l~fP~---ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
|||||+||||++|..||.... ...+...+. .....++. ....++.++.+||.+||..||.+||++.++.+.
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 999999999999999998753 333333222 22222211 012568999999999999999999995544433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=364.60 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=197.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCceEEEeeeeccC-
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFFYSFTCR- 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL--~HPNIVkL~gsfqde- 758 (1091)
....++|++.+.||+|+||.||+|++. |+.||||++... .......|.+++..+ +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 344578999999999999999999875 899999998642 234455666666554 899999999999887
Q ss_pred ---CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecccCCCceEecCCCcEEE
Q 001370 759 ---DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKL 827 (1091)
Q Consensus 759 ---d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~--------GIIHRDLKPeNILLD~nG~VKL 827 (1091)
..+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999965 4699999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCcc------ceeechhh
Q 001370 828 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA------ADWWSVGI 901 (1091)
Q Consensus 828 sDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~k------sDIWSLGV 901 (1091)
+|||+++....... .........+||+.|+|||++.+..++.. +|||||||
T Consensus 184 ~Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 184 ADLGLAVKFISDTN-----------------------EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240 (337)
T ss_dssp CCCTTCEECC--------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHH
T ss_pred EeCCCceeeccccc-----------------------cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHH
Confidence 99999975321000 00111235689999999999988777665 99999999
Q ss_pred hHHHHHhC----------CCCCCCCC----hHHHHHHHhhcCCCCCCCCC-----CCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 902 ILFEFITG----------IPPFTAES----PEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 902 ILYEMLTG----------kpPF~~~s----~~ei~~kIl~~~l~fP~ip~-----~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
++|||++| ..||.... .......+.......+..+. .+++++.+||.+||+.||.+||+
T Consensus 241 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-- 318 (337)
T 3mdy_A 241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT-- 318 (337)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC--
T ss_pred HHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC--
Confidence 99999999 77776532 12222222222111122222 45677999999999999999999
Q ss_pred cHHHHHc
Q 001370 963 GAAEVKA 969 (1091)
Q Consensus 963 gA~EIL~ 969 (1091)
+.++++
T Consensus 319 -~~ell~ 324 (337)
T 3mdy_A 319 -ALRVKK 324 (337)
T ss_dssp -HHHHHH
T ss_pred -HHHHHH
Confidence 555554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=404.14 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=217.5
Q ss_pred ccCCCeEEEE-eeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIK-PISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr-~LGkGgFGtVyLar~k~--TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
...+++.+.+ .||+|+||+||+|.++. ++..||||++++.. .....+.+.+|+.+|.+++|||||++++++.. +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 4556777777 89999999999998763 45679999997642 33456789999999999999999999999976 5
Q ss_pred eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 699999999999999999754 4599999999999999999999999999999999999999999999999999985311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s 917 (1091)
... .........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+
T Consensus 489 ~~~------------------------~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 489 DDS------------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp -------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCc------------------------eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 000 0011123356799999999999999999999999999999998 999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
..++...+..+.. +..+..+++++.+||.+||..||.+||++.++.+.|++.|+
T Consensus 545 ~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 545 GPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp SHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 8888888876542 22357899999999999999999999997777777766554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=381.93 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=202.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec-cCCee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDNL 761 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TG---k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq-ded~L 761 (1091)
..|++.+.||+|+||+||+|++..++ ..||+|.+++. ......+.+.+|+.++.+++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999976433 46899988752 33456788999999999999999999999854 55688
Q ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|+||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999999998654 58899999999999999999999999999999999999999999999999997531100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ 919 (1091)
. ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..
T Consensus 247 ~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 247 F-----------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ----------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred c-----------------------ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 0 00111233568899999999999999999999999999999999 78999888777
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
++...+..+... ..+..++.++.+||.+||..||.+||++.++
T Consensus 304 ~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 304 DITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp CHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 777776665432 2357889999999999999999999994433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=386.10 Aligned_cols=248 Identities=20% Similarity=0.282 Sum_probs=196.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcC-------------
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVR------------- 744 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~-----~~~eie~~l~EieILskL~------------- 744 (1091)
...++|++++.||+|+||+||+|++ +|+.||||++++.... .....+.+.+|+.+|+.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999998 6899999999875321 2334577889999998886
Q ss_pred -------------CCceEEEeeeecc-------------CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 001370 745 -------------NPFVVRFFYSFTC-------------RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 798 (1091)
Q Consensus 745 -------------HPNIVkL~gsfqd-------------ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~A 798 (1091)
||||++++++|.+ ...+||||||+++|++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 4555555555554 7789999999999987777654 678999999999999999
Q ss_pred HHHHH-HcCCeecccCCCceEecCCC--------------------cEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001370 799 LEYLH-SLGIVHRDLKPDNLLIAHDG--------------------HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857 (1091)
Q Consensus 799 LeYLH-s~GIIHRDLKPeNILLD~nG--------------------~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~ 857 (1091)
|.||| ++|||||||||+||||+.+| .+||+|||+|+...
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~-------------------- 233 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER-------------------- 233 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE--------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC--------------------
Confidence 99999 99999999999999999987 99999999998521
Q ss_pred CCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh-HHHHHhCCCCCCCCCh-HHHHHHHhhc-CCC---
Q 001370 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII-LFEFITGIPPFTAESP-EIIFDNILNR-KIP--- 931 (1091)
Q Consensus 858 ~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVI-LYEMLTGkpPF~~~s~-~ei~~kIl~~-~l~--- 931 (1091)
....+||+.|||||++.+.. +.++||||||++ .++++.|..||..... ......+... ...
T Consensus 234 ------------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 300 (336)
T 2vuw_A 234 ------------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300 (336)
T ss_dssp ------------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCC
T ss_pred ------------CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCccc
Confidence 01358999999999999776 899999998777 7889999999954321 2233333322 111
Q ss_pred CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH-cCCCCC
Q 001370 932 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK-AHPFFK 974 (1091)
Q Consensus 932 fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL-~HPFFk 974 (1091)
.+..+..+++++++||.+||++| | |.+++ +||||+
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----s---a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----S---ATDLLCQHSLFK 336 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----S---HHHHHHHCGGGC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----C---HHHHHhcCCCcC
Confidence 11112357889999999999977 5 89999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=367.71 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=213.2
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..+.+..++|++.+.||+|+||.||+|++.. .||+|+++.... .....+.+.+|+.++..++||||+++++++.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4556778999999999999999999999864 499999875432 223345677899999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999999998755 699999999999999999999999999999999999998 7899999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---------CCCCccceeechhhhHHHHHh
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---------TEHGYAADWWSVGIILFEFIT 908 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---------~~Ys~ksDIWSLGVILYEMLT 908 (1091)
.... ...........||+.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 181 ~~~~----------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 238 (319)
T 2y4i_B 181 VLQA----------------------GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238 (319)
T ss_dssp -----------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH
T ss_pred cccc----------------------cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 0000 001122334569999999999975 457899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 909 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 909 GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
|..||...+...+...+..+..+.. .+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 239 g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 239 REWPFKTQPAEAIIWQMGTGMKPNL-SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp SSCSSSSCCHHHHHHHHHTTCCCCC-CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhccCCCCCC-CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 9999999998888877766543322 2346888999999999999999999955554444
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=402.02 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=211.8
Q ss_pred CeEEE-EeeccCCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 687 DFEII-KPISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 687 dFeil-r~LGkGgFGtVyLar~--k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
.+.+. +.||+|+||+||+|.+ +.+++.||||+++... ......+.+.+|+.+|.+++|||||++++++.. +.+|+
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999955 4567899999997643 334456789999999999999999999999864 56899
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||||+++|+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-- 524 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-- 524 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc--
Confidence 999999999999999888899999999999999999999999999999999999999999999999999985321100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~ 922 (1091)
.........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..++.
T Consensus 525 ----------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~ 582 (635)
T 4fl3_A 525 ----------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582 (635)
T ss_dssp --------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred ----------------------ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 0011223457899999999999999999999999999999998 99999999998888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
..+..+.. +..+..+++++.+||.+||..||.+||++.++.+.|+
T Consensus 583 ~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 583 AMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 88776542 2345789999999999999999999999665555554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=392.10 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=219.9
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..+.+..++|++.+.||+|+||+||+|.+.. +..||||+++.... ..+.+.+|+.+|.+++|||||++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3455777899999999999999999999875 46799999976432 24578999999999999999999999876
Q ss_pred CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+.+||||||+.+|+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 6799999999999999999753 46999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
.... ........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+
T Consensus 414 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 414 EDNE--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CCHH--------------------------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CCCc--------------------------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1100 011123457889999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
....++...+..+. .++ .+..++.++.+||.+||..||.+||++.++.+.|+ .+|.
T Consensus 468 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~-~~~~ 523 (535)
T 2h8h_A 468 MVNREVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE-DYFT 523 (535)
T ss_dssp CCHHHHHHHHHTTC-CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH-TSSC
T ss_pred CCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH-HHhh
Confidence 99888888776542 222 34789999999999999999999999665555553 3443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.90 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=204.5
Q ss_pred CeEEEEeeccCCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Ce
Q 001370 687 DFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DN 760 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde--d~ 760 (1091)
.|++++.||+|+||+||++.+ ..+|+.||||++++. ........+.+|+.+|..++||||+++++++.+. ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 359999999999999988865 347889999999764 2345567899999999999999999999999874 67
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+|+||||+++|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 89999999999999999764 49999999999999999999999999999999999999999999999999998531100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 189 ------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 244 (318)
T 3lxp_A 189 ------------------------EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244 (318)
T ss_dssp ------------------------SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred ------------------------cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence 00112234568999999999999999999999999999999999999997643211
Q ss_pred --------------HHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 921 --------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 921 --------------i~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
.....+..... +..+..++.++.+||.+||..||.+||++.++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 304 (318)
T 3lxp_A 245 LELIGIAQGQMTVLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304 (318)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhcccccchhHHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11122222222 22457899999999999999999999995544443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=359.63 Aligned_cols=234 Identities=31% Similarity=0.548 Sum_probs=193.6
Q ss_pred cccCCCeEEE-EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCceEEEeeeecc--
Q 001370 682 RTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTC-- 757 (1091)
Q Consensus 682 ~~~iddFeil-r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieIL-skL~HPNIVkL~gsfqd-- 757 (1091)
....++|.++ +.||+|+||.||+|+++.+|+.||||+++.. ..+.+|+.++ ...+||||++++++|..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3456789998 7899999999999999999999999998642 3466788887 56689999999999887
Q ss_pred --CCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CCcEEEEec
Q 001370 758 --RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDF 830 (1091)
Q Consensus 758 --ed~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDF 830 (1091)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 678999999999999999998764 6999999999999999999999999999999999999998 789999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGk 910 (1091)
|++... .+..|+.++|||||||++|||++|.
T Consensus 165 g~a~~~-------------------------------------------------~~~~~~~~~DiwslG~il~el~tg~ 195 (299)
T 3m2w_A 165 GFAKET-------------------------------------------------TGEKYDKSCDMWSLGVIMYILLCGY 195 (299)
T ss_dssp TTCEEC-------------------------------------------------TTCGGGGHHHHHHHHHHHHHHHHSS
T ss_pred cccccc-------------------------------------------------ccccCCchhhHHHHHHHHHHHHHCC
Confidence 998741 0134778999999999999999999
Q ss_pred CCCCCCChHHHHHHHhh----cCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 911 PPFTAESPEIIFDNILN----RKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 911 pPF~~~s~~ei~~kIl~----~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+||.+.+.......+.. ....+|. ....+++++.+||.+||..||.+||+ +.++++||||++
T Consensus 196 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~e~l~hp~~~~ 262 (299)
T 3m2w_A 196 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 262 (299)
T ss_dssp CSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHT
T ss_pred CCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCC---HHHHhcChhhcc
Confidence 99987765544322221 2222221 01468999999999999999999999 889999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.66 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=199.4
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 768 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i-~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm 768 (1091)
..+.||+|+||+||+|.. +++.||+|++..... ......+.+.+|+.++..++||||+++++++.+.+.+|+||||+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 347899999999999985 588999999875432 23345678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 769 NGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 769 ~GGSL~dlL~k~---g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 186 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF------ 186 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC------
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc------
Confidence 999999999743 45999999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH----H
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----I 921 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e----i 921 (1091)
.........+||+.|+|||++.+ .++.++|||||||++|+|++|.+||....... +
T Consensus 187 -------------------~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 187 -------------------AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp -------------------SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred -------------------cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 00111234679999999999875 48899999999999999999999998755322 2
Q ss_pred HHHHhhcCC--------CCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 922 FDNILNRKI--------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 922 ~~kIl~~~l--------~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
...+..... .++..+...+..+.+||.+||..||.+||++.++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222211111 112222345677999999999999999999443333
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=389.09 Aligned_cols=275 Identities=22% Similarity=0.306 Sum_probs=221.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H-PNIVkL~gsfqded~LY 762 (1091)
..++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+.++..+.| ++|..+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 45789999999999999999999999999999998875432 2347889999999986 56667777778888899
Q ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEe---cCCCcEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILL---D~nG~VKLsDFGLAk~~~~ 838 (1091)
|||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999985 4579999999999999999999999999999999999999 6889999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s- 917 (1091)
.... ...........+||+.|+|||++.+..|+.++|||||||+||||++|..||.+..
T Consensus 159 ~~~~--------------------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 159 TSTH--------------------QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp TTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred Cccc--------------------cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 1000 0000112345789999999999999999999999999999999999999998754
Q ss_pred --hHHHHHHHhhcCCC--CCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH-------HHcCCCCCCCCcchhhcc
Q 001370 918 --PEIIFDNILNRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE-------VKAHPFFKGVNWDSLALQ 984 (1091)
Q Consensus 918 --~~ei~~kIl~~~l~--fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E-------IL~HPFFkgIdWd~L~~~ 984 (1091)
....+..+...... .+.+...++.++.+||.+||..||.+||++..+.+ .+.++|+..++|+.+...
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 219 GTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp SSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred hhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 34444444433211 11122567899999999999999999999654433 345899999999988655
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=362.10 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=206.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 757 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~----k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd 757 (1091)
....++|++++.||+|+||.||+|+. ..+|+.||+|++... .....+.+.+|+.++..++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 35567899999999999999999984 567999999998753 34456789999999999999999999998876
Q ss_pred CC--eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 758 RD--NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 758 ed--~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
.+ .+|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 54 789999999999999999876 459999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
...... ..........||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 194 ~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 194 VLPQDK------------------------EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp ECCSSC------------------------SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred hccccc------------------------cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 531100 00011223467888999999999899999999999999999999999986
Q ss_pred CCChH------------HH---HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 915 AESPE------------II---FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 915 ~~s~~------------ei---~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
..... .. ....+......+ .+..++.++.+||.+||..||.+||++.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~el 313 (326)
T 2w1i_A 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313 (326)
T ss_dssp SHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 43111 11 111222222222 357899999999999999999999994433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=360.19 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=201.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeeccCC-
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD- 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILsk--L~HPNIVkL~gsfqded- 759 (1091)
...++|++.+.||+|+||.||+|++ +|+.||||++.+. ....+.+|.+++.. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 3457899999999999999999988 4899999998642 34567889999987 78999999999998876
Q ss_pred ---eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecccCCCceEecCCCcEEEE
Q 001370 760 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------SLGIVHRDLKPDNLLIAHDGHIKLT 828 (1091)
Q Consensus 760 ---~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLH--------s~GIIHRDLKPeNILLD~nG~VKLs 828 (1091)
.+|+||||+++|+|.+++.+ ..+++..+..++.||+.||.||| +.||+||||||+||||+.+|.+||+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 79999999999999999976 46999999999999999999999 8999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC------CCccceeechhhh
Q 001370 829 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGII 902 (1091)
Q Consensus 829 DFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~------Ys~ksDIWSLGVI 902 (1091)
|||+++....... .........+||+.|+|||++.+.. ++.++|||||||+
T Consensus 190 Dfg~~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 246 (342)
T 1b6c_B 190 DLGLAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246 (342)
T ss_dssp CCTTCEEEETTTT-----------------------EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHH
T ss_pred ECCCceecccccc-----------------------ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHH
Confidence 9999975321000 0001224567999999999998752 3468999999999
Q ss_pred HHHHHhC----------CCCCCCCC-----hHHHHHHHhhcCCCCCCCCC-----CCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 903 LFEFITG----------IPPFTAES-----PEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 903 LYEMLTG----------kpPF~~~s-----~~ei~~kIl~~~l~fP~ip~-----~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
+|||++| ..||.... ...+...+...... |.++. ..+..+.+||.+||..||.+||+
T Consensus 247 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-- 323 (342)
T 1b6c_B 247 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLT-- 323 (342)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC--
T ss_pred HHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC-CCCcccccchhHHHHHHHHHHHHhccChhhCCC--
Confidence 9999999 78997653 34444444443332 22222 23467899999999999999999
Q ss_pred cHHHHHc
Q 001370 963 GAAEVKA 969 (1091)
Q Consensus 963 gA~EIL~ 969 (1091)
+.++++
T Consensus 324 -~~~i~~ 329 (342)
T 1b6c_B 324 -ALRIKK 329 (342)
T ss_dssp -HHHHHH
T ss_pred -HHHHHH
Confidence 445544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=392.66 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=212.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~T---Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
....++|++.+.||+|+||+||+|.+..+ +..||||+++.. ......+.+.+|+.+|..++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 45567899999999999999999998754 457999988653 23445678999999999999999999999985 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+.+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 67899999999999999998654 69999999999999999999999999999999999999999999999999997521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.. .........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 543 ~~--------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 543 DS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp C------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CC--------------------------cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 00 0011223467889999999999999999999999999999997 99999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
+..++...+..+.. +..+..+++++.+||.+||..||.+||++.++
T Consensus 597 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el 642 (656)
T 2j0j_A 597 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642 (656)
T ss_dssp CHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99888888877542 22357899999999999999999999994433
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=381.21 Aligned_cols=253 Identities=17% Similarity=0.181 Sum_probs=199.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-Cce-------------
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFV------------- 748 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H-PNI------------- 748 (1091)
.....|...+.||+|+||+||+|++..+|+.||||+++..........+.+.+|+.++..+.| +++
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 345578999999999999999999999999999999985444444456788999999999876 211
Q ss_pred --EE------Eeeeecc-----CCeeEEEEeecCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 001370 749 --VR------FFYSFTC-----RDNLYLVMEYLNGGDLYSLLRK-------VGCLEEDVARIYIAELVLALEYLHSLGIV 808 (1091)
Q Consensus 749 --Vk------L~gsfqd-----ed~LYLVMEYm~GGSL~dlL~k-------~g~LsE~~ar~yaaQIa~ALeYLHs~GII 808 (1091)
+. ++..+.. ...+|++|+++ +|+|.+++.. ...+++..+..++.||+.||.|||++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 11 1111122 12367777765 6799999852 23477788888889999999999999999
Q ss_pred ecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhh---
Q 001370 809 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--- 885 (1091)
Q Consensus 809 HRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL--- 885 (1091)
||||||+||||+.+|.+||+|||+++... ......+| +.|||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~g-~~y~aPE~~~~~ 282 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG------------------------------ASAVSPIG-RGFAPPETTAER 282 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT------------------------------EEECCCCC-TTTCCHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecC------------------------------CccccCCC-CceeCchhhhcc
Confidence 99999999999999999999999987421 11345678 999999999
Q ss_pred -------cCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCC
Q 001370 886 -------LGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 886 -------~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKR 958 (1091)
.+..|+.++|||||||++|||++|+.||...+.......++... ..+++++.+||.+||..||.+|
T Consensus 283 ~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC-------KNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp TSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSC-------CCCCHHHHHHHHHHTCSSGGGS
T ss_pred ccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhc-------ccCCHHHHHHHHHHccCChhhC
Confidence 55568889999999999999999999999887666555554432 3577999999999999999999
Q ss_pred CCcccHHHHHcCCCCCCCC
Q 001370 959 LGANGAAEVKAHPFFKGVN 977 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkgId 977 (1091)
|+ +.++++||||+.+.
T Consensus 356 pt---~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 356 LL---PLQAMETPEYEQLR 371 (413)
T ss_dssp CC---HHHHTTSHHHHHHH
T ss_pred cC---HHHHHhCHHHHHHH
Confidence 99 88999999998753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=400.01 Aligned_cols=261 Identities=28% Similarity=0.415 Sum_probs=210.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----- 757 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd----- 757 (1091)
...++|++.+.||+|+||+||+|.++.+|+.||||+++.. ........+.+|+.+|..++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 3458899999999999999999999999999999998753 244567789999999999999999999998876
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc---EEEEec
Q 001370 758 -RDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDF 830 (1091)
Q Consensus 758 -ed~LYLVMEYm~GGSL~dlL~k~g---~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~---VKLsDF 830 (1091)
.+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 677899999999999999998754 5999999999999999999999999999999999999997775 999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCC
Q 001370 831 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910 (1091)
Q Consensus 831 GLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGk 910 (1091)
|++.... ........+||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus 169 G~a~~~~----------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~ 220 (676)
T 3qa8_A 169 GYAKELD----------------------------QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220 (676)
T ss_dssp CCCCBTT----------------------------SCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSC
T ss_pred ccccccc----------------------------cccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCC
Confidence 9987521 011123468999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHH--------------HHhhcCCCCCC-------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 911 PPFTAESPEIIFD--------------NILNRKIPWPC-------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 911 pPF~~~s~~ei~~--------------kIl~~~l~fP~-------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
.||.+......+. ....+...++. +...+++.+.+||.+||..||.+||+ +.++++
T Consensus 221 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT---a~elL~ 297 (676)
T 3qa8_A 221 RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT---DPQNPN 297 (676)
T ss_dssp SSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C---CTTCCC
T ss_pred CCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC---HHHHhc
Confidence 9997654322111 01112222211 22346789999999999999999999 668899
Q ss_pred CCCCCCC
Q 001370 970 HPFFKGV 976 (1091)
Q Consensus 970 HPFFkgI 976 (1091)
||||+.+
T Consensus 298 hp~F~~l 304 (676)
T 3qa8_A 298 VGCFQAL 304 (676)
T ss_dssp CTTHHHH
T ss_pred CHHHHHH
Confidence 9999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=346.85 Aligned_cols=225 Identities=14% Similarity=0.148 Sum_probs=188.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++.+.||+|+||.||+|++..+|+.||||+++............+.+|+.++..++||||+++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34478999999999999999999999999999999998765555566788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+||||++||+|.+++.+ + .....+..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999954 3 4566788899999999999999999999999999999999999987544
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
|++ .++.++|||||||++|||++|+.||.+.+.....
T Consensus 175 ------------------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~ 211 (286)
T 3uqc_A 175 ------------------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211 (286)
T ss_dssp ------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred ------------------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence 222 3788999999999999999999999987654322
Q ss_pred H---HHhhcCCCC-CCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 923 D---NILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 923 ~---kIl~~~l~f-P~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
. ++....... ......+++++.+||.+||..||.+| ++.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el 256 (286)
T 3uqc_A 212 APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTL 256 (286)
T ss_dssp EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHH
T ss_pred HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHH
Confidence 1 111222111 11235789999999999999999999 84433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=386.19 Aligned_cols=243 Identities=28% Similarity=0.396 Sum_probs=199.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe-
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN- 760 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~-TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~- 760 (1091)
...++|++.+.||+|+||+||+|.++. +|+.||||++.... .......+.+|+.+|.+++|||||+++++|...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 445899999999999999999999976 78999999987532 33456778999999999999999999999988766
Q ss_pred ----eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 761 ----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 761 ----LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+||||||++||+|.+++.. .+++..++.++.||+.||.|||++|||||||||+||||+.+ .+||+|||+++..
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988765 79999999999999999999999999999999999999875 9999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
. .....+||+.|||||++.+. ++.++|||||||++|+|++|.+||.+.
T Consensus 232 ~-------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 232 N-------------------------------SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp T-------------------------------CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred c-------------------------------cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 1 01345799999999999765 588999999999999999999998753
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
... ..+........++.+.+||.+||..||.+||+ ..+.+.|+|+.
T Consensus 280 ~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 325 (681)
T 2pzi_A 280 YVD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT---TAEEMSAQLTG 325 (681)
T ss_dssp ECS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred ccc---------cccccccccccCHHHHHHHhhhccCChhhCCC---HHHHHHHHHHH
Confidence 211 11100000124578999999999999999998 45667787764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-33 Score=332.05 Aligned_cols=193 Identities=18% Similarity=0.138 Sum_probs=140.9
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-------RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~-------~~~eie~~l~EieILskL-~HPNIVkL~gsfqded~L 761 (1091)
-...++.|++|.+..++....|+.||+|++.+.... .+...+.+.+|+++|.++ .|+||++++++++++..+
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 344578899999988888889999999999864321 223456799999999999 699999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||||||++||+|.++|.+.+.+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--- 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--- 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC---
Confidence 9999999999999999998888865 4789999999999999999999999999999999999999999985311
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
......+.+||+.|||||++.+. +...+|+||+|+++|+|++|..||
T Consensus 392 ------------------------~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 ------------------------DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ------------------------CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 11223567999999999999864 677899999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-28 Score=281.42 Aligned_cols=194 Identities=18% Similarity=0.129 Sum_probs=146.8
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~-----~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
...+.||+|+||+||+|+ ..++.+|+|.+....... ....+++.+|+++|.+++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345689999999999994 357889999875432211 1224568999999999999999965555557777899
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||||++||+|.+++.+ +..++.||+.||.|||++||+||||||+|||++. ++||+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~-- 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED-- 484 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH--
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc--
Confidence 9999999999999876 5688999999999999999999999999999998 999999999985311000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC--CCCCccceeechhhhHHHHHhCCCCCC
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
..........+.+||+.|||||++.+ .+|+..+|+||.++-..+.+.++.+|.
T Consensus 485 ------------------~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 ------------------KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ------------------HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ------------------cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 00000001246789999999999987 678889999999998888888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=239.87 Aligned_cols=135 Identities=21% Similarity=0.178 Sum_probs=110.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch---------------hHHHHHHHHHHHHHhcCCCceEEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---------------NDIERILAERNILITVRNPFVVRF 751 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~---------------~eie~~l~EieILskL~HPNIVkL 751 (1091)
.|.+.+.||+|+||.||+|++ .+|+.||||+++....... .....+.+|+.+|..++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 456779999999999999999 7899999999964321111 23567899999999999 4 555
Q ss_pred eeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecC
Q 001370 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 752 ~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
+.++. .+.+|+||||++||+|.+ +. ......++.||+.||.|||++|||||||||+|||++ +|.+||+|||
T Consensus 167 ~~~~~-~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYA-WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CCEEE-EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred CeEEe-ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 55543 356799999999999987 32 123557899999999999999999999999999999 9999999999
Q ss_pred Ccc
Q 001370 832 LSK 834 (1091)
Q Consensus 832 LAk 834 (1091)
+|+
T Consensus 238 ~a~ 240 (282)
T 1zar_A 238 QSV 240 (282)
T ss_dssp TCE
T ss_pred CCe
Confidence 986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=198.49 Aligned_cols=139 Identities=21% Similarity=0.178 Sum_probs=108.9
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcE--EEEEEeecccccc---------------------hhHHHHHHHHHHHHHhcC
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIR---------------------KNDIERILAERNILITVR 744 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~--VAIKiLkK~~i~~---------------------~~eie~~l~EieILskL~ 744 (1091)
|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|..+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999998778999 9999976432110 111246789999999998
Q ss_pred CCce--EEEeeeeccCCeeEEEEeecCC-C----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecccCCCc
Q 001370 745 NPFV--VRFFYSFTCRDNLYLVMEYLNG-G----DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDN 816 (1091)
Q Consensus 745 HPNI--VkL~gsfqded~LYLVMEYm~G-G----SL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLH-s~GIIHRDLKPeN 816 (1091)
|++| ..++.. ...||||||+.+ | +|.++... +++..+..++.||+.||.||| +.|||||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 7753 333332 357899999942 4 67666432 235567889999999999999 9999999999999
Q ss_pred eEecCCCcEEEEecCCccc
Q 001370 817 LLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 817 ILLD~nG~VKLsDFGLAk~ 835 (1091)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-17 Score=186.20 Aligned_cols=138 Identities=13% Similarity=0.144 Sum_probs=98.4
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc-----------chhHHH--------HHHHHHHHHHhcCCCce
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----------RKNDIE--------RILAERNILITVRNPFV 748 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~-----------~~~eie--------~~l~EieILskL~HPNI 748 (1091)
|++.+.||.|+||.||+|... +|+.||||+++..... ...... ....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999875 6999999998642110 000011 12345566666644332
Q ss_pred EEEeeeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-----
Q 001370 749 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----- 823 (1091)
Q Consensus 749 VkL~gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG----- 823 (1091)
... ..+.. ...+|||||+.|++|..+. ..+.+..++.||+.+|.|||+.|||||||||.||||+.+|
T Consensus 176 ~vp-~p~~~-~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVP-EPIAQ-SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCC-CEEEE-ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCC-eeeec-cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 211 11111 1237999999999886442 2234567789999999999999999999999999999877
Q ss_pred -----cEEEEecCCcc
Q 001370 824 -----HIKLTDFGLSK 834 (1091)
Q Consensus 824 -----~VKLsDFGLAk 834 (1091)
.+.|+||+-+.
T Consensus 248 ~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMV 263 (397)
T ss_dssp TSEEEEEEECCCTTCE
T ss_pred cccccceEEEEeCCcc
Confidence 48999999775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.1e-11 Score=129.19 Aligned_cols=142 Identities=15% Similarity=0.138 Sum_probs=113.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LY 762 (1091)
.++.|++...+|.|+++.||++... |..|++|+...... .....+.+|..+|..+. +..+.++++++.+.+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3467999999999999999999743 78899998865221 11235788999999885 667888888888888999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-------------------------------------- 804 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-------------------------------------- 804 (1091)
+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999876531 222344678899999999998
Q ss_pred ---------------------cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 ---------------------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 ---------------------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765667999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=3.9e-11 Score=122.81 Aligned_cols=137 Identities=15% Similarity=0.137 Sum_probs=100.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--eEEEeeeeccCCee
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFFYSFTCRDNL 761 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN--IVkL~gsfqded~L 761 (1091)
...+|.+....+.|.++.||++.. .+|..|++|+.... ....+.+|..++..+.+.+ +.++++++...+..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 345677655555666799999964 46778999987643 1234678888888886433 56688888888889
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG----------------------------------- 806 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~G----------------------------------- 806 (1091)
|+||||++|.+|. . .... ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999998883 1 1122 1245667777777777643
Q ss_pred -----------------------CeecccCCCceEecCCCcEEEEecCCccc
Q 001370 807 -----------------------IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 807 -----------------------IIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=4.2e-10 Score=123.28 Aligned_cols=141 Identities=17% Similarity=0.310 Sum_probs=106.0
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEee--cccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccC---CeeE
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCR---DNLY 762 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiLk--K~~i~~~~eie~~l~EieILskL~--HPNIVkL~gsfqde---d~LY 762 (1091)
.++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+|..+. +..+.+++..+.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4678999999999998754 5678888765 32211 12346778999999887 45578888888776 4589
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-------------------------------------- 804 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-------------------------------------- 804 (1091)
+||||++|..+.+. ....++......++.+++.+|..||.
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999877431 12346788888889999999999997
Q ss_pred --------------------cCCeecccCCCceEecCCCc--EEEEecCCcccc
Q 001370 805 --------------------LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIG 836 (1091)
Q Consensus 805 --------------------~GIIHRDLKPeNILLD~nG~--VKLsDFGLAk~~ 836 (1091)
.+++|+|++|.|||++.++. +.|+||+++..+
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999998763 699999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.8e-10 Score=121.06 Aligned_cols=133 Identities=20% Similarity=0.223 Sum_probs=97.8
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CC--ceEEEeeeeccCC---eeEEEE
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NP--FVVRFFYSFTCRD---NLYLVM 765 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HP--NIVkL~gsfqded---~LYLVM 765 (1091)
+.++.|.+..||++. ..+++|+.... .....+.+|..+|..+. +. .+.+++....... ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 358999999999873 45888975432 34567889999998873 32 2344444443333 358999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS----------------------------------------- 804 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs----------------------------------------- 804 (1091)
++++|.+|..... ..++......++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988865432 346777778888888888888886
Q ss_pred -----------------cCCeecccCCCceEecC--CCcEEEEecCCcccc
Q 001370 805 -----------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIG 836 (1091)
Q Consensus 805 -----------------~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~ 836 (1091)
..++|+|++|.|||++. .+.+.|+||+.+..+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13699999999999998 456899999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.3e-06 Score=91.45 Aligned_cols=134 Identities=17% Similarity=0.242 Sum_probs=91.6
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---ceEEEeeeec-cCCeeEEEEe
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFT-CRDNLYLVME 766 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HP---NIVkL~gsfq-ded~LYLVME 766 (1091)
++.++.|....||++ |..+++|+-.. ......+.+|..+|..+.+. .|.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 345788999999988 56688887432 23456788999999998742 2445554443 4556889999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL----------------------------------------- 805 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~----------------------------------------- 805 (1091)
|++|..|..... ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988865321 2234444444444555555544432
Q ss_pred -------------------CCeecccCCCceEecC---CCc-EEEEecCCcccc
Q 001370 806 -------------------GIVHRDLKPDNLLIAH---DGH-IKLTDFGLSKIG 836 (1091)
Q Consensus 806 -------------------GIIHRDLKPeNILLD~---nG~-VKLsDFGLAk~~ 836 (1091)
.++|+|++|.|||++. ++. +.|+||+.+..+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999997 455 489999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=6.7e-06 Score=85.71 Aligned_cols=138 Identities=18% Similarity=0.193 Sum_probs=96.2
Q ss_pred CeEEEEeeccCCce-EEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEE
Q 001370 687 DFEIIKPISRGAFG-RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 687 dFeilr~LGkGgFG-tVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLV 764 (1091)
.|+.. .+..|..| .||+......+..+.+|+-.. .....+.+|..+|..+. +--|.+++.++.+.+..|+|
T Consensus 26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 34433 34445554 799888776777899997653 23456788999988775 32366777888888999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------------------------------------- 805 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~--------------------------------------- 805 (1091)
||+++|.++.+..... ......+..++...|.-||..
T Consensus 99 me~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp EECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred EEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9999998877654321 112223444555555555531
Q ss_pred -------------------CCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 806 -------------------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 806 -------------------GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 178999999999999877778999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=3.2e-06 Score=93.99 Aligned_cols=80 Identities=26% Similarity=0.292 Sum_probs=50.6
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhcCC--C-ceEEEeeeeccCCeeE
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRK---NDIERILAERNILITVRN--P-FVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i-~~~---~eie~~l~EieILskL~H--P-NIVkL~gsfqded~LY 762 (1091)
.++.||.|.++.||++....+++.|++|....... ... ....++..|.++|..+.. | .+.+++++ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35689999999999997665678899998653211 000 123456778888887642 3 34455543 345578
Q ss_pred EEEeecCCC
Q 001370 763 LVMEYLNGG 771 (1091)
Q Consensus 763 LVMEYm~GG 771 (1091)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=3.6e-05 Score=82.15 Aligned_cols=136 Identities=13% Similarity=0.119 Sum_probs=78.1
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----CCceEEEe-e--eeccCCeeE
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----NPFVVRFF-Y--SFTCRDNLY 762 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-----HPNIVkL~-g--sfqded~LY 762 (1091)
++.|+.|..+.||++... +..|++|+.... . ..+..|..++..+. .|.++... + +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 456777788999999763 345899988651 1 22334444444432 34444311 1 123456789
Q ss_pred EEEeecCCCcHH--------------HHHHhc-CCC--C-----------HH--------H-------------------
Q 001370 763 LVMEYLNGGDLY--------------SLLRKV-GCL--E-----------ED--------V------------------- 787 (1091)
Q Consensus 763 LVMEYm~GGSL~--------------dlL~k~-g~L--s-----------E~--------~------------------- 787 (1091)
+||+|++|..+. ..++.. ..+ + +. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986431 111111 111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 788 ----ARIYIAELVLALEYLHS-------------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 788 ----ar~yaaQIa~ALeYLHs-------------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
...+...+..++.+|+. .+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11112234445666653 5799999999999998888999999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=5.2e-05 Score=82.61 Aligned_cols=85 Identities=14% Similarity=0.129 Sum_probs=53.7
Q ss_pred EEEEee-ccCCceEEEEEEEC---C---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C--CceEEEeeeeccC
Q 001370 689 EIIKPI-SRGAFGRVFLARKR---T---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N--PFVVRFFYSFTCR 758 (1091)
Q Consensus 689 eilr~L-GkGgFGtVyLar~k---~---TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-H--PNIVkL~gsfqde 758 (1091)
..++.| +.|....+|++... . ++..+++|+..............+.+|..+|..+. + ..+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 456778 88999999998753 1 15678899765422000000134567777777664 2 3466677666554
Q ss_pred ---CeeEEEEeecCCCcH
Q 001370 759 ---DNLYLVMEYLNGGDL 773 (1091)
Q Consensus 759 ---d~LYLVMEYm~GGSL 773 (1091)
...|+||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 357899999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00023 Score=80.11 Aligned_cols=32 Identities=22% Similarity=0.469 Sum_probs=28.4
Q ss_pred HcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 804 s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
...++|+|++|.|||++.++ ++|+||+.+..+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 45799999999999999877 999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0014 Score=72.16 Aligned_cols=76 Identities=14% Similarity=0.132 Sum_probs=59.1
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEEEEe
Q 001370 690 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~---HPNIVkL~gsfqded~LYLVME 766 (1091)
-++.|+.|.+..+|++.. ++..|++|+.... ....+..|...|..+. ...+.+++......+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 457799999999999874 4678889976542 2456788988887774 3567778877777788999999
Q ss_pred ecCCCcH
Q 001370 767 YLNGGDL 773 (1091)
Q Consensus 767 Ym~GGSL 773 (1091)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9999754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0018 Score=69.37 Aligned_cols=132 Identities=14% Similarity=0.087 Sum_probs=72.5
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec-
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL- 768 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYLVMEYm- 768 (1091)
++.|+.|....+|++ ..|++|+....... .....+|..++..+. +....++++.+ .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678999999999999 45888987642110 011235666666553 11113445443 33347899999
Q ss_pred CCCcHHH---------------HH---HhcC-CCC-----HHHHHHHHH--------------HHHHHHHHHHH------
Q 001370 769 NGGDLYS---------------LL---RKVG-CLE-----EDVARIYIA--------------ELVLALEYLHS------ 804 (1091)
Q Consensus 769 ~GGSL~d---------------lL---~k~g-~Ls-----E~~ar~yaa--------------QIa~ALeYLHs------ 804 (1091)
+|.+|.. .| +..+ .+. ......+.. .+...+..|..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6644421 01 1111 011 111111211 11122222211
Q ss_pred --cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 --LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 --~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
..++|+|+.|.||| ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 13899999999999 5677889999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0022 Score=68.63 Aligned_cols=141 Identities=16% Similarity=0.157 Sum_probs=79.2
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--eEEEeee------eccCC
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFFYS------FTCRD 759 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN--IVkL~gs------fqded 759 (1091)
..-++.|+.|....||++... +| .|++|+..... ....+..|..++..+.... +.+++.. ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 345678888999999999754 33 68899886521 1123455666666553111 2333321 12235
Q ss_pred eeEEEEeecCCCcHH-----------H---HHHhc-CCC--------CHHHHHH---------------HHHHHHHHHHH
Q 001370 760 NLYLVMEYLNGGDLY-----------S---LLRKV-GCL--------EEDVARI---------------YIAELVLALEY 801 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~-----------d---lL~k~-g~L--------sE~~ar~---------------yaaQIa~ALeY 801 (1091)
..++||+|++|..+. . .++.. ..+ ....-.. +...+...+.+
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 678999999986431 0 11111 011 1000000 01123445566
Q ss_pred HHH-------cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 802 LHS-------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 802 LHs-------~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
++. .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 653 3699999999999998776668999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0041 Score=66.69 Aligned_cols=136 Identities=14% Similarity=0.173 Sum_probs=76.7
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeee-----eccCCeeEEE
Q 001370 692 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYS-----FTCRDNLYLV 764 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H--PNIVkL~gs-----fqded~LYLV 764 (1091)
..|+ |....||++.. .+|+.|++|+.+.... ....+..|..++..+.. -.+++++.. ....+..|+|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3466 78889998864 3466799998863211 23455667777766641 123444432 1124456889
Q ss_pred EeecCCCcHH-----------HH---HHhc----C-----CCCHHH----HHHH---------------HHHHHHHHHHH
Q 001370 765 MEYLNGGDLY-----------SL---LRKV----G-----CLEEDV----ARIY---------------IAELVLALEYL 802 (1091)
Q Consensus 765 MEYm~GGSL~-----------dl---L~k~----g-----~LsE~~----ar~y---------------aaQIa~ALeYL 802 (1091)
|+|++|..+. .. ++.. . .++... .+.+ ...+-..+..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885421 11 1110 0 111111 0111 11111223333
Q ss_pred H-------HcCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 803 H-------SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 803 H-------s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
. ...++|+|++|.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2 23589999999999998 4 899999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0033 Score=68.03 Aligned_cols=32 Identities=34% Similarity=0.607 Sum_probs=28.0
Q ss_pred cCCeecccCCCceEecCC----CcEEEEecCCcccc
Q 001370 805 LGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIG 836 (1091)
Q Consensus 805 ~GIIHRDLKPeNILLD~n----G~VKLsDFGLAk~~ 836 (1091)
..++|+|+.+.|||++.+ +.+.|+||+.+..+
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999875 78999999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0045 Score=70.66 Aligned_cols=74 Identities=18% Similarity=0.225 Sum_probs=49.4
Q ss_pred EEEeeccCCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001370 690 IIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~-------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~L 761 (1091)
-++.|+.|....||++.... ++..|.+|+..... ....+.+|..++..+. +....++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678888899999998653 25789999874311 1134557888887775 3233566666653
Q ss_pred EEEEeecCCCc
Q 001370 762 YLVMEYLNGGD 772 (1091)
Q Consensus 762 YLVMEYm~GGS 772 (1091)
.+||||++|..
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999998743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0057 Score=67.31 Aligned_cols=74 Identities=15% Similarity=0.202 Sum_probs=42.5
Q ss_pred EEeeccCCceEEEEEEECC--------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001370 691 IKPISRGAFGRVFLARKRT--------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~--------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~L 761 (1091)
++.|+.|....+|++.... .+..|++|+...... .......|..++..+. +..+.++++.+. -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 4567888888999998653 136788998754211 1111356777777664 222345555442 2
Q ss_pred EEEEeecCCCc
Q 001370 762 YLVMEYLNGGD 772 (1091)
Q Consensus 762 YLVMEYm~GGS 772 (1091)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 78999999854
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.28 E-value=0.056 Score=57.35 Aligned_cols=78 Identities=13% Similarity=-0.032 Sum_probs=53.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---CceEEEeeeeccCCeeEE
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H---PNIVkL~gsfqded~LYL 763 (1091)
...-++.+|.|..+.||+++. .+|+.|.+|+-..... .....+..|...|+.+.- --+.+++... .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 456678899999999999986 4689999997653221 112356789888887741 1234444432 2478
Q ss_pred EEeecCCCc
Q 001370 764 VMEYLNGGD 772 (1091)
Q Consensus 764 VMEYm~GGS 772 (1091)
||||+.++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0065 Score=68.78 Aligned_cols=136 Identities=13% Similarity=0.216 Sum_probs=80.9
Q ss_pred EeeccCCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEE
Q 001370 692 KPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~-------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~LYL 763 (1091)
+.|..|-...+|++.... +++.|.+|+..... .....+.+|..+++.+. +....++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 456667777888887642 35789899863311 12344568888887764 3333566666654 29
Q ss_pred EEeecCCCcHH--------------HHHH---hcC-----CC--CHHHHHHHHHHHHH-------------------HHH
Q 001370 764 VMEYLNGGDLY--------------SLLR---KVG-----CL--EEDVARIYIAELVL-------------------ALE 800 (1091)
Q Consensus 764 VMEYm~GGSL~--------------dlL~---k~g-----~L--sE~~ar~yaaQIa~-------------------ALe 800 (1091)
||||++|..|. ..|. ... .. -..++..|+.++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999985442 1111 111 11 13445555544322 233
Q ss_pred HHHH--------cCCeecccCCCceEecCC----CcEEEEecCCccc
Q 001370 801 YLHS--------LGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKI 835 (1091)
Q Consensus 801 YLHs--------~GIIHRDLKPeNILLD~n----G~VKLsDFGLAk~ 835 (1091)
.|.. ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 258999999999999876 7899999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.88 E-value=0.038 Score=64.01 Aligned_cols=75 Identities=16% Similarity=0.202 Sum_probs=47.6
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCeeEEEEeecC
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN-IVkL~gsfqded~LYLVMEYm~ 769 (1091)
++.|+.|-...+|++.....+..|++|+...... ..+. -.+|..+|..+...+ ..++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 4678888899999998764457899998754210 0011 147888888886433 356777663 2 25999999
Q ss_pred CCcH
Q 001370 770 GGDL 773 (1091)
Q Consensus 770 GGSL 773 (1091)
|..|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.06 Score=59.17 Aligned_cols=31 Identities=19% Similarity=0.452 Sum_probs=28.0
Q ss_pred CCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 806 GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
.++|+|+.|.|||++.++.+.|+||+.+..+
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5899999999999998889999999988753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.56 E-value=0.048 Score=58.28 Aligned_cols=122 Identities=17% Similarity=0.124 Sum_probs=80.8
Q ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH-HcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCC
Q 001370 771 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 848 (1091)
Q Consensus 771 GSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLH-s~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~ 848 (1091)
-+|.++|... .+++|++++-++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 3799999865 57999999999999999987762 11212333457999999999988663 2110
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHHhhc
Q 001370 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 928 (1091)
Q Consensus 849 t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kIl~~ 928 (1091)
.....+.|||.+. ...+.+.=|||||++||.-|-=..|
T Consensus 98 -------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------- 135 (229)
T 2yle_A 98 -------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------- 135 (229)
T ss_dssp ----------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC----------------
T ss_pred -------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC----------------
Confidence 1122456777763 3456778899999999988742111
Q ss_pred CCCCCCCCCCCCHHHHHHHhhhccC
Q 001370 929 KIPWPCVPSDMSFEAQDLINRFLIH 953 (1091)
Q Consensus 929 ~l~fP~ip~~lS~eakDLI~rcL~k 953 (1091)
+..+..+|+.+..||..|..-
T Consensus 136 ----e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 136 ----ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ----TTEEECCCHHHHHHHHHHTTC
T ss_pred ----cccchhhCHHHHHHHHHHHhc
Confidence 122467999999999999764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.69 E-value=0.19 Score=57.85 Aligned_cols=75 Identities=12% Similarity=0.135 Sum_probs=46.1
Q ss_pred EEEeeccCCceEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001370 690 IIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~T-------Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~L 761 (1091)
-++.|..|-...+|++..... +..|++|+..... .. .-...+|..++..+. +....++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 345677788889999987521 5789999864421 00 111245777776664 223345555443 2
Q ss_pred EEEEeecCCCc
Q 001370 762 YLVMEYLNGGD 772 (1091)
Q Consensus 762 YLVMEYm~GGS 772 (1091)
++||||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 78999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.86 E-value=1.4 Score=49.48 Aligned_cols=29 Identities=28% Similarity=0.505 Sum_probs=25.6
Q ss_pred CeecccCCCceEe------cCCCcEEEEecCCccc
Q 001370 807 IVHRDLKPDNLLI------AHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 807 IIHRDLKPeNILL------D~nG~VKLsDFGLAk~ 835 (1091)
++|.|+.+.|||+ +.++.+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999999975
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1091 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-90 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-88 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-87 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-85 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-84 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-83 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-79 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-78 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-78 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-77 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-76 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-76 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-75 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-75 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-73 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-71 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-70 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-67 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-64 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-62 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-61 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-60 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-58 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-58 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-58 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-56 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-52 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-20 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 289 bits (740), Expect = 3e-90
Identities = 101/312 (32%), Positives = 170/312 (54%), Gaps = 31/312 (9%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
+ +DF+ K + G+F V LAR+ T +AIK+L+K +I++N + + ER+++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
+ +PF V+ +++F + LY + Y G+L +RK+G +E R Y AE+V ALEY
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV-------------------------L 158
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
++ +S VGT Y++PE+L ++D W++G I+++ + G+PPF A + +I
Sbjct: 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNW 978
F I+ + + P +A+DL+ + L+ D +RLG G +KAHPFF+ V W
Sbjct: 219 FQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275
Query: 979 DSLALQKAVFVP 990
++L Q +
Sbjct: 276 ENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 284 bits (728), Expect = 3e-88
Identities = 116/343 (33%), Positives = 183/343 (53%), Gaps = 35/343 (10%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITV 743
I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803
+PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE++L L++LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
S GIV+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--------------------------- 153
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF + E +F
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 983
+I + P + EA+DL+ + + +P +RLG +++ HP F+ +NW+ L
Sbjct: 214 SIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGV--RGDIRQHPLFREINWEELER 268
Query: 984 QK--AVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 1024
++ F P+ +S D S F F L + D
Sbjct: 269 KEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMD 311
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 283 bits (724), Expect = 2e-87
Identities = 126/356 (35%), Positives = 191/356 (53%), Gaps = 35/356 (9%)
Query: 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 741
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
LHS +V+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG------------------------- 155
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 156 --ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 979
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 980 SLALQKAV--FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDSSSNS 1032
+ +K + F PQ S DT YF F+ S + P D+ S +
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQE 326
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (702), Expect = 3e-85
Identities = 92/292 (31%), Positives = 148/292 (50%), Gaps = 35/292 (11%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
+++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E I +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803
R+P ++R + F +YL++EY G +Y L+K+ +E YI EL AL Y H
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
S ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------------- 154
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923
+ R + GT DYL PE++ G H D WS+G++ +EF+ G PPF A + + +
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
I + + P ++ A+DLI+R L H+P+QR EV HP+
Sbjct: 215 RISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 275 bits (703), Expect = 5e-84
Identities = 104/333 (31%), Positives = 163/333 (48%), Gaps = 38/333 (11%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
+++DF + + I RG FG V+ RK TG ++A+K L K + K L ER +L V
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 744 RN---PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 800
PF+V Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
++H+ +V+RDLKP N+L+ GH++++D GL+
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-------------------------- 155
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
+ H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF +
Sbjct: 156 ---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVN 977
+ +P S E + L+ L D N+RLG GA EVK PFF+ ++
Sbjct: 213 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
Query: 978 WDSLALQK--AVFVPQPESVDDTSYF-LSRFSQ 1007
W + LQK +P V+ F + F +
Sbjct: 273 WQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDE 305
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 271 bits (693), Expect = 3e-83
Identities = 115/323 (35%), Positives = 180/323 (55%), Gaps = 38/323 (11%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803
+PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEYLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
S I++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--------------------------- 154
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923
++ GTPDY+APE++ + + DWWS GI+++E + G PF + ++
Sbjct: 155 ---PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 981
ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W+ L
Sbjct: 212 KILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
Query: 982 ALQK--AVFVPQPE-SVDDTSYF 1001
+ + P + DTS F
Sbjct: 269 LSRNIETPYEPPIQQGQGDTSQF 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (659), Expect = 4e-79
Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 31/291 (10%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+GI HRD+KP+NLL+ ++K++DFGL+ + NN
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN------------------------ 157
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923
R + GT Y+APE+L E H D WS GI+L + G P+ S
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ K + + L+++ L+ +P+ R+ ++K ++
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (658), Expect = 1e-78
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 39/296 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D +EII + GAFG+V+ A+ + T L A KV+ + ++E + E +IL + +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 804
P +V+ +F +NL++++E+ GG + +++ ++ L E ++ + + AL YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
I+HRDLK N+L DG IKL DFG+S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN---------------------------T 161
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 919
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975
+ I + P PS S +D + + L + + R +++ HPF
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 258 bits (660), Expect = 3e-78
Identities = 116/326 (35%), Positives = 183/326 (56%), Gaps = 37/326 (11%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 739
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
EYLHSL +++RDLKP+NLLI G+I++TDFG +K
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR------------------------ 190
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 191 ------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 977
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F +
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
Query: 978 WDSLALQK--AVFVPQPESVDDTSYF 1001
W ++ +K A F+P+ + DTS F
Sbjct: 302 WIAIYQRKVEAPFIPKFKGPGDTSNF 327
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 257 bits (657), Expect = 8e-78
Identities = 76/342 (22%), Positives = 140/342 (40%), Gaps = 38/342 (11%)
Query: 673 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 732
P K +D ++I + + GAFG V +R TG+ FA K + +D E
Sbjct: 13 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKET 69
Query: 733 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIY 791
+ E + +R+P +V +F + + ++ E+++GG+L+ + + + ED A Y
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 129
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPET 849
+ ++ L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA--------------- 174
Query: 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909
++ GT ++ APE+ G GY D WSVG++ + ++G
Sbjct: 175 -------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 910 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968
+ PF E+ + N+ + S +S + +D I + L+ DPN R+ +
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQAL 278
Query: 969 AHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 1010
HP+ N Q + + + +
Sbjct: 279 EHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPP 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (652), Expect = 2e-77
Identities = 124/333 (37%), Positives = 189/333 (56%), Gaps = 38/333 (11%)
Query: 677 SSHKERTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRK-NDIER 732
+ H E+ I++FE++K + GA+G+VFL RK TG L+A+KVLKK +++K E
Sbjct: 15 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 74
Query: 733 ILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 791
ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L + E +IY
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 851
+ E+VLALE+LH LGI++RD+K +N+L+ +GH+ LTDFGLS
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS------------------ 176
Query: 852 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG 909
E+ + + GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG
Sbjct: 177 --------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 910 IPPFTAESPEIIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAE 966
PFT + + I R + P P +MS A+DLI R L+ DP +RLG A E
Sbjct: 229 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288
Query: 967 VKAHPFFKGVNWDSLALQK--AVFVPQPESVDD 997
+K H FF+ +NWD LA +K A F P D
Sbjct: 289 IKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 250 bits (640), Expect = 2e-76
Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 45/303 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNI 739
+++E + + RG V + T +A+K++ + E L E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 740 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 798
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 912
Q GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 159 ----QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
Query: 913 FTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 971
F ++ I++ + D S +DL++RFL+ P +R A E AHP
Sbjct: 215 FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHP 271
Query: 972 FFK 974
FF+
Sbjct: 272 FFQ 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 3e-76
Identities = 90/299 (30%), Positives = 137/299 (45%), Gaps = 38/299 (12%)
Query: 680 KERTSIDD----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 735
+ S+ D + + I +GA G V+ A TG AI+ + +K E I+
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIIN 66
Query: 736 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 795
E ++ +NP +V + S+ D L++VMEYL GG L ++ + C++E E
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 125
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
+ ALE+LHS ++HRD+K DN+L+ DG +KLTDFG
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--------------------- 164
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 915
+ R + VGTP ++APE++ +G D WS+GI+ E I G PP+
Sbjct: 165 ------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
E+P I P P +S +D +NR L D +R A E+ H F K
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLK 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 252 bits (644), Expect = 7e-76
Identities = 74/367 (20%), Positives = 148/367 (40%), Gaps = 49/367 (13%)
Query: 673 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 732
P K+ + D ++I++ + GAFG V ++ TG +F K + + K ++
Sbjct: 16 VPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 75
Query: 733 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 791
E +I+ + +P ++ +F + + L++E+L+GG+L+ + + E Y
Sbjct: 76 ---EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 132
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLINNTIDLSGPET 849
+ + L+++H IVH D+KP+N++ +K+ DFGL+
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT--------------- 177
Query: 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 909
+ + T ++ APEI+ G+ D W++G++ + ++G
Sbjct: 178 -------------KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
Query: 910 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968
+ PF E N+ + S +S EA+D I L +P +RL +
Sbjct: 225 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDAL 281
Query: 969 AHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF-----------LSRFSQISSGLPDDQN 1017
HP+ KG + + + + + Y ++ FS + P +
Sbjct: 282 EHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQ 341
Query: 1018 GSYSDAD 1024
S D
Sbjct: 342 IYDSYFD 348
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (639), Expect = 1e-75
Identities = 83/344 (24%), Positives = 136/344 (39%), Gaps = 76/344 (22%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 804
P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
I+HRD+KP N+L+ G IKL DFG+S Q
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----------------------------Q 154
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
+ +S VGT Y++PE L GT + +D WS+G+ L E G P + +
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 925 ILNR----------------------------------------KIPWPCVPSD-MSFEA 943
+ P P +PS S E
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274
Query: 944 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV 987
QD +N+ LI +P +R ++ H F K + + + +
Sbjct: 275 QDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEVDFAGWL 315
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 2e-75
Identities = 82/298 (27%), Positives = 138/298 (46%), Gaps = 44/298 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+D+E++ I G++GR R+++ G + K L + + + + +++E N+L +++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKH 62
Query: 746 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLAL 799
P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L LAL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 800 EYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
+ H ++HRDLKP N+ + ++KL DFGL++I
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI------------------- 163
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914
D + VGTP Y++PE + + +D WS+G +L+E +PPFT
Sbjct: 164 --------LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
Query: 915 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972
A S + + I K P S E ++I R L R E+ +P
Sbjct: 216 AFSQKELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRP---SVEEILENPL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 247 bits (631), Expect = 9e-75
Identities = 91/328 (27%), Positives = 150/328 (45%), Gaps = 38/328 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D ++ + GAF V LA + T L AIK + K + + + E +L +++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +V + +LYL+M+ ++GG+L+ + + G E A I +++ A++YLH L
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 806 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
GIVHRDLKP+NLL D I ++DFGLSK+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------------------------- 159
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
+ +A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 160 -EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
Query: 923 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981
+ IL + + D+S A+D I + DP +R + HP+ G
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGDTALDK 275
Query: 982 ALQKAVFVPQPESVDDTSYFLSRFSQIS 1009
+ ++V Q + S + F+ +
Sbjct: 276 NIHQSV-SEQIKKNFAKSKWKQAFNATA 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 242 bits (618), Expect = 8e-73
Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
++HRD+K N+L++ G +KL DFG + I
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------------------ 164
Query: 866 DNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEIIF 922
+S VGTP ++APE++L + G D WS+GI E PP +
Sbjct: 165 -MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+I + P S ++ ++ L P R + + H F
Sbjct: 224 YHIAQNESPALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 7e-71
Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 39/293 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 804
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 805 LGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 862
I H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 863 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
Q N P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 923 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+NI+N + + ++S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLK 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 3e-70
Identities = 81/314 (25%), Positives = 142/314 (45%), Gaps = 40/314 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILIT 742
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 743 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 802
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 803 HSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
HSL I H DLKP+N+++ IK+ DFGL+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 165
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918
+ + GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 166 ----KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 919 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 977
+ N+ + S+ S A+D I R L+ DP +R+ + HP+ K +
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKD 278
Query: 978 WDSLALQKAVFVPQ 991
AL A PQ
Sbjct: 279 TQQ-ALSSAWSHPQ 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 6e-70
Identities = 61/301 (20%), Positives = 124/301 (41%), Gaps = 43/301 (14%)
Query: 683 TSIDD--FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
S D + I RG+F V+ T A L+ + K++ +R E +L
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEML 62
Query: 741 ITVRNPFVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
+++P +VRF+ S+ + + LV E + G L + L++ ++ V R + +++
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 797 LALEYLHSLG--IVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
L++LH+ I+HRDLK DN+ I G +K+ D GL+ +
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------------------ 164
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913
+ +GTP+++APE+ ++ + D ++ G+ + E T P+
Sbjct: 165 -----------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212
Query: 914 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973
+ + + E +++I + + ++R ++ H FF
Sbjct: 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFF 269
Query: 974 K 974
+
Sbjct: 270 Q 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 225 bits (573), Expect = 5e-67
Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 31/289 (10%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D +E+ + + G V LAR A+KVL+ + R E + +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 746 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
P +V + + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
H GI+HRD+KP N++I+ +K+ DFG+++
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR------------------------AIA 162
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
+ +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222
Query: 922 FDNILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969
+ IP +S + ++ + L +P R AAE++A
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMRA 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-64
Identities = 70/299 (23%), Positives = 130/299 (43%), Gaps = 49/299 (16%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE---RILAERNILIT 742
+++ + G FG V+ + + AIK ++K + ++ R+ E +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 743 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLAL 799
V + V+R F D+ L++E DL+ + + G L+E++AR + +++ A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 800 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
+ H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------------------- 160
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAES 917
+ GT Y PE + HG +A WS+GI+L++ + G PF +
Sbjct: 161 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 213
Query: 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
+ I+ ++ + +S E Q LI L P+ R E++ HP+ + V
Sbjct: 214 -----EEIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDV 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-64
Identities = 82/311 (26%), Positives = 139/311 (44%), Gaps = 55/311 (17%)
Query: 680 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 738
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 56
Query: 739 ILITV-RNPFVVRFFYSF----TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIY 791
+ + P +VR + R L +VME L+GG+L+S ++ G E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 792 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 848
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG +K
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------------- 162
Query: 849 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 908
+ T + + + TP Y+APE+L ++ + D WS+G+I++ +
Sbjct: 163 --------------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208
Query: 909 GIPPFTAESP----EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG 963
G PPF + + I + +P S++S E + LI L +P QR+
Sbjct: 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---T 265
Query: 964 AAEVKAHPFFK 974
E HP+
Sbjct: 266 ITEFMNHPWIM 276
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-64
Identities = 54/280 (19%), Positives = 112/280 (40%), Gaps = 37/280 (13%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + I G+FG V+ + A+K+L ++ E +L R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRH 63
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 804
++ F ++ L +V ++ G LY L + E + ++YLH+
Sbjct: 64 VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
I+HRDLK +N+ + D +K+ DFGL+ + + +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV-------------------------KSRW 157
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEII 921
+ + G+ ++APE++ + + +D ++ GI+L+E +TG P++ +
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
Query: 922 FDNILNRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQR 958
++ R P V S+ + L+ L ++R
Sbjct: 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 4e-63
Identities = 76/314 (24%), Positives = 117/314 (37%), Gaps = 58/314 (18%)
Query: 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVRNP 746
E + + G F V+ AR + T + AIK +K D L E +L + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
++ +F + N+ LV +++ + L + Y+ + LEYLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 807 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 866
I+HRDLKP+NLL+ +G +KL DFGL+K +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 867 NRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925
NR V T Y APE+L G +G D W+VG IL E + +P +S I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 926 LN-------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 960
IP + S + DLI + +P R+
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI- 272
Query: 961 ANGAAEVKAHPFFK 974
A + +F
Sbjct: 273 --TATQALKMKYFS 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 6e-63
Identities = 61/303 (20%), Positives = 119/303 (39%), Gaps = 35/303 (11%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAER 737
++ +++D K + G FG V + + A+K+LK + + +LAE
Sbjct: 5 RKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEA 59
Query: 738 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
N++ + NP++VR ++ LVME G L L++ +++ + ++ +
Sbjct: 60 NVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 857
++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL--------------------- 157
Query: 858 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916
+ + + + APE + + +D WS G++++E + G P+
Sbjct: 158 ---RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214
Query: 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
+ + + P+ E DL+N +D R G + ++ V
Sbjct: 215 KGSEVTAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
Query: 977 NWD 979
N
Sbjct: 273 NEG 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 211 bits (538), Expect = 3e-62
Identities = 75/316 (23%), Positives = 128/316 (40%), Gaps = 59/316 (18%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + ++ I G +G V+ A+ G+ FA+K ++ + + + E +IL +++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+V+ + + L LV E+L+ L G LE A+ ++ +L+ + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARA---------------------------FGI 152
Query: 866 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 924
R + T Y AP++L+G++ + D WSVG I E + G P F S
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 925 ILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
I +PW + DL+++ L DPNQR
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 959 LGANGAAEVKAHPFFK 974
+ A + H +FK
Sbjct: 273 I---TAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-61
Identities = 76/329 (23%), Positives = 121/329 (36%), Gaps = 65/329 (19%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
+ +E + I +G FG VF AR R TG A+K + + ++ L E IL +
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLL 66
Query: 744 RNPFVVRFFYSFT--------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 795
++ VV C+ ++YLV ++ L + + + L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 796 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 855
+ L Y+H I+HRD+K N+LI DG +KL DFGL++
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-------------------- 166
Query: 856 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 914
+ + + + V T Y PE+LLG ++G D W G I+ E T P
Sbjct: 167 ---FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
Query: 915 AESPEIIFDNILN-----------------------------RKIPWPCVPSDMSFEAQD 945
+ + I RK+ A D
Sbjct: 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
Query: 946 LINRFLIHDPNQRLGANGAAEVKAHPFFK 974
LI++ L+ DP QR+ + + H FF
Sbjct: 284 LIDKLLVLDPAQRI---DSDDALNHDFFW 309
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 2e-60
Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 59/321 (18%)
Query: 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 744
+++F+ ++ I G +G V+ AR + TG++ A+K ++ D + + E ++L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 803
+P +V+ + LYLV E+L+ + + + + Y+ +L+ L + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
S ++HRDLKP NLLI +G IKL DFGL++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARA---------------------------F 152
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 922
R V T Y APEILLG ++ A D WS+G I E +T F +S
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 923 DNILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPN 956
I + + V + + + L+++ L +DPN
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN 272
Query: 957 QRLGANGAAEVKAHPFFKGVN 977
+R+ A AHPFF+ V
Sbjct: 273 KRI---SAKAALAHPFFQDVT 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-60
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 46/291 (15%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
++ + ++++ I +G FG V L R G+ A+K +K + LAE +++ +
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 57
Query: 744 RNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 800
R+ +V+ + LY+V EY+ G L LR G L D + ++ A+E
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
YL VHRDL N+L++ D K++DFGL+K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------------------------ 153
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 919
+ + + + APE L + +D WS GI+L+E + G P+ +
Sbjct: 154 ------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207
Query: 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970
+ + P +++ D R +++
Sbjct: 208 DVVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-59
Identities = 74/322 (22%), Positives = 127/322 (39%), Gaps = 63/322 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + I GA+G V A AIK + + + +R L E IL+ R+
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRH 65
Query: 746 PFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
++ ++ +L G DLY LL+ L D ++ +++ L+Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKY 124
Query: 802 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
+HS ++HRDLKP NLL+ +K+ DFGL+++ +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA------------------------D 160
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920
V T Y APEI+L + + D WSVG IL E ++ P F +
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 921 IFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLI 952
++IL K+PW + + +A DL+++ L
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280
Query: 953 HDPNQRLGANGAAEVKAHPFFK 974
+P++R+ + AHP+ +
Sbjct: 281 FNPHKRI---EVEQALAHPYLE 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 4e-59
Identities = 67/299 (22%), Positives = 111/299 (37%), Gaps = 37/299 (12%)
Query: 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAER 737
++ I D E+ G FG V R AIKVLK+ K D E ++ E
Sbjct: 7 RDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQ--GTEKADTEEMMREA 60
Query: 738 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 796
I+ + NP++VR L LVME GG L+ L K + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
+ ++YL VHRDL N+L+ + + K++DFGLSK
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA--------------------- 158
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915
+ R + + APE + + +D WS G+ ++E ++ G P+
Sbjct: 159 ---LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215
Query: 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ I K P + E L++ I+ R + ++
Sbjct: 216 MKGPEVMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-58
Identities = 59/280 (21%), Positives = 103/280 (36%), Gaps = 31/280 (11%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNIL 740
D +++ + G+FG V A+K LK + + ++ + E N +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLAL 799
++ + ++R + + +V E G L L + G Y ++ +
Sbjct: 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
YL S +HRDL NLL+A +K+ DFGL + + +D HY
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA----------------LPQNDDHY 168
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918
+ + APE L +A+D W G+ L+E T G P+ +
Sbjct: 169 --------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
Query: 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
I I P P D + +++ + H P R
Sbjct: 221 SQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-58
Identities = 82/328 (25%), Positives = 126/328 (38%), Gaps = 64/328 (19%)
Query: 684 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKN--DIERILAERNIL 740
+ +E + I GA+G+VF AR + G A+K ++ R +A L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 741 ITVRNPFVVRFFYSFTC-----RDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAE 794
T +P VVR F T L LV E+++ Y + + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 795 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 854
L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------------------- 165
Query: 855 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914
+ S V T Y APE+LL + + D WSVG I E P F
Sbjct: 166 ---------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 915 AESPEIIFDNILN------------------------RKIPWPCVPSDMSFEAQDLINRF 950
S IL+ P +D+ +DL+ +
Sbjct: 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
Query: 951 LIHDPNQRLGANGAAEVKAHPFFKGVNW 978
L +P +R+ A +HP+F+ +
Sbjct: 277 LTFNPAKRI---SAYSALSHPYFQDLER 301
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 4e-58
Identities = 56/304 (18%), Positives = 101/304 (33%), Gaps = 35/304 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 61
Query: 746 P-FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 804
+ + D +VME L + +++ +EY+HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 805 LGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
+HRD+KPDN L+ + + DFGL+K T
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART-------------------- 161
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921
+Q R + GT Y + LG E D S+G +L F G P+
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 922 FDNILNRK-----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK-G 975
P + E +N + + + ++ + F + G
Sbjct: 222 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 976 VNWD 979
++D
Sbjct: 282 FSYD 285
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-58
Identities = 85/348 (24%), Positives = 135/348 (38%), Gaps = 71/348 (20%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++P+ GA+G V A TG AIK L + + +R E +L +R+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 746 PFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 799
V+ FT + + YLVM ++ G L K L ED + + +++ L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 800 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 859
Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----------------------- 171
Query: 860 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 918
+ V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 172 -------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224
Query: 919 EIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRF 950
I+ K + + ++ S A +L+ +
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284
Query: 951 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 998
L+ D QR+ A E AHP+F+ ++ Q + + VD T
Sbjct: 285 LVLDAEQRV---TAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-57
Identities = 88/367 (23%), Positives = 135/367 (36%), Gaps = 77/367 (20%)
Query: 668 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 727
++ V+TP +R + K I G+FG V+ A+ +G+L AIK + +
Sbjct: 4 TTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------ 55
Query: 728 NDIERILAERNILITVRNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLL---R 778
D E I+ + + +VR Y F L LV++Y+ R
Sbjct: 56 -DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 779 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGL 837
L ++Y+ +L +L Y+HS GI HRD+KP NLL+ D +KL DFG +K
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--- 171
Query: 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADW 896
Q S + + Y APE++ G ++ + D
Sbjct: 172 -------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 897 WSVGIILFEFITGIPPFTAESPEIIFDNILN-------------------------RKIP 931
WS G +L E + G P F +S I+ + P
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 932 WPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVP 990
W V EA L +R L + P RL E AH FF + ++ L P
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNVKLPNGRDTP 323
Query: 991 QPESVDD 997
+
Sbjct: 324 ALFNFTT 330
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 197 bits (502), Expect = 8e-57
Identities = 79/339 (23%), Positives = 135/339 (39%), Gaps = 80/339 (23%)
Query: 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
E + DD+++++ + RG + VF A T + +K+LK ++I E IL
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKIL 83
Query: 741 ITVR-NPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 797
+R P ++ + LV E++N D L + L + R Y+ E++
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILK 140
Query: 798 ALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
AL+Y HS+GI+HRD+KP N++I H+ ++L D+GL++
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-------------------- 180
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 915
+ + V + + PE+L+ + + Y+ D WS+G +L I PF
Sbjct: 181 --------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
Query: 916 ESPEI----------------------------IFDNILNR-------KIPWPCVPSDMS 940
F++IL R + +S
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
Query: 941 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 979
EA D +++ L +D RL A E HP+F V D
Sbjct: 293 PEALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-56
Identities = 52/275 (18%), Positives = 110/275 (40%), Gaps = 35/275 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D +K + G FG V + R AIK++K+ M + + E +++ + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 804
+V+ + T + ++++ EY+ G L + LR + ++ A+EYL S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
+HRDL N L+ G +K++DFGLS+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--------------------------YVLD 152
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 923
+ + + + PE+L+ ++ +D W+ G++++E + G P+ + +
Sbjct: 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+I + P S + ++ ++R
Sbjct: 213 HIAQGLRLYR--PHLASEKVYTIMYSCWHEKADER 245
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 4e-56
Identities = 57/293 (19%), Positives = 114/293 (38%), Gaps = 42/293 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++++ + G FG V++ A+K LK+ + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQH 67
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 803
+VR Y+ ++ +Y++ EY+ G L L+ L + A++ + ++
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
+HRDL+ N+L++ K+ DFGL+++ +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL--------------------------IE 160
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922
+ R A + APE + +D WS GI+L E +T G P+ + +
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFF 973
N+ + P + E L+ P R +++ FF
Sbjct: 221 QNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFF 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (492), Expect = 5e-56
Identities = 71/317 (22%), Positives = 119/317 (37%), Gaps = 59/317 (18%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+E ++ I G +G VF A+ R T ++ A+K ++ D + L E +L +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKH 60
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 805
+VR L LV E+ + G L+ ++ + ++ +L+ L + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 806 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 865
++HRDLKP NLLI +G +KL +FGL++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARA---------------------------FGI 153
Query: 866 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITG-IPPFTAESPEIIFD 923
R + V T Y P++L G + + + D WS G I E P F +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 924 NILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 957
I V ++ +DL+ L +P Q
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 958 RLGANGAAEVKAHPFFK 974
R+ A E HP+F
Sbjct: 274 RI---SAEEALQHPYFS 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-56
Identities = 61/303 (20%), Positives = 114/303 (37%), Gaps = 58/303 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 740
++ E K + GAFG+V A A+K+LK+ ++ E +++E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELKMM 94
Query: 741 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-------------------- 779
+ + +V + T +YL+ EY GDL + LR
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 780 ---VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836
+ L + + ++ +E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD- 213
Query: 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896
++ R +A ++APE L + +D
Sbjct: 214 ------------------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
Query: 897 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 955
WS GI+L+E + G+ P+ + F ++ P + E ++ D
Sbjct: 250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDS 308
Query: 956 NQR 958
+R
Sbjct: 309 RKR 311
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-55
Identities = 61/294 (20%), Positives = 108/294 (36%), Gaps = 42/294 (14%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + + +G FG V++ T AIK LK E L E ++ +R+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLRH 71
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALEYLH 803
+V+ Y+ + +Y+V EY++ G L L A++ + Y+
Sbjct: 72 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
+ VHRDL+ N+L+ + K+ DFGL+++ +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARL--------------------------IE 164
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922
+ R A + APE L +D WS GI+L E T G P+ +
Sbjct: 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
Query: 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFFK 974
D + P + DL+ + +P +R ++A +F
Sbjct: 225 DQVERGYRMP--CPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFT 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 51/275 (18%), Positives = 102/275 (37%), Gaps = 35/275 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++ I G FG V L D AIK +++ E + E +++ + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSH 59
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLHS 804
P +V+ + + + LV E++ G L LR L + ++ + YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 864
++HRDL N L+ + IK++DFG+++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--------------------------VLD 153
Query: 865 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 923
+ + +PE+ + + +D WS G++++E + G P+ S + +
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+I + P S ++N P R
Sbjct: 214 DISTGFRLYK--PRLASTHVYQIMNHCWKERPEDR 246
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-55
Identities = 59/293 (20%), Positives = 107/293 (36%), Gaps = 48/293 (16%)
Query: 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 743
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 744 RN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCLEED 786
+ P ++ + R LYL +EY G+L LRK L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 787 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----------- 176
Query: 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 906
Q + ++A E L + + +D WS G++L+E
Sbjct: 177 -----------------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 907 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
++ G P+ + +++ + P + E DL+ + P +R
Sbjct: 220 VSLGGTPYCGMTCAELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYER 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 3e-55
Identities = 60/303 (19%), Positives = 106/303 (34%), Gaps = 59/303 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALM 70
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------- 781
NP +V+ + L+ EY+ GDL LR +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 782 -----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836
L ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN- 189
Query: 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 896
Y + + ++ PE + + +D
Sbjct: 190 ------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
Query: 897 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 955
W+ G++L+E + G+ P+ + E + + + I P + E +L+ P
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLP 283
Query: 956 NQR 958
R
Sbjct: 284 ADR 286
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 3e-55
Identities = 61/281 (21%), Positives = 104/281 (37%), Gaps = 27/281 (9%)
Query: 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNI 739
+ I +I + I G FG V + G +K L + L+E +I
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 740 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLA 798
+ +P V+ T + ++ E++ G L S LR G + +
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 799 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 858
++YL + VHRDL N+L+ + K++DFGLS+ + D
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----------------FLEDDTS 183
Query: 859 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917
P Y + APE + + A+D WS GI+++E ++ G P+ +
Sbjct: 184 DPTYTSALGG-----KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ + + I P P D L+ D N R
Sbjct: 239 NQDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-54
Identities = 61/288 (21%), Positives = 112/288 (38%), Gaps = 35/288 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 744
+ E+ + I G FG V + + +K + + E+ L E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 745 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLH 803
+P +V+ T + ++++ME G+L S L + L+ +Y +L AL YL
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
S VHRD+ N+L++ + +KL DFGLS+ +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------------------------ME 159
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922
+ ++APE + A+D W G+ ++E + G+ PF +
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970
I N + +P + L+ + +DP++R E+KA
Sbjct: 220 GRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-53
Identities = 58/324 (17%), Positives = 114/324 (35%), Gaps = 33/324 (10%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV-LKKL-DMIRKNDIERILAERNILITV 743
+F+ IK + GAFG V+ G+ I V +K+L + + IL E ++ +V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 744 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 803
NP V R + G L + + + ++ + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------------------- 166
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922
+ ++A E +L + + +D WS G+ ++E +T G P+ I
Sbjct: 167 ---EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
Query: 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 982
+ + P + + ++ + + D + R E+ +
Sbjct: 224 SILEKGERLPQ--PPICTIDVYMIMVKCWMIDADSRP---KFRELIIEFSKMARDPQRYL 278
Query: 983 LQKAVFVPQPESVDDTSYFLSRFS 1006
+ + S D++++ +
Sbjct: 279 VIQGDERMHLPSPTDSNFYRALMD 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 186 bits (474), Expect = 2e-53
Identities = 48/282 (17%), Positives = 96/282 (34%), Gaps = 36/282 (12%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 746
+++ + I G+FG +F AIK + ++D ++ E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 747 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 806
+ +Y + LV++ L L + +++ ++ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 807 IVHRDLKPDNLLIA-----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 861
+V+RD+KPDN LI + I + DFG+ K T
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-------------------- 161
Query: 862 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESP 918
Q R + + GT Y++ LG E D ++G + F+ G A +
Sbjct: 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
Query: 919 EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 958
+ ++ I +K P + + E ++ +
Sbjct: 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (463), Expect = 5e-52
Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 35/276 (12%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
D + + G +G V+ + A+K LK+ ++E L E ++ +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKH 72
Query: 746 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 803
P +V+ T Y++ E++ G+L LR+ + V ++ A+EYL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 804 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 863
+HRDL N L+ + +K+ DFGLS++
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------------------------MT 166
Query: 864 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 922
A + APE L + +D W+ G++L+E T G+ P+ ++
Sbjct: 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
Query: 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ + P + +L+ +P+ R
Sbjct: 227 ELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDR 260
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 9e-52
Identities = 81/347 (23%), Positives = 132/347 (38%), Gaps = 69/347 (19%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ ++ + P+ GA+G V A TG A+K L + +R E +L +++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 746 PFVVRFFYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 800
V+ FT N ++ +L G DL ++++ L +D + I +++ L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
Y+HS I+HRDLKP NL + D +K+ DFGL+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------------------- 168
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 919
+ + V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 169 ---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 920 IIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFL 951
IL K+ + V + A DL+ + L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 952 IHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 998
+ D ++R+ AA+ AH +F + + ES D
Sbjct: 286 VLDSDKRI---TAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLL 329
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 4e-51
Identities = 68/337 (20%), Positives = 129/337 (38%), Gaps = 80/337 (23%)
Query: 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 742
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 743 VRNPFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 796
V + ++ FT + ++YLVME ++ + ++ + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQML 129
Query: 797 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 856
+++LHS GI+HRDLKP N+++ D +K+ DFGL++
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------------------- 168
Query: 857 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 916
+ V T Y APE++LG + D WSVG I+ E + F
Sbjct: 169 -------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 917 SPEIIFDNILN---------------------------RKIPWPCVPSD----------- 938
++ ++ + +P + D
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 939 -MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN 315
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-50
Identities = 59/311 (18%), Positives = 109/311 (35%), Gaps = 48/311 (15%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
+ + + + +G+FG V+ K AIK + + +R + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 741 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----------KVGCLEEDVARI 790
VVR + ++ME + GDL S LR +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 791 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 850
E+ + YL++ VHRDL N ++A D +K+ DFG+
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM------------------ 179
Query: 851 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 910
Y+ R + +++PE L +D WS G++L+E T
Sbjct: 180 -------TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
Query: 911 -PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-- 967
P+ S E + ++ + P + +L+ ++P R
Sbjct: 233 EQPYQGLSNEQVLRFVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
Query: 968 -KAHPFFKGVN 977
+ P F+ V+
Sbjct: 291 EEMEPGFREVS 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-50
Identities = 60/298 (20%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
+ K + GAFG+V A K A+K+LK + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVL 80
Query: 741 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----------------- 782
+ N +V + T ++ EY GDL + LR+
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 783 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841
L+ + + ++ + +L S +HRDL N+L+ H K+ DFGL++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI----- 195
Query: 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 901
++ + +A ++APE + + + +D WS GI
Sbjct: 196 --------------------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 902 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
L+E + G P+ + F ++ P E D++ DP +R
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-49
Identities = 62/298 (20%), Positives = 115/298 (38%), Gaps = 54/298 (18%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGD-------LFAIKVLKKLDMIRKNDIERILAERN 738
D + KP+ GAFG+V LA A+K+LK + D+ +++E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEME 70
Query: 739 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------- 782
++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 783 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841
L ++ +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----- 185
Query: 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 901
+ + + ++APE L + + +D WS G+
Sbjct: 186 --------------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 902 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+L+E T G P+ E +F + PS+ + E ++ P+QR
Sbjct: 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 5e-47
Identities = 56/278 (20%), Positives = 95/278 (34%), Gaps = 32/278 (11%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 741
K I G FG V+ +T+ AIK LK + L E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--GYTEKQRVDFLGEAGIMG 64
Query: 742 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL-LRKVGCLEEDVARIYIAELVLALE 800
+ ++R + + ++ EY+ G L K G + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 801 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 860
YL ++ VHRDL N+L+ + K++DFGLS++
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL------------------------ 160
Query: 861 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920
E + APE + + A+D WS GI+++E +T E
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220
Query: 921 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+N P P D L+ + + +R
Sbjct: 221 EVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-46
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 55/309 (17%)
Query: 686 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 740
D ++ KP+ RGAFG+V A K T A+K+LK+ ++ +++E IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKIL 70
Query: 741 ITVRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----------------C 782
I + + V + L +++E+ G+L + LR
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 783 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842
L + Y ++ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD------- 183
Query: 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902
Y+ D + A ++APE + + +D WS G++
Sbjct: 184 ------------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 225
Query: 903 LFEFITGI-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 961
L+E + P+ + F L P + E + +P+QR
Sbjct: 226 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRP-- 282
Query: 962 NGAAEVKAH 970
+E+ H
Sbjct: 283 -TFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-46
Identities = 55/313 (17%), Positives = 106/313 (33%), Gaps = 67/313 (21%)
Query: 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 745
+ + I +G FG V+ + G+ A+K+ R+ AE + +R+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 746 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 801
++ F + + L+LV +Y G L+ L + E + ++ + L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASGLAH 115
Query: 802 LHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 853
LH I HRDLK N+L+ +G + D GL+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------- 156
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH------GYAADWWSVGIILFEFI 907
+ T + + VGT Y+APE+L + + AD +++G++ +E
Sbjct: 157 ----RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212
Query: 908 TGIPPFTAESP-------------------EIIFDNILNRKIPWPCVPSDMSFEAQDLIN 948
+++ + L IP + ++
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
Query: 949 RFLIHDPNQRLGA 961
+ RL A
Sbjct: 273 ECWYANGAARLTA 285
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 53/271 (19%), Positives = 99/271 (36%), Gaps = 33/271 (12%)
Query: 694 ISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 750
I RG FG V+ A+K L ++ ++ + L E I+ +P V+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 751 FF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 808
+ +V+ Y+ GDL + +R I ++ +++L S V
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 809 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 868
HRDL N ++ +K+ DFGL++ + +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARD-----------------------MYDKEFDSVH 189
Query: 869 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 927
N+ A ++A E L + +D WS G++L+E +T G PP+ + I +L
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 928 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 958
+ P +++ + R
Sbjct: 250 GRRLLQ--PEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (365), Expect = 3e-38
Identities = 57/348 (16%), Positives = 119/348 (34%), Gaps = 87/348 (25%)
Query: 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-------L 740
+ +++ + G F V+LA+ A+K+++ + + + I + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 741 ITVRNPFVVRFFYSFT--CRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAEL 795
++ +++ F + +++VM + G + + + +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 796 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIM 853
+L L+Y+ GI+H D+KP+N+L+ L ++ +G +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---------- 184
Query: 854 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913
+ +++ T +Y +PE+LLG G AD WS ++FE ITG F
Sbjct: 185 ---------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 914 TAESPEIIFDNI------------------------------------LNRKIPWPC--- 934
+ + +++ WP
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
Query: 935 ------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976
D + E D ++ L DP +R A + HP+ K
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 334
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 8e-20
Identities = 27/161 (16%), Positives = 50/161 (31%), Gaps = 28/161 (17%)
Query: 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAER---- 737
I K + G VF +K K K+ R
Sbjct: 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 738 ----NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 793
L ++ V + + ++ME ++ +LY + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLD 110
Query: 794 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834
++ + + GIVH DL N+L+ + I + DF S
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1091 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.14 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.22 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-66 Score=567.23 Aligned_cols=300 Identities=41% Similarity=0.757 Sum_probs=275.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~L 761 (1091)
++++++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|+.++|||||+++++|++.+.+
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 35678999999999999999999999999999999999987666666788999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
|+|||||+||+|.+++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~---- 156 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI---- 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC----
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998531
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.......+.+||+.|||||++.+.+|+.++|||||||++|||++|++||.+.+..++
T Consensus 157 -----------------------~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 213 (337)
T d1o6la_ 157 -----------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp -----------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -----------------------cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH
Confidence 112234567999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 997 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~D 997 (1091)
+..+....+.+| ..+|+++++||.+||++||.+|++. .++.++++||||++++|+.+..+ .||++|.+.+..|
T Consensus 214 ~~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~ 290 (337)
T d1o6la_ 214 FELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVD 290 (337)
T ss_dssp HHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTC
T ss_pred HHHHhcCCCCCC---ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhh
Confidence 999999987776 6899999999999999999999973 25899999999999999998765 7899999999999
Q ss_pred ccccccccccCCCC
Q 001370 998 TSYFLSRFSQISSG 1011 (1091)
Q Consensus 998 ts~Fds~fs~~~s~ 1011 (1091)
+.+|+..+......
T Consensus 291 ~~~f~~~~~~~~~~ 304 (337)
T d1o6la_ 291 TRYFDDEFTAQSIT 304 (337)
T ss_dssp CTTSCHHHHTSCCC
T ss_pred hhhcCchhhhccCC
Confidence 99999877665443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-63 Score=532.78 Aligned_cols=280 Identities=36% Similarity=0.718 Sum_probs=252.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
...++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+++|++++|||||+++++|.+++.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34578999999999999999999999999999999998766555667788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~--- 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999853210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+++
T Consensus 162 ----------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 219 (288)
T d1uu3a_ 162 ----------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219 (288)
T ss_dssp ------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH
Confidence 0112234578999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc---HHHHHcCCCCCCCCcchhhcccCCccC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG---AAEVKAHPFFKGVNWDSLALQKAVFVP 990 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g---A~EIL~HPFFkgIdWd~L~~~~pPfiP 990 (1091)
.+|.+..+.+| ..+++++++||.+||++||.+|||+++ ...|++||||++++|+.+..+.||-+|
T Consensus 220 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 220 QKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHTTCCCCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 99999887766 689999999999999999999999653 456899999999999999988877665
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-62 Score=532.95 Aligned_cols=287 Identities=40% Similarity=0.768 Sum_probs=254.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 46789999999999999999999999999999999987665555667889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||||.||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~------ 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 155 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.
T Consensus 156 ------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 156 ------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp ------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ------------------------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH
Confidence 11235789999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCC-CCCc
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES-VDDT 998 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s-~~Dt 998 (1091)
+|.++...+| ..+|+++++||.+||++||.+|++. ..+.++++||||++++|+.+..+ .+||+|.... ..|+
T Consensus 212 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~ 288 (316)
T d1fota_ 212 KILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDT 288 (316)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-------
T ss_pred HHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchh
Confidence 9999887766 6899999999999999999999852 24889999999999999998665 7889887644 4678
Q ss_pred ccccc
Q 001370 999 SYFLS 1003 (1091)
Q Consensus 999 s~Fds 1003 (1091)
++|+.
T Consensus 289 ~~f~~ 293 (316)
T d1fota_ 289 SQFDK 293 (316)
T ss_dssp -----
T ss_pred hhcCC
Confidence 88765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-62 Score=537.65 Aligned_cols=291 Identities=39% Similarity=0.763 Sum_probs=244.5
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCceEEEeeeeccCCeeEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILs-kL~HPNIVkL~gsfqded~LYL 763 (1091)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|..++. .++|||||+++++|.+.+.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998765555566778888888776 6899999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||||+||+|.+++...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~----- 155 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML----- 155 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-----
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999984210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
........+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.
T Consensus 156 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 156 ----------------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213 (320)
T ss_dssp ----------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ----------------------ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1122344689999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcccc
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 1001 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts~F 1001 (1091)
+|..+...+| ..+|+++++||.+||++||.+||++. .++++||||++++|+.+..+ .||++|...++.|.++|
T Consensus 214 ~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~s~~--~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f 288 (320)
T d1xjda_ 214 SIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 288 (320)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC---------------
T ss_pred HHHcCCCCCC---ccCCHHHHHHHHHhcccCCCCCcCHH--HHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhc
Confidence 9998876655 78999999999999999999999942 27899999999999988655 78999999999999999
Q ss_pred cccccc
Q 001370 1002 LSRFSQ 1007 (1091)
Q Consensus 1002 ds~fs~ 1007 (1091)
+..+..
T Consensus 289 ~~~~~~ 294 (320)
T d1xjda_ 289 DKEFLN 294 (320)
T ss_dssp ------
T ss_pred ChHhhh
Confidence 876543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-62 Score=536.92 Aligned_cols=288 Identities=40% Similarity=0.779 Sum_probs=264.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+++|+.+|+.++|||||+++++|.+...+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 35799999999999999999999999999999999987665555667889999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~------ 192 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS------
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+...++.
T Consensus 193 ------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 248 (350)
T d1rdqe_ 193 ------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp ------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ------------------------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH
Confidence 11235789999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCCCCCCCCcc
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTS 999 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~~~s~~Dts 999 (1091)
+|......+| ..+|+++.+||.+||++||.+|+.. ..+.++++||||++++|+.+..+ .|||+|...++.|++
T Consensus 249 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s 325 (350)
T d1rdqe_ 249 KIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS 325 (350)
T ss_dssp HHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCT
T ss_pred HHhcCCCCCC---ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhh
Confidence 9999887665 7899999999999999999999731 24889999999999999998766 789999999999999
Q ss_pred ccccc
Q 001370 1000 YFLSR 1004 (1091)
Q Consensus 1000 ~Fds~ 1004 (1091)
+|++.
T Consensus 326 ~~~~~ 330 (350)
T d1rdqe_ 326 NFDDY 330 (350)
T ss_dssp TSCCC
T ss_pred hcCCC
Confidence 98763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-60 Score=525.75 Aligned_cols=288 Identities=35% Similarity=0.623 Sum_probs=240.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhcCCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~E---ieILskL~HPNIVkL~gsfqded 759 (1091)
+++++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+| +.++..++|||||+++++|.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 357899999999999999999999999999999999987554444444445555 55666778999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
.+|||||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~-- 158 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-- 158 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS--
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+.
T Consensus 159 ---------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 159 ---------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp ---------------------------SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred ---------------------------CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 112345689999999999974 6799999999999999999999999987654
Q ss_pred H---HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCc--ccHHHHHcCCCCCCCCcchhhcc--cCCccCC
Q 001370 919 E---IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 991 (1091)
Q Consensus 919 ~---ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa--~gA~EIL~HPFFkgIdWd~L~~~--~pPfiP~ 991 (1091)
. .+.+.+......+ +..+|+++++||.+||++||.+|||. ..|.++++||||++++|+.+..+ +||++|.
T Consensus 212 ~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~ 288 (364)
T d1omwa3 212 KDKHEIDRMTLTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 288 (364)
T ss_dssp SCHHHHHHHSSSCCCCC---CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHHHHhcccCCCCC---CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCC
Confidence 3 3444444444443 47899999999999999999999994 35899999999999999998766 7889998
Q ss_pred CCCCCCccccc
Q 001370 992 PESVDDTSYFL 1002 (1091)
Q Consensus 992 ~~s~~Dts~Fd 1002 (1091)
.......+.|+
T Consensus 289 ~~~~~~~~~~d 299 (364)
T d1omwa3 289 RGEVNAADAFD 299 (364)
T ss_dssp CC---------
T ss_pred CCCCCcCCccc
Confidence 77665555554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-60 Score=504.18 Aligned_cols=257 Identities=36% Similarity=0.650 Sum_probs=237.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 35689999999999999999999999999999999998766555556778999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----- 157 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 157 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC-----
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++
T Consensus 158 ------------------------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 213 (263)
T d2j4za1 158 ------------------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213 (263)
T ss_dssp ------------------------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred ------------------------CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH
Confidence 11223568999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 923 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 923 ~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
.++.+....+| ..+|+++++||.+||++||.+||| +.|+++||||.
T Consensus 214 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~t---~~eil~hp~~~ 259 (263)
T d2j4za1 214 KRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWIT 259 (263)
T ss_dssp HHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTCHHHH
T ss_pred HHHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcC---HHHHHcCcCcC
Confidence 99998887666 689999999999999999999999 88999999995
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-59 Score=496.58 Aligned_cols=261 Identities=28% Similarity=0.477 Sum_probs=222.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++++.||+|+||+||+|+++.+|+.||||++++... .+..+.+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5789999999999999999999999999999999986432 23346789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....+
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~---- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 157 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999998532111
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
......+.+||+.|||||++.+..| +.++|||||||++|||++|++||...+......
T Consensus 158 ---------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~ 216 (271)
T d1nvra_ 158 ---------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216 (271)
T ss_dssp ---------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH
T ss_pred ---------------------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH
Confidence 1122346789999999999998776 678999999999999999999998765443333
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.........+.....+|+++++||.+||++||.+||| +.|+++||||+.
T Consensus 217 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~ 265 (271)
T d1nvra_ 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTC
T ss_pred HHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCc
Confidence 3333322333334678999999999999999999999 889999999963
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-58 Score=491.77 Aligned_cols=266 Identities=29% Similarity=0.500 Sum_probs=234.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~---~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+.|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 569999999999999999999999999999999987544322 23678999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC----cEEEEecCCcccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLI 838 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG----~VKLsDFGLAk~~~~ 838 (1091)
||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+| ++||+|||+|+...
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~- 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 168 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT-
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC-
Confidence 9999999999999999989999999999999999999999999999999999999999877 59999999998531
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 169 ---------------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 221 (293)
T d1jksa_ 169 ---------------------------FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221 (293)
T ss_dssp ---------------------------TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH
Confidence 11223456899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchhh
Q 001370 919 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 982 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L~ 982 (1091)
.+++..|......++. .+..+|+++++||.+||+.||.+||| +.++++||||++.+|+...
T Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTCC-------
T ss_pred HHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCChhHhh
Confidence 9999999888776542 23578999999999999999999999 8899999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=493.02 Aligned_cols=256 Identities=34% Similarity=0.547 Sum_probs=228.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
++|++++.||+|+||+||+|+++.+|+.||||++++... ...+.+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 469999999999999999999999999999999986543 23467899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCC
Q 001370 766 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 845 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls 845 (1091)
|||+||+|.+++.+ +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~------- 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------- 168 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-------
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc-------
Confidence 99999999998765 5799999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 846 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 846 ~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
........+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+....+
T Consensus 169 --------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 169 --------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (293)
T ss_dssp --------------------TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred --------------------ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 112234568999999999999999999999999999999999999999999888877777
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 926 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 926 l~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
.....+....+..+|+++++||.+||++||.+||| +.|+|+||||+.
T Consensus 229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~Hp~~~~ 275 (293)
T d1yhwa1 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (293)
T ss_dssp HHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHTTCGGGGG
T ss_pred HhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCC
Confidence 76544333345789999999999999999999999 889999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-57 Score=495.04 Aligned_cols=258 Identities=34% Similarity=0.589 Sum_probs=218.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|..++|||||+++++|.+.+.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35699999999999999999999999999999999875432 2345688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec---CCCcEEEEecCCccccccccc
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD---~nG~VKLsDFGLAk~~~~~~s 841 (1091)
||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||+. .+|++||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~---- 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---- 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc----
Confidence 99999999999999989999999999999999999999999999999999999995 57899999999998521
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..++
T Consensus 162 ------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 162 ------------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp -----------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 11223457899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 922 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 922 ~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+..|......++. .+..+|+++++||.+||++||.+||| +.|+++||||++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 269 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT---CEQALQHPWIAG 269 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTTS
T ss_pred HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCC
Confidence 9999988766542 34679999999999999999999999 889999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=489.72 Aligned_cols=257 Identities=32% Similarity=0.548 Sum_probs=230.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 765 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVM 765 (1091)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. ....+.+.+|+++|++++|||||+++++|.+.+.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999997642 345567899999999999999999999999999999999
Q ss_pred eecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||+||+|.+++.+. +.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~------ 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR------ 162 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH------
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC------
Confidence 999999999998754 5699999999999999999999999999999999999999999999999999975211
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-----CCCCCccceeechhhhHHHHHhCCCCCCCCChH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 919 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ 919 (1091)
......+.+||+.|||||++. +..|+.++|||||||++|||++|++||.+.+..
T Consensus 163 ---------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 163 ---------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp ---------------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred ---------------------CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence 011234578999999999984 456899999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
+++.++.....+....+..+|+++++||.+||++||.+||| +.|+++||||+.
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~ell~hp~~~~ 274 (288)
T d2jfla1 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT---TSQLLQHPFVTV 274 (288)
T ss_dssp GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSGGGCC
T ss_pred HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCC
Confidence 99999988766554456789999999999999999999999 889999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-58 Score=497.95 Aligned_cols=262 Identities=31% Similarity=0.521 Sum_probs=224.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 762 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LY 762 (1091)
+..++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45679999999999999999999999999999999997632 3344678899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 763 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~---- 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 156 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC----
Confidence 999999999999999999999999999999999999999997 599999999999999999999999999998531
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 921 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei 921 (1091)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus 157 -------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 157 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211 (322)
T ss_dssp -------------------------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH
T ss_pred -------------------------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 1122457899999999999999999999999999999999999999987653322
Q ss_pred HH------------------------------------------HHhhcCCCCCCCC-CCCCHHHHHHHhhhccCCCCCC
Q 001370 922 FD------------------------------------------NILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQR 958 (1091)
Q Consensus 922 ~~------------------------------------------kIl~~~l~fP~ip-~~lS~eakDLI~rcL~kDPeKR 958 (1091)
.. .+... ..|..+ ..+|.+++|||.+||+.||.+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 212 ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp HHHC------------------------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHC
Confidence 11 11111 111111 3468999999999999999999
Q ss_pred CCcccHHHHHcCCCCCCCCcch
Q 001370 959 LGANGAAEVKAHPFFKGVNWDS 980 (1091)
Q Consensus 959 pSa~gA~EIL~HPFFkgIdWd~ 980 (1091)
|| |.|+|+||||+..+|+.
T Consensus 290 ~t---a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 290 AD---LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp CC---HHHHHTSHHHHHHHHSC
T ss_pred cC---HHHHhhCHhhCcCCccc
Confidence 99 88999999998776654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-56 Score=496.35 Aligned_cols=264 Identities=28% Similarity=0.510 Sum_probs=236.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|.+++|||||+++++|.+.+.+||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4679999999999999999999999999999999997643 3456788999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC--CCcEEEEecCCcccccccc
Q 001370 764 VMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~-k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~--nG~VKLsDFGLAk~~~~~~ 840 (1091)
|||||+||+|.+++. ..+.+++..++.|+.||+.||.|||++|||||||||+||||+. +|.+||+|||+|+...
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~--- 177 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 177 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC---
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc---
Confidence 999999999999995 4467999999999999999999999999999999999999964 6899999999998531
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 178 -------------------------~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 178 -------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp -------------------------TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 1122345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCcchh
Q 001370 921 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 981 (1091)
Q Consensus 921 i~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdWd~L 981 (1091)
++..|......++. ....+|+++++||.+||++||.+||| +.|+|+||||+..+|...
T Consensus 233 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp HHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC---HHHHHHSTTTSCTTCCSC
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCCCCCc
Confidence 99999988766553 22468999999999999999999999 889999999998877543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-57 Score=480.17 Aligned_cols=256 Identities=32% Similarity=0.546 Sum_probs=219.4
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLY 762 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd--ed~LY 762 (1091)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .+...+.+.+|+++|.+++|||||++++++.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4789999999999999999999999999999999987544 45567789999999999999999999999865 45689
Q ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecccCCCceEecCCCcEEEEecCCc
Q 001370 763 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLS 833 (1091)
Q Consensus 763 LVMEYm~GGSL~dlL~k----~g~LsE~~ar~yaaQIa~ALeYLHs~G-----IIHRDLKPeNILLD~nG~VKLsDFGLA 833 (1091)
+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||+.| ||||||||+||||+.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 357999999999999999999999977 999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCC
Q 001370 834 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 913 (1091)
Q Consensus 834 k~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF 913 (1091)
+.... ......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||
T Consensus 162 ~~~~~---------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 162 RILNH---------------------------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp HHC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eeccc---------------------------CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 85310 112234578999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCC
Q 001370 914 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 973 (1091)
Q Consensus 914 ~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFF 973 (1091)
.+.+..++..+|.++..+ .++..+|+++++||.+||+.||.+||| +.|+++|||.
T Consensus 215 ~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps---~~ell~hp~i 269 (269)
T d2java1 215 TAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLI 269 (269)
T ss_dssp CCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTC
T ss_pred CCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHHcCCChhHCcC---HHHHHhCCcC
Confidence 999999999999887653 345789999999999999999999999 8899999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=475.72 Aligned_cols=252 Identities=24% Similarity=0.456 Sum_probs=220.0
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCeeEE
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYL 763 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd----ed~LYL 763 (1091)
|++.+.||+|+||+||+|+++.+++.||+|++.+... .....+.+.+|+++|++++|||||++|++|.+ ...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4777899999999999999999999999999987543 34567789999999999999999999999865 356899
Q ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecccCCCceEec-CCCcEEEEecCCcccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~G--IIHRDLKPeNILLD-~nG~VKLsDFGLAk~~~~~~ 840 (1091)
||||++||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+||||+ .+|.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence 9999999999999999899999999999999999999999999 99999999999996 58999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC-hH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PE 919 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s-~~ 919 (1091)
.....+.+||+.|||||++.+ +|+.++|||||||++|||++|++||.+.. ..
T Consensus 167 --------------------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~ 219 (270)
T d1t4ha_ 167 --------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219 (270)
T ss_dssp --------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred --------------------------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH
Confidence 112345789999999999876 59999999999999999999999997654 55
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 920 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 920 ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
.+++.+..+..+ +.++...++++++||.+||.+||++||| +.|+++||||+
T Consensus 220 ~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~ell~Hp~fk 270 (270)
T d1t4ha_ 220 QIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC
T ss_pred HHHHHHHcCCCC-cccCccCCHHHHHHHHHHccCCHhHCcC---HHHHhCCcccC
Confidence 666666655332 3345678999999999999999999999 88999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-56 Score=487.19 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=230.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
.|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|.+++|||||+++++|.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987666666677889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
||.||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC---------
Confidence 99999998888888899999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.
T Consensus 167 ----------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 167 ----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (309)
T ss_dssp ----------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 1234689999999999964 468999999999999999999999999999888888
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
++..+..+.+ .+..+|+++++||.+||++||.+||| +.++++||||..
T Consensus 225 ~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 225 HIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLR 272 (309)
T ss_dssp HHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHS
T ss_pred HHHhCCCCCC-CCCCCCHHHHHHHHHHCcCChhHCcC---HHHHHhCHHhcC
Confidence 8887765433 24678999999999999999999999 889999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-56 Score=490.97 Aligned_cols=259 Identities=25% Similarity=0.482 Sum_probs=233.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+|+.+|++++|||||+++++|.+++.+||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999998643 2345678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEec--CCCcEEEEecCCcccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD--~nG~VKLsDFGLAk~~~~~~ 840 (1091)
|||||+||+|.+++.+.+ .|++..++.++.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+...
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~--- 180 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--- 180 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC---
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC---
Confidence 999999999999886654 699999999999999999999999999999999999998 57899999999998531
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 181 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 235 (352)
T d1koba_ 181 -------------------------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235 (352)
T ss_dssp -------------------------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred -------------------------CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1122345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 921 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 921 i~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
++..|......+|. .+..+|+++++||.+||++||.+||| +.|+|+||||++.
T Consensus 236 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~Hp~~~~~ 289 (352)
T d1koba_ 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSC
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCCC
Confidence 99999988776653 34679999999999999999999999 8899999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.5e-55 Score=467.25 Aligned_cols=260 Identities=31% Similarity=0.510 Sum_probs=232.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhcC-CCceEEEeeeecc
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNILITVR-NPFVVRFFYSFTC 757 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~------~~eie~~l~EieILskL~-HPNIVkL~gsfqd 757 (1091)
.++|++.+.||+|+||+||+|+++.+|+.||||++++..... +...+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999998754322 223457889999999997 9999999999999
Q ss_pred CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 758 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
++.+|||||||+||+|.++|...+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC------CCCCccceeechhhhHHHHHhCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g------~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++
T Consensus 162 ~----------------------------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 162 P----------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp T----------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred C----------------------------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence 0 112234689999999999863 457889999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 912 PFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 912 PF~~~s~~ei~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
||.+.+...+...|.++...++. ....+|+++++||.+||++||.+||+ +.|+++||||+.
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s---~~eil~h~~~~~ 275 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQ 275 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCT
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHHHH
Confidence 99999999999999988766553 22479999999999999999999999 889999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=468.90 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=217.0
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchh--HHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 001370 689 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 766 (1091)
Q Consensus 689 eilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~--eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVME 766 (1091)
+.+++||+|+||+||+|+++.+|+.||||++++....... ....+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3578999999999999999999999999999764432211 23568899999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCC
Q 001370 767 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 846 (1091)
Q Consensus 767 Ym~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~ 846 (1091)
|+.||++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~-------- 152 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-------- 152 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--------
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--------
Confidence 999988887777777899999999999999999999999999999999999999999999999999974210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCCCChHHHHHHH
Q 001370 847 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 925 (1091)
Q Consensus 847 ~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~kI 925 (1091)
......+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..++..+|
T Consensus 153 -------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i 213 (299)
T d1ua2a_ 153 -------------------PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213 (299)
T ss_dssp -------------------CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -------------------CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH
Confidence 1122345689999999999875 56899999999999999999999999999998888877
Q ss_pred hhcCC-----CC---------------CC-----CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 926 LNRKI-----PW---------------PC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 926 l~~~l-----~f---------------P~-----ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
..... .+ +. +...++++++|||.+||++||++||| |.|+|+||||++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s---a~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYFSNR 286 (299)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGGTSS
T ss_pred HHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC---HHHHhCCHhhCCC
Confidence 64200 00 11 11357899999999999999999999 8899999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=477.06 Aligned_cols=257 Identities=27% Similarity=0.493 Sum_probs=231.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. .+...+.+|+++|..++|||||+++++|.+.+.+||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999997642 334568899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCC--CcEEEEecCCcccccccc
Q 001370 764 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~n--G~VKLsDFGLAk~~~~~~ 840 (1091)
|||||+||+|.+++.+.+ .+++..++.|+.||+.||.|||++|||||||||+|||++.+ +.+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 999999999999998765 69999999999999999999999999999999999999854 489999999998521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
......+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 156 -------------------------~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 156 -------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------------------------cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence 1122345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 921 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 921 i~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
++..|.+....+|. ....+|+++++||.+||++||.+||| +.|+++||||+.
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~ 263 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred HHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhcc
Confidence 99999998877653 12468999999999999999999999 889999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=477.80 Aligned_cols=287 Identities=42% Similarity=0.792 Sum_probs=244.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEE---CCCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhcCC-CceEEEeeeec
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVRN-PFVVRFFYSFT 756 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~---k~TGk~VAIKiLkK~~i~-~~~eie~~l~EieILskL~H-PNIVkL~gsfq 756 (1091)
++.+++|++++.||+|+||+||+|++ +.+|+.||||++++.... .....+.+.+|+.+|++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 35678999999999999999999987 447899999999765432 22345678899999999976 89999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+...+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC--CCCccceeechhhhHHHHHhCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
.. .......+..||+.|+|||++.+. .|+.++|||||||+||||++|..||.
T Consensus 180 ~~--------------------------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 180 VA--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CG--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cc--------------------------cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 21 112223457899999999999764 46889999999999999999999998
Q ss_pred CCChHHHHHH----HhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc--cHHHHHcCCCCCCCCcchhhcc--cC
Q 001370 915 AESPEIIFDN----ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KA 986 (1091)
Q Consensus 915 ~~s~~ei~~k----Il~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~--gA~EIL~HPFFkgIdWd~L~~~--~p 986 (1091)
+.+..+.... ......++ +..+|+++.+||.+||.+||.+||+.. .|.|+++||||++++|+.+..+ ++
T Consensus 234 ~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~ 310 (322)
T d1vzoa_ 234 VDGEKNSQAEISRRILKSEPPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310 (322)
T ss_dssp CTTSCCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCCHHHHHHHHHHhcccCCCCC---cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCc
Confidence 7665444333 33444443 468999999999999999999999843 5899999999999999999876 78
Q ss_pred CccCCCCCCCC
Q 001370 987 VFVPQPESVDD 997 (1091)
Q Consensus 987 PfiP~~~s~~D 997 (1091)
|++|..++..|
T Consensus 311 p~~p~~~~~~~ 321 (322)
T d1vzoa_ 311 PFKPVIRDELD 321 (322)
T ss_dssp SCCCCCCC-CC
T ss_pred CCCCCCCCCCC
Confidence 99998887655
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=455.91 Aligned_cols=263 Identities=30% Similarity=0.441 Sum_probs=218.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeecc---
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTC--- 757 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~T-Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL---~HPNIVkL~gsfqd--- 757 (1091)
.++|++++.||+|+||+||+|+++.+ ++.||||++++... .......+.+|+.+|+.+ +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999766 67899999976432 222233456777776655 79999999999853
Q ss_pred --CCeeEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcc
Q 001370 758 --RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 834 (1091)
Q Consensus 758 --ed~LYLVMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk 834 (1091)
...+|++|||+.+|.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3568999999999877655443 3569999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC
Q 001370 835 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 914 (1091)
Q Consensus 835 ~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~ 914 (1091)
... ........+||+.|||||++.+..|+.++|||||||++|||++|++||.
T Consensus 165 ~~~----------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 165 IYS----------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CCC----------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhc----------------------------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 421 1122345789999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHhhcC------------------------CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 915 AESPEIIFDNILNRK------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 915 ~~s~~ei~~kIl~~~------------------------l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+.+..++..+|+... .+.+.++..++++++|||.+||++||.+||| |.|+|+|
T Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s---a~e~L~H 293 (305)
T d1blxa_ 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALSH 293 (305)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHHHTS
T ss_pred CCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC---HHHHhcC
Confidence 999888887775410 0111134568999999999999999999999 8899999
Q ss_pred CCCCCCCcc
Q 001370 971 PFFKGVNWD 979 (1091)
Q Consensus 971 PFFkgIdWd 979 (1091)
|||+++++.
T Consensus 294 pff~~i~~~ 302 (305)
T d1blxa_ 294 PYFQDLERC 302 (305)
T ss_dssp GGGTTCCCC
T ss_pred hhhcCchhh
Confidence 999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-54 Score=456.87 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=219.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchh---HHHHHHHHHHHHHhcC--CCceEEEeeeeccCCe
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILITVR--NPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~---eie~~l~EieILskL~--HPNIVkL~gsfqded~ 760 (1091)
++|++.+.||+|+||+||+|+++.+|+.||||++++....... ...++.+|+.+|++++ |||||+++++|.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999999999999999999875433221 2234678999999987 8999999999999999
Q ss_pred eEEEEeecCC-CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-CCcEEEEecCCcccccc
Q 001370 761 LYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 761 LYLVMEYm~G-GSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-nG~VKLsDFGLAk~~~~ 838 (1091)
+|+||||+.+ +++.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~- 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK- 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC-
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc-
Confidence 9999999976 688999988899999999999999999999999999999999999999985 4799999999997521
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
.....+.+||+.|||||++.+..| +.++|||||||++|||++|++||.+.+
T Consensus 163 ----------------------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 163 ----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp ----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred ----------------------------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 112235689999999999987665 678999999999999999999997632
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
.+......++ ..+|+++++||.+||.+||.+||| +.|+++||||+++..
T Consensus 215 ------~i~~~~~~~~---~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 215 ------EIIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVLL 263 (273)
T ss_dssp ------HHHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCCC
T ss_pred ------HHhhcccCCC---CCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCCCC
Confidence 4556665555 689999999999999999999999 889999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=454.99 Aligned_cols=262 Identities=31% Similarity=0.504 Sum_probs=218.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+++|++++|||||+++++|.+.+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 479999999999999999999999999999999997543 2333457889999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccccc
Q 001370 765 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 843 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~d 843 (1091)
|||+.++.+...... ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~------ 153 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG------ 153 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC------
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc------
Confidence 999976544433333 3569999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC-CccceeechhhhHHHHHhCCCCCCCCChHHHH
Q 001370 844 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 922 (1091)
Q Consensus 844 ls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y-s~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~ 922 (1091)
.........+||+.|+|||++....+ +.++|+|||||++|+|++|++||.+.+..+..
T Consensus 154 ---------------------~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~ 212 (298)
T d1gz8a_ 154 ---------------------VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212 (298)
T ss_dssp ---------------------CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ---------------------CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH
Confidence 11223345689999999999887664 78999999999999999999999999887777
Q ss_pred HHHhhcCC-----CC-------------CC--------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 923 DNILNRKI-----PW-------------PC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 923 ~kIl~~~l-----~f-------------P~--------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.++..... .+ +. ....+|++++|||.+||++||.+||| +.|+++||||+++
T Consensus 213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t---~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS---AKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGTTC
T ss_pred HHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhCCHhhccC
Confidence 66653110 00 00 11357899999999999999999999 8899999999877
Q ss_pred C
Q 001370 977 N 977 (1091)
Q Consensus 977 d 977 (1091)
.
T Consensus 290 ~ 290 (298)
T d1gz8a_ 290 T 290 (298)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-52 Score=445.23 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=216.5
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe----
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN---- 760 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~---- 760 (1091)
.++|++.+.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3679999999999999999999999999999999987665556667889999999999999999999999987653
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~ 840 (1091)
+||||||++||+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.++.++|+|||+++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~- 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS- 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc-
Confidence 8999999999999999999999999999999999999999999999999999999999999999999999998743110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
........+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 165 -----------------------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 165 -----------------------GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp -------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH
Confidence 011223456789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHhhhccCCCCCCCC
Q 001370 921 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLG 960 (1091)
Q Consensus 921 i~~kIl~~~l~fP~-ip~~lS~eakDLI~rcL~kDPeKRpS 960 (1091)
+..+++......|. ....+|+++++||.+||++||.+||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh
Confidence 88888877654432 34679999999999999999999995
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=469.88 Aligned_cols=254 Identities=31% Similarity=0.529 Sum_probs=214.4
Q ss_pred ccCCCeEEEE-eeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeecc---
Q 001370 683 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTC--- 757 (1091)
Q Consensus 683 ~~iddFeilr-~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILsk-L~HPNIVkL~gsfqd--- 757 (1091)
..+++|+++. +||+|+||+||+|+++.+|+.||||++++. ..+.+|+.++.+ .+|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3468999985 699999999999999999999999999753 346789988765 489999999999876
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CCcEEEEecC
Q 001370 758 -RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 831 (1091)
Q Consensus 758 -ed~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFG 831 (1091)
...+|||||||+||+|.++|.+.+ .|++..++.|+.||+.||+|||++|||||||||+|||++. ++++||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 467999999999999999998753 6999999999999999999999999999999999999985 5689999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 911 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkp 911 (1091)
+|+.... .......+||+.|||||++.+..|+.++|||||||+||+|++|++
T Consensus 160 ~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 160 FAKETTS----------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp TCEECCC----------------------------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred eeeeccC----------------------------CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 9985311 112345689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHH----HHHhhcCCCCCCC-CCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 912 PFTAESPEIIF----DNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 912 PF~~~s~~ei~----~kIl~~~l~fP~i-p~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
||.+.+..... ..+......+|.. ...+|+++++||.+||++||.+||+ +.|+++||||..
T Consensus 212 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 277 (335)
T d2ozaa1 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 277 (335)
T ss_dssp SCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSHHHHT
T ss_pred CCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHhhC
Confidence 99887654443 3444455555431 1358999999999999999999999 889999999954
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.5e-53 Score=446.67 Aligned_cols=259 Identities=29% Similarity=0.494 Sum_probs=220.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++++.||+|+||+||+|+++ +|+.||||++++... .......+.+|+.+|++++|||||+++++|...+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 478999999999999999999986 789999999976432 334467899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||+.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|.....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~------ 152 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI------ 152 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc------
Confidence 99999988888887788999999999999999999999999999999999999999999999999999975310
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~ei~~ 923 (1091)
........+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.
T Consensus 153 ---------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~ 211 (286)
T d1ob3a_ 153 ---------------------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (286)
T ss_dssp ------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ---------------------CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH
Confidence 11223445799999999999764 56999999999999999999999999988877777
Q ss_pred HHhhcC--------------------------CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCC
Q 001370 924 NILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 975 (1091)
Q Consensus 924 kIl~~~--------------------------l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkg 975 (1091)
++.... .+++.....++++++|||++||++||++||| +.|+++||||+.
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s---~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC
T ss_pred HHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCc
Confidence 664310 0111123567899999999999999999999 889999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-52 Score=450.32 Aligned_cols=254 Identities=21% Similarity=0.339 Sum_probs=217.3
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.++++..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|++++|||||+++++|.+.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 456677889999999999999999999999999999999997643 2456799999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+.+|+|||||++|+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999999764 46899999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCC-CCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkp-PF~~ 915 (1091)
... .........||+.|||||++.+..|+.++|||||||++|||++|.. ||.+
T Consensus 166 ~~~--------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 166 TGD--------------------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CSS--------------------------SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCC--------------------------CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 110 0111234568999999999999999999999999999999999655 5556
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
.+...++..+..+ .. +..+..+|+++++||.+||+.||.+||++.++
T Consensus 220 ~~~~~~~~~i~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei 266 (287)
T d1opja_ 220 IDLSQVYELLEKD-YR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266 (287)
T ss_dssp CCHHHHHHHHHTT-CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred chHHHHHHHHhcC-CC-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 6666666555443 33 33457899999999999999999999994433
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=456.54 Aligned_cols=260 Identities=24% Similarity=0.376 Sum_probs=219.1
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 753 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk-----~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~g 753 (1091)
++.+..++|++.+.||+|+||+||+|+++.+++ .||+|.+.+.. .......+.+|+.+|.++ +|||||++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 445667899999999999999999999876654 69999886532 234456789999999998 8999999999
Q ss_pred eeccCCeeEEEEeecCCCcHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 001370 754 SFTCRDNLYLVMEYLNGGDLYSLLRKV-----------------------GCLEEDVARIYIAELVLALEYLHSLGIVHR 810 (1091)
Q Consensus 754 sfqded~LYLVMEYm~GGSL~dlL~k~-----------------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHR 810 (1091)
+|.+.+.+|+|||||+||+|.++|++. +.+++..++.|+.||+.||.|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 999999999999999999999999754 248999999999999999999999999999
Q ss_pred ccCCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCC
Q 001370 811 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 890 (1091)
Q Consensus 811 DLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Y 890 (1091)
||||+|||++.+|++||+|||+|+..... .......+.+||+.|||||++.+..|
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSD-------------------------SNYVVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGC-------------------------TTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred cCchhccccccCCeEEEeeccccccccCC-------------------------CceeeeccccCCCccCChHHHcCCCC
Confidence 99999999999999999999999853211 00112235678999999999999999
Q ss_pred CccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 891 GYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 891 s~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
+.++|||||||+||||++ |.+||.+.+....+.+++.....++ .|..+|+++++||.+||+.||++||| +.||++
T Consensus 244 ~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPt---~~ei~~ 319 (325)
T d1rjba_ 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPS---FPNLTS 319 (325)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred CcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-CCCcCCHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 999999999999999997 8999999887777777777665533 46789999999999999999999999 556654
Q ss_pred C
Q 001370 970 H 970 (1091)
Q Consensus 970 H 970 (1091)
|
T Consensus 320 ~ 320 (325)
T d1rjba_ 320 F 320 (325)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=451.11 Aligned_cols=259 Identities=32% Similarity=0.480 Sum_probs=215.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded----- 759 (1091)
.+.|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 478999999999999999999999999999999997643 35556788999999999999999999999998765
Q ss_pred -eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 -~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+|+||||+ |++|..+++ .+.|++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 479999999 557777664 5679999999999999999999999999999999999999999999999999998521
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+
T Consensus 173 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 173 -----------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp -----------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----------------------------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 112356899999999999874 56899999999999999999999999887
Q ss_pred hHHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 918 PEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 918 ~~ei~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
.......+... ...++.+...+++++.|||.+||+.||.+||| |.|+|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~eiL~ 300 (346)
T d1cm8a_ 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEALA 300 (346)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHHH
T ss_pred hHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC---HHHHhc
Confidence 76665544321 11222234578999999999999999999999 889999
Q ss_pred CCCCCCCCcc
Q 001370 970 HPFFKGVNWD 979 (1091)
Q Consensus 970 HPFFkgIdWd 979 (1091)
||||+++.+.
T Consensus 301 Hp~f~~~~~~ 310 (346)
T d1cm8a_ 301 HPYFESLHDT 310 (346)
T ss_dssp SGGGTTTC--
T ss_pred ChhhCcCCCc
Confidence 9999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=445.26 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=217.0
Q ss_pred EeeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 001370 692 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 769 (1091)
Q Consensus 692 r~LGkGgFGtVyLar~k~--TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLVMEYm~ 769 (1091)
+.||+|+||+||+|.++. +++.||||+++... ......+.+.+|+.+|++++|||||++++++.+ +.+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 479999999999998653 56789999997543 334456789999999999999999999999865 46799999999
Q ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccCCCCCC
Q 001370 770 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 849 (1091)
Q Consensus 770 GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t 849 (1091)
||+|.+++.+...+++..+..++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~--------- 161 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------- 161 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC---------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc---------
Confidence 99999999998899999999999999999999999999999999999999999999999999998532100
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 001370 850 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 928 (1091)
Q Consensus 850 ~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~ 928 (1091)
..........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..++...+.++
T Consensus 162 ---------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~ 226 (277)
T d1xbba_ 162 ---------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226 (277)
T ss_dssp ---------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred ---------------cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 00112234679999999999999999999999999999999998 99999999998888888765
Q ss_pred CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 929 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 929 ~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.. +..|..+|+++.+||.+||+.||.+||++.++.+.|+|+||.-+
T Consensus 227 ~~--~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 227 ER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp CC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CC--CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 32 33457899999999999999999999997777777888887543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=445.42 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=211.7
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
|.+..++|++.+.||+|+||+||+|+++ ..||||+++.... .....+.+.+|+.+|.+++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4567789999999999999999999754 3599999976433 4456788999999999999999999998764 467
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
+|+|||||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999999765 56999999999999999999999999999999999999999999999999999753110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC---CCCCccceeechhhhHHHHHhCCCCCCCC
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE 916 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~Ys~ksDIWSLGVILYEMLTGkpPF~~~ 916 (1091)
.......+.+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.
T Consensus 158 -------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 158 -------------------------SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp ---------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------------------------CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 01122345689999999999975 35899999999999999999999999987
Q ss_pred ChHHHHHHHhhcCCCCC---CCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 917 SPEIIFDNILNRKIPWP---CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP---~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+.......++......| .++..+++++.+||.+||..||.+||| +.+|++|
T Consensus 213 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~~il~~ 266 (276)
T d1uwha_ 213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL---FPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred ChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 76655555554433222 345788999999999999999999999 5566544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=435.79 Aligned_cols=251 Identities=21% Similarity=0.370 Sum_probs=209.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|+.++.+++|||||++++++...+.+|+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 3578999999999999999999986 577899999976432 23568999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~--- 154 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--- 154 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC---
Confidence 99999999999998765 56899999999999999999999999999999999999999999999999999853110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei 921 (1091)
.........||+.|||||++.+..|+.++|||||||++|||++ |.+||...+..++
T Consensus 155 -----------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~ 211 (263)
T d1sm2a_ 155 -----------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211 (263)
T ss_dssp ---------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH
T ss_pred -----------------------CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH
Confidence 0112234679999999999999999999999999999999999 6888888888888
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
...+..+... ..|..+++++.+||.+||+.||.+||+ +.+|++|
T Consensus 212 ~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~~p~~Rps---~~~il~~ 255 (263)
T d1sm2a_ 212 VEDISTGFRL--YKPRLASTHVYQIMNHCWKERPEDRPA---FSRLLRQ 255 (263)
T ss_dssp HHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhcCCC--CCccccCHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 8888775432 235788999999999999999999999 6666654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=445.28 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=224.6
Q ss_pred ccCCCeEEEEe-eccCCceEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKP-ISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~-LGkGgFGtVyLar~k~T--Gk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
+..++|.+... ||+|+||+||+|.++.+ +..||||++++. ......+.+.+|+++|.+++|||||++++++.+ +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 34467888885 99999999999987654 457999999763 244567889999999999999999999999875 5
Q ss_pred eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+|||||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 689999999999999998654 5799999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s 917 (1091)
.. .........+||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+
T Consensus 162 ~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 162 DD------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CS------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc------------------------cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 10 00112234579999999999999999999999999999999998 999999998
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
..++...|.++.. +..|..+|+++.+||.+||..||++||++.++.+.|+|+|+.
T Consensus 218 ~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 218 GPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp THHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 8888888876543 334578999999999999999999999988888889998873
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=443.22 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=207.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk---~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
...++|++.+.||+|+||+||+|+++.+|+ .||||.+.... .....+.+.+|+.+|++++|||||++++++...+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 345789999999999999999999987765 58888876532 3455678999999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999988764 5699999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s 917 (1091)
.... ..........||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+
T Consensus 181 ~~~~----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 181 DTSD----------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp -------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCc----------------------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 1000 00111223568999999999999999999999999999999998 899999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
..++...+..+.. +..+..++.++.+||.+||+.||.+||++.+
T Consensus 239 ~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 282 (299)
T d1jpaa_ 239 NQDVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282 (299)
T ss_dssp HHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 9988888876532 2235789999999999999999999999543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=442.55 Aligned_cols=264 Identities=28% Similarity=0.383 Sum_probs=217.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-------
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------- 757 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd------- 757 (1091)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5899999999999999999999999999999999976433 33455778999999999999999999998865
Q ss_pred -CCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 758 -RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 758 -ed~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
...+|+||||+.++.+..+......+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999998887776666778999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
..... .......+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+
T Consensus 168 ~~~~~-----------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 168 SLAKN-----------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp CC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccc-----------------------cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 21100 111223456899999999999865 689999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCC-CC----------------------------CCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 916 ESPEIIFDNILNRKIPWPC-VP----------------------------SDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~-ip----------------------------~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
.+.......+......++. .. ...+++++|||.+||++||++||| |.|
T Consensus 225 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s---a~e 301 (318)
T d3blha1 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---SDD 301 (318)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC---HHH
T ss_pred CCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC---HHH
Confidence 8887777666542111110 00 013778899999999999999999 889
Q ss_pred HHcCCCCCC
Q 001370 967 VKAHPFFKG 975 (1091)
Q Consensus 967 IL~HPFFkg 975 (1091)
+|+||||+.
T Consensus 302 lL~Hpff~~ 310 (318)
T d3blha1 302 ALNHDFFWS 310 (318)
T ss_dssp HHHSGGGSS
T ss_pred HHcChhhcc
Confidence 999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=439.35 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=218.4
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
.+.+..++|++++.||+|+||+||+|+++ ++..||||++++... ..+.+.+|+.+|.+++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 44566789999999999999999999986 578899999976432 34679999999999999999999998754 5
Q ss_pred eeEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~--g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 689999999999999987543 369999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.. .........||+.|||||++.+..|+.++|||||||++|||+| |.+||...
T Consensus 161 ~~--------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 161 DN--------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp SS--------------------------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CC--------------------------ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 10 1112234679999999999999999999999999999999999 56777788
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc--CCCCC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFFK 974 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~--HPFFk 974 (1091)
+..++...+..+.. +..|..+++++.+||.+||+.||++||| +.+|++ |+||.
T Consensus 215 ~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rpt---~~ei~~~L~~~ft 269 (272)
T d1qpca_ 215 TNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPT---FDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCC--CCCcccChHHHHHHHHHHcCCCHhHCcC---HHHHHHHhhhhhh
Confidence 88888888776532 2345789999999999999999999999 555555 56764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=428.99 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=224.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYLV 764 (1091)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+...+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 368999999999999999999999999999999997644 3455678899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 765 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 765 MEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|+|+.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~------ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI------ 153 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC------
Confidence 99999999999999888999999999999999999999999999999999999999999999999999985311
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCCC-CCCChHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 922 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDIWSLGVILYEMLTGkpPF-~~~s~~ei~ 922 (1091)
.........+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+.+
T Consensus 154 ---------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~ 212 (292)
T d1unla_ 154 ---------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_dssp ---------------------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred ---------------------CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH
Confidence 111223456889999999998765 689999999999999999999885 556666666
Q ss_pred HHHhhcC--------------------------CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCC
Q 001370 923 DNILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 976 (1091)
Q Consensus 923 ~kIl~~~--------------------------l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgI 976 (1091)
.++.... .........+++++.+||.+||+.||.+||| |.|+|+||||+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s---a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGSSC
T ss_pred HHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC---HHHHhcChhhcCC
Confidence 6554310 0111133567899999999999999999999 8899999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-51 Score=442.96 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=212.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc--CCe
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--RDN 760 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqd--ed~ 760 (1091)
..++|++++.||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+++|..+. ||||++++++|.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 347899999999999999999999999999999999753 2457889999999995 9999999999874 456
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~~~~ 839 (1091)
+|+|||||.+|+|..+. ..+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~-- 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-- 181 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC--
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc--
Confidence 99999999999997653 4699999999999999999999999999999999999999755 69999999998531
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCC-CCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
........+||+.|+|||++.+. .|+.++|||||||++|||++|..||.....
T Consensus 182 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 182 --------------------------PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp --------------------------TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred --------------------------CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 01123456899999999998864 579999999999999999999999976542
Q ss_pred -HHHHHHHhh-------------cCC---------------------CCCCCCCCCCHHHHHHHhhhccCCCCCCCCccc
Q 001370 919 -EIIFDNILN-------------RKI---------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 919 -~ei~~kIl~-------------~~l---------------------~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
.+....+.. ... ........++++++|||++||++||.+|||
T Consensus 236 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t--- 312 (328)
T d3bqca1 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT--- 312 (328)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred hHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC---
Confidence 222221110 000 000112347899999999999999999999
Q ss_pred HHHHHcCCCCCCCCcc
Q 001370 964 AAEVKAHPFFKGVNWD 979 (1091)
Q Consensus 964 A~EIL~HPFFkgIdWd 979 (1091)
|.|+|+||||+++.|+
T Consensus 313 a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 313 AREAMEHPYFYTVVKD 328 (328)
T ss_dssp HHHHHTSGGGTTSCCC
T ss_pred HHHHhcCcccCCCCCC
Confidence 8899999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=443.61 Aligned_cols=252 Identities=31% Similarity=0.460 Sum_probs=211.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------CCe
Q 001370 687 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------RDN 760 (1091)
Q Consensus 687 dFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd------ed~ 760 (1091)
+|+.+++||+|+||+||+|+++.+|+.||||++++.... ..+|+.+|++++|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 699999999999999999999999999999999764322 2469999999999999999999853 335
Q ss_pred eEEEEeecCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC-cEEEEecCCcccc
Q 001370 761 LYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIG 836 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL---~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG-~VKLsDFGLAk~~ 836 (1091)
+|||||||++|.+..+. .....+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+++..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999876444333 3445799999999999999999999999999999999999999876 8999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcC-CCCCccceeechhhhHHHHHhCCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~Ys~ksDIWSLGVILYEMLTGkpPF~~ 915 (1091)
. ......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||..
T Consensus 174 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 174 V----------------------------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp C----------------------------TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred c----------------------------CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 1 1122345689999999999875 5789999999999999999999999999
Q ss_pred CChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc
Q 001370 916 ESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 969 (1091)
Q Consensus 916 ~s~~ei~~kIl~~-----------------~l~fP~---------ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~ 969 (1091)
.+..+.+..|+.. ...++. ....+++++.+||.+||++||++||| |.|+|+
T Consensus 226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L~ 302 (350)
T d1q5ka_ 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PLEACA 302 (350)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHT
T ss_pred CCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC---HHHHhc
Confidence 8887777666531 111121 12457899999999999999999999 889999
Q ss_pred CCCCCCC
Q 001370 970 HPFFKGV 976 (1091)
Q Consensus 970 HPFFkgI 976 (1091)
||||+++
T Consensus 303 Hp~f~~~ 309 (350)
T d1q5ka_ 303 HSFFDEL 309 (350)
T ss_dssp SGGGGGG
T ss_pred CHhhccc
Confidence 9999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-51 Score=430.33 Aligned_cols=251 Identities=21% Similarity=0.350 Sum_probs=220.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~LYL 763 (1091)
..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+++|+.++.+++|||||+++++|.+++.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 3579999999999999999999985 688999999987543 23568999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccc
Q 001370 764 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 842 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k-~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~ 842 (1091)
||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--- 153 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--- 153 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS---
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC---
Confidence 9999999999999764 457999999999999999999999999999999999999999999999999999753110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCChHHH
Q 001370 843 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 921 (1091)
Q Consensus 843 dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~~ei 921 (1091)
.........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++
T Consensus 154 -----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~ 210 (258)
T d1k2pa_ 154 -----------------------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210 (258)
T ss_dssp -----------------------SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred -----------------------CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH
Confidence 1112234679999999999999999999999999999999998 8999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 922 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 922 ~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
..++.++.. +..|...++++++||.+||+.||++||| +.+|++|
T Consensus 211 ~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 254 (258)
T d1k2pa_ 211 AEHIAQGLR--LYRPHLASEKVYTIMYSCWHEKADERPT---FKILLSN 254 (258)
T ss_dssp HHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhCCC--CCCcccccHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 988877542 2246789999999999999999999999 6777765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=429.10 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=209.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~TG---k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
.+..++|++.+.||+|+||+||+|++..++ ..||||.++.. ......+.+.+|+.+|++++|||||++++++. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 345578999999999999999999987654 46888887643 24455678999999999999999999999996 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+.+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 6789999999999999987654 569999999999999999999999999999999999999999999999999998531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
. .........+||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 160 ~--------------------------~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 160 D--------------------------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp -------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred C--------------------------CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 1 01112334678999999999999999999999999999999998 89999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
+..+++.++.++.. +.++..+|+++.+||.+||..||.+||| +.+|++|
T Consensus 214 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ei~~~ 262 (273)
T d1mp8a_ 214 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPR---FTELKAQ 262 (273)
T ss_dssp CGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 99999998887643 2345789999999999999999999999 6666654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=441.05 Aligned_cols=261 Identities=28% Similarity=0.471 Sum_probs=214.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----ee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----NL 761 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded----~L 761 (1091)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+++|+.+|++++|||||++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46999999999999999999999999999999997643 3455678999999999999999999999987654 23
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccccc
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 841 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s 841 (1091)
+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~- 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH- 163 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG-
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC-
Confidence 555566779999999965 469999999999999999999999999999999999999999999999999998532111
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhc-CCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 842 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 842 ~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.........+||+.|+|||++. +..|+.++||||+||++|||++|++||.+.+..+
T Consensus 164 -----------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 164 -----------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp -----------------------CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH
Confidence 0112234578999999999985 4578999999999999999999999999888766
Q ss_pred HHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCC
Q 001370 921 IFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 972 (1091)
Q Consensus 921 i~~kIl~~----------------------------~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPF 972 (1091)
....+... ..++......+++++++||.+||++||.+||+ |.++|+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---a~e~L~hpf 297 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAHPY 297 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGG
T ss_pred HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHh
Confidence 65554321 01111123467899999999999999999999 889999999
Q ss_pred CCCC
Q 001370 973 FKGV 976 (1091)
Q Consensus 973 FkgI 976 (1091)
|+..
T Consensus 298 ~~~~ 301 (345)
T d1pmea_ 298 LEQY 301 (345)
T ss_dssp GTTT
T ss_pred hccC
Confidence 9754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=438.87 Aligned_cols=257 Identities=30% Similarity=0.419 Sum_probs=216.5
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 759 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded----- 759 (1091)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+++|+.++|||||+++++|....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 468999999999999999999999999999999998643 34455678899999999999999999999987443
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
..++||+|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+|++|||++...
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~--- 171 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--- 171 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC---
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc---
Confidence 35677788889999999854 57999999999999999999999999999999999999999999999999998742
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC-CCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
.....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.
T Consensus 172 ---------------------------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 172 ---------------------------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp ---------------------------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------------------------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 11234568999999999987754 58999999999999999999999999988
Q ss_pred HHHHHHHhhcCCCC-----------------------CC-----CCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 919 EIIFDNILNRKIPW-----------------------PC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 919 ~ei~~kIl~~~l~f-----------------------P~-----ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
......|....... +. ....++++++|||.+||+.||.+||| |.|+|+|
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~elL~H 301 (348)
T d2gfsa1 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALAH 301 (348)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTS
T ss_pred HHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC---HHHHhcC
Confidence 77777765421111 10 12467899999999999999999999 8899999
Q ss_pred CCCCCC
Q 001370 971 PFFKGV 976 (1091)
Q Consensus 971 PFFkgI 976 (1091)
|||+..
T Consensus 302 p~f~~~ 307 (348)
T d2gfsa1 302 AYFAQY 307 (348)
T ss_dssp GGGTTT
T ss_pred HhhCCC
Confidence 999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=424.99 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=208.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TG----k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
+..+.|++.++||+|+||+||+|.++.++ ..||||+++... .......+++|+.+|.+++|||||++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 45678999999999999999999987665 479999987532 344556789999999999999999999999999
Q ss_pred CeeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
+.+|+|||||.+|+|.+++.+. +.+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999999988765 579999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
... ..........||+.|||||++.+..|+.++|||||||++|||++ |.+||...
T Consensus 162 ~~~------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 162 DDP------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp ------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCC------------------------ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 110 00112234568999999999999999999999999999999999 46666777
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccH
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 964 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA 964 (1091)
+..+++..+..+. . +..+..++.++.+||.+||..||++||++.++
T Consensus 218 ~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 218 SNHEVMKAINDGF-R-LPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp CHHHHHHHHHTTC-C-CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CHHHHHHHHhccC-C-CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence 7777877776553 2 23457899999999999999999999994433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=429.68 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=206.2
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 754 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gs 754 (1091)
+.+..++|++.+.||+|+||+||+|++.. +++.||||++++.. .....+.+.+|..++.++ +|||||.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 34556889999999999999999999754 44689999997533 344566788888888777 58999999998
Q ss_pred eccC-CeeEEEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCce
Q 001370 755 FTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 817 (1091)
Q Consensus 755 fqde-d~LYLVMEYm~GGSL~dlL~k~----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNI 817 (1091)
+... ..+|+|||||+||+|.++|... ..+++..+..|+.||+.||.|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 7654 4689999999999999999753 2488999999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceee
Q 001370 818 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 897 (1091)
Q Consensus 818 LLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIW 897 (1091)
||+.+|++||+|||+|+..... .........+||+.|||||++.+..|+.++|||
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 220 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220 (299)
T ss_dssp EECGGGCEEECC------CCSC-------------------------TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred eECCCCcEEEccCcchhhcccc-------------------------ccccccCceeeCccccchhHhhcCCCCccccee
Confidence 9999999999999999853110 011123456899999999999999999999999
Q ss_pred chhhhHHHHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 898 SVGIILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 898 SLGVILYEMLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
||||++|||++| .+||.+.+..+.+..++..... +..+..+++++++||.+||+.||.+||| +.++++|
T Consensus 221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~eil~~ 290 (299)
T d1ywna1 221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 290 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 999999999986 5789887765555555554433 3356789999999999999999999999 6676665
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-50 Score=439.13 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=209.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------C
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------R 758 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd------e 758 (1091)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|++++|||||+++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 478999999999999999999999999999999998643 345567789999999999999999999999964 4
Q ss_pred CeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..+|+|||||.||.+ +.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~- 170 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 170 (355)
T ss_dssp CEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc-
Confidence 679999999977544 444 3569999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCCh
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 918 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~ 918 (1091)
........+||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+.
T Consensus 171 ---------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 171 ---------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp -------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence 11223456899999999999999999999999999999999999999999887
Q ss_pred HHHHHHHhhc----------------------CCCCCCC-----------------CCCCCHHHHHHHhhhccCCCCCCC
Q 001370 919 EIIFDNILNR----------------------KIPWPCV-----------------PSDMSFEAQDLINRFLIHDPNQRL 959 (1091)
Q Consensus 919 ~ei~~kIl~~----------------------~l~fP~i-----------------p~~lS~eakDLI~rcL~kDPeKRp 959 (1091)
.....+++.. ....... ...++++++|||++||+.||++||
T Consensus 224 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 303 (355)
T d2b1pa1 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc
Confidence 7766655421 1111000 012467899999999999999999
Q ss_pred CcccHHHHHcCCCCCCCCc
Q 001370 960 GANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 960 Sa~gA~EIL~HPFFkgIdW 978 (1091)
| |.|+|+||||+..-+
T Consensus 304 t---a~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 304 S---VDDALQHPYINVWYD 319 (355)
T ss_dssp C---HHHHHTSTTTGGGCC
T ss_pred C---HHHHhcCcccCCCCC
Confidence 9 889999999986433
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-50 Score=428.84 Aligned_cols=258 Identities=22% Similarity=0.358 Sum_probs=220.9
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 001370 682 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 756 (1091)
Q Consensus 682 ~~~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfq 756 (1091)
....++|++++.||+|+||+||+|+++. +++.||||++++.. .......+.+|+.+|++++||||+++++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 3456789999999999999999999763 56789999987532 3445678999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCcHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccc
Q 001370 757 CRDNLYLVMEYLNGGDLYSLLRKVG------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDL 812 (1091)
Q Consensus 757 ded~LYLVMEYm~GGSL~dlL~k~g------------------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDL 812 (1091)
..+.+++||||+++|+|.+++.... .+++..+..++.||+.||+|||++|||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999996532 3889999999999999999999999999999
Q ss_pred CCCceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCc
Q 001370 813 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY 892 (1091)
Q Consensus 813 KPeNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ 892 (1091)
||+||||+.++++||+|||+|+..... .......+.+||+.|||||++.+..|+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSA-------------------------DYYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGG-------------------------GCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred cccceEECCCCcEEEccchhheeccCC-------------------------ccccccCCCCcCcCcCCHHHHccCCCCh
Confidence 999999999999999999999853211 1112234567999999999999999999
Q ss_pred cceeechhhhHHHHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 893 AADWWSVGIILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 893 ksDIWSLGVILYEMLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
++|||||||+||||++| .+||.+.+..++...+..+.. |.+|..+++++.+||.+||+.||.+|||+.++.+.|
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999998 478999999999988877653 445688999999999999999999999955544433
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=431.71 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=210.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~TGk----~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded 759 (1091)
..++|++++.||+|+||+||+|+++.+|+ .||+|.++.. ......+.+.+|+.+|.+++|||||++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 34689999999999999999999998887 4777776542 2334567899999999999999999999999864
Q ss_pred eeEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 838 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~ 838 (1091)
..++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 578899999999999988765 5799999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCC
Q 001370 839 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 917 (1091)
Q Consensus 839 ~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s 917 (1091)
.. .........||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+
T Consensus 164 ~~-------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 164 EE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TC-------------------------C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cc-------------------------ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 00 0112234579999999999999999999999999999999998 899999988
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 918 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 918 ~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
..++...+..+.. +..|..+++++.+||.+||..||.+||+ +.+|+.|
T Consensus 219 ~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 266 (317)
T d1xkka_ 219 ASEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 266 (317)
T ss_dssp GGGHHHHHHHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCcccCHHHHHHHHHhCCCChhhCcC---HHHHHHH
Confidence 8888877766542 2235789999999999999999999999 6677776
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=426.99 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=215.7
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 758 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqde 758 (1091)
..+.+..++|++.+.||+|+||+||+|+++.+ +.||||++++... ..+.+.+|+.+|.+++|||||++|+++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 34456778999999999999999999998765 5799999975432 34678999999999999999999999865
Q ss_pred CeeEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccc
Q 001370 759 DNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 836 (1091)
Q Consensus 759 d~LYLVMEYm~GGSL~dlL~k--~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~ 836 (1091)
+.+|+||||+++|+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 568999999999999988864 357999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCC
Q 001370 837 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 915 (1091)
Q Consensus 837 ~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~ 915 (1091)
.. ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||..
T Consensus 164 ~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 164 ED--------------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp --------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cC--------------------------CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 11 01112234679999999999999999999999999999999999 5666777
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc--CCCCCCC
Q 001370 916 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFFKGV 976 (1091)
Q Consensus 916 ~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~--HPFFkgI 976 (1091)
.+..+++..+..+. ..| ++..+++++++||.+||+.||++||+ +.+|++ |+||...
T Consensus 218 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~Rps---~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 218 MVNREVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPT---FEYLQAFLEDYFTST 275 (285)
T ss_dssp CCHHHHHHHHHTTC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHTTTSCS
T ss_pred CCHHHHHHHHHhcC-CCC-CCcccCHHHHHHHHHHcccCHhHCcC---HHHHHHHHhhhhcCC
Confidence 77788887776543 222 46789999999999999999999999 556555 7788653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=426.09 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=210.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCC-C--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 001370 684 SIDDFEIIKPISRGAFGRVFLARKRTT-G--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 760 (1091)
Q Consensus 684 ~iddFeilr~LGkGgFGtVyLar~k~T-G--k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqded~ 760 (1091)
..++|++++.||+|+||+||+|++..+ + ..||||++++.........+.+.+|+.+|.+++|||||++|++|.+ +.
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 457899999999999999999987543 3 3689999987666566667889999999999999999999999976 57
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccccc
Q 001370 761 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 839 (1091)
Q Consensus 761 LYLVMEYm~GGSL~dlL~k~-g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~ 839 (1091)
+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 89999999999999887654 56999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCCCh
Q 001370 840 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 918 (1091)
Q Consensus 840 ~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~s~ 918 (1091)
. ..........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+.
T Consensus 165 ~------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~ 220 (273)
T d1u46a_ 165 D------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220 (273)
T ss_dssp C------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred C------------------------CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence 0 01112234568899999999999999999999999999999998 8999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 919 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 919 ~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
.++..++......++ .+..+|+++.+||.+||..||++|||+.++.++|
T Consensus 221 ~~~~~~i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 221 SQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp HHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999999888766543 4678999999999999999999999955555444
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=428.64 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=215.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 759 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~--VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~gsfqded 759 (1091)
+..++|++.+.||+|+||+||+|+++.+|.. ||||.+++. ......+.+.+|+++|.++ +|||||+++++|.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4568999999999999999999999988875 667766542 2344567799999999998 7999999999999999
Q ss_pred eeEEEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCC
Q 001370 760 NLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 823 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~----------------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG 823 (1091)
.+|+||||++||+|.++|++. ..+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999754 4699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhH
Q 001370 824 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 903 (1091)
Q Consensus 824 ~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVIL 903 (1091)
.+||+|||+|+.... ........||+.|+|||.+.+..|+.++|||||||++
T Consensus 165 ~~kl~DfG~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 165 VAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216 (309)
T ss_dssp CEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred ceEEccccccccccc----------------------------cccccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence 999999999974210 1122345799999999999999999999999999999
Q ss_pred HHHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 904 FEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 904 YEMLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
|||++| .+||.+.+..+++..+.++.. |..+..+++++++||.+||..||++||+ +.+|++|
T Consensus 217 ~ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 279 (309)
T d1fvra_ 217 WEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 279 (309)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 999996 578999999999998877532 3345789999999999999999999999 6677765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=419.65 Aligned_cols=243 Identities=26% Similarity=0.425 Sum_probs=207.2
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CC
Q 001370 681 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RD 759 (1091)
Q Consensus 681 e~~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd-ed 759 (1091)
|.+..++|++++.||+|+||.||+|+++ |..||||++++.. ..+.+.+|+++|++++|||||++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4567889999999999999999999985 7899999997632 34678999999999999999999998855 46
Q ss_pred eeEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCccccc
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g--~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~ 837 (1091)
.+|+||||+++|+|.++|.+.+ .+++..++.++.||+.||.|||+++||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 7899999999999999997653 58999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHh-CCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 916 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLT-GkpPF~~~ 916 (1091)
.......||+.|||||++.+..|+.++|||||||++|||++ |++||...
T Consensus 155 ------------------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 155 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ------------------------------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 11234568999999999999999999999999999999998 89999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcc
Q 001370 917 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 962 (1091)
Q Consensus 917 s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~ 962 (1091)
+..++...|.++.. |.++..+++++++||.+||..||.+||++.
T Consensus 205 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 248 (262)
T d1byga_ 205 PLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFL 248 (262)
T ss_dssp CGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcccCHhHCcCHH
Confidence 99999888876532 335678999999999999999999999944
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=420.23 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=215.9
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 751 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~TG-------k~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL 751 (1091)
++.+..++|++.+.||+|+||.||+|+...++ ..||||++++.. .......+.+|..++.++ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 35567789999999999999999999986654 379999997633 345567889999999888 79999999
Q ss_pred eeeeccCCeeEEEEeecCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCC
Q 001370 752 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 815 (1091)
Q Consensus 752 ~gsfqded~LYLVMEYm~GGSL~dlL~k~g----------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPe 815 (1091)
+++|.+++.+|+|||||.+|+|.++|.... .+++..+..++.||+.||+|||++|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999997543 4899999999999999999999999999999999
Q ss_pred ceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccce
Q 001370 816 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 895 (1091)
Q Consensus 816 NILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksD 895 (1091)
|||++.+|.+||+|||+++..... .........+||+.|||||++.+..|+.++|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D 219 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHI-------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGC-------------------------CTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred ceeecCCCCeEeccchhhcccccc-------------------------ccccccccCCCChhhhhhhHhcCCCCCchhh
Confidence 999999999999999999853210 0112234567999999999999999999999
Q ss_pred eechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHH
Q 001370 896 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 966 (1091)
Q Consensus 896 IWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~E 966 (1091)
||||||++|||++ |.+||.+.+...++..+.++. . +..|..+++++++||.+||++||.+|||+.++.+
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~-~-~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-R-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC-C-CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9999999999998 799999999988888776653 2 3346889999999999999999999999444433
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=422.14 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=221.6
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001370 679 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 752 (1091)
Q Consensus 679 ~ee~~~iddFeilr~LGkGgFGtVyLar~k-----~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL-~HPNIVkL~ 752 (1091)
.++.+..++|++.+.||+|+||+||+|+++ .+++.||||++++.. .......+.+|+.++..+ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 355677789999999999999999999863 456799999997643 345567899999999999 699999999
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCC
Q 001370 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 814 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GGSL~dlL~k~g------------------~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKP 814 (1091)
+++.+.+.+|+|||||+||+|.+++.+.. .+++..++.|+.||+.||.|||++|||||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 99999999999999999999999997643 589999999999999999999999999999999
Q ss_pred CceEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccc
Q 001370 815 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 894 (1091)
Q Consensus 815 eNILLD~nG~VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ks 894 (1091)
+|||++.++.+||+|||+++..... .........+||+.|||||++.+..|+.++
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSC-------------------------TTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred ccccccccCcccccccchheeccCC-------------------------CcceEeeecccChHHcCHHHhcCCCCCCcc
Confidence 9999999999999999999853210 001122346899999999999999999999
Q ss_pred eeechhhhHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHH
Q 001370 895 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 967 (1091)
Q Consensus 895 DIWSLGVILYEMLT-GkpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EI 967 (1091)
|||||||++|||++ |.+||.+.+..+.+.+++..... +..+..+++++.+||.+||+.||.+||++.++.++
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999998 77888887777777777665554 33467899999999999999999999995544433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=422.35 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=227.1
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001370 680 KERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 754 (1091)
Q Consensus 680 ee~~~iddFeilr~LGkGgFGtVyLar~k~-----TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gs 754 (1091)
.+.+..++|++.+.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.++++++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 456777999999999999999999998853 35789999997633 34556789999999999999999999999
Q ss_pred eccCCeeEEEEeecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCc
Q 001370 755 FTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 824 (1091)
Q Consensus 755 fqded~LYLVMEYm~GGSL~dlL~k~----------g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~ 824 (1091)
+..++.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+||||+.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999998643 24688999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHH
Q 001370 825 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 904 (1091)
Q Consensus 825 VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILY 904 (1091)
+||+|||+|+...... ........+||+.|||||.+.+..|+.++|||||||++|
T Consensus 172 ~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp EEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEEeecccceeccCCc-------------------------ceeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence 9999999998532110 111233457999999999999999999999999999999
Q ss_pred HHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHc---CCCCCCC
Q 001370 905 EFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKGV 976 (1091)
Q Consensus 905 EMLTG-kpPF~~~s~~ei~~kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~---HPFFkgI 976 (1091)
||++| .+||.+.+..+++..+.++.. +..+..+++.+.+||.+||+.||.+||++.++.+.|+ +|+|+.+
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 99998 589999999999998887653 4456889999999999999999999999444433332 6666543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=409.27 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=207.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCeeEEE
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPN-IVkL~gsfqded~LYLV 764 (1091)
+.|++.+.||+|+||+||+|+++.+|+.||||++..... ...+..|+++++.++|++ |+.+++++.+.+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 469999999999999999999999999999999876332 234788999999998665 55666777888889999
Q ss_pred EeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC---CCcEEEEecCCcccccccc
Q 001370 765 MEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINN 840 (1091)
Q Consensus 765 MEYm~GGSL~dlL~-k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~---nG~VKLsDFGLAk~~~~~~ 840 (1091)
|||+.+ +|...+. ..+.+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+......
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999955 6655554 4567999999999999999999999999999999999999864 4579999999998642111
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCChHH
Q 001370 841 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 920 (1091)
Q Consensus 841 s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s~~e 920 (1091)
.. .........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.......
T Consensus 161 ~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 161 TH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp TC--------------------CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred cc--------------------cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 10 0011223356789999999999999999999999999999999999999998766544
Q ss_pred HHHHHh---hcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCC
Q 001370 921 IFDNIL---NRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 974 (1091)
Q Consensus 921 i~~kIl---~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFk 974 (1091)
....+. ... .+.+.....+|+++.+||.+||..||.+||++..+.++++|+|.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 333221 111 122223367899999999999999999999987788888887653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=404.69 Aligned_cols=251 Identities=20% Similarity=0.259 Sum_probs=203.9
Q ss_pred EEEeeccCCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CCeeEEEE
Q 001370 690 IIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLYLVM 765 (1091)
Q Consensus 690 ilr~LGkGgFGtVyLar~k~TG---k~VAIKiLkK~~i~~~~eie~~l~EieILskL~HPNIVkL~gsfqd-ed~LYLVM 765 (1091)
+-++||+|+||+||+|++..++ ..||||++++ .......+.+.+|+++|.+++|||||++++++.. +..+|+||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3578999999999999987654 3699999975 3355667889999999999999999999998765 56899999
Q ss_pred eecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCCcccccccccccC
Q 001370 766 EYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 844 (1091)
Q Consensus 766 EYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~~~~~~s~dl 844 (1091)
|||++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||||+.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~--- 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--- 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC---
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc---
Confidence 9999999999987554 577888999999999999999999999999999999999999999999999985321110
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCC-CCChHHHHH
Q 001370 845 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT-AESPEIIFD 923 (1091)
Q Consensus 845 s~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~-~~s~~ei~~ 923 (1091)
..........||+.|+|||++.+..|+.++||||||++||||++|..||. ..+..++..
T Consensus 186 --------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~ 245 (311)
T d1r0pa_ 186 --------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245 (311)
T ss_dssp --------------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH
T ss_pred --------------------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 00112234579999999999999999999999999999999999666665 445556666
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHHcC
Q 001370 924 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 970 (1091)
Q Consensus 924 kIl~~~l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~H 970 (1091)
.+..+.. |..|..+++++.+||.+||..||++||+ +.||++|
T Consensus 246 ~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs---~~ei~~~ 287 (311)
T d1r0pa_ 246 YLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPS---FSELVSR 287 (311)
T ss_dssp HHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHcCCC--CCCcccCcHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 6666542 3356789999999999999999999999 6666655
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.1e-46 Score=397.18 Aligned_cols=258 Identities=20% Similarity=0.261 Sum_probs=209.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCeeEE
Q 001370 685 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 685 iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H-PNIVkL~gsfqded~LYL 763 (1091)
-++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+.+|++++..+.| +||+.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 368999999999999999999999999999999986532 22346788899999875 899999999999999999
Q ss_pred EEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecC-----CCcEEEEecCCccccc
Q 001370 764 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-----DGHIKLTDFGLSKIGL 837 (1091)
Q Consensus 764 VMEYm~GGSL~dlL~k~g-~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~-----nG~VKLsDFGLAk~~~ 837 (1091)
||||+ +|+|.+++...+ .+++..+..++.|++.||+|||++|||||||||+||||+. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 689999987654 6999999999999999999999999999999999999974 5789999999998642
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhhHHHHHhCCCCCCCCC
Q 001370 838 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 917 (1091)
Q Consensus 838 ~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVILYEMLTGkpPF~~~s 917 (1091)
..... .........+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+..
T Consensus 158 ~~~~~--------------------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 158 DPVTK--------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp CTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCccc--------------------cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 11000 0011123446789999999999999999999999999999999999999997653
Q ss_pred ---hHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHhhhccCCCCCCCCcccHHHHH
Q 001370 918 ---PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 968 (1091)
Q Consensus 918 ---~~ei~~kIl~~~--l~fP~ip~~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL 968 (1091)
....+.++.... .+.+.+...+|+++.+|+..|+..+|++||+...+.+++
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l 273 (293)
T d1csna_ 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273 (293)
T ss_dssp SCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred chhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 334444443322 122223357889999999999999999999865554443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=391.99 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=189.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH--HHHhcCCCceEEEeeeeccCC----
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN--ILITVRNPFVVRFFYSFTCRD---- 759 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~Eie--ILskL~HPNIVkL~gsfqded---- 759 (1091)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... ...+..|.+ .+..++|||||++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 4688999999999999999986 58999999986422 233444544 445789999999999998764
Q ss_pred eeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeecccCCCceEecCCCcEEEEecC
Q 001370 760 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFG 831 (1091)
Q Consensus 760 ~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs--------~GIIHRDLKPeNILLD~nG~VKLsDFG 831 (1091)
.+|+|||||++|+|.++|++. .+++.....++.|++.||.|||. +|||||||||+||||+.+|++||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 589999999999999999764 68999999999999999999996 599999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCC------CCccceeechhhhHHH
Q 001370 832 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFE 905 (1091)
Q Consensus 832 LAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~------Ys~ksDIWSLGVILYE 905 (1091)
+++....... .........+||+.|||||++.+.. |+.++|||||||+|||
T Consensus 154 l~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~e 210 (303)
T d1vjya_ 154 LAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp TCEEEETTTT-----------------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCc-----------------------ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHH
Confidence 9986421110 0011233568999999999997643 5778999999999999
Q ss_pred HHhCCCCCCCC---------------ChHHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHhhhccCCCCCCCCccc
Q 001370 906 FITGIPPFTAE---------------SPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANG 963 (1091)
Q Consensus 906 MLTGkpPF~~~---------------s~~ei~~kIl~~~l~fP~ip~~-----lS~eakDLI~rcL~kDPeKRpSa~g 963 (1091)
|+||.+||... ........+...... |.++.. ....+.+||.+||..||.+|||+.+
T Consensus 211 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 287 (303)
T d1vjya_ 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccC-CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 99999887432 123333333333332 322222 2346899999999999999999443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-44 Score=388.43 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=198.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCceEEEeee
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----------NPFVVRFFYS 754 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-----------HPNIVkL~gs 754 (1091)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++ |||||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 46999999999999999999999999999999998643 23456778888887765 5789999988
Q ss_pred eccC--CeeEEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecccCCCceEecCCCc----
Q 001370 755 FTCR--DNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGH---- 824 (1091)
Q Consensus 755 fqde--d~LYLVMEYm~GGSL~dlL~---k~g~LsE~~ar~yaaQIa~ALeYLHs-~GIIHRDLKPeNILLD~nG~---- 824 (1091)
+... ...+++|+++..+....... ....+++..++.++.||+.||.|||+ .||+||||||+||||+.+|.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 7643 56777777776655433332 33579999999999999999999998 89999999999999987664
Q ss_pred --EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCChhhhcCCCCCccceeechhhh
Q 001370 825 --IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 902 (1091)
Q Consensus 825 --VKLsDFGLAk~~~~~~s~dls~~~t~g~lps~~~~~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~Ys~ksDIWSLGVI 902 (1091)
+||+|||.++... ......+||+.|+|||++.+..|+.++|+|||||+
T Consensus 169 ~~~kl~dfg~s~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 218 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 218 (362)
T ss_dssp EEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred ceeeEeecccccccc------------------------------cccccccccccccChhhccccCCCccccccchHHH
Confidence 9999999987421 12245689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChH------HHHHHHhh--cC------------------C----CCC---------------CCCC
Q 001370 903 LFEFITGIPPFTAESPE------IIFDNILN--RK------------------I----PWP---------------CVPS 937 (1091)
Q Consensus 903 LYEMLTGkpPF~~~s~~------ei~~kIl~--~~------------------l----~fP---------------~ip~ 937 (1091)
+++|++|+.||...... +....++. +. . .++ ....
T Consensus 219 l~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (362)
T d1q8ya_ 219 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298 (362)
T ss_dssp HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred HHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCc
Confidence 99999999999754321 11111100 00 0 000 0112
Q ss_pred CCCHHHHHHHhhhccCCCCCCCCcccHHHHHcCCCCCCCCc
Q 001370 938 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 978 (1091)
Q Consensus 938 ~lS~eakDLI~rcL~kDPeKRpSa~gA~EIL~HPFFkgIdW 978 (1091)
..+++++|||.+||++||.+||| |.|+|+||||+++.+
T Consensus 299 ~~~~~~~dll~~mL~~dP~~Rpt---a~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 299 DEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDTLG 336 (362)
T ss_dssp HHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTCTT
T ss_pred ccCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccCCCCC
Confidence 34678999999999999999999 889999999996643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.1e-24 Score=214.67 Aligned_cols=135 Identities=21% Similarity=0.179 Sum_probs=107.5
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc---------------chhHHHHHHHHHHHHHhcCCCceEEEe
Q 001370 688 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI---------------RKNDIERILAERNILITVRNPFVVRFF 752 (1091)
Q Consensus 688 Feilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~---------------~~~eie~~l~EieILskL~HPNIVkL~ 752 (1091)
+.+.+.||+|+||+||+|++. +|+.||||+++..... .......+.+|...|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 357899999999999999985 6899999987532110 011223456788899999999999887
Q ss_pred eeeccCCeeEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecccCCCceEecCCCcEEEEecCC
Q 001370 753 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 832 (1091)
Q Consensus 753 gsfqded~LYLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs~GIIHRDLKPeNILLD~nG~VKLsDFGL 832 (1091)
++.. .++||||++++.+. .++...+..++.|++.||.|||++||+||||||+|||+++++ ++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 6532 37999999986653 255666778999999999999999999999999999998654 89999999
Q ss_pred ccc
Q 001370 833 SKI 835 (1091)
Q Consensus 833 Ak~ 835 (1091)
|+.
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.21 E-value=2.2e-06 Score=86.55 Aligned_cols=143 Identities=13% Similarity=0.102 Sum_probs=93.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 001370 683 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 761 (1091)
Q Consensus 683 ~~iddFeilr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqded~L 761 (1091)
..+..|++.+..+.++.+.||++. ..++.+.+|+...... .....+.+|..+|..+. +--+.+++++...++..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 345678888876666668999885 3466788887764322 12334677888877664 32355666777778889
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 001370 762 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS------------------------------------- 804 (1091)
Q Consensus 762 YLVMEYm~GGSL~dlL~k~g~LsE~~ar~yaaQIa~ALeYLHs------------------------------------- 804 (1091)
|+||++++|.++....... .....++.++...|..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999999998775443110 0111122233333333331
Q ss_pred ----------------c------CCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 ----------------L------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 ----------------~------GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
. .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 279999999999999776677999998874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=2.3e-05 Score=85.61 Aligned_cols=81 Identities=25% Similarity=0.279 Sum_probs=49.6
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecc-cccc---hhHHHHHHHHHHHHHhcC-C--CceEEEeeeeccCCeeEE
Q 001370 691 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-DMIR---KNDIERILAERNILITVR-N--PFVVRFFYSFTCRDNLYL 763 (1091)
Q Consensus 691 lr~LGkGgFGtVyLar~k~TGk~VAIKiLkK~-~i~~---~~eie~~l~EieILskL~-H--PNIVkL~gsfqded~LYL 763 (1091)
.+.||.|....||++....+|+.|++|.-... .... .....+...|...|..+. + ..+.++|++ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999988777888999964321 1110 112345567887776653 2 345566544 4455689
Q ss_pred EEeecCCCcH
Q 001370 764 VMEYLNGGDL 773 (1091)
Q Consensus 764 VMEYm~GGSL 773 (1091)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.55 E-value=7e-05 Score=74.83 Aligned_cols=140 Identities=14% Similarity=0.109 Sum_probs=83.0
Q ss_pred eEEEEeeccCC-ceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccCCeeEEE
Q 001370 688 FEIIKPISRGA-FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLV 764 (1091)
Q Consensus 688 Feilr~LGkGg-FGtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~--HPNIVkL~gsfqded~LYLV 764 (1091)
++.. .+..|. -+.||++.. ..+..+.+|.-.... ...+..|...|..+. .-.+.+++.+..+.+..|+|
T Consensus 13 ~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 13 YDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 4443 344444 468998875 456678889765422 223566777776654 22356677777888889999
Q ss_pred EeecCCCcHHH--------------HHHhcC-------CCC--HHHH-----HHH---------------HHHHHHHHHH
Q 001370 765 MEYLNGGDLYS--------------LLRKVG-------CLE--EDVA-----RIY---------------IAELVLALEY 801 (1091)
Q Consensus 765 MEYm~GGSL~d--------------lL~k~g-------~Ls--E~~a-----r~y---------------aaQIa~ALeY 801 (1091)
|+|++|-++.. .|.+.. .+. .... ..+ .......+..
T Consensus 85 ~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 85 LGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp EECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred EEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 99999865421 111110 010 0000 000 0011222333
Q ss_pred HHHc-------CCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 802 LHSL-------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 802 LHs~-------GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
+..+ .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3332 379999999999999876678999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.48 E-value=0.0037 Score=65.69 Aligned_cols=129 Identities=15% Similarity=0.235 Sum_probs=73.4
Q ss_pred eEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---C--ceEEEe--eeeccCCeeEEEEeecCCCc
Q 001370 700 GRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---P--FVVRFF--YSFTCRDNLYLVMEYLNGGD 772 (1091)
Q Consensus 700 GtVyLar~k~TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~H---P--NIVkL~--gsfqded~LYLVMEYm~GGS 772 (1091)
-.||+++. .+|..|++|+.+... ...+.+..|...|..+.. | ..+..- ..+......+.|+++++|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 57999975 468889999986532 123456678877766541 1 111111 12234556789999998743
Q ss_pred HH-----------HH---HHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH------
Q 001370 773 LY-----------SL---LRK----------------------------VGCLEEDVARIYIAELVLALEYLHS------ 804 (1091)
Q Consensus 773 L~-----------dl---L~k----------------------------~g~LsE~~ar~yaaQIa~ALeYLHs------ 804 (1091)
+. .. ++. ...++......+...+-..++.+..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 20 00 110 0111122222233333333444432
Q ss_pred -cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 -LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 -~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.++||+|+.|.|||++. | ..++||+-|..
T Consensus 191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 26899999999999974 4 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.14 E-value=0.0093 Score=64.12 Aligned_cols=78 Identities=18% Similarity=0.290 Sum_probs=51.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc
Q 001370 686 DDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC 757 (1091)
Q Consensus 686 ddFeilr~LGkGgFGtVyLar~k~-------TGk~VAIKiLkK~~i~~~~eie~~l~EieILskL~-HPNIVkL~gsfqd 757 (1091)
+++++ +.|+.|-.-.+|++.... .++.|.+++.-... .. ....+|..+++.+. +.-..+++++|..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34544 568888888999998753 24567777765321 12 23457888888775 4444577777753
Q ss_pred CCeeEEEEeecCCCcH
Q 001370 758 RDNLYLVMEYLNGGDL 773 (1091)
Q Consensus 758 ed~LYLVMEYm~GGSL 773 (1091)
.+||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 689999988543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.22 E-value=0.063 Score=54.94 Aligned_cols=31 Identities=32% Similarity=0.438 Sum_probs=27.8
Q ss_pred cCCeecccCCCceEecCCCcEEEEecCCccc
Q 001370 805 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 835 (1091)
Q Consensus 805 ~GIIHRDLKPeNILLD~nG~VKLsDFGLAk~ 835 (1091)
.|+||+|+.++|||++.++..-|.||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999999874
|